Citrus Sinensis ID: 010856
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 499 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.859 | 0.424 | 0.386 | 3e-64 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.855 | 0.414 | 0.362 | 2e-62 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.841 | 0.409 | 0.385 | 2e-56 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.753 | 0.383 | 0.370 | 8e-55 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.829 | 0.352 | 0.340 | 6e-52 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.809 | 0.413 | 0.322 | 5e-49 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.821 | 0.352 | 0.305 | 2e-47 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.831 | 0.429 | 0.322 | 3e-47 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.845 | 0.403 | 0.299 | 8e-47 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.833 | 0.348 | 0.313 | 2e-46 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 246 bits (628), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 171/442 (38%), Positives = 238/442 (53%), Gaps = 13/442 (2%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC L + + N L G LP S+ NLS L + ISG IP +I NL N +
Sbjct: 332 LTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKL 390
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L N L+G +P +L KL L+ L L N+L G IP I ++ L LDL N G +P
Sbjct: 391 ILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVP 450
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
N + L + +G NKL ++PL ++ +L L+ S N L LP +IG L+ L +
Sbjct: 451 TSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTL 510
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
N SG +P +G +E LFL N G IPD G L+ +K ++LSNN+LSG+IP
Sbjct: 511 SLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIP 569
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSIH 298
S LE LNLSFN LEG++P G F N + S GN LCG Q+ PC +
Sbjct: 570 EYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAP 629
Query: 299 HTSWKN-SLLLRIVLPLST-------TFMIVVILLILRYQQRGKRPSNDANMPLVATWRT 350
K+ S L ++V+ +S FM V L+ LR +++ K +N L
Sbjct: 630 SVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEK 689
Query: 351 FSYLELFRATDEFSENNLIGKGGFGSVYKA-RLGDRMEVAVKVFNLQCGRAFESFDVECE 409
SY +L AT+ FS +N++G G FG+VYKA L ++ VAVKV N+Q A +SF ECE
Sbjct: 690 ISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECE 749
Query: 410 MMKNIRHRNLIKILHGVAVITF 431
+K+IRHRNL+K+L + I F
Sbjct: 750 SLKDIRHRNLVKLLTACSSIDF 771
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 163/450 (36%), Positives = 239/450 (53%), Gaps = 23/450 (5%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC L + + N L G LP S+ NLS +L + ISG IP +I NL + +
Sbjct: 340 VANCTQLEYLDVGYNRLGGELP-ASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQEL 398
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+L N L+G +P++ KL LQ + L N + G IP ++ L +L L+ N G +P
Sbjct: 399 SLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIP 458
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
L + + +N+L ++P + + ++ S+NFLT P E+G L++L+G+
Sbjct: 459 QSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGL 518
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
S N SG +P IGG ++E+LF+ N G+IPD L+SLK ++ SNNNLSG IP
Sbjct: 519 GASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIP 577
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSIH 298
L L L NLNLS NK EG +P G F N +A S GN +CG +Q+ PC
Sbjct: 578 RYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQAS 637
Query: 299 HT-----SWKNSLLLRIVLPLSTTFMIVVILLILRYQQRGKR-PSNDANMPLVATWRTF- 351
S + ++ I + +++ +I+++ + + +R K+ ++D N T F
Sbjct: 638 PRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFH 697
Query: 352 ---SYLELFRATDEFSENNLIGKGGFGSVYKARLGDRME-VAVKVFNLQCGRAFESFDVE 407
SY EL AT FS NLIG G FG+V+K LG + VAVKV NL A +SF E
Sbjct: 698 EKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAE 757
Query: 408 CEMMKNIRHRNLIKILHGVAVITFTVCLCL 437
CE K IRHRNL+K++ TVC L
Sbjct: 758 CETFKGIRHRNLVKLI--------TVCSSL 779
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 220 bits (561), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 168/436 (38%), Positives = 244/436 (55%), Gaps = 16/436 (3%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC L + + N L G LP + NLS L + + ISG IP I NL + +
Sbjct: 348 LTNCSQLQYLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTL 406
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+LG N L G +P +L +L +L+ + L N L G IP + +++ L L L N GS+P
Sbjct: 407 DLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIP 466
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+ + + L ++LG+NKL S+P L ++ LN S N L PL +IG LK L+ +
Sbjct: 467 SSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLAL 526
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N SG IP + +LE+L L N G IPD G L L+FL+LS NNLSG IP
Sbjct: 527 DVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIP 585
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSI- 297
+ S L+NLNLS N +G +P G F N SA S GN LCG P+LQ+ PC +
Sbjct: 586 EYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELP 645
Query: 298 -HHTSWKNSLLLRIVLPLSTTFMIVVILLILR-YQQRGK--RPSNDAN----MPLVATWR 349
H+S + + + + ++ ++ + ++ L Y+ R K R +N+ N P+ + +
Sbjct: 646 RRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYE 705
Query: 350 TFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRME-VAVKVFNLQCGR-AFESFDVE 407
SY EL++ T FS +NLIG G FG+V+K LG + + VA+KV NL C R A +SF E
Sbjct: 706 KISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL-CKRGAAKSFIAE 764
Query: 408 CEMMKNIRHRNLIKIL 423
CE + IRHRNL+K++
Sbjct: 765 CEALGGIRHRNLVKLV 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (547), Expect = 8e-55, Method: Compositional matrix adjust.
Identities = 145/391 (37%), Positives = 210/391 (53%), Gaps = 15/391 (3%)
Query: 45 GGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAE 104
G IP E+ L+ V L N L G IP+ L + +L L + N L GSIPD +L++
Sbjct: 335 GPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQ 394
Query: 105 LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLT-SVPL-TFWNLKDI-LNLNFSSNF 161
L RL L GN LSG++P +L I+ L N LT ++P+ NL+++ L LN SSN
Sbjct: 395 LRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNH 454
Query: 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL 221
L+ P+PLE+ + +++ +D S N SG IP ++G LE+L L N ++P S G L
Sbjct: 455 LSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQL 514
Query: 222 ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281
LK L++S N L+GAIP S ++ S L++LN SFN L G + GSF + ESF G+ L
Sbjct: 515 PYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSL 574
Query: 282 LCGSPNLQVPPCKTSIHHTSWKNSLLLRIVLPLSTTFMIVVI--------LLILRYQQRG 333
LCGS K + + LL I P+ F ++ L + ++
Sbjct: 575 LCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVE 634
Query: 334 KRPSNDANMPLVATWRTFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVF 393
+ N P + SY +L AT F+ ++LIG G FG VYK L + +VAVKV
Sbjct: 635 DEEKQNQNDP---KYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVL 691
Query: 394 NLQCGRAFE-SFDVECEMMKNIRHRNLIKIL 423
+ + F SF EC+++K RHRNLI+I+
Sbjct: 692 DPKTALEFSGSFKRECQILKRTRHRNLIRII 722
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (522), Expect = 6e-52, Method: Compositional matrix adjust.
Identities = 166/487 (34%), Positives = 232/487 (47%), Gaps = 73/487 (14%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
NC +L + +++N L G L K +G L L ++ +++G IP EI NL + I+ L
Sbjct: 453 NCSNLETLSVADNNLTGTL-KPLIGKL-QKLRILQVSYNSLTGPIPREIGNLKDLNILYL 510
Query: 63 GGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPAC 122
N G IP +S L LQGL + N LEG IP+++ + L LDL NK SG +PA
Sbjct: 511 HSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPAL 570
Query: 123 FSNLTSLRIVSLGSNKLT-SVP-----LTFWNLKDI---------------------LNL 155
FS L SL +SL NK S+P L+ N DI L L
Sbjct: 571 FSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYL 630
Query: 156 NFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 215
NFS+N LT +P E+G L+++ ID S N FSG IP + KN+ L N L G IP
Sbjct: 631 NFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIP 690
Query: 216 D-------------------------SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 250
D SFG++ L L+LS+NNL+G IP SL LS L++
Sbjct: 691 DEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKH 750
Query: 251 LNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC--KTSIHHTSWKNSLLL 308
L L+ N L+G +P G F N +A GN LCGS + PC K H S + ++L
Sbjct: 751 LKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVIL 809
Query: 309 RIV----------LPLSTTFMIVVILLILRYQQRGKRPSNDANMPLVATWRTFSYLELFR 358
I+ L + + P D+ + L + F EL +
Sbjct: 810 IILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKL----KRFEPKELEQ 865
Query: 359 ATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQ--CGRAFESFDVECEMMKNIRH 416
ATD F+ N+IG +VYK +L D +AVKV NL+ + + F E + + ++H
Sbjct: 866 ATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKH 925
Query: 417 RNLIKIL 423
RNL+KIL
Sbjct: 926 RNLVKIL 932
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 195 bits (496), Expect = 5e-49, Method: Compositional matrix adjust.
Identities = 145/449 (32%), Positives = 225/449 (50%), Gaps = 45/449 (10%)
Query: 12 LSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSI 71
L N L G +P SV L +L + +SG IP + NLT + + L NKL GSI
Sbjct: 266 LQGNQLSGKIP--SVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSI 323
Query: 72 PITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRI 131
P L + KL L L DN L G IP ++ L +L+ L++ N L G +P S+ T+L
Sbjct: 324 PPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNS 383
Query: 132 VSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI 190
+++ NK + ++P F L+ + LN SSN + P+P+E+ + L +D S N +G+I
Sbjct: 384 LNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGII 443
Query: 191 PTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS---- 246
P+ +G L++L + L N + G +P FG+L S+ ++LSNN++SG IP L +L
Sbjct: 444 PSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIIL 503
Query: 247 -YLEN------------------LNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 287
LEN LN+S N L G+IP+ +F FS +SF GN LCGS
Sbjct: 504 LRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGS-- 561
Query: 288 LQVPPCKTSIH--HTSWKNSLLLRIVLPLSTTFMIVVILLILRYQQRGKRPSNDANMPLV 345
PC S S + +L I + +I++++LI + P D ++
Sbjct: 562 WLNSPCHDSRRTVRVSISRAAILGIAI---GGLVILLMVLIAACRPHNPPPFLDGSLDKP 618
Query: 346 ATWRT------------FSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVF 393
T+ T Y ++ R T+ SE +IG G +VYK L + VA+K
Sbjct: 619 VTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRL 678
Query: 394 NLQCGRAFESFDVECEMMKNIRHRNLIKI 422
++ + F+ E EM+ +I+HRNL+ +
Sbjct: 679 YSHNPQSMKQFETELEMLSSIKHRNLVSL 707
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (483), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 156/510 (30%), Positives = 229/510 (44%), Gaps = 100/510 (19%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI--------- 51
+ CKSL I LS N L G++PK + L L D M+ N++GGIPE I
Sbjct: 422 LGKCKSLKTIDLSFNALTGLIPK-EIWTLPK-LSDLVMWANNLTGGIPESICVDGGNLET 479
Query: 52 ----------------SNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSI 95
S TN ++L N L G IP+ + KL+KL L L +N L G+I
Sbjct: 480 LILNNNLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNI 539
Query: 96 PDDICHLAELYRLDLDGNKLSGSLPACFSNLTSL-------------------------- 129
P ++ + L LDL+ N L+G+LP ++ L
Sbjct: 540 PSELGNCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAG 599
Query: 130 ---RIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNF 186
+ + +L P+ K + + +S +I +D S N
Sbjct: 600 GLVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSN--------GSMIYLDLSYNAV 651
Query: 187 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 246
SG IP G + L+ L LG+N L G+IPDSFG L ++ L+LS+N+L G +P SL LS
Sbjct: 652 SGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLS 711
Query: 247 YLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCK-----TSIHHTS 301
+L +L++S N L G IP GG F + N LCG P +PPC T H
Sbjct: 712 FLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVP---LPPCSSGSRPTRSHAHP 768
Query: 302 WKNSLLLRIVLPLSTTFMIVVILLILRYQQRG------KRPSNDANMPL----------- 344
K S+ + + +FM +V+L++ Y+ R +R ++P
Sbjct: 769 KKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSV 828
Query: 345 -------VATW----RTFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVF 393
VAT+ R ++ L AT+ FS +++IG GGFG VYKA+L D VA+K
Sbjct: 829 HEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKL 888
Query: 394 NLQCGRAFESFDVECEMMKNIRHRNLIKIL 423
G+ F E E + I+HRNL+ +L
Sbjct: 889 IQVTGQGDREFMAEMETIGKIKHRNLVPLL 918
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (482), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 146/453 (32%), Positives = 223/453 (49%), Gaps = 38/453 (8%)
Query: 12 LSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSI 71
L N L G +P+ V L +L + + ++G IP + NL+ + + L GNKL G I
Sbjct: 271 LQGNKLTGRIPE--VIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQI 328
Query: 72 PITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRI 131
P L + +L L L DN+L G IP ++ L +L+ L+L N L G +P+ S+ +L
Sbjct: 329 PPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQ 388
Query: 132 VSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI 190
++ N L+ +VPL F NL + LN SSN +P E+G++ L +D S NNFSG I
Sbjct: 389 FNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSI 448
Query: 191 PTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY--- 247
P +G L++L L L N L G++P FG+L S++ +++S N L+G IP L +L
Sbjct: 449 PLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINS 508
Query: 248 ---------------------LENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 286
L NLN+SFN L G IP +F FS SF GN LCG
Sbjct: 509 LILNNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCG-- 566
Query: 287 NLQVPPCKTSIHHTS-WKNSLLLRIVLPLSTTFMIVVILLILRYQQR------GKRPSND 339
N C S+ + + ++ +VL T ++ I + QQ+ K+P
Sbjct: 567 NWVGSICGPSLPKSQVFTRVAVICMVLGFITLICMIFIAVYKSKQQKPVLKGSSKQPEGS 626
Query: 340 ANMPLV-ATWRTFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG 398
+ ++ ++ ++ R T+ E +IG G +VYK +A+K Q
Sbjct: 627 TKLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYP 686
Query: 399 RAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431
F F+ E E + +IRHRN++ LHG A+ F
Sbjct: 687 SNFREFETELETIGSIRHRNIVS-LHGYALSPF 718
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 8e-47, Method: Compositional matrix adjust.
Identities = 139/464 (29%), Positives = 227/464 (48%), Gaps = 42/464 (9%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSV----------------GNLSHSLED------FRM 38
++N LT++ L N G LP T G + SL D R
Sbjct: 378 IANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRF 437
Query: 39 YNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDD 98
+ SG I E ++L N +G + + QKL L +N + G+IP +
Sbjct: 438 KGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPE 497
Query: 99 ICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNF 157
I ++ +L +LDL N+++G LP SN+ + + L N+L+ +P L ++ L+
Sbjct: 498 IWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDL 557
Query: 158 SSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS 217
SSN +S +P + NL L ++ S N+ IP + L L+ L L YN+L G I
Sbjct: 558 SSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQ 617
Query: 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFE 277
F L +L+ L+LS+NNLSG IP S + + L ++++S N L+G IP +F N ++FE
Sbjct: 618 FRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFE 677
Query: 278 GNELLCGSPNLQ--VPPCKTSIHHTSWKN-SLLLRIVLPLSTTFMIVVIL--LILRYQQR 332
GN+ LCGS N + PC + S K+ +L++ I++P+ +I+ + + + +++R
Sbjct: 678 GNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKR 737
Query: 333 GKR-------PSNDANMPLVATWRTFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDR 385
K+ S + + + Y E+ +AT EF LIG GG G VYKA+L +
Sbjct: 738 TKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA 797
Query: 386 MEVAVKVFNLQCGRAF------ESFDVECEMMKNIRHRNLIKIL 423
+ +AVK N + + F E + IRHRN++K+
Sbjct: 798 I-MAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLF 840
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (475), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 147/469 (31%), Positives = 226/469 (48%), Gaps = 53/469 (11%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPE----------- 49
+ +C SLT + L +N L G +P + L+ L+ + N+SG IP
Sbjct: 516 LGDCTSLTTLDLGSNNLQGQIPD-KITALAQ-LQCLVLSYNNLSGSIPSKPSAYFHQIEM 573
Query: 50 -EISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108
++S L + I +L N+L+G IP L + L + L +N L G IP + L L L
Sbjct: 574 PDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTIL 633
Query: 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFLTSPLP 167
DL GN L+GS+P N L+ ++L +N+L +P +F L ++ LN + N L P+P
Sbjct: 634 DLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVP 693
Query: 168 LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFL 227
+GNLK L +D S NN SG + +E+ ++ L L++ N+ G IP G+L L++L
Sbjct: 694 ASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYL 753
Query: 228 NLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 287
++S N LSG IP + L LE LNL+ N L GE+P G + S GN+ LCG
Sbjct: 754 DVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCG--- 810
Query: 288 LQVPPCKTSIHHTSWKNSLLLRIVLPLSTTFMIVVILLILRYQQRGKRPSN--------- 338
+V I T +++ + ++ L T ++ V + LR KR
Sbjct: 811 -RVVGSDCKIEGTKLRSAWGIAGLM-LGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEE 868
Query: 339 -------DANMPLVATWRTFSYL-----------------ELFRATDEFSENNLIGKGGF 374
D N+ ++ R+ L ++ ATD FS+ N+IG GGF
Sbjct: 869 SRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGF 928
Query: 375 GSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKIL 423
G+VYKA L VAVK + + F E E + ++H NL+ +L
Sbjct: 929 GTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLL 977
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 499 | ||||||
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.845 | 0.387 | 0.521 | 1e-111 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.871 | 0.409 | 0.503 | 1e-111 | |
| 255585401 | 843 | serine-threonine protein kinase, plant-t | 0.843 | 0.499 | 0.528 | 1e-109 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.845 | 0.388 | 0.525 | 1e-108 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.861 | 0.421 | 0.495 | 1e-106 | |
| 359483688 | 1197 | PREDICTED: LRR receptor-like serine/thre | 0.859 | 0.358 | 0.498 | 1e-105 | |
| 147843440 | 868 | hypothetical protein VITISV_043680 [Viti | 0.837 | 0.481 | 0.517 | 1e-105 | |
| 359483675 | 1250 | PREDICTED: LRR receptor-like serine/thre | 0.857 | 0.342 | 0.495 | 1e-104 | |
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.841 | 0.401 | 0.5 | 1e-103 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.855 | 0.300 | 0.504 | 1e-103 |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1052), Expect = e-111, Method: Compositional matrix adjust.
Identities = 223/428 (52%), Positives = 290/428 (67%), Gaps = 6/428 (1%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ NC++L ++LS NPLDG LP SVGNLS+SLE F + I G + E I NL++ T +
Sbjct: 436 LKNCQNLKYLWLSYNPLDGYLPH-SVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRL 494
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
NLG N L G IP T+ L+ LQGL L N L+GSIP ++C L LY L+L GNKLSGS+P
Sbjct: 495 NLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIP 554
Query: 121 ACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
CFSNLTSLR + L SN+ S + T W LKDIL +N +SN+LT LP EI NL+ + I
Sbjct: 555 TCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMI 614
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
+ S N SG IP IGGL++L L+L N+LQG IP S GD+ SL+FL+LS+NNLSG IP
Sbjct: 615 NISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIP 674
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHH 299
SL+ L YL+ N+SFN L+GEIP GGSF NFSA+SF GNE LCGS LQV PCK
Sbjct: 675 KSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSR 734
Query: 300 TSWK--NSLLLRIVLP--LSTTFMIVVILLILRYQQRGKRPSNDANMPLVATWRTFSYLE 355
+ + ++LR VLP + F++ ++++ RY +R + S + + + T R SY E
Sbjct: 735 ATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHE 794
Query: 356 LFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR 415
L AT+ F E+N +G G FGSVYK L D +A KVFNLQ RAF+SFD ECE+++N+R
Sbjct: 795 LQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLR 854
Query: 416 HRNLIKIL 423
HRNL+KI+
Sbjct: 855 HRNLVKII 862
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1045), Expect = e-111, Method: Compositional matrix adjust.
Identities = 221/439 (50%), Positives = 289/439 (65%), Gaps = 4/439 (0%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
NC+SL + + NPL G LP S+GNLS SLE+ ++C I G IP I NL+N + L
Sbjct: 409 NCRSLAYLRFNGNPLRGRLP-VSIGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIGLIL 467
Query: 63 GGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPAC 122
N+L G+IP + +L+ LQ L NKL+G IP++ICHL L L L N SGSLPAC
Sbjct: 468 QQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPAC 527
Query: 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
SN+TSLR + LGSN+ TS+P TFW+LKD+L +N S N LT LPLEIGNLKV+ IDFS
Sbjct: 528 LSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFS 587
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242
N SG IPT I L+NL + L NR+QG IP SFGDL+SL+FL+LS N+LSGAIP SL
Sbjct: 588 SNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSL 647
Query: 243 EKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKT-SIHHTS 301
EKL +L+ N+SFN+L+GEI GG F NFS SF NE LCG +QVPPCK+ S H S
Sbjct: 648 EKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQS 707
Query: 302 WK-NSLLLRIVLPLSTTFMIVVILLILRYQQRGKRPSNDANMPL-VATWRTFSYLELFRA 359
+ ++R ++P ++V+ L ++ +++ KR + PL ATWR SY EL+RA
Sbjct: 708 KRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPATWRKISYHELYRA 767
Query: 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNL 419
T+ F+E NL+G G GSVYK L D + +AVKVF+LQ FD ECE+++ +RHRNL
Sbjct: 768 TEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNL 827
Query: 420 IKILHGVAVITFTVCLCLF 438
+KI+ + F + F
Sbjct: 828 VKIISSCCNLDFKALILEF 846
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 403 bits (1035), Expect = e-109, Method: Compositional matrix adjust.
Identities = 224/424 (52%), Positives = 286/424 (67%), Gaps = 3/424 (0%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++ CK L + L NPL+ LP TS+GNLS S+E F + +CNI G IP EI L+N +
Sbjct: 194 LARCKELRRLVLIGNPLNSTLP-TSIGNLS-SIEYFNVQSCNIKGNIPSEIGVLSNLITL 251
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+L N+L GSIP+T+ LQKLQ L L N L GSIP DICHL+ L L L N L G LP
Sbjct: 252 HLQNNELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDICHLSNLGELFLSNNSLFGPLP 311
Query: 121 ACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
ACF +L SLRI+ L SN TS +P + W+LKD+L LN SSN L+ +PL IGNLKVL +
Sbjct: 312 ACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSSNSLSGHIPLSIGNLKVLTQV 371
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
DFS N+ SG+IP IG L+NL L L +NR +G IP+ FG+LISL+ L+LS+NNLSG IP
Sbjct: 372 DFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFGELISLESLDLSSNNLSGKIP 431
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHH 299
SLE+L YL+ LN+SFN L+GE+P G+F NFSA SF GN LCGS L + PCK + H
Sbjct: 432 KSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALCGSRLLPLMPCKNNTHG 491
Query: 300 TSWKNSLLLRIVLPLSTTFMIVVILLILRYQQRGKRPSNDANMPLVATWRTFSYLELFRA 359
S ++ LL I + ++ I IL+ LR Q+ N ++ V TWR S+ EL +A
Sbjct: 492 GSKTSTKLLLIYVLPASILTIAFILVFLRCQKVKLELENVMDIITVGTWRRISFQELEQA 551
Query: 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNL 419
TD F +NL+G GG+GSVYK RL D VA+KVFNL AF+ FD ECE+M +IRHRNL
Sbjct: 552 TDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIFDTECEVMSSIRHRNL 611
Query: 420 IKIL 423
+KI+
Sbjct: 612 VKII 615
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1020), Expect = e-108, Method: Compositional matrix adjust.
Identities = 224/426 (52%), Positives = 290/426 (68%), Gaps = 4/426 (0%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NCK L ++YLS NPL GILP S+GNLS SL+ F C + G IP EI NL+N ++
Sbjct: 440 LTNCKRLRILYLSFNPLIGILP-ISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLL 498
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+L N L G+IP ++ +LQKLQGL L NKL+GSIP+DIC L L L L N+LSGS+P
Sbjct: 499 SLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIP 558
Query: 121 ACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
AC LT LR + LGSNKL S +P T W+L IL+L+ SSNFL LP ++GNLKVL+ I
Sbjct: 559 ACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKI 618
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N SG IP+ IGGL++L L L +NR +G I SF +L SL+F++LS+N L G IP
Sbjct: 619 DLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIP 678
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHH 299
SLE L YL+ L++SFN L GEIP G F NFSAESF N+ LCGSP L++PPC+T
Sbjct: 679 KSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRW 738
Query: 300 TSWKNSLLLRIVLP--LSTTFMIVVILLILRYQQRGKRPSNDANMPLVATWRTFSYLELF 357
++ + LLL+ +LP LST + +I + R ++R + L ATWR SY E+F
Sbjct: 739 STTISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIF 798
Query: 358 RATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHR 417
+AT+ FS NL+G+G GSVY+ L D A+KVFNLQ AF+SFD ECE+M +IRHR
Sbjct: 799 QATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHR 858
Query: 418 NLIKIL 423
NLIKI+
Sbjct: 859 NLIKIV 864
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 393 bits (1009), Expect = e-106, Method: Compositional matrix adjust.
Identities = 215/434 (49%), Positives = 281/434 (64%), Gaps = 4/434 (0%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++N + L +++ +NPLDG+LP SVGNLS L F +Y + G IP EI NL+N ++
Sbjct: 367 LTNSRQLKELHIGDNPLDGMLP-NSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVL 425
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+L N L G IP T+ L+K+Q L L N L GSIP DIC L + L+ N LSG +P
Sbjct: 426 SLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIP 485
Query: 121 ACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+C NLTSLR + L N L+S +P+ W+LKD+L LN SNFL LP ++G ++ IGI
Sbjct: 486 SCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGI 545
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
S N SG IP+ IG L+NL L N QGSIP++FG L+SL+ L+LS NNLSG IP
Sbjct: 546 RLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIP 605
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHH 299
SLE L YLE ++SFN L+GEIPRGG F NF+A SF N+ LCG LQVPPC
Sbjct: 606 KSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRK 665
Query: 300 TSWKNSLLLRIVLPLSTTFMIVV--ILLILRYQQRGKRPSNDANMPLVATWRTFSYLELF 357
S S LLR LP + ++VV I L++ ++R ++ +P+ A R SYLEL
Sbjct: 666 DSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELL 725
Query: 358 RATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHR 417
AT+EF E+NL+G G FGSVY+ RL D + VAVK+FNLQ RAF SFD ECE+M+NIRHR
Sbjct: 726 HATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHR 785
Query: 418 NLIKILHGVAVITF 431
NL+KI+ + + F
Sbjct: 786 NLVKIICSCSNLDF 799
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483688|ref|XP_003633002.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 387 bits (995), Expect = e-105, Method: Compositional matrix adjust.
Identities = 217/435 (49%), Positives = 288/435 (66%), Gaps = 6/435 (1%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NCK L +++ NPL G LP S+GNL +LE F Y C G IP I NLTN ++
Sbjct: 553 LTNCKFLRTLWIGYNPLKGTLPN-SLGNLPIALESFNAYACQFRGTIPTGIGNLTNLIML 611
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+LG N L GSIP TL +LQKLQ L + N++ GSIP+D+CHL L L L NKLSGS P
Sbjct: 612 HLGANDLTGSIPTTLGQLQKLQALSIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTP 671
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+CF +L +LR + L SN L ++P + W+L+D+L LN SSNFLT LP E+GN+K +I +
Sbjct: 672 SCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKYIITL 731
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N SG IP+ +G L+NL L L N+LQG IP GDL+SL+ L+LS NNLS IP
Sbjct: 732 DLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVECGDLVSLESLDLSQNNLSRIIP 791
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHH 299
SLE L YL+ LN+SFNKL+GEIP GG F NF+AESF NE LCG+P+ QV C +
Sbjct: 792 KSLEALIYLKYLNVSFNKLQGEIPNGGPFVNFNAESFMFNEALCGAPHFQVMACDKNNRT 851
Query: 300 TSWKNS--LLLRIVLPL-STTFMIVVILLILRYQQRGKRPSNDANMPLVATWRTFSYLEL 356
SWK +L I+LP+ ST ++V I+L +R + + P+ A+ L T S+ +L
Sbjct: 852 QSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIASW-LPGTHEKISHQQL 910
Query: 357 FRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRH 416
AT++F E+NLIGKG G VYK L + + VA+KVFNL+ RA SFD ECE+M+ IRH
Sbjct: 911 LYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQRALRSFDSECEVMQGIRH 970
Query: 417 RNLIKILHGVAVITF 431
RNL++I+ + + F
Sbjct: 971 RNLVRIITCCSNLDF 985
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147843440|emb|CAN79970.1| hypothetical protein VITISV_043680 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 387 bits (993), Expect = e-105, Method: Compositional matrix adjust.
Identities = 222/429 (51%), Positives = 284/429 (66%), Gaps = 11/429 (2%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC SL +++S NPL GI+P S+GNLS SLE C + G IP IS LTN +
Sbjct: 242 LTNCNSLRNLWISGNPLKGIIP-NSLGNLSISLESIVASGCQLRGTIPTGISYLTNLIDL 300
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L N L G IP + +LQKLQ L N++ G IP +CHLA L LDL NKLSG++P
Sbjct: 301 RLDDNNLTGLIPTSSGRLQKLQVLYFSQNQIHGPIPSGLCHLANLGFLDLSSNKLSGTIP 360
Query: 121 ACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
CF NLT LR ++L SN L S VP + W L+D+L LN SSNFL S LPLE+GN+K L+ +
Sbjct: 361 GCFGNLTLLRGINLHSNGLASEVPSSLWTLRDLLVLNLSSNFLNSQLPLEVGNMKSLVVL 420
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N FSG IP+ I L+NL L L +N+LQG +P +FGDL+SL++L+LS NNLSG+IP
Sbjct: 421 DLSKNQFSGNIPSTISLLQNLVQLHLSHNKLQGHMPPNFGDLVSLEYLDLSGNNLSGSIP 480
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC-KTSIH 298
SLE L YL+ LN+S NKL+ EIP GG F NF+AESF N LCG+P QV C K +
Sbjct: 481 KSLEALKYLKYLNVSVNKLQREIPNGGPFANFTAESFISNLALCGAPRFQVMACEKDTRR 540
Query: 299 HTSWKNSLLLRIVLPL--STTFMIVVILLILRYQQRGKRPSNDANMPLVATWR---TFSY 353
HT SLLL+ ++PL S + +IVV+L +LR Q++ K + + L R S+
Sbjct: 541 HTK---SLLLKCIVPLAVSLSIIIVVVLFVLRKQRQTKSEALQVQVDLTLLPRMRPMISH 597
Query: 354 LELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKN 413
EL AT+ F E NLIGKG G VYK L D + VAVKVFN++ AF+SF+VE E+M+N
Sbjct: 598 QELLYATNYFDEENLIGKGSLGMVYKGVLSDGLIVAVKVFNVELQGAFKSFEVEYEVMQN 657
Query: 414 IRHRNLIKI 422
IRHRNL KI
Sbjct: 658 IRHRNLAKI 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 384 bits (987), Expect = e-104, Method: Compositional matrix adjust.
Identities = 216/436 (49%), Positives = 290/436 (66%), Gaps = 8/436 (1%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NCK L +++ NPL G LP S+GNLS +LE F C+ G IP I NLTN +
Sbjct: 584 LTNCKFLRTLWIDYNPLKGTLPN-SLGNLSVALESFTASACHFRGTIPTGIGNLTNLIWL 642
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+LG N L GSIP TL +LQKLQ L + N+++GSIP+D+ HL L L L NKLSGS+P
Sbjct: 643 DLGANDLTGSIPTTLGQLQKLQRLYIAGNRIQGSIPNDLFHLKNLGYLHLSSNKLSGSIP 702
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+CF +L +LR +SL SN L ++P++FW+L+D+L L+ SSNFLT LP E+GN+K + +
Sbjct: 703 SCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLSLSSNFLTGNLPPEVGNMKSITTL 762
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N SG IP +G L+NL L L N+LQGSIP FGDL+SL+ ++LS NNLSG IP
Sbjct: 763 DLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLSGTIP 822
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHH 299
SLE L YL++LN+SFNKL+GEIP GG F NF+AESF NE LCG+P+ QV C + H
Sbjct: 823 KSLEALIYLKHLNVSFNKLQGEIPDGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNHT 882
Query: 300 TSWKNS--LLLRIVLPL-STTFMIVVILLILRYQQRGKRPSN-DANMPLVATWRTFSYLE 355
SWK +L I+LP+ S ++ I+L +R Q + P+ D+ +P S +
Sbjct: 883 QSWKTKSFILKYILLPVGSIVTLVAFIVLWIRRQDNTEIPAPIDSWLP--GAHEKISQQQ 940
Query: 356 LFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR 415
L AT++F E+NLIGKG G VYK L + + VA+KVFNL+ A SFD ECE+M+ I
Sbjct: 941 LLYATNDFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIC 1000
Query: 416 HRNLIKILHGVAVITF 431
HRNLI+I+ + + F
Sbjct: 1001 HRNLIRIITCCSNLDF 1016
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 383 bits (984), Expect = e-103, Method: Compositional matrix adjust.
Identities = 214/428 (50%), Positives = 287/428 (67%), Gaps = 8/428 (1%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NCK L +++ NPL G LP S+GNL +LE F C G IP I NLTN +
Sbjct: 402 LTNCKFLRNLWIGYNPLTGTLPN-SLGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWL 460
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+LG N L GSIP TL +LQKLQ L + N++ GSIP+D+CHL L L L NKLSGS+P
Sbjct: 461 DLGANDLTGSIPTTLGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIP 520
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+CF +L +LR +SL SN L ++P++FW+L+D+L LN SSNFLT LP E+GN+K + +
Sbjct: 521 SCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTL 580
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N SG IP+ +G L+NL L L N+LQG IP FGDL+SL+ L+LS NNLSG IP
Sbjct: 581 DLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIP 640
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHH 299
+LE L YL+ LN+SFNKL+GEIP GG F F+AESF NE LCG+P+ QV C +
Sbjct: 641 KTLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRT 700
Query: 300 TSWKNS--LLLRIVLPL-STTFMIVVILLILRYQQRGKRPSN-DANMPLVATWRTFSYLE 355
SWK +L I+LP+ ST ++V I+L +R + + P+ D+ +P T S+ +
Sbjct: 701 QSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLP--GTHEKISHQQ 758
Query: 356 LFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR 415
L AT++F E+NLIGKG G VYK L + + VA+KVFNL+ A SF+ ECE+M+ IR
Sbjct: 759 LLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIR 818
Query: 416 HRNLIKIL 423
HRNL++I+
Sbjct: 819 HRNLVRII 826
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 382 bits (980), Expect = e-103, Method: Compositional matrix adjust.
Identities = 220/436 (50%), Positives = 282/436 (64%), Gaps = 9/436 (2%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NCK L +++ +NPL GILP S+GNLS SLE F C G IP I NL N +
Sbjct: 556 LTNCKFLRRLWIEDNPLKGILPN-SLGNLSISLESFDASACQFKGTIPTGIGNLINLIDL 614
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L N L G IPI+ LQKLQ + N++ GSIP +CHL L LDL NKLSG++P
Sbjct: 615 RLNDNDLTGLIPISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIP 674
Query: 121 ACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
CF NLT+LR +SL SN L S +P + W L+D+L LN SSNFL LPLE+GN+K L+ +
Sbjct: 675 GCFGNLTALRNISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVL 734
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N FSG IP+ I L+NL L+L +N+LQG +P +FG L+SL++L+LS NN SG IP
Sbjct: 735 DLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIP 794
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHH 299
SLE L YL+ LN+SFNKL+GEIP G F NF+AESF N LCG+P QV C+
Sbjct: 795 TSLEALKYLKYLNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPRFQVMACEKDARR 854
Query: 300 TSWKNSLLLRIVLPLSTTF--MIVVILLIL--RYQQRGKRPSNDANMPLVATWRTFSYLE 355
+ SLLL+ ++PLS + MI+V+L L R Q + P ++ L R S+ E
Sbjct: 855 NT--KSLLLKCIVPLSVSLSTMILVVLFTLWKRRQTESESPVQ-VDLLLPRMHRLISHQE 911
Query: 356 LFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR 415
L AT F E NLIGKG G VYK L D + VAVKVFNL+ AF+SF+VECE+M+NIR
Sbjct: 912 LLYATSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIR 971
Query: 416 HRNLIKILHGVAVITF 431
HRNL KI+ + + F
Sbjct: 972 HRNLAKIISSCSNLDF 987
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 499 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.829 | 0.403 | 0.380 | 2.5e-63 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.843 | 0.517 | 0.343 | 1.3e-59 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.841 | 0.409 | 0.357 | 1e-58 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.859 | 0.424 | 0.359 | 2e-58 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.859 | 0.425 | 0.338 | 1.7e-55 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.843 | 0.408 | 0.334 | 1.9e-55 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.859 | 0.424 | 0.314 | 2.5e-53 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.823 | 0.419 | 0.344 | 4.7e-53 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.841 | 0.358 | 0.308 | 3.9e-52 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.591 | 0.253 | 0.323 | 7.7e-40 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 652 (234.6 bits), Expect = 2.5e-63, P = 2.5e-63
Identities = 164/431 (38%), Positives = 231/431 (53%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC L + L N L G+LP S NLS SL + I+G IP++I NL +
Sbjct: 347 LTNCSKLQTLNLGENNLGGVLPN-SFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHL 405
Query: 61 NLGGNKLNGSIPITLSXXXXXXXXXXEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L N GS+P +L +N L GSIP I +L EL L L NK SG +P
Sbjct: 406 YLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIP 465
Query: 121 ACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDI-LNLNFSSNFLTSPLPLEIGNLKVLIG 178
SNLT+L + L +N L+ +P +N++ + + +N S N L +P EIG+LK L+
Sbjct: 466 YTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVE 525
Query: 179 IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAI 238
N SG IP +G + L YL+L N L GSIP + G L G I
Sbjct: 526 FHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQI 585
Query: 239 PASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSI 297
P SL ++ L +LNLSFN GE+P G+F S S +GN LCG P+L +P C +
Sbjct: 586 PTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLL 645
Query: 298 HHTSWKNSLLLRIVLPLSTTFMIVVIL-LILRYQQRGKR--PSNDA--NMPLVATWRTFS 352
+ K+ +L I + L+ I+ L L++ + +R K+ PS + PLV S
Sbjct: 646 ENR--KHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPLV------S 697
Query: 353 YLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMK 412
Y +L +ATD F+ NL+G G FGSVYK +L + VAVKV L+ +A +SF ECE ++
Sbjct: 698 YSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALR 757
Query: 413 NIRHRNLIKIL 423
N+RHRNL+KI+
Sbjct: 758 NMRHRNLVKIV 768
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 1.3e-59, P = 1.3e-59
Identities = 148/431 (34%), Positives = 221/431 (51%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC +L + L G+LP SV NLS SL + + ISG +P +I NL N +
Sbjct: 321 LTNCSNLQEVELGGCKFGGVLPD-SVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYL 379
Query: 61 NLGGNKLNGSIPITLSXXXXXXXXXXEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+L N L GS+P + S ++NKL GS+P I +L +L +++ N G++P
Sbjct: 380 SLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIP 439
Query: 121 ACFSNLTSLRIVSLGSNK-LTSVPLTFWNLKDILN-LNFSSNFLTSPLPLEIGNLKVLIG 178
+ NLT L ++LG N + +P+ +++ + L+ S N L +P EIG LK ++
Sbjct: 440 STLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVE 499
Query: 179 IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAI 238
N SG P+ IG + L++LFL N L GSIP + L G I
Sbjct: 500 FHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQI 559
Query: 239 PASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSI 297
P SL + L +LNLSFN GE+P G F N S +GN +CG P L +P C
Sbjct: 560 PMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKS 619
Query: 298 HHTSWKNSLLLRIVLPLSTTFMIVVILLILRYQQRGKRPSNDANMPLVATWRTFSYLELF 357
LLL +V+ L +T + +L +L + ++ A + +Y +L
Sbjct: 620 RKKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQGH-PMITYKQLV 678
Query: 358 RATDEFSENNLIGKGGFGSVYKARL----GDRME-VAVKVFNLQCGRAFESFDVECEMMK 412
+ATD FS ++L+G G FGSVYK G+ VAV+V L+ +A +SF ECE ++
Sbjct: 679 KATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLR 738
Query: 413 NIRHRNLIKIL 423
N RHRNL+KI+
Sbjct: 739 NTRHRNLVKIV 749
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 610 (219.8 bits), Expect = 1.0e-58, P = 1.0e-58
Identities = 156/436 (35%), Positives = 226/436 (51%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC L + + N L G LP + NLS L + + ISG IP I NL + +
Sbjct: 348 LTNCSQLQYLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTL 406
Query: 61 NLGGNKLNGSIPITLSXXXXXXXXXXEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+LG N L G +P +L N L G IP + +++ L L L N GS+P
Sbjct: 407 DLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIP 466
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+ + + L ++LG+NKL S+P L ++ LN S N L PL +IG LK L+ +
Sbjct: 467 SSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLAL 526
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIP 239
D S N SG IP + +LE+L L N G IPD G L G IP
Sbjct: 527 DVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIP 585
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSI- 297
+ S L+NLNLS N +G +P G F N SA S GN LCG P+LQ+ PC +
Sbjct: 586 EYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELP 645
Query: 298 -HHTSWKNSLLLRIVLPLSTTFMIVVILLILR-YQQRGK--RPSNDAN----MPLVATWR 349
H+S + + + + ++ ++ + ++ L Y+ R K R +N+ N P+ + +
Sbjct: 646 RRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYE 705
Query: 350 TFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRME-VAVKVFNLQCGR-AFESFDVE 407
SY EL++ T FS +NLIG G FG+V+K LG + + VA+KV NL C R A +SF E
Sbjct: 706 KISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL-CKRGAAKSFIAE 764
Query: 408 CEMMKNIRHRNLIKIL 423
CE + IRHRNL+K++
Sbjct: 765 CEALGGIRHRNLVKLV 780
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 607 (218.7 bits), Expect = 2.0e-58, P = 2.0e-58
Identities = 159/442 (35%), Positives = 221/442 (50%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC L + + N L G LP S+ NLS L + ISG IP +I NL N +
Sbjct: 332 LTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKL 390
Query: 61 NLGGNKLNGSIPITLSXXXXXXXXXXEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L N L+G +P +L N+L G IP I ++ L LDL N G +P
Sbjct: 391 ILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVP 450
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
N + L + +G NKL ++PL ++ +L L+ S N L LP +IG L+ L +
Sbjct: 451 TSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTL 510
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIP 239
N SG +P +G +E LFL N G IPD G L+ G+IP
Sbjct: 511 SLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIP 569
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSIH 298
S LE LNLSFN LEG++P G F N + S GN LCG Q+ PC +
Sbjct: 570 EYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAP 629
Query: 299 HTSWKNSLLLR-IVLPLST-------TFMIVVILLILRYQQRGKRPSNDANMPLVATWRT 350
K+S L+ +V+ +S FM V L+ LR +++ K +N L
Sbjct: 630 SVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEK 689
Query: 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECE 409
SY +L AT+ FS +N++G G FG+VYKA L ++ VAVKV N+Q A +SF ECE
Sbjct: 690 ISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECE 749
Query: 410 MMKNIRHRNLIKILHGVAVITF 431
+K+IRHRNL+K+L + I F
Sbjct: 750 SLKDIRHRNLVKLLTACSSIDF 771
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 1.7e-55, P = 1.7e-55
Identities = 149/440 (33%), Positives = 225/440 (51%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC L + +S N L G LP TS+ N+S L + I G IP +I NL +
Sbjct: 333 LTNCSHLHGLSVSYNRLGGALP-TSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSL 391
Query: 61 NLGGNKLNGSIPITLSXXXXXXXXXXEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L N L G +P +L N+ G IP I +L +L +L L N G +P
Sbjct: 392 LLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVP 451
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+ + + + +G NKL ++P + +++LN SN L+ LP +IG L+ L+ +
Sbjct: 452 PSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVEL 511
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIP 239
NN SG +P +G ++E ++L N G+IPD G L+ G+I
Sbjct: 512 LLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSIS 570
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSIH 298
E S LE LNLS N EG +P G F N + S GN+ LCGS L++ PC
Sbjct: 571 EYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAP 630
Query: 299 HTSWKN-SLLLRIVLPLSTTFMIVVILLILR---YQQR--GKRPSNDANMPLVATWRTFS 352
++ SLL ++ + +S ++++L I+ +++R ++ +N A L S
Sbjct: 631 PVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLS 690
Query: 353 YLELFRATDEFSENNLIGKGGFGSVYKARLGDRME-VAVKVFNLQCGRAFESFDVECEMM 411
Y +L ATD FS +N++G G FG+V+KA L + VAVKV N+Q A +SF ECE +
Sbjct: 691 YGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESL 750
Query: 412 KNIRHRNLIKILHGVAVITF 431
K+IRHRNL+K+L A I F
Sbjct: 751 KDIRHRNLVKLLTACASIDF 770
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 1.9e-55, P = 1.9e-55
Identities = 146/436 (33%), Positives = 220/436 (50%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC L + + N L G LP S+ NLS +L + ISG IP +I NL + +
Sbjct: 340 VANCTQLEYLDVGYNRLGGELP-ASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQEL 398
Query: 61 NLGGNKLNGSIPITLSXXXXXXXXXXEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+L N L+G +P++ N + G IP ++ L +L L+ N G +P
Sbjct: 399 SLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIP 458
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
L + + +N+L ++P + + ++ S+NFLT P E+G L++L+G+
Sbjct: 459 QSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGL 518
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIP 239
S N SG +P IGG ++E+LF+ N G+IPD L+ G IP
Sbjct: 519 GASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIP 577
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN-LQVPPC--KTS 296
L L L NLNLS NK EG +P G F N +A S GN +CG +Q+ PC + S
Sbjct: 578 RYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQAS 637
Query: 297 IHHT---SWKNSLLLRIVLPLSTTFMIVVILLILRYQQRGKRPS-NDANMPLVATWRTF- 351
S + ++ I + +++ +I+++ + + +R K+ + +D N T F
Sbjct: 638 PRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFH 697
Query: 352 ---SYLELFRATDEFSENNLIGKGGFGSVYKARLGDRME-VAVKVFNLQCGRAFESFDVE 407
SY EL AT FS NLIG G FG+V+K LG + VAVKV NL A +SF E
Sbjct: 698 EKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAE 757
Query: 408 CEMMKNIRHRNLIKIL 423
CE K IRHRNL+K++
Sbjct: 758 CETFKGIRHRNLVKLI 773
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 560 (202.2 bits), Expect = 2.5e-53, P = 2.5e-53
Identities = 139/442 (31%), Positives = 220/442 (49%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++NC L L+ + L G LP TS+ N+S L + + G IP++I NL +
Sbjct: 333 LTNCTHLQLLSVGYTRLGGALP-TSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRL 391
Query: 61 NLGGNKLNGSIPITLSXXXXXXXXXXEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
LG N L G +P +L N++ G IP I +L +L L L N G +P
Sbjct: 392 QLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVP 451
Query: 121 ACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+ + + +G NKL ++P + ++NL+ N L+ LP +IG+L+ L+ +
Sbjct: 452 PSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKL 511
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIP 239
N FSG +P +G +E LFL N G+IP+ G L+ G+IP
Sbjct: 512 SLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIP 570
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPC----- 293
S LE LNLS N G++P G+F N + GN+ LCG +L++ PC
Sbjct: 571 EYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEP 630
Query: 294 KTSIHHTSWKNSLLLRIVLPLSTTFMIVVILLIL---RYQQRGKRPSNDANMPLVATWRT 350
H+S + + + + ++ ++V+ ++L R +++ ++ +N L
Sbjct: 631 PVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEK 690
Query: 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRME-VAVKVFNLQCGRAFESFDVECE 409
SY +L AT+ FS +N++G G FG+V+KA L + VAVKV N+Q A +SF ECE
Sbjct: 691 ISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECE 750
Query: 410 MMKNIRHRNLIKILHGVAVITF 431
+K+ RHRNL+K+L A F
Sbjct: 751 SLKDTRHRNLVKLLTACASTDF 772
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 557 (201.1 bits), Expect = 4.7e-53, P = 4.7e-53
Identities = 149/432 (34%), Positives = 220/432 (50%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
+L I+L N + G +P + NL + L + + +SG IP E+ L+ V L N
Sbjct: 298 NLVQIHLDQNRIHGSIPP-EISNLLN-LTLLNLSSNLLSGPIPRELCKLSKLERVYLSNN 355
Query: 66 KLNGSIPITLSXXXXXXXXXXEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSN 125
L G IP+ L N L GSIPD +L++L RL L GN LSG++P
Sbjct: 356 HLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGK 415
Query: 126 LTSLRIVSLGSNKLT-SVPL-TFWNLKDI-LNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
+L I+ L N LT ++P+ NL+++ L LN SSN L+ P+PLE+ + +++ +D S
Sbjct: 416 CINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLS 475
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXGAIPASL 242
N SG IP ++G LE+L L N ++P S G L GAIP S
Sbjct: 476 SNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSF 535
Query: 243 EKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSIHHTS 301
++ S L++LN SFN L G + GSF + ESF G+ LLCGS +Q CK + S
Sbjct: 536 QQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKKHKYPS 593
Query: 302 WKNSLLLRIVL-PLSTTFMIVVI--------LLILRYQQRGKRPSNDANMPLVATWRTFS 352
+LL ++ P+ F ++ L + ++ + N P + S
Sbjct: 594 VLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP---KYPRIS 650
Query: 353 YLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFE-SFDVECEMM 411
Y +L AT F+ ++LIG G FG VYK L + +VAVKV + + F SF EC+++
Sbjct: 651 YQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQIL 710
Query: 412 KNIRHRNLIKIL 423
K RHRNLI+I+
Sbjct: 711 KRTRHRNLIRII 722
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 551 (199.0 bits), Expect = 3.9e-52, P = 3.9e-52
Identities = 135/437 (30%), Positives = 232/437 (53%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ N K L ++YL +N G +P+ + NL+ L+ RMY+ ++ G IPEE+ ++ +++
Sbjct: 499 IGNLKDLNILYLHSNGFTGRIPR-EMSNLT-LLQGLRMYSNDLEGPIPEEMFDMKLLSVL 556
Query: 61 NLGGNKLNGSIPITLSXXXXXXXXXXEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+L NK +G IP S + NK GSIP + L+ L D+ N L+G++P
Sbjct: 557 DLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIP 616
Query: 121 A-CFSNLTSLRI-VSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
++L ++++ ++ +N LT ++P L+ + ++ S+N + +P + K +
Sbjct: 617 GELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVF 676
Query: 178 GIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPDSFGDLIXXXXXXXXXXXXXG 236
+DFS NN SG IP E+ G+ + L L N G IP SFG++ G
Sbjct: 677 TLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTG 736
Query: 237 AIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC--K 294
IP SL LS L++L L+ N L+G +P G F N +A GN LCGS + PC K
Sbjct: 737 EIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIK 795
Query: 295 TSIHHTSWKNSLLLRIVLPLSTTFMIVVILLIL---RYQQRGKRPSNDANMPLVAT---W 348
H S + ++L I+ + ++++++LIL + +++ S+++++P + +
Sbjct: 796 QKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKL 855
Query: 349 RTFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQ--CGRAFESFDV 406
+ F EL +ATD F+ N+IG +VYK +L D +AVKV NL+ + + F
Sbjct: 856 KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYT 915
Query: 407 ECEMMKNIRHRNLIKIL 423
E + + ++HRNL+KIL
Sbjct: 916 EAKTLSQLKHRNLVKIL 932
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 333 (122.3 bits), Expect = 7.7e-40, Sum P(2) = 7.7e-40
Identities = 99/306 (32%), Positives = 151/306 (49%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSV-GNLSHSLEDFRMYNCNISGGIPEEISNLTNST- 58
+SNCK L + LS N L G +P GN + L + + SG IP E+S L +
Sbjct: 247 LSNCKLLETLNLSRNSLIGKIPGDDYWGNFQN-LRQLSLAHNLYSGEIPPELSLLCRTLE 305
Query: 59 IVNLGGNKLNGSIPITLSXXXXXXXXXXEDNKLEGS-IPDDICHLAELYRLDLDGNKLSG 117
+++L GN L G +P + + +NKL G + + L+ + L L N +SG
Sbjct: 306 VLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISG 365
Query: 118 SLPACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKD--ILN-LNFSSNFLTSPLPLEIGNL 173
S+P +N ++LR++ L SN+ T VP F +L+ +L L ++N+L+ +P+E+G
Sbjct: 366 SVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKC 425
Query: 174 KVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFG-DLIXXXXXXXXXX 232
K L ID S N +G+IP EI L L L + N L G IP+S D
Sbjct: 426 KSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNNN 485
Query: 233 XXXGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPNLQVP 291
G++P S+ K + + ++LS N L GEIP G G + GN L G+ ++
Sbjct: 486 LLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQL-GNNSLTGNIPSELG 544
Query: 292 PCKTSI 297
CK I
Sbjct: 545 NCKNLI 550
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 499 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-42 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-38 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-25 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-08 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-08 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-08 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-07 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-07 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-07 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-07 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-04 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-04 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 0.001 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 0.001 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.001 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 0.001 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 0.001 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.001 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 0.002 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.003 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.003 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 0.003 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.004 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 0.004 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-42
Identities = 103/263 (39%), Positives = 144/263 (54%), Gaps = 5/263 (1%)
Query: 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLG 63
SL + LSNN G +P+ S+ NL E + N +SG IP +I + ++ +++LG
Sbjct: 117 SSSLRYLNLSNNNFTGSIPRGSIPNL----ETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172
Query: 64 GNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACF 123
GN L G IP +L+ L L+ L L N+L G IP ++ + L + L N LSG +P
Sbjct: 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232
Query: 124 SNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
LTSL + L N LT +P + NLK++ L N L+ P+P I +L+ LI +D S
Sbjct: 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242
N+ SG IP + L+NLE L L N G IP + L L+ L L +N SG IP +L
Sbjct: 293 DNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
Query: 243 EKLSYLENLNLSFNKLEGEIPRG 265
K + L L+LS N L GEIP G
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 7e-41
Identities = 117/394 (29%), Positives = 182/394 (46%), Gaps = 23/394 (5%)
Query: 42 NISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICH 101
N++G IPE + + N + L N L G IP +L + L+ + L+DN G +P +
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 102 LAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNF 161
L +Y LD+ N L G + + ++ SL+++SL NK + K + NL+ S N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486
Query: 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL 221
+ +P ++G+L L+ + S N SG IP E+ K L L L +N+L G IP SF ++
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 222 ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281
L L+LS N LSG IP +L + L +N+S N L G +P G+F +A + GN
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID 606
Query: 282 LCGSPNLQ-VPPCKTSIHHTSW---KNSLLLRIVLPLSTTFMIVVILLILRYQQRGKRPS 337
LCG +PPCK SW L ++ F V I R KR
Sbjct: 607 LCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIR--GRNNLELKRVE 664
Query: 338 NDANMPLVATWRTFSYLELFRAT-------DEFSENNLIGKGGFGSVYKAR-LGDRMEVA 389
N+ TW + + E N+I +G G+ YK + + + M+
Sbjct: 665 NED-----GTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 390 VKVFNLQCGRAFESFDVECEMMKNIRHRNLIKIL 423
VK N S + M ++H N++K++
Sbjct: 720 VKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLI 749
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 7e-38
Identities = 94/224 (41%), Positives = 123/224 (54%), Gaps = 4/224 (1%)
Query: 42 NISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKL-QKLQGLGLEDNKLEGSIPDDIC 100
NISG I I L +NL N+L+G IP + L+ L L +N GSIP
Sbjct: 80 NISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG-- 137
Query: 101 HLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSS 159
+ L LDL N LSG +P + +SL+++ LG N L +P + NL + L +S
Sbjct: 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS 197
Query: 160 NFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFG 219
N L +P E+G +K L I NN SG IP EIGGL +L +L L YN L G IP S G
Sbjct: 198 NQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG 257
Query: 220 DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
+L +L++L L N LSG IP S+ L L +L+LS N L GEIP
Sbjct: 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 9e-25
Identities = 70/202 (34%), Positives = 106/202 (52%), Gaps = 6/202 (2%)
Query: 73 ITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP-ACFSNLTSLRI 131
IT + ++ + L + G I I L + ++L N+LSG +P F+ +SLR
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 132 VSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI 190
++L +N T S+P + L+L S+N L+ +P +IG+ L +D N G I
Sbjct: 123 LNLSNNNFTGSIPRGSIPNLETLDL--SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 191 PTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 250
P + L +LE+L L N+L G IP G + SLK++ L NNLSG IP + L+ L +
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 251 LNLSFNKLEGEIPRGGSFGNFS 272
L+L +N L G IP S GN
Sbjct: 241 LDLVYNNLTGPIP--SSLGNLK 260
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 52/160 (32%), Positives = 84/160 (52%), Gaps = 9/160 (5%)
Query: 175 VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234
+ G+ G IP +I L++L+ + L N ++G+IP S G + SL+ L+LS N+
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 235 SGAIPASLEKLSYLENLNLSFNKLEGEIPR--GGSFGNFSAESFEGNELLCGSPNLQVPP 292
+G+IP SL +L+ L LNL+ N L G +P GG + ++ +F N LCG P L
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RA 536
Query: 293 CKTSIHHTSWKNSLLLRIVLPLSTTFMIVVILLILRYQQR 332
C H S + I +S F+ +VI + +++R
Sbjct: 537 CGP---HLS--VGAKIGIAFGVSVAFLFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 32/81 (39%), Positives = 45/81 (55%)
Query: 60 VNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
+ L L G IP +SKL+ LQ + L N + G+IP + + L LDL N +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 120 PACFSNLTSLRIVSLGSNKLT 140
P LTSLRI++L N L+
Sbjct: 483 PESLGQLTSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 34/82 (41%), Positives = 48/82 (58%)
Query: 40 NCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI 99
N + G IP +IS L + +NL GN + G+IP +L + L+ L L N GSIP+ +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 100 CHLAELYRLDLDGNKLSGSLPA 121
L L L+L+GN LSG +PA
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 75/240 (31%), Positives = 106/240 (44%), Gaps = 32/240 (13%)
Query: 44 SGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLA 103
S E + NL ++L N+L +I L +L L L L++N + IP I L
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLK 139
Query: 104 -ELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFL 162
L LDL NK+ SLP+ NL +L+ + L N L+ +P NL ++ NL+ S N +
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKI 198
Query: 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLI 222
+ +P EI L LE L L N + + S +L
Sbjct: 199 SD-------------------------LPPEIELLSALEELDLSNNSII-ELLSSLSNLK 232
Query: 223 SLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL 282
+L L LSNN L +P S+ LS LE L+LS N++ I GS N GN L
Sbjct: 233 NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLS 290
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 79/254 (31%), Positives = 115/254 (45%), Gaps = 14/254 (5%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLT-NSTI 59
+ N L + L+ N L + + SL + N NI+ IP I L N
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISELLELTNLTSL---DLDNNNITD-IPPLIGLLKSNLKE 144
Query: 60 VNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
++L NK+ S+P L L L+ L L N L +P + +L+ L LDL GNK+S L
Sbjct: 145 LDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DL 201
Query: 120 PACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
P L++L + L +N + + + NLK++ L S+N L LP IGNL L +
Sbjct: 202 PPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETL 260
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N S + +G L NL L L N L ++P L+ L+ L L
Sbjct: 261 DLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL---KA 315
Query: 240 ASLEKLSYLENLNL 253
L+ S L N N+
Sbjct: 316 LELKLNSILLNNNI 329
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 4/112 (3%)
Query: 83 GLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLT-S 141
GLGL++ L G IP+DI L L ++L GN + G++P ++TSL ++ L N S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 142 VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGV--IP 191
+P + L + LN + N L+ +P +G +L F+ + +G+ IP
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGR-LLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 12 LSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSI 71
L N L G +P + L H L+ + +I G IP + ++T+ +++L N NGSI
Sbjct: 425 LDNQGLRGFIPND-ISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 72 PITLSKLQKLQGLGLEDNKLEGSIP 96
P +L +L L+ L L N L G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 75/248 (30%), Positives = 114/248 (45%), Gaps = 15/248 (6%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG 64
+LT + L NN + I P + + D N +P + NL N ++L
Sbjct: 116 TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSD---NKIESLPSPLRNLPNLKNLDLSF 172
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFS 124
N L+ +P LS L L L L NK+ +P +I L+ L LDL N + L + S
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLS 229
Query: 125 NLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN 184
NL +L + L +NKL +P + NL ++ L+ S+N ++S +G+L L +D S N
Sbjct: 230 NLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGN 287
Query: 185 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEK 244
+ S +P L LE L + + L + L+NN LS +S E
Sbjct: 288 SLSNALPLIALLLLLLE-------LLLNLLLTLKALELKLNSILLNNNILSNGETSSPEA 340
Query: 245 LSYLENLN 252
LS LE+LN
Sbjct: 341 LSILESLN 348
|
Length = 394 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 6e-09
Identities = 23/66 (34%), Positives = 31/66 (46%), Gaps = 7/66 (10%)
Query: 369 IGKGGFGSVYKARL-----GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKI 422
+G+G FG VYK L G +VAVK E F E +MK + H N+++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR- 65
Query: 423 LHGVAV 428
L GV
Sbjct: 66 LLGVCT 71
|
Length = 258 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 5/172 (2%)
Query: 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI-DF 181
NL L + L N+L S L ++ +L+ +N +T +P IG LK + D
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDL 147
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
S N +P+ + L NL+ L L +N L +P +L +L L+LS N +S +P
Sbjct: 148 SDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPE 204
Query: 242 LEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC 293
+E LS LE L+LS N + + + N S N+L ++
Sbjct: 205 IELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 23/71 (32%), Positives = 38/71 (53%), Gaps = 3/71 (4%)
Query: 369 IGKGGFGSVYKARLGDRME-VAVKVFNLQ-CGRAFESFDVECEMMKNIRHRNLIKILHGV 426
+G+GGFG+VY AR + VA+K+ + E E E++K + H N++K L+GV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVK-LYGV 59
Query: 427 AVITFTVCLCL 437
+ L +
Sbjct: 60 FEDENHLYLVM 70
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-08
Identities = 25/60 (41%), Positives = 33/60 (55%)
Query: 199 NLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
NL+ L L NRL +F L +LK L+LS NNL+ P + L L +L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 23/69 (33%), Positives = 33/69 (47%), Gaps = 7/69 (10%)
Query: 366 NNLIGKGGFGSVYKARLGD-----RMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNL 419
+G+G FG VYK +L ++EVAVK E F E +M+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 420 IKILHGVAV 428
+K L GV
Sbjct: 64 VK-LLGVCT 71
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 20/74 (27%), Positives = 34/74 (45%), Gaps = 5/74 (6%)
Query: 367 NLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAF-ESFDVECEMMKNIRHRNLIKILH 424
+G+G FG VY AR VA+KV + + E E +++K ++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 425 GVAVITFTVCLCLF 438
V L L
Sbjct: 65 ---VFEDEDKLYLV 75
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 9e-08
Identities = 23/69 (33%), Positives = 32/69 (46%), Gaps = 7/69 (10%)
Query: 366 NNLIGKGGFGSVYKARLGD-----RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNL 419
+G+G FG VYK L +EVAVK + E F E +M+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 420 IKILHGVAV 428
+K L GV
Sbjct: 64 VK-LLGVCT 71
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 24/65 (36%), Positives = 33/65 (50%), Gaps = 1/65 (1%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRME-VAVKVFNLQCGRAFESFDVECEMMKNIRHRNL 419
+++ IG G +G VYKAR E VA+KV L+ G FE E M+K RH N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 420 IKILH 424
+
Sbjct: 63 VAYFG 67
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 17/61 (27%), Positives = 31/61 (50%), Gaps = 7/61 (11%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDV----ECEMMKNIRHRNLIKIL 423
+G G FG+VYKA+ G VAVK+ + D E +++ + H N+++++
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 424 H 424
Sbjct: 65 D 65
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 23/82 (28%), Positives = 39/82 (47%), Gaps = 8/82 (9%)
Query: 362 EFSENNLIGKGGFGSVYKARL---GDRMEVAVKVFNLQCGRA--FESFDVECEMMKNIRH 416
E++ L+G+G FGSVY A G+ M AVK L E+ + E ++ +++H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELM--AVKSVELSGDSEEELEALEREIRILSSLQH 58
Query: 417 RNLIKILHGVAVITFTVCLCLF 438
N+++ G L +F
Sbjct: 59 PNIVRYY-GSERDEEKNTLNIF 79
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 6e-07
Identities = 24/56 (42%), Positives = 32/56 (57%), Gaps = 1/56 (1%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKIL 423
IGKGGFG VYKAR EVA+KV L+ E E +++K +H N++K
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 6e-07
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 12/77 (15%)
Query: 367 NLIGKGGFGSVYKARL----GDRMEVAVKV----FNLQCGRAFESFDVECEMMKNIRHRN 418
+G+G FG VYK +L G EVAVK + + + F E +MK + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57
Query: 419 LIKILHGVAVITFTVCL 435
++++L GV + L
Sbjct: 58 VVRLL-GVCTEEEPLYL 73
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 7e-07
Identities = 26/63 (41%), Positives = 33/63 (52%), Gaps = 3/63 (4%)
Query: 172 NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSN 231
NLK L D S N + + GL NL+ L L N L P++F L SL+ L+LS
Sbjct: 1 NLKSL---DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57
Query: 232 NNL 234
NNL
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 20/67 (29%), Positives = 32/67 (47%), Gaps = 8/67 (11%)
Query: 369 IGKGGFGSVYKARL------GDRMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIK 421
+G+G FG V+ D+ VAVK A + F+ E E++ N +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 422 ILHGVAV 428
+GV
Sbjct: 73 -FYGVCT 78
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 21/69 (30%), Positives = 36/69 (52%), Gaps = 1/69 (1%)
Query: 358 RATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHR 417
R +EF+ +G G FG V++ +R+ VA+K+ + F E + +K +RH+
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62
Query: 418 NLIKILHGV 426
+LI L V
Sbjct: 63 HLIS-LFAV 70
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 26/66 (39%), Positives = 32/66 (48%), Gaps = 10/66 (15%)
Query: 368 LIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAF-----ESFDVECEMMKNIRHRNLIKI 422
IGKG FG VYK L EVAVK C F E E++K H N++K+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKT----CRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 423 LHGVAV 428
+ GV V
Sbjct: 58 I-GVCV 62
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 20/67 (29%), Positives = 30/67 (44%), Gaps = 7/67 (10%)
Query: 367 NLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQCGRAFES-FDVECEMMKNIRHRNLI 420
+G+G FG V R +VAVK N S F+ E E+++ + H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 421 KILHGVA 427
K GV
Sbjct: 70 K-YKGVC 75
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 27/86 (31%), Positives = 39/86 (45%), Gaps = 4/86 (4%)
Query: 185 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEK 244
+ G+ + +++ L + G I + L ++ +NLSNN LSG IP +
Sbjct: 59 LWQGITCNNSSRVVSID---LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFT 115
Query: 245 LSY-LENLNLSFNKLEGEIPRGGSFG 269
S L LNLS N G IPRG
Sbjct: 116 TSSSLRYLNLSNNNFTGSIPRGSIPN 141
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 2/75 (2%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+S + L I LS N + G +P S+G+++ SLE + + +G IPE + LT+ I+
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIP-PSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRIL 495
Query: 61 NLGGNKLNGSIPITL 75
NL GN L+G +P L
Sbjct: 496 NLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 5e-05
Identities = 19/57 (33%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 105 LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
L LDL N+L+ F L +L+++ L N LTS+ F L + +L+ S N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 7e-05
Identities = 19/54 (35%), Positives = 27/54 (50%), Gaps = 2/54 (3%)
Query: 369 IGKGGFGSVYKA-RLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIK 421
IG+G G VYKA EVA+K L+ E E +MK+ +H N++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVD 79
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 17/63 (26%), Positives = 30/63 (47%), Gaps = 5/63 (7%)
Query: 366 NNLIGKGGFGSVYKA----RLGDRMEVAVKVFNLQCGRAF-ESFDVECEMMKNIRHRNLI 420
IG+G FG VY+ +++ VAVK + E F E +M+ H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 421 KIL 423
K++
Sbjct: 71 KLI 73
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVA-VKVFNLQCGRAFESFDVECEMMKNIRHRNL 419
++F IG G +G VYKAR + E+A +KV L+ G F E MMK+ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 420 I 420
+
Sbjct: 69 V 69
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 7/62 (11%)
Query: 367 NLIGKGGFGSVYKA---RLGDRMEVAVKVFNLQ--CGRAFESFDVECEMMKNIRHRNLIK 421
+LIG+G FG VYK GD VA+K +L+ A +S E +++KN++H N++K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDF--VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 422 IL 423
+
Sbjct: 64 YI 65
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 19/59 (32%), Positives = 35/59 (59%), Gaps = 7/59 (11%)
Query: 369 IGKGGFGSVYKARLGDRME-VAVKVFNLQCGRAFESFDV----ECEMMKNIRHRNLIKI 422
IG+G +G VYKAR E VA+K ++ + E F + E ++++ +RH N++++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRL 63
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 23/59 (38%), Positives = 33/59 (55%), Gaps = 4/59 (6%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVA---VKVFNLQCGRAFESFDVECEMMKNIRHRNLIKIL 423
IGKG F VYKA L D VA V++F + +A + E +++K + H N+IK L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 18/55 (32%), Positives = 32/55 (58%), Gaps = 3/55 (5%)
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKIL 423
IG+G FG+V + G+ V V N++C ++F E +M + H+NL+++L
Sbjct: 14 IGEGEFGAVLQ---GEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLL 65
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 23/65 (35%), Positives = 34/65 (52%), Gaps = 4/65 (6%)
Query: 367 NLIGKGGFGSVYKARLGDRMEV-AVKVFNLQCGR--AFESFDVECEMMKNIRHRNLIKIL 423
N IG G FG VY A D E+ AVK +Q + E ++++ ++H NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-Y 64
Query: 424 HGVAV 428
+GV V
Sbjct: 65 YGVEV 69
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.001
Identities = 20/58 (34%), Positives = 27/58 (46%), Gaps = 3/58 (5%)
Query: 367 NLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDV--ECEMMKNIRHRNLIK 421
IGKG FG VY R D +K +L E D E +++K + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 23/67 (34%), Positives = 36/67 (53%), Gaps = 7/67 (10%)
Query: 368 LIGKGGFGSVYKARL----GDRMEVAVKVFNLQ--CGRAFESFDVECEMMKNIRHRNLIK 421
++G+G FGSV + +L G +++VAVK L E F E MK+ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 422 ILHGVAV 428
++ GV
Sbjct: 66 LI-GVCF 71
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 22/63 (34%), Positives = 33/63 (52%), Gaps = 6/63 (9%)
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFNLQCGRA-FESFDVECEMMKNIRHRNLIKILHGVA 427
+G G FG V++ + VAVK L+ G + F E ++MK +RH LI++ A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLY---A 68
Query: 428 VIT 430
V T
Sbjct: 69 VCT 71
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 21/57 (36%), Positives = 31/57 (54%), Gaps = 4/57 (7%)
Query: 368 LIGKGGFGSVYKARLGDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKIL 423
IGKG FG V + +VAVK L+ A ++F E +M +RH NL+++L
Sbjct: 13 TIGKGEFGDVMLGDYRGQ-KVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLL 66
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 20/57 (35%), Positives = 31/57 (54%), Gaps = 1/57 (1%)
Query: 368 LIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFE-SFDVECEMMKNIRHRNLIKIL 423
L+GKG FG V+K L D+ VAVK + + F E ++K H N++K++
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.003
Identities = 16/36 (44%), Positives = 20/36 (55%), Gaps = 1/36 (2%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL 395
+ F+ IGKG FG VYKA VA+KV +L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL 36
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 33/150 (22%), Positives = 56/150 (37%), Gaps = 31/150 (20%)
Query: 6 SLTLIYLSNNPL-DGILPK--TSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
SL + L+NN L D L + +L +LE + + G E ++
Sbjct: 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA-------- 160
Query: 63 GGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC----HLAELYRLDLDGNKL--- 115
L + L+ L L +N + + + L LDL+ N L
Sbjct: 161 ------------LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208
Query: 116 -SGSLPACFSNLTSLRIVSLGSNKLTSVPL 144
+ +L ++L SL +++LG N LT
Sbjct: 209 GASALAETLASLKSLEVLNLGDNNLTDAGA 238
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 20/64 (31%), Positives = 31/64 (48%), Gaps = 6/64 (9%)
Query: 368 LIGKGGFGSV----YKARLGDRMEVAVKVF-NLQCGRAFESFDVECEMMKNIRHRNLIKI 422
+G G FG V + G + VAVK + + + F E +M ++ H NLI+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR- 60
Query: 423 LHGV 426
L+GV
Sbjct: 61 LYGV 64
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 20/71 (28%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 362 EFSENN---LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHR 417
E+ EN ++GKG +G VY AR L ++ +A+K + R + E + ++HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 418 NLIKILHGVAV 428
N+++ L +
Sbjct: 66 NIVQYLGSDSE 76
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 20/63 (31%), Positives = 33/63 (52%), Gaps = 13/63 (20%)
Query: 369 IGKGGFGSVYKARLGDRME-VAVKVFNLQCGRAFESFDVECEMMKNIR-------HRNLI 420
+G G FGSVY AR + E VA+K + F S++ EC ++ ++ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 421 KIL 423
K+
Sbjct: 62 KLK 64
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.004
Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 15/66 (22%)
Query: 367 NLIGKGGFGSVYKA---RLGDRMEVAVKVFNLQCGRAFES-FDV-----ECEMMKNIRHR 417
IG G +G V A R G + VA+K + F+ D E ++++++RH
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRK--VAIK----KISNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 418 NLIKIL 423
N+I +L
Sbjct: 60 NIIGLL 65
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 499 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.92 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.89 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.87 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.87 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.84 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.83 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.83 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.82 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.82 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.81 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.8 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.8 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.79 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.79 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.79 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.79 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.78 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.78 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.77 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.77 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.77 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.76 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.75 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.75 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.74 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.73 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.73 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.71 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.71 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.71 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.71 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.71 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.7 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.69 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.69 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.68 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.68 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.68 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.68 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.68 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.67 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.66 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.66 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.66 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.65 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.65 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.65 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.65 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.65 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.64 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.64 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.64 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.64 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.64 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.64 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.64 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.64 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.64 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.63 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.63 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.63 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.63 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.63 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.63 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.63 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.62 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.62 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.62 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.62 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.62 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.62 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.62 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.62 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.62 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.62 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.62 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.61 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.61 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.61 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.61 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.61 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.61 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.61 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.6 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.6 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.6 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.6 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.6 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.6 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.6 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.6 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.6 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.6 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.6 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.59 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.59 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.59 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.59 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.59 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.59 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.59 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.59 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.59 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.59 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.58 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.58 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.58 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.58 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.58 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.58 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.58 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.58 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.58 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.58 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.58 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.58 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.57 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.57 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.57 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.57 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.57 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.57 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.57 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.57 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.57 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.57 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.57 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.57 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.56 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.56 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.56 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.56 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.56 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.56 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.56 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.56 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.56 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.55 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.55 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.55 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.55 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.55 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.55 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.55 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.55 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.55 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.55 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.55 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.55 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.55 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.55 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.55 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.55 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.55 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.55 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.55 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.54 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.54 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.54 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.54 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.54 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.54 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.54 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.54 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.54 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.54 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.54 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.54 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.54 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.54 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.54 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.54 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.54 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.54 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.54 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.54 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.54 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.54 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.54 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.54 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.54 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.53 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.53 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.53 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.53 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.53 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.53 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.53 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.53 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.53 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.53 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.53 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.53 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.53 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.53 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.53 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.53 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.53 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.53 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.53 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.53 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.53 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.53 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.53 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.53 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.53 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.52 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.52 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.52 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.52 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.52 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.52 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.52 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.52 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.52 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.52 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.52 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.52 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.52 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.52 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.52 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.52 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.52 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.52 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.52 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.52 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.52 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.52 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.51 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.51 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.51 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.51 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.51 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.51 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.51 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.51 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.51 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.51 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.51 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.51 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.51 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.51 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.51 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.51 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.5 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.5 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.5 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.5 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.5 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.5 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.5 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.5 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.5 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.5 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.5 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.5 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.5 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.5 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.5 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.5 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.5 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.49 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.49 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.49 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.49 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.49 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.49 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.49 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.49 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.49 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.49 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.49 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.49 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.49 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.49 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.49 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.49 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.49 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.49 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.49 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.49 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.49 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.48 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.48 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.48 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.48 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.48 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.48 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.48 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.48 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.48 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.48 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.48 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.48 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.48 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.48 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.48 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.48 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.48 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.48 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.48 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.48 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.47 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.47 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.47 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.47 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.47 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.47 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.47 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.47 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.47 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.47 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.47 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.46 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.46 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.46 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.46 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.46 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.46 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.46 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.46 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.46 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.45 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.45 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.45 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.45 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.45 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.45 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.45 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.45 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.45 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.45 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.44 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.44 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.44 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.44 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.43 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.43 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.43 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.43 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.43 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.43 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.43 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.43 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.43 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.42 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.42 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.42 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.42 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.42 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.42 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.42 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.42 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.42 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.41 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.41 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.41 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.41 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.41 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.4 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.4 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.4 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.4 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.39 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.39 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.38 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.38 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.38 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.38 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.37 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.37 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.37 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.36 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.36 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.36 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.35 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.35 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.35 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.35 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.35 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.35 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.35 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.34 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.33 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.33 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.32 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.32 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.32 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.31 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.3 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.3 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.3 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.28 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.28 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.28 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.27 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.27 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.26 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.26 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.26 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.24 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.24 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.23 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.22 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.21 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.19 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.16 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.15 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.13 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.13 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.13 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.12 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.12 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.1 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.08 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.03 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.03 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.03 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.03 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.01 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.01 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.97 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.94 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 98.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 98.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 98.9 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 98.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 98.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 98.83 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.76 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.71 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.66 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.6 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.57 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 98.56 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 98.54 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.49 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.48 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.47 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.44 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 98.43 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.39 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.37 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.36 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.35 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.34 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.33 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.25 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.12 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.1 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 98.04 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.99 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 97.97 | |
| PF13306 | 129 | LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ | 97.96 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 97.81 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.74 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 97.71 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 97.68 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 97.61 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 97.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.52 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 97.5 | |
| KOG2739 | 260 | consensus Leucine-rich acidic nuclear protein [Cel | 97.45 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 97.42 | |
| KOG2123 | 388 | consensus Uncharacterized conserved protein [Funct | 97.41 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.27 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 97.14 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.02 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-54 Score=474.78 Aligned_cols=476 Identities=26% Similarity=0.411 Sum_probs=323.8
Q ss_pred CCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCcc------------
Q 010856 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGS------------ 70 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~------------ 70 (499)
++++|+.|++++|.+++..|. .+..++ +|+.|++++|.+++..|..+..+++|+.|++++|++++.
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~-~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~ 383 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPV-ALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF 383 (968)
T ss_pred CCCCCcEEECCCCccCCcCCh-hHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCC
Confidence 455666666666666555554 445555 556666655555555555555555555555555555444
Q ss_pred ------------CCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccC
Q 010856 71 ------------IPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNK 138 (499)
Q Consensus 71 ------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 138 (499)
.|..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|+
T Consensus 384 ~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 463 (968)
T PLN00113 384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463 (968)
T ss_pred EEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCce
Confidence 44445555556666666666555555556666666666666666666666555666666666666666
Q ss_pred CCC-CCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCcc
Q 010856 139 LTS-VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS 217 (499)
Q Consensus 139 l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 217 (499)
+.. +|. ....++|+.|++++|++++..|..+.++++|+.|++++|.+.+..|..+..+++|++|++++|.+++..|..
T Consensus 464 ~~~~~p~-~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 542 (968)
T PLN00113 464 FFGGLPD-SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS 542 (968)
T ss_pred eeeecCc-ccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChh
Confidence 665 333 334577888888888888888888899999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCCC-CCCCCCCCCC
Q 010856 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP-NLQVPPCKTS 296 (499)
Q Consensus 218 l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~~-~~~~~~~~~~ 296 (499)
|..+++|+.|++++|++++..|..+..+++|+.+++++|++++.+|....+..+....+.||+.+|+.+ ....++|...
T Consensus 543 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~ 622 (968)
T PLN00113 543 FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV 622 (968)
T ss_pred HhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc
Confidence 999999999999999999999999999999999999999999999998888888888999999999864 3345667532
Q ss_pred ccccccccccceeeeccchhhhHHHHHHHH-HHhhhcCCCCCCC-C--CCc----ccc--cccccCHHHHHHHhhhcccc
Q 010856 297 IHHTSWKNSLLLRIVLPLSTTFMIVVILLI-LRYQQRGKRPSND-A--NMP----LVA--TWRTFSYLELFRATDEFSEN 366 (499)
Q Consensus 297 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~--~~~----~~~--~~~~~~~~~~~~~~~~~~~~ 366 (499)
. +....+++++++++++++++++++. ++++++++..... . ... ... ....++.+++ ...+...
T Consensus 623 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 695 (968)
T PLN00113 623 R----KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEE 695 (968)
T ss_pred c----ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcc
Confidence 1 1112222222222222222222222 2222222111110 0 000 000 1122333333 3457778
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCCc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSASA 445 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~ 445 (499)
+++|+|+||.||+|+. .++..||||+++.... ...+|++++++++|||||+++|+|...+ ..++++||+.++.
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~Ey~~~g~ 769 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIHEYIEGKN 769 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEEeCCCCCc
Confidence 8999999999999996 5789999999865432 1235688999999999999999997744 3456778876554
Q ss_pred cc-ccc-ccccccccccccccccceeecc---------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 446 SA-SLV-SSLTLSRPAKGGGFRGCVLWHV---------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 446 ~~-~l~-~~~~~~~~~~~~i~~gl~yLH~---------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
.. .++ ..+.....++.|+|+||+|||. ++||.|++++.++.+++ +||..
T Consensus 770 L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~-~~~~~ 829 (968)
T PLN00113 770 LSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLP 829 (968)
T ss_pred HHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE-Eeccc
Confidence 33 332 2344456678999999999993 68899999876655544 46654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=308.62 Aligned_cols=283 Identities=35% Similarity=0.544 Sum_probs=229.7
Q ss_pred CCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCC
Q 010856 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKL 81 (499)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 81 (499)
.++++|++|++++|.+.+..|. .+..++ +|++|++++|.+++..|..+..+++|+.|++++|.+++..|..+..+++|
T Consensus 281 ~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~-~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L 358 (968)
T PLN00113 281 FSLQKLISLDLSDNSLSGEIPE-LVIQLQ-NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL 358 (968)
T ss_pred hhccCcCEEECcCCeeccCCCh-hHcCCC-CCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCC
Confidence 4688999999999999988887 777888 89999999999999999999999999999999999998899999999999
Q ss_pred CeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC-CCccccCCCCCcEEEcCCC
Q 010856 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSN 160 (499)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n 160 (499)
+.|++++|++.+..|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|+++. +|..+..+++|+.|++++|
T Consensus 359 ~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 438 (968)
T PLN00113 359 TVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNN 438 (968)
T ss_pred cEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCC
Confidence 999999999987777777777777777777777666666666666666666666666654 4545555555555555555
Q ss_pred cCCCCCccccc-----------------------CCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCcc
Q 010856 161 FLTSPLPLEIG-----------------------NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS 217 (499)
Q Consensus 161 ~l~~~~~~~~~-----------------------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 217 (499)
.+++..+..+. ..++|+.|++++|++++..|..+..+++|++|++++|++.+..|..
T Consensus 439 ~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 518 (968)
T PLN00113 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518 (968)
T ss_pred cccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChH
Confidence 55444333322 2356777777777777778888888899999999999999889999
Q ss_pred ccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcCCCCCC
Q 010856 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP 286 (499)
Q Consensus 218 l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~~c~~~ 286 (499)
+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++.+|.. ..+..+..+++.+|++.+..|
T Consensus 519 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 519 LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred HcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 999999999999999999999999999999999999999999888865 456778899999999877554
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=279.38 Aligned_cols=286 Identities=22% Similarity=0.222 Sum_probs=178.0
Q ss_pred CCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCC
Q 010856 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKL 81 (499)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 81 (499)
+.++.|++||||.|.|+.+... .+..-+ ++++|+|++|.|+.+..+.|.++.+|.+|.|+.|+|+...+..|.++++|
T Consensus 146 ~~l~alrslDLSrN~is~i~~~-sfp~~~-ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L 223 (873)
T KOG4194|consen 146 SALPALRSLDLSRNLISEIPKP-SFPAKV-NIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKL 223 (873)
T ss_pred HhHhhhhhhhhhhchhhcccCC-CCCCCC-CceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchh
Confidence 3456677777777777755333 444433 67777777777777777777777777777777777776666677777777
Q ss_pred CeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCC-ccccCCCCCcEEEcCCC
Q 010856 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSN 160 (499)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n 160 (499)
+.|+|..|+|.-...-.|.++++|+.|.|..|.+.....+.|..+.++++|+|..|++..+. .+++++++|+.|++++|
T Consensus 224 ~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~N 303 (873)
T KOG4194|consen 224 ESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYN 303 (873)
T ss_pred hhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchh
Confidence 77777777776444455666666666666666666555556666666666666666655543 24555555555555555
Q ss_pred cCCCCCcccccCCCCccEEEccCCcccccCccc------------------------ccCCcCCceeeCcCCcCCCCC--
Q 010856 161 FLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTE------------------------IGGLKNLEYLFLGYNRLQGSI-- 214 (499)
Q Consensus 161 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------------------------l~~l~~L~~L~L~~n~l~~~~-- 214 (499)
.|..+.++.+...++|+.|+|++|+|+...+.. |.++++|++|||++|.++..+
T Consensus 304 aI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 304 AIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred hhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 555555555555555555555555555544444 445555555555555554322
Q ss_pred -CccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCCCCCC
Q 010856 215 -PDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQ 289 (499)
Q Consensus 215 -~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~~~~~ 289 (499)
...|.++++|+.|++.+|+|..+.-.+|.+++.|+.|||.+|.|.+.-|....-..++.+-+..-.++|+|...|
T Consensus 384 aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~W 459 (873)
T KOG4194|consen 384 AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKW 459 (873)
T ss_pred chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHH
Confidence 234556666666666666666666666666777777777777766655554333355666666666789885433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=276.34 Aligned_cols=276 Identities=23% Similarity=0.245 Sum_probs=252.6
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
.+|+.|+|.+|.|+.+... .+..+| .|++|||+.|.|+.+.-.+|..-.++++|+|++|+|+.+..+.|.++.+|..|
T Consensus 125 ghl~~L~L~~N~I~sv~se-~L~~l~-alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVTSE-ELSALP-ALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred cceeEEeeeccccccccHH-HHHhHh-hhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence 4699999999999988776 888888 89999999999998887888888899999999999999999999999999999
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCCCCCcEEEcCCCcCC
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~ 163 (499)
.|+.|+++...+..|.++++|+.|+|..|+|.-..--+|.++++|+.|.|..|.|..+.+ .|+.+.++++|+|..|++.
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~ 282 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ 282 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence 999999998888899999999999999999996656789999999999999999999755 6889999999999999999
Q ss_pred CCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCccccc
Q 010856 164 SPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLE 243 (499)
Q Consensus 164 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 243 (499)
......+-+++.|+.|++|+|.|..+.++.++..++|++|+|++|+|+...++.|..+..|+.|+|++|.+.......|.
T Consensus 283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~ 362 (873)
T KOG4194|consen 283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV 362 (873)
T ss_pred hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence 98888999999999999999999999999999999999999999999999999999999999999999999988888999
Q ss_pred CCCCCCEEEccCCcCcccCCCC----CCCCCccccccCCCcCC
Q 010856 244 KLSYLENLNLSFNKLEGEIPRG----GSFGNFSAESFEGNELL 282 (499)
Q Consensus 244 ~l~~L~~L~l~~N~l~~~~~~~----~~~~~l~~~~l~~N~~~ 282 (499)
.+++|++|||+.|.++..+... ..++.++.+.+.||...
T Consensus 363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee
Confidence 9999999999999998766543 23677888888888753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=244.88 Aligned_cols=276 Identities=27% Similarity=0.413 Sum_probs=219.3
Q ss_pred CCCCCCCCEEECcCCCCCcc-CChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCC
Q 010856 1 MSNCKSLTLIYLSNNPLDGI-LPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQ 79 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~~-~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 79 (499)
++.+|.|+.+++..|++... +|. .+..+. .|..|+|++|+++ ..|..+...+++-.|+|++|+|..++...|.++.
T Consensus 74 Ls~Lp~LRsv~~R~N~LKnsGiP~-diF~l~-dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLt 150 (1255)
T KOG0444|consen 74 LSDLPRLRSVIVRDNNLKNSGIPT-DIFRLK-DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLT 150 (1255)
T ss_pred hccchhhHHHhhhccccccCCCCc-hhcccc-cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhH
Confidence 35667777777777776432 232 455566 6888888888887 6677787788888888888888866666677888
Q ss_pred CCCeEecccccccccCCccccCcccccEEeeecCCCC-------------------------CcCCccccCCccCCeeec
Q 010856 80 KLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLS-------------------------GSLPACFSNLTSLRIVSL 134 (499)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L~L 134 (499)
.|-.||||+|++. .+|..+..+..|++|.|++|.+. ..+|.++..+.+|..+|+
T Consensus 151 DLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDl 229 (1255)
T KOG0444|consen 151 DLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDL 229 (1255)
T ss_pred hHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccc
Confidence 8888888888887 55666777777888888887653 134556667778888888
Q ss_pred cccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCC-C
Q 010856 135 GSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-S 213 (499)
Q Consensus 135 ~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~ 213 (499)
+.|.+..+|..+..+++|+.|+||+|.|+. .........+|++|++|.|+++ ..|..+..++.|+.|++.+|+++- -
T Consensus 230 S~N~Lp~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeG 307 (1255)
T KOG0444|consen 230 SENNLPIVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEG 307 (1255)
T ss_pred cccCCCcchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccC
Confidence 999888888888889999999999998885 3445566788899999999988 678889999999999999998763 3
Q ss_pred CCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCC
Q 010856 214 IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC 283 (499)
Q Consensus 214 ~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c 283 (499)
+|..++.+.+|+.+..++|.+. ..|+.++.+..|+.|.|+.|++.+.+.....++.+..+++..||.+.
T Consensus 308 iPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLV 376 (1255)
T KOG0444|consen 308 IPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLV 376 (1255)
T ss_pred CccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCcc
Confidence 5788899999999999999988 88999999999999999999999665555678899999999998655
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-28 Score=222.56 Aligned_cols=276 Identities=23% Similarity=0.236 Sum_probs=221.6
Q ss_pred EECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEeccc-
Q 010856 10 IYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLED- 88 (499)
Q Consensus 10 L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~- 88 (499)
.+.++-.++.+ |. ++|+.-..++|..|+|+.+.+.+|+.+++|+.|||++|+|+.+.|++|.++++|..|-+.+
T Consensus 51 VdCr~~GL~eV-P~----~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 51 VDCRGKGLTEV-PA----NLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred EEccCCCcccC-cc----cCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence 34445555533 32 4677899999999999999999999999999999999999999999999999988877766
Q ss_pred ccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCCCCCcEEEcCCCcCC----
Q 010856 89 NKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLT---- 163 (499)
Q Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~---- 163 (499)
|+|+.+..+.|.++.+|+.|.+.-|++.-+..+.|..+++|..|.+..|.+..++. .+..+.+++.+.+..|.+-
T Consensus 126 NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 126 NKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred CchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence 89998878889999999999999999998888899999999999999999998887 7888888999988888732
Q ss_pred --------CCCcccccCCCCccEEEccCCc--------------------------ccccCcccccCCcCCceeeCcCCc
Q 010856 164 --------SPLPLEIGNLKVLIGIDFSMNN--------------------------FSGVIPTEIGGLKNLEYLFLGYNR 209 (499)
Q Consensus 164 --------~~~~~~~~~l~~L~~L~l~~n~--------------------------l~~~~~~~l~~l~~L~~L~L~~n~ 209 (499)
...+..++.........+.+++ ........|..+++|+.|+|++|+
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~ 285 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK 285 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence 1122222222222111121111 111223457889999999999999
Q ss_pred CCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcCCCCCCCC
Q 010856 210 LQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPNL 288 (499)
Q Consensus 210 l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~~c~~~~~ 288 (499)
|+++.+.+|.+...+++|.|..|+|.......|.++..|+.|+|.+|+|+...|.. .....+..+.+.+|||.|+|...
T Consensus 286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 99999999999999999999999999888889999999999999999999887765 34567888999999999999654
Q ss_pred CC
Q 010856 289 QV 290 (499)
Q Consensus 289 ~~ 290 (499)
|+
T Consensus 366 wl 367 (498)
T KOG4237|consen 366 WL 367 (498)
T ss_pred HH
Confidence 43
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-28 Score=232.00 Aligned_cols=256 Identities=28% Similarity=0.386 Sum_probs=142.6
Q ss_pred cccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCc-cCCccccCCCCCCeEecccccccccCCccccCccc
Q 010856 26 VGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNG-SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAE 104 (499)
Q Consensus 26 ~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 104 (499)
++.+. +|++|.+++|++..+ ...++.++.|+.+.+.+|++.. -+|..+..+..|+.||||+|++. ..|..+...++
T Consensus 51 L~~lq-kLEHLs~~HN~L~~v-hGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn 127 (1255)
T KOG0444|consen 51 LSRLQ-KLEHLSMAHNQLISV-HGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKN 127 (1255)
T ss_pred HHHHh-hhhhhhhhhhhhHhh-hhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcC
Confidence 34443 455555555555522 2335555555555555555543 12344455666666666666666 45556666666
Q ss_pred ccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCC-------------------
Q 010856 105 LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSP------------------- 165 (499)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~------------------- 165 (499)
+-.|+|++|+|..++...|.+++.|-.|||++|++..+|+.+..+..|++|+|++|.+...
T Consensus 128 ~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~T 207 (1255)
T KOG0444|consen 128 SIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNT 207 (1255)
T ss_pred cEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccc
Confidence 6666666666665555556666666666666666666666666666666666666655432
Q ss_pred ------CcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCc
Q 010856 166 ------LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239 (499)
Q Consensus 166 ------~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 239 (499)
+|..+..+.+|..+|+|.|.+. ..|+.+-.+++|+.|+||+|+|+. .........+|+.|++|.|+++ ..|
T Consensus 208 qRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP 284 (1255)
T KOG0444|consen 208 QRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLP 284 (1255)
T ss_pred cchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cch
Confidence 3344444455555555555554 445555555555555555555552 2223333445555555555555 556
Q ss_pred ccccCCCCCCEEEccCCcCc--ccCCCCCCCCCccccccCCCcC------CCCCCC
Q 010856 240 ASLEKLSYLENLNLSFNKLE--GEIPRGGSFGNFSAESFEGNEL------LCGSPN 287 (499)
Q Consensus 240 ~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~~~l~~~~l~~N~~------~c~~~~ 287 (499)
+++.++++|+.|++.+|+++ |.+...+.+..+..+....|.. +|.|+.
T Consensus 285 ~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~k 340 (1255)
T KOG0444|consen 285 DAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVK 340 (1255)
T ss_pred HHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHH
Confidence 66666677777777776664 3333334455555555555542 566654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=213.36 Aligned_cols=150 Identities=31% Similarity=0.395 Sum_probs=126.1
Q ss_pred cccccCHHHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeE
Q 010856 347 TWRTFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426 (499)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~ 426 (499)
....|+++++..+|++|...+.||+|+||.||+|...+|+.||||++........++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999988899999988765432145699999999999999999999999
Q ss_pred EccccceeeeeecccCCC-ccccccc------cccccccccccccccceeecc---------CCCcccEEEeeCCCeEEE
Q 010856 427 AVITFTVCLCLFHHSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV---------GVDFAAFVFVLEPGVEVI 490 (499)
Q Consensus 427 ~~~~~~~~~~l~~~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~---------~~~p~~~l~~~~~~~~~~ 490 (499)
.+.+. ...+++|||.++ +.+.++. .|..+.+||.++|+||+|||+ ++||.|||++.+..+|++
T Consensus 141 ~e~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 87543 467789999654 4344332 455677889999999999998 567788899989999999
Q ss_pred EEEEeec
Q 010856 491 CFVFEIL 497 (499)
Q Consensus 491 ~f~~~~~ 497 (499)
|||+++.
T Consensus 220 DFGLa~~ 226 (361)
T KOG1187|consen 220 DFGLAKL 226 (361)
T ss_pred CccCccc
Confidence 9999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-27 Score=217.09 Aligned_cols=264 Identities=31% Similarity=0.446 Sum_probs=224.5
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEe
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLG 85 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 85 (499)
.|+.|.+++|.+....+ .+.++. .|..|++.+|+++ ..|.+++.+..++.|+.++|++. ..|..+..+.+|..|+
T Consensus 46 ~l~~lils~N~l~~l~~--dl~nL~-~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 46 DLQKLILSHNDLEVLRE--DLKNLA-CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred chhhhhhccCchhhccH--hhhccc-ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 46778899999886655 466777 7999999999998 56778888899999999999988 6778888899999999
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCC
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSP 165 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (499)
.++|.+. ..++.++.+..|+.++..+|+++ ..|+.+..+.+|..+++.+|+++.+|+..-.++.|++||...|.++ .
T Consensus 121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 121 CSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-T 197 (565)
T ss_pred cccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-c
Confidence 9999988 66777888889999999999998 5667788888999999999999998887777899999999999887 4
Q ss_pred CcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCC
Q 010856 166 LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKL 245 (499)
Q Consensus 166 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 245 (499)
+|..++.+.+|..|++.+|+|. ..| .|.++..|.+|+++.|+|.-...+...+++++..||+.+|+++ ..|+.+..+
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL 274 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL 274 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence 7778899999999999999998 445 7899999999999999998444445568999999999999998 678888889
Q ss_pred CCCCEEEccCCcCcccCCCCCCCCCccccccCCCcC
Q 010856 246 SYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281 (499)
Q Consensus 246 ~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~ 281 (499)
.+|..||+|+|.+++..+..+.+ .+..+.+.|||.
T Consensus 275 rsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 275 RSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred hhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence 99999999999999887777766 788888999985
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-26 Score=209.48 Aligned_cols=278 Identities=23% Similarity=0.259 Sum_probs=226.2
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccC-CcCCccCCccccCCCCCCeE
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG-NKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L 84 (499)
.-.+++|+.|.|+.+++. .|+.++ +|+.|||++|+|+.+-|++|.++++|.+|-+-+ |+|+.+..+.|.++..|+.|
T Consensus 68 ~tveirLdqN~I~~iP~~-aF~~l~-~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPG-AFKTLH-RLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRL 145 (498)
T ss_pred cceEEEeccCCcccCChh-hccchh-hhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHH
Confidence 457899999999977766 999999 999999999999999999999999998887666 99998888999999999999
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC---C----------CccccCCC-
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS---V----------PLTFWNLK- 150 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~----------~~~~~~l~- 150 (499)
.+.-|++.-+..+.|..+++|..|.+.+|.+..+...+|..+..++.+.+..|.+-. + |..++...
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc 225 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC 225 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence 999999998888899999999999999999997666699999999999998887321 1 11111110
Q ss_pred ---------------------CCcEE----EcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeC
Q 010856 151 ---------------------DILNL----NFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFL 205 (499)
Q Consensus 151 ---------------------~L~~L----~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 205 (499)
.++.+ ....+....-....|..+++|++|+|++|+|+++-+.+|.++..+++|.|
T Consensus 226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 11111 11112222223356889999999999999999999999999999999999
Q ss_pred cCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCC
Q 010856 206 GYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS 285 (499)
Q Consensus 206 ~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~ 285 (499)
..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+.+|.+|++-.|++.+...-.+...+++.-...||| -|..
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~-~Cq~ 384 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP-RCQS 384 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCC-CCCC
Confidence 999999888889999999999999999999999999999999999999999998755444333344444455555 4544
Q ss_pred C
Q 010856 286 P 286 (499)
Q Consensus 286 ~ 286 (499)
|
T Consensus 385 p 385 (498)
T KOG4237|consen 385 P 385 (498)
T ss_pred C
Confidence 3
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-26 Score=210.85 Aligned_cols=247 Identities=29% Similarity=0.443 Sum_probs=223.1
Q ss_pred CCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCC
Q 010856 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKL 81 (499)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 81 (499)
.++..|++|++++|+++..+| +++.+. .++.|+.++|+++ .+|+.+.++.+|..|++++|.+. ..++.++.+..|
T Consensus 65 ~nL~~l~vl~~~~n~l~~lp~--aig~l~-~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l 139 (565)
T KOG0472|consen 65 KNLACLTVLNVHDNKLSQLPA--AIGELE-ALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDL 139 (565)
T ss_pred hcccceeEEEeccchhhhCCH--HHHHHH-HHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhh
Confidence 467889999999999996654 677777 8999999999998 78889999999999999999998 567778999999
Q ss_pred CeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCc
Q 010856 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNF 161 (499)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~ 161 (499)
+.|+..+|++. ..|..+.++.+|..|++.+|.+....|.... ++.|++||...|-++.+|..++.+.+|+-|++..|+
T Consensus 140 ~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nk 217 (565)
T KOG0472|consen 140 EDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNK 217 (565)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcc
Confidence 99999999998 5677888999999999999999976666655 999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCccc
Q 010856 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241 (499)
Q Consensus 162 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~ 241 (499)
|.. .| .|.++..|+.|+++.|+|.-.......+++++..|||.+|+++ ..|+.+.-+.+|..||+|+|.|+ ..|..
T Consensus 218 i~~-lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~s 293 (565)
T KOG0472|consen 218 IRF-LP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYS 293 (565)
T ss_pred ccc-CC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcc
Confidence 985 45 8999999999999999998555555679999999999999999 78999999999999999999999 56778
Q ss_pred ccCCCCCCEEEccCCcCcc
Q 010856 242 LEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 242 ~~~l~~L~~L~l~~N~l~~ 260 (499)
++++ .|+.|-+.||++.+
T Consensus 294 Lgnl-hL~~L~leGNPlrT 311 (565)
T KOG0472|consen 294 LGNL-HLKFLALEGNPLRT 311 (565)
T ss_pred cccc-eeeehhhcCCchHH
Confidence 9999 99999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-23 Score=191.68 Aligned_cols=141 Identities=20% Similarity=0.286 Sum_probs=111.4
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
...++|...+.||+|+||+||+|++ +++..||||.+.+.. .+..+....|++|++.++|||||++++++...++. +
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i-~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI-Y 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE-E
Confidence 3457888999999999999999996 468999999997763 44567789999999999999999999999886643 3
Q ss_pred eeeecccCCCccccccccccccccc----cccccccceeecc------CCCcccEEEeeC------CCeEEEEEEEeecc
Q 010856 435 LCLFHHSSASASASLVSSLTLSRPA----KGGGFRGCVLWHV------GVDFAAFVFVLE------PGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~~~~~~~~----~~~i~~gl~yLH~------~~~p~~~l~~~~------~~~~~~~f~~~~~~ 498 (499)
++|++|-+|++...++..+...+.. ..|+|.||++||+ |+||+|+|+... ...||+||||+|.|
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 3344444677777776654443333 4789999988754 999999999765 45799999999987
Q ss_pred C
Q 010856 499 N 499 (499)
Q Consensus 499 ~ 499 (499)
+
T Consensus 166 ~ 166 (429)
T KOG0595|consen 166 Q 166 (429)
T ss_pred C
Confidence 4
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-24 Score=216.75 Aligned_cols=246 Identities=29% Similarity=0.382 Sum_probs=169.1
Q ss_pred ccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEee
Q 010856 31 HSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDL 110 (499)
Q Consensus 31 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 110 (499)
.+|+++++++|+++. +|+.+..+.+|+.|+..+|+++ ..|..+...++|+.|.+..|.+. -+|....+++.|++|+|
T Consensus 241 ~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 355555555555552 2355555555555555555553 33444444555555555555555 23334444555555555
Q ss_pred ecCCCCCcCCccccCCcc-CCeeeccccCCCCCCcc-ccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccc
Q 010856 111 DGNKLSGSLPACFSNLTS-LRIVSLGSNKLTSVPLT-FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSG 188 (499)
Q Consensus 111 ~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 188 (499)
..|++...++..|..... |+.|+.+.|.+...|.. -..++.|+.|++.+|.+++.....+.+..+|+.|+|++|++..
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 555555333323332222 44555555555544421 1235678889999999998777788889999999999999997
Q ss_pred cCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcc-cCCCCCC
Q 010856 189 VIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG-EIPRGGS 267 (499)
Q Consensus 189 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~ 267 (499)
.....+.+++.|++|+||+|+++ .+|+.+..++.|++|...+|+|. ..| .+..++.|+.+|++.|.++. .+|....
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC
Confidence 77788899999999999999999 66789999999999999999998 556 78899999999999999985 3455555
Q ss_pred CCCccccccCCCcCC
Q 010856 268 FGNFSAESFEGNELL 282 (499)
Q Consensus 268 ~~~l~~~~l~~N~~~ 282 (499)
+++++.++++||+|.
T Consensus 475 ~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 475 SPNLKYLDLSGNTRL 489 (1081)
T ss_pred CcccceeeccCCccc
Confidence 689999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-23 Score=185.17 Aligned_cols=136 Identities=18% Similarity=0.188 Sum_probs=110.3
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+.|+...++|+|+||+||+|+.+ +|+.||||++..... .-.+-.+|||+++++++|+|+|.++++|.. -.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 45777889999999999999964 699999999965542 234567899999999999999999999877 3355667
Q ss_pred ecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+||+....+..+.. +....+.+..|+++|+.|+|+ |+||+||+++..|.+|+|||||+|.|
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTL 151 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence 88887665555432 122345567899999999876 89999999999999999999999976
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=199.10 Aligned_cols=176 Identities=27% Similarity=0.248 Sum_probs=85.1
Q ss_pred CCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCC
Q 010856 80 KLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSS 159 (499)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~ 159 (499)
+|+.|++++|+++. +|. .+++|+.|++++|++++. |.. ..+|+.|++++|+++.+|.. .++|+.|+|++
T Consensus 283 ~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~LP~l---p~~Lq~LdLS~ 351 (788)
T PRK15387 283 GLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTSLPTL---PSGLQELSVSD 351 (788)
T ss_pred hcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CCC---cccccccccccCcccccccc---ccccceEecCC
Confidence 34445555555542 222 124566666666666532 221 12344455555555544421 13566666666
Q ss_pred CcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCc
Q 010856 160 NFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239 (499)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 239 (499)
|+|+++ |.. ..+|+.|++++|+++. +|.. ..+|+.|++++|++++ +|.. .++|+.|++++|++++ +|
T Consensus 352 N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP 418 (788)
T PRK15387 352 NQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LP 418 (788)
T ss_pred CccCCC-CCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CC
Confidence 666642 221 2345555555555553 2221 2356666666666653 2221 2356666666666653 23
Q ss_pred ccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCC
Q 010856 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL 282 (499)
Q Consensus 240 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~ 282 (499)
.. ..+|+.|++++|+|+..+.....++.+..+++.+|++.
T Consensus 419 ~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 419 ML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred cc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCC
Confidence 22 23455566666666532222234555556666666643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-22 Score=188.10 Aligned_cols=138 Identities=20% Similarity=0.179 Sum_probs=114.9
Q ss_pred hhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+.|+..++||+|.||.||+|+ ..+|+.||+|++.... ........|||.||++++|||||+|.+.+.+......+++
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457777899999999999999 4689999999997665 3445667899999999999999999999887655677889
Q ss_pred ecccCCCcccccc-----ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSSASASASLV-----SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~~~~~~l~-----~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+|||..++...+. ......+.+..|++.||+|||. |+|..|+|+++++..|++|||++++.
T Consensus 197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999887644433 3344455556899999998866 89999999999999999999999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-21 Score=202.44 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=177.3
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
.+.+.|+++++.++.+ |. . ++++|+.|+|++|+++. +|..+. ++|++|++++|+++. +|..+. .+|+.|
T Consensus 178 ~~~~~L~L~~~~LtsL-P~-~---Ip~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L 246 (754)
T PRK15370 178 NNKTELRLKILGLTTI-PA-C---IPEQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEM 246 (754)
T ss_pred cCceEEEeCCCCcCcC-Cc-c---cccCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCcccc-CChhhh--ccccEE
Confidence 3567899999888854 33 2 34589999999999985 444443 589999999999884 454443 478999
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCC
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTS 164 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (499)
+|++|.+. .+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|+++.+|..+. ++|+.|++++|.++.
T Consensus 247 ~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 247 ELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred ECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCcccc
Confidence 99999988 4555553 578999999999884 455443 589999999999988876543 578888999998886
Q ss_pred CCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccC
Q 010856 165 PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEK 244 (499)
Q Consensus 165 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 244 (499)
+ |..+ .++|+.|++++|.++. +|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+++.. |..+.
T Consensus 319 L-P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~L-P~~l~- 387 (754)
T PRK15370 319 L-PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNL-PENLP- 387 (754)
T ss_pred C-Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCC-CHhHH-
Confidence 3 3332 2678888899998885 454443 68899999999887 4555443 5888999999988854 44332
Q ss_pred CCCCCEEEccCCcCcccCCCC-----CCCCCccccccCCCcCCC
Q 010856 245 LSYLENLNLSFNKLEGEIPRG-----GSFGNFSAESFEGNELLC 283 (499)
Q Consensus 245 l~~L~~L~l~~N~l~~~~~~~-----~~~~~l~~~~l~~N~~~c 283 (499)
..|+.|++++|++++ +|.. ...+.+..+++.+||+..
T Consensus 388 -~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 388 -AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred -HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH
Confidence 368888889998874 3332 123556678888888643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-21 Score=198.30 Aligned_cols=224 Identities=27% Similarity=0.324 Sum_probs=162.4
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCcccc-----------------CCCCCCEEeccCCcCC
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEIS-----------------NLTNSTIVNLGGNKLN 68 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~-----------------~l~~L~~L~L~~n~l~ 68 (499)
+|+.|++++|+++.+ |. ++++|++|++++|+++.+ |.... ..++|+.|++++|+++
T Consensus 223 ~L~~L~L~~N~Lt~L-P~-----lp~~Lk~LdLs~N~LtsL-P~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt 295 (788)
T PRK15387 223 HITTLVIPDNNLTSL-PA-----LPPELRTLEVSGNQLTSL-PVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT 295 (788)
T ss_pred CCCEEEccCCcCCCC-CC-----CCCCCcEEEecCCccCcc-cCcccccceeeccCCchhhhhhchhhcCEEECcCCccc
Confidence 466666666666643 21 123666666666666633 22111 1134555666666665
Q ss_pred ccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccC
Q 010856 69 GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWN 148 (499)
Q Consensus 69 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 148 (499)
.+ |. .+++|+.|+|++|++++. |.. ..+|+.|++++|++++ +|. + ..+|+.|+|++|+|+.+|..
T Consensus 296 ~L-P~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~-l--p~~Lq~LdLS~N~Ls~LP~l--- 360 (788)
T PRK15387 296 SL-PV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LPT-L--PSGLQELSVSDNQLASLPTL--- 360 (788)
T ss_pred cc-cc---cccccceeECCCCccccC-CCC---cccccccccccCcccc-ccc-c--ccccceEecCCCccCCCCCC---
Confidence 32 32 247899999999999854 432 3468899999999985 343 2 25899999999999998864
Q ss_pred CCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEe
Q 010856 149 LKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLN 228 (499)
Q Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 228 (499)
.++|+.|++++|.++. +|.. ..+|+.|++++|++++. |.. .++|+.|++++|++++ +|.. ..+|+.|+
T Consensus 361 p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~L-P~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~ 428 (788)
T PRK15387 361 PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSL-PVL---PSELKELMVSGNRLTS-LPML---PSGLLSLS 428 (788)
T ss_pred Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCC-CCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhh
Confidence 3678899999999986 4432 35799999999999854 432 3689999999999995 4543 34688999
Q ss_pred CCCCcCCccCcccccCCCCCCEEEccCCcCcccCCC
Q 010856 229 LSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR 264 (499)
Q Consensus 229 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 264 (499)
+++|+|+ .+|..+..+++|+.|++++|+|++..+.
T Consensus 429 Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 429 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 9999999 5788899999999999999999986554
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-20 Score=205.33 Aligned_cols=261 Identities=25% Similarity=0.288 Sum_probs=117.6
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEe
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLG 85 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 85 (499)
+|+.|++.++.+...+.. +. +.+|++|++.+|.+. .++..+..+++|+.|+|+++......| .+..+++|+.|+
T Consensus 590 ~Lr~L~~~~~~l~~lP~~--f~--~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~ 663 (1153)
T PLN03210 590 KLRLLRWDKYPLRCMPSN--FR--PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLK 663 (1153)
T ss_pred ccEEEEecCCCCCCCCCc--CC--ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEE
Confidence 355666665555533221 21 225555555555555 334445555555555555543222333 244555555555
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCCccccCCcc---------------------CCeeeccccCCCCCCc
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTS---------------------LRIVSLGSNKLTSVPL 144 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~---------------------L~~L~L~~n~l~~~~~ 144 (499)
|++|.....+|..+..+++|+.|++++|.....+|..+ ++++ |+.|++++|.+..+|.
T Consensus 664 L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~lP~ 742 (1153)
T PLN03210 664 LSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPS 742 (1153)
T ss_pred ecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccccccc
Confidence 55554333445555555555555555543222333322 3344 4444455554444443
Q ss_pred cccCC-------------------------------CCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCccc
Q 010856 145 TFWNL-------------------------------KDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTE 193 (499)
Q Consensus 145 ~~~~l-------------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 193 (499)
.+ .+ ++|+.|++++|.....+|..+.++++|+.|++++|...+.+|..
T Consensus 743 ~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~ 821 (1153)
T PLN03210 743 NL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTG 821 (1153)
T ss_pred cc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCC
Confidence 21 11 23344444444333334444444444444444444322223332
Q ss_pred ccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccC-CcCcccCCCCCCCCCcc
Q 010856 194 IGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF-NKLEGEIPRGGSFGNFS 272 (499)
Q Consensus 194 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~~~l~ 272 (499)
+ .+++|+.|++++|......|.. .++|+.|+|++|.++ ..|..+..+++|+.|++++ |++++..+....++.+.
T Consensus 822 ~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~ 896 (1153)
T PLN03210 822 I-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLE 896 (1153)
T ss_pred C-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCC
Confidence 2 3444444444444322222221 234555555555555 3445555556666666655 33443333233344444
Q ss_pred ccccCCC
Q 010856 273 AESFEGN 279 (499)
Q Consensus 273 ~~~l~~N 279 (499)
.+++.++
T Consensus 897 ~L~l~~C 903 (1153)
T PLN03210 897 TVDFSDC 903 (1153)
T ss_pred eeecCCC
Confidence 4454443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-19 Score=203.00 Aligned_cols=269 Identities=21% Similarity=0.260 Sum_probs=181.4
Q ss_pred CCCCCCCCEEECcCCCC------CccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCcc
Q 010856 1 MSNCKSLTLIYLSNNPL------DGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPIT 74 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l------~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 74 (499)
|.+|++|+.|.+..+.. ....|. .+..+|.+|+.|++.++.++ ..|..| ...+|++|++++|.+. ..+..
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~-~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPE-GFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCc-chhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 45789999999976643 223444 56667778999999999987 556666 5689999999999998 56777
Q ss_pred ccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecccc-CCCCCCccccCCCCCc
Q 010856 75 LSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSN-KLTSVPLTFWNLKDIL 153 (499)
Q Consensus 75 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~l~~L~ 153 (499)
+..+++|+.|+|++|.....+| .+..+++|++|++++|.....+|..+..+++|+.|++++| .++.+|..+ ++++|+
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 8899999999999876544555 4888999999999998877788899999999999999997 566688655 678888
Q ss_pred EEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccc------------------------------cCCcCCcee
Q 010856 154 NLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI------------------------------GGLKNLEYL 203 (499)
Q Consensus 154 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l------------------------------~~l~~L~~L 203 (499)
.|++++|......|.. ..+|+.|++++|.+... |..+ ...++|+.|
T Consensus 708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~l-P~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L 783 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI---STNISWLDLDETAIEEF-PSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRL 783 (1153)
T ss_pred EEeCCCCCCccccccc---cCCcCeeecCCCccccc-cccccccccccccccccchhhccccccccchhhhhccccchhe
Confidence 8888887543333321 24555566666555422 2111 112356666
Q ss_pred eCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCC---------------------CCEEEccCCcCcccC
Q 010856 204 FLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY---------------------LENLNLSFNKLEGEI 262 (499)
Q Consensus 204 ~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~---------------------L~~L~l~~N~l~~~~ 262 (499)
++++|.....+|..++.+++|+.|++++|...+.+|... .+++ |+.|++++|.++..+
T Consensus 784 ~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~nL~~L~Ls~n~i~~iP 862 (1153)
T PLN03210 784 FLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEEVP 862 (1153)
T ss_pred eCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccccCEeECCCCCCccCh
Confidence 666665555566666666666666666654322333332 3444 455555555555332
Q ss_pred CCCCCCCCccccccCCCc
Q 010856 263 PRGGSFGNFSAESFEGNE 280 (499)
Q Consensus 263 ~~~~~~~~l~~~~l~~N~ 280 (499)
.....++++..+++.+++
T Consensus 863 ~si~~l~~L~~L~L~~C~ 880 (1153)
T PLN03210 863 WWIEKFSNLSFLDMNGCN 880 (1153)
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 223345566666666543
|
syringae 6; Provisional |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=178.21 Aligned_cols=136 Identities=14% Similarity=0.131 Sum_probs=111.9
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+.+..+.||+|..|+||++++ ++++.+|+|.+.... ....+++.+|++|+.+.+||+||++||+|..... +..+++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehh
Confidence 344558899999999999996 579999999995543 3446889999999999999999999999987433 4667899
Q ss_pred ccCCCccccccc-----cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
||+|+.++.+.. .+.....++.++++||.|||+ |+||.|+|++..+.||+||||.+..|
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 998887776543 334455567899999999984 89999999999999999999988643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-22 Score=193.93 Aligned_cols=272 Identities=22% Similarity=0.216 Sum_probs=201.8
Q ss_pred EEECcCCCCCccCChhccccccccccEEEcccCCCccc----CCccccCCCCCCEEeccCCcCCc------cCCccccCC
Q 010856 9 LIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGG----IPEEISNLTNSTIVNLGGNKLNG------SIPITLSKL 78 (499)
Q Consensus 9 ~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l 78 (499)
.|+|..+.+++..-...+..+. +|+.|++++|.++.. ++..+...++|++|+++++.+.. ..+..+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~-~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLL-CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHh-hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 5788888888544443666677 799999999998542 45556778889999999998862 223456778
Q ss_pred CCCCeEecccccccccCCccccCccc---ccEEeeecCCCCC----cCCccccCC-ccCCeeeccccCCCC-----CCcc
Q 010856 79 QKLQGLGLEDNKLEGSIPDDICHLAE---LYRLDLDGNKLSG----SLPACFSNL-TSLRIVSLGSNKLTS-----VPLT 145 (499)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~n~l~~-----~~~~ 145 (499)
++|+.|++++|.+....+..+..+.+ |++|++++|++++ .....+..+ ++|+.|++++|.++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 89999999999997666666655555 9999999999873 222345566 899999999999983 4445
Q ss_pred ccCCCCCcEEEcCCCcCCCC----CcccccCCCCccEEEccCCcccccC----cccccCCcCCceeeCcCCcCCCCCCcc
Q 010856 146 FWNLKDILNLNFSSNFLTSP----LPLEIGNLKVLIGIDFSMNNFSGVI----PTEIGGLKNLEYLFLGYNRLQGSIPDS 217 (499)
Q Consensus 146 ~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~~~~~ 217 (499)
+..+++|++|++++|.+++. .+..+..+++|+.|++++|.+++.. ...+..+++|++|++++|.+++.....
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~ 240 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA 240 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence 67788999999999998852 2234556679999999999987543 344567889999999999988633333
Q ss_pred cc-----CCCCCCEEeCCCCcCCc----cCcccccCCCCCCEEEccCCcCcccC----CC-CCCC-CCccccccCCCcC
Q 010856 218 FG-----DLISLKFLNLSNNNLSG----AIPASLEKLSYLENLNLSFNKLEGEI----PR-GGSF-GNFSAESFEGNEL 281 (499)
Q Consensus 218 l~-----~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~----~~-~~~~-~~l~~~~l~~N~~ 281 (499)
+. ..+.|+.|++++|.+++ .....+..+++|+.+++++|.++... .. ...+ +.+..+++.+|||
T Consensus 241 l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 22 24799999999999973 23345666789999999999998541 11 1223 5677788888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-22 Score=203.54 Aligned_cols=246 Identities=28% Similarity=0.314 Sum_probs=205.6
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
.+|+++++++|+++... . .+..++ +|+.++..+|+++ ..|..+....+|+.|++.+|.+. -.|.....++.|+.|
T Consensus 241 ~nl~~~dis~n~l~~lp-~-wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tL 315 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSNLP-E-WIGACA-NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTL 315 (1081)
T ss_pred ccceeeecchhhhhcch-H-HHHhcc-cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeee
Confidence 47899999999999664 5 788888 9999999999996 67888888999999999999998 455667889999999
Q ss_pred ecccccccccCCccccCccc-ccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC-CCccccCCCCCcEEEcCCCcC
Q 010856 85 GLEDNKLEGSIPDDICHLAE-LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l 162 (499)
+|..|++....+..+..+.. |..|+.+.|.+.......=..++.|+.|.+.+|.+++ .-+.+.+.+.|+.|+|++|++
T Consensus 316 dL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL 395 (1081)
T KOG0618|consen 316 DLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRL 395 (1081)
T ss_pred eehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccc
Confidence 99999998554444555544 8888889999886554344456789999999999998 333677889999999999999
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
.......+.++..|+.|+||+|+++ .+|..+..++.|++|...+|++. ..| .+..++.|+.+|++.|+++......-
T Consensus 396 ~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~ 472 (1081)
T KOG0618|consen 396 NSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEA 472 (1081)
T ss_pred ccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhh
Confidence 9877888899999999999999998 56788899999999999999998 566 88999999999999999985544444
Q ss_pred cCCCCCCEEEccCCcC
Q 010856 243 EKLSYLENLNLSFNKL 258 (499)
Q Consensus 243 ~~l~~L~~L~l~~N~l 258 (499)
...++|++||+++|.-
T Consensus 473 ~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 473 LPSPNLKYLDLSGNTR 488 (1081)
T ss_pred CCCcccceeeccCCcc
Confidence 4448999999999984
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=195.04 Aligned_cols=226 Identities=23% Similarity=0.366 Sum_probs=179.1
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|+.|+|++|+++..... . +.+|++|++++|+++. +|..+. ++|+.|+|++|+++ .+|..+. .+|+.|
T Consensus 199 ~~L~~L~Ls~N~LtsLP~~-l----~~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L 267 (754)
T PRK15370 199 EQITTLILDNNELKSLPEN-L----QGNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSL 267 (754)
T ss_pred cCCcEEEecCCCCCcCChh-h----ccCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEE
Confidence 4689999999999965432 2 2389999999999985 465553 57999999999998 4555553 589999
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCC
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTS 164 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (499)
++++|+++ .+|..+. ++|+.|++++|+++.. |..+. ++|+.|++++|+++.+|..+. ++|+.|++++|.++.
T Consensus 268 ~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 268 DLFHNKIS-CLPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTS 339 (754)
T ss_pred ECcCCccC-ccccccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCcccc
Confidence 99999998 4566553 5899999999999954 44443 579999999999999886553 789999999999986
Q ss_pred CCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcc----
Q 010856 165 PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA---- 240 (499)
Q Consensus 165 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~---- 240 (499)
+|..+. ++|+.|++++|+++. +|..+ .++|+.|++++|.++. +|..+. ++|+.|++++|+++. +|.
T Consensus 340 -LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~ 409 (754)
T PRK15370 340 -LPASLP--PELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVR-LPESLPH 409 (754)
T ss_pred -CChhhc--CcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCccc-CchhHHH
Confidence 454443 789999999999984 55544 3689999999999995 455544 379999999999984 444
Q ss_pred cccCCCCCCEEEccCCcCc
Q 010856 241 SLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 241 ~~~~l~~L~~L~l~~N~l~ 259 (499)
.+..++.+..|++.+|+++
T Consensus 410 ~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 410 FRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HhhcCCCccEEEeeCCCcc
Confidence 3445688999999999997
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-21 Score=167.29 Aligned_cols=135 Identities=16% Similarity=0.256 Sum_probs=110.1
Q ss_pred hhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccCCc--cHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGR--AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
..|...+++|+|.||.||+|+ ..+|+.||||+++..... -.....|||+.++.++|+||+.++++|-..+ -.-.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS--NLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceEEE
Confidence 357778999999999999999 468999999999876532 2456789999999999999999999987644 33457
Q ss_pred ecccCCCccccccccccc-----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVSSLTL-----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~~~~~-----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|+|..++...++..... .+.++.++.+|++|||+ |+||.|.|+..++.+|++|||+++.
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARF 150 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhc
Confidence 899998876655543322 23335788999999876 8999999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-21 Score=175.90 Aligned_cols=137 Identities=16% Similarity=0.178 Sum_probs=108.1
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-c------cHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-R------AFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~------~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
.+.|.+.+.+|+|+||.|.+|.. ++|+.||||++.++.. . ....+.+|++||++++|||||+++++|...++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35578889999999999999994 6899999999987641 1 12335799999999999999999999988765
Q ss_pred ceeeeeeccc-CCCccccccccccc----cccccccccccceeecc------CCCcccEEEeeC---CCeEEEEEEEeec
Q 010856 432 TVCLCLFHHS-SASASASLVSSLTL----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLE---PGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~-~~~~~~~l~~~~~~----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~---~~~~~~~f~~~~~ 497 (499)
. ++++||+ +|++++.+...... .+.++.|++.|+.|||+ |+||+|||+.++ --+||.|||++.+
T Consensus 251 ~--YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 S--YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred e--EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 4 4456666 66666665544333 33445899999999987 899999999765 4899999999876
Q ss_pred c
Q 010856 498 L 498 (499)
Q Consensus 498 ~ 498 (499)
.
T Consensus 329 ~ 329 (475)
T KOG0615|consen 329 S 329 (475)
T ss_pred c
Confidence 4
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.6e-21 Score=183.41 Aligned_cols=136 Identities=15% Similarity=0.245 Sum_probs=115.6
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
++|...+.||+|+||.||+|+.+ +.+.||+|.+++.. .+..+.+.+|++|+++++|||||.++++|.. ..+.+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 46778889999999999999964 68999999997754 3446778999999999999999999999987 4566778
Q ss_pred ecccCCCccccccccccc----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSSASASASLVSSLTL----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~~~~~~l~~~~~~----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.||..|+++..+..++.. .+.++.+++.||.|||+ +.||.|||+...+++|+|||||+++.
T Consensus 80 te~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred ehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence 888888887777766554 44556888999999987 89999999999999999999999863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-20 Score=179.14 Aligned_cols=134 Identities=16% Similarity=0.192 Sum_probs=104.9
Q ss_pred ccccccccCCcceEEEEEeCCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 364 SENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
...+.+|+|+||+||+|.++....||||++..... ...++|.+|+.+|.+++|||||+++|+|..... ...+++||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtEy~ 122 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTEYM 122 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEEeC
Confidence 34456999999999999995444499999976542 225689999999999999999999999987543 456678888
Q ss_pred CCCcccccccc---c----cccccccccccccceeecc-------CCCcccEEEeeCC-CeEEEEEEEeecc
Q 010856 442 SASASASLVSS---L----TLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEP-GVEVICFVFEILL 498 (499)
Q Consensus 442 ~~~~~~~l~~~---~----~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~-~~~~~~f~~~~~~ 498 (499)
.++.+..+... . ..+.++|.+||+||.|||+ |.||.|+|++.++ .+||+|||+++..
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 66655543322 1 1233457999999999988 5689999999997 9999999999864
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-21 Score=188.07 Aligned_cols=255 Identities=20% Similarity=0.226 Sum_probs=191.9
Q ss_pred CCCCCCEEECcCCCCCccCCh---hccccccccccEEEcccCCCcc------cCCccccCCCCCCEEeccCCcCCccCCc
Q 010856 3 NCKSLTLIYLSNNPLDGILPK---TSVGNLSHSLEDFRMYNCNISG------GIPEEISNLTNSTIVNLGGNKLNGSIPI 73 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~---~~~~~l~~~L~~L~l~~n~i~~------~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 73 (499)
.+++|++|+++++.++..... ..+...+ ++++|+++++.+.+ ..+..+..+++|+.|++++|.+....+.
T Consensus 21 ~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~-~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~ 99 (319)
T cd00116 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQP-SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG 99 (319)
T ss_pred HHhhccEEeecCCCCcHHHHHHHHHHHhhCC-CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHH
Confidence 356799999999998653211 1344444 79999999998872 3345677899999999999999865555
Q ss_pred cccCCCC---CCeEecccccccc----cCCccccCc-ccccEEeeecCCCCCc----CCccccCCccCCeeeccccCCCC
Q 010856 74 TLSKLQK---LQGLGLEDNKLEG----SIPDDICHL-AELYRLDLDGNKLSGS----LPACFSNLTSLRIVSLGSNKLTS 141 (499)
Q Consensus 74 ~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~ 141 (499)
.+..+.+ |++|++++|+++. .+...+..+ ++|+.|++++|.+++. .+..+..+++|+.|++++|.++.
T Consensus 100 ~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 100 VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 5555554 9999999999873 223345566 8999999999999842 23456677899999999999984
Q ss_pred -----CCccccCCCCCcEEEcCCCcCCCCC----cccccCCCCccEEEccCCcccccCccccc-----CCcCCceeeCcC
Q 010856 142 -----VPLTFWNLKDILNLNFSSNFLTSPL----PLEIGNLKVLIGIDFSMNNFSGVIPTEIG-----GLKNLEYLFLGY 207 (499)
Q Consensus 142 -----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-----~l~~L~~L~L~~ 207 (499)
++..+..+++|++|++++|.+++.. ...+..+++|+.|++++|.+++.....+. ..+.|++|++++
T Consensus 180 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~ 259 (319)
T cd00116 180 AGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSC 259 (319)
T ss_pred HHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccC
Confidence 3445566789999999999987532 34466789999999999999864333332 247999999999
Q ss_pred CcCCC----CCCccccCCCCCCEEeCCCCcCCcc----CcccccCC-CCCCEEEccCCcC
Q 010856 208 NRLQG----SIPDSFGDLISLKFLNLSNNNLSGA----IPASLEKL-SYLENLNLSFNKL 258 (499)
Q Consensus 208 n~l~~----~~~~~l~~l~~L~~L~l~~N~l~~~----~~~~~~~l-~~L~~L~l~~N~l 258 (499)
|.+++ .....+..+++|+.+++++|.++.. ....+... +.|+.+++.+|++
T Consensus 260 n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 260 NDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 99973 2234566778999999999999855 33444445 7899999999875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-20 Score=168.32 Aligned_cols=140 Identities=16% Similarity=0.156 Sum_probs=112.8
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCc--cHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGR--AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
...++|+..+.|++|+||.||+|+. ++++.||+|+++..... -.-...|||.++.+++|||||.+.+++...+....
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 4567788999999999999999995 57999999999876522 23346899999999999999999999877655567
Q ss_pred eeeecccCCCccccccccc-----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVSSL-----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~~-----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++|+..++...+..-. ...+.+..|+.+|++|||. |.||.|.|+.+.|..+++|||++|-
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 7889999888655443221 1223334899999998765 8999999999999999999999974
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=171.24 Aligned_cols=140 Identities=16% Similarity=0.138 Sum_probs=114.2
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--------------ccHHHHHHHHHHHhcCCCCCccc
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--------------RAFESFDVECEMMKNIRHRNLIK 421 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~il~~l~H~niv~ 421 (499)
....+.|++.+.||+|.||+|.+|+. .+++.||||++.+... ...+++.+||.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 35567899999999999999999994 5799999999965320 01367899999999999999999
Q ss_pred cceeEEccccceeeeeecccCCCcccccccccc-----ccccccccccccceeecc------CCCcccEEEeeCCCeEEE
Q 010856 422 ILHGVAVITFTVCLCLFHHSSASASASLVSSLT-----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVI 490 (499)
Q Consensus 422 l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~-----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~ 490 (499)
|+++.-+.+....++++||+.++.......+.. ..+.+.++++.||+|||. ++||.|.|+..++.|||.
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 999988877777778888887765554443333 345556888999999976 899999999999999999
Q ss_pred EEEEee
Q 010856 491 CFVFEI 496 (499)
Q Consensus 491 ~f~~~~ 496 (499)
|||-+.
T Consensus 253 DFGVs~ 258 (576)
T KOG0585|consen 253 DFGVSN 258 (576)
T ss_pred ccceee
Confidence 999765
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=177.05 Aligned_cols=137 Identities=20% Similarity=0.225 Sum_probs=110.4
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
..|...+.||+|+|+.||.++. .+|+.||+|++.+.. ...++++.+||+|.++++|||||+++++|.+.++. ++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV--Yi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV--YI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce--EE
Confidence 4599999999999999999996 789999999998753 45678899999999999999999999999885544 33
Q ss_pred eeccc-CCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeeccC
Q 010856 437 LFHHS-SASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILLN 499 (499)
Q Consensus 437 l~~~~-~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~~ 499 (499)
+.|++ .+.+...+... ++.++.+.+||+.||.|||+ |+|-.|++++++-.|||.|||++-.++
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec
Confidence 45555 44443333322 33344455899999999987 788999999999999999999997764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-20 Score=162.36 Aligned_cols=140 Identities=18% Similarity=0.191 Sum_probs=113.2
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
.+.++|++.+.+|+|.||.||.|+. +++-.||+|++.+.. .+..+++.+|++|.+.++||||+++|+++.+.. ..
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-RI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-ee
Confidence 5567889999999999999999996 578899999997654 344578999999999999999999999998743 33
Q ss_pred eeeeecccCCCcccccc------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHSSASASASLV------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+..+++...|+++..++ ..+........|+|.|+.|+|. ++||+|.|...++..+++|||-+++-
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 44455556777776665 2233344445899999999865 89999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.1e-20 Score=175.57 Aligned_cols=138 Identities=19% Similarity=0.152 Sum_probs=110.7
Q ss_pred HHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
....+.+.+.+.||+|.||+||.|.+.....||+|.++... -..++|.+|+++|++++|+|||+++|+|...+ +..+
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyI 278 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYI 278 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEE
Confidence 33444566779999999999999999777799999998753 33578999999999999999999999998744 5566
Q ss_pred eeccc-CCCccccccccccc------cccccccccccceee------ccCCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHS-SASASASLVSSLTL------SRPAKGGGFRGCVLW------HVGVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~-~~~~~~~l~~~~~~------~~~~~~~i~~gl~yL------H~~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++||| .|.+.+.++..... ...++.|||+||+|| |+|.-..||||+++..|||+|||++++
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 78887 55566666652221 223368999999966 778999999999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.1e-20 Score=162.63 Aligned_cols=136 Identities=18% Similarity=0.159 Sum_probs=112.2
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..+|+..+.+|.|+||.|.+++. .+|..||+|++++.. -++.+...+|.++++.+.||+++++++.+.+. ...+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC--CeEE
Confidence 45677889999999999999996 468999999998775 34567789999999999999999999888763 3455
Q ss_pred eeeccc-CCCccccccccccccccc----cccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHS-SASASASLVSSLTLSRPA----KGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~-~~~~~~~l~~~~~~~~~~----~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|. +|+++..++...+..++. |.||+.|++|||+ +.||+|+|+++.|-.+++||||+.-
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence 567766 555666666555554444 6899999999998 8999999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-20 Score=177.02 Aligned_cols=137 Identities=17% Similarity=0.162 Sum_probs=112.4
Q ss_pred HhhhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccCCccHHH--HHHHHHHHhcCC-CCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFES--FDVECEMMKNIR-HRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~ 434 (499)
...+|...+.+|.|+||.||+|+ ..+|..||||++++.-.. .++ -.||++-++++. |||||++.+++.+.+. ..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-IL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence 34678999999999999999999 467899999999765432 233 368999999998 9999999999988654 56
Q ss_pred eeeecccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.++|||...+++.+... +...+.+..||++||+|+|. |+||+|+|+...+-+|++|||++|-
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence 678999998876655433 22345556999999998865 8999999999999999999999984
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4e-21 Score=157.52 Aligned_cols=177 Identities=28% Similarity=0.469 Sum_probs=116.4
Q ss_pred CcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEE
Q 010856 101 HLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180 (499)
Q Consensus 101 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 180 (499)
.+..++.|.|++|+++ ..|..++.+.+|+.|++++|+|+++|..+..+++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 4445555556666655 3344455556666666666666666666666666666666666654 4556666666666666
Q ss_pred ccCCcccc-cCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCc
Q 010856 181 FSMNNFSG-VIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 181 l~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
|++|++.. ..|..|-.+..|+.|+|++|.+. ..|...+++++|+.|.+.+|.+- ..|..++.+..|++|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 66666543 45667777788888888888887 77778888888888888888887 56778888888888888888888
Q ss_pred ccCCCCCCC---CCccccccCCCcC
Q 010856 260 GEIPRGGSF---GNFSAESFEGNEL 281 (499)
Q Consensus 260 ~~~~~~~~~---~~l~~~~l~~N~~ 281 (499)
-..|+...+ .+-....+..|||
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPw 211 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPW 211 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCC
Confidence 655553221 1222344455654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.8e-20 Score=167.56 Aligned_cols=137 Identities=15% Similarity=0.168 Sum_probs=111.4
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
...++|++.++||+|+||+|+.++. .+++.||+|++++.. ....+...+|..|+.+++||+||++...|.+.+ .
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--k 99 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--K 99 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--e
Confidence 3457899999999999999999995 469999999998765 334677899999999999999999997777744 4
Q ss_pred eeeeeccc-CCCcccccccccccccc----ccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 434 CLCLFHHS-SASASASLVSSLTLSRP----AKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 434 ~~~l~~~~-~~~~~~~l~~~~~~~~~----~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.+.+.+|+ +|+++..+.......+. .+..|+.||.|||+ |+||+|||++..|-++++|||++.
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence 45566666 55666655544444433 35789999999998 899999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=183.36 Aligned_cols=136 Identities=18% Similarity=0.169 Sum_probs=110.1
Q ss_pred HhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
...+....+.+|+|+||+||+|+. .+.+.||||.++..... ..++|.||+++++.++|||||+|+|+|...+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~- 562 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD- 562 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-
Confidence 344556678899999999999984 23578999999887654 6789999999999999999999999998844
Q ss_pred ceeeeeeccc-CCCccccccccccc------------------cccccccccccceee------ccCCCcccEEEeeCCC
Q 010856 432 TVCLCLFHHS-SASASASLVSSLTL------------------SRPAKGGGFRGCVLW------HVGVDFAAFVFVLEPG 486 (499)
Q Consensus 432 ~~~~~l~~~~-~~~~~~~l~~~~~~------------------~~~~~~~i~~gl~yL------H~~~~p~~~l~~~~~~ 486 (499)
+..+++||| .|++.++++...+. ...+|.|||.||+|| |+|.-.-|.|+...-.
T Consensus 563 -P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 563 -PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred -eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 666788888 67877776532211 123368999999987 7788889999999999
Q ss_pred eEEEEEEEee
Q 010856 487 VEVICFVFEI 496 (499)
Q Consensus 487 ~~~~~f~~~~ 496 (499)
|||.|||++|
T Consensus 642 VKIsDfGLsR 651 (774)
T KOG1026|consen 642 VKISDFGLSR 651 (774)
T ss_pred EEecccccch
Confidence 9999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-19 Score=171.77 Aligned_cols=136 Identities=16% Similarity=0.152 Sum_probs=108.7
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
....+.++||+|.||+|..|+...+..||||.++.... ..+.+|.+|+++|.+++|||||+++|+|...| +.-++.|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI~E 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMITE 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHHHH
Confidence 34556789999999999999987789999999987763 34688999999999999999999999998744 3334556
Q ss_pred cc-CCCcccccccccc------ccccccccccccceee------ccCCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HS-SASASASLVSSLT------LSRPAKGGGFRGCVLW------HVGVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~-~~~~~~~l~~~~~------~~~~~~~~i~~gl~yL------H~~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|| .|++..++...+. ..-+++.|||.||+|| |++.-|-|.|++.+..+||+|||.+|-|
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 65 5666555543321 1223568999999987 7799999999999999999999999843
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-19 Score=178.05 Aligned_cols=148 Identities=20% Similarity=0.202 Sum_probs=115.2
Q ss_pred cccCHHHHHHHhhh---------cccccccccCCcceEEEEEeC----CCCEEEEEEeeccC-CccHHHHHHHHHHHhcC
Q 010856 349 RTFSYLELFRATDE---------FSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC-GRAFESFDVECEMMKNI 414 (499)
Q Consensus 349 ~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l 414 (499)
.++++++--.+... ..+.++||.|.||+|++|+++ ....||||.++... .+++.+|..|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 45555554444333 345789999999999999963 24679999999876 45678899999999999
Q ss_pred CCCCccccceeEEccccceeeeeecccCCCcccc-ccccccc--ccc---ccccccccceee------ccCCCcccEEEe
Q 010856 415 RHRNLIKILHGVAVITFTVCLCLFHHSSASASAS-LVSSLTL--SRP---AKGGGFRGCVLW------HVGVDFAAFVFV 482 (499)
Q Consensus 415 ~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~~~-l~~~~~~--~~~---~~~~i~~gl~yL------H~~~~p~~~l~~ 482 (499)
+||||++|.|++.. ..+.+++-|||.++.++. ++..... ..+ +.++||.||.|| |+|.-.-|||++
T Consensus 688 dHPNIIrLEGVVTk--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN 765 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTK--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN 765 (996)
T ss_pred CCCcEEEEEEEEec--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec
Confidence 99999999999876 668888899997666554 4433222 111 237888887755 889999999999
Q ss_pred eCCCeEEEEEEEeecc
Q 010856 483 LEPGVEVICFVFEILL 498 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~~ 498 (499)
.+--+||+|||++|||
T Consensus 766 snLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 766 SNLVCKVSDFGLSRVL 781 (996)
T ss_pred cceEEEeccccceeec
Confidence 9999999999999997
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-19 Score=166.64 Aligned_cols=134 Identities=24% Similarity=0.237 Sum_probs=100.7
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhc--CCCCCccccceeEEcc--ccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKN--IRHRNLIKILHGVAVI--TFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~H~niv~l~~~~~~~--~~~~~~~ 436 (499)
...++..++|+|+||.||+|++ +++.||||++... ..+.|.+|-+|.+. ++|+||++++++-... +.+++..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455668899999999999998 5589999999753 45678899998764 6999999999764332 1333444
Q ss_pred ee-cccCCCcccccc---ccccccccccccccccceeecc------CCCc---------ccEEEeeCCCeEEEEEEEeec
Q 010856 437 LF-HHSSASASASLV---SSLTLSRPAKGGGFRGCVLWHV------GVDF---------AAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~-~~~~~~~~~~l~---~~~~~~~~~~~~i~~gl~yLH~------~~~p---------~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+. ++..|.+.+.+. ..|....+++..+++||+|||+ +.|| .|||+-.|..++|+|||++..
T Consensus 286 Vt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred EeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 44 455666655543 3566677888999999999998 3444 566777788999999999987
Q ss_pred c
Q 010856 498 L 498 (499)
Q Consensus 498 ~ 498 (499)
+
T Consensus 366 ~ 366 (534)
T KOG3653|consen 366 L 366 (534)
T ss_pred e
Confidence 5
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-19 Score=162.67 Aligned_cols=138 Identities=17% Similarity=0.191 Sum_probs=110.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCC-ccccceeEEcccc----
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRN-LIKILHGVAVITF---- 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~n-iv~l~~~~~~~~~---- 431 (499)
...|...+++|+|+||+||+|+. .+|+.||+|++..... .-.....+|+.++++++|+| ||++++++...+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45577778899999999999994 6899999999976543 23456789999999999999 9999999877431
Q ss_pred ceeeeeecccCCCccccccccc--------cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSASASASLVSSL--------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~~--------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
....++++++..++...+.... ...+.+.+|+++||+|||+ |+||+|+|++..+..|++|||+++-
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 2455678888877765544322 1345556999999999977 8999999999999999999999873
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-20 Score=153.69 Aligned_cols=154 Identities=31% Similarity=0.525 Sum_probs=79.1
Q ss_pred CCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCee
Q 010856 53 NLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIV 132 (499)
Q Consensus 53 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 132 (499)
++.+.+.|.|++|+++ ..|..++.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3445555555666555 33334555555555555555555 44455555555555555555555 455555555555555
Q ss_pred eccccCCCC--CCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcC
Q 010856 133 SLGSNKLTS--VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRL 210 (499)
Q Consensus 133 ~L~~n~l~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 210 (499)
||.+|++.+ +|..|+.++.|+.|+|++|.+. ..|.+++++++|+.|.+..|.+- ..|..++.+..|++|.+.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 555555554 4555555555555555555544 34444444444444444444443 2344444444444444444444
Q ss_pred C
Q 010856 211 Q 211 (499)
Q Consensus 211 ~ 211 (499)
+
T Consensus 186 ~ 186 (264)
T KOG0617|consen 186 T 186 (264)
T ss_pred e
Confidence 4
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-19 Score=163.51 Aligned_cols=133 Identities=19% Similarity=0.212 Sum_probs=102.9
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcc-cc--ceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVI-TF--TVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~-~~--~~~~~l 437 (499)
.|...+++|.|+||.||+|.. .+++.||||++-.+... -.+|..+|+.++|||||++..+|... +. ...-.+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 477789999999999999995 56889999998654321 23899999999999999999887542 11 223347
Q ss_pred ecccCCCcccccccccc--------ccccccccccccceeecc------CCCcccEEEeeC-CCeEEEEEEEeecc
Q 010856 438 FHHSSASASASLVSSLT--------LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE-PGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~~~~~~l~~~~~--------~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~-~~~~~~~f~~~~~~ 498 (499)
+|||+.++.+.++.... ..+-...|+.+||+|||+ |+||.|+|++.+ +..|+||||=+.+|
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 89999988777663211 122334899999999876 899999999865 89999999988776
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.7e-19 Score=165.43 Aligned_cols=136 Identities=15% Similarity=0.160 Sum_probs=109.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGR---AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
...|++.+.+|+|.||+|.+|.. ..|+.||||.+++...+ +.-.+.+||+||+.++||||+.+|++|...+ ..+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd--KIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD--KIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--eEE
Confidence 34688889999999999999994 68999999999877633 3445789999999999999999999887644 334
Q ss_pred eeeccc-CCCccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHS-SASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~-~~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|||. +|++++.+.... ...+++.+||+.|+.|+|. +.|-+|||++++++++|+|||++-+
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhh
Confidence 455554 666766665433 3455566999999999976 7899999999999999999999754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-18 Score=159.96 Aligned_cols=141 Identities=17% Similarity=0.193 Sum_probs=115.7
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEee--ccCCccHHHHHHHHHHHhcCCCCCccccceeEEc---ccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFN--LQCGRAFESFDVECEMMKNIRHRNLIKILHGVAV---ITF 431 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~---~~~ 431 (499)
.....|...+.+|+|+||.|+.+.. ++|+.||+|++. -......++..||+++++.++|+|||.+++.+.. .++
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3344566678899999999999995 579999999996 2334456888999999999999999999998865 345
Q ss_pred ceeeeeecccCCCccccccccccccccc----cccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 432 TVCLCLFHHSSASASASLVSSLTLSRPA----KGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~----~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
...++++++|+.++...++......... .+|+.+||.|+|+ |+||.|++++.+...|++|||++|.+
T Consensus 99 ~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 99 NDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 5677789999888877766554343333 4899999999988 89999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-18 Score=167.45 Aligned_cols=139 Identities=17% Similarity=0.199 Sum_probs=111.3
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC----C-ccHHHHHHHHHHHhcCC-CCCccccceeEEccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC----G-RAFESFDVECEMMKNIR-HRNLIKILHGVAVIT 430 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~----~-~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~ 430 (499)
...+.|...+.||+|+||+|+.|+. .+++.||+|++++.. . ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999985 578999999776642 1 23456779999999999 999999999988754
Q ss_pred cceeeeeeccc-CCCccccccccccc----cccccccccccceeecc------CCCcccEEEeeC-CCeEEEEEEEeecc
Q 010856 431 FTVCLCLFHHS-SASASASLVSSLTL----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLE-PGVEVICFVFEILL 498 (499)
Q Consensus 431 ~~~~~~l~~~~-~~~~~~~l~~~~~~----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~-~~~~~~~f~~~~~~ 498 (499)
. .++++||+ +|++++.+....+. .+.+.+|++.|++|||+ |+||+|++++.+ +.+|++|||++.+.
T Consensus 94 ~--~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 K--IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred e--EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 4 44455555 56777776654443 33445899999999987 799999999998 99999999998764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-18 Score=163.38 Aligned_cols=131 Identities=17% Similarity=0.263 Sum_probs=106.5
Q ss_pred ccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 366 NNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
.+++|+|.||+||-|+. ++|+.||||++++.. .++..++.+|++|+.+++||.||.+.--|...| ..++++|-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEEehhhc
Confidence 58899999999999995 689999999998765 455678999999999999999999875555544 4456899999
Q ss_pred CCccccccccc--ccccc----ccccccccceeecc------CCCcccEEEeeC---CCeEEEEEEEeecc
Q 010856 443 ASASASLVSSL--TLSRP----AKGGGFRGCVLWHV------GVDFAAFVFVLE---PGVEVICFVFEILL 498 (499)
Q Consensus 443 ~~~~~~l~~~~--~~~~~----~~~~i~~gl~yLH~------~~~p~~~l~~~~---~~~~~~~f~~~~~~ 498 (499)
|+.++.+...+ +..++ ++.||..||.|||. +.||+|+|+.+. ++||+|||||+|..
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence 99877765432 22222 35899999999988 899999999764 59999999999863
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-18 Score=142.63 Aligned_cols=134 Identities=18% Similarity=0.205 Sum_probs=105.1
Q ss_pred hcccccccccCCcceEEEEE-eCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|.-.++||+|.||+|++|+ ..+++.||+|+++..+ ........+||.+++.++|.|||+++++... ....-.++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEeH
Confidence 45666889999999999999 4579999999997654 3445678899999999999999999988755 23444578
Q ss_pred cccCCCccccccc-cc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVS-SL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~-~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.+++...... .+ ...+....|+.+|+.|+|+ +.||+|.+.+.++..+++|||++|-
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhh
Confidence 8888776444322 11 2233445789999998876 7999999999999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-18 Score=162.05 Aligned_cols=139 Identities=16% Similarity=0.166 Sum_probs=110.1
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
...++|+...+||+|+||.||+|+. .+|..||+|++++.. ..+.+.+..|-.+|...++|+||+|+..|.+.++.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L- 216 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL- 216 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee-
Confidence 4568899999999999999999995 479999999998765 45678899999999999999999999888886644
Q ss_pred eeeeecccCCCcccccc-ccccccccc----c------ccccccceeeccCCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHSSASASASLV-SSLTLSRPA----K------GGGFRGCVLWHVGVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~-~~~~~~~~~----~------~~i~~gl~yLH~~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+.+|||++|+-...+. ....+.+.. + ++..+-+.|+|+|+||.|+|++..|-+++.|||++..+
T Consensus 217 -YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 217 -YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred -EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 5567777666444433 222222222 2 34456667999999999999999999999999998544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-18 Score=165.11 Aligned_cols=142 Identities=20% Similarity=0.237 Sum_probs=112.3
Q ss_pred cCHHHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEc
Q 010856 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAV 428 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~ 428 (499)
.+.+++....+.+.+...||+|+||+||+|++. | .||||++.... ....+.|.+|+.++++-+|.||+=+.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344666666777788899999999999999983 3 69999998765 3467889999999999999999999999987
Q ss_pred cccceeeeeecccC-CCccccccccc-----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 429 ITFTVCLCLFHHSS-ASASASLVSSL-----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 429 ~~~~~~~~l~~~~~-~~~~~~l~~~~-----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
..+ .++-.+++ ..++..++..+ .....+|.|||+||.|||. |.|--||.+.++..|+|-|||++-
T Consensus 460 p~~---AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 460 PPL---AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred Cce---eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 554 33454444 44444555332 3355668999999999987 788888888888999999999986
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
|
T Consensus 537 v 537 (678)
T KOG0193|consen 537 V 537 (678)
T ss_pred e
Confidence 5
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-18 Score=168.72 Aligned_cols=146 Identities=15% Similarity=0.197 Sum_probs=110.0
Q ss_pred ccCHHHHHHHhhhcccccccccCCcceEEEEEeC--CC---CEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccc
Q 010856 350 TFSYLELFRATDEFSENNLIGKGGFGSVYKARLG--DR---MEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIK 421 (499)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~--~~---~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~ 421 (499)
++..+.|+...++..+.++||+|+||.||+|+++ ++ ..||+|..+... .....+|++|+++|++++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 3444556666677777899999999999999963 23 238999987522 455788999999999999999999
Q ss_pred cceeEEccccceeeeeecccCCC-cccccccccc---c--cccccccccccceeecc------CCCcccEEEeeCCCeEE
Q 010856 422 ILHGVAVITFTVCLCLFHHSSAS-ASASLVSSLT---L--SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEV 489 (499)
Q Consensus 422 l~~~~~~~~~~~~~~l~~~~~~~-~~~~l~~~~~---~--~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~ 489 (499)
+||++.. ..+.++++|++.|+ +.+.+..... . ....+.++|+||+|||+ |+-.-|.|+..++.+|+
T Consensus 226 ~yGVa~~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 226 FYGVAVL--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEEcC--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEe
Confidence 9999877 34667778877655 4444443321 2 22336899999999987 55568889988888999
Q ss_pred EEEEEeec
Q 010856 490 ICFVFEIL 497 (499)
Q Consensus 490 ~~f~~~~~ 497 (499)
+|||+++.
T Consensus 304 SDFGLs~~ 311 (474)
T KOG0194|consen 304 SDFGLSRA 311 (474)
T ss_pred CccccccC
Confidence 99999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.6e-18 Score=164.88 Aligned_cols=142 Identities=14% Similarity=0.179 Sum_probs=115.6
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEcccc
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITF 431 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~ 431 (499)
.....+|...+.+|+|+|++|++|+. .+++.||||++.+.. ....+-+.+|..+|.++ .||.||+|+..|.+.+
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~- 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE- 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-
Confidence 45567899999999999999999995 579999999998764 23345678999999999 8999999998887743
Q ss_pred ceeeeeecccCCCccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeeccC
Q 010856 432 TVCLCLFHHSSASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILLN 499 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~~ 499 (499)
..++++++..+|+++..+...+ ...+..|.+|+.|++|||+ |+||+|||+++++.++|.|||-+.+|.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 3445566667888877776543 3455667899999999876 899999999999999999999887763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-18 Score=157.76 Aligned_cols=138 Identities=19% Similarity=0.233 Sum_probs=107.3
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
..+|...+.+|+|+||.||++... +|...|||.+........+.+.+|++++++++|||||+.+|.....+...+.+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777899999999999999964 5999999999776433367789999999999999999999975443333344566
Q ss_pred cccCCCcc-ccccc-----cccccccccccccccceeecc------CCCcccEEEee-CCCeEEEEEEEeec
Q 010856 439 HHSSASAS-ASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL-EPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~-~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~-~~~~~~~~f~~~~~ 497 (499)
||+.|+.. +.+.. .+...+..++||++||+|||+ ++||.|+|+.. ++.+|++|||.+..
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 77655443 33332 333455567999999999986 89999999998 69999999998764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.9e-19 Score=154.85 Aligned_cols=140 Identities=19% Similarity=0.176 Sum_probs=104.7
Q ss_pred HhhhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
...+|.+.++||.|+||+||+++ ..+|..+|.|.++-.. .+.+++...|+.++++++|||||+++++-...+.....
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 34568888999999999999999 5799999999997443 34567899999999999999999999854332333233
Q ss_pred eeeccc-CCCccccccc--------cccccccccccccccceeec----------cCCCcccEEEeeCCCeEEEEEEEee
Q 010856 436 CLFHHS-SASASASLVS--------SLTLSRPAKGGGFRGCVLWH----------VGVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 436 ~l~~~~-~~~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH----------~~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+++|++ .|++...+.. .++.+.++..|+++||+.+| +|+||+||.++..+.||+-|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 445555 5665444332 22233333478888887555 5899999999999999999999998
Q ss_pred cc
Q 010856 497 LL 498 (499)
Q Consensus 497 ~~ 498 (499)
.+
T Consensus 177 ~l 178 (375)
T KOG0591|consen 177 FL 178 (375)
T ss_pred Hh
Confidence 65
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-17 Score=162.33 Aligned_cols=136 Identities=17% Similarity=0.170 Sum_probs=106.5
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+ ..++++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG--EIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC--eEEEEE
Confidence 4566678999999999999996 478999999996543 233567899999999999999999999886633 445677
Q ss_pred cccCCCcccc-ccccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSSASASAS-LVSSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~~~~~-l~~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
||+.++.+.. ....+.....++.|++.||+|||+ +++|.||++++++.++++|||++..+
T Consensus 152 e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 152 EFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred ecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 7776654332 222333445567899999999876 79999999999999999999998653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-17 Score=163.14 Aligned_cols=138 Identities=16% Similarity=0.144 Sum_probs=102.3
Q ss_pred HhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVIT 430 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~ 430 (499)
..++|.+.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++..+ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 446788999999999999999973 235689999997543 23356789999999999 8999999999886543
Q ss_pred cceeeeeecccCCC-ccccccccc--------------------------------------------------------
Q 010856 431 FTVCLCLFHHSSAS-ASASLVSSL-------------------------------------------------------- 453 (499)
Q Consensus 431 ~~~~~~l~~~~~~~-~~~~l~~~~-------------------------------------------------------- 453 (499)
.. .+++++|+.++ +.+.+....
T Consensus 85 ~~-~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 85 GP-LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred Cc-eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 33 34456666544 332222110
Q ss_pred ----------cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 454 ----------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 454 ----------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.....++.|+++||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~ 223 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 223 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccc
Confidence 0011234699999999877 7999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-17 Score=153.74 Aligned_cols=139 Identities=17% Similarity=0.216 Sum_probs=109.0
Q ss_pred HHhhhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
....+|++..+||.|..++||+|+ .+.++.||||+++..+ ..+.+.+.+|+..|+.++||||++.+..|.. ....+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeE
Confidence 344679999999999999999999 4788999999998765 3346889999999999999999998876666 33566
Q ss_pred eeecccCCCcccccc---cccccc----ccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASASASLV---SSLTLS----RPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~---~~~~~~----~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++.+|.++....+. ..+... ..+.+++++||.|||+ ++|+.|||++++|.|++.|||+..-|
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 788888666543332 122222 2233788899988765 89999999999999999999987543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.1e-18 Score=152.05 Aligned_cols=140 Identities=19% Similarity=0.189 Sum_probs=110.0
Q ss_pred HHhhhcccccccccCCcceEEEEEeC---C--CCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG---D--RMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
+....|+....||+|.||.||+|..+ + ...+|+|.++..+ ..-.....||+.+++.++|||||.+..++...+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 44456888999999999999999632 2 2379999997654 233566889999999999999999999988764
Q ss_pred cceeeeeecccCCCccccccccc---------cccccccccccccceeecc------CCCcccEEEeeC----CCeEEEE
Q 010856 431 FTVCLCLFHHSSASASASLVSSL---------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE----PGVEVIC 491 (499)
Q Consensus 431 ~~~~~~l~~~~~~~~~~~l~~~~---------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~----~~~~~~~ 491 (499)
.. ..++++|..-++...++... ...+.+..||..|++|||+ +.||+||++..+ +.|||.|
T Consensus 101 ~~-v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KK-VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ce-EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 44 45688888877766554322 1233345899999999977 899999999877 9999999
Q ss_pred EEEeecc
Q 010856 492 FVFEILL 498 (499)
Q Consensus 492 f~~~~~~ 498 (499)
|||+|+.
T Consensus 180 lGlaR~~ 186 (438)
T KOG0666|consen 180 LGLARLF 186 (438)
T ss_pred ccHHHHh
Confidence 9999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-17 Score=163.41 Aligned_cols=138 Identities=17% Similarity=0.178 Sum_probs=112.2
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.++.|++.+.+|+|+.|.|..|+. .+|+..|||++.+.. ......+.+||.||+-+.||||+++|++|....+. +
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l-y 88 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL-Y 88 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE-E
Confidence 356789999999999999999995 689999999997663 23356688999999999999999999999774433 3
Q ss_pred eeeecccCCCcccccccccccccccc----ccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVSSLTLSRPAK----GGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~~~~~~~~~----~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|..+|++++.+...+...++-| .||+.|++|+|. |.||+|.|++.+++.||+|||.+-+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec
Confidence 33555557888888777666655443 788888888765 8999999999999999999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-17 Score=156.59 Aligned_cols=135 Identities=16% Similarity=0.154 Sum_probs=107.3
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|...+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++...+ ..+.++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER--CLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC--eEEEEE
Confidence 5688899999999999999996 478999999997543 233456889999999999999999999886633 345678
Q ss_pred cccCCCccccccccc-----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSSL-----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~~-----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|++.+++...+.... .....++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 83 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 83 EYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA 152 (288)
T ss_pred eCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence 888877655443221 2234446899999999987 8999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-17 Score=157.53 Aligned_cols=136 Identities=15% Similarity=0.165 Sum_probs=108.5
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++...+ ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--eEEEE
Confidence 357899999999999999999964 78999999997543 223456789999999999999999999887643 45567
Q ss_pred ecccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.+++...+... ....+.++.|++.||+|||+ ++||.||++++++.++++|||++..
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 82 FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence 888888765544322 12234456899999998877 8999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.9e-17 Score=158.26 Aligned_cols=142 Identities=19% Similarity=0.231 Sum_probs=114.1
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
...++.|.+...||+|.|++|..|+. -++..||+|.+++.. ......+.+|+++|+.++|||||+++.+... +...
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-ccee
Confidence 35567799999999999999999995 479999999998765 3334668999999999999999999988765 2344
Q ss_pred eeeeecccCCCccccccccccc----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeeccC
Q 010856 434 CLCLFHHSSASASASLVSSLTL----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILLN 499 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~~~~~----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~~ 499 (499)
+.+++++.+|+.++.+...... .+....|+.+|++|||+ +.|.+|++++.+-.++|+||||+..++
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 4445556677777766554433 44445899999999988 799999999999999999999998753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=9e-17 Score=156.60 Aligned_cols=136 Identities=13% Similarity=0.136 Sum_probs=106.4
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..+|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN--RVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC--EEE
Confidence 467889999999999999999964 68999999997643 234567899999999999999999999887643 345
Q ss_pred eeecccC-CCcccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSS-ASASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~-~~~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|+. |++.+.+..... ....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 5667664 444444433222 233345789999998876 8999999999999999999998764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.3e-17 Score=158.74 Aligned_cols=139 Identities=11% Similarity=0.059 Sum_probs=107.0
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
....++|+..+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++...+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~-- 116 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK-- 116 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--
Confidence 34457899999999999999999996 468899999997532 223456889999999999999999998887633
Q ss_pred eeeeeecccCCC-ccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSAS-ASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~-~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++||+.|+ +...+.. .......++.|++.||+|||+ ++||.||++++++.++++|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 445577777554 4333321 222344456789999998766 8999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-17 Score=160.06 Aligned_cols=133 Identities=13% Similarity=0.091 Sum_probs=103.8
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.|...+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--EEEEE
Confidence 578889999999999999995 578999999997643 233567899999999999999999999887644 44556
Q ss_pred ecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 438 FHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+|++.|+ +...+... +...+.++.|++.||+|||+ ++||.||+++.++.++++|||++.
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 7777554 43333222 22234445788999988866 899999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-16 Score=154.48 Aligned_cols=135 Identities=14% Similarity=0.097 Sum_probs=102.0
Q ss_pred hhcccccccccCCcceEEEEEeC-----------------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCcccc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-----------------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKI 422 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l 422 (499)
++|...+.||+|+||.||+|... ++..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46888899999999999999742 23479999987643 2235679999999999999999999
Q ss_pred ceeEEccccceeeeeecccCCC-cccccccc-----------------------ccccccccccccccceeecc------
Q 010856 423 LHGVAVITFTVCLCLFHHSSAS-ASASLVSS-----------------------LTLSRPAKGGGFRGCVLWHV------ 472 (499)
Q Consensus 423 ~~~~~~~~~~~~~~l~~~~~~~-~~~~l~~~-----------------------~~~~~~~~~~i~~gl~yLH~------ 472 (499)
++++...+ ...+++||+.++ +.+.+... +.....++.|++.||+|||+
T Consensus 85 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 85 LGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99987643 345567776544 33222111 11123456899999999877
Q ss_pred CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 473 GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 473 ~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|.||++++++.++++|||+++.
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~ 187 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRN 187 (304)
T ss_pred CcchhheEEcCCccEEECCCcccee
Confidence 7999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.9e-17 Score=159.78 Aligned_cols=133 Identities=11% Similarity=0.094 Sum_probs=104.0
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|...+.||+|+||+||+|+. .+++.||+|++.+.. ....+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~lv 79 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ--YLYLI 79 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--eeEEE
Confidence 688889999999999999985 578999999996543 223466889999999999999999999887643 44557
Q ss_pred ecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 438 FHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+||+.| ++...+.... ...+.++.|++.||+|||+ ++||.||+++.++.++++|||++.
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 777754 4433332222 2234456789999998877 899999999999999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.3e-17 Score=155.81 Aligned_cols=134 Identities=19% Similarity=0.289 Sum_probs=112.4
Q ss_pred hhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
..|+.-..+|+|+.|.||.+. ..+++.||||+++.......+-+.+|+.+|+..+|+|||++++.|... .+.+++||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEEEe
Confidence 457777889999999999998 467899999999988766677899999999999999999999988874 46778999
Q ss_pred ccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 440 HSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 440 ~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
||.|+.+..+... +.....+++++++||+|||. |+|-.||++..++.||+.||||..
T Consensus 351 ym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred ecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeee
Confidence 9987765554332 33444556888999999876 899999999999999999999975
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-16 Score=158.09 Aligned_cols=134 Identities=11% Similarity=0.081 Sum_probs=105.0
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|+..+.||+|+||+||+|+. .+|+.||||++.... ......+.+|++++..++||||+++++++...+ ..+++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~lv 79 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN--YLYLI 79 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--eEEEE
Confidence 688899999999999999996 468999999997543 233456889999999999999999999887643 34556
Q ss_pred ecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|++.| ++...+.... ...+.++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 777654 4433333222 2234456899999999876 8999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-16 Score=155.75 Aligned_cols=136 Identities=15% Similarity=0.154 Sum_probs=107.4
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc---cceee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT---FTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~---~~~~~ 435 (499)
.|+..+.||+|+||.||+|+. .+|+.||+|++.... .....++.+|++++++++||||+++++++...+ +...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 377889999999999999995 478999999986432 233457889999999999999999999876432 22356
Q ss_pred eeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|++++++...+... +.....++.|+++||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 68888887765544322 22334456899999999977 8999999999999999999998764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=155.54 Aligned_cols=134 Identities=15% Similarity=0.128 Sum_probs=105.1
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE--YLYLA 79 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC--EEEEE
Confidence 6888999999999999999964 68999999997643 233567889999999999999999998887643 44567
Q ss_pred ecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+||+.|+ +...+... +...+.++.|++.||+|||+ +++|.|++++.++.++++|||+++.
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 7777554 43333222 22233445799999998876 8999999999999999999998864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-16 Score=157.15 Aligned_cols=138 Identities=13% Similarity=0.092 Sum_probs=106.9
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
...++|+..+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|+++++.++||||+++++++...+ .
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~--~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK--Y 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--E
Confidence 3457899999999999999999996 468999999997532 233456789999999999999999998877633 4
Q ss_pred eeeeecccCCCccccc-cc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSASASASL-VS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l-~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++++||+.|+.+..+ .. ...+...++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 4557777755533332 21 223344456799999999876 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-16 Score=150.50 Aligned_cols=133 Identities=19% Similarity=0.205 Sum_probs=98.1
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhc--CCCCCccccceeEEcc--ccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKN--IRHRNLIKILHGVAVI--TFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~H~niv~l~~~~~~~--~~~~~~~ 436 (499)
....+.+.||+|.||+||+|.+ .|+.||||++...+ .+.+.+|.+|.+. ++|+||+.+++.-... ...+.+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 4567789999999999999998 67799999997543 3568889999875 5999999999763221 1223333
Q ss_pred ee-cccCCCcccccccccc---ccccccccccccceeecc--------------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LF-HHSSASASASLVSSLT---LSRPAKGGGFRGCVLWHV--------------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~-~~~~~~~~~~l~~~~~---~~~~~~~~i~~gl~yLH~--------------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+- ++..|++++.+....- ..-++++.+|.||++||. |+|--|||+-+++.++|+|+|+++-
T Consensus 287 vTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred eeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 33 4556666666544221 123446888999999986 5666789999999999999999873
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-16 Score=156.70 Aligned_cols=135 Identities=11% Similarity=0.085 Sum_probs=104.8
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|+..+.||+|+||+||+|+. .+++.||+|++.+.. ......+.+|++++.+++||||+++++++...+ ..++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~--~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL--NLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--eEEE
Confidence 3688899999999999999985 468999999997543 233456889999999999999999998887633 4455
Q ss_pred eecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++||+.|+ +...+... +...+.++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 67777554 43333322 22334446889999998876 8999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-16 Score=154.58 Aligned_cols=136 Identities=18% Similarity=0.132 Sum_probs=102.5
Q ss_pred hhcccccccccCCcceEEEEEe-CCCC----EEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRM----EVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|+..+.||+|+||.||+|++ .+++ .||+|.++... ....+++.+|+.+++.++||||++++|+|... ...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cce
Confidence 4688899999999999999985 3343 48999986543 23456789999999999999999999988763 233
Q ss_pred eeeecccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++.+++..|.+.+.+... +.....++.|++.||+|||+ +++|.|+++++++.++++|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 333334455554444322 12233456899999999987 79999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-16 Score=151.59 Aligned_cols=134 Identities=16% Similarity=0.168 Sum_probs=107.0
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..++++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 79 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG--KLYLVF 79 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC--EEEEEE
Confidence 5888999999999999999964 68899999997643 234567889999999999999999999887633 455678
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
||+.++....+.. .......++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 8887775554322 112234456899999999876 7999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6e-17 Score=154.25 Aligned_cols=134 Identities=18% Similarity=0.172 Sum_probs=103.3
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+=|.+.+.||+|.|++|.+|+. -+|..||||++++.+ .-....+.+|++.|+-++|||||++|++.-. ....+. +
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTKlyL-i 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTKLYL-I 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cceEEE-E
Confidence 4588889999999999999984 589999999998775 2335678999999999999999999987543 222333 3
Q ss_pred eccc-CCCcccccccc-----ccccccccccccccceeecc------CCCcccEEE-eeCCCeEEEEEEEee
Q 010856 438 FHHS-SASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVF-VLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~-~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~-~~~~~~~~~~f~~~~ 496 (499)
.|.- +|++++++... +...++...||++|+.|+|. +.||+|++| .+-+-||+.||||+-
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 3433 45666665432 23455666899999999876 899999987 567889999999974
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-16 Score=156.42 Aligned_cols=144 Identities=14% Similarity=0.097 Sum_probs=110.3
Q ss_pred HHHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEc
Q 010856 353 YLELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAV 428 (499)
Q Consensus 353 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~ 428 (499)
..++....++|+..+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344555668899999999999999999996 468899999996532 2234567899999999999999999988876
Q ss_pred cccceeeeeecccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 429 ITFTVCLCLFHHSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.+ ..++++||+.|+.+..+.. .....+.++.|++.||+|||+ ++||.||+++.++.++++|||++..+
T Consensus 115 ~~--~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 115 DR--YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred CC--EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 33 4556778876554333222 122234445789999998876 89999999999999999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-16 Score=152.35 Aligned_cols=134 Identities=15% Similarity=0.101 Sum_probs=103.8
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv 79 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR--FLYML 79 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC--eEEEE
Confidence 688889999999999999996 468999999997543 233566889999999999999999998876533 44556
Q ss_pred ecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+||+.++ +.+.+... +.....++.|++.||+|||+ +++|.||++++++.++++|||++..
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 7776544 43333222 22234456899999998877 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.7e-16 Score=151.73 Aligned_cols=136 Identities=12% Similarity=0.026 Sum_probs=99.2
Q ss_pred HHHHhhhcccccccccCCcceEEEEEeC--CCCEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCccccceeEEc
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARLG--DRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIRHRNLIKILHGVAV 428 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~ 428 (499)
+....+.|...+.||+|+||+||+|+.+ +++.||||++.... ....+.|.+|++++++++|+|+++.+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3345567999999999999999999853 57888999875331 12345689999999999999999633221
Q ss_pred cccceeeeeecccCCCccccccccccccccccccccccceeecc------CC-CcccEEEeeCCCeEEEEEEEeecc
Q 010856 429 ITFTVCLCLFHHSSASASASLVSSLTLSRPAKGGGFRGCVLWHV------GV-DFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~~~~i~~gl~yLH~------~~-~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
...++++||+.|+.+...... ....+..|+++||+|||+ ++ ||.||+++.++.++++|||+++.+
T Consensus 91 ---~~~~LVmE~~~G~~L~~~~~~--~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLARPH--GDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred ---CCcEEEEEccCCCCHHHhCcc--chHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 123557777766644322111 113445778888888876 78 999999988889999999998854
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.7e-16 Score=156.39 Aligned_cols=129 Identities=12% Similarity=0.058 Sum_probs=101.7
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
..|...+.||+|+||.||+|+. .+++.||+|... .+.+.+|++++++++|||||++++++...+ ....+++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNK--FTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC--eeEEEEe
Confidence 5699999999999999999995 578999999653 245789999999999999999999886533 3344566
Q ss_pred ccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+++...+... ......++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 164 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 164 RYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 6666655444322 22234456899999999876 8999999999999999999999853
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.1e-16 Score=152.13 Aligned_cols=130 Identities=18% Similarity=0.176 Sum_probs=99.4
Q ss_pred ccccccCCcceEEEEEeC---CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 366 NNLIGKGGFGSVYKARLG---DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
.+.||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++........++++++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 367999999999999853 46789999986532 2356789999999999999999999886544445566788887
Q ss_pred CCcccccc-------------ccccccccccccccccceeecc------CCCcccEEEe----eCCCeEEEEEEEeec
Q 010856 443 ASASASLV-------------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV----LEPGVEVICFVFEIL 497 (499)
Q Consensus 443 ~~~~~~l~-------------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~----~~~~~~~~~f~~~~~ 497 (499)
+++...+. ......+.++.|++.||+|||+ ++||.|+++. ..+.++++|||+++.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 76543322 1122234556899999999877 7999999994 446899999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-16 Score=150.49 Aligned_cols=133 Identities=10% Similarity=0.073 Sum_probs=101.9
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
|...+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|++++++++|+||+++++++...+ ....++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--ALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--eEEEEE
Confidence 67788999999999999995 579999999987543 222346789999999999999999998887643 345566
Q ss_pred cccCCCccc-cccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASA-SLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~-~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++.+. .+.. .+.....++.|++.||+|||+ +++|.|+++++++.++++|||++..
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 776554332 2211 122233445789999998877 7999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-16 Score=156.50 Aligned_cols=134 Identities=13% Similarity=0.074 Sum_probs=104.3
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|+..+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--EEEE
Confidence 3688999999999999999995 468999999996543 233567889999999999999999998887643 4455
Q ss_pred eecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 437 LFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++||+.| ++.+.+.... ...+.++.|++.||+|||+ ++||.|++++.++.++++|||++.
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 6777754 4444333222 2234446789999998876 899999999999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=3e-16 Score=155.71 Aligned_cols=136 Identities=16% Similarity=0.131 Sum_probs=107.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc---cceee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT---FTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~---~~~~~ 435 (499)
+|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+++.+|+++++.++||||+++++++...+ +...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 578999999986532 223467889999999999999999999886533 12456
Q ss_pred eeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|+.+++...+... ......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 67888887765544322 22244456899999999877 8999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-16 Score=151.64 Aligned_cols=135 Identities=15% Similarity=0.160 Sum_probs=106.8
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|...+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|++++++++||||+++++++...+ ...+++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK--SLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC--eEEEEE
Confidence 46888999999999999999964 68899999997554 233456789999999999999999999887633 455678
Q ss_pred cccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|+.+++...+... ......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence 88877665544322 12233445799999999877 7999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.6e-16 Score=152.00 Aligned_cols=128 Identities=15% Similarity=0.134 Sum_probs=98.5
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+ ..++++||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEEEeCCC
Confidence 3689999999999995 578999999997643 233456789999999999999999998887643 3455677775
Q ss_pred CC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 443 AS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 443 ~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
|+ +...+... +.....++.|++.||+|||+ ++||.||+++.++.++++|||++.
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~ 143 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 54 33333222 22334445799999998877 799999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.9e-16 Score=155.00 Aligned_cols=139 Identities=16% Similarity=0.104 Sum_probs=109.8
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc----c
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT----F 431 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----~ 431 (499)
...+|...+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457799999999999999999996 468999999996542 233567889999999999999999999875432 2
Q ss_pred ceeeeeecccCCCcccccccc--ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSASASASLVSS--LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~--~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...+++++++.+++...+... ......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 245668888888765544322 22334456899999999987 7999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-16 Score=158.61 Aligned_cols=134 Identities=18% Similarity=0.146 Sum_probs=101.8
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccc------cc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVIT------FT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~------~~ 432 (499)
..+|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|||||++++++.... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999996 468999999885432 23457999999999999999998874321 12
Q ss_pred eeeeeecccCCCccccccc--------cccccccccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~~ 497 (499)
...+++||+.+++...+.. .......++.|++.||+|||+ ++||.||+++.++ .++++|||+++.
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 3446788888775443321 122334456799999999877 8999999998665 599999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.2e-16 Score=152.32 Aligned_cols=138 Identities=12% Similarity=0.090 Sum_probs=105.6
Q ss_pred HhhhcccccccccCCcceEEEEEeC-C-CCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-D-RMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
..++|...+.||+|+||.||+|+.+ + +..||+|++.... ....+.+.+|+++++.++||||+++++++...+ .
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES--Y 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC--E
Confidence 3456889999999999999999853 3 4689999997543 234567889999999999999999999987643 4
Q ss_pred eeeeecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++++||+.| .+...+.... .....++.|++.||+|||+ +++|.||++++++.++++|||++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 4557777754 4444433222 2234456889999998866 89999999999999999999998643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-16 Score=154.14 Aligned_cols=141 Identities=18% Similarity=0.153 Sum_probs=108.0
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc---
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT--- 430 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~--- 430 (499)
....+.|...+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34557899999999999999999995 578899999987543 223456789999999999999999998875321
Q ss_pred -cceeeeeecccCCCcccccc---ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 -FTVCLCLFHHSSASASASLV---SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 -~~~~~~l~~~~~~~~~~~l~---~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
....+.+++++++.+...+. ........++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 23345567777666533322 1223344556899999998876 7999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-16 Score=152.79 Aligned_cols=138 Identities=14% Similarity=0.199 Sum_probs=108.0
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCC-CCCccccceeEEccccce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG---RAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~ 433 (499)
....|++.+.+|.|.||.||+|+.+ +|+.+|+|.+.+... ...+.+.+|++||+++. |||||.++++|...+ .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--S 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--e
Confidence 3456888999999999999999964 599999999987653 23468999999999998 999999999998754 3
Q ss_pred eeeeeccc-CCCcccccccc---ccccccccccccccceeecc------CCCcccEEEeeC----CCeEEEEEEEeecc
Q 010856 434 CLCLFHHS-SASASASLVSS---LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE----PGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~-~~~~~~~l~~~---~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~----~~~~~~~f~~~~~~ 498 (499)
...++|++ +|++++.+... +.....++.|++.|+.|||+ +.||+|+++... +.++++|||+++..
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 34455555 56666655433 23334445888999998877 899999999754 37999999998754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-16 Score=155.53 Aligned_cols=133 Identities=12% Similarity=0.100 Sum_probs=103.4
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.|+..+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|++++++++|||||++++++...+ ..+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~--~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--EEEEE
Confidence 478889999999999999995 578899999997543 233567889999999999999999999887643 44557
Q ss_pred ecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 438 FHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+||+.|+ +...+... +...+.++.|++.||+|||+ ++||.||+++.++.++++|||++.
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 7777554 43333322 22233445788899988766 899999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.4e-16 Score=148.40 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=102.4
Q ss_pred hcccccccccCCcceEEEEEe-C-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcC---CCCCccccceeEEcc---cc
Q 010856 362 EFSENNLIGKGGFGSVYKARL-G-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNI---RHRNLIKILHGVAVI---TF 431 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~H~niv~l~~~~~~~---~~ 431 (499)
+|...+.||+|+||.||+|+. . +++.||+|+++... ......+.+|+++++.+ +||||++++++|... +.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 588889999999999999985 3 47889999987543 22345677788877665 799999999988532 12
Q ss_pred ceeeeeecccCCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
....++++++.+++...+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||+++.
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 23456778887765444322 122334556899999999876 8999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-16 Score=155.59 Aligned_cols=138 Identities=16% Similarity=0.121 Sum_probs=101.9
Q ss_pred HHhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
...++|...+.||+|+||.||+|+. .++..||+|+++... ....+.+.+|+++++.+ +||||++++++|...
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3345788899999999999999973 236689999997543 33456789999999999 899999999998764
Q ss_pred ccceeeeeecccCC-Ccccccccc--------------------------------------------------------
Q 010856 430 TFTVCLCLFHHSSA-SASASLVSS-------------------------------------------------------- 452 (499)
Q Consensus 430 ~~~~~~~l~~~~~~-~~~~~l~~~-------------------------------------------------------- 452 (499)
+ ..++++||+.| ++...++..
T Consensus 112 ~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 112 G--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred C--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 3 33455666644 332222110
Q ss_pred -----------------------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 453 -----------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 453 -----------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.....++.|+++||+|||+ ++||.|+++++++.++++|||++..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcccee
Confidence 01112335789999999876 7999999999888999999999764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.5e-17 Score=155.28 Aligned_cols=132 Identities=22% Similarity=0.260 Sum_probs=102.3
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
|...+.||.|+||.||.|+. ++.+.||||++.-.. .....++..|++++.+++|||+|.+.|||.. +. ..+.++
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~-TaWLVM 105 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EH-TAWLVM 105 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cc-hHHHHH
Confidence 66678899999999999994 678999999996543 2345778999999999999999999999987 23 344567
Q ss_pred cccCCCcccccc---cccccc--ccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 439 HHSSASASASLV---SSLTLS--RPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 439 ~~~~~~~~~~l~---~~~~~~--~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+|+-|+..+.+. .....+ ..++.|.+.||+|||+ ++|..|||+.+++.||+.|||-+-
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchh
Confidence 776665444322 222222 2334788999999987 899999999999999999999653
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.6e-16 Score=151.20 Aligned_cols=128 Identities=15% Similarity=0.150 Sum_probs=98.9
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|+++++.++||||+++++++...+ ..++++||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEEEeCCC
Confidence 3689999999999995 578999999997643 233456788999999999999999998887643 4455777776
Q ss_pred CCcc-ccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 443 ASAS-ASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 443 ~~~~-~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++.+ ..+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++.
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 143 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhc
Confidence 5533 22222 222344456899999998877 799999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.9e-16 Score=148.04 Aligned_cols=130 Identities=15% Similarity=0.159 Sum_probs=100.6
Q ss_pred cccccCCcceEEEEEeCCCCEEEEEEeeccCCcc---HHHHHHHHHHHhcCCCCCccccceeEEc--cccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRA---FESFDVECEMMKNIRHRNLIKILHGVAV--ITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~H~niv~l~~~~~~--~~~~~~~~l~~~~ 441 (499)
..+|+|++|.||+|.+ +|+.||||+++...... .+.+.+|++++++++|||||+++|++.. .+.....+++||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 78899999997654222 4678899999999999999999999866 2333455677887
Q ss_pred CCCccc-ccccc----ccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 442 SASASA-SLVSS----LTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 442 ~~~~~~-~l~~~----~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.|+.+. .+... +.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 105 ~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 665433 33222 12233446789999999985 5889999999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.5e-16 Score=148.50 Aligned_cols=137 Identities=18% Similarity=0.129 Sum_probs=106.5
Q ss_pred hhcccccccccCCcceEEEEEe-----CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.+|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++...+....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3577889999999999999974 25789999998765545567899999999999999999999987654444455
Q ss_pred eeecccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|+.++ +.+.+.. .+.....++.|++.||+|||+ +++|.|+++.+++.++++|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 677777554 4333322 122233446899999999877 7999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.1e-16 Score=151.17 Aligned_cols=128 Identities=16% Similarity=0.143 Sum_probs=98.7
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
+.||+|+||.||+++. .+|+.||+|++.+.. ......+.+|+++++.++||||+++++++...+ ..++++||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEEEeCCC
Confidence 3689999999999995 578999999997643 234567889999999999999999998877633 3455677775
Q ss_pred CCcc-cccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 443 ASAS-ASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 443 ~~~~-~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++.+ ..+... +.....++.|++.||+|||+ ++||.||+++.++.++++|||+++
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~ 143 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCc
Confidence 5433 222221 22334456899999999877 799999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.5e-16 Score=163.52 Aligned_cols=134 Identities=19% Similarity=0.189 Sum_probs=104.4
Q ss_pred hhcccccccccCCcceEEEEEeCC--C----CEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGD--R----MEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
...+..+.||+|+||.||.|.+.+ | ..||+|.+.+.. .+...+|.+|..+|+.++|||||+++|+|.+ .. .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~-~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SG-P 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CC-C
Confidence 445677899999999999999632 4 349999997765 4557889999999999999999999999998 33 4
Q ss_pred eeeeeccc-CCCccccccccccc-----------cccccccccccceee------ccCCCcccEEEeeCCCeEEEEEEEe
Q 010856 434 CLCLFHHS-SASASASLVSSLTL-----------SRPAKGGGFRGCVLW------HVGVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 434 ~~~l~~~~-~~~~~~~l~~~~~~-----------~~~~~~~i~~gl~yL------H~~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
.+++.||| +|++..+++..... ...++.|||+|+.|| |+|+-.-|.|++-+..|||.|||++
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 44566666 66666666644211 112258999999987 4577778999999999999999999
Q ss_pred e
Q 010856 496 I 496 (499)
Q Consensus 496 ~ 496 (499)
|
T Consensus 850 r 850 (1025)
T KOG1095|consen 850 R 850 (1025)
T ss_pred H
Confidence 7
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.61 E-value=7e-16 Score=150.54 Aligned_cols=136 Identities=13% Similarity=0.096 Sum_probs=105.5
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|+..+.||+|+||.||+|+.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--EEEEE
Confidence 357899999999999999999964 68899999987643 233467899999999999999999999987743 44567
Q ss_pred ecccCC-Cccccccccc----cccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|+.+ .+.+.+.... .....++.|++.||+|||+ +++|.||++++++.++++|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 777755 4433333222 2233445789999998874 6899999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.6e-16 Score=151.13 Aligned_cols=135 Identities=14% Similarity=0.094 Sum_probs=104.0
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|+..+.||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|+.++..++|+||+++++++...+ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN--NLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC--eEEE
Confidence 3688899999999999999996 468999999997532 223456889999999999999999998887643 4455
Q ss_pred eecccCC-Cccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSA-SASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++||+.| ++...+.. .+...+.++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence 6776644 44333322 112234456899999999876 7999999999999999999998753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3e-16 Score=159.72 Aligned_cols=134 Identities=14% Similarity=0.159 Sum_probs=105.9
Q ss_pred hhcccccccccCCcceEEEEEeCC-CCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCcccccee-EEc---cc-cce
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGD-RMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIKILHG-VAV---IT-FTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~~~-~~~---~~-~~~ 433 (499)
..+++.+.|.+|||+.||.|+... |..||+|++-..+....+.+.+||++|+.+. |+|||.+++. ... .. ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 346778999999999999999754 4999999997666667888999999999997 9999999983 221 11 356
Q ss_pred eeeeecccC-CCccccccc------cccccccccccccccceeecc--------CCCcccEEEeeCCCeEEEEEEE
Q 010856 434 CLCLFHHSS-ASASASLVS------SLTLSRPAKGGGFRGCVLWHV--------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 434 ~~~l~~~~~-~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~--------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
+++++||+. |++.+.+.. .+..+.+|..++++|+++||. |+|.+|+|+.+++..|+||||=
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 777888887 566665542 233455667899999998766 6777999999999999999994
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.9e-16 Score=151.02 Aligned_cols=135 Identities=13% Similarity=0.081 Sum_probs=104.7
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|...+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++...+ ..+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~--~~~lv 79 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD--NLYLV 79 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--eEEEE
Confidence 588889999999999999996 478999999997643 234566889999999999999999998877633 34557
Q ss_pred ecccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++|+.|+ +...+.. .+...+.++.|++.||+|||+ +++|.||+++.++.++++|||++..+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 7777544 4333322 122334445789999998876 79999999999999999999988643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.6e-16 Score=150.25 Aligned_cols=135 Identities=13% Similarity=0.086 Sum_probs=105.0
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|+..+.||+|+||.||+++. .++..||+|.+..... ...+++.+|++++++++||||+++++++...+ ...+++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEEEEe
Confidence 5788999999999999999996 4688999999976432 33567999999999999999999999887633 345577
Q ss_pred cccCCCccc-cccc----cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASA-SLVS----SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~-~l~~----~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|+.|+.+. .+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 777655433 3322 122234456789999988874 6899999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.3e-16 Score=152.42 Aligned_cols=140 Identities=16% Similarity=0.100 Sum_probs=109.7
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc----
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT---- 430 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~---- 430 (499)
...++|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999985 468899999997543 233467889999999999999999999876432
Q ss_pred cceeeeeecccCCCcccccccc--ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 FTVCLCLFHHSSASASASLVSS--LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 ~~~~~~l~~~~~~~~~~~l~~~--~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
....+.+++++.+++...+... ......++.|+++||+|||+ ++||.||++++++.++++|||+++.
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 2235667888887765543321 22233456899999999887 8999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.6e-16 Score=145.03 Aligned_cols=135 Identities=19% Similarity=0.238 Sum_probs=108.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.|+..+.||+|+||.||+|.. ++++.||+|+++.... ...+++.+|+.++.+++|+||.+.||.|.. ....+.++|
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHHHH
Confidence 466778999999999999995 6799999999987763 446889999999999999999999998876 334456788
Q ss_pred ccCCCccccccccccc-cc----cccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSASASASLVSSLTL-SR----PAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~~l~~~~~~-~~----~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|++|+....+...... .+ -+.+++..|+.|||. ++|++|+++..++.|+++|||.+.-+
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQL 161 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeee
Confidence 8877765544433333 22 223788899999987 89999999998899999999988754
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.9e-16 Score=152.94 Aligned_cols=135 Identities=13% Similarity=0.110 Sum_probs=105.5
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|...+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|++++..++||||+++++++...+ ..+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 79 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE--HLYLV 79 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC--eEEEE
Confidence 688899999999999999996 479999999997643 234567889999999999999999998887633 44556
Q ss_pred ecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++|+.|+ +...+... ....+.++.|++.||+|||+ +++|.||+++.++.++++|||++..+
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 7777554 33333222 22334456899999998876 89999999999999999999987643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.2e-16 Score=149.14 Aligned_cols=127 Identities=13% Similarity=0.099 Sum_probs=97.6
Q ss_pred cccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC
Q 010856 369 IGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS 444 (499)
Q Consensus 369 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~ 444 (499)
||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++...+ ..+++++|+.|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEcCCCCC
Confidence 699999999999964 68899999997542 234567889999999999999999998887633 344566766554
Q ss_pred -cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 445 -ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 445 -~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+...+... +.....++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 43333222 22234446799999999877 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.7e-16 Score=148.66 Aligned_cols=130 Identities=18% Similarity=0.191 Sum_probs=98.8
Q ss_pred cccccCCcceEEEEEeC---CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCC
Q 010856 367 NLIGKGGFGSVYKARLG---DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSA 443 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~ 443 (499)
+.||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++...+....+++++++++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999953 45789999886543 23467899999999999999999998865444455667888877
Q ss_pred Cccccccc-------------cccccccccccccccceeecc------CCCcccEEEe----eCCCeEEEEEEEeecc
Q 010856 444 SASASLVS-------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV----LEPGVEVICFVFEILL 498 (499)
Q Consensus 444 ~~~~~l~~-------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~----~~~~~~~~~f~~~~~~ 498 (499)
++...+.. .+.....++.|++.||+|||+ ++||.||++. .++.++++|||+++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 65443321 112233456899999998876 7999999993 4568999999998753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-15 Score=151.26 Aligned_cols=138 Identities=17% Similarity=0.183 Sum_probs=109.4
Q ss_pred HHHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEcccc
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITF 431 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~ 431 (499)
.....+|...+++|+|+||+|++++.+ +++.||||+++++. ..+.+..+.|.+|+... +||.+++++.+|.+.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~- 442 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE- 442 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-
Confidence 345678999999999999999999964 68899999999876 34577889999998877 5999999998887755
Q ss_pred ceeeeeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 432 TVCLCLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
..+.++||..|+....+... +...+-+|+.|+.||+|||+ |+|-.|+|++.+|-++++|||+..
T Consensus 443 -~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 443 -HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred -eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence 33446666655543333332 23344446899999999998 789999999999999999999853
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.4e-16 Score=152.66 Aligned_cols=138 Identities=16% Similarity=0.160 Sum_probs=101.6
Q ss_pred HHhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
...++|+..+.||+|+||.||+|+. .++..||+|+++... ....+.+.+|+++++.+ +|||||+++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 4455788999999999999999883 124579999997543 23356788999999999 899999999988763
Q ss_pred ccceeeeeecccCC-Cccccccc---------------------------------------------------------
Q 010856 430 TFTVCLCLFHHSSA-SASASLVS--------------------------------------------------------- 451 (499)
Q Consensus 430 ~~~~~~~l~~~~~~-~~~~~l~~--------------------------------------------------------- 451 (499)
. ..+++++|+.+ ++.+.+..
T Consensus 115 ~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 115 G--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred C--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 3 33456666643 33222211
Q ss_pred -----------------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 452 -----------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 452 -----------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+.....++.|+++||+|||+ ++||.|+++++++.++++|||++..
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~ 261 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARD 261 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeee
Confidence 001122345789999998876 8999999999889999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.9e-16 Score=150.89 Aligned_cols=137 Identities=17% Similarity=0.155 Sum_probs=100.6
Q ss_pred hhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~ 431 (499)
.++|...+.||+|+||+||+|.. .+++.||||+++... ......+.+|++++.++ +||||+++++++...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999973 357899999997543 22345788999999999 68999999998866443
Q ss_pred ceeeeeecccCCC-cccccccc----------------------------------------------------------
Q 010856 432 TVCLCLFHHSSAS-ASASLVSS---------------------------------------------------------- 452 (499)
Q Consensus 432 ~~~~~l~~~~~~~-~~~~l~~~---------------------------------------------------------- 452 (499)
.. ++++||+.++ +.+.++..
T Consensus 86 ~~-~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 86 PL-MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred ce-EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 33 3455666443 32222110
Q ss_pred -------------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 453 -------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 453 -------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.....++.|+++||+|||+ +++|.|++++.++.++++|||++..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~ 228 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 228 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccc
Confidence 00011234689999998866 8999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.6e-16 Score=143.23 Aligned_cols=136 Identities=14% Similarity=0.175 Sum_probs=105.8
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||.|.-|+||+++.+ ++..+|+|++++.. .+...+...|.+|++.++||.++.||+.+...++ .++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~-~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY-SCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce-eEE
Confidence 345677799999999999999975 57899999998765 2334567889999999999999999998877443 344
Q ss_pred eeecccCCCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 436 CLFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++++|.+|+++...+.. +...+-.|..++-||+|||. |.||+|||+.++|-+.++||-++.
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccc
Confidence 45566677765443321 12233335789999999998 899999999999999999998763
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-15 Score=151.02 Aligned_cols=134 Identities=11% Similarity=0.088 Sum_probs=103.8
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++.+++||||+++++++...+ ..+++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~lv 79 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR--NLYLI 79 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEEE
Confidence 688889999999999999996 468999999997532 233567889999999999999999998887633 44567
Q ss_pred ecccCCC-ccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSAS-ASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+||+.|+ +...+.... ...+.++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 7777554 433333222 2233445788888888766 8999999999999999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.8e-16 Score=151.58 Aligned_cols=139 Identities=16% Similarity=0.098 Sum_probs=109.3
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc----c
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT----F 431 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----~ 431 (499)
..++|...+.||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 456799999999999999999995 468899999997543 233567889999999999999999998875422 2
Q ss_pred ceeeeeecccCCCcccccccc--ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSASASASLVSS--LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~--~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...+++++++.+++...+... ......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 245668888888765544322 22233456899999999876 7999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=147.86 Aligned_cols=129 Identities=13% Similarity=0.107 Sum_probs=98.8
Q ss_pred cccccCCcceEEEEEe----CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 367 NLIGKGGFGSVYKARL----GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+ ..++++||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EEEEEEcC
Confidence 5799999999999874 358899999997643 223456788999999999999999998887633 44557777
Q ss_pred cCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 441 SSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 441 ~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+ ++...+.. .+.....++.|+++||+|||+ +++|.||++++++.++++|||++..
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 754 44333322 222334456899999999877 7999999999999999999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.6e-16 Score=150.88 Aligned_cols=135 Identities=19% Similarity=0.206 Sum_probs=102.6
Q ss_pred hcccccccccCCcceEEEEEeC---CC--CEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG---DR--MEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..++.+.||+|.||.||+|.+. .| .-||||.-+..+ ..+.+.|.+|..+|++++|||||+++|+|.+. ..++
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~--P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ--PMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc--ceeE
Confidence 3455678999999999999962 23 358899888755 44578899999999999999999999999763 2333
Q ss_pred eeecccCCCccccccccccc-----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASASASLVSSLTL-----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~~~~-----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++-+-.|++...+...... ....+.||+.||+|||+ ++-.-|||+..++.||+.|||++|-+
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 33344456665555443322 12235899999999865 77789999999999999999999854
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-15 Score=145.59 Aligned_cols=134 Identities=10% Similarity=0.075 Sum_probs=102.4
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.|+..+.||+|+||.||++.. .+++.||+|++.... ......+.+|++++++++||||+++++++...+ ....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--eEEEE
Confidence 377789999999999999995 478999999997543 122355788999999999999999998886643 34556
Q ss_pred ecccCCCccc-cccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASA-SLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~-~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|+.|+.+. .+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 7777655333 2221 122233446899999998875 8999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-15 Score=148.19 Aligned_cols=135 Identities=13% Similarity=0.091 Sum_probs=103.1
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|...+.||+|+||.||+++. .+++.||+|++.+.. ......+.+|+.++..++|+||+++++++...+ ..++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~--~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN--YLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEE
Confidence 3688899999999999999996 468899999997532 223455788999999999999999998887643 3455
Q ss_pred eecccCC-Cccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSA-SASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++||+.| ++...+.. .+.....++.|++.||+|||+ ++||.|++++.++.++++|||++..
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~ 151 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence 6777654 44433332 112233445789999998876 8999999999999999999998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-15 Score=161.59 Aligned_cols=135 Identities=17% Similarity=0.078 Sum_probs=104.1
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|...+.||+|+||.||+|+. .+|+.||+|++.... ....+++.+|++++++++||||+++++++...+ ..+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~--~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD--PVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC--EEEE
Confidence 5788999999999999999996 468999999997543 223567999999999999999999999887643 3445
Q ss_pred eecccCCCcccc-ccccc---------------cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEE
Q 010856 437 LFHHSSASASAS-LVSSL---------------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 437 l~~~~~~~~~~~-l~~~~---------------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
+++++.|+.+.. +...+ .....++.|+++||+|||+ ++||.||+++.++.++++|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 677776554332 21100 0112345789999999877 8999999999999999999999
Q ss_pred eec
Q 010856 495 EIL 497 (499)
Q Consensus 495 ~~~ 497 (499)
++.
T Consensus 160 Ak~ 162 (932)
T PRK13184 160 AIF 162 (932)
T ss_pred cee
Confidence 864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.6e-16 Score=154.08 Aligned_cols=135 Identities=18% Similarity=0.173 Sum_probs=105.6
Q ss_pred hcccccccccCCcceEEEEEeC--CCC--EEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG--DRM--EVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
...+.+.||+|.||+||+|.+. .|+ .||||+++..... ...+|.+|+.+|.+++|||+|+|||++.+. ..++
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q---p~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc---hhhH
Confidence 3456688999999999999973 454 5899999876633 578999999999999999999999998862 3344
Q ss_pred eeccc-CCCccccccccccc------cccccccccccceee------ccCCCcccEEEeeCCCeEEEEEEEeeccC
Q 010856 437 LFHHS-SASASASLVSSLTL------SRPAKGGGFRGCVLW------HVGVDFAAFVFVLEPGVEVICFVFEILLN 499 (499)
Q Consensus 437 l~~~~-~~~~~~~l~~~~~~------~~~~~~~i~~gl~yL------H~~~~p~~~l~~~~~~~~~~~f~~~~~~~ 499 (499)
++|.. .|.+++.++..... ....+.|||.||+|| |+|+-.-|+++-....|||+|||+.|-|.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 55554 56666666552221 223368999999997 77888899999999999999999998763
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-15 Score=147.39 Aligned_cols=128 Identities=15% Similarity=0.131 Sum_probs=97.8
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|+++++.++||||+++++++...+ ..++++||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--EEEEEEeCCC
Confidence 3689999999999995 578999999997643 223456788999999999999999998876633 4455777776
Q ss_pred CCcc-ccccc----cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 443 ASAS-ASLVS----SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 443 ~~~~-~~l~~----~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
|+.+ ..+.. .+.....++.|++.||+|||+ ++||.||+++.++.++++|||+++
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~ 144 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence 5533 22222 122234446899999999985 689999999999999999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.7e-16 Score=150.39 Aligned_cols=137 Identities=17% Similarity=0.185 Sum_probs=101.3
Q ss_pred hhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~ 431 (499)
-+.|.+.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.++ +||||++++++|...+.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 34688999999999999999973 235789999987543 22345688999999999 89999999998876544
Q ss_pred ceeeeeecccCCCccc-cccc-----------------------------------------------------------
Q 010856 432 TVCLCLFHHSSASASA-SLVS----------------------------------------------------------- 451 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~-~l~~----------------------------------------------------------- 451 (499)
.. +.+++|+.++.+. .+..
T Consensus 86 ~~-~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 86 PL-MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CE-EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 33 3456666554322 2211
Q ss_pred ------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 452 ------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 452 ------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+.....++.|++.||+|||+ +++|.|+++++++.++++|||+++.
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~ 222 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 222 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchh
Confidence 111122335789999999876 8999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-15 Score=143.80 Aligned_cols=134 Identities=16% Similarity=0.090 Sum_probs=105.9
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|+..+.||+|+||.||+|+. .+++.||+|.+.... ....+++.+|++++++++||||+++++++...+ ....+++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EEEEEEe
Confidence 567788999999999999995 578999999987543 233467899999999999999999999887643 3345677
Q ss_pred ccCCCccccc-cccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASL-VSSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l-~~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+.++..... ...+.....++.|++.|++|||+ +++|.|+++..++.++++|||++..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 80 FMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred cCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 7766644322 22333445567899999988877 8999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-15 Score=145.90 Aligned_cols=137 Identities=15% Similarity=0.154 Sum_probs=107.0
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++.+|...+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++|+||+++++++...+ ....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--eEEE
Confidence 356799999999999999999985 468899999996543 223346789999999999999999999887633 3445
Q ss_pred eecccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.+++...+... ......++.|++.||+|||+ +++|.|++++.++.++++|||+++.
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 7788877765443221 12234456899999998877 8999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-15 Score=142.98 Aligned_cols=135 Identities=18% Similarity=0.191 Sum_probs=106.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.+|+..+.+|+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..+++++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~--~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--KLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--EEEEEEe
Confidence 5688999999999999999995 578899999997655445567889999999999999999999887633 4455777
Q ss_pred ccCCCccc-ccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASA-SLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~-~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++.+. .+... ......++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCcccee
Confidence 77655433 33222 12234446899999998877 7899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-15 Score=143.86 Aligned_cols=127 Identities=14% Similarity=0.143 Sum_probs=96.8
Q ss_pred cccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC
Q 010856 369 IGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS 444 (499)
Q Consensus 369 lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~ 444 (499)
||+|+||+||+|+. .+++.||+|.+.... ....+.+..|+++++.++||||+++.+++.... ..+.+++|+.|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--DLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--eEEEEEeCCCCC
Confidence 69999999999996 478999999997543 123456788999999999999999988776532 345677777655
Q ss_pred ccc-ccc--------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 445 ASA-SLV--------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 445 ~~~-~l~--------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+. .+. ..+.....++.|++.||+|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 433 211 1122233446899999999877 7999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-15 Score=146.52 Aligned_cols=134 Identities=16% Similarity=0.170 Sum_probs=106.1
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.|...+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|++++++++||||+++++++...+ ....++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~--~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC--eEEEEE
Confidence 56888999999999999999964 68899999997543 233456789999999999999999999987633 445678
Q ss_pred cccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 439 HHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 439 ~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+|+.+++...+... ......++.|+++||+|||+ +++|.||+++.++.++++|||++.
T Consensus 84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 88877665443321 12234446789999998877 799999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-15 Score=147.32 Aligned_cols=132 Identities=16% Similarity=0.128 Sum_probs=99.2
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHH---hcCCCCCccccceeEEccccceee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMM---KNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il---~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
|...+.||+|+||.||+|+. .+++.||+|++++.. ....+.+.+|++++ +.++||||+++++++...+ ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~--~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED--HVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC--EEE
Confidence 56678999999999999996 478999999997543 22345677777665 5678999999999887633 445
Q ss_pred eeecccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 436 CLFHHSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+++||+.|+.+..... .+.....++.|++.||+|||+ +++|.|++++.++.++++|||++.
T Consensus 79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 6777776554332221 222333456889999998876 899999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-15 Score=151.13 Aligned_cols=86 Identities=19% Similarity=0.266 Sum_probs=64.4
Q ss_pred HHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCC-CCCccccceeEEcc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIR-HRNLIKILHGVAVI 429 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~ 429 (499)
...+.|.+.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|++++++++ |||||++++++...
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34567888999999999999999841 23479999997543 233567999999999996 99999999998663
Q ss_pred ccceeeeeecccC-CCc
Q 010856 430 TFTVCLCLFHHSS-ASA 445 (499)
Q Consensus 430 ~~~~~~~l~~~~~-~~~ 445 (499)
+ ..++++||+. |++
T Consensus 114 ~--~~~lv~Ey~~~g~L 128 (400)
T cd05105 114 G--PIYIITEYCFYGDL 128 (400)
T ss_pred C--ceEEEEEecCCCcH
Confidence 3 3344556654 443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-15 Score=147.25 Aligned_cols=128 Identities=13% Similarity=0.127 Sum_probs=96.9
Q ss_pred cccccCCcceEEEEEe----CCCCEEEEEEeeccC----CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 367 NLIGKGGFGSVYKARL----GDRMEVAVKVFNLQC----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.||+|+||.||+++. .+++.||+|+++... ......+.+|+++++.++||||+++++++...+ ..++++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG--KLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--eEEEEE
Confidence 5799999999999984 357899999997542 223456789999999999999999999887633 345567
Q ss_pred cccCCC-cccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 439 HHSSAS-ASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 439 ~~~~~~-~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+|+.|+ +...+..... ....++.|++.||+|||+ +++|.||+++.++.++++|||+++
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 776554 4333322222 223345788999998866 899999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-15 Score=147.90 Aligned_cols=128 Identities=13% Similarity=0.124 Sum_probs=98.2
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
++||+|+||.||+|+. .+++.||+|++++.. ....+.+.+|+.++..+ +||||+++++++...+ ..++++||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEEEEeCC
Confidence 4689999999999996 468999999997643 23345688999999988 7999999999887633 445567777
Q ss_pred CCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+ +...+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||++.
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 144 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 144 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccc
Confidence 554 3333322 222334456899999998877 799999999999999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-15 Score=143.84 Aligned_cols=134 Identities=15% Similarity=0.167 Sum_probs=103.5
Q ss_pred hhcccccccccCCcceEEEEEeC----CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.+|+..+.||+|+||.||+|... .+..||+|.++.... .....+.+|+.++++++||||+++++++...+ ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN--TMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC--CcE
Confidence 46888899999999999999852 367899999976532 33467899999999999999999999887633 445
Q ss_pred eeecccCCCcccc-ccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 436 CLFHHSSASASAS-LVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 436 ~l~~~~~~~~~~~-l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+++||+.++.+.. +.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||...
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 6788887664443 222 122234456889999998876 799999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-15 Score=144.11 Aligned_cols=138 Identities=20% Similarity=0.225 Sum_probs=109.0
Q ss_pred HHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.+..+|+..+.||+|+||.||+|...++..+|+|.+........+++.+|+.+++.++||||+++++++...+ ..+++
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--PVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC--CeEEE
Confidence 3456799999999999999999998778999999997665545678999999999999999999999887643 34567
Q ss_pred ecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.+ .+.+.+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhh
Confidence 777755 44333322 112233456788999998876 7999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-15 Score=147.27 Aligned_cols=128 Identities=12% Similarity=0.106 Sum_probs=97.3
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||.||+|+. .+++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++...+ ..++++||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEEEEeCC
Confidence 4689999999999996 468899999997643 23345678899988776 8999999999887633 445567777
Q ss_pred CCCcc-ccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SASAS-ASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~~~-~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.++.+ ..+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||+++
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~ 144 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 144 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccc
Confidence 65433 22222 222334456799999998876 899999999999999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.6e-16 Score=136.12 Aligned_cols=136 Identities=15% Similarity=0.046 Sum_probs=105.4
Q ss_pred hhhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccc--c--cee
Q 010856 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVIT--F--TVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~--~--~~~ 434 (499)
...|.+.+.+|+|+|+.||.++ ..++..||+|++.-...++.+..++|++.-++++||||++++++....+ . ..+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4568899999999999999999 5789999999997766667788999999999999999999998765422 1 234
Q ss_pred eeeecccCCCcccccccc--------ccccccccccccccceee--------ccCCCcccEEEeeCCCeEEEEEEEe
Q 010856 435 LCLFHHSSASASASLVSS--------LTLSRPAKGGGFRGCVLW--------HVGVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~--------~~~~~~~~~~i~~gl~yL--------H~~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
.++.+|..|.+.+.+... +.....+..|+++||++| |+|+||.|+++.+++..++.|||=.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 445566677776655321 112223347788887755 5589999999999999999999954
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-15 Score=160.50 Aligned_cols=137 Identities=13% Similarity=0.099 Sum_probs=106.6
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|.+.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN--NVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC--EEE
Confidence 357889999999999999999964 689999999975432 22467889999999999999999998776533 445
Q ss_pred eeecccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++|+.|+ +...+.. .+.....++.||+.||+|||+ ++||.||++..++.++++|||+++..
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 577777544 4333322 223345566899999998876 89999999999999999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.5e-16 Score=153.70 Aligned_cols=134 Identities=18% Similarity=0.147 Sum_probs=101.0
Q ss_pred cccccccccCCcceEEEEEe-CC----CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GD----RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
....++||+|+||+||+|.+ +. +.+||+|++.... .+..+++..|+-+|.+++|||+++++|+|.... ..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---HHH
Confidence 34568899999999999995 44 3579999997655 445678999999999999999999999997632 223
Q ss_pred eeccc-CCCcccccccccc-----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeeccC
Q 010856 437 LFHHS-SASASASLVSSLT-----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILLN 499 (499)
Q Consensus 437 l~~~~-~~~~~~~l~~~~~-----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~~ 499 (499)
+.++| .|.+++.++.... ....+..|||+||.|||. ++-.-|+||-..+-|++.|||++.+|.
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 34455 3444444433211 122335899999999965 677789999999999999999998874
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-17 Score=142.86 Aligned_cols=137 Identities=16% Similarity=0.289 Sum_probs=106.0
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.+.|++.++||+|.|+.|+++.. ++|+.+|+|+++... ..+.+++.+|++|-+.++|||||++.+.+.. +. ..++
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~-~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ES-FHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-cc-eeEE
Confidence 46688889999999999999984 689999999986543 4567889999999999999999999987755 23 3345
Q ss_pred eecccCC-Cccccccccccccc----cccccccccceeecc------CCCcccEEEeeC---CCeEEEEEEEeecc
Q 010856 437 LFHHSSA-SASASLVSSLTLSR----PAKGGGFRGCVLWHV------GVDFAAFVFVLE---PGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~~~~~~~----~~~~~i~~gl~yLH~------~~~p~~~l~~~~---~~~~~~~f~~~~~~ 498 (499)
+++.|.| ++...+....-+.+ ...+||.+||.|+|. +.||.|.++... --||++|||.++-+
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 7787754 45444443333333 224899999999976 899999999643 37899999999855
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-15 Score=145.05 Aligned_cols=137 Identities=20% Similarity=0.229 Sum_probs=102.4
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcC---CCCCccccceeEEccc---cc
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNI---RHRNLIKILHGVAVIT---FT 432 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~H~niv~l~~~~~~~~---~~ 432 (499)
+|...+.||+|+||+||+|+. .+++.||+|.++... ......+.+|+++++.+ +||||+++++++.... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 377889999999999999996 478999999987543 22234567788877665 7999999999876421 12
Q ss_pred eeeeeecccCCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 433 VCLCLFHHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
....+++++.+++...+.. .+.....++.|++.||+|||+ +++|.|+++++++.++++|||++..+
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 3455778887765444322 122334456899999999876 89999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-15 Score=143.50 Aligned_cols=134 Identities=18% Similarity=0.214 Sum_probs=105.1
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+ ..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES--RLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--eEEEEE
Confidence 477889999999999999996 478999999986543 233467889999999999999999999987633 445677
Q ss_pred cccCCCccccccc-------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVS-------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~-------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.+++...+.. .+.....++.|+++||+|||+ +++|.||++++++.++++|||++..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence 7877665443321 122233446899999999988 7999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.7e-15 Score=141.18 Aligned_cols=136 Identities=17% Similarity=0.156 Sum_probs=105.5
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|...+.+|+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+ ..+.+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--PIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC--Ceeeeee
Confidence 45688889999999999999997777889999987543 33567999999999999999999999876633 3455677
Q ss_pred cc-CCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HS-SASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~-~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+. ++.+.+.+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..+
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 77 4544433322 122234445788999988776 79999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.6e-15 Score=142.18 Aligned_cols=135 Identities=16% Similarity=0.167 Sum_probs=103.3
Q ss_pred cccccccccCCcceEEEEEe-----CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
|...+.||+|+||+||++.+ .++..||+|.++.... ...+.+.+|++++++++||||+++++++...+....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 3578999999975432 34567889999999999999999999886644334455
Q ss_pred eecccCCCcccccc----ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLV----SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~----~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.++.+.... ..+.....++.|++.|++|||+ +++|.|++++.++.++++|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 67777655433322 1233344556899999999887 7999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-15 Score=152.77 Aligned_cols=131 Identities=12% Similarity=0.062 Sum_probs=101.6
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
...|...+.||+|+||.||+|... +++.||+|... ...+.+|++++++++|+|||++++++...+ ...+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~--~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG--LTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC--EEEEEE
Confidence 346888999999999999999964 58899999542 234678999999999999999999887633 233455
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++.+++...+.. .+.....++.|+++||+|||+ ++||.||+++.++.++++|||+++.+
T Consensus 240 e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred EccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 6666666554432 223344567899999998876 89999999999999999999998643
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.57 E-value=3e-15 Score=145.41 Aligned_cols=128 Identities=16% Similarity=0.153 Sum_probs=97.4
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|+. .+++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+ ..++++||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEEEeCC
Confidence 4689999999999996 468899999997642 23345678899998865 8999999999887643 345577777
Q ss_pred CCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.++ +...+... +.....++.|++.||+|||+ +++|.|++++.++.++++|||++.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~ 144 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccce
Confidence 554 33333222 22234456889999998876 899999999999999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-15 Score=153.89 Aligned_cols=134 Identities=13% Similarity=0.031 Sum_probs=102.9
Q ss_pred hcccccccccCCcceEEEEEe-CC-CCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GD-RMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.|...+.+|+|+||.||+|.. .+ ++.||+|.+..........+.+|+++++.++|||||++++++...+ ..++++|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD--KLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC--EEEEEEE
Confidence 388899999999999999985 34 6789999876544444556788999999999999999999987643 4556778
Q ss_pred ccCCCcc-ccccc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASAS-ASLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~-~~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+.|+.+ ..+.. .+.....++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 8755433 32211 111223345789999998876 8999999999999999999999864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.56 E-value=3e-15 Score=141.37 Aligned_cols=135 Identities=19% Similarity=0.167 Sum_probs=104.4
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|+..+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+ ....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN--ELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC--eEEE
Confidence 5788999999999999999995 578999999886533 233456899999999999999999999887643 3445
Q ss_pred eecccCCCccccccc---------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVS---------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~---------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.++....+.. .......++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~ 155 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECcccccee
Confidence 677776553332211 111223446799999999988 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.1e-15 Score=150.92 Aligned_cols=132 Identities=20% Similarity=0.240 Sum_probs=103.0
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-C-----CCccccceeEEcccccee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-H-----RNLIKILHGVAVITFTVC 434 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H-----~niv~l~~~~~~~~~~~~ 434 (499)
.|.+.++||+|+||+|.+|.. ++++.||||+++... .-..+-..|++++..++ | -|+|++++++.--+ +.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~--Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN--HL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc--ce
Confidence 688999999999999999995 679999999997544 23455678999999886 4 38999999876522 44
Q ss_pred eeeecccCCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeC--CCeEEEEEEEee
Q 010856 435 LCLFHHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE--PGVEVICFVFEI 496 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~--~~~~~~~f~~~~ 496 (499)
.+++|.+...+.+.+.. .....+.++.||+.||.+||+ |.||+|||+.+. ..|||||||-+.
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 45677777776665542 234566777899888887766 999999999864 599999999764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.7e-15 Score=142.98 Aligned_cols=135 Identities=16% Similarity=0.124 Sum_probs=101.4
Q ss_pred hhcccccccccCCcceEEEEEe-----CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++...+ ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--PV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--ce
Confidence 4677889999999999999983 246789999997543 233467899999999999999999999877633 34
Q ss_pred eeeecccCCC-ccccccc---------------------cccccccccccccccceeecc------CCCcccEEEeeCCC
Q 010856 435 LCLFHHSSAS-ASASLVS---------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG 486 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~---------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~ 486 (499)
+.++|++.++ +.+.+.. .+.....++.|++.||+|||+ +++|.|+++++++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 4566766544 3322211 011122345789999999887 79999999999999
Q ss_pred eEEEEEEEeec
Q 010856 487 VEVICFVFEIL 497 (499)
Q Consensus 487 ~~~~~f~~~~~ 497 (499)
++++|||++..
T Consensus 163 ~kl~dfg~~~~ 173 (283)
T cd05090 163 VKISDLGLSRE 173 (283)
T ss_pred EEecccccccc
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.1e-15 Score=141.34 Aligned_cols=127 Identities=11% Similarity=0.097 Sum_probs=95.6
Q ss_pred cccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC
Q 010856 369 IGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS 444 (499)
Q Consensus 369 lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~ 444 (499)
||+|+||.||+++. .+|+.||+|.+.... ....+.+..|++++++++||||+++++++... ...++++||+.|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCCC
Confidence 69999999999996 469999999996533 12234567799999999999999998887653 3455677777555
Q ss_pred ccc-cccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 445 ASA-SLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 445 ~~~-~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+. .+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 332 2211 111223345789999998886 8999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.3e-15 Score=141.01 Aligned_cols=137 Identities=18% Similarity=0.178 Sum_probs=104.4
Q ss_pred hhhcccccccccCCcceEEEEEeC----CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.++|+..+.||+|+||.||+|+.+ +...||+|.++... .....+|.+|+.++++++||||+++++++...+ ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR--PV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC--ce
Confidence 356888999999999999999863 24579999987544 334567899999999999999999999887633 34
Q ss_pred eeeecccCCCccc-cccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSASASA-SLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~~~~~-~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++++++.++.+. .+.. .+.....++.|++.|++|||+ +++|.|++++.++.++++|||+++.+
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 5567777654333 2221 122234446889999999877 79999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.56 E-value=3e-15 Score=145.00 Aligned_cols=129 Identities=17% Similarity=0.171 Sum_probs=96.0
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhc-CCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKN-IRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~-l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|+. .+++.||+|+++... ....+.+..|.+++.. .+||||+++++++...+ ..++++|++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcCC
Confidence 3689999999999996 468899999997543 2334556778777765 48999999998887633 445567777
Q ss_pred CCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 442 SAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 442 ~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.|+ +...+... ......++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 554 33333222 22234456899999999877 7999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-15 Score=145.05 Aligned_cols=128 Identities=18% Similarity=0.157 Sum_probs=95.0
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHH-HHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECE-MMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
++||+|+||.||+|+. .+++.||+|++.+.. ......+.+|.. +++.++||||+++++++...+ ..++++||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEEEcCC
Confidence 3689999999999996 468999999997543 222345666664 678899999999998887643 445577777
Q ss_pred CCCcc-cccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SASAS-ASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~~~-~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+.+ ..+... ......++.|+++||+|||+ +++|.|++++.++.++++|||++.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 144 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCc
Confidence 65433 222221 22233446899999998876 899999999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.3e-15 Score=140.18 Aligned_cols=133 Identities=14% Similarity=0.111 Sum_probs=103.7
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
++|+..+.+|+|+||.||.|...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+ ..+.++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR--PIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC--CcEEEEEc
Confidence 4688889999999999999987666779999987543 33467999999999999999999999886643 34556777
Q ss_pred cCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 441 SSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 441 ~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+.++ +.+.+.. .+.....++.|++.|++|||+ +++|.||++++++.++++|||.+.
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccce
Confidence 6544 3333322 122234456899999999876 799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.5e-15 Score=144.09 Aligned_cols=134 Identities=12% Similarity=0.064 Sum_probs=104.4
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|...+.||+|+||.||+++. .++..+|+|.++... ....+++.+|++++++++||||+++++++...+ ...+++|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--EISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--EEEEEee
Confidence 588889999999999999995 468899999987543 223466889999999999999999999987643 4455777
Q ss_pred ccCCC-ccccccc----cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+.|+ +...+.. .......++.|+++||+|||+ +++|.|+++++++.++++|||++..
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccc
Confidence 77654 4333322 223344556899999999985 5899999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.7e-15 Score=142.10 Aligned_cols=134 Identities=18% Similarity=0.205 Sum_probs=98.1
Q ss_pred ccccccccCCcceEEEEEeC-CCC--EEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc----ccee
Q 010856 364 SENNLIGKGGFGSVYKARLG-DRM--EVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT----FTVC 434 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----~~~~ 434 (499)
.+.+.||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|+++++.++||||+++++++.... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45688999999999999964 343 58999886543 233567899999999999999999999875421 1233
Q ss_pred eeeecccCCC-cccccc----------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSAS-ASASLV----------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~----------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++|+.++ +...+. ..+.....++.|++.|++|||+ +++|.|++++.++.++++|||++..
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 4556676544 322221 1112233445789999999986 7999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-15 Score=159.77 Aligned_cols=141 Identities=13% Similarity=0.161 Sum_probs=106.4
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
.....+|.+.+.||+|+||+||+|+. .++..||+|.+.... ......+.+|+.++++++|||||+++++|...+...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34456899999999999999999996 468899999987543 234567899999999999999999999886644444
Q ss_pred eeeeecccCCC-ccccccc--------cccccccccccccccceeecc-------------CCCcccEEEeeC-------
Q 010856 434 CLCLFHHSSAS-ASASLVS--------SLTLSRPAKGGGFRGCVLWHV-------------GVDFAAFVFVLE------- 484 (499)
Q Consensus 434 ~~~l~~~~~~~-~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~-------------~~~p~~~l~~~~------- 484 (499)
.+++++|+.++ +...+.. .+.....++.||+.||+|||+ ++||.||++..+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 56677777654 4333321 222344556899999999885 689999999642
Q ss_pred ----------CCeEEEEEEEeec
Q 010856 485 ----------PGVEVICFVFEIL 497 (499)
Q Consensus 485 ----------~~~~~~~f~~~~~ 497 (499)
+.++++|||++..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~ 191 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKN 191 (1021)
T ss_pred cccccccCCCCceEEccCCcccc
Confidence 3489999998764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.1e-15 Score=140.36 Aligned_cols=133 Identities=17% Similarity=0.131 Sum_probs=103.1
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
.+|+..+.||+|+||.||+|+.+++..+|+|.+.... ...+++.+|++++++++||||+++++++...+ ..+.++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK--PLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC--CEEEEEEc
Confidence 4688889999999999999998777789999886443 23467899999999999999999999886633 34556777
Q ss_pred cC-CCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 441 SS-ASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 441 ~~-~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+. |.+.+.++. .+.....++.|++.||+|||+ +++|.|+++++++.++++|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcc
Confidence 65 444433322 112234445789999998876 789999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-15 Score=148.53 Aligned_cols=131 Identities=14% Similarity=0.109 Sum_probs=102.5
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
...+|...+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++...+ ...++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA--ITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC--eeEEE
Confidence 3456999999999999999999964 5789999975432 2357999999999999999999887643 33456
Q ss_pred ecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.+++...+.. .+.....++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 67777776554432 222344556899999999866 8999999999999999999998763
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-15 Score=143.93 Aligned_cols=140 Identities=19% Similarity=0.203 Sum_probs=108.1
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..++|+..+.||+|+||.||+|.. .+|+.||+|.++... ......+.+|++++++++|+||+++++++...+....+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 356799999999999999999996 469999999987543 22234567899999999999999999988764433455
Q ss_pred eeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.+++++.+++...+.. .+.....++.|+++|++|||+ +++|.|+++++++.++++|||++...
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 6778877654333321 222334456889999988877 79999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.55 E-value=3e-15 Score=143.36 Aligned_cols=135 Identities=16% Similarity=0.192 Sum_probs=105.9
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|+..+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|++++++++||||+++++++...+ ....++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK--TLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC--eEEEEE
Confidence 56888999999999999999964 68999999987543 223355778999999999999999999887643 445678
Q ss_pred cccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
||+.+++...+... ......++.|+++||.|||+ +++|.|+++++++.++++|||.++.
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence 88887665433321 12234445789999999877 7999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.6e-16 Score=148.15 Aligned_cols=124 Identities=17% Similarity=0.219 Sum_probs=96.3
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCCc
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSASA 445 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~ 445 (499)
.+-+|+|+-|.||+|++ .++.||||+++..+ ..+|+.+++++|||||.|.|+|... -+..+++++|..|.+
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs-PcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS-PCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC-ceeEEeeeccccccH
Confidence 35699999999999998 45689999885432 3688999999999999999999763 344454555557776
Q ss_pred cccccccccccccc----cccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 446 SASLVSSLTLSRPA----KGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 446 ~~~l~~~~~~~~~~----~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
...++......... ..|||.||.|||. +.|-||||+.-++-|||+|||-+.-+
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 66655443332222 3799999999976 89999999999999999999977644
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.9e-15 Score=141.62 Aligned_cols=136 Identities=18% Similarity=0.121 Sum_probs=102.0
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCC----EEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRM----EVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
..+|+..+.||+|+||+||+|+. .++. .||+|++.... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST--V 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC--c
Confidence 35688889999999999999984 4454 48999986543 233567889999999999999999999886522 2
Q ss_pred eeeeeccc-CCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHS-SASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~-~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
. .+++++ .|.+.+.+... ......++.|+++||+|||+ +++|.||++.+++.++++|||+++.+
T Consensus 84 ~-l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 84 Q-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred E-EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 3 355555 45544444321 11233446899999999876 89999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.2e-15 Score=145.18 Aligned_cols=134 Identities=15% Similarity=0.156 Sum_probs=101.3
Q ss_pred hcccccccccCCcceEEEEEe----CCCCEEEEEEeeccC----CccHHHHHHHHHHHhcC-CCCCccccceeEEccccc
Q 010856 362 EFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQC----GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFT 432 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~ 432 (499)
+|+..+.||+|+||.||+++. .+++.||+|++.+.. ....+.+.+|++++..+ +||||+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-- 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence 478889999999999999884 358899999997532 22345688999999999 5999999998776533
Q ss_pred eeeeeecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...++++|+.|+ +...+... +.....++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 344567777554 43333222 22233445789999999876 8999999999999999999998763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-15 Score=151.73 Aligned_cols=138 Identities=22% Similarity=0.183 Sum_probs=102.5
Q ss_pred hhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccc-----cce
Q 010856 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT-----FTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~-----~~~ 433 (499)
..|...+.+|+|+||.||+|+ ..+|+.||||.+++.. ...++...+|+++|++++|||||++++.=.+.. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 346677899999999999999 5689999999997644 456788999999999999999999887533321 123
Q ss_pred eeeeecccCCCccccccccccc-------cccccccccccceeecc------CCCcccEEEee-CC---CeEEEEEEEee
Q 010856 434 CLCLFHHSSASASASLVSSLTL-------SRPAKGGGFRGCVLWHV------GVDFAAFVFVL-EP---GVEVICFVFEI 496 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~~~~~-------~~~~~~~i~~gl~yLH~------~~~p~~~l~~~-~~---~~~~~~f~~~~ 496 (499)
..++++|.+|++...+..+++- ...+...++.||.|||+ |+||.||+.-. .| -.|++|||.++
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 4445566677776666655432 12223567888888854 99999998743 32 46899999997
Q ss_pred cc
Q 010856 497 LL 498 (499)
Q Consensus 497 ~~ 498 (499)
-+
T Consensus 173 el 174 (732)
T KOG4250|consen 173 EL 174 (732)
T ss_pred cC
Confidence 54
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.6e-15 Score=155.31 Aligned_cols=141 Identities=15% Similarity=0.087 Sum_probs=105.1
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc--
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF-- 431 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~-- 431 (499)
.....+|...+.||+|+||+||+|+. .+|+.||+|++.... ......+.+|+.++..++|+||+++++.+...+.
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34456899999999999999999985 579999999997643 2335668899999999999999998876643211
Q ss_pred ----ceeeeeecccCC-Ccccccccc--------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEE
Q 010856 432 ----TVCLCLFHHSSA-SASASLVSS--------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICF 492 (499)
Q Consensus 432 ----~~~~~l~~~~~~-~~~~~l~~~--------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f 492 (499)
....++++|+.+ ++.+.+... +.....++.|++.||+|||+ ++||.||+++.++.++++||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 123456677654 443333211 11223345799999998875 89999999999999999999
Q ss_pred EEeec
Q 010856 493 VFEIL 497 (499)
Q Consensus 493 ~~~~~ 497 (499)
|+++.
T Consensus 188 Gls~~ 192 (496)
T PTZ00283 188 GFSKM 192 (496)
T ss_pred ccCee
Confidence 99764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-15 Score=145.59 Aligned_cols=141 Identities=14% Similarity=0.146 Sum_probs=107.6
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc---
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT--- 430 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~--- 430 (499)
....++|+..+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567799999999999999999985 579999999986432 223456889999999999999999999886532
Q ss_pred -cceeeeeecccCCCcccccc---ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 -FTVCLCLFHHSSASASASLV---SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 -~~~~~~l~~~~~~~~~~~l~---~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...+..+++++++.+..... ..+.....++.|+++|++|||+ +++|.|+++++++.++++|||+++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 12345677787655433221 2223344556899999998877 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.7e-15 Score=144.20 Aligned_cols=128 Identities=18% Similarity=0.154 Sum_probs=94.7
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHH-HHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECE-MMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|+. .+|+.||+|++.... ....+.+.+|.. +++.++||||+++++++...+ ..++++||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEEEEcCC
Confidence 3689999999999996 479999999997543 223345566655 567899999999998887633 345567777
Q ss_pred CCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+ +...+... +.....++.|++.||+|||+ +++|.||++++++.++++|||++.
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~ 144 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence 554 33333222 22233456899999998877 899999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.9e-15 Score=139.93 Aligned_cols=135 Identities=21% Similarity=0.247 Sum_probs=105.4
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
++|...+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+ ..+.++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~--~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD--KLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--EEEEEEe
Confidence 4688889999999999999995 568999999997655444567889999999999999999999887643 3455677
Q ss_pred ccCCCcccc-ccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASAS-LVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~-l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++.+.. +.. .......++.|++.|++|||+ +++|.|++++.++.++++|||.+..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 776543332 222 222334456889999998876 7999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.4e-15 Score=145.72 Aligned_cols=133 Identities=14% Similarity=0.100 Sum_probs=101.0
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|...+.||+|+||.||+++.+ +++.||+|++.+.. ....+.+.+|+.++..++|+||+++++++...+ ..+++
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 79 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN--NLYLV 79 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC--EEEEE
Confidence 6888999999999999999964 58899999996532 223445888999999999999999998887633 34556
Q ss_pred eccc-CCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 438 FHHS-SASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~-~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+||+ +|++...+.. .+...+.++.|++.|++|||+ ++||.|++++.++.++++|||++.
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence 6666 4555444432 112233445788888887655 899999999999999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.6e-16 Score=149.83 Aligned_cols=142 Identities=18% Similarity=0.135 Sum_probs=114.0
Q ss_pred HHHHHHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 354 LELFRATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 354 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
+.|+-...+.++..++|-|.||.||.|.++ ..-.||||.++.+. ...++|..|+.+|+.++|||+|+++|+|.. ..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~--Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CC
Confidence 566666677888999999999999999985 46789999997654 447899999999999999999999999976 33
Q ss_pred eeeeeeccc-CCCcccccccccc------ccccccccccccceee------ccCCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 433 VCLCLFHHS-SASASASLVSSLT------LSRPAKGGGFRGCVLW------HVGVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 433 ~~~~l~~~~-~~~~~~~l~~~~~------~~~~~~~~i~~gl~yL------H~~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++++-||| .|.+++.++...+ ....+|-||+.||+|| |++.-.-|-|+-.+.-|||+|||++|+.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 555666666 6777777654322 1233468999999875 8888888999988899999999999875
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.2e-15 Score=142.54 Aligned_cols=135 Identities=19% Similarity=0.111 Sum_probs=98.7
Q ss_pred hhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
.+|...+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-- 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP-- 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc--
Confidence 45777889999999999999852 257899999975432 234678899999999999999999998876432
Q ss_pred eeeeecccCCC-ccccccc--------------------cccccccccccccccceeecc------CCCcccEEEeeCCC
Q 010856 434 CLCLFHHSSAS-ASASLVS--------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG 486 (499)
Q Consensus 434 ~~~l~~~~~~~-~~~~l~~--------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~ 486 (499)
...++++..++ +...+.. .......++.|++.||+|+|+ ++||.|+++.+++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 33455555433 2222210 111122345789999999776 89999999999999
Q ss_pred eEEEEEEEeec
Q 010856 487 VEVICFVFEIL 497 (499)
Q Consensus 487 ~~~~~f~~~~~ 497 (499)
++++|||+++.
T Consensus 163 ~kl~Dfg~~~~ 173 (283)
T cd05091 163 VKISDLGLFRE 173 (283)
T ss_pred eEecccccccc
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.7e-15 Score=145.53 Aligned_cols=147 Identities=16% Similarity=0.139 Sum_probs=111.8
Q ss_pred cCHHHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEE
Q 010856 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVA 427 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~ 427 (499)
...+++....++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566777889999999999999999999985 578999999997542 223466889999999999999999999875
Q ss_pred ccc----cceeeeeecccCCCcccccc---ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEE
Q 010856 428 VIT----FTVCLCLFHHSSASASASLV---SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 428 ~~~----~~~~~~l~~~~~~~~~~~l~---~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
... ......+++++++.+...+. ..+.....++.|+++|++|||+ +++|.|+++.+++.++++|||+
T Consensus 87 ~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 87 PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred ecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 422 12344566777665432221 1223344456899999998877 7899999999999999999998
Q ss_pred eec
Q 010856 495 EIL 497 (499)
Q Consensus 495 ~~~ 497 (499)
+..
T Consensus 167 ~~~ 169 (345)
T cd07877 167 ARH 169 (345)
T ss_pred ccc
Confidence 753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.5e-15 Score=143.90 Aligned_cols=135 Identities=18% Similarity=0.197 Sum_probs=106.6
Q ss_pred cccccccccCCcceEEEEEeC---CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 363 FSENNLIGKGGFGSVYKARLG---DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+....++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 677889999999999999963 58899999997643 334567889999999999999999999998753345667
Q ss_pred eecccCCCccccccc---------cccccccccccccccceeecc------CCCcccEEEee----CCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVS---------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL----EPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~---------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~----~~~~~~~~f~~~~~ 497 (499)
++|++.+++...+.. .......++.|++.|++|||+ +++|.|++++. ++.++++|||++..
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~ 161 (316)
T cd07842 82 LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161 (316)
T ss_pred EEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence 888887765443321 112233456899999999866 89999999988 88999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.4e-15 Score=140.65 Aligned_cols=135 Identities=19% Similarity=0.197 Sum_probs=99.8
Q ss_pred cccccccccCCcceEEEEEeC----CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc----c
Q 010856 363 FSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF----T 432 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~----~ 432 (499)
|.+.+.+|+|+||.||+|... .+..||+|+++... ....+.+.+|+++++.++||||+++++++...+. .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999853 24789999987543 2234678999999999999999999998765332 1
Q ss_pred eeeeeecccCCC-ccccccc----------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 433 VCLCLFHHSSAS-ASASLVS----------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 433 ~~~~l~~~~~~~-~~~~l~~----------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
..+++++|+.++ +...+.. .+.....++.|++.||+|||+ +++|.|+++++++.++++|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 234566666544 3222211 111223346899999998877 79999999999999999999998
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
+.
T Consensus 161 ~~ 162 (273)
T cd05035 161 KK 162 (273)
T ss_pred ee
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-15 Score=143.68 Aligned_cols=135 Identities=15% Similarity=0.097 Sum_probs=100.6
Q ss_pred hhcccccccccCCcceEEEEEeCC---------------CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGD---------------RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILH 424 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~ 424 (499)
.+|.+.+.||+|+||.||+|+.+. ...||+|.+.... ....+.|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987532 2358999987543 223467999999999999999999999
Q ss_pred eEEccccceeeeeecccCCCccc-cccc----------------cccccccccccccccceeecc------CCCcccEEE
Q 010856 425 GVAVITFTVCLCLFHHSSASASA-SLVS----------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVF 481 (499)
Q Consensus 425 ~~~~~~~~~~~~l~~~~~~~~~~-~l~~----------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~ 481 (499)
++...+ ...+++|++.++... .+.. .+.....++.|+++|++|||+ +++|.|+++
T Consensus 85 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 85 VCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 987643 345567777654332 2211 111123345789999998866 899999999
Q ss_pred eeCCCeEEEEEEEeec
Q 010856 482 VLEPGVEVICFVFEIL 497 (499)
Q Consensus 482 ~~~~~~~~~~f~~~~~ 497 (499)
++++.++++|||++..
T Consensus 163 ~~~~~~kl~dfg~~~~ 178 (295)
T cd05097 163 GNHYTIKIADFGMSRN 178 (295)
T ss_pred cCCCcEEecccccccc
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.1e-15 Score=143.86 Aligned_cols=134 Identities=16% Similarity=0.198 Sum_probs=105.6
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.+|+|+||.||+|+. .+|+.||+|+++... ......+.+|++++++++||||+++++++.... ....++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK--KLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--ceEEEE
Confidence 377788999999999999996 478999999996543 223456788999999999999999999887633 445677
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.+++...+.. .+.....++.|+++||+|||+ +++|.|++++.++.++++|||+++.
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 8887776554332 222344556899999999877 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-15 Score=141.16 Aligned_cols=133 Identities=19% Similarity=0.287 Sum_probs=104.4
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
|+..+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+++++.++||||+++++++...+ ..+.+++|.
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--EEEEEEEec
Confidence 567788999999999999964 68889999997655455677899999999999999999999887633 445567777
Q ss_pred CCCccccc-cc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 442 SASASASL-VS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 442 ~~~~~~~l-~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++..... .. .+.....++.|+++||+|||+ +++|.|++++.++.++++|||++..
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 66554332 11 122334456899999999877 7999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.6e-15 Score=139.62 Aligned_cols=136 Identities=17% Similarity=0.174 Sum_probs=105.2
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|+..+.+|+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+ ..+.+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE--PIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--CcEEEEe
Confidence 45788999999999999999998788889999986543 23578999999999999999999998876643 3455677
Q ss_pred ccCC-Ccccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSA-SASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~-~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++.+ .+.+.+... ......++.|+++|++|||+ +++|.|+++++++.++++|||++...
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 7654 443333221 11223345789999998877 78999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.3e-15 Score=141.17 Aligned_cols=133 Identities=10% Similarity=0.074 Sum_probs=101.0
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
|+..+.||+|+||+||+|.. .+++.||+|.+..... .....+.+|++++++++|+||+++.+++...+ ....++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD--ALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--EEEEEE
Confidence 56678899999999999996 5789999999975431 22345788999999999999999988876643 344566
Q ss_pred cccCCCccc-cccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASA-SLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~-~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++... .+.. .+.....++.|++.||+|||+ +++|.|+++++++.++++|||++..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 666554332 2221 122334456899999998876 8999999999999999999998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.2e-15 Score=144.06 Aligned_cols=128 Identities=10% Similarity=0.110 Sum_probs=98.2
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|+. .+++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++...+ ..++++||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEEEEeCC
Confidence 4689999999999996 468899999997643 23356688999999888 6999999998886633 445567777
Q ss_pred CCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+ +...+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||++.
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~ 144 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK 144 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccce
Confidence 554 3322222 223344556899999998876 899999999999999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.8e-15 Score=141.29 Aligned_cols=135 Identities=19% Similarity=0.201 Sum_probs=107.1
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+ ..+.+++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--EEEEeec
Confidence 5688899999999999999995 579999999997665555677899999999999999999999987633 4456778
Q ss_pred ccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++....... .+.....++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceE
Confidence 876654433221 122334456788999988876 7999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.54 E-value=3e-15 Score=143.14 Aligned_cols=138 Identities=17% Similarity=0.143 Sum_probs=103.2
Q ss_pred HHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
...++|+..+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34567999999999999999999742 24579999886543 223456889999999999999999999887643
Q ss_pred cceeeeeecccC-CCccccccccc--------------cccccccccccccceeecc------CCCcccEEEeeCCCeEE
Q 010856 431 FTVCLCLFHHSS-ASASASLVSSL--------------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEV 489 (499)
Q Consensus 431 ~~~~~~l~~~~~-~~~~~~l~~~~--------------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~ 489 (499)
..++++||+. |.+.+.+.... .....++.|++.||+|||+ +++|.|+++++++.+++
T Consensus 83 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 83 --PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred --CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 3455677765 44433332211 1123346789999998877 79999999999999999
Q ss_pred EEEEEeec
Q 010856 490 ICFVFEIL 497 (499)
Q Consensus 490 ~~f~~~~~ 497 (499)
+|||+++.
T Consensus 161 ~Dfg~~~~ 168 (288)
T cd05061 161 GDFGMTRD 168 (288)
T ss_pred CcCCcccc
Confidence 99998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.8e-15 Score=139.86 Aligned_cols=137 Identities=18% Similarity=0.217 Sum_probs=104.4
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|+..+.+|+|+||.||.|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++...+....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999996 468999999986432 1224578899999999999999999998765433334
Q ss_pred eeeecccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++++.|+ +.+.+.. .......++.|++.||+|||+ +++|.|+++++++.++++|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 4567777554 4333322 122234456889999998877 7999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.54 E-value=6e-15 Score=146.81 Aligned_cols=90 Identities=19% Similarity=0.256 Sum_probs=66.2
Q ss_pred HHHHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCC-CCCccccceeEE
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIR-HRNLIKILHGVA 427 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~niv~l~~~~~ 427 (499)
+....++|...+.||+|+||.||+|+.+ .++.||+|+++... ....+.+.+|++++.++. |||||++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344456888899999999999999852 34689999997543 233457899999999997 999999999887
Q ss_pred ccccceeeeeecccC-CCccc
Q 010856 428 VITFTVCLCLFHHSS-ASASA 447 (499)
Q Consensus 428 ~~~~~~~~~l~~~~~-~~~~~ 447 (499)
... ..++++||+. |++.+
T Consensus 112 ~~~--~~~iv~E~~~~g~L~~ 130 (401)
T cd05107 112 KGG--PIYIITEYCRYGDLVD 130 (401)
T ss_pred cCC--CcEEEEeccCCCcHHH
Confidence 633 3344565554 44433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-15 Score=140.36 Aligned_cols=128 Identities=16% Similarity=0.153 Sum_probs=95.5
Q ss_pred ccccCCcceEEEEEeC---CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCC
Q 010856 368 LIGKGGFGSVYKARLG---DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSA 443 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~ 443 (499)
.||+|+||+||+|... ....+|+|.+.... ......+.+|+++++.++||||+++++++...+ ..++++|++.+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--ceEEEEEeCCC
Confidence 5899999999999743 34578888775443 233456889999999999999999999887633 34556777765
Q ss_pred Cccc-ccccc---------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 444 SASA-SLVSS---------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 444 ~~~~-~l~~~---------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+. .+... +.....++.|++.|++|||+ ++||.|+++++++.++++|||+++.
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccc
Confidence 4333 33221 11223456899999999887 7999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.4e-15 Score=141.30 Aligned_cols=136 Identities=18% Similarity=0.275 Sum_probs=108.4
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.++|++.+.+|+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++...+ ..++++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--KLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC--eEEEEe
Confidence 45688899999999999999996 468899999997655455678999999999999999999999887633 445677
Q ss_pred cccCCCcccccc-c-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLV-S-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~-~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|++.++.+..+. . .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchh
Confidence 888765444332 1 222344556899999999876 7999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-15 Score=141.72 Aligned_cols=134 Identities=19% Similarity=0.206 Sum_probs=106.2
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+.++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 79 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK--RLYLVF 79 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--eEEEEE
Confidence 5788899999999999999974 68999999986543 223567889999999999999999999987633 455678
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|+.++....+.. .+.....++.|+++|++|||+ +++|.|+++++++.++++|||++..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 8887765544321 223344456899999999988 6899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.4e-15 Score=138.96 Aligned_cols=129 Identities=16% Similarity=0.175 Sum_probs=98.0
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS 444 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~ 444 (499)
+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+ ..++++|++.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--CeEEEEeeccCC
Confidence 3689999999999996 478999999886443 233567999999999999999999999887643 344566776544
Q ss_pred -cccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 445 -ASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 445 -~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+.+... +.....++.|++.||+|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcc
Confidence 33333221 12233446899999999876 7899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.1e-15 Score=140.73 Aligned_cols=134 Identities=18% Similarity=0.206 Sum_probs=106.6
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.+|+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ....++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v~ 79 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR--KLHLVF 79 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--EEEEEE
Confidence 5888899999999999999964 68999999986543 223456889999999999999999999887633 445678
Q ss_pred cccCCCcccccc-----ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLV-----SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~-----~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++....+. ..+.....++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI 149 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECcccccee
Confidence 888776554432 1223345556899999999987 7999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.54 E-value=7e-15 Score=143.12 Aligned_cols=128 Identities=18% Similarity=0.144 Sum_probs=95.3
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHH-HHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECE-MMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|+. .+|+.||+|++.+.. ....+.+.+|.. +++.++||||+++++++...+ ..++++||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEEEEcCC
Confidence 4689999999999995 579999999997542 223345666665 467899999999998887633 345567777
Q ss_pred CCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+ +...+... +.....++.|+++||+|||+ +++|.||++++++.++++|||++.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~ 144 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCK 144 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcc
Confidence 554 33333222 22234456899999998887 899999999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.5e-15 Score=143.27 Aligned_cols=133 Identities=14% Similarity=0.101 Sum_probs=99.9
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCC-CccccceeEEccccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHR-NLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~-niv~l~~~~~~~~~~~~~~ 436 (499)
+|+..+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|++++..++|+ +|+++++++...+ ..++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--EEEE
Confidence 4778899999999999999964 68899999997642 23456788999999999765 5777777776533 3445
Q ss_pred eecccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 437 LFHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++||+.|+ +...+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++.
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 67776544 4333322 222334446899999998877 799999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.3e-14 Score=149.79 Aligned_cols=118 Identities=35% Similarity=0.611 Sum_probs=105.6
Q ss_pred CccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEcc
Q 010856 175 VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 254 (499)
Q Consensus 175 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 254 (499)
.++.|+|++|.+.+..|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCcccCCCCCC--CCCccccccCCCcCCCCCCCCCCCCCC
Q 010856 255 FNKLEGEIPRGGS--FGNFSAESFEGNELLCGSPNLQVPPCK 294 (499)
Q Consensus 255 ~N~l~~~~~~~~~--~~~l~~~~l~~N~~~c~~~~~~~~~~~ 294 (499)
+|++++.+|.... ...+..+++.+|+.+|+.+. .+.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence 9999999987532 23456788999999998764 45664
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-15 Score=141.22 Aligned_cols=137 Identities=17% Similarity=0.134 Sum_probs=103.6
Q ss_pred hcccccccccCCcceEEEEEe-----CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
-|+..+.||+|+||.||.|++ .++..||+|.++... ....+.+.+|+++++.++||||+++++++...+....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 367788999999999999973 357889999987543 33356799999999999999999999988764333344
Q ss_pred eeecccCCCccc-cccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASASA-SLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~-~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++||+.|+.+. .+.. .+.....++.|++.||+|||+ +++|.|+++..++.++++|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 567777555433 2221 122233445789999998876 89999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.5e-15 Score=140.59 Aligned_cols=140 Identities=19% Similarity=0.221 Sum_probs=107.2
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEcccc----
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITF---- 431 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~---- 431 (499)
.+.+.|+..+.+|+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +||||+++++++...+.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3556788889999999999999996 468899999997543 3446788999999998 79999999999865321
Q ss_pred ceeeeeecccCCCcccc-ccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 432 TVCLCLFHHSSASASAS-LVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~-l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
...+.++|++.++.... +.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||+++.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 23456777776643333 222 112233456899999999988 68999999999999999999998653
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.54 E-value=6e-15 Score=142.85 Aligned_cols=128 Identities=16% Similarity=0.198 Sum_probs=96.6
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhc-CCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKN-IRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~-l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|+. .+++.||+|+++... ....+.+..|.+++.. .+||||+++++++...+ ..++++||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEEEEeCC
Confidence 3689999999999996 468899999997642 2334567788888876 59999999999887644 345567776
Q ss_pred CC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.| ++...+.. .......++.|++.||+|||+ +++|.|++++.++.++++|||++.
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCK 144 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcce
Confidence 54 44333322 122234456899999998876 899999999999999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.7e-15 Score=140.98 Aligned_cols=134 Identities=16% Similarity=0.228 Sum_probs=106.0
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+.|+..+.+|+|+||.||+|+. .+++.||+|.+........+.+.+|+++++.++||||+++++++.... ....+++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--KLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--eEEEEEe
Confidence 5688889999999999999996 468999999997665555678899999999999999999999876532 4455777
Q ss_pred ccCCCcccccc------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 440 HSSASASASLV------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 440 ~~~~~~~~~l~------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++.|+....+. ..+.....++.|++.|++|||+ +++|.|++++.++.++++|||++.
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccce
Confidence 77666543221 1223334456889999988777 799999999989999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.2e-15 Score=140.47 Aligned_cols=134 Identities=16% Similarity=0.174 Sum_probs=104.6
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCc-----cHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGR-----AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+..|++++++++|+||+++++++...+ ..+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS--NIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC--EEE
Confidence 367788999999999999996 46899999999765422 2355778999999999999999999987733 345
Q ss_pred eeecccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++++.+++...+... +.....++.|+++||+|||+ +++|.|++++.++.++++|||++..
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence 57777766554444322 12234456899999999866 8999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.54 E-value=8e-15 Score=137.92 Aligned_cols=134 Identities=16% Similarity=0.193 Sum_probs=103.0
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|...++||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++||||+++++++.. + ....+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-E--PIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-C--CcEEEEE
Confidence 35688899999999999999998888999999987544 335679999999999999999999987643 2 2345666
Q ss_pred ccC-CCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSS-ASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~-~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++. +++.+.+.. .+.....++.|++.||+|||+ +++|.|+++++++.++++|||.+..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence 664 444333322 112223345788899988876 7999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-15 Score=143.27 Aligned_cols=128 Identities=17% Similarity=0.154 Sum_probs=97.7
Q ss_pred cccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|+.. +++.||+|++++.. ....+.+.+|++++..+ +||||+++++++...+ ..+++++|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcCC
Confidence 46899999999999964 68899999997643 23356678899999887 7999999999887643 445677777
Q ss_pred CCCcc-cccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SASAS-ASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~~~-~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+.+ ..+... +.....++.|++.||+|||+ +++|.|++++.++.++++|||+++
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 144 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCe
Confidence 55433 332222 22233446799999999877 899999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.8e-15 Score=139.96 Aligned_cols=133 Identities=11% Similarity=0.078 Sum_probs=101.2
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++|++|+++++.+...+ ....++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--EEEEEE
Confidence 66778899999999999996 4789999999875432 22345778999999999999999998887643 345567
Q ss_pred cccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.|+ +...+.. .......++.|++.||+|||+ +++|.|+++++++.++++|||++..
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 777554 4333321 112233445789999998877 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.4e-15 Score=144.64 Aligned_cols=138 Identities=15% Similarity=0.154 Sum_probs=107.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccc---cee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF---TVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~---~~~ 434 (499)
.++|...+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.++++++||||+++++++....+ ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999985 578999999986433 2345678899999999999999999998765322 234
Q ss_pred eeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+++++.+++...+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 56788888765443322 222334456789999988876 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.5e-15 Score=141.77 Aligned_cols=140 Identities=21% Similarity=0.209 Sum_probs=109.5
Q ss_pred HHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc----
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT---- 430 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~---- 430 (499)
...++|+..+.+|+|+||.||+|..+ +|+.||+|.++... ......+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35577999999999999999999964 68999999997543 233456789999999999999999999886532
Q ss_pred ----cceeeeeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 431 ----FTVCLCLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 431 ----~~~~~~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
......+++++.+++...+.. .+.....++.|++.||+|||+ +++|.|+++++++.++++|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 124556788888765444332 223344556899999999886 79999999999999999999987
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 164 ~~ 165 (302)
T cd07864 164 RL 165 (302)
T ss_pred cc
Confidence 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.5e-15 Score=141.18 Aligned_cols=138 Identities=14% Similarity=0.125 Sum_probs=108.4
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.++|+..+.||+|+||.||+|..+ +++.+|+|.++... ......+.+|+.++++++||||+++++++...+....+.
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357888899999999999999964 68899999997543 222346788999999999999999999887653345566
Q ss_pred eecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.+++...+.. .+.....++.|++.||+|||+ +++|.||++++++.++++|||.+..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 788887755433322 222344556899999999987 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.6e-15 Score=140.12 Aligned_cols=134 Identities=16% Similarity=0.155 Sum_probs=104.7
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|+..+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..+.+
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 79 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS--NLYLV 79 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--eEEEE
Confidence 688889999999999999996 468999999997543 234567899999999999999999999887633 44557
Q ss_pred eccc-CCCccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHS-SASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~-~~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++ ++.+.+.+.... .....++.|++.||+|||+ +++|.||++++++.++++|||++..
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 7787 444433333222 2233345789999998876 8999999999999999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.2e-15 Score=140.47 Aligned_cols=134 Identities=11% Similarity=0.074 Sum_probs=101.6
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHH-HhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEM-MKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~i-l~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.||+|+||.||+|+. .+|+.||+|+++... .....++..|+.+ ++..+||||+++++++.... ....++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG--DVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cEEEEh
Confidence 688889999999999999996 479999999997653 2233456667765 66679999999999987633 345577
Q ss_pred cccCCCccccccc--------cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVS--------SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.|.+...+.. .+.....++.|++.|++|||+ +++|.|++++.++.++++|||.+..
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 8887764333321 122333556899999988886 5899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.9e-15 Score=141.30 Aligned_cols=133 Identities=20% Similarity=0.251 Sum_probs=103.9
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+ ..+.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC--cEEEEe
Confidence 477889999999999999996 478999999986543 233467899999999999999999999887633 445577
Q ss_pred cccCCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 439 HHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 439 ~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+++.+++...+.. .+.....++.|+++|++|||+ +++|.|+++++++.++++|||++.
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 7777654433322 122334456889999999866 799999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.9e-15 Score=140.05 Aligned_cols=139 Identities=19% Similarity=0.169 Sum_probs=105.0
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
+.++.++.....+|+|+||.||+|.. .++..||+|.+........+.+.+|++++++++|+||+++++++...+ ..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--FFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--EEE
Confidence 34555666667899999999999995 468899999987665555678999999999999999999999887643 345
Q ss_pred eeecccCCC-cccccccc-------ccccccccccccccceeecc------CCCcccEEEee-CCCeEEEEEEEeec
Q 010856 436 CLFHHSSAS-ASASLVSS-------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL-EPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~-~~~~l~~~-------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~-~~~~~~~~f~~~~~ 497 (499)
++++++.++ +...+... ......++.|+++|++|||+ +++|.|++++. ++.++++|||....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 567777554 43333321 11122345789999998877 79999999975 56899999998753
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.3e-15 Score=134.26 Aligned_cols=137 Identities=16% Similarity=0.196 Sum_probs=107.2
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--------ccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--------RAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
-..|...+.+|.|..++|.++.. ++|..+|+|++..... ...+.-.+|+.|++++ -||+|+.+.++|...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35678889999999999999985 5789999999965431 1245567899999997 699999999999774
Q ss_pred ccceeeeeeccc-CCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 430 TFTVCLCLFHHS-SASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 430 ~~~~~~~l~~~~-~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
. ..+.+++.| .|++++.+.. ++...+.+.+|+.+|++|||. +.||+|||.+++-++++.||||+--|
T Consensus 96 s--F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 A--FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred c--hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 3 334466666 5666666543 334455666889999999876 89999999999999999999998643
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.4e-15 Score=141.92 Aligned_cols=137 Identities=18% Similarity=0.179 Sum_probs=102.3
Q ss_pred HHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
...++|+..+.+|+|+||.||+|... ++..||+|.+.... .....++.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34577999999999999999998742 35679999986433 233567899999999999999999999886533
Q ss_pred cceeeeeecccCCC-ccccccccc--------------cccccccccccccceeecc------CCCcccEEEeeCCCeEE
Q 010856 431 FTVCLCLFHHSSAS-ASASLVSSL--------------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEV 489 (499)
Q Consensus 431 ~~~~~~l~~~~~~~-~~~~l~~~~--------------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~ 489 (499)
...+++|++.++ +.+.+.... .....++.|++.|++|||+ +++|.|+++++++.+++
T Consensus 83 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 83 --PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred --CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 345567776554 332222111 1123345789999998877 89999999999999999
Q ss_pred EEEEEee
Q 010856 490 ICFVFEI 496 (499)
Q Consensus 490 ~~f~~~~ 496 (499)
+|||++.
T Consensus 161 ~dfg~~~ 167 (277)
T cd05062 161 GDFGMTR 167 (277)
T ss_pred CCCCCcc
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.53 E-value=9e-15 Score=138.09 Aligned_cols=136 Identities=15% Similarity=0.216 Sum_probs=103.5
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
+|+..+.+|+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.........
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688889999999999999996 468999999986542 12345688999999999999999999987653333444
Q ss_pred eeecccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++++..++ +...+.. .+.....++.|++.||+|||+ +++|.||++++++.++++|||+++.
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 566777554 3333322 122233456889999998887 7899999999889999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-14 Score=137.57 Aligned_cols=135 Identities=19% Similarity=0.117 Sum_probs=104.7
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|+..+.+|+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++...+ ..+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~--~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN--ELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEEE
Confidence 57889999999999999999964 79999999986432 233567999999999999999999999887643 3455
Q ss_pred eecccCCCccc-cccc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASA-SLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~-~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.++.+. .+.. .......++.|++.|++|||+ +++|.|++++.++.++++|||+++.
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~ 155 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeee
Confidence 77777654333 2211 112233445788999988876 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.8e-15 Score=139.56 Aligned_cols=134 Identities=17% Similarity=0.150 Sum_probs=98.8
Q ss_pred hhcccccccccCCcceEEEEEe-CCCC----EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRM----EVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|...+.||+|+||+||+|.. .+++ .+|+|.+..... ....++..|+.++++++||||+++++++.. ....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccE
Confidence 4677889999999999999995 3454 467777754322 224567888889999999999999998754 2233
Q ss_pred eeeeccc-CCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHS-SASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~-~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+ +++++ +|.+.+.+... +.....++.|++.||+|||+ +++|.|++++.++.++++|||.++.
T Consensus 85 ~-i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 L-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred E-EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 3 44554 55554444321 22334556899999999887 7999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.8e-15 Score=141.23 Aligned_cols=136 Identities=15% Similarity=0.112 Sum_probs=102.0
Q ss_pred hhhcccccccccCCcceEEEEEeCC-----------------CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGD-----------------RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIK 421 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~ 421 (499)
..+|.+.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568889999999999999987431 2468999987554 234567899999999999999999
Q ss_pred cceeEEccccceeeeeecccCCC-cccccccc---------------ccccccccccccccceeecc------CCCcccE
Q 010856 422 ILHGVAVITFTVCLCLFHHSSAS-ASASLVSS---------------LTLSRPAKGGGFRGCVLWHV------GVDFAAF 479 (499)
Q Consensus 422 l~~~~~~~~~~~~~~l~~~~~~~-~~~~l~~~---------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~ 479 (499)
+++++...+ ..+.+++++.++ +...+... +.....++.|++.||+|||+ +++|.|+
T Consensus 84 ~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999887643 344566666544 33222211 11223345789999998877 8999999
Q ss_pred EEeeCCCeEEEEEEEeec
Q 010856 480 VFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 480 l~~~~~~~~~~~f~~~~~ 497 (499)
++++++.++++|||+++.
T Consensus 162 li~~~~~~~l~dfg~~~~ 179 (296)
T cd05051 162 LVGKNYTIKIADFGMSRN 179 (296)
T ss_pred eecCCCceEEccccceee
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.5e-15 Score=137.39 Aligned_cols=134 Identities=22% Similarity=0.176 Sum_probs=104.6
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
..+|+..+.+|+|+||.||+|.. .|+.||+|.+..... ..+++.+|+.++++++|+||+++++++... ...+.+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCeEEEEE
Confidence 35688889999999999999986 478899999975543 467899999999999999999999988762 23445677
Q ss_pred ccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+ .+.+.+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence 7754 44333322 222344556889999998877 7999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-15 Score=142.71 Aligned_cols=133 Identities=20% Similarity=0.205 Sum_probs=102.7
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCcc--HHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRA--FESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
|+..+.||+|+||+||+++.. +++.||+|++....... .....+|++++++++||||+++++++...+ ...++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--YLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--EEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc--ccccccc
Confidence 667889999999999999964 57799999998765322 233466999999999999999999887733 3345677
Q ss_pred ccCC-Ccccccc----ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSA-SASASLV----SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~-~~~~~l~----~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+ .+...+. ........++.|+++||+|||+ +++|.||+++.++.++++|||.+..
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 7766 5444443 1223344556899999998876 8999999999999999999998753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.2e-15 Score=140.30 Aligned_cols=135 Identities=18% Similarity=0.204 Sum_probs=106.6
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.+|+..+.+|+|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+ ..+++++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~--~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC--EEEEeec
Confidence 4688889999999999999995 578899999998766555678999999999999999999999887633 4556778
Q ss_pred ccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+.|+.+..+.. .......++.|++.|++|||+ +++|.|++++.++.++++|||+...
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred ccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 876554433221 122233456789999988866 8999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.5e-15 Score=140.69 Aligned_cols=137 Identities=18% Similarity=0.099 Sum_probs=103.3
Q ss_pred hhhcccccccccCCcceEEEEEeCC-----CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGD-----RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
.++|...+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++..... .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE-P 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-C
Confidence 4678889999999999999999644 6789999986543 2345678899999999999999999998876332 3
Q ss_pred eeeeecccCC-Ccccccccc------------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEE
Q 010856 434 CLCLFHHSSA-SASASLVSS------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~~------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
.+.+++++.+ .+...+... +.....++.|++.||+|||+ +++|.|+++.+++.++++|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 3445666643 333332211 11223446799999998876 7899999999999999999999
Q ss_pred eec
Q 010856 495 EIL 497 (499)
Q Consensus 495 ~~~ 497 (499)
++.
T Consensus 164 ~~~ 166 (280)
T cd05043 164 SRD 166 (280)
T ss_pred ccc
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.2e-15 Score=137.92 Aligned_cols=133 Identities=14% Similarity=0.117 Sum_probs=102.9
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
.+|+..+.+|+|+||.||+|..+++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+ ..+.++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR--PIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ceEEEEec
Confidence 3577889999999999999998777789999986543 23457889999999999999999998876543 34556777
Q ss_pred cCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 441 SSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 441 ~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+.|+ +.+.+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||+++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccce
Confidence 7554 4333322 122234456889999998876 799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-15 Score=141.82 Aligned_cols=132 Identities=19% Similarity=0.196 Sum_probs=99.4
Q ss_pred cccccccCCcceEEEEEeC-----CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 365 ENNLIGKGGFGSVYKARLG-----DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 365 ~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
..+.||+|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|++...+ ...+++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc--cccccc
Confidence 4578999999999999964 257899999965432 34688999999999999999999999998532 345567
Q ss_pred cccC-CCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSS-ASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~-~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|++. |.+.+.+... ......++.|+++||+|||+ ++.|.|+++++++.+|++|||+....
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 7775 4454444332 22344557899999999887 78899999999999999999987643
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-14 Score=137.18 Aligned_cols=134 Identities=17% Similarity=0.234 Sum_probs=104.1
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-----ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-----RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
++|...+.+|+|++|.||.|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE--TL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eE
Confidence 4688899999999999999985 4689999999865431 12456889999999999999999999987644 44
Q ss_pred eeeecccCCCccc-cccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 435 LCLFHHSSASASA-SLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 435 ~~l~~~~~~~~~~-~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
..+++++.|+... .+.. .......++.|++.|++|||+ +++|.||+++.++.++++|||++.
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 5577777655333 2222 122334556889999998876 799999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.9e-15 Score=141.29 Aligned_cols=146 Identities=20% Similarity=0.225 Sum_probs=112.3
Q ss_pred cCHHHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEc
Q 010856 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAV 428 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~ 428 (499)
++++++..++++|...+.+|+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566667788999999999999999999996 578999999986543 2346688999999998 89999999999875
Q ss_pred ccc---ceeeeeecccCCCccccc-c--------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEE
Q 010856 429 ITF---TVCLCLFHHSSASASASL-V--------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVI 490 (499)
Q Consensus 429 ~~~---~~~~~l~~~~~~~~~~~l-~--------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~ 490 (499)
.+. ...+.+++|+.|+.+..+ . ..+.....++.|++.||+|||+ +++|.|++++++++++++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 432 234567777766543322 1 1222334456899999999887 799999999999999999
Q ss_pred EEEEeec
Q 010856 491 CFVFEIL 497 (499)
Q Consensus 491 ~f~~~~~ 497 (499)
|||+.+.
T Consensus 171 dfg~~~~ 177 (291)
T cd06639 171 DFGVSAQ 177 (291)
T ss_pred ecccchh
Confidence 9998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.4e-15 Score=141.41 Aligned_cols=135 Identities=14% Similarity=0.098 Sum_probs=100.9
Q ss_pred hhcccccccccCCcceEEEEEeC-----------------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCcccc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-----------------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKI 422 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l 422 (499)
++|+..+.||+|+||.||+++.. ++..||+|++.... ....+++.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998532 23468999987543 2345679999999999999999999
Q ss_pred ceeEEccccceeeeeecccCC-Cccccccccc---------------cccccccccccccceeecc------CCCcccEE
Q 010856 423 LHGVAVITFTVCLCLFHHSSA-SASASLVSSL---------------TLSRPAKGGGFRGCVLWHV------GVDFAAFV 480 (499)
Q Consensus 423 ~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~~~---------------~~~~~~~~~i~~gl~yLH~------~~~p~~~l 480 (499)
++++...+ ...++++++.+ ++...+.... .....++.|++.|++|||+ +++|.|++
T Consensus 85 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 85 LAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99887644 33456776654 4433332211 1123345788898888776 79999999
Q ss_pred EeeCCCeEEEEEEEeec
Q 010856 481 FVLEPGVEVICFVFEIL 497 (499)
Q Consensus 481 ~~~~~~~~~~~f~~~~~ 497 (499)
+.+++.++++|||++..
T Consensus 163 i~~~~~~~l~dfg~~~~ 179 (296)
T cd05095 163 VGKNYTIKIADFGMSRN 179 (296)
T ss_pred EcCCCCEEeccCccccc
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.1e-15 Score=143.03 Aligned_cols=128 Identities=17% Similarity=0.156 Sum_probs=93.4
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHH-HHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECE-MMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|+. .+++.||+|++.... ......+.+|.. +++.++||||+++++++...+ ..++++|++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEEEEeCC
Confidence 3689999999999996 468899999997543 122334555554 567899999999998887643 345567777
Q ss_pred CCC-ccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SAS-ASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~-~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+ +...+.... ...+.++.|+++||+|||+ ++||.||+++.++.++++|||++.
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~ 144 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK 144 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCc
Confidence 554 333332221 2233446889999998876 899999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.52 E-value=7e-15 Score=140.57 Aligned_cols=134 Identities=18% Similarity=0.179 Sum_probs=102.3
Q ss_pred hhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|...+.+|+|+||+||++.. .++..+|+|.+........+.+.+|++++++++||||+++++++...+ ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--PL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--cc
Confidence 4688889999999999999974 234568999987655445677999999999999999999999887633 34
Q ss_pred eeeecccCCCcc-ccccc-----------------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEE
Q 010856 435 LCLFHHSSASAS-ASLVS-----------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVI 490 (499)
Q Consensus 435 ~~l~~~~~~~~~-~~l~~-----------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~ 490 (499)
+.+++++.++.+ +.+.. .+.....++.|++.||+|||+ +++|.|+++++++.++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 556777754433 22221 112233445789999998877 799999999999999999
Q ss_pred EEEEee
Q 010856 491 CFVFEI 496 (499)
Q Consensus 491 ~f~~~~ 496 (499)
|||++.
T Consensus 163 dfg~~~ 168 (288)
T cd05093 163 DFGMSR 168 (288)
T ss_pred cCCccc
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=138.90 Aligned_cols=138 Identities=17% Similarity=0.137 Sum_probs=104.6
Q ss_pred hhcccccccccCCcceEEEEEeC-----CCCEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-----DRMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
+.|+..+.+|+|+||.||+|+.. ++..||+|++...... ..+.|.+|+++++.++||||+++++++........
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999852 3689999999765432 46789999999999999999999988765333344
Q ss_pred eeeecccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
..+++++.++ +.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 5567777544 3333321 122234456888999998877 89999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.7e-15 Score=142.03 Aligned_cols=128 Identities=17% Similarity=0.147 Sum_probs=97.1
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|+. .+++.||+|++.+.. ....+.+.+|++++... +||||+++++++...+ ..++++||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--RLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--EEEEEEcCC
Confidence 3689999999999996 468999999997542 23456678899998876 7999999999887643 445577777
Q ss_pred CCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+ +...+... ......++.|++.||+|||+ +++|.||+++.++.++++|||++.
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~ 144 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence 654 33333222 22233446889999998876 899999999999999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.8e-15 Score=139.44 Aligned_cols=135 Identities=17% Similarity=0.123 Sum_probs=103.6
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|...+.||+|+||.||+|+. .+++.+|+|.+.... ....+++.+|+++++.++||||+++++++...+ ..+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--eEEE
Confidence 4688889999999999999995 578999999886533 233467899999999999999999999887633 3445
Q ss_pred eecccCCCcccc-ccc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASAS-LVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~-l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.|+.+.. +.. .+.....++.|++.|++|||+ +++|.|++++.++.++++|||++..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence 677776543332 211 112223445789999999987 7999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-14 Score=138.14 Aligned_cols=135 Identities=17% Similarity=0.178 Sum_probs=106.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+ ..+.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS--GFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--eeEEEe
Confidence 477889999999999999996 478999999997654 233567999999999999999999999887633 445677
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++++++...+.. .+.....++.|+++||+|||+ +++|.|+++++++.++++|||++..+
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 7776665443322 222344556889999998877 78999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.9e-15 Score=141.39 Aligned_cols=128 Identities=15% Similarity=0.135 Sum_probs=96.2
Q ss_pred cccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhc-CCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKN-IRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~-l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||.||+|+.+ +|+.||+|+++... ....+.+..|.+++.. .+||||+++++++...+ ..++++||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEEEECCC
Confidence 46899999999999964 68999999997643 2334567788888875 59999999999887633 445567777
Q ss_pred CCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+ +...+... ......++.|++.||+|||+ +++|.|++++.++.++++|||++.
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK 144 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCe
Confidence 554 33333222 22233445799999998876 899999999999999999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=137.12 Aligned_cols=134 Identities=19% Similarity=0.179 Sum_probs=102.8
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.+.|...+.+|+|+||.||+|+..+...||+|++.... ...+.+.+|++++++++||||+++++++.. + . .+.+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~-~-~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-P-IYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-C-C-cEEEEE
Confidence 35688999999999999999997666679999997543 234678999999999999999999987643 2 2 345777
Q ss_pred ccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++ +.+.+.. .+.....++.|+++||+|+|+ +++|.|+++.+++.++++|||.++.
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 77654 3333322 112233446899999999887 7999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.2e-15 Score=143.44 Aligned_cols=139 Identities=15% Similarity=0.116 Sum_probs=108.6
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcC-CCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~ 434 (499)
..++|+..+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++++ +||||+++++++...+....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999964 68899999985432 23345678899999999 99999999998876544455
Q ss_pred eeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++++.+++...+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||.+..
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 66888887765444322 222233456899999998876 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.3e-15 Score=143.95 Aligned_cols=140 Identities=16% Similarity=0.097 Sum_probs=108.7
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc----c
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT----F 431 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----~ 431 (499)
....|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.... +
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 446799999999999999999995 578999999986432 233466889999999999999999999875432 2
Q ss_pred ceeeeeecccCCCccccccc--cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 432 TVCLCLFHHSSASASASLVS--SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~--~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
...+++++++.+++...+.. .......++.|++.||+|||+ +++|.|++++.++.++++|||+++..
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 23456788888766554332 222334456889999988877 79999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.4e-15 Score=140.25 Aligned_cols=134 Identities=16% Similarity=0.162 Sum_probs=102.9
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.... ..+.++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG--AVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC--eEEEEEe
Confidence 5788899999999999999964 78999999986542 233467899999999999999999999887633 3445677
Q ss_pred ccCCCcccccc-c-------cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLV-S-------SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~-~-------~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+.|+....+. . .+.....++.|++.|++|||+ +++|.|++++.++.++++|||++.-
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 77665433321 1 122334446788888888874 6899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=140.73 Aligned_cols=139 Identities=16% Similarity=0.192 Sum_probs=107.3
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc----
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF---- 431 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~---- 431 (499)
..++|+..+.+|+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 345799999999999999999996 468999999986543 2223456789999999999999999998865332
Q ss_pred --ceeeeeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 --TVCLCLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 --~~~~~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...+++++++.+++...+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 23456778887765443322 222334556899999999887 7999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-14 Score=136.72 Aligned_cols=134 Identities=19% Similarity=0.171 Sum_probs=103.6
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
++|+..+.+|+|+||.||+|...++..+|+|.+..... ..+++.+|+.++++++|||++++++++.. .. .+.++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~-~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE--EP-IYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC--CC-cEEEEEe
Confidence 46888899999999999999987888899999976442 34679999999999999999999987643 22 3456777
Q ss_pred cCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 441 SSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 441 ~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+.++ +.+.+.. .+.....++.|++.|++|||+ +++|.|+++.+++.++++|||++..+
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 7554 3333321 122234556889999999877 78999999999889999999998643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.7e-15 Score=140.99 Aligned_cols=146 Identities=18% Similarity=0.209 Sum_probs=110.1
Q ss_pred cCHHHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEc
Q 010856 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAV 428 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~ 428 (499)
+.++.+..+.++|+..+.||+|+||.||+|+. .+++.+|+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44566667888999999999999999999996 468899999886432 2246688999999999 79999999998754
Q ss_pred cc---cceeeeeecccCCCccccc-cc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEE
Q 010856 429 IT---FTVCLCLFHHSSASASASL-VS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVI 490 (499)
Q Consensus 429 ~~---~~~~~~l~~~~~~~~~~~l-~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~ 490 (499)
.+ ....+.++||+.|+.+..+ .. .+.....++.|+++|+.|||+ +++|.|+++.+++.++++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 22 2345567788766544322 10 111123356788999999876 789999999999999999
Q ss_pred EEEEeec
Q 010856 491 CFVFEIL 497 (499)
Q Consensus 491 ~f~~~~~ 497 (499)
|||++..
T Consensus 167 dfg~~~~ 173 (286)
T cd06638 167 DFGVSAQ 173 (286)
T ss_pred cCCceee
Confidence 9999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-14 Score=137.51 Aligned_cols=134 Identities=18% Similarity=0.156 Sum_probs=103.5
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.+|...+.+|+|+||.||+|.. ++++.||+|.+.... ...+++.+|++++++++||||+++++++...+ ..+.+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC--CcEEEEE
Confidence 4578889999999999999996 468899999987543 34567899999999999999999999886633 3445677
Q ss_pred ccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++ +.+.+.. .+.....++.|+++||+|||+ +++|.|+++.+++.++++|||++..
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 77544 3333321 112233446899999998876 8999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=138.61 Aligned_cols=135 Identities=16% Similarity=0.146 Sum_probs=102.2
Q ss_pred hhcccccccccCCcceEEEEEeC-CCC----EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRM----EVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|...+.||+|+||+||+|..+ +|. .+|+|....... .....+.+|+.++++++||||+++++++.. . ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~-~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--S-QV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C-ce
Confidence 56788899999999999999853 333 689998865542 345678999999999999999999998876 2 23
Q ss_pred eeeeccc-CCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHS-SASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~-~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+.+++++ +|.+.+.+... +.....++.|++.|++|||+ +++|.|+++++++.++++|||+++.+
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 3455555 44444433321 22234446899999999987 79999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-14 Score=136.14 Aligned_cols=135 Identities=18% Similarity=0.172 Sum_probs=104.9
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|.+.+.||+|+||.||+|...+++.||+|.+.... ...+++.+|++++++++||||+++++++.... ..+.+++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE--PIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC--ceEEEEe
Confidence 45788899999999999999998777889999987543 33567999999999999999999998876532 3455677
Q ss_pred ccCCC-cccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSAS-ASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~-~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++ +.+.+... +.....++.|++.|++|||+ +++|.|+++.+++.++++|||++..
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcccccee
Confidence 77554 33333221 12233445788999988877 7999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-14 Score=138.20 Aligned_cols=135 Identities=19% Similarity=0.168 Sum_probs=100.9
Q ss_pred hhcccccccccCCcceEEEEEeCC------CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGD------RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
++|+..+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--P 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC--c
Confidence 468888999999999999998532 2579999986543 233567899999999999999999999887633 3
Q ss_pred eeeeecccCC-Ccccccccc--------------------ccccccccccccccceeecc------CCCcccEEEeeCCC
Q 010856 434 CLCLFHHSSA-SASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG 486 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~ 486 (499)
...+++++.+ ++.+.+... ......++.|++.||+|||+ +++|.|+++++++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 3446666654 443333211 01122346889999999876 89999999999999
Q ss_pred eEEEEEEEeec
Q 010856 487 VEVICFVFEIL 497 (499)
Q Consensus 487 ~~~~~f~~~~~ 497 (499)
++++|||++..
T Consensus 163 ~~L~dfg~~~~ 173 (283)
T cd05048 163 VKISDFGLSRD 173 (283)
T ss_pred EEECCCcceee
Confidence 99999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-14 Score=135.52 Aligned_cols=129 Identities=18% Similarity=0.168 Sum_probs=98.1
Q ss_pred cccccCCcceEEEEEeCCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCCc
Q 010856 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSASA 445 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~ 445 (499)
++||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++...+ ...+++|++.++.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEECCCCCc
Confidence 36899999999999987889999999875442 22456889999999999999999999887643 3455677765443
Q ss_pred cc-cccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 446 SA-SLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 446 ~~-~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+. .+.. .+.....++.|++.|+.|+|+ +++|.|+++++++.++++|||+++.
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCcccee
Confidence 33 2221 112223445788888888876 7999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.9e-16 Score=135.33 Aligned_cols=136 Identities=18% Similarity=0.170 Sum_probs=106.6
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcc--cc-ceeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVI--TF-TVCLC 436 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~--~~-~~~~~ 436 (499)
.+..+.||-|+||+||.+.. ++|+.||.|++..-- -...+.+.+|++++..++|.|++..++..... ++ .+.++
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45678999999999999996 579999999885322 22357789999999999999999999865431 12 24555
Q ss_pred eecccCCCccccccccccccc----cccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHSSASASASLVSSLTLSR----PAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~~~~~~----~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+.|.|..++++.+........ -..+||.+||.|||+ ++||.|.|++.+=-.||||||++||-
T Consensus 135 ~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence 678888887776655444322 224899999999977 89999999999999999999999974
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-14 Score=137.47 Aligned_cols=135 Identities=16% Similarity=0.111 Sum_probs=104.8
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|...+.+|.|++|.||+|.. .+++.+|+|.+..... ....++.+|++++++++||||++++++|...+....+++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 577889999999999999996 4688999999975432 34567999999999999999999999887644444456777
Q ss_pred ccCCCcccc-ccc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 440 HSSASASAS-LVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 440 ~~~~~~~~~-l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++.|+.+.. +.. .......++.|++.||+|||+ +++|.|+++++++.++++|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 776554332 111 112233456899999999877 789999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.9e-15 Score=137.40 Aligned_cols=130 Identities=20% Similarity=0.140 Sum_probs=96.0
Q ss_pred cccccCCcceEEEEEeC----CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+...+. +++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l-v~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV-VLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE-EEecC
Confidence 46899999999999852 24579999986433 33457889999999999999999999988765544444 55555
Q ss_pred C-CCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 442 S-ASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 442 ~-~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
. +++...+... ......++.|++.|++|||+ +++|.|+++++++.++++|||+++.
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~ 147 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARD 147 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcccccc
Confidence 4 4443333221 11123345789999998877 7999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-14 Score=140.12 Aligned_cols=134 Identities=19% Similarity=0.213 Sum_probs=99.7
Q ss_pred hhcccccccccCCcceEEEEEe-CCCC----EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRM----EVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|+..+.||+|+||.||+|.. .+|. .||+|.+..... .....+.+|+.+++.++||||+++++++.... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~- 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT--I- 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC--c-
Confidence 4577888999999999999985 3454 478888865432 22346889999999999999999999886532 2
Q ss_pred eeeecccC-CCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSS-ASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~-~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++++. |.+.+.+... +.....++.|++.||+|||+ +++|.||++.+++.++++|||++..
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 23555554 4444433221 12234446899999999887 7899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.7e-14 Score=135.35 Aligned_cols=135 Identities=15% Similarity=0.080 Sum_probs=104.4
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.+|+|+||.||.++. .+++.+++|.+.... ....+++.+|++++++++|+||+++++++...+ ..+.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--TLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--eEEEEE
Confidence 477889999999999999985 578899999987543 344567899999999999999999999987743 445567
Q ss_pred cccCCC-cccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSSAS-ASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~-~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++.++ +.+.+... ......++.|+++|++|||+ +++|.|+++++++.++++|||++...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 777554 33333221 11223445789999999876 79999999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-14 Score=141.39 Aligned_cols=133 Identities=14% Similarity=0.104 Sum_probs=100.3
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~ 436 (499)
+|...+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|.+++... +|++|+++++++...+ ..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD--RLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC--EEEE
Confidence 4778899999999999999964 68899999997643 22345677888888877 6899999988876643 3455
Q ss_pred eecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 437 LFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++||+.++ +...+... +.....++.|++.||+|||+ +++|.|+++++++.++++|||+++
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~ 149 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence 67777544 43333222 22234456899999998876 799999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-14 Score=138.75 Aligned_cols=134 Identities=10% Similarity=0.074 Sum_probs=105.7
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|+..+.||+|+||+||+++. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++... ...+.++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEE
Confidence 5688889999999999999995 468999999986543 33457899999999999999999999998774 3456678
Q ss_pred cccCCCccccc-cc----cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 439 HHSSASASASL-VS----SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 439 ~~~~~~~~~~l-~~----~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
||+.++.+..+ .. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++.
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence 88876654432 22 222344556888999988874 589999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-14 Score=139.97 Aligned_cols=135 Identities=21% Similarity=0.225 Sum_probs=106.0
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
..|...+.+|+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+ ..++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~--~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--eEEE
Confidence 4488889999999999999996 468999999986443 223457889999999999999999999987643 3456
Q ss_pred eecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.|++...+.. .+.....++.|++.||.|||+ +++|.|+++++++.++++|||++..
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCccee
Confidence 788887765443321 222233456899999999987 6899999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=138.68 Aligned_cols=136 Identities=20% Similarity=0.189 Sum_probs=102.6
Q ss_pred hhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
.++|...+.+|+|+||.||+|... +++.||+|.++..... ..+.+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD-- 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--
Confidence 356888899999999999999852 2578999999765433 4578999999999999999999999887643
Q ss_pred eeeeeecccCCC-cccccccc------------------ccccccccccccccceeecc------CCCcccEEEeeCCCe
Q 010856 433 VCLCLFHHSSAS-ASASLVSS------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGV 487 (499)
Q Consensus 433 ~~~~l~~~~~~~-~~~~l~~~------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~ 487 (499)
..+++++++.++ +...+... +.....++.|++.|++|||+ +++|.|++++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 345567776544 33222211 11122335788888888876 789999999999999
Q ss_pred EEEEEEEeec
Q 010856 488 EVICFVFEIL 497 (499)
Q Consensus 488 ~~~~f~~~~~ 497 (499)
+++|||+++.
T Consensus 162 kl~d~g~~~~ 171 (280)
T cd05049 162 KIGDFGMSRD 171 (280)
T ss_pred EECCccccee
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=137.47 Aligned_cols=135 Identities=18% Similarity=0.159 Sum_probs=101.1
Q ss_pred hhcccccccccCCcceEEEEEeC-C---CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-D---RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
++|+..+.+|+|+||.||+|+.. + +..+|+|.++... ....+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK--PVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--ccE
Confidence 56888899999999999999852 2 3479999986543 233567899999999999999999999887643 345
Q ss_pred eeecccCCC-cccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSAS-ASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~-~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++|++.++ +.+.+... ......++.|++.|++|||+ +++|.|++++.++.++++|||.+..
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 567777554 33333221 11233445788888887765 8999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.5e-14 Score=138.63 Aligned_cols=135 Identities=19% Similarity=0.225 Sum_probs=104.5
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
++|+..+.||+|++|.||+|+. .+|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+ ..+.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--RLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--eEEEE
Confidence 4688889999999999999996 478999999986543 233467889999999999999999999987643 45567
Q ss_pred ecccCCCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeC-CCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE-PGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~-~~~~~~~f~~~~~ 497 (499)
+||+.+++...+... ......++.|++.||+|||+ +++|.|++++.+ +.++++|||++..
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 888877654443221 12233456799999999877 799999999854 5689999998753
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=137.88 Aligned_cols=135 Identities=21% Similarity=0.201 Sum_probs=98.7
Q ss_pred cccccccccCCcceEEEEEeC----CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccc----
Q 010856 363 FSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT---- 432 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~---- 432 (499)
|...+.||+|+||.||+|..+ +++.||+|++.... ....+++.+|++++++++||||+++++++...+..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999852 46889999996543 23456789999999999999999999987653211
Q ss_pred eeeeeecccC-CCcccccc----------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 433 VCLCLFHHSS-ASASASLV----------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 433 ~~~~l~~~~~-~~~~~~l~----------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
..+.+++++. |++...+. ........++.|++.|++|||+ +++|.|+++++++.++++|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 1233455554 44322221 1112234456899999999877 79999999999999999999987
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
+.
T Consensus 161 ~~ 162 (273)
T cd05074 161 KK 162 (273)
T ss_pred cc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-14 Score=141.55 Aligned_cols=138 Identities=14% Similarity=0.125 Sum_probs=104.8
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc----cc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT----FT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----~~ 432 (499)
..+|...+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+++++.++||||+++++++...+ ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36799999999999999999995 478999999986532 223456889999999999999999999876432 12
Q ss_pred eeeeeecccCCCcccccc--ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLV--SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~--~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++.+++++.+.+..... ..+.....++.|++.||+|||+ +++|.|++++.++.++++|||+++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 345667777654332211 1222334456889999988776 7899999999999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-14 Score=135.42 Aligned_cols=135 Identities=18% Similarity=0.116 Sum_probs=103.8
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.+|+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+ ..++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG--KLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--EEEEEE
Confidence 477788999999999999996 468999999987543 344677899999999999999999999887633 445577
Q ss_pred cccCCC-cccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSSAS-ASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~-~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++.|+ +.+.+... +.....++.|++.|++|||+ +++|.||+++.++.++++|||++..+
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 777544 33333221 11223345789999998877 79999999999999999999987643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-14 Score=137.49 Aligned_cols=128 Identities=18% Similarity=0.204 Sum_probs=95.6
Q ss_pred cccccCCcceEEEEEeC---CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 367 NLIGKGGFGSVYKARLG---DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
+.||+|+||.||+|... ++..+|+|.++.... .....+.+|+.++++++||||+++++++...+ ..+.++||+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEEEEECCC
Confidence 35899999999999853 346799998865542 23457889999999999999999999886633 3455677776
Q ss_pred CCcc-cccccc---------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 443 ASAS-ASLVSS---------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 443 ~~~~-~~l~~~---------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++.+ +.+... +.....++.|++.|++|||+ +++|.|++++.++.++++|||++.
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 148 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccc
Confidence 5433 333211 11223446789999998865 899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.9e-15 Score=132.61 Aligned_cols=137 Identities=15% Similarity=0.188 Sum_probs=108.9
Q ss_pred CHHHHHHHhhhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 352 SYLELFRATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 352 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
+++++.+-++ +.+|+|+|+.|--|. ..+|..||||++++.....+.++.+|++++.+. .|+||++++++|.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd- 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED- 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-
Confidence 4666666654 679999999999888 678999999999988766788899999999998 59999999999987
Q ss_pred ccceeeeeecccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCC---CeEEEEEEEe
Q 010856 430 TFTVCLCLFHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVICFVFE 495 (499)
Q Consensus 430 ~~~~~~~l~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~~f~~~ 495 (499)
...++.++|-|.|+ ++..++. .+....+++..|+.||.|||. +.||+|||-++.+ -||+|||-+.
T Consensus 148 -d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 148 -DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred -cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccc
Confidence 34566788888665 4444433 333344556788999999976 8999999998775 6799999653
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=139.33 Aligned_cols=134 Identities=16% Similarity=0.127 Sum_probs=97.9
Q ss_pred hcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
+|.+.+.||+|+||.||+|+.. ....+|+|.+..... ...+++.+|+.+++.++||||+++++.+...+. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP--L 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC--c
Confidence 4677899999999999999842 235788988865432 335678999999999999999999998876432 3
Q ss_pred eeeecccCCC-cccccccc----------------------------ccccccccccccccceeecc------CCCcccE
Q 010856 435 LCLFHHSSAS-ASASLVSS----------------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAF 479 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~~----------------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~ 479 (499)
+.+++++.++ +.+.+... +.....++.|++.|++|||+ +++|.||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 4456666544 32222110 11112345789999988876 8999999
Q ss_pred EEeeCCCeEEEEEEEeec
Q 010856 480 VFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 480 l~~~~~~~~~~~f~~~~~ 497 (499)
++.+++.++++|||+++.
T Consensus 159 ll~~~~~~kl~dfg~~~~ 176 (290)
T cd05045 159 LVAEGRKMKISDFGLSRD 176 (290)
T ss_pred EEcCCCcEEecccccccc
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-14 Score=136.16 Aligned_cols=137 Identities=17% Similarity=0.203 Sum_probs=104.7
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|...+.+|+|+||.||+|+. .++..||+|.+.... ....+.+.+|++++++++||||+++++++...+....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999995 468999999885432 2234578899999999999999999998876544444
Q ss_pred eeeecccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++|+..++ +...+.. .......++.|++.|++|||+ +++|.|++++.++.++++|||++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 4566776554 3333322 122334556889999998876 7899999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.9e-15 Score=139.83 Aligned_cols=136 Identities=21% Similarity=0.170 Sum_probs=102.8
Q ss_pred hhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
..+|+..+.+|+|+||.||+|... ++..||+|++..... ...+.+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-- 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-- 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence 457888999999999999999852 467899999875432 33467999999999999999999999887633
Q ss_pred eeeeeecccCCC-cccccccc--------------------------ccccccccccccccceeecc------CCCcccE
Q 010856 433 VCLCLFHHSSAS-ASASLVSS--------------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAF 479 (499)
Q Consensus 433 ~~~~l~~~~~~~-~~~~l~~~--------------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~ 479 (499)
...++++++.++ +...+... +.....++.|++.||+|||+ +++|.|+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 345567776554 33232210 11123456889999998866 7999999
Q ss_pred EEeeCCCeEEEEEEEeec
Q 010856 480 VFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 480 l~~~~~~~~~~~f~~~~~ 497 (499)
++.+++.++++|||++..
T Consensus 162 l~~~~~~~~l~dfg~~~~ 179 (288)
T cd05050 162 LVGENMVVKIADFGLSRN 179 (288)
T ss_pred EecCCCceEECcccccee
Confidence 999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.5e-14 Score=140.52 Aligned_cols=133 Identities=14% Similarity=0.117 Sum_probs=100.0
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~ 436 (499)
+|...+.||+|+||.||+|+. .+|+.||+|++.+.. ....+.+..|+++++.+. |++|+++++++...+ ..++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD--RLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC--EEEE
Confidence 366778999999999999995 478999999997542 233456888999998885 567778887776533 3455
Q ss_pred eecccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 437 LFHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++||+.|+ +...+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||+++
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccccc
Confidence 77777554 3333222 223344556899999999887 799999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-14 Score=135.05 Aligned_cols=135 Identities=21% Similarity=0.272 Sum_probs=106.8
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
++|+..+.+|+|+||.||+|.. .+++.+|+|.+........+.+.+|++++++++||||+++++++...+ ..+++++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD--KLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC--EEEEEEe
Confidence 5688889999999999999996 467899999998665556678999999999999999999999886633 4456778
Q ss_pred ccCCCcccccc-c-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLV-S-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~-~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+..++....+. . .......++.|++.|++|||+ +++|.||++++++.++++|||++..
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchh
Confidence 87765444322 1 112233446889999999877 7999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.5e-14 Score=137.86 Aligned_cols=134 Identities=15% Similarity=0.213 Sum_probs=105.7
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|+..+.||+|++|.||+|+.. +|+.||+|.++... ....+.+.+|++++++++||||+++++++...+ ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEEEe
Confidence 4778899999999999999964 68999999997654 233466789999999999999999999987743 3456788
Q ss_pred ccCCCccccccc-------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVS-------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~-------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+++...+.. .+.....++.|+++||+|||+ +++|.|+++++++.++++|||.+..
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 79 YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred cCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 888765444322 122233446889999999876 7899999999999999999998753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-14 Score=144.64 Aligned_cols=130 Identities=14% Similarity=0.114 Sum_probs=101.2
Q ss_pred hhcccccccccCCcceEEEEEeC---CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG---DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
..|...+.||+|+||.||+|... .+..||+|.+... +...+|++++++++|||||++++++.... ...++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS--TVCMV 164 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC--EEEEE
Confidence 46899999999999999999742 4678999988643 23568999999999999999998876532 34456
Q ss_pred ecccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.+++...+.. .+.....++.|++.||+|||+ ++||.|++++.++.++++|||++..
T Consensus 165 ~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 165 MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred ehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 67777766554422 222344556899999998877 7999999999999999999998753
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.7e-14 Score=133.95 Aligned_cols=133 Identities=19% Similarity=0.124 Sum_probs=102.1
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
.+|...+.+|+|+||.||+|.. .|..||+|.++... ..+.+.+|+.++++++|+|++++++++...+.. .+.++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG-LYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc-eEEEEEC
Confidence 4688889999999999999986 47789999886432 346789999999999999999999987653333 3456777
Q ss_pred cCC-Ccccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 441 SSA-SASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 441 ~~~-~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+ .+.+.+... +.....++.|++.||+|||+ +++|.|+++++++.++++|||+...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCcccee
Confidence 755 443333221 12234456789999998877 7999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-14 Score=138.35 Aligned_cols=134 Identities=16% Similarity=0.170 Sum_probs=106.4
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.||+|+||.||+|..+ +++.||+|.++... ....+.+.+|++++++++|+||+++++++...+ ...+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG--RLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC--EEEEEE
Confidence 5888899999999999999964 68899999986543 334578999999999999999999999987633 455678
Q ss_pred cccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++....+... ......++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 88877765433221 22233445889999998876 7899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-14 Score=136.09 Aligned_cols=133 Identities=17% Similarity=0.269 Sum_probs=102.8
Q ss_pred hcccccccccCCcceEEEEEeCCCCEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 362 EFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG------RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
+|+..+.||+|+||.||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++... ....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEE
Confidence 3777899999999999999987899999999865421 1235688999999999999999999998764 3445
Q ss_pred eeecccCCCccc-cccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 436 CLFHHSSASASA-SLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 436 ~l~~~~~~~~~~-~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+++|++.|+.+. .+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||+..
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence 567777654333 3322 222233445789999998877 799999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-14 Score=141.74 Aligned_cols=141 Identities=17% Similarity=0.133 Sum_probs=108.4
Q ss_pred HHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
+...+++|+..+.||+|+||.||+|.. .+++.||+|++.+.. ....+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~- 83 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE- 83 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC-
Confidence 345677899999999999999999985 479999999986432 2345678899999999999999999998865332
Q ss_pred eeeeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+.+++++++++...+.. .......++.|+++||+|||+ +++|.|+++++++.++++|||.+..
T Consensus 84 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 3345778887664333321 122233456889999988877 7899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-14 Score=140.08 Aligned_cols=134 Identities=18% Similarity=0.189 Sum_probs=99.5
Q ss_pred hhcccccccccCCcceEEEEEeC-CCC--EEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRM--EVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~ 435 (499)
.+|+..+.||+|+||.||+|+.+ ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+ ..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~--~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC--Cce
Confidence 56888899999999999999963 454 45777765433 23356788999999999 8999999999886643 334
Q ss_pred eeecccCC-Ccccccccc--------------------ccccccccccccccceeecc------CCCcccEEEeeCCCeE
Q 010856 436 CLFHHSSA-SASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVE 488 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~ 488 (499)
.+++|+.+ .+...+... ......++.|++.|++|||+ +++|.|+++++++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 56677654 433333211 11233446789999998887 7999999999999999
Q ss_pred EEEEEEee
Q 010856 489 VICFVFEI 496 (499)
Q Consensus 489 ~~~f~~~~ 496 (499)
++|||++.
T Consensus 165 l~dfg~~~ 172 (303)
T cd05088 165 IADFGLSR 172 (303)
T ss_pred eCccccCc
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-15 Score=143.49 Aligned_cols=138 Identities=15% Similarity=0.137 Sum_probs=106.8
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
++|...+++|+|+||.++.++. .++..|++|.+.... ...++...+|+.++++++|||||...+.|...+ +...++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEEE
Confidence 5688899999999999999985 467899999997655 344557889999999999999999999887643 423445
Q ss_pred ecccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeeccC
Q 010856 438 FHHSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILLN 499 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~~ 499 (499)
++|+.|+ +.+.+.. .+.....+..|++.|+.|||+ ++|+.||.+++++.|++-|||+|.+++
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 6666554 4333322 222233335799999999885 899999999999999999999998874
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.50 E-value=3e-14 Score=134.15 Aligned_cols=137 Identities=15% Similarity=0.165 Sum_probs=104.6
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.+|+|+||.||++.. .+++.||+|.++... ....+++.+|++++++++||||+++++++...+....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 578899999987543 23356788999999999999999999987654444455677
Q ss_pred cccCCCccc-cccc--------cccccccccccccccceeec-----c------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSSASASA-SLVS--------SLTLSRPAKGGGFRGCVLWH-----V------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~~~~-~l~~--------~~~~~~~~~~~i~~gl~yLH-----~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|++.++.+. .+.. .+.....++.|++.|++||| + +++|.|+++++++.++++|||+...+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 777654332 2221 11223344678999999888 3 79999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-14 Score=138.62 Aligned_cols=136 Identities=15% Similarity=0.115 Sum_probs=104.9
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCC-CCCccccceeEEcccc---cee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIR-HRNLIKILHGVAVITF---TVC 434 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~---~~~ 434 (499)
+|+..+.||+|+||.||+|+. .+++.||+|.++... ......+.+|+.+++.++ ||||+++++++...+. ...
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 588889999999999999996 478999999986543 223467889999999995 6999999998866432 124
Q ss_pred eeeecccCCCccccccc---------cccccccccccccccceeecc------CCCcccEEEee-CCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVS---------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL-EPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~---------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~-~~~~~~~~f~~~~~ 497 (499)
+++++++.+++...+.. .+.....++.|+++||+|||+ +++|.|+++++ ++.++++|||+++.
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 56788888765444322 222334456899999998877 79999999988 78999999998763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-14 Score=137.53 Aligned_cols=136 Identities=18% Similarity=0.162 Sum_probs=103.3
Q ss_pred hhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
.++|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ-- 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--
Confidence 357888899999999999999853 23689999986543 233567889999999999999999999887643
Q ss_pred eeeeeecccCC-Ccccccccc--------------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEE
Q 010856 433 VCLCLFHHSSA-SASASLVSS--------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVIC 491 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~~--------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~ 491 (499)
..++++|++.+ .+...+... +.....++.|++.|++|||+ +++|.|++++.++.++++|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 34556777754 433333211 11223346799999999987 7999999999999999999
Q ss_pred EEEeec
Q 010856 492 FVFEIL 497 (499)
Q Consensus 492 f~~~~~ 497 (499)
||+++.
T Consensus 163 fg~~~~ 168 (277)
T cd05032 163 FGMTRD 168 (277)
T ss_pred cccchh
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-14 Score=138.22 Aligned_cols=127 Identities=10% Similarity=0.029 Sum_probs=94.3
Q ss_pred ccccCCcceEEEEEeCC-------------------------CCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCcccc
Q 010856 368 LIGKGGFGSVYKARLGD-------------------------RMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKI 422 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l 422 (499)
.||+|+||.||+|.... ...||+|+++.........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997411 13588998865544445678899999999999999999
Q ss_pred ceeEEccccceeeeeecccCCCcccccc-c-----cccccccccccccccceeecc------CCCcccEEEeeCC-----
Q 010856 423 LHGVAVITFTVCLCLFHHSSASASASLV-S-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP----- 485 (499)
Q Consensus 423 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~-~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~----- 485 (499)
++++.... ..++++||+.++.+..+. . .+.+...++.|+++||+|||+ +++|.|+++++.+
T Consensus 82 ~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 99987633 445677888766544332 1 122334556899999999887 7899999997542
Q ss_pred --CeEEEEEEEee
Q 010856 486 --GVEVICFVFEI 496 (499)
Q Consensus 486 --~~~~~~f~~~~ 496 (499)
.++++|||++.
T Consensus 160 ~~~~kl~d~g~~~ 172 (274)
T cd05076 160 SPFIKLSDPGVSF 172 (274)
T ss_pred cceeeecCCcccc
Confidence 37999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.1e-14 Score=135.05 Aligned_cols=133 Identities=18% Similarity=0.172 Sum_probs=102.4
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
++|.....||+|+||.||+|....+..+|+|.+.... ...+.+.+|++++++++|||++++++++.. .. .+.++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~-~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EP-IYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CC-cEEEEEc
Confidence 4588889999999999999997666789999886543 234678999999999999999999987643 22 3456777
Q ss_pred cCC-Ccccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 441 SSA-SASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 441 ~~~-~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+ .+.+.+... +.....++.|++.||+|||+ +++|.|+++++++.++++|||++..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence 755 444433221 12233446789999999987 7999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.8e-14 Score=136.24 Aligned_cols=135 Identities=18% Similarity=0.157 Sum_probs=101.5
Q ss_pred hhcccccccccCCcceEEEEEeC-CC---CEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DR---MEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.+|...+.+|+|+||.||+|+.+ ++ ..||+|.++... ....++|.+|+.+++.++||||+++++++...+ ..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR--PVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC--ceE
Confidence 45788899999999999999953 33 369999987543 234568999999999999999999999876533 345
Q ss_pred eeecccCCCccc-ccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASA-SLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~-~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++|++.++.+. .+... ......++.|++.|++|||+ +++|.|++++.++.++++|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 567777655433 22211 11233445788888888776 8999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-15 Score=148.86 Aligned_cols=132 Identities=17% Similarity=0.234 Sum_probs=104.9
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
|.+.-.+|.|+||+||+|.-+ ++-.-|.|++........++++-||+|++.++||+||++++.|.- +. ..+++.+++
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-en-kLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-EN-KLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cC-ceEEEEeec
Confidence 445567899999999999954 466677888877766778899999999999999999999987654 22 345577888
Q ss_pred CCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+|+..+.+.. .+...+-+++|++.||.|||+ +.|..|||++.+|.++++|||.+-
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccc
Confidence 8886665431 223344557899999999987 799999999999999999999764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-14 Score=135.60 Aligned_cols=127 Identities=14% Similarity=0.175 Sum_probs=95.4
Q ss_pred ccccCCcceEEEEEeC---CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCC
Q 010856 368 LIGKGGFGSVYKARLG---DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSA 443 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~ 443 (499)
.||+|+||.||+|..+ ++..||+|++..... ...+.+.+|++++++++||||+++++++.. + ..+.++|++.+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~--~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-E--ALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-C--CeEEEEEeCCC
Confidence 3899999999999753 355799999875542 334679999999999999999999998743 2 23456677755
Q ss_pred Cccc-cccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 444 SASA-SLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 444 ~~~~-~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+. .+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 144 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKA 144 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCcccc
Confidence 4333 3321 122234456899999999877 7999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-14 Score=136.50 Aligned_cols=136 Identities=17% Similarity=0.161 Sum_probs=106.4
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
|+..+.+|+|+||.||+|... +++.+|+|++.... ....+.+.+|+++++.++|||++++++++...+....+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999964 58899999997653 334567889999999999999999999987642234556788
Q ss_pred ccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++.+++...+... +.....++.|+++|++|||+ +++|.|+++++++.++++|||++...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 8877654433221 22234456899999999877 79999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-14 Score=138.20 Aligned_cols=132 Identities=20% Similarity=0.232 Sum_probs=102.4
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
|.....||+|+||.||+|.. .+++.||+|.++.......+.+.+|+.+++.++||||+++++++...+ ..+++++++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--ELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC--eEEEEEecC
Confidence 44456799999999999996 478999999997655445677899999999999999999999887633 345577777
Q ss_pred CCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.++....+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||++.
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHh
Confidence 6654433322 122334456889999988876 899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.3e-14 Score=133.28 Aligned_cols=134 Identities=13% Similarity=0.106 Sum_probs=103.8
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|+..+.+|+|+||.||+++. .+++.||+|.++... ....+.+.+|+.+++.++||||+++++++...+ ..+++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--HLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEEEe
Confidence 477889999999999999996 468899999986543 334567889999999999999999999887633 4456777
Q ss_pred ccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++ +...+.. .......++.|++.||.|||+ +++|.|+++++++.++++|||.+..
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCccee
Confidence 77554 3332221 112233446899999999887 7999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-14 Score=138.78 Aligned_cols=138 Identities=19% Similarity=0.193 Sum_probs=102.4
Q ss_pred HHhhhcccccccccCCcceEEEEEe--------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEE
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL--------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVA 427 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~ 427 (499)
....+|...+.||+|+||.||+|+. .++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4456788899999999999999973 124579999986543 23456789999999999 8999999999887
Q ss_pred ccccceeeeeecccCCC-ccccccccc--------------------cccccccccccccceeecc------CCCcccEE
Q 010856 428 VITFTVCLCLFHHSSAS-ASASLVSSL--------------------TLSRPAKGGGFRGCVLWHV------GVDFAAFV 480 (499)
Q Consensus 428 ~~~~~~~~~l~~~~~~~-~~~~l~~~~--------------------~~~~~~~~~i~~gl~yLH~------~~~p~~~l 480 (499)
... ..+++++++.++ +...+.... .....++.|+++||+|||+ +++|.|++
T Consensus 92 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 92 QDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred cCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 633 344567776554 333322111 1112335789999999877 79999999
Q ss_pred EeeCCCeEEEEEEEeec
Q 010856 481 FVLEPGVEVICFVFEIL 497 (499)
Q Consensus 481 ~~~~~~~~~~~f~~~~~ 497 (499)
+++++.++++|||+++.
T Consensus 170 i~~~~~~kl~D~g~~~~ 186 (304)
T cd05101 170 VTENNVMKIADFGLARD 186 (304)
T ss_pred EcCCCcEEECCCcccee
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-14 Score=140.46 Aligned_cols=137 Identities=15% Similarity=0.104 Sum_probs=107.7
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcc--ccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVI--TFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~--~~~~~~ 435 (499)
++|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++... +....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6788899999999999999995 469999999997543 23456788999999999999999999877542 223456
Q ss_pred eeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|+.+++...+... +.....++.|+++||+|||+ +++|.|+++++++.++++|||++..
T Consensus 85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 67888877654444322 22344556899999999887 7899999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.1e-14 Score=140.07 Aligned_cols=126 Identities=14% Similarity=0.073 Sum_probs=93.2
Q ss_pred cccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC---CCCCccccceeEEccccceeeeeeccc
Q 010856 369 IGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI---RHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 369 lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l---~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
||+|+||+||+|+. .+++.||+|++.+.. ......+.+|..++... +||||+++++++...+ ..++++||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEEEEcCC
Confidence 69999999999996 468999999997543 12234456677777655 7999999998887643 345567776
Q ss_pred CCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.++ +...+... ......++.|+++||+|||+ +++|.||+++.++.++++|||++.
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~ 144 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK 144 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCc
Confidence 544 43333222 22334446899999999876 899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.2e-14 Score=134.37 Aligned_cols=133 Identities=18% Similarity=0.187 Sum_probs=103.2
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
|+..+.||+|+||.||+|.. .+++.||+|...... ....+.+.+|++++++++||||+++++++...+ ..+.++++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--eEEEEEEe
Confidence 66778899999999999985 468899999986543 233467889999999999999999999887633 45567888
Q ss_pred cCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 441 SSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 441 ~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.++....+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence 86654333221 122233446888999998877 7999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-14 Score=139.03 Aligned_cols=136 Identities=19% Similarity=0.188 Sum_probs=101.8
Q ss_pred hhhcccccccccCCcceEEEEEeC--------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG--------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
.++|.+.+.||+|+||.||+|+.. +...+|+|.++... .....++.+|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367999999999999999999742 23579999997543 23456788999999999 899999999988764
Q ss_pred ccceeeeeecccCC-Ccccccccc--------------------ccccccccccccccceeecc------CCCcccEEEe
Q 010856 430 TFTVCLCLFHHSSA-SASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV 482 (499)
Q Consensus 430 ~~~~~~~l~~~~~~-~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~ 482 (499)
+ ..+++++++.+ ++...+... +.....++.|++.||+|||+ +++|.||+++
T Consensus 97 ~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 97 G--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred C--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 3 34456666654 443333221 11122346889999998877 7999999999
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
+++.++++|||++..
T Consensus 175 ~~~~~kL~dfg~a~~ 189 (307)
T cd05098 175 EDNVMKIADFGLARD 189 (307)
T ss_pred CCCcEEECCCccccc
Confidence 999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-14 Score=133.94 Aligned_cols=134 Identities=19% Similarity=0.197 Sum_probs=102.9
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
|...+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+ ..+.
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~l 79 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED--NLYI 79 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC--eEEE
Confidence 667788999999999999965 78999999986543 123467899999999999999999999886633 4455
Q ss_pred eecccCCCccc-cccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHSSASASA-SLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~~~~~~-~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++|++.++... .+.. .+.....++.|+++|++|||+ +++|.|++++.++.++++|||....+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 67777654333 2222 122233446789999999976 78999999999999999999987653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-14 Score=138.78 Aligned_cols=138 Identities=17% Similarity=0.175 Sum_probs=103.6
Q ss_pred HHhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
...++|...+.||+|+||.||+|.. .++..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3345788999999999999999973 135579999987543 23346789999999999 899999999988764
Q ss_pred ccceeeeeecccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 430 TFTVCLCLFHHSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 430 ~~~~~~~l~~~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+ ..+.+++|+.++ +...+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++.
T Consensus 112 ~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 112 G--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred C--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 3 345567776544 4333322 122233446789999999887 689999999988899999999886
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
.
T Consensus 190 ~ 190 (302)
T cd05055 190 D 190 (302)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-14 Score=137.96 Aligned_cols=134 Identities=19% Similarity=0.191 Sum_probs=102.7
Q ss_pred hhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
++|...+.+|+|+||.||+|+. .++..+|+|.+........+.+.+|++++++++||||+++++++...+ ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD--PL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC--ce
Confidence 4688889999999999999973 235578999887655445577999999999999999999999887633 34
Q ss_pred eeeecccCCCcc-ccccc--------------------cccccccccccccccceeecc------CCCcccEEEeeCCCe
Q 010856 435 LCLFHHSSASAS-ASLVS--------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGV 487 (499)
Q Consensus 435 ~~l~~~~~~~~~-~~l~~--------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~ 487 (499)
..+++++.++.+ +.+.. .+.....++.|++.|++|||+ +++|.|+++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 556777754433 22221 112233446889999999877 799999999999999
Q ss_pred EEEEEEEee
Q 010856 488 EVICFVFEI 496 (499)
Q Consensus 488 ~~~~f~~~~ 496 (499)
+++|||++.
T Consensus 163 ~l~dfg~a~ 171 (291)
T cd05094 163 KIGDFGMSR 171 (291)
T ss_pred EECCCCccc
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.3e-14 Score=136.45 Aligned_cols=135 Identities=19% Similarity=0.232 Sum_probs=107.1
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
..|+..+.+|.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+ ..+.+++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD--ELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc--eEEEEEE
Confidence 3588889999999999999985 578999999997665555678899999999999999999999887633 4556778
Q ss_pred ccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++.+..... .+.....++.|++.|++|||+ +++|.|+++++++.++++|||+...
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 97 YLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred ecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 876665443322 222334445788999998876 8999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-14 Score=135.22 Aligned_cols=136 Identities=17% Similarity=0.199 Sum_probs=103.8
Q ss_pred hhhcccccccccCCcceEEEEEeC-CC---CEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DR---MEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
..+|+..+.+|+|+||.||+|..+ ++ ..+|+|.++... ....+.+.+|++++++++||||+++.+++...+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK--PA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC--Cc
Confidence 356888899999999999999963 33 379999986543 233567899999999999999999999887644 44
Q ss_pred eeeecccCCCcccccc-c-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLV-S-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~-~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.++|++.++.+.... . .+.....++.|++.|++|||+ +++|.|+++++++.++++|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 5677777665443322 1 112234445788899988766 8999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.6e-14 Score=134.91 Aligned_cols=134 Identities=22% Similarity=0.251 Sum_probs=101.1
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCc---------cHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGR---------AFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
|.....||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-- 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Confidence 66778999999999999985 46889999988654311 1256889999999999999999999887644
Q ss_pred eeeeeecccCCCccc-ccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 433 VCLCLFHHSSASASA-SLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~-~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
....+++++.++... .+... ......++.|++.|++|||+ +++|.|+++++++.++++|||+++.+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 333456776554332 22221 22234456889999998876 79999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-14 Score=139.69 Aligned_cols=137 Identities=18% Similarity=0.179 Sum_probs=101.1
Q ss_pred HhhhcccccccccCCcceEEEEEeC--------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG--------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAV 428 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~ 428 (499)
..++|...+.||+|+||.||+|+.. ....+|+|.++... ......+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467888999999999999999731 24579999987543 23356788999999999 69999999998865
Q ss_pred cccceeeeeecccCCC-ccccccccc--------------------cccccccccccccceeecc------CCCcccEEE
Q 010856 429 ITFTVCLCLFHHSSAS-ASASLVSSL--------------------TLSRPAKGGGFRGCVLWHV------GVDFAAFVF 481 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~~-~~~~l~~~~--------------------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~ 481 (499)
.. ..+++++|+.++ +...+.... .....++.|++.||+|||+ +++|.|+++
T Consensus 90 ~~--~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 EG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred CC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 33 344567776554 332222111 1112335789999998877 899999999
Q ss_pred eeCCCeEEEEEEEeec
Q 010856 482 VLEPGVEVICFVFEIL 497 (499)
Q Consensus 482 ~~~~~~~~~~f~~~~~ 497 (499)
++++.++++|||+++.
T Consensus 168 ~~~~~~kL~Dfg~~~~ 183 (314)
T cd05099 168 TEDNVMKIADFGLARG 183 (314)
T ss_pred cCCCcEEEcccccccc
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.4e-14 Score=136.28 Aligned_cols=135 Identities=19% Similarity=0.182 Sum_probs=101.7
Q ss_pred hhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|...+.+|+|+||.||+++. .++..+|+|.+........+.+.+|+++++.++|+||+++++++...+ ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR--PL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC--ce
Confidence 3567789999999999999973 235689999887655455678999999999999999999999887633 34
Q ss_pred eeeecccCCC-ccccccc-------------------cccccccccccccccceeecc------CCCcccEEEeeCCCeE
Q 010856 435 LCLFHHSSAS-ASASLVS-------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVE 488 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~-------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~ 488 (499)
..+++++.++ +...+.. .+.....++.|++.|++|||+ +++|.|+++.+++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 4566666544 3322221 112233445789999998876 8999999999999999
Q ss_pred EEEEEEeec
Q 010856 489 VICFVFEIL 497 (499)
Q Consensus 489 ~~~f~~~~~ 497 (499)
++|||++..
T Consensus 163 L~dfg~~~~ 171 (280)
T cd05092 163 IGDFGMSRD 171 (280)
T ss_pred ECCCCceeE
Confidence 999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.4e-14 Score=133.82 Aligned_cols=134 Identities=19% Similarity=0.200 Sum_probs=105.5
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.|...+.||+|+||.||+|.. .+++.||+|.++.... ...+.+.+|+.++++++|+||+++++++... ...+.++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEEEE
Confidence 377889999999999999996 4788999999976553 2567899999999999999999999987653 3455677
Q ss_pred cccCCCcccccc-c----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLV-S----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~-~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++....+. . .+.....++.|+++|++|||+ +++|.|+++++++.++++|||++..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccc
Confidence 777655443322 1 222334456899999999887 7899999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-14 Score=138.56 Aligned_cols=139 Identities=19% Similarity=0.178 Sum_probs=102.9
Q ss_pred HHHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEc
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAV 428 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~ 428 (499)
....++|+..+.||+|+||.||+|... ....+|+|.+.... ......+.+|++++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344567888999999999999999853 23679999987543 23345688999999999 89999999998876
Q ss_pred cccceeeeeecccCC-Cccccccc--------------------cccccccccccccccceeecc------CCCcccEEE
Q 010856 429 ITFTVCLCLFHHSSA-SASASLVS--------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVF 481 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~-~~~~~l~~--------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~ 481 (499)
.+ ..+++++|..+ .+...+.. .+.....++.|++.|++|||+ +++|.|+++
T Consensus 88 ~~--~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 88 EG--PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred CC--CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 33 34556666544 43322221 111123346899999999876 799999999
Q ss_pred eeCCCeEEEEEEEeec
Q 010856 482 VLEPGVEVICFVFEIL 497 (499)
Q Consensus 482 ~~~~~~~~~~f~~~~~ 497 (499)
.+++.++++|||+++.
T Consensus 166 ~~~~~~kL~Dfg~~~~ 181 (293)
T cd05053 166 TEDHVMKIADFGLARD 181 (293)
T ss_pred cCCCeEEeCccccccc
Confidence 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-14 Score=141.23 Aligned_cols=138 Identities=17% Similarity=0.133 Sum_probs=106.5
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccc---------
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVIT--------- 430 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~--------- 430 (499)
++|...+.||+|+||.||+|+. .+|+.||+|.+........+.+.+|++++++++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5688899999999999999995 578999999997665556678899999999999999999998765421
Q ss_pred ---cceeeeeecccCCCcccccc---ccccccccccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEeec
Q 010856 431 ---FTVCLCLFHHSSASASASLV---SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEIL 497 (499)
Q Consensus 431 ---~~~~~~l~~~~~~~~~~~l~---~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~~ 497 (499)
+...+++++++.+++...+. ..+...+.++.|++.||+|||+ +++|.|++++.++ .++++|||.+..
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~ 164 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164 (342)
T ss_pred ccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccccee
Confidence 12345678888775543322 2233445556899999998877 7899999997554 579999998865
Q ss_pred c
Q 010856 498 L 498 (499)
Q Consensus 498 ~ 498 (499)
+
T Consensus 165 ~ 165 (342)
T cd07854 165 V 165 (342)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-14 Score=134.70 Aligned_cols=128 Identities=11% Similarity=0.067 Sum_probs=95.2
Q ss_pred cccccCCcceEEEEEeCC-------------CCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 367 NLIGKGGFGSVYKARLGD-------------RMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
+.||+|+||.||+|+..+ ...+|+|.++.........+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--E 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--C
Confidence 358999999999998421 2358888876654444567889999999999999999999987633 3
Q ss_pred eeeeecccCCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCC-------eEEEEEEE
Q 010856 434 CLCLFHHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG-------VEVICFVF 494 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~-------~~~~~f~~ 494 (499)
.+++++++.++..+.... .+.....++.|+++||+|||+ +++|.|+++..++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 456778887664433221 222334557899999999887 79999999976543 89999998
Q ss_pred ee
Q 010856 495 EI 496 (499)
Q Consensus 495 ~~ 496 (499)
+.
T Consensus 159 ~~ 160 (262)
T cd05077 159 PI 160 (262)
T ss_pred Cc
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.4e-14 Score=135.44 Aligned_cols=134 Identities=16% Similarity=0.166 Sum_probs=100.5
Q ss_pred hhcccccccccCCcceEEEEEeCC----CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGD----RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.+|...+.+|+|+||.||+|...+ ...||+|...... ....+.+.+|+.++++++||||+++++++... .. +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~-~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN--PV-W 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC--Cc-E
Confidence 457788999999999999998532 3468999886554 33456899999999999999999999987652 22 3
Q ss_pred eeecccC-CCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSS-ASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~-~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+++++. +++.+.+.. .+.....++.|++.|++|||+ +++|.|++++.++.++++|||++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeee
Confidence 4556664 444333322 122233345789999988877 7999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-15 Score=135.78 Aligned_cols=134 Identities=15% Similarity=0.183 Sum_probs=105.4
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+.|.+..++|+|+||.||++.+ .+|..+|+|.+... .+.+++..|+.||.+.+.|.+|+.||.|+. ....++++|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEeehh
Confidence 3467778999999999999996 57999999998654 457889999999999999999999998876 445677888
Q ss_pred ccCCCccccccc--ccccccc----ccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSASASASLVS--SLTLSRP----AKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~~l~~--~~~~~~~----~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|++.+....+.. ..+..++ +.+..++||+|||. ++|..|||++.++-++++|||.+--|
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchh
Confidence 888776544322 1122221 12566789999865 89999999999999999999987543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.8e-14 Score=135.59 Aligned_cols=134 Identities=18% Similarity=0.195 Sum_probs=104.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.|+..+.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|++++++++||||+++++++.... ..+.++|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT--KLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--ceEEEEE
Confidence 366778899999999999985 468899999987543 334567899999999999999999999887633 4556788
Q ss_pred ccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++....... .+.....++.|+++|++|||+ +++|.|+++.+++.++++|||++..
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 83 YLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccccc
Confidence 887654333221 222334456899999999986 7899999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-14 Score=134.48 Aligned_cols=129 Identities=18% Similarity=0.195 Sum_probs=97.8
Q ss_pred cccccCCcceEEEEEeC--CC--CEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARLG--DR--MEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||.||+|... .+ ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...+.+++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 46899999999999863 23 3699999977654 556789999999999999999999998876 2344566666
Q ss_pred C-CCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 442 S-ASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 442 ~-~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
. +.+...+... +.....++.|++.||+|||+ +++|.|+++..++.++++|||++..+
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccc
Confidence 4 4444333222 12233345789999988776 89999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.8e-15 Score=146.21 Aligned_cols=170 Identities=31% Similarity=0.504 Sum_probs=84.7
Q ss_pred CEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecccc
Q 010856 58 TIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSN 137 (499)
Q Consensus 58 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 137 (499)
...||+.|++. ..|..+..+..|+.+.|..|.+. .+|..+.++..|+.|||+.|+++ ..|..+..+ -|+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEEecC
Confidence 34455555554 44444555555555555555554 44455555555555555555555 333333332 2555555555
Q ss_pred CCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCcc
Q 010856 138 KLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS 217 (499)
Q Consensus 138 ~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 217 (499)
+++.+|..++..++|..||.+.|.+.. .|..+..+.+|+.|.+..|++.. .|..+.. -.|..||++.|++. .+|-.
T Consensus 154 kl~~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~~-lp~El~~-LpLi~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 154 KLTSLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLED-LPEELCS-LPLIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred ccccCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhhh-CCHHHhC-CceeeeecccCcee-ecchh
Confidence 555555555555555555555555543 33444455555555555555542 2333332 23445555555555 44445
Q ss_pred ccCCCCCCEEeCCCCcCC
Q 010856 218 FGDLISLKFLNLSNNNLS 235 (499)
Q Consensus 218 l~~l~~L~~L~l~~N~l~ 235 (499)
|..|..|++|-|.+|.+.
T Consensus 230 fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhheeeeeccCCCC
Confidence 555555555555555554
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.8e-15 Score=124.78 Aligned_cols=136 Identities=13% Similarity=0.105 Sum_probs=100.1
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHH-HhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEM-MKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~i-l~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
++......||+|+||.|-+-++ .+|+..|+|++...- .+..++..+|+.+ ++..+.|.+|++||.+.. ....++-
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEEe
Confidence 3344557799999999998885 589999999997654 3445678889987 455689999999998765 2233445
Q ss_pred ecccCCCccccc--------cccccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSSASASASL--------VSSLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~~~~~~l--------~~~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+|.|..++-... ...+...-++|..+.+||.|||+ ++||.|+|.+.+++||+||||++-.|
T Consensus 124 ME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 124 MELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred HHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 666654432221 12333445567788899988765 89999999999999999999998654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.8e-14 Score=139.61 Aligned_cols=137 Identities=15% Similarity=0.151 Sum_probs=106.9
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc---ccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT---FTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~---~~~~ 434 (499)
..|...+.+|+|+||.||+|+. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.... +...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4688899999999999999995 578999999987532 233556789999999999999999999876532 1235
Q ss_pred eeeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++++++++...+... ......++.|++.||+|||+ +++|.|++++.++.++++|||++..
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 85 YIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 667888877665443322 22334456899999998877 7899999999999999999998764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.8e-14 Score=134.77 Aligned_cols=134 Identities=18% Similarity=0.193 Sum_probs=101.3
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG------RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
+|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS--HF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC--eE
Confidence 377788999999999999985 6789999999865331 12467899999999999999999999987643 44
Q ss_pred eeeecccCCCccc-cccc----cccccccccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEeec
Q 010856 435 LCLFHHSSASASA-SLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~-~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~~ 497 (499)
.++++++.|+... .+.. .+.....++.|++.||+|||+ +++|.|++++.++ .++++|||+...
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 5566776655433 2222 122334446899999998877 7999999997665 589999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-14 Score=149.37 Aligned_cols=137 Identities=13% Similarity=0.106 Sum_probs=95.7
Q ss_pred HhhhcccccccccCCcceEEEEEeC--CCCEEEEEEee--------------cc---CCccHHHHHHHHHHHhcCCCCCc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG--DRMEVAVKVFN--------------LQ---CGRAFESFDVECEMMKNIRHRNL 419 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~--------------~~---~~~~~~~~~~E~~il~~l~H~ni 419 (499)
..++|.+.+.||+|+||+||+|..+ ++...+.|.+. +. .......+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4568999999999999999998753 23333333111 00 01224568899999999999999
Q ss_pred cccceeEEccccceeeeeecccCCCcccccccc---------ccccccccccccccceeecc------CCCcccEEEeeC
Q 010856 420 IKILHGVAVITFTVCLCLFHHSSASASASLVSS---------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE 484 (499)
Q Consensus 420 v~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~---------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~ 484 (499)
|++++++...+. .++++++..+++...+... ....+.++.|++.||+|||+ ++||.||+++.+
T Consensus 226 v~l~~~~~~~~~--~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRSEAN--TYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEECCe--eEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999998876443 3344555555443332111 11123456899999998876 899999999999
Q ss_pred CCeEEEEEEEeec
Q 010856 485 PGVEVICFVFEIL 497 (499)
Q Consensus 485 ~~~~~~~f~~~~~ 497 (499)
+.++++|||++..
T Consensus 304 ~~vkL~DFGla~~ 316 (501)
T PHA03210 304 GKIVLGDFGTAMP 316 (501)
T ss_pred CCEEEEeCCCcee
Confidence 9999999999864
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.7e-14 Score=133.04 Aligned_cols=134 Identities=17% Similarity=0.138 Sum_probs=102.5
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
.+|+..+.+|+|+||.||+|...++..+|+|.+.... ....++.+|++++++++||||+++++++.... ..+.++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS--PICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC--ceEEEEEc
Confidence 4678889999999999999997667899999886543 23467999999999999999999998876533 34556777
Q ss_pred cCCCccc-cccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 441 SSASASA-SLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 441 ~~~~~~~-~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.++.+. .+.. .+.....++.|++.|++|||+ +++|.|++++.++.++++|||+++.
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceee
Confidence 7655433 2221 112233445788889888775 8999999999899999999998753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.3e-15 Score=137.81 Aligned_cols=137 Identities=18% Similarity=0.185 Sum_probs=101.8
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-------CccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-------GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
...|-+...+|+|+|+.||+|.. ...+.||||+-...+ ....+...+|-+|.+.++||.||++|+++.....
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45677889999999999999994 567789999874332 1224667899999999999999999998854222
Q ss_pred ceeeeeecccCCCcccc-ccc----cccccccccccccccceeecc--------CCCcccEEEeeC---CCeEEEEEEEe
Q 010856 432 TVCLCLFHHSSASASAS-LVS----SLTLSRPAKGGGFRGCVLWHV--------GVDFAAFVFVLE---PGVEVICFVFE 495 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~-l~~----~~~~~~~~~~~i~~gl~yLH~--------~~~p~~~l~~~~---~~~~~~~f~~~ 495 (499)
.+-.+.||+.|..+++ +.. .+...+.++.||+.||.||.+ +.||.|||+++. +..+|.|||++
T Consensus 542 -sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 -SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred -cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 3334555555544443 332 334466677899999999865 888999988764 68899999998
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 621 KI 622 (775)
T KOG1151|consen 621 KI 622 (775)
T ss_pred hh
Confidence 64
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-14 Score=138.44 Aligned_cols=138 Identities=16% Similarity=0.120 Sum_probs=106.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccc------
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVIT------ 430 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~------ 430 (499)
+++|...+.||+|+||.||+|+. .+++.||+|++..... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999996 4689999999865432 22356789999999999999999998875432
Q ss_pred cceeeeeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 FTVCLCLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 ~~~~~~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
....+.+++|+.+++...+.. .+.....++.|+++||+|||+ +++|.||++++++.++++|||+++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 123455778877665443322 223344456899999999877 7999999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.2e-14 Score=132.23 Aligned_cols=129 Identities=19% Similarity=0.168 Sum_probs=98.9
Q ss_pred cccccCCcceEEEEEeCCCCEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC-
Q 010856 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS- 444 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~- 444 (499)
+.||+|+||.||+|...+++.||+|.+...... ..+.+.+|++++++++||||+++++++...+ ..+.+++++.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEEcCCCCc
Confidence 468999999999999766999999998765433 4567999999999999999999999887643 344567777544
Q ss_pred cccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 445 ASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 445 ~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+.+... ......++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 33333221 11223345788889988876 8999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.2e-15 Score=138.83 Aligned_cols=137 Identities=11% Similarity=0.093 Sum_probs=105.1
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
....|..-+++|+|+||.||.|+. .+|+.||+|.+.+.. .+......+|..|+.+++.+.||.+-.+|.+.+..
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L-- 260 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL-- 260 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce--
Confidence 345577889999999999999996 479999999996653 23345578999999999999999988777765432
Q ss_pred eeeecccCCC-ccccccccc------cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSAS-ASASLVSSL------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~~~------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
-.++..|+|+ +...+.... ....-.|.+|+.||++||+ |+||+|||+++++.|.|+|.|+++-
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 2345666444 433333222 2233346899999999998 8999999999999999999999874
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.4e-14 Score=133.60 Aligned_cols=135 Identities=17% Similarity=0.179 Sum_probs=104.4
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
..|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...++++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEE
Confidence 3477778999999999999996 468899999987543 33456789999999999999999999988763 3556678
Q ss_pred cccCCCcccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|++.|+.......... ....++.|++.|++|||+ +++|.|+++++++.++++|||.+..
T Consensus 82 e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 82 EYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEccccccee
Confidence 8886654333222111 223445788899988876 7899999999999999999998854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.4e-14 Score=136.97 Aligned_cols=133 Identities=15% Similarity=0.187 Sum_probs=103.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|...+.+|+|+||.||+++. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++.+...+ ...++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR--HLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC--EEEEE
Confidence 588889999999999999996 468899999987654 223457889999999999999999998887633 44567
Q ss_pred ecccCCCcccc-cccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 438 FHHSSASASAS-LVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~~~~~~-l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+|++.|+.+.. +... +.....++.|++.|++|||+ +++|.|++++.++.++++|||+++
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 77776654332 2221 12233445788899998877 789999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=5e-14 Score=134.97 Aligned_cols=135 Identities=19% Similarity=0.215 Sum_probs=105.7
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
++|...+.+|+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++||||+++++++...+ ..+.+++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD--ELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--cEEEEEe
Confidence 5788889999999999999985 468899999987555455677899999999999999999999887643 3455777
Q ss_pred ccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++.+..... .+.....++.|++.|++|||+ +++|.|+++.+++.++++|||++..
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred cCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 776554333221 122234456788999988887 7999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.4e-14 Score=133.54 Aligned_cols=127 Identities=17% Similarity=0.177 Sum_probs=93.4
Q ss_pred ccccCCcceEEEEEeCC---CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCC
Q 010856 368 LIGKGGFGSVYKARLGD---RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSA 443 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~ 443 (499)
.||+|+||.||+|+..+ ...+++|.+.... ....+.+.+|+.+++.++||||+++++++.... ..++++||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEEEEecCCC
Confidence 58999999999998533 2346677665443 234568999999999999999999999887633 34556777654
Q ss_pred -Ccccccccc--------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 444 -SASASLVSS--------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 444 -~~~~~l~~~--------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++...+... ......++.|+++||+|||+ +++|.|++++.++.++++|||++.
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~ 147 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGP 147 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEeccccccc
Confidence 443333221 11123446789999998887 799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.6e-14 Score=134.66 Aligned_cols=134 Identities=15% Similarity=0.166 Sum_probs=101.2
Q ss_pred hhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
.+|.....+|+|+||.||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++||||+++++++...+ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--P 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC--c
Confidence 56888899999999999999853 2467999988655433 3567999999999999999999999876533 3
Q ss_pred eeeeecccCC-Ccccccccc-------------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEE
Q 010856 434 CLCLFHHSSA-SASASLVSS-------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFV 493 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~~-------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~ 493 (499)
.+.+++++.+ .+.+.+... +.....++.|++.||+|||+ +++|.|+++..++.+++.|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 3456666654 443333221 11223345789999999877 799999999999999999999
Q ss_pred Eee
Q 010856 494 FEI 496 (499)
Q Consensus 494 ~~~ 496 (499)
+..
T Consensus 163 ~~~ 165 (275)
T cd05046 163 LSK 165 (275)
T ss_pred ccc
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.2e-14 Score=134.63 Aligned_cols=134 Identities=11% Similarity=0.025 Sum_probs=103.2
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeeeeec
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
|+..+.+|+|+||.||+|.. .+++.||+|+++... ........+|+.++.++. ||||+++++++...+....+.++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 55678899999999999995 478999999986543 222234567999999885 999999999988753344566788
Q ss_pred ccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+++.+.+.. .+.....++.|++.||+|||+ +++|.|+++++ +.++++|||++..
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccc
Confidence 888776655432 222344556899999999877 78999999988 9999999998764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.3e-14 Score=133.77 Aligned_cols=135 Identities=19% Similarity=0.220 Sum_probs=104.0
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|...+.+|+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+.+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEE
Confidence 35688899999999999999997677789999886543 235678999999999999999999888765 23455777
Q ss_pred ccCC-Ccccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSA-SASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~-~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++.+ ++.+.+... +.....++.|++.|++|||+ +++|.|++++.++.++++|||.+..+
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 7754 443333221 12233345789999998876 89999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=3e-14 Score=135.38 Aligned_cols=137 Identities=16% Similarity=0.221 Sum_probs=100.8
Q ss_pred HhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
..++|...+.||+|+||.||+|... .+..||+|.+.... ......|.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL- 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence 3467889999999999999999963 35689999886443 223456999999999999999999999887643
Q ss_pred ceeeeeecccCC-Ccccccccc-----------ccccccccccccccceeecc------CCCcccEEEeeCC---CeEEE
Q 010856 432 TVCLCLFHHSSA-SASASLVSS-----------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVI 490 (499)
Q Consensus 432 ~~~~~l~~~~~~-~~~~~l~~~-----------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~ 490 (499)
..+.+++++.| .+...+... +.....++.||+.|++|||+ +++|.||++++++ .++++
T Consensus 83 -~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 83 -PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred -CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 23456666644 443333221 11123346789999998776 7999999997654 58999
Q ss_pred EEEEeec
Q 010856 491 CFVFEIL 497 (499)
Q Consensus 491 ~f~~~~~ 497 (499)
|||++..
T Consensus 162 dfg~~~~ 168 (277)
T cd05036 162 DFGMARD 168 (277)
T ss_pred cCccccc
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.3e-14 Score=137.69 Aligned_cols=137 Identities=14% Similarity=0.141 Sum_probs=102.3
Q ss_pred HHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--------CccHHHHHHHHHHHhcCC---CCCcccccee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--------GRAFESFDVECEMMKNIR---HRNLIKILHG 425 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~---H~niv~l~~~ 425 (499)
....+|+..+.+|+|+||+|+.|.++ ....|.+|.+.+.+ .+....+-.||.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 44567888999999999999999975 46679999987653 122334678999999997 9999999999
Q ss_pred EEccccceeeeeeccc--CCCcccccccccccc----ccccccccccceeecc------CCCcccEEEeeCCCeEEEEEE
Q 010856 426 VAVITFTVCLCLFHHS--SASASASLVSSLTLS----RPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFV 493 (499)
Q Consensus 426 ~~~~~~~~~~~l~~~~--~~~~~~~l~~~~~~~----~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~ 493 (499)
|.+.+|. +.+.+-- +=++++.+....++. ..+..||+.|+++||+ ++|-+|++++.++-|++||||
T Consensus 638 FEddd~y--yl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 638 FEDDDYY--YLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eecCCee--EEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 9886543 2233322 223444444433333 3344899999999977 789999999999999999999
Q ss_pred Eee
Q 010856 494 FEI 496 (499)
Q Consensus 494 ~~~ 496 (499)
-+-
T Consensus 716 saa 718 (772)
T KOG1152|consen 716 SAA 718 (772)
T ss_pred chh
Confidence 654
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.6e-14 Score=133.88 Aligned_cols=134 Identities=21% Similarity=0.181 Sum_probs=104.7
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|...+.+|.|+||.||+|+. .+++.||+|.+.... ......+.+|+++++.++||||+++++++... ...+++++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEEE
Confidence 577889999999999999996 468999999997553 33456789999999999999999999988763 34455677
Q ss_pred ccCCC-ccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSAS-ASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~-~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++ +.+.+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||.+..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 80 YCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccccccee
Confidence 77554 3333222 223344556899999998877 7999999999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.7e-14 Score=134.11 Aligned_cols=127 Identities=15% Similarity=0.079 Sum_probs=94.8
Q ss_pred cccccCCcceEEEEEeCC-C----------CEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 367 NLIGKGGFGSVYKARLGD-R----------MEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
+.||+|+||.||+|..++ + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. + ..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D--ENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C--CcE
Confidence 368999999999999643 3 24778877544332 6789999999999999999999998876 2 234
Q ss_pred eeecccCCCccc-cccc-----cccccccccccccccceeecc------CCCcccEEEeeCC-------CeEEEEEEEee
Q 010856 436 CLFHHSSASASA-SLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-------GVEVICFVFEI 496 (499)
Q Consensus 436 ~l~~~~~~~~~~-~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-------~~~~~~f~~~~ 496 (499)
++++++.++.+. .+.. .......++.|++.||+|||+ +++|.|+++..++ .++++|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 567777655433 3222 122234446899999999887 7999999998776 69999999876
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
.
T Consensus 157 ~ 157 (259)
T cd05037 157 T 157 (259)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.6e-14 Score=125.88 Aligned_cols=126 Identities=11% Similarity=0.032 Sum_probs=85.8
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEeeccCCc--c-------H-----------------HHHHHHHHHHhcCCCCCc
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR--A-------F-----------------ESFDVECEMMKNIRHRNL 419 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~il~~l~H~ni 419 (499)
...||+|+||.||+|..++|+.||+|+++..... . . ....+|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999878999999999764311 1 1 122459999999988887
Q ss_pred cccceeEEccccceeeeeecccCCCccccc-cccc----cccccccccccccceee-cc------CCCcccEEEeeCCCe
Q 010856 420 IKILHGVAVITFTVCLCLFHHSSASASASL-VSSL----TLSRPAKGGGFRGCVLW-HV------GVDFAAFVFVLEPGV 487 (499)
Q Consensus 420 v~l~~~~~~~~~~~~~~l~~~~~~~~~~~l-~~~~----~~~~~~~~~i~~gl~yL-H~------~~~p~~~l~~~~~~~ 487 (499)
.....+... ..++++|+++|+..... .... .....++.|++.+|+|+ |+ |+||.|++++ ++.+
T Consensus 82 ~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 543322211 22467888876533221 1111 12333456777777776 34 8999999997 5889
Q ss_pred EEEEEEEee
Q 010856 488 EVICFVFEI 496 (499)
Q Consensus 488 ~~~~f~~~~ 496 (499)
++||||++.
T Consensus 157 ~LiDFG~a~ 165 (190)
T cd05147 157 YIIDVSQSV 165 (190)
T ss_pred EEEEccccc
Confidence 999999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-14 Score=139.72 Aligned_cols=136 Identities=19% Similarity=0.182 Sum_probs=100.3
Q ss_pred hhhcccccccccCCcceEEEEEeC--------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG--------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
...|.+.+.||+|+||.||+|+.. .+..||+|.++... ....+++.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346888999999999999999741 12368999886543 33456799999999999 899999999988763
Q ss_pred ccceeeeeecccCC-Cccccccccc--------------------cccccccccccccceeecc------CCCcccEEEe
Q 010856 430 TFTVCLCLFHHSSA-SASASLVSSL--------------------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFV 482 (499)
Q Consensus 430 ~~~~~~~l~~~~~~-~~~~~l~~~~--------------------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~ 482 (499)
+ ..+++++++.+ .+...+.... .....++.|+++||+|||+ +++|.||++.
T Consensus 91 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 91 G--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred C--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 3 34456666654 4333322110 1112245789999998876 8999999999
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
.++.++++|||+++.
T Consensus 169 ~~~~~kL~Dfg~~~~ 183 (334)
T cd05100 169 EDNVMKIADFGLARD 183 (334)
T ss_pred CCCcEEECCccccee
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.6e-14 Score=133.29 Aligned_cols=134 Identities=14% Similarity=0.081 Sum_probs=103.7
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|...+.||+|+||.||+|... +++.||+|.+.+.. ....+.+.+|++++++++||||+++++++...+ ..+.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE--NMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--eEEEE
Confidence 4778899999999999999964 68999999997643 234578999999999999999999998876533 44556
Q ss_pred ecccCCCcc-cccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASAS-ASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~-~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.|+.+ ..+... ......++.|+++||+|||+ +++|.|+++++++.++++|||+...
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 777755433 233222 12233445789999998877 7999999999999999999998754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.4e-14 Score=137.47 Aligned_cols=134 Identities=16% Similarity=0.180 Sum_probs=98.5
Q ss_pred hhcccccccccCCcceEEEEEeC-CCC--EEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRM--EVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~ 435 (499)
++|+..+.||+|+||.||+|..+ ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++.... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG--YLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC--cce
Confidence 46888899999999999999864 343 47888886432 33456789999999999 7999999999876533 234
Q ss_pred eeecccC-CCcccccccc--------------------ccccccccccccccceeecc------CCCcccEEEeeCCCeE
Q 010856 436 CLFHHSS-ASASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVE 488 (499)
Q Consensus 436 ~l~~~~~-~~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~ 488 (499)
.+++++. +.+.+.+... +.....++.|++.|++|||+ +++|.|+++++++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 4556654 4443333211 11223445789999998877 8999999999999999
Q ss_pred EEEEEEee
Q 010856 489 VICFVFEI 496 (499)
Q Consensus 489 ~~~f~~~~ 496 (499)
++|||++.
T Consensus 160 l~dfg~~~ 167 (297)
T cd05089 160 IADFGLSR 167 (297)
T ss_pred ECCcCCCc
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.7e-14 Score=136.16 Aligned_cols=133 Identities=17% Similarity=0.158 Sum_probs=102.5
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+...+ ..+++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET--YLCLV 79 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC--EEEEE
Confidence 5888899999999999999964 589999999976542 24567899999999999999999998886633 34556
Q ss_pred ecccCCCcccc-ccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 438 FHHSSASASAS-LVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~~~~~~-l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+++..|+.+.. +.. .+.....++.|++.||+|||+ +++|.|+++..++.++++|||++.
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 67665543332 221 112233445789999998866 799999999999999999999865
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.9e-14 Score=137.99 Aligned_cols=129 Identities=15% Similarity=0.097 Sum_probs=97.6
Q ss_pred cccccccC--CcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 365 ENNLIGKG--GFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 365 ~~~~lg~G--~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+.++||+| +|++||++.. .+|+.||+|+++.... ...+.+.+|+++++.++||||+++++++...+ ..+++++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEEEEe
Confidence 35789999 6789999985 5799999999976432 23456778999999999999999999987644 3455777
Q ss_pred ccCCCcccc-ccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 440 HSSASASAS-LVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 440 ~~~~~~~~~-l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
|+.++.... +.. .+.....++.|++.||+|||+ +++|.||++..++.++++||+..
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchh
Confidence 776543332 211 122234456899999999877 79999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.1e-14 Score=134.17 Aligned_cols=133 Identities=20% Similarity=0.216 Sum_probs=103.7
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
|+..+.+|+|++|.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|||++++++++... ...+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEe
Confidence 55678899999999999996 479999999997543 23346788999999999999999999998763 34456777
Q ss_pred ccCCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+.+...+.. .+.....++.|+++||+|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 777655443322 122334456889999988877 7899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.9e-14 Score=135.64 Aligned_cols=132 Identities=17% Similarity=0.170 Sum_probs=103.4
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
|.....||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++||||+++++.+...+ ..++++|++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD--ELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--eEEEEEeCC
Confidence 33346799999999999985 468899999987655455677999999999999999999999887643 445678888
Q ss_pred CCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.++....+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++.
T Consensus 102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 7665443321 222334456889999999865 899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1e-14 Score=128.37 Aligned_cols=129 Identities=16% Similarity=0.077 Sum_probs=95.1
Q ss_pred ccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-ccHHHHHHHHHH-HhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 366 NNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RAFESFDVECEM-MKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~i-l~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
...||.|+||+|++-.. +.|+..|||++..... +..+++..|.+. ++.-+.||||++||+++... ..++-+|.|.
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcWiCMELMd 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCWICMELMD 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--ceeeeHHHHh
Confidence 36799999999999985 5799999999987653 556788899875 66668999999999876622 2333456665
Q ss_pred CCcccc---------ccccccccccccccccccceee-------ccCCCcccEEEeeCCCeEEEEEEEee
Q 010856 443 ASASAS---------LVSSLTLSRPAKGGGFRGCVLW-------HVGVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 443 ~~~~~~---------l~~~~~~~~~~~~~i~~gl~yL-------H~~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
-++-.. -+..+.....++...+.||.|| |+++||.|||++.++.||+||||+.-
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 432111 1123334444455667788775 88999999999999999999999864
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.7e-14 Score=131.28 Aligned_cols=135 Identities=12% Similarity=0.103 Sum_probs=104.1
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.+|+|+||.+|.++. .+|+.||+|.+.... ....+++.+|++++++++||||+++++++...+ ..+.++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG--NLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--eEEEEE
Confidence 477889999999999999995 578999999987542 234567899999999999999999999886633 445567
Q ss_pred cccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++.+ .+...+.. .+.....++.|++.|++|||+ +++|.|++++.++.++++|||++..+
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 77654 44333322 122234456899999999876 79999999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.9e-14 Score=145.67 Aligned_cols=139 Identities=15% Similarity=0.067 Sum_probs=99.7
Q ss_pred HHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCC------CCccccceeEEc
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRH------RNLIKILHGVAV 428 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H------~niv~l~~~~~~ 428 (499)
+....++|...+.||+|+||+||+|+. .+++.||||+++... ...+.+..|++++..++| ++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 344567899999999999999999996 468899999996432 223445667777766654 457888877765
Q ss_pred cccceeeeeecccCCCcccccccc----ccccccccccccccceeecc-------CCCcccEEEeeCC------------
Q 010856 429 ITFTVCLCLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEP------------ 485 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~------------ 485 (499)
.. ....++++++++++...+... +.....++.|++.||+|||+ ++||.||++..++
T Consensus 203 ~~-~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ET-GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CC-ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 32 344556777777765544332 22334556899999988884 6999999997665
Q ss_pred ----CeEEEEEEEee
Q 010856 486 ----GVEVICFVFEI 496 (499)
Q Consensus 486 ----~~~~~~f~~~~ 496 (499)
.++++|||++.
T Consensus 282 ~~~~~vkl~DfG~~~ 296 (467)
T PTZ00284 282 PDPCRVRICDLGGCC 296 (467)
T ss_pred CCCceEEECCCCccc
Confidence 39999999753
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.1e-14 Score=135.98 Aligned_cols=133 Identities=20% Similarity=0.235 Sum_probs=103.4
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
|...+.+|+|+||.||+|+. .++..||+|.+.... ....+.+.+|++++++++|||++++++++...+ ..++++
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 104 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--TAWLVM 104 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--eEEEEE
Confidence 66778899999999999995 468899999987543 223457889999999999999999999887633 445678
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|+.|.+.+.+.. .+.....++.|++.|+.|||+ +++|.|+++++++.++++|||++..
T Consensus 105 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 105 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred eCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 8887765443322 112233446789999999876 7899999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.3e-14 Score=132.68 Aligned_cols=134 Identities=11% Similarity=0.032 Sum_probs=103.6
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|+..+.||+|+||.||+|..+ +++.+|+|.+.... ....+++.+|++++++++||||+++++++... ...+++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEEE
Confidence 5777889999999999999964 68999999997654 23456789999999999999999999988764 34455677
Q ss_pred ccCCCccc-ccccc-----ccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASA-SLVSS-----LTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~-~l~~~-----~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+..+. .+... ......++.|++.|++|||+ +++|.|+++++++.++++|||.+..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence 77644333 22211 12233456888999998887 5889999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.8e-14 Score=132.12 Aligned_cols=131 Identities=17% Similarity=0.196 Sum_probs=100.3
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
.+|+..+.+|+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++||||+++++++.... .+.++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG---LYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC---cEEEEEC
Confidence 5688999999999999999975 67789999986432 3467899999999999999999999876532 2456677
Q ss_pred cCC-Ccccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 441 SSA-SASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 441 ~~~-~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+ .+...+... ......++.|++.|++|||+ +++|.|++++.++.++++|||++..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 654 443333221 11223345788999988776 8999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.7e-14 Score=134.38 Aligned_cols=145 Identities=17% Similarity=0.213 Sum_probs=109.2
Q ss_pred cCHHHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEc
Q 010856 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAV 428 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~ 428 (499)
.+..++..+.+.|+..+.+|+|+||.||+|+. .+++.+|+|.+.... ....++.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 35556666778899999999999999999996 568899999986543 2345688999999998 79999999998854
Q ss_pred cc----cceeeeeecccCCCcccc-ccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEE
Q 010856 429 IT----FTVCLCLFHHSSASASAS-LVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVIC 491 (499)
Q Consensus 429 ~~----~~~~~~l~~~~~~~~~~~-l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~ 491 (499)
.+ ....++++|++.++.... +.. .+.....++.|+++|++|||+ +++|.|+++.+++.++++|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 21 223456777776643332 221 111223345789999999977 7999999999999999999
Q ss_pred EEEee
Q 010856 492 FVFEI 496 (499)
Q Consensus 492 f~~~~ 496 (499)
||++.
T Consensus 165 fg~~~ 169 (282)
T cd06636 165 FGVSA 169 (282)
T ss_pred Ccchh
Confidence 99875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-14 Score=127.64 Aligned_cols=134 Identities=12% Similarity=0.079 Sum_probs=97.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.+....+|.|+.|+||+++. .+|...|||.+.... .+..+++.+.+.++..- +.|.||+.+|||.... ...+-+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHHHHH
Confidence 334457799999999999996 468999999997654 45567788888876654 6999999999997622 222345
Q ss_pred cccCCCcccccc-ccccccccc----cccccccceee-------ccCCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLV-SSLTLSRPA----KGGGFRGCVLW-------HVGVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~-~~~~~~~~~----~~~i~~gl~yL-------H~~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+|.......+. ...+..+++ ...++.||.|| |+++||.|||++..+++|+||||++--
T Consensus 171 elMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 171 ELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred HHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 555443222211 122233333 46678899886 889999999999999999999999754
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.8e-14 Score=131.81 Aligned_cols=127 Identities=13% Similarity=0.121 Sum_probs=96.1
Q ss_pred ccccCCcceEEEEEe---CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 368 LIGKGGFGSVYKARL---GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
.||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.+++.++||||+++++++.. + ....+++++.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-E--SWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C--CcEEEEecCC
Confidence 589999999999974 357899999986543 2235678999999999999999999988753 2 2344667766
Q ss_pred CC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 443 AS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 443 ~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++ +...+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~ 144 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKA 144 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccc
Confidence 54 3333322 222344456899999998876 7999999999988999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.1e-14 Score=134.55 Aligned_cols=133 Identities=12% Similarity=0.100 Sum_probs=99.4
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. ||||+++++++.... ..+.++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--DCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--cEEEEE
Confidence 455668899999999999995 468999999987543 234567889999999996 999999999886632 334456
Q ss_pred cccCCCccccc---------cccccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 439 HHSSASASASL---------VSSLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 439 ~~~~~~~~~~l---------~~~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+++.+.+.... ...+.....++.|++.||+|||+ +++|.|++++.++.++++|||+++
T Consensus 83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 77665432211 11222334456888999888874 699999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-14 Score=151.58 Aligned_cols=70 Identities=31% Similarity=0.526 Sum_probs=59.0
Q ss_pred HHHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeE
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGV 426 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~ 426 (499)
.+...+|+....+|+|+||.||+++-+ ||+.||||++.... ......+.+|++++++++|||||+++..|
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 456678888999999999999999954 89999999997653 33356788999999999999999998654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.1e-13 Score=123.18 Aligned_cols=128 Identities=16% Similarity=0.085 Sum_probs=89.1
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEeeccCCc---------------------c-----HHHHHHHHHHHhcCCCCCc
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR---------------------A-----FESFDVECEMMKNIRHRNL 419 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~il~~l~H~ni 419 (499)
...||+|+||+||+|...+|+.||||+++..... . ...+.+|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3679999999999999778999999999764210 0 1224578999999999998
Q ss_pred cccceeEEccccceeeeeecccCCCcc-cc-cc---ccccccccccccccccceeec-------cCCCcccEEEeeCCCe
Q 010856 420 IKILHGVAVITFTVCLCLFHHSSASAS-AS-LV---SSLTLSRPAKGGGFRGCVLWH-------VGVDFAAFVFVLEPGV 487 (499)
Q Consensus 420 v~l~~~~~~~~~~~~~~l~~~~~~~~~-~~-l~---~~~~~~~~~~~~i~~gl~yLH-------~~~~p~~~l~~~~~~~ 487 (499)
.....+... ..++++|+++|+.. .. +. ........++.|++.++.|+| +|++|.|+++. ++.+
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 654443322 12457788876521 11 11 111123344577777776655 48999999998 8899
Q ss_pred EEEEEEEeecc
Q 010856 488 EVICFVFEILL 498 (499)
Q Consensus 488 ~~~~f~~~~~~ 498 (499)
+++|||++..+
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.8e-15 Score=143.80 Aligned_cols=135 Identities=16% Similarity=0.150 Sum_probs=98.9
Q ss_pred ccccccccCCcceEEEEEe-CCCCEEEEEEeeccC----CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 364 SENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
....+||+|+|-+||+|.. .+|..||--.++..+ ....++|..|+++++.++|||||++|..|.+.......++-
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3457899999999999996 468888755443222 34568899999999999999999999998876554455566
Q ss_pred cccCCC-ccccccccc----cccccccccccccceeeccCCCc--------ccEEEee-CCCeEEEEEEEeecc
Q 010856 439 HHSSAS-ASASLVSSL----TLSRPAKGGGFRGCVLWHVGVDF--------AAFVFVL-EPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~-~~~~l~~~~----~~~~~~~~~i~~gl~yLH~~~~p--------~~~l~~~-~~~~~~~~f~~~~~~ 498 (499)
|.+..| +..+..... ...+.+++||.+||.|||++.+| .||.++. .|.|||-|.|++.++
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 776444 433332222 23455679999999999996555 4555554 489999999998775
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.6e-14 Score=133.15 Aligned_cols=134 Identities=14% Similarity=0.135 Sum_probs=100.6
Q ss_pred hcccccccccCCcceEEEEEe----CCCCEEEEEEeeccC----CccHHHHHHHHHHHhcC-CCCCccccceeEEccccc
Q 010856 362 EFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQC----GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFT 432 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~ 432 (499)
+|+..+.||+|+||.||.|+. .+|+.||+|++.... ....+.+.+|++++.++ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 477789999999999999985 368899999997533 23346788999999999 699999998877652 2
Q ss_pred eeeeeecccCCC-ccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSAS-ASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~-~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++++++.++ +.+.+.... .....++.|+++||+|||+ +++|.|++++.++.++++|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 444577777654 333332221 2233334689999998876 7999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.7e-14 Score=132.63 Aligned_cols=139 Identities=17% Similarity=0.219 Sum_probs=106.9
Q ss_pred HHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccc----c
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVIT----F 431 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~----~ 431 (499)
.++++|+..+.+|+|+||.||+|..+ +++.+|+|++..... ..+++.+|+++++++ +|+||+++++++.... .
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45678999999999999999999964 688999999876543 346789999999998 7999999999986532 2
Q ss_pred ceeeeeecccCCCccccc-cc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 432 TVCLCLFHHSSASASASL-VS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l-~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
...+++++++.++....+ .. .+.....++.|+++||+|||+ +++|.|++++.++.++++|||+..
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 234567777766533322 11 122233456899999999877 789999999999999999999875
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
.
T Consensus 162 ~ 162 (275)
T cd06608 162 Q 162 (275)
T ss_pred e
Confidence 3
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.9e-14 Score=132.05 Aligned_cols=134 Identities=19% Similarity=0.200 Sum_probs=100.7
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC----------ccHHHHHHHHHHHhcCCCCCccccceeEEccc
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG----------RAFESFDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
+|...+.+|+|+||.||+|.. .+|+.||+|.++.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999985 4689999998864210 11346788999999999999999999886633
Q ss_pred cceeeeeecccCCC-ccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 FTVCLCLFHHSSAS-ASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 ~~~~~~l~~~~~~~-~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+.++|++.++ +...+.... .....++.|++.|++|||+ +++|.|+++..++.++++|||++..
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 --YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred --ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 344566776544 333332222 2233445789999998887 7899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.3e-14 Score=130.65 Aligned_cols=132 Identities=21% Similarity=0.217 Sum_probs=100.0
Q ss_pred ccccccccCCcceEEEEEeCC-----CCEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 364 SENNLIGKGGFGSVYKARLGD-----RMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+..+.+|+|+||.||+|+... +..||+|.+...... ..+.+.+|++++.+++|+||+++++++...+ ....+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE--PLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--eeEEE
Confidence 456889999999999999642 388999999765433 5678999999999999999999999887643 34456
Q ss_pred ecccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.++ +.+.+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||+...
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCcee
Confidence 6666554 3322221 222234445788899988877 7999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.7e-16 Score=133.93 Aligned_cols=138 Identities=17% Similarity=0.222 Sum_probs=100.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc------c
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT------F 431 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~------~ 431 (499)
+.|....++|+|.||+||+|+. .+|+.||+|++-... ..-.....+|++++..+.|+|++.+++.|...+ .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4466678899999999999995 468889998764322 233456789999999999999999999885421 2
Q ss_pred ceeeeeecccCCCcccccccc-----ccccccccccccccceeec------cCCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 432 TVCLCLFHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWH------VGVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH------~~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
..++.++.++..++...+... ....+.+..++..||.|+| ++.||+|+|.+.++-.|++|||++|++
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 235667776665543333211 1122333356677777655 599999999999999999999999875
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.45 E-value=1e-13 Score=129.98 Aligned_cols=133 Identities=17% Similarity=0.155 Sum_probs=104.7
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
++|+..+.+|+|+||.||+|... +++.||+|.+..... .+++.+|++++++++||||+++++++... ...+.+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEEEe
Confidence 56888899999999999999965 488999999875432 67899999999999999999999988764 34455777
Q ss_pred ccCCCccccc-cc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASL-VS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l-~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++....+ .. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchh
Confidence 7765543322 11 222334456889999998876 7899999999999999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.6e-14 Score=130.64 Aligned_cols=128 Identities=16% Similarity=0.151 Sum_probs=96.7
Q ss_pred cccccCCcceEEEEEeC--C--CCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARLG--D--RMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||.||+|.+. + +..+|+|.+..... ...+++.+|++++++++||||+++++++... ....+++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---ceEEEEEeC
Confidence 46899999999999852 2 36899999876543 2456789999999999999999999877542 234566666
Q ss_pred CC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 442 SA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 442 ~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+ .+.+.+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||.++.
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~ 144 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRA 144 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccce
Confidence 54 44433332 222334556889999988876 7999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.8e-14 Score=131.24 Aligned_cols=134 Identities=16% Similarity=0.192 Sum_probs=104.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|+..+.+|.|+||.||+|.. .++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+ ..+++++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--ELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--EEEEEEe
Confidence 688899999999999999995 468899999997543 335677999999999999999999998876633 4456777
Q ss_pred ccCCCccc-cccc-------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASA-SLVS-------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~-~l~~-------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.|+... .+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 77655333 2221 122234446889999999877 7999999999999999999998754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.7e-14 Score=149.66 Aligned_cols=139 Identities=14% Similarity=0.101 Sum_probs=106.4
Q ss_pred HHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEcc
Q 010856 354 LELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVI 429 (499)
Q Consensus 354 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~ 429 (499)
.++.-..++|.+.++||+|+||.|..++. .+++.||+|++.+.. ......|..|-.||..-+.+.|+.++.+|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 44555668899999999999999999996 479999999998743 34456688899999999999999999888775
Q ss_pred ccceeeeeeccc-CCCccccccccccccccc----------cccccccceeeccCCCcccEEEeeCCCeEEEEEEE
Q 010856 430 TFTVCLCLFHHS-SASASASLVSSLTLSRPA----------KGGGFRGCVLWHVGVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 430 ~~~~~~~l~~~~-~~~~~~~l~~~~~~~~~~----------~~~i~~gl~yLH~~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
+|. +++|+|| +|++...+.......+.+ |+.-++-|.|+|+|+||.|+|++..|-++++|||=
T Consensus 148 ~~L--YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYL--YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cce--EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchh
Confidence 433 4456666 555433333322233333 24556778899999999999999999999999994
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-13 Score=131.01 Aligned_cols=134 Identities=16% Similarity=0.222 Sum_probs=103.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCC---CCCccccceeEEccccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIR---HRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~---H~niv~l~~~~~~~~~~~~~~ 436 (499)
.|+..+.+|+|+||.||+|.. .+++.||+|.++... ....+++.+|++++++++ |||++++++++... ...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEEEE
Confidence 477788999999999999995 578999999987543 344567889999999986 99999999988763 34455
Q ss_pred eecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.|+.+..+... +.....++.|+++|+.|||+ +++|.|+++++++.++++|||++..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL 150 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence 7777765543332221 12233445789999999877 7999999999999999999998764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-13 Score=129.85 Aligned_cols=129 Identities=20% Similarity=0.187 Sum_probs=100.2
Q ss_pred cccccCCcceEEEEEeC-C---CCEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARLG-D---RMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||.||+|... . +..||+|.+...... ..+.+.+|+++++.++|+||+++++++.. ....+++++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence 46899999999999964 3 789999999765432 36789999999999999999999998876 33445567777
Q ss_pred -CCCcccccccc-------------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 442 -SASASASLVSS-------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 442 -~~~~~~~l~~~-------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+...+... +.....++.|++.|++|||+ +++|.||+++.++.++++|||.++.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 45444333321 12234446889999998877 8999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.43 E-value=1e-13 Score=132.78 Aligned_cols=129 Identities=18% Similarity=0.185 Sum_probs=101.3
Q ss_pred ccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC
Q 010856 366 NNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS 444 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~ 444 (499)
...||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+ ..+.++|++.++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEEEEEecCCCC
Confidence 46799999999999986 578999999986554445567999999999999999999999887643 455678887665
Q ss_pred ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 445 ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 445 ~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
....+.. .+.....++.|++.|++|||+ +++|.|++++.++.++++|||++.
T Consensus 103 ~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~ 164 (292)
T cd06657 103 ALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 164 (292)
T ss_pred cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccce
Confidence 4443321 222233446889999999866 899999999988899999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.3e-14 Score=124.97 Aligned_cols=135 Identities=16% Similarity=0.187 Sum_probs=106.4
Q ss_pred HhhhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~ 436 (499)
..++|++.+.+|+|.|++|+.|. ..+.+.+.||++++.+ .+.+.+|++|+..++ |||||++++...+.+....-.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45679999999999999999999 4678899999998643 467899999999997 999999999998877766666
Q ss_pred eecccCCCcccccccccc--ccccccccccccceeecc------CCCcccEEEeeC-CCeEEEEEEEee
Q 010856 437 LFHHSSASASASLVSSLT--LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE-PGVEVICFVFEI 496 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~~~--~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~-~~~~~~~f~~~~ 496 (499)
++|+.....+..+-.... ..+-...++..||.|+|+ ++||.|++.+.. -...+||.|++-
T Consensus 113 iFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred HhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 888887765554433221 223334677777777765 899999999864 588999999863
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=129.03 Aligned_cols=135 Identities=13% Similarity=0.095 Sum_probs=101.0
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.+|+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++|||++++++.+...+. ...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG-LLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC-EEEEEe
Confidence 478889999999999999995 467899999997543 2345678999999999999999999887654332 234566
Q ss_pred cccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++ +.+.+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~ 151 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV 151 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEE
Confidence 776544 3333321 112234456788888887766 8999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.3e-13 Score=134.67 Aligned_cols=136 Identities=14% Similarity=0.085 Sum_probs=102.7
Q ss_pred hcccccccccCCcceEEEEEeC-C--CCEEEEEEeeccC--CccHHHHHHHHHHHhcC-CCCCccccceeEEcc--ccce
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-D--RMEVAVKVFNLQC--GRAFESFDVECEMMKNI-RHRNLIKILHGVAVI--TFTV 433 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~--~~~~ 433 (499)
+|+..+.||+|+||.||+|+.. + +..||+|++.... ....+.+.+|+++++++ +||||+++++++... .+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3777889999999999999953 4 7899999986432 22356788999999999 599999999875432 2233
Q ss_pred eeeeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+.+++++++++...+... +.....++.|++.||+|||+ +++|.||++++++.++++|||++..
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 4556777777655444322 22234456899999999887 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-13 Score=130.92 Aligned_cols=132 Identities=17% Similarity=0.168 Sum_probs=102.1
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
|...+.||+|++|.||+|.. .+++.+|+|+++.......+.+.+|+.+++.++||||+++++++...+ ..+++++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~--~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD--ELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--eEEEEEecc
Confidence 45567899999999999995 578899999987655445567899999999999999999999887643 345567777
Q ss_pred CCCccccc-cc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 442 SASASASL-VS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 442 ~~~~~~~l-~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.|+..... .. .......++.|++.|++|||+ +++|.|++++.++.++++|||++.
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 99 EGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccch
Confidence 55443332 22 112233456889999999877 789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-13 Score=136.48 Aligned_cols=202 Identities=34% Similarity=0.481 Sum_probs=159.6
Q ss_pred EEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCC-CCCeEecccccccccCCccccCcccccEEeeecC
Q 010856 35 DFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQ-KLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGN 113 (499)
Q Consensus 35 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 113 (499)
.+++..|.+... ......++.++.|++.+|.++.+ +.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~~i-~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNITDI-PPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccccC-ccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 578888887422 33456668899999999999844 44455664 8999999999998 44466888999999999999
Q ss_pred CCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCccc
Q 010856 114 KLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTE 193 (499)
Q Consensus 114 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 193 (499)
+++.. +......++|+.|++++|+++.+|........|++|++++|.+. ..+..+..+.++..+.+.+|++.. .+..
T Consensus 174 ~l~~l-~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~ 250 (394)
T COG4886 174 DLSDL-PKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPES 250 (394)
T ss_pred hhhhh-hhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccch
Confidence 99944 44444778999999999999999987666777999999999543 255677888888888899998874 3677
Q ss_pred ccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccC
Q 010856 194 IGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEK 244 (499)
Q Consensus 194 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 244 (499)
+..++++++|++++|.++.+.. +..+.+++.|++++|.+....+.....
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred hccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence 8888999999999999996544 888999999999999998766655443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.43 E-value=7e-14 Score=136.43 Aligned_cols=136 Identities=15% Similarity=0.113 Sum_probs=107.1
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc---cceee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT---FTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~---~~~~~ 435 (499)
+|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ....+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999964 58999999997543 334567999999999999999999999887643 22445
Q ss_pred eeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++++.+++...+... +.....++.|+++||+|||+ +++|.|++++.++.++++|||+...
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 67888877654444332 22234456889999988876 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=134.54 Aligned_cols=134 Identities=13% Similarity=0.064 Sum_probs=102.5
Q ss_pred hcc-cccccccCCcceEEEEEe-CCCCEEEEEEeeccCCcc--------------HHHHHHHHHHHhcCCCCCcccccee
Q 010856 362 EFS-ENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRA--------------FESFDVECEMMKNIRHRNLIKILHG 425 (499)
Q Consensus 362 ~~~-~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l~H~niv~l~~~ 425 (499)
.|. ..+.||+|+||+||+|.. .+++.||+|.+....... ...+.+|++++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 343 457799999999999995 468999999986543111 1257899999999999999999999
Q ss_pred EEccccceeeeeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 426 VAVITFTVCLCLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 426 ~~~~~~~~~~~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
+...+ ....++|++.|++...+... ......++.|++.||+|||+ +++|.||++.+++.++++|||.+
T Consensus 89 ~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 89 YVEGD--FINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EecCC--cEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 87644 44567888887765544322 22233446889999998877 78999999999999999999987
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 167 ~~ 168 (335)
T PTZ00024 167 RR 168 (335)
T ss_pred ee
Confidence 64
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=129.59 Aligned_cols=134 Identities=13% Similarity=0.116 Sum_probs=105.1
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+|...+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|++++.+++|+||+++++++... ...+.+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEEE
Confidence 5778899999999999999965 599999999976543 3467899999999999999999999988764 34455677
Q ss_pred ccCCCccc-cccc----cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASA-SLVS----SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~-~l~~----~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++.+. .+.. .......++.|+++|++|||+ +++|.|+++++++.++++|||+...
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 77644333 3322 122233446889999999987 6899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.4e-14 Score=138.56 Aligned_cols=140 Identities=16% Similarity=0.133 Sum_probs=107.5
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc---
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF--- 431 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~--- 431 (499)
...++|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3456799999999999999999996 468899999986532 2334667889999999999999999987754332
Q ss_pred -ceeeeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 -TVCLCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 -~~~~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...+++++++++++.+.+.. .+.....++.|+++|++|||+ +++|.|+++++++.++++|||++..
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 33566788887665443322 223344456889999998876 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-13 Score=132.96 Aligned_cols=136 Identities=13% Similarity=0.061 Sum_probs=102.6
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.++|+..+.+|+|+||.||+|... +++.||+|.++... ......+.+|++++.+. +||||+++++++.... ..++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS--DVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC--eEEE
Confidence 356788899999999999999975 48999999997643 22345677788777666 5999999999987633 4456
Q ss_pred eecccCCCcccccc-----ccccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLV-----SSLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~-----~~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.+.+..... ..+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 92 v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 92 CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 77887664322221 1222334567899999998885 5899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=132.65 Aligned_cols=132 Identities=20% Similarity=0.203 Sum_probs=101.4
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
|...+.+|+|+||+||+|+. .+++.||+|.+..... ...+.+.+|+++++.++|||++++++++...+ ..++++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--TAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--EEEEEE
Confidence 55567799999999999995 4688999999975432 23456889999999999999999999987743 445677
Q ss_pred cccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 439 HHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 439 ~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+++.|++...+... +.....++.|++.|++|||+ +++|.||++++++.++++|||++.
T Consensus 101 e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 101 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCc
Confidence 88777654443221 11223345788899888877 789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=2e-13 Score=127.94 Aligned_cols=137 Identities=20% Similarity=0.241 Sum_probs=106.1
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+........++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677889999999999999964 789999999976542 3467899999999999999999999988764223455677
Q ss_pred cccCCCcccc-ccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSSASASAS-LVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~~~~~-l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++.++.... +.. .+.....++.|+++|++|||+ +++|.|++++.++.++++|||++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 7775543332 221 222234456889999999887 78999999999999999999988753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.4e-13 Score=126.88 Aligned_cols=134 Identities=25% Similarity=0.307 Sum_probs=105.1
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
+|+..+.+|+|++|.||++... +++.+++|++........+.+.+|++++++++||||+++++++... .....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEec
Confidence 4777899999999999999964 7889999999766544567899999999999999999999988763 234556777
Q ss_pred cCCCcccccc-c-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 441 SSASASASLV-S-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 441 ~~~~~~~~l~-~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.|..+..+. . .+.....++.|+++|++|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 7654433321 1 122233445788899988877 8999999999999999999998764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.3e-14 Score=133.60 Aligned_cols=129 Identities=15% Similarity=0.103 Sum_probs=95.2
Q ss_pred cccccCCcceEEEEEeC-CC-------CEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 367 NLIGKGGFGSVYKARLG-DR-------MEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.||+|+||.||+|... .+ ..||+|.+........+.+.+|+.+++.++||||+++++++...+ ..+.++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--CcEEEE
Confidence 36899999999999853 22 348888886554445577899999999999999999999987643 334567
Q ss_pred cccCCCccc-cccc-----cccccccccccccccceeecc------CCCcccEEEeeCCC--------eEEEEEEEeec
Q 010856 439 HHSSASASA-SLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG--------VEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~-~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~--------~~~~~f~~~~~ 497 (499)
||+.++.+. .+.. .+.....++.|++.|++|||+ +++|.|+++.+++. ++++|||++..
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 777655433 3322 222233456899999999877 79999999987765 58999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.5e-13 Score=130.65 Aligned_cols=127 Identities=11% Similarity=0.079 Sum_probs=95.7
Q ss_pred cccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC
Q 010856 369 IGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS 444 (499)
Q Consensus 369 lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~ 444 (499)
||+|+||+||+|.. .+|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+ ...++++|+.++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--DLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--eEEEEEecCCCC
Confidence 68999999999985 468999999997543 223456788999999999999999998886633 345577777654
Q ss_pred ccc-cccccc------cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 445 ASA-SLVSSL------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 445 ~~~-~l~~~~------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+. .+.... .....++.|++.|+.|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 333 322211 1223335789999998877 7999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.2e-13 Score=136.14 Aligned_cols=199 Identities=36% Similarity=0.504 Sum_probs=151.1
Q ss_pred EEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcc-cccEEeeecCCCCCcCCccccCCccCCeeecccc
Q 010856 59 IVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLA-ELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSN 137 (499)
Q Consensus 59 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 137 (499)
.+++..|.+.. .......++.++.|++.+|.++ .++.....++ +|+.|++++|++. ..+..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 57777777642 2333455678889999999888 4445555564 8899999999988 44456778889999999999
Q ss_pred CCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCcc
Q 010856 138 KLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS 217 (499)
Q Consensus 138 ~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 217 (499)
+++++|......+.|+.|++++|+++. +|........|++|.+++|.+. ..+..+..+.++..+.+.+|++.. .+..
T Consensus 174 ~l~~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~ 250 (394)
T COG4886 174 DLSDLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPES 250 (394)
T ss_pred hhhhhhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccch
Confidence 999888776678889999999998885 4444445566888889888543 345667788888888888888873 3677
Q ss_pred ccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC
Q 010856 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265 (499)
Q Consensus 218 l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 265 (499)
+..+++++.|++++|.++.... +..+.+++.|++++|.+....|..
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 7888889999999999885544 778888999999999888666554
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.7e-13 Score=130.57 Aligned_cols=134 Identities=19% Similarity=0.206 Sum_probs=105.0
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
|...+.||+|++|.||+|.. .+++.+|+|.++.... .....+.+|++++++++|+||+++++++... .....+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEe
Confidence 45667899999999999996 4789999999876542 2456788999999999999999999988763 34456778
Q ss_pred ccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++.+++...+... +.....++.|++.|++|||+ +++|.|+++.+++.++++|||.+..+
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 8877665544332 22234456889999998877 89999999999999999999988643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.2e-13 Score=128.25 Aligned_cols=128 Identities=16% Similarity=0.123 Sum_probs=98.0
Q ss_pred cccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCC-
Q 010856 369 IGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSA- 443 (499)
Q Consensus 369 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~- 443 (499)
||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++...+ ..+++++++.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEecCCCC
Confidence 699999999999964 58999999997643 233567999999999999999999999876633 34556777654
Q ss_pred Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 444 SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 444 ~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.+.+.+.... .....++.|++.||+|||+ +++|.|+++++++.++++|||+...+
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~ 143 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence 4433333222 2233345789999998877 79999999999999999999987643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.5e-14 Score=132.69 Aligned_cols=135 Identities=14% Similarity=0.178 Sum_probs=104.5
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~ 436 (499)
+|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|.+++++++ ||||+++++++...+ ....
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~l 79 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE--NLYF 79 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc--eEEE
Confidence 688889999999999999996 479999999997532 223467889999999998 999999998876533 3445
Q ss_pred eeccc-CCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHS-SASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~-~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++++ ++++.+.+... +.....++.|++.||+|||+ +++|.|+++..++.++++|||....+
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 67777 55544443322 22344456889999998887 79999999999999999999987654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-13 Score=130.43 Aligned_cols=128 Identities=19% Similarity=0.194 Sum_probs=93.9
Q ss_pred cccccCCcceEEEEEeC-CCC--EEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARLG-DRM--EVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.+|+|+||.||+|+.. ++. .+|+|.+.... ....+.+.+|+++++++ +||||+++++++.... ..+.+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--CceEEEEeC
Confidence 36899999999999964 444 46888886433 33456789999999999 8999999999887643 234566666
Q ss_pred C-CCcccccccc--------------------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEE
Q 010856 442 S-ASASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 442 ~-~~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
. |++.+.+... +.....++.|++.|++|||+ +++|.|+++++++.++++|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 4 4443333211 11223445788999988866 8999999999999999999998
Q ss_pred ee
Q 010856 495 EI 496 (499)
Q Consensus 495 ~~ 496 (499)
+.
T Consensus 159 ~~ 160 (270)
T cd05047 159 SR 160 (270)
T ss_pred cc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.1e-13 Score=126.44 Aligned_cols=134 Identities=20% Similarity=0.258 Sum_probs=104.0
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.+|+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|||++++++++...+ ..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD--SLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--EEEEEE
Confidence 4777899999999999999864 688999999976543 35678999999999999999999998887632 445577
Q ss_pred cccCCCcccc-ccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASAS-LVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~-l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++.+.. +.. .+.....++.|++.|++|||+ +++|.|++++.++.++++|||++..
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEecccccee
Confidence 7776543332 221 222234456788898888777 7999999999999999999998764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.8e-13 Score=128.08 Aligned_cols=134 Identities=15% Similarity=0.162 Sum_probs=99.3
Q ss_pred hcccccccccCCcceEEEEEeC--CCCEEEEEEeeccC----------CccHHHHHHHHHHHhc-CCCCCccccceeEEc
Q 010856 362 EFSENNLIGKGGFGSVYKARLG--DRMEVAVKVFNLQC----------GRAFESFDVECEMMKN-IRHRNLIKILHGVAV 428 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~-l~H~niv~l~~~~~~ 428 (499)
+|+..+.||+|+||.||+|+.. .++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3777889999999999999964 37889999885321 1223557789988865 799999999998876
Q ss_pred cccceeeeeecccCCCcccccc---------ccccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEE
Q 010856 429 ITFTVCLCLFHHSSASASASLV---------SSLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICF 492 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~~~~~~l~---------~~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f 492 (499)
.+ ..++++||+.|+....+. ........++.|++.|++|||+ +++|.|+++++++.++++||
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 ND--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 33 445677777654333221 1112234446789999999984 58899999999999999999
Q ss_pred EEeec
Q 010856 493 VFEIL 497 (499)
Q Consensus 493 ~~~~~ 497 (499)
|++..
T Consensus 159 g~~~~ 163 (269)
T cd08528 159 GLAKQ 163 (269)
T ss_pred cceee
Confidence 98864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.2e-13 Score=127.72 Aligned_cols=134 Identities=13% Similarity=0.147 Sum_probs=101.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|...+.+|+|+||.||++.. .+++.+|+|.+.... ....+.+.+|++++++++||||+++++.+... ...+.++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEEEE
Confidence 477889999999999999985 468899999997543 23456789999999999999999999887653 2445677
Q ss_pred cccCCCc-cccccc------cccccccccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEeec
Q 010856 439 HHSSASA-SASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~-~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~~ 497 (499)
+++.|+. .+.+.. .+.....++.|++.|++|||+ +++|.|+++++++ .++++|||++..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI 151 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence 7776543 333221 122234445789999998876 7999999997655 468999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-13 Score=129.05 Aligned_cols=127 Identities=13% Similarity=0.087 Sum_probs=97.9
Q ss_pred cccCCcceEEEEEeC-CCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC
Q 010856 369 IGKGGFGSVYKARLG-DRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS 444 (499)
Q Consensus 369 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~ 444 (499)
+|+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|++++++++||||+++++.+.. ....+++++++.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 689999999999975 599999999975542 345678999999999999999999988765 33445677777654
Q ss_pred ccc-cccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 445 ASA-SLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 445 ~~~-~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+. .+.. .+.....++.|+++||+|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 332 2222 222334456889999988876 7999999999999999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.1e-13 Score=131.64 Aligned_cols=134 Identities=22% Similarity=0.219 Sum_probs=103.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.|+..+.+|+|+||.||+|+. .+++.+|+|.+.... ....+++.+|+++++.++|+|++++++++...+ ..+.+
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 93 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLV 93 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--eeEEE
Confidence 366778899999999999996 468899999986432 223456889999999999999999999887633 44567
Q ss_pred ecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.|.+...+.. .+.....++.|++.|++|||+ +++|.|+++++++.++++|||++..
T Consensus 94 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence 77777765443321 112233445788999999877 7999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.7e-13 Score=128.51 Aligned_cols=135 Identities=14% Similarity=0.119 Sum_probs=101.5
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|...+.+|+|+||.||+|.. .+|..||+|.+.... ....+.+.+|+++++.++|+||+++++.+...+ ..+.++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG--RLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC--eEEEEE
Confidence 477889999999999999996 468899999986543 234567889999999999999999999886633 445567
Q ss_pred cccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEeecc
Q 010856 439 HHSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~~~ 498 (499)
+++.+. +.+.+.. .+.....++.|+++|++|||+ +++|.|+++++++ .++++|||.+..+
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 777554 3332221 222344556789999998877 7999999998775 4699999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.7e-13 Score=129.41 Aligned_cols=135 Identities=19% Similarity=0.195 Sum_probs=104.9
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
....|+..+.+|+|+||.||+|... ++..||+|++..... ..+.+.+|+++++.++|+||+++++++...+ ..+.+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD--ELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC--EEEEE
Confidence 4456788889999999999999975 688999999976543 4577899999999999999999999887643 34556
Q ss_pred ecccCCCccc-ccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 438 FHHSSASASA-SLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~~~~~-~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++++.|+.+. .+... +.....++.|++.||+|||+ +++|.|++++.++.++++|||+..
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 7777644333 33222 11233346889999998886 789999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.3e-13 Score=129.83 Aligned_cols=135 Identities=20% Similarity=0.214 Sum_probs=101.7
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcC---CCCCccccceeEEcccc---ce
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNI---RHRNLIKILHGVAVITF---TV 433 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~H~niv~l~~~~~~~~~---~~ 433 (499)
|+..+.+|+|+||.||+|+.+ +++.||+|++.... ......+.+|+.+++++ +||||+++++++...+. ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999975 58999999997543 22245677888877655 69999999999876543 23
Q ss_pred eeeeecccCCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...+++++.+++...+.. .+.....++.|+++||+|||+ +++|.|+++++++.++++|||+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 556778887665443322 222334456899999998876 7999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.5e-13 Score=127.28 Aligned_cols=134 Identities=18% Similarity=0.163 Sum_probs=103.1
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|+..+.+|+|+||.||+++. .+++.+|+|.+.... .....++.+|++++++++|+||+++++++... ...+.++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEe
Confidence 477788999999999999985 478899999997543 23356788999999999999999999888763 3455677
Q ss_pred cccCCCcccc-ccc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASAS-LVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~-l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.+..... +.. .+.....++.|+++|++|||+ +++|.|+++++++.++++|||....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 8776553332 211 112233445789999999876 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-13 Score=130.45 Aligned_cols=128 Identities=21% Similarity=0.258 Sum_probs=95.2
Q ss_pred cccccCCcceEEEEEeCC-------CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 367 NLIGKGGFGSVYKARLGD-------RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.+|+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+ ....++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--CeEEEE
Confidence 368999999999998532 2579999886543 234567899999999999999999999887644 334566
Q ss_pred cccCC-Ccccccccc-----------ccccccccccccccceeecc------CCCcccEEEeeCC-----CeEEEEEEEe
Q 010856 439 HHSSA-SASASLVSS-----------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-----GVEVICFVFE 495 (499)
Q Consensus 439 ~~~~~-~~~~~l~~~-----------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-----~~~~~~f~~~ 495 (499)
+++.+ .+.+.+... +.....++.|++.|++|||+ +++|.|++++.++ .++++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 66654 443333211 11223346789999998887 7999999998776 8999999987
Q ss_pred e
Q 010856 496 I 496 (499)
Q Consensus 496 ~ 496 (499)
.
T Consensus 159 ~ 159 (269)
T cd05044 159 R 159 (269)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-13 Score=129.46 Aligned_cols=133 Identities=17% Similarity=0.118 Sum_probs=102.4
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeeeeec
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
|...+.||+|+||.||+|+.. +++.||+|++..... .......+|+..+++++ ||||+++++++... ...+.+++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEEEEe
Confidence 566788999999999999974 588999999865432 22334567999999999 99999999988763 34456777
Q ss_pred ccCCCccccccccc------cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVSSL------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~~~------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.+.+.+.... .....++.|++.||+|||+ +++|.|+++++++.++++|||++..
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~ 148 (283)
T cd07830 79 YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE 148 (283)
T ss_pred cCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeeccccee
Confidence 77776655443322 2233445789999998887 7899999999999999999998764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.3e-13 Score=124.73 Aligned_cols=135 Identities=15% Similarity=0.181 Sum_probs=99.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+++|+|.||+|.+++. .+++.||+|++++.-. .....-..|-++++..+||.+..+...|...+ ...+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-rlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-RLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-eEEE
Confidence 46788889999999999999995 5799999999987642 22344567999999999999998875555433 3333
Q ss_pred eeecccCCCccccccccccc----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 436 CLFHHSSASASASLVSSLTL----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~~~~----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
++++..+|+++..+...... .+-.-..|+.||.|||+ +.|-+|.++++++-.||.|||+-
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLC 315 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLC 315 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccc
Confidence 33344455554444332222 22223678999999999 68889999999999999999973
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-14 Score=139.73 Aligned_cols=169 Identities=31% Similarity=0.452 Sum_probs=80.9
Q ss_pred EEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCC
Q 010856 35 DFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNK 114 (499)
Q Consensus 35 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 114 (499)
..+|+.|++. .+|..+..+..|+.+.|.+|.+. .+|..+.++..|++|||+.|+++ ..|..++.++ |+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 3444555544 34444444444555555555544 34444455555555555555554 3344444332 4455555555
Q ss_pred CCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccc
Q 010856 115 LSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI 194 (499)
Q Consensus 115 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 194 (499)
++ .+|..++....|..|+.+.|++..+|..++.+.+|+.|++..|++.. .|..+. .-.|..||+|.|++. .+|-.|
T Consensus 155 l~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~-lp~El~-~LpLi~lDfScNkis-~iPv~f 230 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLED-LPEELC-SLPLIRLDFSCNKIS-YLPVDF 230 (722)
T ss_pred cc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhh-CCHHHh-CCceeeeecccCcee-ecchhh
Confidence 54 33444444455555555555555555555555555555555555443 222333 223445555555554 344445
Q ss_pred cCCcCCceeeCcCCcCC
Q 010856 195 GGLKNLEYLFLGYNRLQ 211 (499)
Q Consensus 195 ~~l~~L~~L~L~~n~l~ 211 (499)
..+..|++|-|.+|.++
T Consensus 231 r~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 231 RKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhheeeeeccCCCC
Confidence 55555555555555554
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.4e-13 Score=125.01 Aligned_cols=134 Identities=17% Similarity=0.126 Sum_probs=103.9
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+|...+.+|+|+||.||++.. .++..||+|++..... ...+.+.+|+++++.++|||++++++.+... .....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 477889999999999999996 4688999999976542 4566789999999999999999999988764 3444567
Q ss_pred cccCCC-cccccccc--------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSAS-ASASLVSS--------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~-~~~~l~~~--------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++ +...+... ......++.|++.|++|||+ +++|.|+++++++.++++|||+...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceee
Confidence 777654 33333221 12233446788999998887 7999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-13 Score=129.25 Aligned_cols=133 Identities=19% Similarity=0.217 Sum_probs=104.6
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+ ..+++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER--KLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--ceEEEec
Confidence 456678999999999999964 68999999997653 334567889999999999999999999887643 4456778
Q ss_pred ccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+++...+... ......++.|+++|++|||+ +++|.|+++.+++.++++|||+...
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 8877654444322 22334456889999999976 7999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.7e-13 Score=136.77 Aligned_cols=140 Identities=16% Similarity=0.194 Sum_probs=94.3
Q ss_pred HHhhhcccccccccCCcceEEEEEe-----------------CCCCEEEEEEeeccCCccHH--------------HHHH
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-----------------GDRMEVAVKVFNLQCGRAFE--------------SFDV 406 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~ 406 (499)
...++|...++||+|+||.||+|.. ..++.||||++........+ ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3567899999999999999999963 23568999998654322222 3445
Q ss_pred HHHHHhcCCCCCc-----cccceeEEcc------ccceeeeeecccCCCccc-cccc-----------------------
Q 010856 407 ECEMMKNIRHRNL-----IKILHGVAVI------TFTVCLCLFHHSSASASA-SLVS----------------------- 451 (499)
Q Consensus 407 E~~il~~l~H~ni-----v~l~~~~~~~------~~~~~~~l~~~~~~~~~~-~l~~----------------------- 451 (499)
|+.++.+++|.++ ++++++|... +....+++++|+.++.+. .++.
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777776654 6677766431 112234567777554322 1110
Q ss_pred -----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 452 -----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 452 -----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+...+.++.|+++||+|||+ ++||.|++++.++.++++|||+++.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~ 358 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVD 358 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccc
Confidence 011223345788889988866 7999999999999999999999854
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.6e-14 Score=131.55 Aligned_cols=205 Identities=22% Similarity=0.269 Sum_probs=107.5
Q ss_pred cccEEEcccCCCcccCC-ccccCCCCCCEEeccCCcCCccCC--ccccCCCCCCeEecccccccccCCcc-ccCcccccE
Q 010856 32 SLEDFRMYNCNISGGIP-EEISNLTNSTIVNLGGNKLNGSIP--ITLSKLQKLQGLGLEDNKLEGSIPDD-ICHLAELYR 107 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~ 107 (499)
+|+...|.++.+..... .....+++++.|||+.|-+....+ .....+++|+.|+|+.|++....... -..++.|+.
T Consensus 122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 45555555555542111 234445666666666665543221 12345566666666666554221111 123455666
Q ss_pred EeeecCCCCCc-CCccccCCccCCeeeccccC-CCCCCccccCCCCCcEEEcCCCcCCCCC-cccccCCCCccEEEccCC
Q 010856 108 LDLDGNKLSGS-LPACFSNLTSLRIVSLGSNK-LTSVPLTFWNLKDILNLNFSSNFLTSPL-PLEIGNLKVLIGIDFSMN 184 (499)
Q Consensus 108 L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n 184 (499)
|.|+.|.++.. +......+|+|+.|+|..|. +..-.....-+..|++|||++|.+-+.. ......++.|..|+++.+
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~t 281 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSST 281 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcccc
Confidence 66666666521 11223445666666666663 2211222333455666666666654321 123445666666666666
Q ss_pred cccccC-ccc-----ccCCcCCceeeCcCCcCCCC-CCccccCCCCCCEEeCCCCcCCc
Q 010856 185 NFSGVI-PTE-----IGGLKNLEYLFLGYNRLQGS-IPDSFGDLISLKFLNLSNNNLSG 236 (499)
Q Consensus 185 ~l~~~~-~~~-----l~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~l~~N~l~~ 236 (499)
.+..+. |+. ...+++|++|+++.|++.+. ....+..+++|+.|.+..|.++.
T Consensus 282 gi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 282 GIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred CcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 665432 111 24567888888888888532 12445666778888888888764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.1e-13 Score=127.06 Aligned_cols=127 Identities=16% Similarity=0.064 Sum_probs=90.8
Q ss_pred ccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHH---HhcCCCCCccccceeEEccccceeeeeecc
Q 010856 368 LIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEM---MKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~i---l~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
.||+|+||.||++.. .+++.||+|.+..... .....+.+|..+ +...+||||+.+++++...+ ..+.++||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEEEec
Confidence 489999999999996 4689999999975431 122334455543 33458999999988887643 34456777
Q ss_pred cCCCccc-cccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 441 SSASASA-SLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 441 ~~~~~~~-~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+.|+.+. .+.. .+.....++.|++.||+|||+ +++|.|++++.++.++++|||++.
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 6555433 3322 223344456899999998876 799999999999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.5e-13 Score=118.52 Aligned_cols=129 Identities=9% Similarity=-0.044 Sum_probs=86.4
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcC-----CCCCccccceeEEcccc--cee
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNI-----RHRNLIKILHGVAVITF--TVC 434 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~H~niv~l~~~~~~~~~--~~~ 434 (499)
+.....||+|+||.||. .+ ++. .+||++........+.+.+|+++++.+ +||||++++|++.+... ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34567899999999996 43 343 479998765544567899999999999 67999999999877431 223
Q ss_pred eeeecccC---CCccccccccccccc--cccccccccc-eeecc------CCCcccEEEeeC----CCeEEEE-EEEe
Q 010856 435 LCLFHHSS---ASASASLVSSLTLSR--PAKGGGFRGC-VLWHV------GVDFAAFVFVLE----PGVEVIC-FVFE 495 (499)
Q Consensus 435 ~~l~~~~~---~~~~~~l~~~~~~~~--~~~~~i~~gl-~yLH~------~~~p~~~l~~~~----~~~~~~~-f~~~ 495 (499)
..++++.+ +++.+.+.. ..... ....|++.++ +|||+ ++||.||++... +.++++| ||..
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 23566643 344444322 11111 1234555555 66655 899999999742 3799999 5543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.1e-13 Score=127.04 Aligned_cols=137 Identities=16% Similarity=0.129 Sum_probs=89.1
Q ss_pred hhcccccccccCCcceEEEEEeC-C---CCEEEEEEeeccCCcc-----------HHHHHHHHHHHhcCCCCCcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-D---RMEVAVKVFNLQCGRA-----------FESFDVECEMMKNIRHRNLIKILHG 425 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~~~~-----------~~~~~~E~~il~~l~H~niv~l~~~ 425 (499)
..|.+.+.||+|+||+||+|+.. + +..+|+|+........ ......+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 56899999999999999999964 3 4566777543322111 0112334445667899999999987
Q ss_pred EEccccc--eeeeeecccCCCcccccc----ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEE
Q 010856 426 VAVITFT--VCLCLFHHSSASASASLV----SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFV 493 (499)
Q Consensus 426 ~~~~~~~--~~~~l~~~~~~~~~~~l~----~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~ 493 (499)
+...+.. ..+.+++.........+. ..+.....++.|+++||+|||+ ++||.|++++.++.++++|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFG 171 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYG 171 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcC
Confidence 6542211 112233433333222111 1222334567899999998866 899999999999999999999
Q ss_pred Eeec
Q 010856 494 FEIL 497 (499)
Q Consensus 494 ~~~~ 497 (499)
+++.
T Consensus 172 la~~ 175 (294)
T PHA02882 172 IASH 175 (294)
T ss_pred Ccee
Confidence 9864
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.36 E-value=6.2e-13 Score=127.09 Aligned_cols=134 Identities=15% Similarity=0.131 Sum_probs=100.2
Q ss_pred hcccccccccCCcceEEEEEe----CCCCEEEEEEeeccC----CccHHHHHHHHHHHhcC-CCCCccccceeEEccccc
Q 010856 362 EFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQC----GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFT 432 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~ 432 (499)
+|+..+.||+|+||.||+++. .+++.||+|++++.. ....+.+.+|++++.++ +||||+++++++...+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~-- 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT-- 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence 367788999999999999884 357889999997542 22346688999999999 6999999998776532
Q ss_pred eeeeeecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...++++|+.++ +...+... ......++.|+++||+|||+ +++|.|+++..++.++++|||+++.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 344577777554 33332221 22233445789999998877 6899999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.2e-13 Score=133.50 Aligned_cols=128 Identities=17% Similarity=0.223 Sum_probs=97.8
Q ss_pred ccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCCcc
Q 010856 368 LIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSASAS 446 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~ 446 (499)
++|+|.||+||.|+.. +...+|||-+........+-...||++.++++|.|||+.+|.|.... .+-+.+|...|+.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG--f~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG--FFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC--eEEEEeecCCCCcH
Confidence 6999999999999964 56679999998777667778899999999999999999999876533 44445666665554
Q ss_pred c-cccccccccc---c----ccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEeec
Q 010856 447 A-SLVSSLTLSR---P----AKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEIL 497 (499)
Q Consensus 447 ~-~l~~~~~~~~---~----~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~~ 497 (499)
. .++..|...+ . ...||.+||.|||+ ++|=.|+|++.-. -+||+|||-+.-
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKR 725 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKR 725 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchh
Confidence 4 4444443221 1 13899999999987 7888999998754 567889997643
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-13 Score=123.64 Aligned_cols=129 Identities=25% Similarity=0.240 Sum_probs=77.2
Q ss_pred ccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCc
Q 010856 127 TSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLG 206 (499)
Q Consensus 127 ~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~ 206 (499)
..|+.|||++|.|+.+..+..-.|.++.|++++|.|..+ ..+..+++|+.||||+|.++.. ..+-..+-+.++|.|+
T Consensus 284 q~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 284 QELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhhHhhhcCEeeeehh
Confidence 456677777777777666666667777777777766543 2355666666666666666532 2333455666666666
Q ss_pred CCcCCCCCCccccCCCCCCEEeCCCCcCCccCc-ccccCCCCCCEEEccCCcCcc
Q 010856 207 YNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP-ASLEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 207 ~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~ 260 (499)
+|.|.+. ..+..+-+|..||+++|+|..... ..++++|-|+.+.|.+|++.+
T Consensus 361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 6666532 345555666666666666653221 345556666666666666653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.2e-14 Score=135.70 Aligned_cols=138 Identities=12% Similarity=0.149 Sum_probs=110.6
Q ss_pred HhhhcccccccccCCcceEEEEEeCC-CCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGD-RMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
...++.....+|-|+||.|-+++... ...+|+|++++.. ..+.+.+..|-+||...+.|.||++|..|.+.+|. +
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv-Y 496 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV-Y 496 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh-h
Confidence 34556667889999999999998643 3358999997754 45567789999999999999999999999886655 3
Q ss_pred eeeecccCCCccccccccccc----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVSSLTL----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~~~~----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.++-|++|++...++..+.. .+-++..+.+|++|||+ +.||+|.+++.++=+|+.||||+.-
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence 446678899877766654443 34445788999999999 8999999999999999999999853
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.5e-13 Score=123.77 Aligned_cols=129 Identities=16% Similarity=0.115 Sum_probs=94.6
Q ss_pred cccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHH-hcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMM-KNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il-~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.+|+|+||.||+|.. .+|+.||+|.+.+... .....+..|..++ ...+||||+++++++...+ ..++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEEEEecc
Confidence 5689999999999996 4689999999865431 1223445565544 4569999999999887633 445577777
Q ss_pred CCCccccc-cc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 442 SASASASL-VS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 442 ~~~~~~~l-~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.|+.+..+ .. .......++.|++.||+|||+ +++|.|+++..++.++++|||++..
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 65543332 21 223345556899999999887 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.3e-13 Score=129.55 Aligned_cols=126 Identities=19% Similarity=0.184 Sum_probs=94.3
Q ss_pred cccccC--CcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKG--GFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G--~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
..||+| +||+||+++. .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+ ....+++++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEEEecc
Confidence 346666 8999999996 5799999999875432 23467889999999999999999999987744 334566776
Q ss_pred CCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEE
Q 010856 442 SAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 442 ~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
.++ +.+.+.. .+.....++.|++.||+|||+ ++||.|+++..++.+++.||+.
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHH
Confidence 554 3332221 112233456899999998876 8999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.35 E-value=7e-13 Score=126.05 Aligned_cols=127 Identities=15% Similarity=0.066 Sum_probs=90.6
Q ss_pred ccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHH---HHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 368 LIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVEC---EMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
.||+|+||.||+|+. .+++.||+|.+.+... .....+..|. +.++..+||+|+++++++...+ ....++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEEec
Confidence 479999999999985 4689999999976431 1122344444 3455568999999998877643 33446677
Q ss_pred cCCCcc-ccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 441 SSASAS-ASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 441 ~~~~~~-~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+.|+.+ ..+.. .+.....++.|+++|++|||+ +++|.|++++.++.++++|||++.
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 655433 32322 222344456899999999975 799999999999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3e-13 Score=130.65 Aligned_cols=136 Identities=15% Similarity=0.167 Sum_probs=104.4
Q ss_pred HhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~ 435 (499)
.-..|+..+.||+||.+.||++...+.+.||+|++.... .+...-|.+|++.+.++ .|.+||++++|=.. |. ..+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~-~lY 436 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DG-YLY 436 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-Cc-eEE
Confidence 335688899999999999999998888889988875432 34467799999999999 59999999998665 32 345
Q ss_pred eeecccCCCccccccccccc-----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVSSLTL-----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~~~~-----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++||-.-++...+...+.. .+.+..|++.|+.|+|. |.||+|||+++ |.+|+||||++-.
T Consensus 437 mvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 57888776665555544332 33344777888877655 89999999975 8999999999854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-13 Score=135.75 Aligned_cols=134 Identities=22% Similarity=0.274 Sum_probs=106.0
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.++|.....+|+|+||.||+++. .+++..|+|+++.....+.+-..+|+-+++..+|||||.++|-|...+ ..++-+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d--klwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD--KLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc--CcEEEE
Confidence 45788899999999999999995 578999999998876666677789999999999999999999887633 445567
Q ss_pred cccCCCcccccc-cccccc----ccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 439 HHSSASASASLV-SSLTLS----RPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 439 ~~~~~~~~~~l~-~~~~~~----~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
||++|+..+.+. -..... ...++...+|++|||+ ++|=+|+++++.+-|++.|||.+
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCch
Confidence 777666555543 222222 2224777899999988 45569999999999999999975
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-13 Score=129.12 Aligned_cols=161 Identities=21% Similarity=0.193 Sum_probs=87.0
Q ss_pred cCCCCCCEEeccCCcCCccCC-ccccCCCCCCeEecccccccccC--CccccCcccccEEeeecCCCCCcCCcc-ccCCc
Q 010856 52 SNLTNSTIVNLGGNKLNGSIP-ITLSKLQKLQGLGLEDNKLEGSI--PDDICHLAELYRLDLDGNKLSGSLPAC-FSNLT 127 (499)
Q Consensus 52 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~ 127 (499)
+++.+|++..|.+..+..... .....+++++.|||+.|-+..-. ......+++|+.|+|+.|++....... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 345667777777776652221 24556777777777777665321 123456777777777777766322111 12356
Q ss_pred cCCeeeccccCCCC--CCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccC-cccccCCcCCceee
Q 010856 128 SLRIVSLGSNKLTS--VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI-PTEIGGLKNLEYLF 204 (499)
Q Consensus 128 ~L~~L~L~~n~l~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~ 204 (499)
.|+.|.|+.|.++. +......+|+|+.|+|..|..-........-+..|+.|||++|++-... -.....++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 67777777776664 3334455666666766666422222233334455556666665554221 12234455555555
Q ss_pred CcCCcCCC
Q 010856 205 LGYNRLQG 212 (499)
Q Consensus 205 L~~n~l~~ 212 (499)
++.+.+.+
T Consensus 278 ls~tgi~s 285 (505)
T KOG3207|consen 278 LSSTGIAS 285 (505)
T ss_pred ccccCcch
Confidence 55555543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-12 Score=117.57 Aligned_cols=132 Identities=11% Similarity=0.009 Sum_probs=94.7
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHH---H------HHHHHHHHhcCCCCCccccceeEEccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFE---S------FDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
.++|...+++|.|+||.||.... ++..+|+|.+......... . +.+|++.+.++.||+|....+++.+.+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46799999999999999999765 5668999999755422222 2 689999999999999999998876543
Q ss_pred cc------eeeeeecccCCCccccccccccccccccccccccce------eeccCCCcccEEEeeCCCeEEEEEEEee
Q 010856 431 FT------VCLCLFHHSSASASASLVSSLTLSRPAKGGGFRGCV------LWHVGVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 431 ~~------~~~~l~~~~~~~~~~~l~~~~~~~~~~~~~i~~gl~------yLH~~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+. ...+++||+.|.....+. ........+++.++. +.|.|.+|.||+++.++ +++||||...
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~---~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~ 182 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP---EISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKR 182 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh---hccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcc
Confidence 22 345688888876443331 111222234444444 55669999999997655 9999999754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.7e-14 Score=129.72 Aligned_cols=184 Identities=23% Similarity=0.241 Sum_probs=121.5
Q ss_pred cCCCCCCeEecccccccccCCcc----ccCcccccEEeeecCCCCCcCC-------------ccccCCccCCeeeccccC
Q 010856 76 SKLQKLQGLGLEDNKLEGSIPDD----ICHLAELYRLDLDGNKLSGSLP-------------ACFSNLTSLRIVSLGSNK 138 (499)
Q Consensus 76 ~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~n~l~~~~~-------------~~~~~l~~L~~L~L~~n~ 138 (499)
..+++|++|+||+|-+....+.. +.+...|+.|+|.+|.+..... .....-+.|+.+...+|+
T Consensus 89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNr 168 (382)
T KOG1909|consen 89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNR 168 (382)
T ss_pred hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccc
Confidence 34455666666666554333322 2344556666666665542111 112334678888888888
Q ss_pred CCCCC-----ccccCCCCCcEEEcCCCcCCCC----CcccccCCCCccEEEccCCccccc----CcccccCCcCCceeeC
Q 010856 139 LTSVP-----LTFWNLKDILNLNFSSNFLTSP----LPLEIGNLKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFL 205 (499)
Q Consensus 139 l~~~~-----~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L 205 (499)
+..-+ ..+...+.|+.+.+..|.|... ....|..+++|+.|||..|-++.. ....++.+++|+.|++
T Consensus 169 len~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l 248 (382)
T KOG1909|consen 169 LENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNL 248 (382)
T ss_pred cccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecc
Confidence 87643 3466678888888888887642 234567788888888888887643 3345667888999999
Q ss_pred cCCcCCCCCCccc-----cCCCCCCEEeCCCCcCCcc----CcccccCCCCCCEEEccCCcCc
Q 010856 206 GYNRLQGSIPDSF-----GDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 206 ~~n~l~~~~~~~l-----~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
++|.+.......| ...|+|+.|.+.+|.|+.. +.......+.|..|+|++|++.
T Consensus 249 ~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 249 GDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9998876443333 3468999999999998732 3344556789999999999994
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-12 Score=126.87 Aligned_cols=128 Identities=12% Similarity=0.058 Sum_probs=93.2
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCC
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSA 443 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~ 443 (499)
.+..|.|+++.||++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+++++|+.+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~~e~~~~ 83 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVVSPLMAY 83 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEEEeccCC
Confidence 34444555544444443 78999999997652 344578999999999999999999999887643 34556777765
Q ss_pred Ccccc-ccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 444 SASAS-LVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 444 ~~~~~-l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+.... +.. .+.....++.|++.||+|||+ +++|.|+++++++.++++|||.+.
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~ 149 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSV 149 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccce
Confidence 54332 221 122334456899999999887 799999999999999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.3e-14 Score=127.15 Aligned_cols=231 Identities=20% Similarity=0.201 Sum_probs=141.2
Q ss_pred ccCCCCCCEEeccCCcCCcc----CCccccCCCCCCeEeccccc---ccccCCc-------cccCcccccEEeeecCCCC
Q 010856 51 ISNLTNSTIVNLGGNKLNGS----IPITLSKLQKLQGLGLEDNK---LEGSIPD-------DICHLAELYRLDLDGNKLS 116 (499)
Q Consensus 51 ~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~---l~~~~~~-------~~~~l~~L~~L~L~~n~l~ 116 (499)
......++.|+|++|.+... +...+.+.++|+..++++-- ....+|+ ++...++|++|+||+|-+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 34445666666666665431 12234455566666665421 1122222 3445567888888888876
Q ss_pred CcCCcc----ccCCccCCeeeccccCCCCCC--------------ccccCCCCCcEEEcCCCcCCCCC----cccccCCC
Q 010856 117 GSLPAC----FSNLTSLRIVSLGSNKLTSVP--------------LTFWNLKDILNLNFSSNFLTSPL----PLEIGNLK 174 (499)
Q Consensus 117 ~~~~~~----~~~l~~L~~L~L~~n~l~~~~--------------~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~ 174 (499)
...+.. +.++..|++|.|.+|.+.... .....-+.|+.+...+|++.+-. ...|...+
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~ 185 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHP 185 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcc
Confidence 444433 355678888888888775421 12334567888888888876522 23456667
Q ss_pred CccEEEccCCccccc----CcccccCCcCCceeeCcCCcCCCC----CCccccCCCCCCEEeCCCCcCCccCcccc----
Q 010856 175 VLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFLGYNRLQGS----IPDSFGDLISLKFLNLSNNNLSGAIPASL---- 242 (499)
Q Consensus 175 ~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~~~~~~---- 242 (499)
.|+.+.++.|.|... ....|..+++|+.|||.+|-++.. ....+..+++|+.|++++|.+.......|
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 888888888877532 223456788888888888877642 23456677788888888888765443332
Q ss_pred -cCCCCCCEEEccCCcCcccC-----CCCCCCCCccccccCCCcC
Q 010856 243 -EKLSYLENLNLSFNKLEGEI-----PRGGSFGNFSAESFEGNEL 281 (499)
Q Consensus 243 -~~l~~L~~L~l~~N~l~~~~-----~~~~~~~~l~~~~l~~N~~ 281 (499)
...|+|+.|.+.+|.++..- -....-+.+..+.+.||.+
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 23578888888888886311 0012255677778888875
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-12 Score=112.26 Aligned_cols=84 Identities=25% Similarity=0.309 Sum_probs=21.3
Q ss_pred CCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCC-CccccCCCCCCEEe
Q 010856 150 KDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI-PDSFGDLISLKFLN 228 (499)
Q Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~ 228 (499)
.+|+.|++++|.|+.+ ..+..++.|+.|++++|+|+...+.....+++|++|++++|+|.+.. -..+..+++|+.|+
T Consensus 42 ~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~ 119 (175)
T PF14580_consen 42 DKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLS 119 (175)
T ss_dssp TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE
T ss_pred cCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceee
Confidence 3344444444444322 12333444444444444444322111123445555555555444321 13344455555555
Q ss_pred CCCCcCC
Q 010856 229 LSNNNLS 235 (499)
Q Consensus 229 l~~N~l~ 235 (499)
+.+|+++
T Consensus 120 L~~NPv~ 126 (175)
T PF14580_consen 120 LEGNPVC 126 (175)
T ss_dssp -TT-GGG
T ss_pred ccCCccc
Confidence 5555554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.3e-12 Score=132.67 Aligned_cols=146 Identities=18% Similarity=0.222 Sum_probs=110.0
Q ss_pred CHHHHHHHhhhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 352 SYLELFRATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 352 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
.++.+...++.|++..++|.|.+|.||+++ .++++..|+|+++..... .++...|.+|++.. +|||++.++|+|...
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344445566778899999999999999999 467999999999876543 36678888998876 799999999998652
Q ss_pred c---cceeeeeecccCCCccccccc-------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEE
Q 010856 430 T---FTVCLCLFHHSSASASASLVS-------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFV 493 (499)
Q Consensus 430 ~---~~~~~~l~~~~~~~~~~~l~~-------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~ 493 (499)
+ .-+.+.++|+++|+....+.. .+.+..-+++.+++|+++||. ++|=.|||++.+++||++|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 2 235667888887775444321 222222234777888887766 788899999999999999999
Q ss_pred Eeecc
Q 010856 494 FEILL 498 (499)
Q Consensus 494 ~~~~~ 498 (499)
.+.-|
T Consensus 169 vSaQl 173 (953)
T KOG0587|consen 169 VSAQL 173 (953)
T ss_pred eeeee
Confidence 98643
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-12 Score=112.09 Aligned_cols=108 Identities=22% Similarity=0.317 Sum_probs=26.6
Q ss_pred cCCCCCCeEecccccccccCCcccc-CcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCcccc-CCCCCc
Q 010856 76 SKLQKLQGLGLEDNKLEGSIPDDIC-HLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFW-NLKDIL 153 (499)
Q Consensus 76 ~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~l~~L~ 153 (499)
.+..++++|+|.+|.|+.+ +.+. .+.+|+.|++++|.|+.. +.+..++.|+.|++++|+|++++..+. .+++|+
T Consensus 16 ~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ 91 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred ccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence 3444566666666666633 2333 355666666666666643 235556666666666666666544332 356666
Q ss_pred EEEcCCCcCCCCCc-ccccCCCCccEEEccCCccc
Q 010856 154 NLNFSSNFLTSPLP-LEIGNLKVLIGIDFSMNNFS 187 (499)
Q Consensus 154 ~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~ 187 (499)
+|++++|+|.+... ..+..+++|+.|++.+|.++
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 66666666554211 22333444444444444443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.7e-12 Score=119.85 Aligned_cols=127 Identities=15% Similarity=0.121 Sum_probs=97.3
Q ss_pred cccCCcceEEEEEeC-CCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc-CC
Q 010856 369 IGKGGFGSVYKARLG-DRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS-SA 443 (499)
Q Consensus 369 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~-~~ 443 (499)
+|+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++.+...+ ..+++++++ ++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--KLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--eeEEEEecCCCC
Confidence 699999999999964 589999999976542 24567899999999999999999998876533 344566666 55
Q ss_pred Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 444 SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 444 ~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+.+.+... +.....++.|++.|+.|+|+ +++|.|+++++++.++++|||....
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCccee
Confidence 544443322 22233445789999998866 7999999999999999999998764
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.5e-12 Score=119.70 Aligned_cols=138 Identities=12% Similarity=0.043 Sum_probs=97.2
Q ss_pred HHHHHHHhhhccccccc--ccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhc-CCCCCccccceeEEc
Q 010856 353 YLELFRATDEFSENNLI--GKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKN-IRHRNLIKILHGVAV 428 (499)
Q Consensus 353 ~~~~~~~~~~~~~~~~l--g~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~H~niv~l~~~~~~ 428 (499)
..+.....++|+..+.+ |+|+||.||+++. .++..+|+|.+....... .|+.+... .+||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556677777776 9999999999995 578899999987543211 12222221 279999999999877
Q ss_pred cccceeeeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEee
Q 010856 429 ITFTVCLCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEI 496 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~ 496 (499)
.+ ..+.++|++.+ ++...+.. .+.....++.|+++|++|||+ +++|.|+++.+++ .++++|||++.
T Consensus 81 ~~--~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 81 LK--GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred CC--eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 44 45567777754 44333322 223334456899999998877 7999999998887 99999999876
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
.
T Consensus 159 ~ 159 (267)
T PHA03390 159 I 159 (267)
T ss_pred e
Confidence 4
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.7e-13 Score=135.84 Aligned_cols=259 Identities=27% Similarity=0.299 Sum_probs=182.4
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEe
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLG 85 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 85 (499)
.++.++...+.+...... ...+. .++.+++..|.+.. .-..+..+.+|+.|++.+|.|..+.. .+..+++|++|+
T Consensus 50 ~~~~~~~~~~~~~~~~~~--~~~l~-~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ 124 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL--VESLT-SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLD 124 (414)
T ss_pred hhhhhcchhccccchhhh--HHHhH-hHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchhee
Confidence 445555555544322111 12334 68888888888874 23347778899999999999984432 367889999999
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCcc-ccCCCCCcEEEcCCCcCCC
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT-FWNLKDILNLNFSSNFLTS 164 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~ 164 (499)
+++|.|+.+ ..+..++.|+.|++++|.|+.. ..+..+++|+.+++++|++..+... ...+.+++.+++.+|.+..
T Consensus 125 ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 125 LSFNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIRE 200 (414)
T ss_pred ccccccccc--cchhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhc
Confidence 999999865 3567777899999999999854 4466688999999999999987654 4778899999999998874
Q ss_pred CCcccccCCCCccEEEccCCcccccCcccccCCcC--CceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 165 PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKN--LEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 165 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~--L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
+ ..+..+..+..+++..|.++... .+..+.. |+.+++++|++.. .+..+..+..+..|++.+|++... ..+
T Consensus 201 i--~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~ 273 (414)
T KOG0531|consen 201 I--EGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGL 273 (414)
T ss_pred c--cchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccc
Confidence 3 33444555666688888887542 2333444 8999999999883 336677888899999999988743 234
Q ss_pred cCCCCCCEEEccCCcCccc---CCC--CCCCCCccccccCCCc
Q 010856 243 EKLSYLENLNLSFNKLEGE---IPR--GGSFGNFSAESFEGNE 280 (499)
Q Consensus 243 ~~l~~L~~L~l~~N~l~~~---~~~--~~~~~~l~~~~l~~N~ 280 (499)
...+.+..+....|++... ... ....+.+....+.+||
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (414)
T KOG0531|consen 274 ERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNP 316 (414)
T ss_pred cccchHHHhccCcchhcchhhhhccccccccccccccccccCc
Confidence 5567777888888887632 111 2345566666777776
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.1e-13 Score=119.24 Aligned_cols=133 Identities=24% Similarity=0.308 Sum_probs=110.5
Q ss_pred CcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEE
Q 010856 101 HLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180 (499)
Q Consensus 101 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 180 (499)
....|+++||++|.|+ .+.++..-.|.++.|++++|.|+.+.. +..+++|+.|||++|.++. ....-..+-++++|.
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLK 358 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHh-hhhhHhhhcCEeeee
Confidence 3467899999999998 555677778999999999999998775 8889999999999999875 334445678899999
Q ss_pred ccCCcccccCcccccCCcCCceeeCcCCcCCCCC-CccccCCCCCCEEeCCCCcCCccC
Q 010856 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI-PDSFGDLISLKFLNLSNNNLSGAI 238 (499)
Q Consensus 181 l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~l~~N~l~~~~ 238 (499)
|++|.|... ..+..+-+|..||+++|+|.... ...++++|.|+.+.|.+|++.+..
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 999999744 56778889999999999998532 456899999999999999998543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.6e-12 Score=122.28 Aligned_cols=133 Identities=14% Similarity=0.087 Sum_probs=95.8
Q ss_pred hcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.|.+.+.||+|+||.||++... .+..+++|.++... .....++.+|+.+++.++||||+++++++...+ ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceE
Confidence 3778899999999999999853 45556666665322 223446778999999999999999999886643 345
Q ss_pred eeecccCCCcccc-cc--------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASAS-LV--------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~-l~--------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+++++.++.... +. ..+.....++.|+++|++|||+ +++|.|+++.+ +.++++|||++..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 5777776554332 21 1122334446889999999877 78999999864 6799999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.9e-13 Score=133.94 Aligned_cols=238 Identities=27% Similarity=0.281 Sum_probs=174.4
Q ss_pred cccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEe
Q 010856 30 SHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLD 109 (499)
Q Consensus 30 ~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 109 (499)
+..++.++...+.+....-. ...+..++.+++..|.+.. .-..+..+.+|+.|++.+|.|..+. ..+..+++|++|+
T Consensus 48 ~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ 124 (414)
T KOG0531|consen 48 PSDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLD 124 (414)
T ss_pred cchhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcc-cchhhhhcchhee
Confidence 33677777777665533222 2567788888899999884 3344788899999999999998543 3378899999999
Q ss_pred eecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCc-ccccCCCCccEEEccCCcccc
Q 010856 110 LDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLP-LEIGNLKVLIGIDFSMNNFSG 188 (499)
Q Consensus 110 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~ 188 (499)
+++|.|+.+. .+..++.|+.|++++|.|+.+. .+..++.|+.+++++|++..+.+ . ...+.+++.+.+.+|.+..
T Consensus 125 ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~~-~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 125 LSFNKITKLE--GLSTLTLLKELNLSGNLISDIS-GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE 200 (414)
T ss_pred cccccccccc--chhhccchhhheeccCcchhcc-CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence 9999999663 4667788999999999999876 45558999999999999986544 2 4778899999999999874
Q ss_pred cCcccccCCcCCceeeCcCCcCCCCCCccccCCCC--CCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCC
Q 010856 189 VIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIS--LKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG 266 (499)
Q Consensus 189 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~--L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 266 (499)
. ..+..+..+..+++..|.++... .+..++. |+.+++++|++.. .+..+..+..+..+++..|++...-. ..
T Consensus 201 i--~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~~-~~ 274 (414)
T KOG0531|consen 201 I--EGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLEG-LE 274 (414)
T ss_pred c--cchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccccc-cc
Confidence 4 45566667777789999888542 2333343 8999999999984 33567778889999999999874322 22
Q ss_pred CCCCccccccCCCc
Q 010856 267 SFGNFSAESFEGNE 280 (499)
Q Consensus 267 ~~~~l~~~~l~~N~ 280 (499)
..+.+..+....|+
T Consensus 275 ~~~~~~~~~~~~~~ 288 (414)
T KOG0531|consen 275 RLPKLSELWLNDNK 288 (414)
T ss_pred ccchHHHhccCcch
Confidence 23334444444554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.3e-12 Score=115.12 Aligned_cols=134 Identities=19% Similarity=0.191 Sum_probs=102.1
Q ss_pred cccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 363 FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
|...+.+|+|++|.||+|... +++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+ ....++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE--PLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC--ceEEEEec
Confidence 456688999999999999975 4889999999866544 5678999999999999999999999887633 34456677
Q ss_pred cCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 441 SSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 441 ~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+.+ .+...+... +.....++.+++++++|||+ +++|.|+++++++.++++|||+....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 665 433332221 12233445778888877765 79999999999999999999987653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.2e-13 Score=121.04 Aligned_cols=133 Identities=13% Similarity=0.072 Sum_probs=97.4
Q ss_pred Hhhhccc-ccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhc-CCCCCccccceeEEcc-c-cce
Q 010856 359 ATDEFSE-NNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKN-IRHRNLIKILHGVAVI-T-FTV 433 (499)
Q Consensus 359 ~~~~~~~-~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~H~niv~l~~~~~~~-~-~~~ 433 (499)
.+++|.+ ..+||-|--|+|..|.. ++++.+|+|++.. ..+..+|++..-. -.|||||+++++|... . ..-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4566655 46799999999999985 5799999999853 3456689987544 4799999999988541 1 223
Q ss_pred eeeeeccc-CCCcccccccccc------ccccccccccccceeecc------CCCcccEEEeeC---CCeEEEEEEEee
Q 010856 434 CLCLFHHS-SASASASLVSSLT------LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE---PGVEVICFVFEI 496 (499)
Q Consensus 434 ~~~l~~~~-~~~~~~~l~~~~~------~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~---~~~~~~~f~~~~ 496 (499)
..+++|+| +|+++..+...+. ....+..||+.|+.|||+ |+||+|+|+... --+|++||||+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 45577887 4556555544332 233344889999999987 899999999753 478999999985
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.3e-12 Score=134.65 Aligned_cols=140 Identities=14% Similarity=0.150 Sum_probs=107.0
Q ss_pred HHHHhhhcccccccccCCcceEEEEEe----CC----CCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCcccccee
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARL----GD----RMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHG 425 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~----~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~ 425 (499)
++....+....+.+|+|.||.||+|.. +. ...||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 444445556667999999999999983 12 4579999997654 34567899999999998 79999999999
Q ss_pred EEccccceeeeeecccCCCccccccccc---cc-----------------cccccccccccceeec------cCCCcccE
Q 010856 426 VAVITFTVCLCLFHHSSASASASLVSSL---TL-----------------SRPAKGGGFRGCVLWH------VGVDFAAF 479 (499)
Q Consensus 426 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~---~~-----------------~~~~~~~i~~gl~yLH------~~~~p~~~ 479 (499)
|.. +....++++++..|++...++... .. .-..+.|||.||+||+ +|.-.-||
T Consensus 371 ~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 371 CTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred ecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 987 444555566667888777665544 00 1122589999999974 56777899
Q ss_pred EEeeCCCeEEEEEEEee
Q 010856 480 VFVLEPGVEVICFVFEI 496 (499)
Q Consensus 480 l~~~~~~~~~~~f~~~~ 496 (499)
++..+..++++|||+++
T Consensus 450 Li~~~~~~kIaDFGlar 466 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLAR 466 (609)
T ss_pred EecCCCEEEEcccccee
Confidence 99999999999999997
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.5e-13 Score=139.54 Aligned_cols=139 Identities=20% Similarity=0.249 Sum_probs=105.3
Q ss_pred HHhhhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
..+-+|.....||.|.||.||-|. ..+|...|+|-+.-.. ....+.+.+|+.++..+.|||+|+.||+=..-| ..
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--kv 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--KV 1309 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH--HH
Confidence 334567778899999999999999 5679999999885443 344567889999999999999999998754423 22
Q ss_pred eeeecccCCCccccccccccc-----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSASASASLVSSLTL-----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~~~~-----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.+.+||+.|+.+..+...++. .+....|++.|++|||+ ++||+||+++..+-.|..|||-++-.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEe
Confidence 334566665555544433322 23334799999999987 89999999999999999999998743
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.1e-12 Score=123.01 Aligned_cols=124 Identities=15% Similarity=0.134 Sum_probs=98.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-----C---CCccccceeEEc--
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-----H---RNLIKILHGVAV-- 428 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----H---~niv~l~~~~~~-- 428 (499)
.+.|...++||-|.|++||+|.. .+.+.||+|+++... ...+..+.||+++++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36799999999999999999995 568899999997543 34567889999998763 3 379999998854
Q ss_pred cccceeeeeecccCCCcccccccc------ccccccccccccccceeecc-------CCCcccEEEeeC
Q 010856 429 ITFTVCLCLFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLE 484 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~ 484 (499)
+...+.-+++|+++..++..+... ...++++++||+.||.|||+ ++||+|+|+...
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 455666778999988887766532 23467888999999999988 899999998544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.3e-12 Score=126.33 Aligned_cols=133 Identities=12% Similarity=0.105 Sum_probs=99.1
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
+.|...+.||-|+||+|.+++. .+...||+|.+.+.+ ..+...+..|-.||+..+.+.||+||.-|.+.+ ..+.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEE
Confidence 4467788899999999999984 567899999998765 344566889999999999999999997777644 3344
Q ss_pred eecccCCC-ccccccccccc----ccccc------ccccccceeeccCCCcccEEEeeCCCeEEEEEEEe
Q 010856 437 LFHHSSAS-ASASLVSSLTL----SRPAK------GGGFRGCVLWHVGVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~~~~~----~~~~~------~~i~~gl~yLH~~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
+++|+.|+ +-..+..-+.. .+-.+ ..-++-|.|+|+++||.|||++.++-.|+.|||+-
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccc
Confidence 67777555 33333222222 22222 34456677899999999999999999999999974
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-11 Score=111.23 Aligned_cols=137 Identities=15% Similarity=0.017 Sum_probs=93.3
Q ss_pred HHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCc----------------------cHHHHHHHHHHHh
Q 010856 355 ELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR----------------------AFESFDVECEMMK 412 (499)
Q Consensus 355 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~il~ 412 (499)
++...-..|...+.||+|+||.||+|..++|+.||||++...... ....+.+|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444443447778999999999999999888999999987643200 0123678899999
Q ss_pred cCCCCC--ccccceeEEccccceeeeeecccCCCccccccccccccccccccccccce------eeccCCCcccEEEeeC
Q 010856 413 NIRHRN--LIKILHGVAVITFTVCLCLFHHSSASASASLVSSLTLSRPAKGGGFRGCV------LWHVGVDFAAFVFVLE 484 (499)
Q Consensus 413 ~l~H~n--iv~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~~~~i~~gl~------yLH~~~~p~~~l~~~~ 484 (499)
.+.|++ +++.++. ...+++++++.|.....+... .....++.+++.++. .+|.+++|.|++++.+
T Consensus 89 ~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 89 ALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL-EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred HHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc-ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence 998875 3333321 122457788877654433221 222344456666665 4556899999999988
Q ss_pred CCeEEEEEEEeecc
Q 010856 485 PGVEVICFVFEILL 498 (499)
Q Consensus 485 ~~~~~~~f~~~~~~ 498 (499)
+.++++|||.++.+
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.8e-11 Score=126.74 Aligned_cols=131 Identities=11% Similarity=0.021 Sum_probs=91.6
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEe-eccC-C------ccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVF-NLQC-G------RAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~-~~~~-~------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
...|...+.||+|+||+||+|.+... .+++|+. .+.. . ...+++.+|+++++.++|++++....++...+
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~- 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE- 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-
Confidence 34456678999999999999987444 3444433 2211 1 11356889999999999999988776655432
Q ss_pred ceeeeeecccCCCccccccccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSASASASLVSSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...+++||+.|+.+..... ....++.|++++++|||+ |++|.||++ +++.++++|||+++.
T Consensus 410 -~~~lv~E~~~g~~L~~~l~---~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 -EKTIVMEYIGGKDLKDVLE---GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred -CCEEEEEecCCCcHHHHHH---HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 2345777876654333211 234456778888887765 899999999 788999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-11 Score=128.44 Aligned_cols=135 Identities=17% Similarity=0.130 Sum_probs=82.8
Q ss_pred HhhhcccccccccCCcceEEEEEe-CC----CCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEc----c
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GD----RMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAV----I 429 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~----~ 429 (499)
..++|...+.||+|+||.||+|+. .+ +..||+|++.... ..+.+..| .+....+.+++.+...+.. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999996 35 7899999876432 11222222 1122223333333222111 1
Q ss_pred ccceeeeeecccCCCcccc-cccc------------------------ccccccccccccccceeecc------CCCccc
Q 010856 430 TFTVCLCLFHHSSASASAS-LVSS------------------------LTLSRPAKGGGFRGCVLWHV------GVDFAA 478 (499)
Q Consensus 430 ~~~~~~~l~~~~~~~~~~~-l~~~------------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~ 478 (499)
+....+++++|++++.+.. +... ......++.|++.||+|||+ ++||.|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 2234455666665443221 1110 01122356788999988876 899999
Q ss_pred EEEee-CCCeEEEEEEEeec
Q 010856 479 FVFVL-EPGVEVICFVFEIL 497 (499)
Q Consensus 479 ~l~~~-~~~~~~~~f~~~~~ 497 (499)
||++. ++.++++|||++..
T Consensus 286 ILl~~~~~~~KL~DFGlA~~ 305 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAAD 305 (566)
T ss_pred EEEeCCCCcEEEEeCCCccc
Confidence 99986 46899999999864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.3e-11 Score=125.41 Aligned_cols=113 Identities=38% Similarity=0.547 Sum_probs=103.6
Q ss_pred CCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCC
Q 010856 151 DILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLS 230 (499)
Q Consensus 151 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 230 (499)
.++.|+|++|.+.+..|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCccCcccccCC-CCCCEEEccCCcCcccCC
Q 010856 231 NNNLSGAIPASLEKL-SYLENLNLSFNKLEGEIP 263 (499)
Q Consensus 231 ~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~ 263 (499)
+|++++..|..+... .++..+++.+|+..+..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999888764 567889999998765443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.2e-11 Score=110.77 Aligned_cols=132 Identities=11% Similarity=-0.014 Sum_probs=88.7
Q ss_pred hhcccccccccCCcceEEEEE--eCCCCEEEEEEeeccCCc------------------------cHHHHHHHHHHHhcC
Q 010856 361 DEFSENNLIGKGGFGSVYKAR--LGDRMEVAVKVFNLQCGR------------------------AFESFDVECEMMKNI 414 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~il~~l 414 (499)
..|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|++++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357788999999999999998 468999999999754210 012356899999999
Q ss_pred CCCCccccceeEEccccceeeeeecccCCCcccccc-cccc----ccccccccccccceeec-------cCCCcccEEEe
Q 010856 415 RHRNLIKILHGVAVITFTVCLCLFHHSSASASASLV-SSLT----LSRPAKGGGFRGCVLWH-------VGVDFAAFVFV 482 (499)
Q Consensus 415 ~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~-~~~~----~~~~~~~~i~~gl~yLH-------~~~~p~~~l~~ 482 (499)
.+.. +.+..++... ..+.++|+++|....... .... ....++.|++.+++||| .+++|.||+++
T Consensus 108 ~~~~-i~~p~~~~~~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAG-VPVPKPIAWR---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcC-CCCCeeeEec---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 7643 3222222211 224677888775433221 1111 12345577888776555 57899999998
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
++.++++|||.+..
T Consensus 184 -~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 -DGKVVIIDVSQSVE 197 (237)
T ss_pred -CCCEEEEEChhhhc
Confidence 88999999998763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.8e-11 Score=108.82 Aligned_cols=124 Identities=10% Similarity=-0.014 Sum_probs=85.6
Q ss_pred ccccCCcceEEEEEeCCCCEEEEEEeeccC--Cc------cHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 368 LIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GR------AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~------~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.||+|+||.||+|.. +|..+++|...... .. ..+++.+|++++..++|+++.....++...+ ...++++
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEEE
Confidence 379999999999985 67789999865432 11 1356789999999999887655444444322 2345778
Q ss_pred ccCCCccccccccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVSSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.|.....+...... .++.+++.+|+++|+ +.+|.|+++. ++.++++|||.+..
T Consensus 78 ~~~g~~l~~~~~~~~~--~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND--ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH--HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 8766644332211111 455666777766655 8999999998 89999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-11 Score=108.78 Aligned_cols=127 Identities=13% Similarity=0.023 Sum_probs=90.1
Q ss_pred cccccCCcceEEEEEeCCCCEEEEEEeeccCCc--------cHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR--------AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.||+|++|.||+|.. .|..+++|+....... ....+.+|++++..+.|++|.....++...+ ..++++
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEEE
Confidence 5789999999999987 6778999986543211 1245789999999999999887766655432 345577
Q ss_pred cccCCCcccccccc-ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSS-LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~-~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.|.....+... ......++.+++.+++++|+ +.+|.|+++. ++.++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 88766544433211 11223445677777776665 8899999998 88999999998753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.9e-11 Score=103.96 Aligned_cols=125 Identities=13% Similarity=-0.007 Sum_probs=83.2
Q ss_pred ccccccccCCcceEEEEEeCCCCEEEEEEeeccCC--c--cHHHHHHHHHHHhcCC-CCCccccceeEEccccceeeeee
Q 010856 364 SENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG--R--AFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~--~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.....+++|+||+||.+.. .+..++.+.+..... . ....+.+|+++|+++. |++|++++++. ....++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence 3457899999999997765 667777777754431 1 1235789999999995 57898888751 123456
Q ss_pred cccCCCccccccccccccccccccccccceeec------cCC-CcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSSLTLSRPAKGGGFRGCVLWH------VGV-DFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~~~~~~~~~~~i~~gl~yLH------~~~-~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|+.|..+....... ......|++++++|+| +|+ ||.||+++.++.+++||||++..
T Consensus 78 eyI~G~~L~~~~~~~--~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 78 SYLAGAAMYQRPPRG--DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred eeecCccHHhhhhhh--hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 666555433211111 1123345556666555 588 78899998888899999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.7e-11 Score=111.30 Aligned_cols=118 Identities=7% Similarity=-0.019 Sum_probs=87.2
Q ss_pred CCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC-ccccc
Q 010856 372 GGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS-ASASL 449 (499)
Q Consensus 372 G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~-~~~~l 449 (499)
|.||.||+++. .+++.||+|++.... .+.+|...+....||||+++++++...+ ...+++|++.|+ +.+.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCCCCCHHHHH
Confidence 89999999995 578999999997543 2345555666667999999999887643 445577777654 33333
Q ss_pred cc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 450 VS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 450 ~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.. .+.....++.|+++||+|||+ +++|.|++++.++.++++|||+..
T Consensus 77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~ 133 (237)
T cd05576 77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWS 133 (237)
T ss_pred HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchh
Confidence 22 222234456788999998876 899999999999999999999754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.7e-11 Score=105.71 Aligned_cols=127 Identities=20% Similarity=0.224 Sum_probs=96.7
Q ss_pred cccCCcceEEEEEeC-CCCEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCCcc
Q 010856 369 IGKGGFGSVYKARLG-DRMEVAVKVFNLQCGR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSASAS 446 (499)
Q Consensus 369 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~ 446 (499)
||+|++|.||+++.. +++.+++|++...... ..+.+.+|++.++.++|++|+++++++... ...++++++..|...
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCCCcH
Confidence 689999999999974 4899999999765432 346799999999999999999999888763 344567788874433
Q ss_pred c-cccc-----cccccccccccccccceeecc------CCCcccEEEee-CCCeEEEEEEEeec
Q 010856 447 A-SLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL-EPGVEVICFVFEIL 497 (499)
Q Consensus 447 ~-~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~-~~~~~~~~f~~~~~ 497 (499)
. .+.. .......++.+++++++|||+ +++|.|++++. ++.++++|||....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~ 142 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKL 142 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEE
Confidence 3 2221 112233445788888887766 78999999998 89999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-11 Score=115.41 Aligned_cols=134 Identities=14% Similarity=0.156 Sum_probs=104.9
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~ 434 (499)
..+|....+||+|+||+|.+|+.+ +.+.||||++++.- ..+.+--+.|.++++-. +-|.+++++.++..++..
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL-- 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL-- 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe--
Confidence 356888999999999999999964 57899999998764 23345567899999877 678999999888877643
Q ss_pred eeeeccc-CCCccccccccccccccc----cccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 435 LCLFHHS-SASASASLVSSLTLSRPA----KGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 435 ~~l~~~~-~~~~~~~l~~~~~~~~~~----~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
+.++||+ +|++...+++.+...+.. |..||-||-|||+ +.|-.|++++.++-+++.|||..
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccc
Confidence 3355555 555555555555554444 4789999999998 68889999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-11 Score=121.65 Aligned_cols=133 Identities=14% Similarity=0.080 Sum_probs=101.8
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+..|.....+|.|+|+.|..+.. .+++.+|+|++.+.. .+-.+|+.++... +||||+++.+.+.+ ....+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecC--Cceeeee
Confidence 56678888899999999999995 578999999997652 2344678776665 79999999999876 5566778
Q ss_pred ecccCCC-cccccccccc---ccccccccccccceeecc------CCCcccEEEe-eCCCeEEEEEEEeecc
Q 010856 438 FHHSSAS-ASASLVSSLT---LSRPAKGGGFRGCVLWHV------GVDFAAFVFV-LEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~~~~---~~~~~~~~i~~gl~yLH~------~~~p~~~l~~-~~~~~~~~~f~~~~~~ 498 (499)
++.+.|+ +.+.+..... ....++++++.|+.|||+ |.+|.|||++ +++.++++||||..-+
T Consensus 395 ~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 8887655 3443332221 223367899999999987 8999999995 6777999999998754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.4e-11 Score=107.65 Aligned_cols=135 Identities=11% Similarity=0.112 Sum_probs=97.1
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.+.|++.+.+|+|.||.+.+++++ +.+.+++|.+..... ..++|.+|..---.+ .|.||+.-|++.++... .++.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d-~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD-AYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCc-eEEEe
Confidence 356888899999999999999964 688999999875442 347899998765455 69999998876444222 22334
Q ss_pred eccc-CCCccccccc---cccccccccccccccceeecc------CCCcccEEEee--CCCeEEEEEEEee
Q 010856 438 FHHS-SASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL--EPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~-~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~--~~~~~~~~f~~~~ 496 (499)
.|+. .|++...+.. .+...+.++.|++.|++|+|+ ++|.+|||+=+ ...||+||||..+
T Consensus 101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 4444 4554443322 233455667899999999987 89999998843 4599999999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-10 Score=108.09 Aligned_cols=124 Identities=18% Similarity=0.133 Sum_probs=94.1
Q ss_pred CcceEEEEEeC-CCCEEEEEEeeccCCcc-HHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCC-ccccc
Q 010856 373 GFGSVYKARLG-DRMEVAVKVFNLQCGRA-FESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSAS-ASASL 449 (499)
Q Consensus 373 ~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~-~~~~l 449 (499)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+||+++++++... ...+.++++..++ +...+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHHH
Confidence 58999999975 58999999997665433 67899999999999999999999988763 3445567777664 33222
Q ss_pred cc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 450 VS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 450 ~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.. .......++.++++|++|||+ +++|.|+++++++.++++|||+...+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 137 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQL 137 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeee
Confidence 21 112233445778888887766 79999999999999999999998754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.1e-10 Score=81.17 Aligned_cols=60 Identities=32% Similarity=0.456 Sum_probs=35.7
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccc
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKL 91 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 91 (499)
+|++|++++|+++.+.+++|.++++|++|++++|.++.+.+..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666655555566666666666666666655555566666666666665543
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-10 Score=124.18 Aligned_cols=199 Identities=21% Similarity=0.262 Sum_probs=119.0
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCC--CcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCe
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCN--ISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQG 83 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~--i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 83 (499)
..+...+-+|.+..+... ...+ +|++|-+..|. +..+..+.|..++.|+.|||++|.--+.+|..++++-+|++
T Consensus 524 ~~rr~s~~~~~~~~~~~~---~~~~-~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 524 SVRRMSLMNNKIEHIAGS---SENP-KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred heeEEEEeccchhhccCC---CCCC-ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 445666666666533221 1233 68888888875 55455555777888888888887766677888888888888
Q ss_pred EecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCC---CccccCCCCCcEEEcCCC
Q 010856 84 LGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSV---PLTFWNLKDILNLNFSSN 160 (499)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~---~~~~~~l~~L~~L~l~~n 160 (499)
|+|++..+. .+|..+.+++.|.+|++..+.-...++.....+.+|++|.+..-....- -..+..+.+|+.+.....
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence 888888887 6777888888888888887776656666667788888888866552221 122334444444444322
Q ss_pred cCCCCCcccccCCCCcc----EEEccCCcccccCcccccCCcCCceeeCcCCcCCC
Q 010856 161 FLTSPLPLEIGNLKVLI----GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 212 (499)
Q Consensus 161 ~l~~~~~~~~~~l~~L~----~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 212 (499)
.. .....+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.+.+
T Consensus 679 s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 679 SV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred hh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 21 0111122222222 2222222221 233445566667777776666653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.5e-11 Score=111.66 Aligned_cols=134 Identities=18% Similarity=0.179 Sum_probs=94.9
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCC------CccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHR------NLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~------niv~l~~~~~~~~~~ 432 (499)
+..|.+...+|+|.||+|..+.. +++..||+|+++.-. ...+...-|++++.++.+. -+|.+.+|+.- ..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-rg- 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-RG- 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc-cC-
Confidence 56799999999999999999995 458999999996443 3456677899999998322 24555444321 11
Q ss_pred eeeeeecccCCCcccccc------ccccccccccccccccceeecc------CCCcccEEEeeC----------------
Q 010856 433 VCLCLFHHSSASASASLV------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE---------------- 484 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~---------------- 484 (499)
..-+++|.++-+.++++. .+....+.++.|++++++|||+ |.||+||++++.
T Consensus 165 hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 222356666655555443 3444567778999999999987 899999988643
Q ss_pred ----CCeEEEEEEEee
Q 010856 485 ----PGVEVICFVFEI 496 (499)
Q Consensus 485 ----~~~~~~~f~~~~ 496 (499)
..+++||||=++
T Consensus 245 ~~ks~~I~vIDFGsAt 260 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSAT 260 (415)
T ss_pred cCCCcceEEEecCCcc
Confidence 246889998654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.6e-10 Score=100.54 Aligned_cols=125 Identities=14% Similarity=0.056 Sum_probs=76.9
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEeeccCCc--cHHH----------------------HHHHHHHHhcCCCCC--c
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR--AFES----------------------FDVECEMMKNIRHRN--L 419 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~il~~l~H~n--i 419 (499)
.+.||+|+||.||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999998754311 1111 124555555554332 2
Q ss_pred cccceeEEccccceeeeeecccCCCc-----cccccccccccccccccccccceee-------ccCCCcccEEEeeCCCe
Q 010856 420 IKILHGVAVITFTVCLCLFHHSSASA-----SASLVSSLTLSRPAKGGGFRGCVLW-------HVGVDFAAFVFVLEPGV 487 (499)
Q Consensus 420 v~l~~~~~~~~~~~~~~l~~~~~~~~-----~~~l~~~~~~~~~~~~~i~~gl~yL-------H~~~~p~~~l~~~~~~~ 487 (499)
.+.+++ ....++++++.|+. ....... ...+.++.+++.++.++ |.+++|.|++++ ++.+
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 222221 12345777777632 1111111 22333445566555554 558999999998 8899
Q ss_pred EEEEEEEeecc
Q 010856 488 EVICFVFEILL 498 (499)
Q Consensus 488 ~~~~f~~~~~~ 498 (499)
+++|||.++..
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-10 Score=80.67 Aligned_cols=61 Identities=36% Similarity=0.501 Sum_probs=38.5
Q ss_pred CCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCC
Q 010856 55 TNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKL 115 (499)
Q Consensus 55 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 115 (499)
|+|++|++++|+++.+.+..|.++++|++|++++|.++.+.++.|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666655556666666666666666666655556666666666666666653
|
... |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.3e-10 Score=117.97 Aligned_cols=130 Identities=18% Similarity=0.178 Sum_probs=87.0
Q ss_pred cccccccccCCcc-eEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeecc
Q 010856 363 FSENNLIGKGGFG-SVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 363 ~~~~~~lg~G~~g-~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
|...+++|.|+-| .||+|.+ .|+.||||++-.. ..+-..+||..++.- +|||||+++ |.+.+....++..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyy--c~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYY--CSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEE--eeccCCceEEEEehH
Confidence 3445678899887 4689998 6789999988542 234467999998877 699999975 444333333444444
Q ss_pred cCCCcccccccc--c------cccccccccccccceeecc------CCCcccEEEeeC-----CCeEEEEEEEeecc
Q 010856 441 SSASASASLVSS--L------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE-----PGVEVICFVFEILL 498 (499)
Q Consensus 441 ~~~~~~~~l~~~--~------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~-----~~~~~~~f~~~~~~ 498 (499)
+...+.+.+... . -.......|++.|+++||+ +.||+|||++.. -.++++|||+..-|
T Consensus 585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 444443333221 1 1112223678888887765 899999999763 47999999998644
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.5e-12 Score=126.96 Aligned_cols=128 Identities=30% Similarity=0.373 Sum_probs=77.6
Q ss_pred CCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCC
Q 010856 151 DILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLS 230 (499)
Q Consensus 151 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 230 (499)
.|...+.++|.+.. ....+.-++.|+.|+|++|+++.. ..+..++.|++|||++|.+..+.--...++ .|..|.++
T Consensus 165 ~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeec
Confidence 45566666666652 334555566677777777777654 356677777777777777763322222333 37777777
Q ss_pred CCcCCccCcccccCCCCCCEEEccCCcCccc--CCCCCCCCCccccccCCCcCCCC
Q 010856 231 NNNLSGAIPASLEKLSYLENLNLSFNKLEGE--IPRGGSFGNFSAESFEGNELLCG 284 (499)
Q Consensus 231 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~l~~~~l~~N~~~c~ 284 (499)
+|.++.. ..+.++.+|+.||+++|-|.+- +...+.+..+..+++.|||.-|.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 7777633 2455677777777777777642 22223445566777777776554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.94 E-value=9.8e-10 Score=93.80 Aligned_cols=125 Identities=11% Similarity=-0.013 Sum_probs=88.8
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCC--CCccccceeEEccccceeeeeecccCC
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRH--RNLIKILHGVAVITFTVCLCLFHHSSA 443 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H--~niv~l~~~~~~~~~~~~~~l~~~~~~ 443 (499)
.+.+|+|.++.||++...+ ..+++|....... ...+.+|+.++..++| ..+++++++.... ...+.+++++.|
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEecCC
Confidence 4679999999999999744 6899998865433 4678999999999977 4888877665442 245567788877
Q ss_pred Cccccccccccccccccccccccce---------eeccCCCcccEEEeeCCCeEEEEEEEeec
Q 010856 444 SASASLVSSLTLSRPAKGGGFRGCV---------LWHVGVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 444 ~~~~~l~~~~~~~~~~~~~i~~gl~---------yLH~~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.....+ ........+.+++++++ .+|.+.+|.|+++...+.++++|||.+..
T Consensus 78 ~~~~~~--~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 654432 11112222333444333 56778999999999889999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.94 E-value=1e-09 Score=101.07 Aligned_cols=130 Identities=12% Similarity=0.050 Sum_probs=87.7
Q ss_pred cccc-cCCcceEEEEEeCCCCEEEEEEeeccC-------------CccHHHHHHHHHHHhcCCCCCc--cccceeEEccc
Q 010856 367 NLIG-KGGFGSVYKARLGDRMEVAVKVFNLQC-------------GRAFESFDVECEMMKNIRHRNL--IKILHGVAVIT 430 (499)
Q Consensus 367 ~~lg-~G~~g~v~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~il~~l~H~ni--v~l~~~~~~~~ 430 (499)
..+| .|+.|+||.+... +..+++|.+.... ......+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999874 6789999885321 1123567899999999999885 56666543321
Q ss_pred cc--eeeeeecccCC-Cccccccccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 FT--VCLCLFHHSSA-SASASLVSSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 ~~--~~~~l~~~~~~-~~~~~l~~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.. ...++++++.| .....+............|+++++.+||+ |++|.||+++.++.+++||||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 11 11256677765 33322222222233335677888887766 8999999998888999999998754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.6e-10 Score=103.90 Aligned_cols=134 Identities=11% Similarity=0.147 Sum_probs=100.0
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~ 433 (499)
...+|.+.++||+|+|++|..+++ ++.+.||+|++++.- .++.+.+..|..+..+. +||.+|.++.+|.. |...
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-esrl 326 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-ESRL 326 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-cceE
Confidence 346788999999999999999995 578999999998753 34556677888887765 79999999876654 4444
Q ss_pred eeeeeccc-CCCcccccccccccccccc----ccccccceeecc------CCCcccEEEeeCCCeEEEEEEE
Q 010856 434 CLCLFHHS-SASASASLVSSLTLSRPAK----GGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 434 ~~~l~~~~-~~~~~~~l~~~~~~~~~~~----~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
++ +.||. +|++....+......+..| ..|+-||.|||+ +.|-.|+|++.++-.|+.|+|.
T Consensus 327 ff-vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 327 FF-VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred EE-EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence 44 44444 4444333333333333333 678899999998 6888999999999999999986
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.1e-09 Score=106.24 Aligned_cols=134 Identities=16% Similarity=0.163 Sum_probs=93.5
Q ss_pred hcccccccccCCcceEEEEEeCC--CCEEEEEEeeccCCccHHHHHHHHHHHhcCCC----CCccccceeEEccccceee
Q 010856 362 EFSENNLIGKGGFGSVYKARLGD--RMEVAVKVFNLQCGRAFESFDVECEMMKNIRH----RNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H----~niv~l~~~~~~~~~~~~~ 435 (499)
.|.+.+.||+|+||.||.|.... ...+|+|.-..........+..|..++..+.. +++.++++.... .....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~-~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS-TEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccC-CCceeE
Confidence 79999999999999999999643 35789988866543333368889999888863 577777766632 122345
Q ss_pred eeecccCCCcccccccc------ccccccccccccccc------eeeccCCCcccEEEeeC-----CCeEEEEEEEee
Q 010856 436 CLFHHSSASASASLVSS------LTLSRPAKGGGFRGC------VLWHVGVDFAAFVFVLE-----PGVEVICFVFEI 496 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl------~yLH~~~~p~~~l~~~~-----~~~~~~~f~~~~ 496 (499)
+++...+.++.+..... ....-.++.|++.+| .|+|+|+||.|+.+... ..+.++|||+++
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 56777776654432111 112233356777777 57777999999999765 359999999987
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-10 Score=105.45 Aligned_cols=135 Identities=16% Similarity=0.094 Sum_probs=101.9
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEc----ccccee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAV----ITFTVC 434 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~----~~~~~~ 434 (499)
.|...+.+|.|.= .|..+.. -.++.||+|++...- ....++..+|..++..+.|+||++++.++.- .++...
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4566677888876 5555553 358899999885432 2335678899999999999999999998853 244567
Q ss_pred eeeecccCCCccccccc--cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVS--SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~--~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.++|+|...+...++. +......+..|++.|+.|||+ +.||.|+++..+..+||.|||.++-
T Consensus 97 y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 97 YLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 78899998887665542 222344456888888888876 7999999999999999999999863
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=8.1e-10 Score=118.47 Aligned_cols=264 Identities=22% Similarity=0.193 Sum_probs=166.0
Q ss_pred CCCCCCEEECcCCC--CCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCC
Q 010856 3 NCKSLTLIYLSNNP--LDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQK 80 (499)
Q Consensus 3 ~l~~L~~L~L~~n~--l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 80 (499)
++++|++|-+..|. +..+... +|..+| .|+.|||++|.--+.+|..++++-+|++|++++..++ .+|..+.++..
T Consensus 543 ~~~~L~tLll~~n~~~l~~is~~-ff~~m~-~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~ 619 (889)
T KOG4658|consen 543 ENPKLRTLLLQRNSDWLLEISGE-FFRSLP-LLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKK 619 (889)
T ss_pred CCCccceEEEeecchhhhhcCHH-HHhhCc-ceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHh
Confidence 46789999999997 5544443 788888 8999999998777789999999999999999999998 78889999999
Q ss_pred CCeEecccccccccCCccccCcccccEEeeecCCCC--CcCCccccCCccCCeeeccccCCCCCCccccCCCCCc----E
Q 010856 81 LQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLS--GSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDIL----N 154 (499)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~----~ 154 (499)
|.+|++..+.-....+.....+.+|++|.+..-... ...-..+..+.+|+.+....... .+-..+..++.|. .
T Consensus 620 L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~-~~~e~l~~~~~L~~~~~~ 698 (889)
T KOG4658|consen 620 LIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV-LLLEDLLGMTRLRSLLQS 698 (889)
T ss_pred hheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh-HhHhhhhhhHHHHHHhHh
Confidence 999999998866566777788999999999776522 11222334455555555543333 1111122222222 2
Q ss_pred EEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccC------CcCCceeeCcCCcCCCCCCccccCCCCCCEEe
Q 010856 155 LNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGG------LKNLEYLFLGYNRLQGSIPDSFGDLISLKFLN 228 (499)
Q Consensus 155 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~------l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 228 (499)
+.+.++... ..+..+..+.+|+.|.+.++.+......+... ++++..+...++..- ..+.+..-.++|+.|+
T Consensus 699 l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~ 776 (889)
T KOG4658|consen 699 LSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLS 776 (889)
T ss_pred hhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEE
Confidence 222222222 23455667778888888877775432222211 223333333333222 2223334457788888
Q ss_pred CCCCcCCccCcccccCCCCCCEEEccCCcCccc--CCCCCCCCCcc
Q 010856 229 LSNNNLSGAIPASLEKLSYLENLNLSFNKLEGE--IPRGGSFGNFS 272 (499)
Q Consensus 229 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~l~ 272 (499)
+..+.....+......+..+..+-+..+.+.+. +...+.++++.
T Consensus 777 l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~ 822 (889)
T KOG4658|consen 777 LVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLY 822 (889)
T ss_pred EecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeE
Confidence 887776655555555666666666666666554 33333444433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.9e-10 Score=95.95 Aligned_cols=133 Identities=14% Similarity=0.112 Sum_probs=90.9
Q ss_pred hhhcccccccccCCcceEEEEE-eCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCC-CCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRH-RNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H-~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|...+.||+|+||.+|.|. ..+|+.||+|+=.... ...+...|.++...++| ..|..+..+..+.+ ...++
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~--ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKD--YNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccc--cceee
Confidence 4679999999999999999999 5789999999764432 22457789999888876 45555555544433 33557
Q ss_pred ecccCCCccccccccc-----cccccccccccccce------eeccCCCcccEEEee---CCCeEEEEEEEee
Q 010856 438 FHHSSASASASLVSSL-----TLSRPAKGGGFRGCV------LWHVGVDFAAFVFVL---EPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~~~~~~l~~~~-----~~~~~~~~~i~~gl~------yLH~~~~p~~~l~~~---~~~~~~~~f~~~~ 496 (499)
++.++-++.+.+..-. ....-.|-|++.-++ |+|+++||.|||+-- -..+-+||||++.
T Consensus 90 MdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 8888766544332111 111111345555555 556799999999942 3688899999974
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.8e-10 Score=104.58 Aligned_cols=136 Identities=20% Similarity=0.164 Sum_probs=95.4
Q ss_pred HHHHhhhcccccccccCCcceEEEEEe-C---CCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccc
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARL-G---DRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVIT 430 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~ 430 (499)
+......|...++||+|.|+.||++.. . ..+.||+|.+.... ....+.+|++++..+ -|.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 344556688999999999999999984 3 46789999997654 345689999999998 5999999998776543
Q ss_pred cceeeeeecccCCCcccccccccc--ccccccccccccce------eeccCCCcccEEEeeC-CCeEEEEEEEe
Q 010856 431 FTVCLCLFHHSSASASASLVSSLT--LSRPAKGGGFRGCV------LWHVGVDFAAFVFVLE-PGVEVICFVFE 495 (499)
Q Consensus 431 ~~~~~~l~~~~~~~~~~~l~~~~~--~~~~~~~~i~~gl~------yLH~~~~p~~~l~~~~-~~~~~~~f~~~ 495 (499)
....+++|+...-+..+..... ..+...+.+..||+ ++|+|+||.||+++.. +.-.++|||++
T Consensus 109 --~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 --QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred --eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 3344566665443333322211 12222233344444 5677999999999864 67889999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.2e-09 Score=98.10 Aligned_cols=131 Identities=13% Similarity=0.093 Sum_probs=93.7
Q ss_pred hcccccccccCCcceEEEEE-eCCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeec
Q 010856 362 EFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.|...++||+|+||+.+.|+ +-+++.||||.=.... ..-++..|-+..+.+ ..+.|...| |+..+.....++++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vY--YFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVY--YFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCcee--eeccccchhhhhhh
Confidence 58889999999999999999 5589999999654332 223455666666655 467888765 44556677777888
Q ss_pred ccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEee-----CCCeEEEEEEEee
Q 010856 440 HSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL-----EPGVEVICFVFEI 496 (499)
Q Consensus 440 ~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~-----~~~~~~~~f~~~~ 496 (499)
.++-++.+.... ....+.-+|.|+..-++|+|+ ++||.|||+-. ..-+-+||||++.
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 887665443321 122234446899999999998 89999999943 2456789999874
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.2e-11 Score=118.29 Aligned_cols=126 Identities=28% Similarity=0.292 Sum_probs=60.9
Q ss_pred ccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCC
Q 010856 105 LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN 184 (499)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 184 (499)
|.+.+.++|.+. ....++.-++.|+.|+|++|+++++. .+..+++|++|||++|.++.+....-..+. |+.|.+++|
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN 242 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNN 242 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhh-heeeeeccc
Confidence 444455555554 33344444455555555555555544 444555555555555555532222222222 555555555
Q ss_pred cccccCcccccCCcCCceeeCcCCcCCCC-CCccccCCCCCCEEeCCCCcCC
Q 010856 185 NFSGVIPTEIGGLKNLEYLFLGYNRLQGS-IPDSFGDLISLKFLNLSNNNLS 235 (499)
Q Consensus 185 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~l~~N~l~ 235 (499)
.++.. ..+.++.+|+.||+++|-|.+- ....++.+..|+.|+|.+|++-
T Consensus 243 ~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 243 ALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 55433 3344555555555555555431 1122334445555555555553
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.9e-08 Score=99.92 Aligned_cols=135 Identities=15% Similarity=0.100 Sum_probs=84.7
Q ss_pred hhcccccccccCCcceEEEEEeCC-CCEEEEEEeeccCCc--------------------------c--------HH---
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGD-RMEVAVKVFNLQCGR--------------------------A--------FE--- 402 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~~--- 402 (499)
.+|+. +.+|+|++|+||+|++++ |+.||||++++.... + .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999876 999999999754210 0 11
Q ss_pred ---HHHHHHHHHhcC----CCCCccccceeEEccccceeeeeecccCCCccccc---cccccccccc--------ccccc
Q 010856 403 ---SFDVECEMMKNI----RHRNLIKILHGVAVITFTVCLCLFHHSSASASASL---VSSLTLSRPA--------KGGGF 464 (499)
Q Consensus 403 ---~~~~E~~il~~l----~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~~~l---~~~~~~~~~~--------~~~i~ 464 (499)
++.+|++.+.++ .+...+.+-.+|.+.. ...++++|++.|.....+ ...+.....+ ..|+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 134455444433 2444444444554432 234567888877654332 1111111111 24444
Q ss_pred ccceeeccCCCcccEEEeeCC----CeEEEEEEEeecc
Q 010856 465 RGCVLWHVGVDFAAFVFVLEP----GVEVICFVFEILL 498 (499)
Q Consensus 465 ~gl~yLH~~~~p~~~l~~~~~----~~~~~~f~~~~~~ 498 (499)
+ -.+.|.|.+|.|+++..++ .++++|||+...+
T Consensus 278 ~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 3 5689999999999998777 8999999997654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.4e-09 Score=93.73 Aligned_cols=221 Identities=20% Similarity=0.176 Sum_probs=135.8
Q ss_pred ccEEEcccCCCcccCC-ccc-cCCCCCCEEeccCCcCCc--cCCccccCCCCCCeEecccccccccCCccccCcccccEE
Q 010856 33 LEDFRMYNCNISGGIP-EEI-SNLTNSTIVNLGGNKLNG--SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108 (499)
Q Consensus 33 L~~L~l~~n~i~~~~~-~~~-~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 108 (499)
++-|.+.++.|..+.. +.| ...+.+++|||.+|.|+. .+...+.++|.|+.|+|+.|++...+-..-..+.+|++|
T Consensus 47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~l 126 (418)
T KOG2982|consen 47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVL 126 (418)
T ss_pred hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEE
Confidence 4466667776653321 122 235678888888888874 223345788888999999888875443222466788888
Q ss_pred eeecCCCCCcC-CccccCCccCCeeeccccCCCCC--C-ccccCC-CCCcEEEcCCCcCCC--CCcccccCCCCccEEEc
Q 010856 109 DLDGNKLSGSL-PACFSNLTSLRIVSLGSNKLTSV--P-LTFWNL-KDILNLNFSSNFLTS--PLPLEIGNLKVLIGIDF 181 (499)
Q Consensus 109 ~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~--~-~~~~~l-~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l 181 (499)
-|.+..+.-.. ...+..+|.++.|.++.|++..+ . ...... +.+++|+...|.... ..-..-...+++..+.+
T Consensus 127 VLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v 206 (418)
T KOG2982|consen 127 VLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFV 206 (418)
T ss_pred EEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheee
Confidence 88888776322 23456778888888888865542 1 112221 245555555442210 00001122456677777
Q ss_pred cCCcccccC-cccccCCcCCceeeCcCCcCCCC-CCccccCCCCCCEEeCCCCcCCccCc------ccccCCCCCCEEEc
Q 010856 182 SMNNFSGVI-PTEIGGLKNLEYLFLGYNRLQGS-IPDSFGDLISLKFLNLSNNNLSGAIP------ASLEKLSYLENLNL 253 (499)
Q Consensus 182 ~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~l~~N~l~~~~~------~~~~~l~~L~~L~l 253 (499)
..|.+.... ...+..++.+.-|+|+.|+|.+. ..+.+.+++.|..|.+++|++.+... -.++.+++++.|+=
T Consensus 207 ~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLNG 286 (418)
T KOG2982|consen 207 CEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVLNG 286 (418)
T ss_pred ecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEecC
Confidence 778765432 24456677778899999988753 23568888999999999998864332 12456677777653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.9e-08 Score=97.91 Aligned_cols=131 Identities=12% Similarity=0.043 Sum_probs=81.5
Q ss_pred cccccCCcceEEEEEeCCCCEEEEEEeeccCCccH----------------------------------------HHHHH
Q 010856 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAF----------------------------------------ESFDV 406 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 406 (499)
+.+|+|++|+||+|++++|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865421000 02445
Q ss_pred HHHHHhcC----CCCCccccceeEEccccceeeeeecccCCCccccccccc--c-cccccccc-------ccccceeecc
Q 010856 407 ECEMMKNI----RHRNLIKILHGVAVITFTVCLCLFHHSSASASASLVSSL--T-LSRPAKGG-------GFRGCVLWHV 472 (499)
Q Consensus 407 E~~il~~l----~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~--~-~~~~~~~~-------i~~gl~yLH~ 472 (499)
|++.+.++ .|.+-+.+-.+|..... ..++++||+.|.......... . ....++.+ -+..-.++|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~-~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~ 281 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTS-ERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHA 281 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcC-CceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeC
Confidence 55554443 23333443444433222 245678888776544332110 0 11112211 1223457899
Q ss_pred CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 473 GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 473 ~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+.+|.|+++..++.++++|||+...+
T Consensus 282 D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 282 DLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CCCcccEEECCCCcEEEEeCCCeeEC
Confidence 99999999998999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.57 E-value=9.2e-09 Score=92.71 Aligned_cols=207 Identities=20% Similarity=0.186 Sum_probs=124.1
Q ss_pred CCCCCEEeccCCcCCccCC-ccc-cCCCCCCeEecccccccc--cCCccccCcccccEEeeecCCCCCcCCccccCCccC
Q 010856 54 LTNSTIVNLGGNKLNGSIP-ITL-SKLQKLQGLGLEDNKLEG--SIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSL 129 (499)
Q Consensus 54 l~~L~~L~L~~n~l~~~~~-~~~-~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 129 (499)
...++.|.+.++.|..... ..| ...+.+++|||.+|.|+. .+...+.++|.|+.|+|+.|++...+...-..+.+|
T Consensus 44 ~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl 123 (418)
T KOG2982|consen 44 LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNL 123 (418)
T ss_pred ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccce
Confidence 3345566666666653322 112 346788999999999873 222346788999999999999885443322456788
Q ss_pred CeeeccccCCCC--CCccccCCCCCcEEEcCCCcCCCCC--cccccC-CCCccEEEccCCccccc--CcccccCCcCCce
Q 010856 130 RIVSLGSNKLTS--VPLTFWNLKDILNLNFSSNFLTSPL--PLEIGN-LKVLIGIDFSMNNFSGV--IPTEIGGLKNLEY 202 (499)
Q Consensus 130 ~~L~L~~n~l~~--~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~-l~~L~~L~l~~n~l~~~--~~~~l~~l~~L~~ 202 (499)
+.|-|.+..+.- ....+..+|.+++|+++.|.+.-.. ...... -+.+.+|.+..|....- .-..-.-+|++..
T Consensus 124 ~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~s 203 (418)
T KOG2982|consen 124 RVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNS 203 (418)
T ss_pred EEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchh
Confidence 888888876653 5556677888888888888544211 111111 12445555544432200 0001123567777
Q ss_pred eeCcCCcCCCCC-CccccCCCCCCEEeCCCCcCCccC-cccccCCCCCCEEEccCCcCcc
Q 010856 203 LFLGYNRLQGSI-PDSFGDLISLKFLNLSNNNLSGAI-PASLEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 203 L~L~~n~l~~~~-~~~l~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~ 260 (499)
+.+..|.+.... ...+..+|.+..|+|+.|+|.+.. -+.+.+++.|..|.+++|++..
T Consensus 204 v~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 204 VFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred eeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 777777665432 234556666777777777776322 2456667777777777777663
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.8e-08 Score=94.20 Aligned_cols=142 Identities=15% Similarity=0.107 Sum_probs=96.9
Q ss_pred HHHHHhhhcccccccccCCcceEEEEEeCC------CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEE
Q 010856 355 ELFRATDEFSENNLIGKGGFGSVYKARLGD------RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVA 427 (499)
Q Consensus 355 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~ 427 (499)
++......+.....+-+|.||.||+|.+++ .+.|-+|.++... .-+...+..|.-.+..+.|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 344444557777889999999999997643 2345567665543 345677899999999999999999999987
Q ss_pred ccccceeeeeecccC-CCcccccccc----cccc--------ccccccccccceeecc------CCCcccEEEeeCCCeE
Q 010856 428 VITFTVCLCLFHHSS-ASASASLVSS----LTLS--------RPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVE 488 (499)
Q Consensus 428 ~~~~~~~~~l~~~~~-~~~~~~l~~~----~~~~--------~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~ 488 (499)
+ ++..-++++.+++ |.+..++..- .... -.+|.|++.|++|||+ ++-.-|-+.++--+|+
T Consensus 358 e-~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 358 E-DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred e-ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 6 3444455777765 4444444311 1111 1225899999999998 3444666777777888
Q ss_pred EEEEEEeec
Q 010856 489 VICFVFEIL 497 (499)
Q Consensus 489 ~~~f~~~~~ 497 (499)
++|=-++|-
T Consensus 437 ltDsaLSRD 445 (563)
T KOG1024|consen 437 LTDSALSRD 445 (563)
T ss_pred eccchhccc
Confidence 888766653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.5e-08 Score=93.03 Aligned_cols=131 Identities=18% Similarity=0.174 Sum_probs=94.8
Q ss_pred cccccccccCCcceEEEEEeCCCCEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCC-CccccceeEEccccceeeeee
Q 010856 363 FSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR---AFESFDVECEMMKNIRHR-NLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~H~-niv~l~~~~~~~~~~~~~~l~ 438 (499)
|.....+|.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +|+++.+++.... ....+.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG--SLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--EEEEEE
Confidence 566788999999999999975 78899999765422 367899999999999988 7999998884422 234455
Q ss_pred cccCCCcccc-ccccc---c----ccccccccccccceeec------cCCCcccEEEeeCC-CeEEEEEEEeec
Q 010856 439 HHSSASASAS-LVSSL---T----LSRPAKGGGFRGCVLWH------VGVDFAAFVFVLEP-GVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~-l~~~~---~----~~~~~~~~i~~gl~yLH------~~~~p~~~l~~~~~-~~~~~~f~~~~~ 497 (499)
+++.+..... ..... . ....+..|++.|++|+| +++||.|+++...+ .++++|||++..
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 6655443332 22111 1 12233477778777665 48999999999888 699999998764
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-09 Score=98.27 Aligned_cols=173 Identities=21% Similarity=0.199 Sum_probs=82.3
Q ss_pred CCeEeccccccccc-CCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccC-CCC--CCccccCCCCCcEEE
Q 010856 81 LQGLGLEDNKLEGS-IPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNK-LTS--VPLTFWNLKDILNLN 156 (499)
Q Consensus 81 L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~--~~~~~~~l~~L~~L~ 156 (499)
|++|||++..|+.. .-..+..+.+|+.|.|.++++.+.+...++.-.+|+.|+++.+. +++ +.-.+.+++.|..|+
T Consensus 187 lq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LN 266 (419)
T KOG2120|consen 187 LQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELN 266 (419)
T ss_pred hHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcC
Confidence 55556655555421 11223445556666666666655555555555566666665542 332 222344556666666
Q ss_pred cCCCcCCCCCccc-ccC-CCCccEEEccCCccc--c-cCcccccCCcCCceeeCcCCc-CCCCCCccccCCCCCCEEeCC
Q 010856 157 FSSNFLTSPLPLE-IGN-LKVLIGIDFSMNNFS--G-VIPTEIGGLKNLEYLFLGYNR-LQGSIPDSFGDLISLKFLNLS 230 (499)
Q Consensus 157 l~~n~l~~~~~~~-~~~-l~~L~~L~l~~n~l~--~-~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~l~ 230 (499)
++++.+....... ..+ -++|+.|+++++.=. . ....--..+|+|.+|||++|. ++......|.+++.|++|.++
T Consensus 267 lsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSls 346 (419)
T KOG2120|consen 267 LSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLS 346 (419)
T ss_pred chHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehh
Confidence 6666544321111 111 134555555554311 0 011112345666666666653 333333345555666666666
Q ss_pred CCcCCccCcc---cccCCCCCCEEEccC
Q 010856 231 NNNLSGAIPA---SLEKLSYLENLNLSF 255 (499)
Q Consensus 231 ~N~l~~~~~~---~~~~l~~L~~L~l~~ 255 (499)
.|.. ++|+ .+...|+|.+||+-+
T Consensus 347 RCY~--i~p~~~~~l~s~psl~yLdv~g 372 (419)
T KOG2120|consen 347 RCYD--IIPETLLELNSKPSLVYLDVFG 372 (419)
T ss_pred hhcC--CChHHeeeeccCcceEEEEecc
Confidence 6543 2332 234456666666554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.3e-09 Score=83.99 Aligned_cols=111 Identities=18% Similarity=0.284 Sum_probs=70.6
Q ss_pred cccEEEcccCCCcccCCcccc---CCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEE
Q 010856 32 SLEDFRMYNCNISGGIPEEIS---NLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 108 (499)
.+..++|++|++. .++++.. ....|+..+|++|.+....+..-..++.++.|+|++|.|+ ..|..+..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 4556777777765 3344433 3345556677777777433333344557777777777777 445557777777777
Q ss_pred eeecCCCCCcCCccccCCccCCeeeccccCCCCCCcc
Q 010856 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT 145 (499)
Q Consensus 109 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 145 (499)
+++.|.+. ..|..+..+.+|-.|+..+|.+..+|..
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~d 141 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVD 141 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHH
Confidence 77777777 4555555577777777777777666644
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.7e-09 Score=97.37 Aligned_cols=221 Identities=22% Similarity=0.243 Sum_probs=136.2
Q ss_pred CCEEECcCCCCCccCChhccccc-cccccEEEcccCCCccc-CCccccCC-CCCCEEeccCCcCCcc-CCccccCCCCCC
Q 010856 7 LTLIYLSNNPLDGILPKTSVGNL-SHSLEDFRMYNCNISGG-IPEEISNL-TNSTIVNLGGNKLNGS-IPITLSKLQKLQ 82 (499)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~~l-~~~L~~L~l~~n~i~~~-~~~~~~~l-~~L~~L~L~~n~l~~~-~~~~~~~l~~L~ 82 (499)
-+.||+.+-+|. |+ .++.+ ......+.+...-+... ..+.+.-. +.|++|||+...|+.. ....++.+.+|+
T Consensus 138 W~~lDl~~r~i~---p~-~l~~l~~rgV~v~Rlar~~~~~prlae~~~~frsRlq~lDLS~s~it~stl~~iLs~C~kLk 213 (419)
T KOG2120|consen 138 WQTLDLTGRNIH---PD-VLGRLLSRGVIVFRLARSFMDQPRLAEHFSPFRSRLQHLDLSNSVITVSTLHGILSQCSKLK 213 (419)
T ss_pred eeeeccCCCccC---hh-HHHHHHhCCeEEEEcchhhhcCchhhhhhhhhhhhhHHhhcchhheeHHHHHHHHHHHHhhh
Confidence 356777766654 32 22222 22455555554333321 11112211 3588888888877632 223467788888
Q ss_pred eEecccccccccCCccccCcccccEEeeecCC-CCCc-CCccccCCccCCeeeccccCCCC--CCccccC-CCCCcEEEc
Q 010856 83 GLGLEDNKLEGSIPDDICHLAELYRLDLDGNK-LSGS-LPACFSNLTSLRIVSLGSNKLTS--VPLTFWN-LKDILNLNF 157 (499)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~-~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~-l~~L~~L~l 157 (499)
.|.|.++++.+.+...++...+|+.|+|+.+. ++.. ..-.+.+++.|..|+++.|.++. +...+.. -++|+.|++
T Consensus 214 ~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNl 293 (419)
T KOG2120|consen 214 NLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVAVAHISETLTQLNL 293 (419)
T ss_pred hccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHHHhhhchhhhhhhh
Confidence 88888888887777778888888888888764 3311 11235677888888888887764 2211111 257788888
Q ss_pred CCCcCC---CCCcccccCCCCccEEEccCCc-ccccCcccccCCcCCceeeCcCCcCCCCCCc---cccCCCCCCEEeCC
Q 010856 158 SSNFLT---SPLPLEIGNLKVLIGIDFSMNN-FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD---SFGDLISLKFLNLS 230 (499)
Q Consensus 158 ~~n~l~---~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~---~l~~l~~L~~L~l~ 230 (499)
++.+-. +.+..-...+++|..||||+|. ++......|-.++-|++|.++.|.. ++|. .+...|+|.+||+-
T Consensus 294 sG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~ 371 (419)
T KOG2120|consen 294 SGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVF 371 (419)
T ss_pred hhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEec
Confidence 876321 1122223567888899998875 3333334556788899999988864 3444 35777899999987
Q ss_pred CCc
Q 010856 231 NNN 233 (499)
Q Consensus 231 ~N~ 233 (499)
++-
T Consensus 372 g~v 374 (419)
T KOG2120|consen 372 GCV 374 (419)
T ss_pred ccc
Confidence 763
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.6e-09 Score=82.26 Aligned_cols=60 Identities=27% Similarity=0.335 Sum_probs=27.3
Q ss_pred cCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCc
Q 010856 198 KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 198 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
+.++.|+|++|+|+ .+|..+..++.|+.|+++.|++. ..|..+..+.++..|+..+|.+.
T Consensus 77 ~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 77 PTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred chhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 34444444444444 23333444444555555555444 33333333444444554444443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.43 E-value=9.4e-08 Score=92.54 Aligned_cols=134 Identities=16% Similarity=0.148 Sum_probs=87.6
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCC------CCccccceeEEcccc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRH------RNLIKILHGVAVITF 431 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H------~niv~l~~~~~~~~~ 431 (499)
--..|......|+|-|++|.+|.. ..|+.||||++.... -..+.=.+|++||+++.. -++++++..|.-.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk-- 506 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK-- 506 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc--
Confidence 345688888899999999999995 458899999997543 122344689999998852 3667776544321
Q ss_pred ceeeeeecccCCCccccccccc-------ccccccccc------ccccceeeccCCCcccEEEee-CCCeEEEEEEEe
Q 010856 432 TVCLCLFHHSSASASASLVSSL-------TLSRPAKGG------GFRGCVLWHVGVDFAAFVFVL-EPGVEVICFVFE 495 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~~-------~~~~~~~~~------i~~gl~yLH~~~~p~~~l~~~-~~~~~~~~f~~~ 495 (499)
.+.-+++|-+.-.+.+.+...+ ..++.++.| ++.-...||.++||.||||+. ..-.++||||-+
T Consensus 507 nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 1223345544444333322211 112333334 445556899999999999974 578899999965
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.7e-08 Score=88.60 Aligned_cols=186 Identities=20% Similarity=0.175 Sum_probs=102.0
Q ss_pred ccCCCCCCeEecccccccccCCcc----ccCcccccEEeeecCCCCCcCCc-------------cccCCccCCeeecccc
Q 010856 75 LSKLQKLQGLGLEDNKLEGSIPDD----ICHLAELYRLDLDGNKLSGSLPA-------------CFSNLTSLRIVSLGSN 137 (499)
Q Consensus 75 ~~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~L~L~~n 137 (499)
+.+||+|+..+||+|-+....|.. +++-+.|+.|.+++|.+...... -..+-|.|+......|
T Consensus 88 Llkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrN 167 (388)
T COG5238 88 LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRN 167 (388)
T ss_pred HhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccc
Confidence 345556666666666554443332 33445566666666655422111 1123356777777777
Q ss_pred CCCCCCcc-----ccCCCCCcEEEcCCCcCCCCC-----cccccCCCCccEEEccCCcccccC----cccccCCcCCcee
Q 010856 138 KLTSVPLT-----FWNLKDILNLNFSSNFLTSPL-----PLEIGNLKVLIGIDFSMNNFSGVI----PTEIGGLKNLEYL 203 (499)
Q Consensus 138 ~l~~~~~~-----~~~l~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~l~~n~l~~~~----~~~l~~l~~L~~L 203 (499)
++...+.. +..-..|+.+.+..|.|.... ...+..+.+|+.||+..|-++... ...+...+.|++|
T Consensus 168 Rlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL 247 (388)
T COG5238 168 RLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLREL 247 (388)
T ss_pred hhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhc
Confidence 76664432 222346677777777665321 112234567777777777665332 2233455667777
Q ss_pred eCcCCcCCCCCCccc------cCCCCCCEEeCCCCcCCccCccc-------ccCCCCCCEEEccCCcCcc
Q 010856 204 FLGYNRLQGSIPDSF------GDLISLKFLNLSNNNLSGAIPAS-------LEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 204 ~L~~n~l~~~~~~~l------~~l~~L~~L~l~~N~l~~~~~~~-------~~~l~~L~~L~l~~N~l~~ 260 (499)
.+.+|-++......+ ...|+|..|...+|.+.+..-.. -..+|-|..|.+.+|++..
T Consensus 248 ~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E 317 (388)
T COG5238 248 RLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKE 317 (388)
T ss_pred cccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchh
Confidence 777777664433322 22467777777777665322111 1346777888888888873
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.9e-07 Score=77.89 Aligned_cols=121 Identities=9% Similarity=-0.057 Sum_probs=78.3
Q ss_pred cccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccCCCcc
Q 010856 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSSASAS 446 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~ 446 (499)
+.++.|.++.||+++.. +..|++|....... ....+.+|+++++.+.+.++++-.-++.. ...+.+++++.|...
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~---~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP---ETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC---CCCeEEEEecCCCcc
Confidence 56899999999999874 67899998754432 12346789999998876665543322221 123568888887654
Q ss_pred ccccccccccccccccccccce-----------eeccCCCcccEEEeeCCCeEEEEEEEee
Q 010856 447 ASLVSSLTLSRPAKGGGFRGCV-----------LWHVGVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 447 ~~l~~~~~~~~~~~~~i~~gl~-----------yLH~~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
..... .......+++++++ ++|.|.+|.|++++ ++++.++||+.+.
T Consensus 79 ~~~~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTEDF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 42210 11111122332222 47888999999998 7789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.7e-07 Score=76.19 Aligned_cols=102 Identities=23% Similarity=0.207 Sum_probs=54.6
Q ss_pred CCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCC-CccccCCCCCCEEeC
Q 010856 151 DILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI-PDSFGDLISLKFLNL 229 (499)
Q Consensus 151 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~l 229 (499)
....+||++|.+.. ...|..++.|.+|.+++|+|+.+.|.--.-+++|..|.|.+|.|.... .+.+..+|+|++|.+
T Consensus 43 ~~d~iDLtdNdl~~--l~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltl 120 (233)
T KOG1644|consen 43 QFDAIDLTDNDLRK--LDNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTL 120 (233)
T ss_pred ccceecccccchhh--cccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeee
Confidence 34455555555542 234555566666666666666555544444556666666666655321 233455566666666
Q ss_pred CCCcCCccCc---ccccCCCCCCEEEcc
Q 010856 230 SNNNLSGAIP---ASLEKLSYLENLNLS 254 (499)
Q Consensus 230 ~~N~l~~~~~---~~~~~l~~L~~L~l~ 254 (499)
-+|+++...- ..+..+|+|+.||.+
T Consensus 121 l~Npv~~k~~YR~yvl~klp~l~~LDF~ 148 (233)
T KOG1644|consen 121 LGNPVEHKKNYRLYVLYKLPSLRTLDFQ 148 (233)
T ss_pred cCCchhcccCceeEEEEecCcceEeehh
Confidence 6666553211 234455666666654
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.4e-07 Score=76.68 Aligned_cols=103 Identities=21% Similarity=0.249 Sum_probs=58.3
Q ss_pred CEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecccc
Q 010856 58 TIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSN 137 (499)
Q Consensus 58 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 137 (499)
+.++|.+.++..+.. .=.-+.+...+||++|.+... +.|..++.|.+|.|++|+|+.+.|..-.-+++|+.|.|.+|
T Consensus 22 ~e~~LR~lkip~ien-lg~~~d~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnN 98 (233)
T KOG1644|consen 22 RELDLRGLKIPVIEN-LGATLDQFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNN 98 (233)
T ss_pred cccccccccccchhh-ccccccccceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecCc
Confidence 455566555542211 001223456677777776533 45666777777777777777665554455566777777777
Q ss_pred CCCCCCc--cccCCCCCcEEEcCCCcCC
Q 010856 138 KLTSVPL--TFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 138 ~l~~~~~--~~~~l~~L~~L~l~~n~l~ 163 (499)
+|..+.+ .+..+|+|++|.+-+|.++
T Consensus 99 si~~l~dl~pLa~~p~L~~Ltll~Npv~ 126 (233)
T KOG1644|consen 99 SIQELGDLDPLASCPKLEYLTLLGNPVE 126 (233)
T ss_pred chhhhhhcchhccCCccceeeecCCchh
Confidence 6665422 3445556666665555554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.8e-07 Score=98.11 Aligned_cols=132 Identities=20% Similarity=0.209 Sum_probs=78.8
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC---CCCccccceeE-------Ecc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR---HRNLIKILHGV-------AVI 429 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---H~niv~l~~~~-------~~~ 429 (499)
-..|.+.+.+|+|+||+||+|...+|+.||+|+=++..... |.---+++.+++ -+.|+.+..++ ...
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 35677888999999999999998779999999887655321 111112333333 12233333222 223
Q ss_pred ccceeeeeecccCCCccccccccccccccccccc------cccceeeccCCCcccEEEee-------CCCeEEEEEEEee
Q 010856 430 TFTVCLCLFHHSSASASASLVSSLTLSRPAKGGG------FRGCVLWHVGVDFAAFVFVL-------EPGVEVICFVFEI 496 (499)
Q Consensus 430 ~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~~~~i------~~gl~yLH~~~~p~~~l~~~-------~~~~~~~~f~~~~ 496 (499)
+|..+|.|.+++.+.. ..++.+...++.|+ +++...+|-|+||.|+|+.+ ..+.++||||-+|
T Consensus 774 ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 4444555555444221 11222222223343 45666677799999998843 2489999999887
Q ss_pred cc
Q 010856 497 LL 498 (499)
Q Consensus 497 ~~ 498 (499)
-+
T Consensus 850 Dm 851 (974)
T KOG1166|consen 850 DM 851 (974)
T ss_pred ee
Confidence 43
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.6e-06 Score=84.09 Aligned_cols=32 Identities=16% Similarity=0.241 Sum_probs=16.0
Q ss_pred CCCcEEEcCCCcCCCCCcccccCCCCccEEEccCC
Q 010856 150 KDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN 184 (499)
Q Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 184 (499)
++|++|++++|.... .|..+. .+|+.|+++.+
T Consensus 156 sSLk~L~Is~c~~i~-LP~~LP--~SLk~L~ls~n 187 (426)
T PRK15386 156 PSLKTLSLTGCSNII-LPEKLP--ESLQSITLHIE 187 (426)
T ss_pred CcccEEEecCCCccc-Cccccc--ccCcEEEeccc
Confidence 456666666555432 222222 45666666554
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.6e-08 Score=86.66 Aligned_cols=230 Identities=17% Similarity=0.147 Sum_probs=151.7
Q ss_pred cCCCCCCEEeccCCcCCccCC----ccccCCCCCCeEeccccccc---cc-------CCccccCcccccEEeeecCCCCC
Q 010856 52 SNLTNSTIVNLGGNKLNGSIP----ITLSKLQKLQGLGLEDNKLE---GS-------IPDDICHLAELYRLDLDGNKLSG 117 (499)
Q Consensus 52 ~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~---~~-------~~~~~~~l~~L~~L~L~~n~l~~ 117 (499)
..+..++.++||+|.|..... ..+.+-.+|+..++++-... .. +...+.++++|+..+||+|.+..
T Consensus 27 ~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~ 106 (388)
T COG5238 27 EMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGS 106 (388)
T ss_pred HhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCc
Confidence 345677777777777764322 23445566777766653211 11 22346678999999999999886
Q ss_pred cCCcc----ccCCccCCeeeccccCCCCCCc--------------cccCCCCCcEEEcCCCcCCCCCc----ccccCCCC
Q 010856 118 SLPAC----FSNLTSLRIVSLGSNKLTSVPL--------------TFWNLKDILNLNFSSNFLTSPLP----LEIGNLKV 175 (499)
Q Consensus 118 ~~~~~----~~~l~~L~~L~L~~n~l~~~~~--------------~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~ 175 (499)
..|.. +++-+.|++|.|++|.+.-+.. ...+-|.|+......|++..-.. ..+..-..
T Consensus 107 ~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~ 186 (388)
T COG5238 107 EFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHEN 186 (388)
T ss_pred ccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcC
Confidence 65543 4566889999999998765321 23456889999999999864211 22333468
Q ss_pred ccEEEccCCcccccCc-----ccccCCcCCceeeCcCCcCCCC----CCccccCCCCCCEEeCCCCcCCccCcccc----
Q 010856 176 LIGIDFSMNNFSGVIP-----TEIGGLKNLEYLFLGYNRLQGS----IPDSFGDLISLKFLNLSNNNLSGAIPASL---- 242 (499)
Q Consensus 176 L~~L~l~~n~l~~~~~-----~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~~~~~~---- 242 (499)
|+.+.+..|.|..... ..+..+.+|+.|||.+|-++-. ....+...+.|+.|.+.+|-++.....++
T Consensus 187 lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f 266 (388)
T COG5238 187 LKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRF 266 (388)
T ss_pred ceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHh
Confidence 8999999998863311 2235678999999999988743 23445667889999999998875443322
Q ss_pred --cCCCCCCEEEccCCcCcccCCCC--------CCCCCccccccCCCcC
Q 010856 243 --EKLSYLENLNLSFNKLEGEIPRG--------GSFGNFSAESFEGNEL 281 (499)
Q Consensus 243 --~~l~~L~~L~l~~N~l~~~~~~~--------~~~~~l~~~~l~~N~~ 281 (499)
...|+|..|-..+|...+.+-.. ..+|.+..+...||..
T Consensus 267 ~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~ 315 (388)
T COG5238 267 NEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRI 315 (388)
T ss_pred hhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcc
Confidence 23588899999999887643222 2344555566677764
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.2e-06 Score=80.54 Aligned_cols=32 Identities=22% Similarity=0.169 Sum_probs=15.6
Q ss_pred cCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCC
Q 010856 198 KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNN 232 (499)
Q Consensus 198 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N 232 (499)
++|++|++++|... ..|..+. .+|+.|+++.|
T Consensus 156 sSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls~n 187 (426)
T PRK15386 156 PSLKTLSLTGCSNI-ILPEKLP--ESLQSITLHIE 187 (426)
T ss_pred CcccEEEecCCCcc-cCccccc--ccCcEEEeccc
Confidence 35556666555543 2232222 35666666554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.3e-07 Score=84.30 Aligned_cols=106 Identities=14% Similarity=0.175 Sum_probs=72.0
Q ss_pred ccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 364 SENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
....++.+...|+.|+|++. |..+++|++.-+. ....++|..|.--++-+.||||+.++|+|..+. ....+-.||
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp--nlv~isq~m 269 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP--NLVIISQYM 269 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC--CceEeeeec
Confidence 34456888899999999984 4466677775443 344578999999999999999999999996642 122233444
Q ss_pred C-CCccccccc------cccccccccccccccceeecc
Q 010856 442 S-ASASASLVS------SLTLSRPAKGGGFRGCVLWHV 472 (499)
Q Consensus 442 ~-~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~ 472 (499)
. |+++..++. +....-+.|+.+|+|++|||+
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhs 307 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS 307 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh
Confidence 3 222222322 122333446899999999999
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.3e-06 Score=55.35 Aligned_cols=36 Identities=31% Similarity=0.502 Sum_probs=16.2
Q ss_pred cCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCC
Q 010856 128 SLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 128 ~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~ 163 (499)
+|++|++++|+|+++|..+..+++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 344444444444444444444444444444444444
|
... |
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.2e-05 Score=66.35 Aligned_cols=85 Identities=16% Similarity=0.204 Sum_probs=32.8
Q ss_pred ccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCcc
Q 010856 49 EEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTS 128 (499)
Q Consensus 49 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 128 (499)
.+|.++++|+.+.+.. .+..+....|.++++|+.+.+..+ +.......|.++++|+.+.+.+ .+.......|..+++
T Consensus 6 ~~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~ 82 (129)
T PF13306_consen 6 NAFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTN 82 (129)
T ss_dssp TTTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TT
T ss_pred HHHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-ccccccccccccccc
Confidence 3445555555555543 344344444555555555555443 3333334444544455555533 333233344444555
Q ss_pred CCeeeccc
Q 010856 129 LRIVSLGS 136 (499)
Q Consensus 129 L~~L~L~~ 136 (499)
|+.+.+..
T Consensus 83 l~~i~~~~ 90 (129)
T PF13306_consen 83 LKNIDIPS 90 (129)
T ss_dssp ECEEEETT
T ss_pred ccccccCc
Confidence 55555543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.9e-06 Score=53.85 Aligned_cols=36 Identities=31% Similarity=0.615 Sum_probs=16.3
Q ss_pred CCCeEecccccccccCCccccCcccccEEeeecCCCC
Q 010856 80 KLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLS 116 (499)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 116 (499)
+|++|++++|+|+. +|..+.++++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCC
Confidence 44555555555552 2223445555555555555544
|
... |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.3e-06 Score=90.64 Aligned_cols=133 Identities=18% Similarity=0.147 Sum_probs=86.1
Q ss_pred ccccccccCCcceEEEEEe-CCCCEEEEEEee----ccC-Cc-cHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 364 SENNLIGKGGFGSVYKARL-GDRMEVAVKVFN----LQC-GR-AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~----~~~-~~-~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
....++|.|++|.|+.... .....++.|... ... .. ....+..|..+-..+.|||++..+..+...... ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~--~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI--LQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc--hh
Confidence 3467899999997777763 334444555432 111 11 112266788888899999998777655442211 11
Q ss_pred eecccCCCcccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHSSASASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.+||+.++++..+..... .+.....|+.+|+.|+|+ ++||+|.+++.++.++++|||.+.|.
T Consensus 399 ~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 399 SMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence 255554444443322211 122334789999999988 78999999999999999999998874
|
|
| >PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A | Back alignment and domain information |
|---|
Probab=97.96 E-value=2e-05 Score=65.09 Aligned_cols=121 Identities=21% Similarity=0.265 Sum_probs=65.4
Q ss_pred ccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCccc
Q 010856 25 SVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAE 104 (499)
Q Consensus 25 ~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 104 (499)
.+.... +|+.+.+.. .+..+...+|.++++|+.+.+.++ +..+....|.++++|+.+.+.+ .+.......|...++
T Consensus 7 ~F~~~~-~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~ 82 (129)
T PF13306_consen 7 AFYNCS-NLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTN 82 (129)
T ss_dssp TTTT-T-T--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TT
T ss_pred HHhCCC-CCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-ccccccccccccccc
Confidence 555555 688888774 566677777888888888888775 6666667788887788888865 444455567777888
Q ss_pred ccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCC-ccccCCCCC
Q 010856 105 LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDI 152 (499)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~l~~L 152 (499)
|+.+++..+ +..+....|.++ +|+.+.+.. .+..++ ..|.++++|
T Consensus 83 l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 83 LKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp ECEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred ccccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 888888665 555666677776 888887775 444443 345555555
|
|
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=3.9e-06 Score=88.26 Aligned_cols=108 Identities=15% Similarity=0.207 Sum_probs=48.4
Q ss_pred CCCCCEEeccCCcCCcc-CCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCC-cCCccccCCccCCe
Q 010856 54 LTNSTIVNLGGNKLNGS-IPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG-SLPACFSNLTSLRI 131 (499)
Q Consensus 54 l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~ 131 (499)
+|.|+.|.+++=.+... ......++++|..||+|+.+++.. .+++.+++|+.|.+.+=.+.. ..-..+.++++|+.
T Consensus 147 LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~~~~l~~LF~L~~L~v 224 (699)
T KOG3665|consen 147 LPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFESYQDLIDLFNLKKLRV 224 (699)
T ss_pred CcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCchhhHHHHhcccCCCe
Confidence 45555555554333211 112233455555555555555433 344555555555554443331 00112334555555
Q ss_pred eeccccCCCCCCc-------cccCCCCCcEEEcCCCcCC
Q 010856 132 VSLGSNKLTSVPL-------TFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 132 L~L~~n~l~~~~~-------~~~~l~~L~~L~l~~n~l~ 163 (499)
||+|.......+. .-..+|+|+.||.|++.+.
T Consensus 225 LDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~ 263 (699)
T KOG3665|consen 225 LDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDIN 263 (699)
T ss_pred eeccccccccchHHHHHHHHhcccCccccEEecCCcchh
Confidence 5555544433221 1223566666666655554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.74 E-value=4.4e-05 Score=69.61 Aligned_cols=79 Identities=8% Similarity=0.047 Sum_probs=53.4
Q ss_pred cccccCCcceEEEEEeCCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCC--CccccceeEEcccc-ceeeeeecccC
Q 010856 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHR--NLIKILHGVAVITF-TVCLCLFHHSS 442 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~--niv~l~~~~~~~~~-~~~~~l~~~~~ 442 (499)
+.++.|..+.+|+++..+|+.+++|....... ....++.+|.++++.+.+. .+.+++.+...... ...+.+++++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999986678899998765432 2345789999999998763 45666655433110 12245677776
Q ss_pred CCc
Q 010856 443 ASA 445 (499)
Q Consensus 443 ~~~ 445 (499)
|..
T Consensus 84 G~~ 86 (223)
T cd05154 84 GRV 86 (223)
T ss_pred CEe
Confidence 653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=97.71 E-value=5.6e-05 Score=66.70 Aligned_cols=125 Identities=14% Similarity=0.053 Sum_probs=76.1
Q ss_pred cccccCCcceEEEEEeCC-------CCEEEEEEeeccC------------C---------cc-HHHH----HHHHHHHhc
Q 010856 367 NLIGKGGFGSVYKARLGD-------RMEVAVKVFNLQC------------G---------RA-FESF----DVECEMMKN 413 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~------------~---------~~-~~~~----~~E~~il~~ 413 (499)
-.||.|.-+.||.|...+ +..+|||+.+... . .. .+.+ .+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4799999885321 0 00 1223 389999988
Q ss_pred CCC--CCccccceeEEccccceeeeeecccCCCccc--cccc---cccccccccccccccc-------eeeccCCCcccE
Q 010856 414 IRH--RNLIKILHGVAVITFTVCLCLFHHSSASASA--SLVS---SLTLSRPAKGGGFRGC-------VLWHVGVDFAAF 479 (499)
Q Consensus 414 l~H--~niv~l~~~~~~~~~~~~~~l~~~~~~~~~~--~l~~---~~~~~~~~~~~i~~gl-------~yLH~~~~p~~~ 479 (499)
+.- -++.+.+++ ....++||+++++... .+.. .......+..+++.+| ...|.|..|.|+
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 753 355555543 2345578888764211 1111 0001111122333333 467779999999
Q ss_pred EEeeCCCeEEEEEEEeecc
Q 010856 480 VFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 480 l~~~~~~~~~~~f~~~~~~ 498 (499)
++. ++++.+||||.++..
T Consensus 157 L~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEE-CCcEEEEECCCceeC
Confidence 995 678999999988753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=1.4e-05 Score=84.24 Aligned_cols=56 Identities=18% Similarity=0.238 Sum_probs=22.9
Q ss_pred CccCCeeeccccCCCC--CCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccC
Q 010856 126 LTSLRIVSLGSNKLTS--VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSM 183 (499)
Q Consensus 126 l~~L~~L~L~~n~l~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 183 (499)
+|+|+.|.+++-.+.. +..-..++|+|..||+|+.+++.. ..++++++|+.|.+.+
T Consensus 147 LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrn 204 (699)
T KOG3665|consen 147 LPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRN 204 (699)
T ss_pred CcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccC
Confidence 3444444444433322 122223344444444444444432 3334444444444433
|
|
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.61 E-value=2.1e-06 Score=77.12 Aligned_cols=98 Identities=20% Similarity=0.299 Sum_probs=52.2
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccC-CccccCcccccEEee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSI-PDDICHLAELYRLDL 110 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L 110 (499)
+.+.|++.+|.++++ .....++.|+.|.|+-|.|+...| |..+++|++|+|..|.|.+.. -..+.++++|+.|.|
T Consensus 20 ~vkKLNcwg~~L~DI--sic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~LWL 95 (388)
T KOG2123|consen 20 NVKKLNCWGCGLDDI--SICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTLWL 95 (388)
T ss_pred HhhhhcccCCCccHH--HHHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhHhh
Confidence 455566666666543 223455666666666666654332 555666666666666655331 123456666666666
Q ss_pred ecCCCCCcCCc-----cccCCccCCeee
Q 010856 111 DGNKLSGSLPA-----CFSNLTSLRIVS 133 (499)
Q Consensus 111 ~~n~l~~~~~~-----~~~~l~~L~~L~ 133 (499)
..|.-.+..+. .+.-+|+|+.||
T Consensus 96 ~ENPCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 96 DENPCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred ccCCcccccchhHHHHHHHHcccchhcc
Confidence 66665543322 233455555554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.61 E-value=4.7e-06 Score=83.26 Aligned_cols=128 Identities=15% Similarity=0.132 Sum_probs=88.0
Q ss_pred ccccCCcceEEEEEe----CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeeeeecc
Q 010856 368 LIGKGGFGSVYKARL----GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 368 ~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
++|+|.||.|+.++. ..|..||+|++++... +.......|..++...+ ||.+|++..++. .+......+.+.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq-t~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ-TDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec-cccchhHhhhhc
Confidence 479999999997762 3478899999976542 22335667888999887 999999875544 344444444455
Q ss_pred cCCCccccccccccccccc----cccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 441 SSASASASLVSSLTLSRPA----KGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 441 ~~~~~~~~l~~~~~~~~~~----~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
-+|+++..+.......... ...++-|++++|. +.||.||+++-+|-+++.|||.++
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglsk 145 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSK 145 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhh
Confidence 5556655544333222211 2455666666665 899999999888889999999875
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00021 Score=72.59 Aligned_cols=129 Identities=13% Similarity=0.041 Sum_probs=81.0
Q ss_pred cccccCCcceEEEEEeCCCCEEEEEEeeccCCcc------------------------------HH----------HHHH
Q 010856 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRA------------------------------FE----------SFDV 406 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 406 (499)
..++.++-|+||+|++++|+.||||+.+++-... .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999987532100 00 1234
Q ss_pred HHHHHhcC----CCCCccccceeEEccccceeeeeecccCCCcccccc---cccccccccc--------ccccccceeec
Q 010856 407 ECEMMKNI----RHRNLIKILHGVAVITFTVCLCLFHHSSASASASLV---SSLTLSRPAK--------GGGFRGCVLWH 471 (499)
Q Consensus 407 E~~il~~l----~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~---~~~~~~~~~~--------~~i~~gl~yLH 471 (499)
|.+-+.++ +..-=+++-.+|++.. ...++.+||+.|-....+. ........++ .|+.+ -.|.|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~-dgffH 288 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-DGFFH 288 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhcc-CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh-cCccc
Confidence 44433332 2222222333444321 2345578888887555432 1111112221 44444 67899
Q ss_pred cCCCcccEEEeeCCCeEEEEEEEeec
Q 010856 472 VGVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 472 ~~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.|.+|.|+++..++....+|||+-.-
T Consensus 289 aDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 289 ADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred cCCCccceEEecCCcEEEEcCcceec
Confidence 99999999999999999999998654
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=4.4e-05 Score=68.48 Aligned_cols=35 Identities=26% Similarity=0.393 Sum_probs=15.1
Q ss_pred CCccCCeeeccccCCCCCCccccCCCCCcEEEcCCC
Q 010856 125 NLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSN 160 (499)
Q Consensus 125 ~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n 160 (499)
.+..|+.|++.+..++++. .+-.+++|+.|.++.|
T Consensus 41 ~~~~le~ls~~n~gltt~~-~~P~Lp~LkkL~lsdn 75 (260)
T KOG2739|consen 41 EFVELELLSVINVGLTTLT-NFPKLPKLKKLELSDN 75 (260)
T ss_pred cccchhhhhhhccceeecc-cCCCcchhhhhcccCC
Confidence 3444555555554444322 1223344444444444
|
|
| >KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=7.8e-05 Score=66.88 Aligned_cols=33 Identities=27% Similarity=0.317 Sum_probs=14.0
Q ss_pred ccccEEeeecCCCCCcCCccccCCccCCeeecccc
Q 010856 103 AELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSN 137 (499)
Q Consensus 103 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 137 (499)
..|+.|.+.+..++.. ..|..+++|+.|.++.|
T Consensus 43 ~~le~ls~~n~gltt~--~~~P~Lp~LkkL~lsdn 75 (260)
T KOG2739|consen 43 VELELLSVINVGLTTL--TNFPKLPKLKKLELSDN 75 (260)
T ss_pred cchhhhhhhccceeec--ccCCCcchhhhhcccCC
Confidence 3344444444444321 22334445555555555
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=1.4e-05 Score=87.28 Aligned_cols=81 Identities=12% Similarity=-0.089 Sum_probs=50.2
Q ss_pred cCCC-CCccccceeEEcc-----ccceeeeeecccCCCcccccccc-----ccccccccccccccceeecc------CCC
Q 010856 413 NIRH-RNLIKILHGVAVI-----TFTVCLCLFHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVD 475 (499)
Q Consensus 413 ~l~H-~niv~l~~~~~~~-----~~~~~~~l~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~ 475 (499)
.++| +||.++++++... +...++.++|++++++.+.+... ......++.||++||+|||+ ++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 5777888776211 11234445677777776655322 12233446899999999987 799
Q ss_pred cccEEEeeCCCeEEEEEE
Q 010856 476 FAAFVFVLEPGVEVICFV 493 (499)
Q Consensus 476 p~~~l~~~~~~~~~~~f~ 493 (499)
|.|||+...+.++++|||
T Consensus 108 P~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESA 125 (793)
T ss_pred chhEEEcccCcEEEeecc
Confidence 999999654444444443
|
|
| >KOG2123 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.41 E-value=6.6e-06 Score=73.99 Aligned_cols=100 Identities=22% Similarity=0.195 Sum_probs=68.5
Q ss_pred CCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCC-ccccCCCCCC
Q 010856 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIP-ITLSKLQKLQ 82 (499)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~ 82 (499)
+.+.+.|++.+|.++++ .....++ .|+.|.|+-|.|+..-| |..+++|++|+|..|.|..+.. ..+.++++|+
T Consensus 18 l~~vkKLNcwg~~L~DI---sic~kMp-~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr 91 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDI---SICEKMP-LLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLR 91 (388)
T ss_pred HHHhhhhcccCCCccHH---HHHHhcc-cceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhh
Confidence 44667788888888766 2334566 78888888888876533 7778888888888888774321 2357788888
Q ss_pred eEecccccccccCCc-----cccCcccccEEe
Q 010856 83 GLGLEDNKLEGSIPD-----DICHLAELYRLD 109 (499)
Q Consensus 83 ~L~L~~n~l~~~~~~-----~~~~l~~L~~L~ 109 (499)
.|+|..|.-.+..+. .+.-+++|+.||
T Consensus 92 ~LWL~ENPCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 92 TLWLDENPCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred hHhhccCCcccccchhHHHHHHHHcccchhcc
Confidence 888888876544432 355677777763
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0011 Score=60.37 Aligned_cols=126 Identities=14% Similarity=-0.022 Sum_probs=84.7
Q ss_pred hcccccccccCCcceEEEEEeCCCCEEEEEEeeccCC----------------------ccHHHHHHHHHHHhcCCCC--
Q 010856 362 EFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG----------------------RAFESFDVECEMMKNIRHR-- 417 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~il~~l~H~-- 417 (499)
-..+...||.|.-+.||.|..+.|..+|||.-+.+.. -.+....+|.++|.++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3456688999999999999999999999996543210 0123357899999988544
Q ss_pred CccccceeEEccccceeeeeecccCCCccccccc-cccc---ccccc--ccccccceeeccCCCcccEEEeeCCCeEEEE
Q 010856 418 NLIKILHGVAVITFTVCLCLFHHSSASASASLVS-SLTL---SRPAK--GGGFRGCVLWHVGVDFAAFVFVLEPGVEVIC 491 (499)
Q Consensus 418 niv~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~-~~~~---~~~~~--~~i~~gl~yLH~~~~p~~~l~~~~~~~~~~~ 491 (499)
.|.+.+++ .-..++|++..|-.+..++. .++. ...+. ...+--..|.|-|..+=||+++.++++.+||
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vID 245 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVID 245 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEe
Confidence 66665543 22245677777655444441 1111 11111 2233466789999999999999999999999
Q ss_pred EE
Q 010856 492 FV 493 (499)
Q Consensus 492 f~ 493 (499)
|=
T Consensus 246 wP 247 (304)
T COG0478 246 WP 247 (304)
T ss_pred Cc
Confidence 83
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0005 Score=64.25 Aligned_cols=134 Identities=18% Similarity=0.175 Sum_probs=73.3
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCC----------CCccccceeEE
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRH----------RNLIKILHGVA 427 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H----------~niv~l~~~~~ 427 (499)
.+.....||.|+++.||.++. .+|+.+|+|+..... ....+++.+|.-....+.+ -.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 355678899999999999997 569999999985433 3345667777755544332 12222222221
Q ss_pred c----------cc---c--ceeeeeecccCCCccccccc---cccc-------c-ccccccccccceeec------cCCC
Q 010856 428 V----------IT---F--TVCLCLFHHSSASASASLVS---SLTL-------S-RPAKGGGFRGCVLWH------VGVD 475 (499)
Q Consensus 428 ~----------~~---~--~~~~~l~~~~~~~~~~~l~~---~~~~-------~-~~~~~~i~~gl~yLH------~~~~ 475 (499)
. .+ + .....++.-+.+++...+.. .... . ..+..|+++.+++|| .+++
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1 00 1 01234556666665443221 1011 1 111155565555554 5999
Q ss_pred cccEEEeeCCCeEEEEEEEe
Q 010856 476 FAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 476 p~~~l~~~~~~~~~~~f~~~ 495 (499)
|.||+++.++++.+-||+.-
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGE
T ss_pred eeeEEEcCCCCEEEcChHHH
Confidence 99999999999999999754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0016 Score=57.22 Aligned_cols=115 Identities=17% Similarity=0.001 Sum_probs=66.8
Q ss_pred eEEEEEeCCCCEEEEEEeeccC-------------Cc-------------cHHHHHHHHHHHhcCCCC--CccccceeEE
Q 010856 376 SVYKARLGDRMEVAVKVFNLQC-------------GR-------------AFESFDVECEMMKNIRHR--NLIKILHGVA 427 (499)
Q Consensus 376 ~v~~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~il~~l~H~--niv~l~~~~~ 427 (499)
.||.|..++|..+|+|..+... .. ......+|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998899999999885421 00 023467899999999766 455554321
Q ss_pred ccccceeeeeecccC--CCccccccccc---ccccccc-------ccccccceeeccCCCcccEEEeeCCCeEEEEEEEe
Q 010856 428 VITFTVCLCLFHHSS--ASASASLVSSL---TLSRPAK-------GGGFRGCVLWHVGVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 428 ~~~~~~~~~l~~~~~--~~~~~~l~~~~---~~~~~~~-------~~i~~gl~yLH~~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
...++|||++ |.....+.... .....+. ..+.+.....|-|..+-||++.++ ++.+||||-+
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred -----CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2346788887 55444333222 1111111 122334567899999999999665 9999999976
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
+-
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 53
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 499 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-23 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-05 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-23 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-05 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-20 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 8e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-09 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 5e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-04 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 2e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 499 | |||
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-90 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-42 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-27 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-88 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-73 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-72 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-70 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-65 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-65 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-63 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-49 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-44 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-32 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-56 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-52 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-49 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-47 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-46 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-37 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-18 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-50 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-49 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-47 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-46 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-44 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-27 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-45 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-40 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-39 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-38 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-33 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 9e-16 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-09 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-44 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-39 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-39 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-37 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-30 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-26 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-40 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-38 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-37 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-42 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-41 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-40 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-40 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-39 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-39 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-35 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-29 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-40 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-31 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-15 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-39 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-33 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-32 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 9e-31 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-06 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-38 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-35 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-33 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-29 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-20 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-10 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-35 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-28 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-20 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-36 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-35 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-30 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-29 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-24 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-17 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-35 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-31 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-34 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 6e-32 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-30 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-25 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-25 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-10 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-05 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-33 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-23 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-12 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-33 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-32 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-32 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-27 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-27 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-25 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-19 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-31 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-31 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-26 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-24 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-22 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 8e-22 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-31 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-29 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-28 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-28 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-26 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-25 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-14 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-31 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-30 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-24 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-22 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 6e-21 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-29 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-28 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-26 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-25 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-25 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-14 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-20 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-13 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-28 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-27 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-17 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-10 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-17 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-26 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 7e-21 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 7e-26 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-25 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-25 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-24 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 9e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-25 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-22 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-23 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-20 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-16 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-10 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-23 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-17 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-15 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-12 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-17 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-23 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-19 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-11 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-23 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-22 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-20 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-19 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-15 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-22 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-22 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-18 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-21 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 4e-16 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 8e-09 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-21 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 8e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 6e-11 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-08 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 5e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-19 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-13 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-19 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-09 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 8e-18 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 9e-08 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 3e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 6e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 8e-12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-06 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-14 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-14 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-04 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-14 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-14 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 6e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-04 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 9e-14 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-12 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-05 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 7e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-06 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-11 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 8e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-04 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-10 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-10 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 4e-10 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-10 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-10 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-10 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-09 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-09 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-09 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-09 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-09 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-09 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-09 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-09 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-09 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-09 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-09 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 8e-09 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 8e-09 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-09 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-08 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 4e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-05 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-08 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-08 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-08 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-06 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-08 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-08 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-08 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-08 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-08 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-08 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-08 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-08 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-08 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 6e-08 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-08 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 6e-08 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 6e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 7e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-06 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-08 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-08 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 8e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 3e-06 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-08 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-08 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 9e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-05 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-07 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-07 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-07 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-07 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-07 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-07 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-07 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-07 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-07 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-07 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-07 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-07 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-07 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-07 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-07 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-07 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-07 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-07 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 5e-07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-07 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-07 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 7e-07 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-07 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-07 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-07 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 8e-07 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-06 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-06 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-06 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-06 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-06 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-04 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-06 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-06 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-06 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-06 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-06 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-06 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-06 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-06 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-06 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-06 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 6e-06 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-06 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 7e-06 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 7e-06 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-04 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-05 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-05 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-05 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-05 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-05 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-05 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-05 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-05 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-05 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-05 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-05 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-05 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 4e-05 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-05 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-05 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 8e-05 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-05 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 9e-05 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 9e-05 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-04 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-04 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-04 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-04 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-04 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-04 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-04 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-04 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-04 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-04 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-04 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-04 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-04 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 4e-04 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 5e-04 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-04 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-04 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 6e-04 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 6e-04 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-04 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 7e-04 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-04 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 8e-04 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 8e-04 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 8e-04 |
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-90
Identities = 86/295 (29%), Positives = 133/295 (45%), Gaps = 30/295 (10%)
Query: 1 MSNCKSLTLIYLSNNPLDGILP-KTSVGNLSHSLEDFRMYNCN-ISGGIPEEISNLTNST 58
+ + + LS L P +S+ NL L + N + G IP I+ LT
Sbjct: 46 DTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 59 IVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGS 118
+ + ++G+IP LS+++ L L N L G++P I L L + DGN++SG+
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 119 LPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIG 178
+P + + + L ++ S N LT +P NL L
Sbjct: 165 IPDSYGSFSKL----------------------FTSMTISRNRLTGKIPPTFANLN-LAF 201
Query: 179 IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAI 238
+D S N G G KN + + L N L + G +L L+L NN + G +
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTL 260
Query: 239 PASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC 293
P L +L +L +LN+SFN L GEIP+GG+ F ++ N+ LCGSP +P C
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-42
Identities = 52/188 (27%), Positives = 77/188 (40%), Gaps = 27/188 (14%)
Query: 88 DNKLEGSIPDDICHLAELYRLDLDGNKLSGS--LPACFSNLTSLRIVSLGSNKLTSVPLT 145
+ G + D + LDL G L +P+ +NL L + +G
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI-------- 86
Query: 146 FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFL 205
N L P+P I L L + + N SG IP + +K L L
Sbjct: 87 --------------NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 206 GYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL-ENLNLSFNKLEGEIPR 264
YN L G++P S L +L + N +SGAIP S S L ++ +S N+L G+IP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 265 GGSFGNFS 272
+F N +
Sbjct: 193 --TFANLN 198
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 33/122 (27%), Positives = 54/122 (44%), Gaps = 5/122 (4%)
Query: 154 NLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGV--IPTEIGGLKNLEYLFL-GYNRL 210
+ + L + +D S N IP+ + L L +L++ G N L
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 211 QGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGN 270
G IP + L L +L +++ N+SGAIP L ++ L L+ S+N L G +P S +
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP--SISS 147
Query: 271 FS 272
Sbjct: 148 LP 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 7e-88
Identities = 95/324 (29%), Positives = 138/324 (42%), Gaps = 28/324 (8%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ + L + L N L+G +P + + +LE + +++G IP +SN TN +
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIP-QELMYVK-TLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL- 119
+L N+L G IP + +L+ L L L +N G+IP ++ L LDL+ N +G++
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 120 -------------------PACFSNLTSLRIVSLGSNKLT---SVPLTFWNLKDILNLNF 157
N + N L L N
Sbjct: 556 AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
Query: 158 SSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS 217
+S N ++ +D S N SG IP EIG + L L LG+N + GSIPD
Sbjct: 616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675
Query: 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFE 277
GDL L L+LS+N L G IP ++ L+ L ++LS N L G IP G F F F
Sbjct: 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL 735
Query: 278 GNELLCGSPNLQVPPCKTSIHHTS 301
N LCG P +P C S
Sbjct: 736 NNPGLCGYP---LPRCDPSNADGY 756
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 5e-73
Identities = 83/276 (30%), Positives = 135/276 (48%), Gaps = 8/276 (2%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
KSL + L+ N G +P G +L + + G +P + + +
Sbjct: 266 LPLKSLQYLSLAENKFTGEIPDFLSGACD-TLTGLDLSGNHFYGAVPPFFGSCSLLESLA 324
Query: 62 LGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDICHL-AELYRLDLDGNKLSGSL 119
L N +G +P+ TL K++ L+ L L N+ G +P+ + +L A L LDL N SG +
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384
Query: 120 PA--CFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVL 176
C + +L+ + L +N T +P T N ++++L+ S N+L+ +P +G+L L
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL 444
Query: 177 IGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG 236
+ +N G IP E+ +K LE L L +N L G IP + +L +++LSNN L+G
Sbjct: 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG 504
Query: 237 AIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
IP + +L L L LS N G IP G+
Sbjct: 505 EIPKWIGRLENLAILKLSNNSFSGNIPA--ELGDCR 538
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-72
Identities = 92/279 (32%), Positives = 137/279 (49%), Gaps = 13/279 (4%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+S C +L + +S+N +P +G+ S +L+ + +SG IS T ++
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIP--FLGDCS-ALQHLDISGNKLSGDFSRAISTCTELKLL 252
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICH-LAELYRLDLDGNKLSGSL 119
N+ N+ G IP L+ LQ L L +NK G IPD + L LDL GN G++
Sbjct: 253 NISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310
Query: 120 PACFSNLTSLRIVSLGSNKLT-SVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKV-L 176
P F + + L ++L SN + +P+ T ++ + L+ S N + LP + NL L
Sbjct: 311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL 370
Query: 177 IGIDFSMNNFSGVIPTEIGG--LKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234
+ +D S NNFSG I + L+ L+L N G IP + + L L+LS N L
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 235 SGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSA 273
SG IP+SL LS L +L L N LEGEIP+
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ--ELMYVKT 467
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 3e-70
Identities = 88/331 (26%), Positives = 142/331 (42%), Gaps = 11/331 (3%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEE-ISNLTNSTIV 60
C +LT + LS N G +P G+ S LE + + N SG +P + + + ++
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPP-FFGSCS-LLESLALSSNNFSGELPMDTLLKMRGLKVL 348
Query: 61 NLGGNKLNGSIPITLSKL-QKLQGLGLEDNKLEGSIPDDICH--LAELYRLDLDGNKLSG 117
+L N+ +G +P +L+ L L L L N G I ++C L L L N +G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 118 SLPACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVL 176
+P SN + L + L N L+ ++P + +L + +L N L +P E+ +K L
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468
Query: 177 IGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG 236
+ N+ +G IP+ + NL ++ L NRL G IP G L +L L LSNN+ SG
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528
Query: 237 AIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTS 296
IPA L L L+L+ N G IP + S + + G + +
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFKQSGK--IAANFIAGKRYVYIKNDGMK 584
Query: 297 IHHTSWKNSLLLRIVLPLSTTFMIVVILLIL 327
N L + + + +
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-65
Identities = 82/278 (29%), Positives = 127/278 (45%), Gaps = 15/278 (5%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
C L + +S N + G + V +LE + + N S GIP + + + +
Sbjct: 174 SDGCGELKHLAISGNKISGDVD---VSRCV-NLEFLDVSSNNFSTGIP-FLGDCSALQHL 228
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
++ GNKL+G +S +L+ L + N+ G IP L L L NK +G +P
Sbjct: 229 DISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK--SLQYLSLAENKFTGEIP 286
Query: 121 AC-FSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLE-IGNLKVLI 177
+L + L N +VP F + + +L SSN + LP++ + ++ L
Sbjct: 287 DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346
Query: 178 GIDFSMNNFSGVIPTEIGGLK-NLEYLFLGYNRLQGSIPDSFGD--LISLKFLNLSNNNL 234
+D S N FSG +P + L +L L L N G I + +L+ L L NN
Sbjct: 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 406
Query: 235 SGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
+G IP +L S L +L+LSFN L G IP S G+ S
Sbjct: 407 TGKIPPTLSNCSELVSLHLSFNYLSGTIPS--SLGSLS 442
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-65
Identities = 82/280 (29%), Positives = 125/280 (44%), Gaps = 13/280 (4%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI---SNLTNST 58
+C L + +S+N LD + L+ SLE + +ISG
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVSGGLKLN-SLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 59 IVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGS 118
+ + GNK++G + + S+ L+ L + N IP + + L LD+ GNKLSG
Sbjct: 182 HLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGD 238
Query: 119 LPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEI-GNLKVLI 177
S T L+++++ SN+ P+ LK + L+ + N T +P + G L
Sbjct: 239 FSRAISTCTELKLLNISSNQFVG-PIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 178 GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-DSFGDLISLKFLNLSNNNLSG 236
G+D S N+F G +P G LE L L N G +P D+ + LK L+LS N SG
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 237 AIPASLEKLSY-LENLNLSFNKLEGEIPRGGSFGNFSAES 275
+P SL LS L L+LS N G I + +
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILP--NLCQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 7e-63
Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 16/281 (5%)
Query: 2 SNCKSLTLIYLSNNPLDGILP-KTSVGNLSHSLEDFRMYNCNISGGIP-EEISNLTNSTI 59
SLT + LS N L G + TS+G+ S L+ + + + L + +
Sbjct: 97 KCSASLTSLDLSRNSLSGPVTTLTSLGSCS-GLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155
Query: 60 VNLGGNKLNGSIPITL---SKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLS 116
++L N ++G+ + +L+ L + NK+ G + + L LD+ N S
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213
Query: 117 GSLPACFSNLTSLRIVSLGSNKLT-SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKV 175
+P + ++L+ + + NKL+ ++ LN SSN P+P LK
Sbjct: 214 TGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKS 270
Query: 176 LIGIDFSMNNFSGVIPTEIGG-LKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234
L + + N F+G IP + G L L L N G++P FG L+ L LS+NN
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330
Query: 235 SGAIPA-SLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAE 274
SG +P +L K+ L+ L+LSFN+ GE+P S N SA
Sbjct: 331 SGELPMDTLLKMRGLKVLDLSFNEFSGELPE--SLTNLSAS 369
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-49
Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 13/227 (5%)
Query: 44 SGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDD--ICH 101
+ + +LT + L + +NGS+ L L L N L G + +
Sbjct: 66 FSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGS 124
Query: 102 LAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLT-SVPLTFW---NLKDILNLN 156
+ L L++ N L L SL ++ L +N ++ + + + ++ +L
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLA 184
Query: 157 FSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD 216
S N ++ + + L +D S NNFS IP +G L++L + N+L G
Sbjct: 185 ISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSR 241
Query: 217 SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
+ LK LN+S+N G IP L L+ L+L+ NK GEIP
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIP 286
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-44
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 14/216 (6%)
Query: 58 TIVNLGGNKLN---GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNK 114
T ++L LN ++ +L L L+ L L ++ + GS+ A L LDL N
Sbjct: 53 TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNS 111
Query: 115 LSGSLPA--CFSNLTSLRIVSLGSNKLT-SVPLT-FWNLKDILNLNFSSNFLTSPLPLEI 170
LSG + + + L+ +++ SN L ++ L + L+ S+N ++ +
Sbjct: 112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW 171
Query: 171 ---GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFL 227
L + S N SG + + NLE+L + N IP GD +L+ L
Sbjct: 172 VLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHL 228
Query: 228 NLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
++S N LSG ++ + L+ LN+S N+ G IP
Sbjct: 229 DISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 264
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-32
Identities = 43/182 (23%), Positives = 75/182 (41%), Gaps = 14/182 (7%)
Query: 100 CHLAELYRLDLDGNKLS---GSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLN 156
C ++ +DL L+ ++ + +LT L + L ++ + F + +L+
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLD 106
Query: 157 FSSNFLTSPLP--LEIGNLKVLIGIDFSMNNFSGVIPTEIG-GLKNLEYLFLGYNRLQGS 213
S N L+ P+ +G+ L ++ S N G L +LE L L N + G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 214 IPDSF---GDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGN 270
+ LK L +S N +SG + S + LE L++S N IP G+
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIP---FLGD 221
Query: 271 FS 272
S
Sbjct: 222 CS 223
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-56
Identities = 62/315 (19%), Positives = 111/315 (35%), Gaps = 46/315 (14%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKT------------------SVGNLSHSLEDFRMYNCN 42
+ L Y+ N+P NL L D +YNC
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLK-DLTDVEVYNCP 260
Query: 43 ISGGIPEEISNLTNSTIVNLGGNKL--------NGSIPITLSKLQKLQGLGLEDNKL-EG 93
+P + L ++N+ N+ + +K+Q + + N L
Sbjct: 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTF 320
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFW-NLKDI 152
+ + + +L L+ N+L G LPA F + L ++L N++T +P F + +
Sbjct: 321 PVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQV 379
Query: 153 LNLNFSSNFLTS-PLPLEIGNLKVLIGIDFSMNNFSGV-------IPTEIGGLKNLEYLF 204
NL+F+ N L P + ++ V+ IDFS N V + N+ +
Sbjct: 380 ENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSIN 439
Query: 205 LGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG-------AIPASLEKLSYLENLNLSFNK 257
L N++ + F L +NL N L+ + + L +++L FNK
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499
Query: 258 LEGEIPRGGSFGNFS 272
L +
Sbjct: 500 LTK-LSDDFRATTLP 513
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-52
Identities = 53/286 (18%), Positives = 96/286 (33%), Gaps = 32/286 (11%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
K L ++ N L+G LP + G+ L + I+ ++
Sbjct: 327 QKMKKLGMLECLYNQLEGKLP--AFGSEI-KLASLNLAYNQITEIPANFCGFTEQVENLS 383
Query: 62 LGGNKLNGSIPITLS--KLQKLQGLGLEDNKLEG-------SIPDDICHLAELYRLDLDG 112
NKL IP + + + N++ + + ++L
Sbjct: 384 FAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN 442
Query: 113 NKLSGSLPACFSNLTSLRIVSLGSNKLTSVP--------LTFWNLKDILNLNFSSNFLTS 164
N++S FS + L ++L N LT +P F N + +++ N LT
Sbjct: 443 NQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
Query: 165 -PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLG------YNRLQGSIPDS 217
L L+GID S N+FS PT+ L+ + NR P+
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561
Query: 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
SL L + +N++ + + + L++ N
Sbjct: 562 ITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-49
Identities = 44/282 (15%), Positives = 98/282 (34%), Gaps = 31/282 (10%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPE--EISNLTNSTI 59
+ L + L+ N + I + + +E+ + + IP + +++ +
Sbjct: 350 GSEIKLASLNLAYNQITEIPA--NFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSA 406
Query: 60 VNLGGNKLNG-------SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG 112
++ N++ + T K + + L +N++ + + L ++L G
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466
Query: 113 NKLSG-------SLPACFSNLTSLRIVSLGSNKLTSVP--LTFWNLKDILNLNFSSNFLT 163
N L+ F N L + L NKLT + L ++ ++ S N +
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS 526
Query: 164 SPLPLEIGNLKVLIGI------DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS 217
P + N L G D N P I +L L +G N ++ + +
Sbjct: 527 K-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEK 584
Query: 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
++ L++ +N + + L ++K +
Sbjct: 585 I--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-47
Identities = 47/287 (16%), Positives = 100/287 (34%), Gaps = 25/287 (8%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGG----IPEEISNLTN 56
+++ +T + L G +P ++G L+ LE + + P+ IS +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPD-AIGQLTE-LEVLALGSHGEKVNERLFGPKGISANMS 134
Query: 57 STIVNLGGNKLNGSIPITLSKLQ--KLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNK 114
+ + L + + + SI + ++ N
Sbjct: 135 DEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNN 194
Query: 115 LSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLK 174
++ + LT LR +G++ + + + N N L+ NLK
Sbjct: 195 IT-FVSKAVMRLTKLRQFYMGNSPFVAENI----CEAWENENSEYAQQYKTEDLKWDNLK 249
Query: 175 VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRL--------QGSIPDSFGDLISLKF 226
L ++ +PT + L ++ + + NR ++
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 227 LNLSNNNL-SGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
+ + NNL + + SL+K+ L L +N+LEG++P +FG+
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP---AFGSEI 353
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-46
Identities = 43/312 (13%), Positives = 97/312 (31%), Gaps = 36/312 (11%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+S S L + + I + T +
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEG-------------------SIPDDICH 101
N + + + +L KL+ + ++ + +
Sbjct: 189 GQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDN 247
Query: 102 LAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP---------LTFWNLKDI 152
L +L +++ LP L ++++++ N+ S + I
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 153 LNLNFSSNFLTS-PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 211
+ N L + P+ + +K L ++ N G +P G L L L YN++
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT 366
Query: 212 GSIPDSFGDLISLKFLNLSNNNLSGAIPASLE--KLSYLENLNLSFNKLEGEIPRGGSFG 269
+ G ++ L+ ++N L IP + +S + ++ S+N++ +F
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDG--KNFD 423
Query: 270 NFSAESFEGNEL 281
F+G +
Sbjct: 424 PLDPTPFKGINV 435
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-37
Identities = 37/259 (14%), Positives = 78/259 (30%), Gaps = 31/259 (11%)
Query: 40 NCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI 99
N + G + +N + +++ G ++L+ ++ GL LE G +PD I
Sbjct: 46 NWSQQGFGTQPGANWNFNKELDMWGA----QPGVSLNSNGRVTGLSLEGFGASGRVPDAI 101
Query: 100 CHLAELYRLDLDGNKLSG----SLPACFSNLTSLRIVSLGSNKLTSVP---LTFWNLKDI 152
L EL L L + P S S + D+
Sbjct: 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161
Query: 153 LNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 212
+ +S+ + I NN + + + L L ++G +
Sbjct: 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVA 220
Query: 213 -------------------SIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 253
+ + +L L + + N +P L+ L ++ +N+
Sbjct: 221 ENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINV 280
Query: 254 SFNKLEGEIPRGGSFGNFS 272
+ N+ + +
Sbjct: 281 ACNRGISGEQLKDDWQALA 299
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 24/149 (16%), Positives = 43/149 (28%), Gaps = 11/149 (7%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTN---- 56
N LT I L N L + L L + + S P + N +
Sbjct: 484 FKNTYLLTSIDLRFNKLTKLSDDFRATTLP-YLVGIDLSYNSFS-KFPTQPLNSSTLKGF 541
Query: 57 --STIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNK 114
+ GN+ P ++ L L + N + + + I + LD+ N
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNP 598
Query: 115 LSGSLPACFSNLTSLRIVSLGSNKLTSVP 143
+ + L +K +
Sbjct: 599 NISIDLSYVCPYIEAGMYMLFYDKTQDIR 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-50
Identities = 60/274 (21%), Positives = 106/274 (38%), Gaps = 12/274 (4%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG 64
++T++ L++N L + P + S L + IS PE L ++NL
Sbjct: 25 TNITVLNLTHNQLRRL-PAANFTRYSQ-LTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFS 124
N+L+ T + L L L N ++ + L LDL N LS +
Sbjct: 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 125 NLTSLRIVSLGSNKLTSVP---LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
L +L+ + L +NK+ ++ L + + L SSN + P + L G+
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL 202
Query: 182 SMNNFSGVIPTEIG---GLKNLEYLFLGYNRLQGSIPDSFGDL--ISLKFLNLSNNNLSG 236
+ + ++ ++ L L ++L + +F L +L L+LS NNL+
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262
Query: 237 AIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGN 270
S L LE L +N ++ S
Sbjct: 263 VGNDSFAWLPQLEYFFLEYNNIQHLFS--HSLHG 294
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-49
Identities = 63/306 (20%), Positives = 110/306 (35%), Gaps = 20/306 (6%)
Query: 1 MSNCKSLTLIYLSNNPL--DGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNST 58
+ +L + LSN+ + +T V L + IS + S L +
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408
Query: 59 IVNLGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG 117
+++LG N++ + L+ + + L NK + + L RL L L
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 118 --SLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTS--------PL 166
S P+ F L +L I+ L +N + ++ L+ + L+ N L
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 167 PLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKF 226
+ L L ++ N F + L L+ + LG N L F + +SLK
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
Query: 227 LNLSNNNLSGAIPASLEK-LSYLENLNLSFNKLEGEIPRGGSFGNFSAES-----FEGNE 280
LNL N ++ L L++ FN + F N+ E+ +
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSH 648
Query: 281 LLCGSP 286
LC +P
Sbjct: 649 YLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-47
Identities = 64/291 (21%), Positives = 108/291 (37%), Gaps = 19/291 (6%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ C +LT ++L +N + I +L + + +S L N +
Sbjct: 94 AFCTNLTELHLMSNSIQKI-KNNPFVKQK-NLITLDLSHNGLSSTKLGTQVQLENLQELL 151
Query: 62 LGGNKLNGSIPITLS--KLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
L NK+ L L+ L L N+++ P + L+ L L+ +L SL
Sbjct: 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSL 211
Query: 120 PA---CFSNLTSLRIVSLGSNKLTSV-PLTFWNLKD--ILNLNFSSNFLTSPLPLEIGNL 173
TS+R +SL +++L++ TF LK + L+ S N L L
Sbjct: 212 TEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWL 271
Query: 174 KVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYN---------RLQGSIPDSFGDLISL 224
L NN + + GL N+ YL L + L SF L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 225 KFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAES 275
+ LN+ +N++ G L L+ L+LS + +F + +
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-46
Identities = 59/275 (21%), Positives = 103/275 (37%), Gaps = 15/275 (5%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
S + S+ L + +L ++ + + + + + T +++G N
Sbjct: 5 SHEVADCSHLKLTQVPD-----DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSN 125
++ P KL L+ L L+ N+L L L L N + F
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 126 LTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTS--PLPLEIGNLKVLIGIDFS 182
+L + L N L+S L T L+++ L S+N + + L+I L ++ S
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGD---LISLKFLNLSNNNLSGAIP 239
N P + L LFL +L S+ + S++ L+LSN+ LS
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 240 ASLEKLSY--LENLNLSFNKLEGEIPRGGSFGNFS 272
+ L + L L+LS+N L SF
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGN--DSFAWLP 272
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-44
Identities = 65/285 (22%), Positives = 104/285 (36%), Gaps = 11/285 (3%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ LT + + N + + P+ L L+ + + +S + + TN T ++
Sbjct: 46 TRYSQLTSLDVGFNTISKLEPE-LCQKLPM-LKVLNLQHNELSQLSDKTFAFCTNLTELH 103
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L N + K + L L L N L + L L L L NK+
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163
Query: 122 CFS--NLTSLRIVSLGSNKLTSV-PLTFWNLKDILNLNFSSNFLTSPLPLEIG---NLKV 175
+SL+ + L SN++ P F + + L ++ L L ++
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223
Query: 176 LIGIDFSMNNFSGVIPTEIGGLK--NLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNN 233
+ + S + S T GLK NL L L YN L DSF L L++ L NN
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN 283
Query: 234 LSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEG 278
+ SL L + LNL + + I S SF+
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSIS-LASLPKIDDFSFQW 327
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 35/146 (23%), Positives = 50/146 (34%), Gaps = 4/146 (2%)
Query: 127 TSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNF 186
S + KLT VP +I LN + N L L +D N
Sbjct: 4 VSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 187 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 246
S + P L L+ L L +N L +F +L L+L +N++ K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 247 YLENLNLSFNKLEGEIPRGGSFGNFS 272
L L+LS N L G+
Sbjct: 122 NLITLDLSHNGLSSTKL--GTQVQLE 145
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-45
Identities = 57/317 (17%), Positives = 103/317 (32%), Gaps = 38/317 (11%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNS-TIV 60
L L+ +N + + + G L D ++ I IPE+ T+ +
Sbjct: 570 QKMVKLGLLDCVHNKVRHL---EAFGTNV-KLTDLKLDYNQIEE-IPEDFCAFTDQVEGL 624
Query: 61 NLGGNKLNGSIP--ITLSKLQKLQGLGLEDNKLEGSIPD-----DICHLAELYRLDLDGN 113
NKL IP + + + NK+ + D + L N
Sbjct: 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683
Query: 114 KLSGSLPACFSNLTSLRIVSLGSNKLTSVP--------LTFWNLKDILNLNFSSNFLTS- 164
++ F+ + + + L +N +TS+P + N + ++ N LTS
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSL 743
Query: 165 PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYL------FLGYNRLQGSIPDSF 218
L L +D S N FS PT+ L+ NR+ P
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
Query: 219 GDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAE---- 274
SL L + +N++ + L L L+++ N I A
Sbjct: 803 TTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNI-SIDVTSVCPYIEAGMYVL 858
Query: 275 SFEGNELLCGSPNLQVP 291
++ + + G L +
Sbjct: 859 LYDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 41/280 (14%), Positives = 86/280 (30%), Gaps = 38/280 (13%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ + L + ++ N + + ++ I
Sbjct: 511 LYDLPELQSLNIACNRGISAAQLKADWT-----------------RLADDEDTGPKIQIF 553
Query: 61 NLGGNKLNG-SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
+G N L +L K+ KL L NK+ + +L L LD N++
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIP 611
Query: 120 PACFSNLTSLRIVSLGSNKLTSVP--LTFWNLKDILNLNFSSNFLTS-----PLPLEIGN 172
+ + + NKL +P ++ + +++FS N + S ++
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671
Query: 173 LKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ-------GSIPDSFGDLISLK 225
+ S N + + L N + ++ + L
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731
Query: 226 FLNLSNNNLSGAIPASLE--KLSYLENLNLSFNKLEGEIP 263
++L N L+ + L YL N+++S+N P
Sbjct: 732 TIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFP 769
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-39
Identities = 48/282 (17%), Positives = 90/282 (31%), Gaps = 23/282 (8%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSH-SLEDFRMYNC-NISGGIPEEISNLTNSTI 59
+ L L L + ++ + S SL+D ++ N N I + I LT I
Sbjct: 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQI 452
Query: 60 VNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
+ + + + K + +L +L ++L L
Sbjct: 453 IYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 120 PACFSNLTSLRIVSLGSNKLTSV----------PLTFWNLKDILNLNFSSNFLTS-PLPL 168
P +L L+ +++ N+ S I N L P
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 169 EIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLN 228
+ + L +D N G L L L YN+++ D ++ L
Sbjct: 568 SLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLG 625
Query: 229 LSNNNLSGAIP--ASLEKLSYLENLNLSFNKLEGEIPRGGSF 268
S+N L IP + + + + +++ S+NK+ E
Sbjct: 626 FSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-38
Identities = 48/287 (16%), Positives = 96/287 (33%), Gaps = 29/287 (10%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ N +T + L+ G +P ++G L+ L+ + + +
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPD-AIGQLTE-LKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 61 NLGGNKLNGSI-PITLSKLQKLQGLGLEDNKLE-----GSIPDDICHLAELYRLDLDGNK 114
+++ + L Q+L L + + I D + ++ N+
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 115 LSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLK 174
++ + LT L+I+ ++ T + D + N L NLK
Sbjct: 437 IT-FISKAIQRLTKLQIIYFANSPFTYDNIAV----DWEDANSDYAKQYENEELSWSNLK 491
Query: 175 VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG---------SIPDSFGDLISLK 225
L ++ +P + L L+ L + NR + D ++
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 226 FLNLSNNNLSGAIPAS--LEKLSYLENLNLSFNKLEGEIPRGGSFGN 270
+ NNL PAS L+K+ L L+ NK+ + +FG
Sbjct: 552 IFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HLE---AFGT 593
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 41/255 (16%), Positives = 85/255 (33%), Gaps = 15/255 (5%)
Query: 35 DFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGS 94
+F ++ N T ++L G G +P + +L +L+ L + S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 95 IPDDICHLAELYRLDLDGNKLSGSLPACF-SNLTSLRIVSLGSNKLTSVP-------LTF 146
+ +++ F L + L + + P +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 147 WNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLG 206
+LKD + +N +T + I L L I F+ + F+ + E
Sbjct: 423 ISLKD-TQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSD 475
Query: 207 YNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG 266
Y + + S+ +L L + L N +P L L L++LN++ N+
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535
Query: 267 SFGNFSAESFEGNEL 281
+ + + G ++
Sbjct: 536 DWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 9e-16
Identities = 30/264 (11%), Positives = 72/264 (27%), Gaps = 38/264 (14%)
Query: 30 SHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDN 89
++ + + Y+ + E ++ + + +KL K + ++
Sbjct: 215 TYQVVAYTTYSQSGIKRSELETQSVRGESFT------------VIDNKLTKDANVPIQLK 262
Query: 90 KLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNL 149
+ I D A LD + + + WN
Sbjct: 263 ETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLN------------------WNF 304
Query: 150 KDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNR 209
N + +++ N + G+ + G +P IG L L+ L G +
Sbjct: 305 ------NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHS 358
Query: 210 LQGSIPDSFGDLISLKFLNLSNNNLSGAI-PASLEKLSYLENLNLSFNKLEGEIPRGGSF 268
S + ++ + + L+ L +L + + P
Sbjct: 359 ETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPI 417
Query: 269 GNFSAESFEGNELLCGSPNLQVPP 292
S S + ++ + +
Sbjct: 418 KKDSRISLKDTQIGNLTNRITFIS 441
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 18/122 (14%), Positives = 35/122 (28%), Gaps = 12/122 (9%)
Query: 1 MSNCKSLTLIYLSNNPLDGI------LPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNL 54
+ L+ + +S N + + H + I P I+
Sbjct: 749 ATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRD---AEGNRILRQWPTGITTC 805
Query: 55 TNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNK 114
+ + +G N + + L +L L + DN +C E L +K
Sbjct: 806 PSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
Query: 115 LS 116
Sbjct: 863 TQ 864
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-44
Identities = 53/267 (19%), Positives = 97/267 (36%), Gaps = 15/267 (5%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ +++ L + ++ + + H + NC L ++
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFGWQH----LELVNCKFGQ-----FPTLKLKSLKR 329
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKL--EGSIPDDICHLAELYRLDLDGNKLSGSL 119
L G + L L+ L L N L +G L LDL N + +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 120 PACFSNLTSLRIVSLGSNKLTSV--PLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
+ F L L + + L + F +L++++ L+ S L L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 178 GIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG 236
+ + N+F +I L+NL +L L +L+ P +F L SL+ LN+S+NN
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 237 AIPASLEKLSYLENLNLSFNKLEGEIP 263
+ L+ L+ L+ S N +
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKK 535
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-39
Identities = 46/259 (17%), Positives = 90/259 (34%), Gaps = 15/259 (5%)
Query: 28 NLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLE 87
NL S ++ + + + +++L ++ L L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 88 DNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL--T 145
N ++ L+ L +L L+ +L +L+ +++ N + S L
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 146 FWNLKDILNLNFSSNFLTSPLPLEIGNLK----VLIGIDFSMNNFSGVIPTEIGGLKNLE 201
F NL ++ +L+ SSN + S ++ L + + +D S+N + + P + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLH 203
Query: 202 YLFLGYNRLQGSIP-DSFGDLISLKFLNLSNN------NLSGAIPASLEKLSYLENLNLS 254
L L N ++ L L+ L NL ++LE L L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 255 FNKLEGEIPRG-GSFGNFS 272
L+ + F +
Sbjct: 264 LAYLDYYLDDIIDLFNCLT 282
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-39
Identities = 52/268 (19%), Positives = 99/268 (36%), Gaps = 9/268 (3%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
KSL + ++N + + +L D + G + T+ ++
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL--DLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLP 120
L N + + L++L+ L + + L+ + L L LD+ +
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 121 ACFSNLTSLRIVSLGSNKLTS--VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIG 178
F+ L+SL ++ + N +P F L+++ L+ S L P +L L
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 179 IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLI-SLKFLNLSNNNLSGA 237
++ S NNF + L +L+ L N + S SL FLNL+ N+ +
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558
Query: 238 IPAS--LEKLSYLENLNLSFNKLEGEIP 263
L+ + L + ++E P
Sbjct: 559 CEHQSFLQWIKDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-37
Identities = 67/326 (20%), Positives = 108/326 (33%), Gaps = 44/326 (13%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
S + LS NPL + S + L+ + C I +L++ + + L GN
Sbjct: 29 STKNLDLSFNPLRHLGS-YSFFSFPE-LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKL-SGSLPACFS 124
+ S L LQ L + L I HL L L++ N + S LP FS
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 125 NLTSLRIVSLGSNKLTSV-PLTFWNLK----DILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
NLT+L + L SNK+ S+ L L+L+ S N + P ++ L +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKL 205
Query: 180 DFSMNNFSGVIPTEI----------------------------GGLKNLEYLFLGYNRLQ 211
N S + L+ L L + RL
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 212 ------GSIPDSFGDLISLKFLNLSNNNLSGAIPAS-LEKLSYLENLNLSFNKLEGEIPR 264
I D F L ++ +L + + S +LE +N F + +
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 265 GGSFGNFSAESFEGNELLCGSPNLQV 290
F++ P+L+
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLEF 351
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 53/277 (19%), Positives = 98/277 (35%), Gaps = 26/277 (9%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ + K+L + +++N + NL+ +LE + + I ++ L ++
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 61 ----NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICH-LAELYRLDLDGNKL 115
+L N +N P ++ +L L L +N ++ LA L L +
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 116 SGSL------PACFSNLTSLRIVSLGSNKLT----SVPLTFWNLKDILNLNFSSNFLTSP 165
+ L +L I L + F L ++ + + S +
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297
Query: 166 LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLK 225
++ F ++ LK L + +G S DL SL+
Sbjct: 298 KDF--SYNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLE 350
Query: 226 FLNLSNNNLS--GAIPASLEKLSYLENLNLSFNKLEG 260
FL+LS N LS G S + L+ L+LSFN +
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 30/151 (19%), Positives = 50/151 (33%), Gaps = 4/151 (2%)
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
C + ++ +P NL+ S N L + L +D
Sbjct: 3 CVEVVPNI-TYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
S + L +L L L N +Q +F L SL+ L NL+
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 242 LEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
+ L L+ LN++ N ++ F N +
Sbjct: 120 IGHLKTLKELNVAHNLIQS-FKLPEYFSNLT 149
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-43
Identities = 47/268 (17%), Positives = 100/268 (37%), Gaps = 18/268 (6%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSH-SLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
N + + + L + + + + + + P++ L++ +
Sbjct: 54 NSNNPQIETRTGRAL-KATAD-LLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMT 110
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
+ L +P T+ + L+ L L N L ++P I L L L + LP
Sbjct: 111 IDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168
Query: 122 CFSN---------LTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGN 172
++ L +L+ + L + S+P + NL+++ +L ++ L++ L I +
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHH 227
Query: 173 LKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFL-GYNRLQGSIPDSFGDLISLKFLNLSN 231
L L +D P GG L+ L L + L ++P L L+ L+L
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRG 286
Query: 232 NNLSGAIPASLEKLSYLENLNLSFNKLE 259
+P+ + +L + + +
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 60/283 (21%), Positives = 99/283 (34%), Gaps = 27/283 (9%)
Query: 1 MSNCKSLT--------LIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEIS 52
+L N + N ++ + R + +
Sbjct: 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETR--TGRALKATADLLE 76
Query: 53 NLT--NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDL 110
+ T + L L P +L LQ + ++ L +PD + A L L L
Sbjct: 77 DATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTL 134
Query: 111 DGNKLSGSLPACFSNLTSLRIVSL-GSNKLTSVP---------LTFWNLKDILNLNFSSN 160
N L +LPA ++L LR +S+ +LT +P L ++ +L
Sbjct: 135 ARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 161 FLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGD 220
+ S LP I NL+ L + + S + I L LE L L + P FG
Sbjct: 194 GIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 221 LISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
LK L L + + +P + +L+ LE L+L +P
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 46/251 (18%), Positives = 92/251 (36%), Gaps = 20/251 (7%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG 64
+ L + PL P LSH L+ + + +P+ + + L
Sbjct: 81 PGRVALELRSVPLP-QFPD-QAFRLSH-LQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC---------HLAELYRLDLDGNKL 115
N L ++P +++ L +L+ L + +P+ + L L L L+ +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 116 SGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSS-NFLTSPLPLEIGNLK 174
SLPA +NL +L+ + + ++ L+++ +L + L+ L + P G
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRA 253
Query: 175 VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNN-- 232
L + + +P +I L LE L L +P L + + + +
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
Query: 233 -NLSGAIPASL 242
L P +
Sbjct: 314 AQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 49/251 (19%), Positives = 84/251 (33%), Gaps = 24/251 (9%)
Query: 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKL 91
E+ + +S + Q L
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRAL 68
Query: 92 EGSIPDDI--CHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNL 149
+ + D + L+L L P L+ L+ +++ + L +P T
Sbjct: 69 K-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQF 126
Query: 150 KDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIG---------GLKNL 200
+ L + N L + LP I +L L + +P + GL NL
Sbjct: 127 AGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 201 EYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS-FNKLE 259
+ L L + ++ S+P S +L +LK L + N+ LS A+ ++ L LE L+L L
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 260 GEIPRGGSFGN 270
P FG
Sbjct: 244 -NYPP--IFGG 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 35/209 (16%), Positives = 60/209 (28%), Gaps = 37/209 (17%)
Query: 93 GSIPDDICHLAELYRLDLDGNKLSGSLPACFSNL--------------------TSLRIV 132
GS H + L G+ S + +I
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 133 SLGSNKLTSVPLTFWNLKDI--LNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI 190
+ L + + + L S L P + L L + +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 191 PTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL-------- 242
P + LE L L N L+ ++P S L L+ L++ +P L
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 243 -EKLSYLENLNLSFNKLEGEIPRGGSFGN 270
+ L L++L L + + +P S N
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPA--SIAN 204
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-42
Identities = 64/279 (22%), Positives = 96/279 (34%), Gaps = 11/279 (3%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S +SL L + + I P G S+E + + ++
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL-P 120
L L+ +P L L L+ L L NK E + L L + GN L
Sbjct: 285 LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPL---TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
C NL +LR + L + + + NL + +LN S N S L
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403
Query: 178 GIDFSMNNFSGVIP-TEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG 236
+D + + L L+ L L ++ L S F L +L+ LNL N+
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 237 AI---PASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
SL+ L LE L LSF L +F +
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQ--HAFTSLK 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-41
Identities = 57/278 (20%), Positives = 100/278 (35%), Gaps = 9/278 (3%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ L ++ NN + + K + +L + N N GI + +N
Sbjct: 150 FPTEKLKVLDFQNNAIHYL-SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLN 208
Query: 62 LGGNKLNGSIPITLS--KLQKLQGLGLEDNKLEGSIPDDICHLAELY--RLDLDGNKLSG 117
GG + I L +Q L ED E P L E+ ++L +
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268
Query: 118 SLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
F + L+ + L + L+ +P L + L S+N + + N L
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328
Query: 178 GIDFSMNNFSGVIPTE-IGGLKNLEYLFLGYNRLQGS--IPDSFGDLISLKFLNLSNNNL 234
+ N + T + L+NL L L ++ ++ S +L L+ LNLS N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 235 SGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
+ ++ LE L+L+F +L+ F N
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLH 425
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-40
Identities = 61/268 (22%), Positives = 107/268 (39%), Gaps = 11/268 (4%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEE-ISNLTNSTI 59
+ +L + LS N + + + S N SL + + + NL N
Sbjct: 297 LVGLSTLKKLVLSANKFENL-CQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 60 VNLGGNKLNGS--IPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG 117
++L + + S + L L LQ L L N+ + +L LDL +L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 118 SLP-ACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIG---N 172
+ F NL L++++L + L F L + +LN N +
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474
Query: 173 LKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNN 232
L L + S + S + LK + ++ L +NRL S ++ L + +LNL++N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN 533
Query: 233 NLSGAIPASLEKLSYLENLNLSFNKLEG 260
++S +P+ L LS +NL N L+
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-40
Identities = 53/277 (19%), Positives = 97/277 (35%), Gaps = 11/277 (3%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S +LT + L+ + I + + + L+ + + +S +
Sbjct: 54 SRLINLTFLDLTRCQIYWI-HEDTFQSQHR-LDTLVLTANPLIFMAETALSGPKALKHLF 111
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
++ I L + L+ L L N + +L LD N +
Sbjct: 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171
Query: 122 CFSNLTSLRIVSL--GSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKV--LI 177
S+L +SL N + + ++ +LNF + + N + L
Sbjct: 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231
Query: 178 GIDFSMNNFSGVIPTEIGGLK--NLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLS 235
F + + P GL ++E + L + ++F L+ L+L+ +LS
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
Query: 236 GAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
+P+ L LS L+ L LS NK E S NF
Sbjct: 292 -ELPSGLVGLSTLKKLVLSANKFENLCQ--ISASNFP 325
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-39
Identities = 49/271 (18%), Positives = 94/271 (34%), Gaps = 11/271 (4%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ L + L+ NPL + +T++ +L+ IS + N +
Sbjct: 78 QSQHRLDTLVLTANPLIFM-AETALSGPK-ALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAEL--YRLDLDGNKLSGSL 119
LG N ++ +KL+ L ++N + +D+ L + L+L+GN ++ +
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GI 194
Query: 120 PACFSNLTSLRIVSLGSNKLTSVP---LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKV- 175
+ + ++ G + V L ++ + F P L
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
Query: 176 -LIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234
+ I+ + F + L+ L L L +P L +LK L LS N
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 235 SGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265
S L +L++ N E+ G
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-39
Identities = 61/293 (20%), Positives = 105/293 (35%), Gaps = 17/293 (5%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
L + L+ L + + LS +L+ + SN + T ++
Sbjct: 275 HCFSGLQELDLTATHLSELPS--GLVGLS-TLKKLVLSANKFENLCQISASNFPSLTHLS 331
Query: 62 LGGNKLNGSI-PITLSKLQKLQGLGLEDNKLEGS--IPDDICHLAELYRLDLDGNKLSGS 118
+ GN + L L+ L+ L L + +E S + +L+ L L+L N+
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 119 LPACFSNLTSLRIVSLGSNKLTSVPL--TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVL 176
F L ++ L +L F NL + LN S + L L L
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451
Query: 177 IGIDFSMNNFSGVIPTEIG---GLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNN 233
++ N+F + L LE L L + L +F L + ++LS+N
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511
Query: 234 LSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAES---FEGNELLC 283
L+ + +L L + LNL+ N + +P S + N L C
Sbjct: 512 LTSSSIEALSHLKGIY-LNLASNHISIILP--SLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-35
Identities = 52/269 (19%), Positives = 90/269 (33%), Gaps = 13/269 (4%)
Query: 10 IYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNG 69
N L+ I P G L +S E + S L N T ++L ++
Sbjct: 17 YNCENLGLNEI-P----GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 70 SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSL 129
T +L L L N L + L L +S N +L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 130 RIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN-NFS 187
+ LGSN ++S+ L + + + L+F +N + ++ +L+ + ++N N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 188 GVIPTEIGGLKNLEYLFLGYNRLQGSIPD--SFGDLISLKFLNLSNNNLSGAIPASLEKL 245
I + L G + I + SL + + PA E L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 246 S--YLENLNLSFNKLEGEIPRGGSFGNFS 272
+E++NL + +F FS
Sbjct: 252 CEMSVESINLQKHYFFNISS--NTFHCFS 278
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 45/205 (21%), Positives = 71/205 (34%), Gaps = 6/205 (2%)
Query: 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSV-PL 144
E+ L IP + L+ N L FS L +L + L ++ +
Sbjct: 19 CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 145 TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLF 204
TF + + L ++N L + K L + F S + + K LE L+
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 205 LGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN--LNLSFNKLEGEI 262
LG N + LK L+ NN + + L N LNL+ N + G
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195
Query: 263 PRGGSFGNFSAESFEGNELLCGSPN 287
P F + +F G + L
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFK 220
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-24
Identities = 50/238 (21%), Positives = 83/238 (34%), Gaps = 10/238 (4%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
N L + LS N + + LE + + + NL ++
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKE--CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSI---PDDICHLAELYRLDLDGNKLSG 117
NL + L+ S L LQ L L+ N + + L L L L LS
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 118 SLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
F++L + V L N+LTS + + + LN +SN ++ LP + L
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQR 550
Query: 178 GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLS 235
I+ N LE+ +L+ + + L+ + LS+ LS
Sbjct: 551 TINLRQNPLDCTC--SNIYF--LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 5e-40
Identities = 58/258 (22%), Positives = 112/258 (43%), Gaps = 18/258 (6%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
N +L +YL+ + + I P + NL+ + + + +SN+T +
Sbjct: 107 QNLTNLRELYLNEDNISDISP---LANLT-KMYSLNLGANHNLS-DLSPLSNMTGLNYLT 161
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
+ +K+ PI + L L L L N++E P + L L+ N+++ P
Sbjct: 162 VTESKVKDVTPI--ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP- 216
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+N+T L + +G+NK+T + NL + L +N ++ + +L L ++
Sbjct: 217 -VANMTRLNSLKIGNNKITDLS-PLANLSQLTWLEIGTNQISDINAV--KDLTKLKMLNV 272
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
N S + + L L LFL N+L + G L +L L LS N+++ P
Sbjct: 273 GSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-- 328
Query: 242 LEKLSYLENLNLSFNKLE 259
L LS +++ + + ++
Sbjct: 329 LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 18/262 (6%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
SN LT +Y+ N + I +++ NL+ +L + + NIS ++NLT +N
Sbjct: 85 SNLVKLTNLYIGTNKITDI---SALQNLT-NLRELYLNEDNISD--ISPLANLTKMYSLN 138
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
LG N S LS + L L + ++K++ P I +L +LY L L+ N++ P
Sbjct: 139 LGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP- 194
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
++LTSL + N++T + N+ + +L +N +T PL NL L ++
Sbjct: 195 -LASLTSLHYFTAYVNQITDIT-PVANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEI 250
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
N S + + L L+ L +G N++ S +L L L L+NN L
Sbjct: 251 GTNQISDINA--VKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEV 306
Query: 242 LEKLSYLENLNLSFNKLEGEIP 263
+ L+ L L LS N + P
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-39
Identities = 63/264 (23%), Positives = 112/264 (42%), Gaps = 20/264 (7%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ +L + L+ N + I P + NL L + + I+ + NLTN +
Sbjct: 62 IEYLTNLEYLNLNGNQITDISP---LSNLV-KLTNLYIGTNKIT--DISALQNLTNLREL 115
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L + ++ P L+ L K+ L L N S + ++ L L + +K+ P
Sbjct: 116 YLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP 172
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
+NLT L +SL N++ + +L + N +T P+ N+ L +
Sbjct: 173 --IANLTDLYSLSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITPV--ANMTRLNSLK 227
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
N + + P + L L +L +G N++ ++ DL LK LN+ +N +S +
Sbjct: 228 IGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--IS 281
Query: 241 SLEKLSYLENLNLSFNKLEGEIPR 264
L LS L +L L+ N+L E
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 58/259 (22%), Positives = 105/259 (40%), Gaps = 20/259 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
++ L + ++ + L S+ + ++ + I LTN +N
Sbjct: 19 ADLAEGIRAVLQKASVTDVVTQ---EELE-SITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L GN++ P LS L KL L + NK+ + + +L L L L+ + +S P
Sbjct: 73 LNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP- 127
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+NLT + ++LG+N S N+ + L + + + P I NL L +
Sbjct: 128 -LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
+ N + P + L +L Y N++ P ++ L L + NN ++ P
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238
Query: 242 LEKLSYLENLNLSFNKLEG 260
L LS L L + N++
Sbjct: 239 LANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 47/215 (21%), Positives = 92/215 (42%), Gaps = 14/215 (6%)
Query: 49 EEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108
++L L + +T +L+ + L + K+ SI I +L L L
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYL 71
Query: 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPL 168
+L+GN+++ P SNL L + +G+NK+T + NL ++ L + + ++ PL
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS-ALQNLTNLRELYLNEDNISDISPL 128
Query: 169 EIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLN 228
NL + ++ N+ + + + L YL + ++++ P +L L L+
Sbjct: 129 --ANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 229 LSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
L+ N + P L L+ L N++ P
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 26/138 (18%), Positives = 55/138 (39%), Gaps = 12/138 (8%)
Query: 126 LTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNN 185
+L + N++ +L + + +T + E L+ + + +
Sbjct: 2 AATLATLPAPINQIFPDA----DLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEK 55
Query: 186 FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKL 245
+ + I L NLEYL L N++ P +L+ L L + N ++ ++L+ L
Sbjct: 56 VASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNL 109
Query: 246 SYLENLNLSFNKLEGEIP 263
+ L L L+ + + P
Sbjct: 110 TNLRELYLNEDNISDISP 127
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 68/263 (25%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+S SL + N D + NL+ +LE + + +S ++ LTN +
Sbjct: 152 LSGLTSLQQLSFGNQVTDLK----PLANLT-TLERLDISSNKVSD--ISVLAKLTNLESL 204
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
N+++ P L L L L L N+L+ + L L LDL N++S P
Sbjct: 205 IATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
S LT L + LG+N+++++ L + NL + N L P I NLK L +
Sbjct: 261 --LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
NN S + P + L L+ LF N++ S S +L ++ +L+ +N +S P
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP- 370
Query: 241 SLEKLSYLENLNLSFNKLEGEIP 263
L L+ + L L+
Sbjct: 371 -LANLTRITQLGLNDQAWTNAPV 392
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 22/262 (8%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ L + + +T + + + I + + L N T +N
Sbjct: 21 TALAEKMKTVLGKTNVTDTVSQTDLDQV----TTLQADRLGIK--SIDGVEYLNNLTQIN 74
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
N+L P L L KL + + +N++ P + +L L L L N+++ P
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP- 129
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
NLT+L + L SN ++ + L + L+F + + NL L +D
Sbjct: 130 -LKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDI 184
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
S N S + + L NLE L N++ P G L +L L+L+ N L +
Sbjct: 185 SSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGT 238
Query: 242 LEKLSYLENLNLSFNKLEGEIP 263
L L+ L +L+L+ N++ P
Sbjct: 239 LASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 54/258 (20%), Positives = 107/258 (41%), Gaps = 19/258 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ +L + +NN + I P +G L+ +L++ + + +++LTN T ++
Sbjct: 196 AKLTNLESLIATNNQISDITP---LGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLD 249
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L N+++ P LS L KL L L N++ P + L L L+L+ N+L P
Sbjct: 250 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP- 304
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
SNL +L ++L N ++ + +L + L F +N ++ L NL + +
Sbjct: 305 -ISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFYNNKVSDVSSL--ANLTNINWLSA 360
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
N S + P + L + L L + + ++ + L PA+
Sbjct: 361 GHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APAT 416
Query: 242 LEKLSYLENLNLSFNKLE 259
+ ++++N
Sbjct: 417 ISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-29
Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 49 EEISNLTNSTIVNLGGNKLNGSIPIT--------------------LSKLQKLQGLGLED 88
+ L LG + ++ T + L L + +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSN 77
Query: 89 NKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWN 148
N+L P + +L +L + ++ N+++ P +NLT+L ++L +N++T + N
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID-PLKN 132
Query: 149 LKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYN 208
L ++ L SSN ++ L L L + F N + + P + L LE L + N
Sbjct: 133 LTNLNRLELSSNTISDISAL--SGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSN 187
Query: 209 RLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG 260
++ S L +L+ L +NN +S P L L+ L+ L+L+ N+L+
Sbjct: 188 KV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 44/213 (20%), Positives = 74/213 (34%), Gaps = 36/213 (16%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S LT + L N + I + + L+ +L + + + ISNL N T +
Sbjct: 262 SGLTKLTELKLGANQISNI---SPLAGLT-ALTNLELNENQLED--ISPISNLKNLTYLT 315
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L N ++ P +S L KLQ L +NK+ + +L + L N++S P
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 370
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVL----- 176
+NLT + + L T+ P+ + I N + P I +
Sbjct: 371 -LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIA-PATISDGGSYTEPDI 428
Query: 177 ------------------IGIDFSMNNFSGVIP 191
+ I FSG +
Sbjct: 429 TWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 18/94 (19%), Positives = 34/94 (36%), Gaps = 6/94 (6%)
Query: 170 IGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNL 229
L + N + + L + L + D L +L +N
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 230 SNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
SNN L+ P L+ L+ L ++ ++ N++ P
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 45/281 (16%), Positives = 103/281 (36%), Gaps = 18/281 (6%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
N + ++++ L L S+ + ++++ + +S +++ T ++NL
Sbjct: 8 NGNRYKIEKVTDSSLKQALA--SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 63 GGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPAC 122
N L ++ + L L+ L L +N ++ ++ + L N +S +
Sbjct: 66 SSNVLYETLDL--ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSR 118
Query: 123 FSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTS-PLPLEIGNLKVLIGID 180
++ L +NK+T + L + L+ N + + + L ++
Sbjct: 119 GQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
N + ++ L+ L L N+L + F + +++L NN L I
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 241 SLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281
+L LE+ +L N R N ++ +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-35
Identities = 44/229 (19%), Positives = 87/229 (37%), Gaps = 17/229 (7%)
Query: 46 GIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAEL 105
I E N I + + L ++ ++ L L N L D+ +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 106 YRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSP 165
L+L N L +L++LR + L +N + + I L+ ++N ++
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQELL----VGPSIETLHAANNNISR- 113
Query: 166 LPLEIG-NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPDSFGDLIS 223
+ G K + + N + + + G ++YL L N + + + +
Sbjct: 114 VSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 224 LKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
L+ LNL N + + + + L+ L+LS NKL + F + +
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGP--EFQSAA 214
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 45/253 (17%), Positives = 93/253 (36%), Gaps = 17/253 (6%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ L L+ LS+N L L + +LS +L + N + E+ + ++
Sbjct: 55 APFTKLELLNLSSNVLYETLD---LESLS-TLRTLDLNNNYVQ-----ELLVGPSIETLH 105
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG-SLP 120
N ++ ++ S+ Q + + L +NK+ D + + LDL N++ +
Sbjct: 106 AANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
++ +L ++L N + V + L+ SSN L + E + + I
Sbjct: 163 ELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ-GSIPDSFGDLISLKFLNLSNNNLSGAIP 239
N +I + +NLE+ L N G++ D F ++ +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 240 ASLEKLSYLENLN 252
+ L +
Sbjct: 280 EEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 33/235 (14%), Positives = 81/235 (34%), Gaps = 15/235 (6%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S+ ++ +NN + + + ++ + N I+ + + ++
Sbjct: 96 LVGPSIETLHAANNNISRVSC-----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 62 LGGNKLNG-SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L N+++ + + L+ L L+ N + + + A+L LDL NKL+ +
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMG 207
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
F + + +SL +NKL + +++ + + N L K
Sbjct: 208 PEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQT 266
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLS 235
+ + + + L +P F D + + L +++
Sbjct: 267 VAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL----IALGHHHHH 316
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-36
Identities = 49/279 (17%), Positives = 86/279 (30%), Gaps = 25/279 (8%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSH-----------------SLEDFRMYNCNIS 44
+++ + L+ + + L+ + S
Sbjct: 282 HCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS 341
Query: 45 GGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQ--KLQGLGLEDNKLEGSIPDDICHL 102
I + L + + ++L N L+ S + S L L+ L L N + + L
Sbjct: 342 --ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGL 398
Query: 103 AELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
EL LD + L F +L L + + F L + L + N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 161 -FLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFG 219
F + L N L +D S + L L+ L + +N L +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 220 DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
L SL L+ S N + + L NL+ N +
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 63/291 (21%), Positives = 105/291 (36%), Gaps = 19/291 (6%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
S I LS NPL + S N S L+ + C I + L + + + L GN
Sbjct: 33 STKNIDLSFNPLKIL-KSYSFSNFSE-LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG-SLPACFS 124
+ P + S L L+ L + KL I L L +L++ N + LPA FS
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 125 NLTSLRIVSLGSNKLTSVP-LTFWNLKD----ILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
NLT+L V L N + ++ L++ L+L+ S N + + + L +
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHEL 209
Query: 180 DFSMNNFSGVIP-TEIGGLKNLEYL------FLGYNRLQGSIPDSFGDLISLKF--LNLS 230
N S I T + L L F L+ P L + L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269
Query: 231 NNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281
N L+ + ++L+ ++ + + + S +L
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-33
Identities = 47/283 (16%), Positives = 93/283 (32%), Gaps = 20/283 (7%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
++T + L + ++ S ++ + + SN + ++L
Sbjct: 10 VVPNITY-QCMDQKLSKVPD-----DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDL 63
Query: 63 GGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPAC 122
++ L L L L N ++ P L L L KL+
Sbjct: 64 SRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP 123
Query: 123 FSNLTSLRIVSLGSNKLTSVPL--TFWNLKDILNLNFSSNFLTSPLPLEIGNLK----VL 176
L +L+ +++ N + S L F NL ++++++ S N++ + ++ L+ V
Sbjct: 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVN 183
Query: 177 IGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-DSFGDLISLKFLNLS----- 230
+ +D S+N I + L L L N +I +L L L
Sbjct: 184 LSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242
Query: 231 -NNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
NL P+ +E L + F +
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 59/284 (20%), Positives = 98/284 (34%), Gaps = 24/284 (8%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKT--SVGNLSHSLEDFRMYNCNISGGIPEEISNLTNST 58
SN +L + LS N + I + M I I ++
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLH 207
Query: 59 IVNLGGNKLNGSIP-ITLSKLQKLQGLGLEDNKLEG---------SIPDDICHLAELYRL 108
+ L GN + +I L L L L + + SI + +C +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE-F 266
Query: 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPL 168
L F L ++ +SL + + +L+ L L
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE-DVPKHFKWQSLSIIRCQLKQFPTL 325
Query: 169 EIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL--ISLKF 226
++ LK L +MN S I + L +L YL L N L S S+ DL SL+
Sbjct: 326 DLPFLKSL---TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 227 LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGN 270
L+LS N + A+ L L++L+ + L+ + +F +
Sbjct: 381 LDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 49/280 (17%), Positives = 91/280 (32%), Gaps = 23/280 (8%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
L+ + L+ NP+ S L+ SLE+ ++ I L +N
Sbjct: 77 HGLHHLSNLILTGNPIQSF-SPGSFSGLT-SLENLVAVETKLASLESFPIGQLITLKKLN 134
Query: 62 LGGNKLNG-SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAEL----YRLDLDGNKLS 116
+ N ++ +P S L L + L N ++ +D+ L E LD+ N +
Sbjct: 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194
Query: 117 GSLPACFSNLTSLRIVSLGSNKLTS--VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLK 174
F + L ++L N +S + NL + LEI
Sbjct: 195 FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253
Query: 175 VLIG--------IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKF 226
++ G + N + L N+ + L + + +
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQS 311
Query: 227 LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG 266
L++ L P L +L++L L+ NK +
Sbjct: 312 LSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVA 348
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 39/157 (24%), Positives = 59/157 (37%), Gaps = 6/157 (3%)
Query: 117 GSLPACFSNLTSLRIVSLGSNKLTSVPLT-FWNLKDILNLNFSSNFLTSPLPLEIGNLKV 175
GSL C + ++ KL+ VP + K N++ S N L N
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSKVPDDIPSSTK---NIDLSFNPLKILKSYSFSNFSE 57
Query: 176 LIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLS 235
L +D S + GL +L L L N +Q P SF L SL+ L L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 236 GAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
+ +L L+ LN++ N + F N +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 29/156 (18%), Positives = 51/156 (32%), Gaps = 3/156 (1%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
+ + L + +S L+ SL +M + + +N TN T +
Sbjct: 421 LSLEKLLYLDISYTNTKID-FDGIFLGLT-SLNTLKMAGNSFKDNTLSNVFANTTNLTFL 478
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+L +L L +LQ L + N L L L LD N++ S
Sbjct: 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLN 156
SL +L +N + + L+ +
Sbjct: 539 ILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQK 574
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-35
Identities = 60/287 (20%), Positives = 109/287 (37%), Gaps = 10/287 (3%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
++ L + L+ N + + P +L + + + IP + + L+N T +
Sbjct: 53 ASFPHLEELELNENIVSAVEPGAFNNL--FNLRTLGLRSNRLKL-IPLGVFTGLSNLTKL 109
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSL 119
++ NK+ + L L+ L + DN L I L L +L L+ L+
Sbjct: 110 DISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIP 168
Query: 120 PACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIG 178
S+L L ++ L + ++ +F L + L S + L
Sbjct: 169 TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228
Query: 179 IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAI 238
+ + N + V + L L +L L YN + +L+ L+ + L L+
Sbjct: 229 LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288
Query: 239 PASLEKLSYLENLNLSFNKLEGEIPRG--GSFGNFSAESFEGNELLC 283
P + L+YL LN+S N+L + S GN + N L C
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 54/269 (20%), Positives = 104/269 (38%), Gaps = 10/269 (3%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
+ + P+ + + I +E ++ + + L N
Sbjct: 12 QDRAVLCHRKRFVAV-PE----GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLPACFS 124
++ P + L L+ LGL N+L+ IP + L+ L +LD+ NK+ L F
Sbjct: 67 IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 125 NLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSM 183
+L +L+ + +G N L + F L + L LTS + +L LI +
Sbjct: 126 DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185
Query: 184 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLE 243
N + + L L+ L + + ++ + ++L L++++ NL+ ++
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245
Query: 244 KLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
L YL LNLS+N + I
Sbjct: 246 HLVYLRFLNLSYNPIS-TIEG-SMLHELL 272
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 45/281 (16%), Positives = 103/281 (36%), Gaps = 18/281 (6%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
N + ++++ L L S+ + ++++ + +S +++ T ++NL
Sbjct: 8 NGNRYKIEKVTDSSLKQALA--SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 63 GGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPAC 122
N L ++ + L L+ L L +N ++ ++ + L N +S +
Sbjct: 66 SSNVLYETLDL--ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSR 118
Query: 123 FSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTS-PLPLEIGNLKVLIGID 180
++ L +NK+T + L + L+ N + + + L ++
Sbjct: 119 GQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
N + ++ L+ L L N+L + F + +++L NN L I
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 241 SLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281
+L LE+ +L N R N ++ +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 43/216 (19%), Positives = 83/216 (38%), Gaps = 14/216 (6%)
Query: 46 GIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAEL 105
I E N I + + L ++ ++ L L N L D+ +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 106 YRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSP 165
L+L N L +L++LR + L +N + + I L+ ++N ++
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQELL----VGPSIETLHAANNNISR- 113
Query: 166 LPLEIG-NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPDSFGDLIS 223
+ G K + + N + + + G ++YL L N + + + +
Sbjct: 114 VSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 224 LKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
L+ LNL N + + + + L+ L+LS NKL
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-30
Identities = 39/259 (15%), Positives = 92/259 (35%), Gaps = 19/259 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ ++ + LS NPL I + + LE + + + ++ +L+ ++
Sbjct: 31 QSAWNVKELDLSGNPLSQISAAD-LAPFT-KLELLNLSSNVLYE--TLDLESLSTLRTLD 86
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L N + L ++ L +N + + + L NK++
Sbjct: 87 LNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDL 138
Query: 122 CFSNLTSLRIVSLGSNKLTSVPL--TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+ ++ + L N++ +V + + +LN NF+ + ++ L +
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTL 196
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLS-GAI 238
D S N + + E + ++ L N+L I + +L+ +L N G +
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 239 PASLEKLSYLENLNLSFNK 257
K ++ + K
Sbjct: 255 RDFFSKNQRVQTVAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 39/267 (14%), Positives = 74/267 (27%), Gaps = 11/267 (4%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISG-GIPEEISNLTNSTIV 60
S + IYL+NN + + G S ++ + I E ++ +
Sbjct: 117 SRGQGKKNIYLANNKITML-RDLDEGCRS-RVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
NL N + + KL+ L L NKL + + A + + L NKL +
Sbjct: 175 NLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
+L L N L + K+ + + V
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS----IPDSFGDLISLKFLNLSNNNLSG 236
+ + L L+ QGS + + + ++
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 237 AIPASLEKLSYLENLNLSFNKLEGEIP 263
I + L L+ ++
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 35/269 (13%), Positives = 85/269 (31%), Gaps = 15/269 (5%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S+ ++ +NN + + + ++ + N I+ + + ++
Sbjct: 96 LVGPSIETLHAANNNISRVSC-----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 62 LGGNKLNG-SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L N+++ + + L+ L L+ N + + + A+L LDL NKL+ +
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMG 207
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
F + + +SL +NKL + +++ + + N L K
Sbjct: 208 PEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQT 266
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG---- 236
+ + G + LI+LK + + G
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE 326
Query: 237 AIPASLEKLSYLENLNLSFNKLEGEIPRG 265
+ E + ++ + +
Sbjct: 327 RLECERENQARQREIDALKEQYR-TVIDQ 354
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 31/264 (11%), Positives = 71/264 (26%), Gaps = 13/264 (4%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ + L N +D + + +LE + I + ++ +
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASS-DTLEHLNLQYNFIYD-VKGQV-VFAKLKTL 196
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLS-GSL 119
+L NKL + + + L +NKL I + L DL GN G+L
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 120 PACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIG 178
FS ++ ++ + + ++ + L L
Sbjct: 255 RDFFSKNQRVQ--TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKR 312
Query: 179 IDFSM----NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234
+ ++ + + + E + + + I + L L
Sbjct: 313 KEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKAL 372
Query: 235 SGAIPASLEKLSYLENLNLSFNKL 258
+ + L+
Sbjct: 373 DEQVSNGRRAHAELDGTLQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 24/98 (24%), Positives = 38/98 (38%), Gaps = 3/98 (3%)
Query: 170 IGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNL 229
N + ++ + + N++ L L N L L+ LNL
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 230 SNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGS 267
S+N L LE LS L L+L+ N ++ E+ G S
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPS 100
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 19/71 (26%), Positives = 29/71 (40%)
Query: 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 249
I + + + L+ ++ ++K L+LS N LS A L + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 250 NLNLSFNKLEG 260
LNLS N L
Sbjct: 62 LLNLSSNVLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 16/242 (6%), Positives = 42/242 (17%), Gaps = 26/242 (10%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLS----------HSLEDFRMYNC--------- 41
+ ++L L N + L C
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 42 -----NISGGIPEEISNLTNSTIVNLGG-NKLNGSIPITLSKLQKLQGLGLEDNKLEGSI 95
++ + + L L G + + + + + I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 96 PDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNL 155
L+ L + L + + + L
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLL 412
Query: 156 NFSSNFLTSPL-PLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI 214
+ + D + + + K L ++
Sbjct: 413 RAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATL 472
Query: 215 PD 216
+
Sbjct: 473 QE 474
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-34
Identities = 64/261 (24%), Positives = 102/261 (39%), Gaps = 41/261 (15%)
Query: 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLG 63
++ + + L LP L + + + N++ +P L + +
Sbjct: 39 NNGNAVLNVGESGL-TTLPD----CLPAHITTLVIPDNNLTS-LPALPPELRT---LEVS 89
Query: 64 GNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACF 123
GN+L S+P+ L +L L L +L + GN+L+ SLP
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLP 140
Query: 124 SNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSM 183
L L S+ N+L S+P L L +N LTS LP+ L+ L S
Sbjct: 141 PGLQEL---SVSDNQLASLPALPSELC---KLWAYNNQLTS-LPMLPSGLQEL---SVSD 190
Query: 184 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLE 243
N + +PT L L NRL S+P LK L +S N L+ ++P
Sbjct: 191 NQLA-SLPTLPSELYKLWAY---NNRLT-SLPALPS---GLKELIVSGNRLT-SLPVLPS 241
Query: 244 KLSYLENLNLSFNKLEGEIPR 264
+ L+ L +S N+L +P
Sbjct: 242 E---LKELMVSGNRLT-SLPM 258
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-33
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 37/263 (14%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
L++ L + L ++ ++ +P L +
Sbjct: 100 PPGLLELSIFSNPLTHLPALPS---------GLCKLWIFGNQLTS-LPVLPPGLQE---L 146
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
++ N+L S+P S+L KL +N+L S+P L EL + N+L+ SLP
Sbjct: 147 SVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLP 197
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
S L L +N+LTS+P LK L S N LTS LP+ LK L
Sbjct: 198 TLPSELYKL---WAYNNRLTSLPALPSGLK---ELIVSGNRLTS-LPVLPSELKEL---M 247
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
S N + +P L L + N+L +P+S L S +NL N LS
Sbjct: 248 VSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302
Query: 241 SLEKLSYLENLNLSFNKLEGEIP 263
+L +++ + + +
Sbjct: 303 ALREITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 49/208 (23%), Positives = 79/208 (37%), Gaps = 37/208 (17%)
Query: 73 ITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIV 132
+ L + ++ L ++PD + A + L + N L+ SLPA L +L
Sbjct: 34 MRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE-- 87
Query: 133 SLGSNKLTSVPLTFWNLK--DILN---------------LNFSSNFLTSPLPLEIGNLKV 175
+ N+LTS+P+ L I + L N LTS LP+ L+
Sbjct: 88 -VSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LPVLPPGLQE 145
Query: 176 LIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLS 235
L S N + +P L L N+L S+P L+ L++S+N L+
Sbjct: 146 L---SVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPS---GLQELSVSDNQLA 194
Query: 236 GAIPASLEKLSYLENLNLSFNKLEGEIP 263
++P +L L N L
Sbjct: 195 -SLPTLPSELYKLWAYNNRLTSLPALPS 221
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 32/171 (18%), Positives = 62/171 (36%), Gaps = 16/171 (9%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
L ++ NN L TS+ L L++ + ++ +P S L + + GN
Sbjct: 202 ELYKLWAYNNRL------TSLPALPSGLKELIVSGNRLTS-LPVLPSELKE---LMVSGN 251
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSN 125
+L S+P+ S L L + N+L +P+ + HL+ ++L+GN LS
Sbjct: 252 RLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR 305
Query: 126 LTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVL 176
+ G + + ++++L E
Sbjct: 306 EITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRW 356
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 62/293 (21%), Positives = 115/293 (39%), Gaps = 26/293 (8%)
Query: 2 SNCK-SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
C+ L ++ S+ L+ + PK +L + N I+ + NL N +
Sbjct: 27 FRCQCHLRVVQCSDLGLEKV-PK----DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTL 81
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L NK++ P + L KL+ L L N+L+ +P+ + L L + N+++
Sbjct: 82 ILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRK 138
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPL---TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
+ F+ L + +V LG+N L S + F +K + + + +T+ + G L
Sbjct: 139 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLT 195
Query: 178 GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGA 237
+ N + V + GL NL L L +N + S + L+ L+L+NN L
Sbjct: 196 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 254
Query: 238 IPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQV 290
+P L Y++ + L N + + F +
Sbjct: 255 VPGGLADHKYIQVVYLHNNNIS----------AIGSNDFCPPGYNTKKASYSG 297
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 58/272 (21%), Positives = 103/272 (37%), Gaps = 21/272 (7%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG 64
L+ L NN + I NL + L + N IS P + L + L
Sbjct: 52 PDTALLDLQNNKITEI-KDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSL--PA 121
N+L +P + + LQ L + +N++ + + L ++ ++L N L S
Sbjct: 110 NQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 122 CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
F + L + + +T++P +L L+ N +T + L L +
Sbjct: 166 AFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLG 222
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG---- 236
S N+ S V + +L L L N+L +P D ++ + L NNN+S
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281
Query: 237 --AIPASLEKLSYLENLNLSFNKLE-GEIPRG 265
P K + ++L N ++ EI
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 49/269 (18%), Positives = 100/269 (37%), Gaps = 48/269 (17%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
+ L +YLS N L + + +L++ R++ I+ + + + + L +V
Sbjct: 97 APLVKLERLYLSKNQLKELPE-----KMPKTLQELRVHENEITK-VRKSVFNGLNQMIVV 150
Query: 61 NLGGNKLNGSI--PITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGS 118
LG N L S ++KL + + D + +IP + L L LDGNK++
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKV 207
Query: 119 LPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
A L +L + L N +++V + N + L+ ++N L
Sbjct: 208 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK------------- 254
Query: 178 GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS-------FGDLISLKFLNLS 230
+P + K ++ ++L N + +I + S ++L
Sbjct: 255 ------------VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLF 301
Query: 231 NNNLSGAI--PASLEKLSYLENLNLSFNK 257
+N + P++ + + L K
Sbjct: 302 SNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 65/292 (22%), Positives = 106/292 (36%), Gaps = 27/292 (9%)
Query: 2 SNCK-SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
C L ++ S+ L + PK +S + N +IS ++ L + +
Sbjct: 29 FGCHCHLRVVQCSDLGLKAV-PK----EISPDTTLLDLQNNDISELRKDDFKGLQHLYAL 83
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L NK++ S L+KLQ L + N L IP ++ + L L + N++
Sbjct: 84 VLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPK 140
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPL---TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
FS L ++ + +G N L + F LK + L S LT L L
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKDLPETLNEL- 198
Query: 178 GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGA 237
N + ++ L L LG+N+++ S L +L+ L+L NN LS
Sbjct: 199 --HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-R 255
Query: 238 IPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQ 289
+PA L L L+ + L N + F
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNIT----------KVGVNDFCPVGFGVKRAYYN 297
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/267 (21%), Positives = 99/267 (37%), Gaps = 45/267 (16%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
S + L +Y+S N L I P NL SL + R+++ I +P+ + S L N +
Sbjct: 99 SPLRKLQKLYISKNHLVEIPP-----NLPSSLVELRIHDNRIRK-VPKGVFSGLRNMNCI 152
Query: 61 NLGGNKL-NGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
+GGN L N KL L + + KL IP D+ L L LD NK+
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIE 209
Query: 120 PACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIG 178
+ L + LG N++ + + L + L+ +N L+
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-------------- 255
Query: 179 IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL------ISLKFLNLSNN 232
+P + LK L+ ++L N + + F + ++L NN
Sbjct: 256 -----------VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNN 304
Query: 233 NLSGAI--PASLEKLSYLENLNLSFNK 257
+ PA+ ++ + K
Sbjct: 305 PVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 50/262 (19%), Positives = 100/262 (38%), Gaps = 15/262 (5%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ +++ L + ++ + + + + + NC ++ +L +
Sbjct: 279 NCLTNVSSFSLVSVTIERVKD----FSYNFGWQHLELVNCKFGQFPTLKLKSLKR---LT 331
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLE--GSIPDDICHLAELYRLDLDGNKLSGSL 119
NK + + L L+ L L N L G L LDL N + ++
Sbjct: 332 FTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 388
Query: 120 PACFSNLTSLRIVSLGSNKLTSVP--LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
+ F L L + + L + F +L++++ L+ S L L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 178 GIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG 236
+ + N+F +I L+NL +L L +L+ P +F L SL+ LN+++N L
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS 508
Query: 237 AIPASLEKLSYLENLNLSFNKL 258
++L+ L+ + L N
Sbjct: 509 VPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-29
Identities = 59/294 (20%), Positives = 101/294 (34%), Gaps = 40/294 (13%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSH------SLEDFRMYNCNISGGIPEEISNLTNSTI 59
L + L NN + KT + L+ L +FR N+ + L N TI
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG-NLEKFDKSALEGLCNLTI 259
Query: 60 VNLGGNKLNGS---IPITLSKLQKLQGLGLEDNKLEGSIPDDICH--------------- 101
L+ I + L + L +E + D +
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQ 318
Query: 102 -----LAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT---FWNLKDIL 153
L L RL NK + +L SL + L N L+ + +
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 154 NLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQG 212
L+ S N + + + L+ L +DF +N + + L+NL YL + + +
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 213 SIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLSFNKLEGEIPRG 265
+ F L SL+ L ++ N+ +L L L+LS +LE ++
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 488
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 62/269 (23%), Positives = 95/269 (35%), Gaps = 19/269 (7%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
S + LS NPL + S + L+ + C I +L++ + + L GN
Sbjct: 29 STKNLDLSFNPLRHL-GSYSFFSFPE-LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKL-SGSLPACFS 124
+ S L LQ L + L I HL L L++ N + S LP FS
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 125 NLTSLRIVSLGSNKLTSVPL-TFWNLK----DILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
NLT+L + L SNK+ S+ L L+L+ S N + + L +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205
Query: 180 DFSMNNFSGVIP-TEIGGLKNLEYL------FLGYNRLQGSIPDSFGDLISLKFLNLSNN 232
N S + T I GL LE F L+ + L +L
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 233 NLSG---AIPASLEKLSYLENLNLSFNKL 258
L I L+ + + +L +
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-27
Identities = 45/245 (18%), Positives = 86/245 (35%), Gaps = 14/245 (5%)
Query: 28 NLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLE 87
NL S ++ + + + +++L ++ L L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 88 DNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL--T 145
N ++ L+ L +L L+ +L +L+ +++ N + S L
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 146 FWNLKDILNLNFSSNFLTSPLPLEIGNLKVL----IGIDFSMNNFSGVIPTEIGGLKNLE 201
F NL ++ +L+ SSN + S ++ L + + +D S+N + I L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203
Query: 202 YLFLGYNRLQGSIPD-SFGDLISLKFLNL------SNNNLSGAIPASLEKLSYLENLNLS 254
L L N ++ L L+ L + NL ++LE L L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 255 FNKLE 259
L+
Sbjct: 264 LAYLD 268
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 57/311 (18%), Positives = 108/311 (34%), Gaps = 54/311 (17%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV- 60
+ K+L + +++N + NL+ +LE + + I ++ L ++
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 61 ---NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC----------------- 100
+L N +N I K +L L L +N ++
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 101 --------------HLAELYRLDLDGNKLSGS---LPACFSNLTSLRIVSLGSNKLTSVP 143
L L + L + F+ LT++ SL S + V
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 144 --LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLE 201
+ + + +N + L++ +LK L F+ N L +LE
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRL---TFTSNKGGNAFSEV--DLPSLE 350
Query: 202 YLFLGYNRLQ--GSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
+L L N L G S SLK+L+LS N + + ++ L LE+L+ + L+
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
Query: 260 GEIPRGGSFGN 270
++ F +
Sbjct: 410 -QMSEFSVFLS 419
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 45/241 (18%), Positives = 80/241 (33%), Gaps = 18/241 (7%)
Query: 1 MSNCKSLTLIYLSNNPLDGI-LPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTI 59
+ L L+ + L + N G E+ +L +
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS----------NKGGNAFSEV-DLPSLEF 351
Query: 60 VNLGGNKLN--GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG 117
++L N L+ G + L+ L L N + ++ + L +L LD + L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 118 SLPAC-FSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEI-GNLK 174
F +L +L + + F L + L + N +I L+
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 175 VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234
L +D S + PT L +L+ L + N+L+ F L SL+ + L N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
Query: 235 S 235
Sbjct: 531 D 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-22
Identities = 61/304 (20%), Positives = 103/304 (33%), Gaps = 40/304 (13%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ L+ + L+ NP+ L + LS SL+ N++ I +L +N
Sbjct: 73 QSLSHLSTLILTGNPIQS-LALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 62 LGGNKLN-GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAEL----YRLDLDGNKLS 116
+ N + +P S L L+ L L NK++ D+ L ++ LDL N ++
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 117 GSLPACFSNLTSLRIVSLGSNKLTS--VPLTFWNLKD------ILNLNFSSNFLTSPLPL 168
P F + L ++L +N + + L +L + L
Sbjct: 191 FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 169 EIGNLKVLIGIDFSMN---NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSF------- 218
+ L L +F + + I L N+ L ++ S+
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 219 ------------GDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG 266
L SLK L ++N A S L LE L+LS N L +
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 267 SFGN 270
S
Sbjct: 368 SDFG 371
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 39/218 (17%), Positives = 69/218 (31%), Gaps = 28/218 (12%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ SL + LS N L + + SL+ + + + L ++
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 402
Query: 62 LGGNKLNGSIP-ITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+ L L+ L L + + L+ L L + GN +
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 121 A-CFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIG 178
F+ L +L + L +L + F +L + LN +SN L S +P I
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGI-------- 513
Query: 179 IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD 216
L +L+ ++L N S P
Sbjct: 514 ---------------FDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 31/152 (20%), Positives = 53/152 (34%), Gaps = 6/152 (3%)
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLT-FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
C + ++ +P ++ K NL+ S N L + L +D
Sbjct: 3 CVEVVPNI-TYQCMELNFYKIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
S + L +L L L N +Q +F L SL+ L NL+
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 241 SLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
+ L L+ LN++ N ++ F N +
Sbjct: 119 PIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 58/284 (20%), Positives = 107/284 (37%), Gaps = 22/284 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
+ ++ +Y+ N + LP N+ L + ++S +P I N T +
Sbjct: 90 AYAHTIQKLYMGFNAIR-YLPPHVFQNVP-LLTVLVLERNDLSS-LPRGIFHNTPKLTTL 146
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
++ N L T LQ L L N+L + + + L+ ++ N LS
Sbjct: 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLST--- 200
Query: 121 ACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+ ++ + N + V L L N LT L N L+ +
Sbjct: 201 --LAIPIAVEELDASHNSINVVRGPVNVELT---ILKLQHNNLTDTAWLL--NYPGLVEV 253
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N ++ ++ LE L++ NRL ++ + +LK L+LS+N+L +
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 311
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC 283
+ + LENL L N + + + + N+ C
Sbjct: 312 RNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKNLTLSHNDWDC 353
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 62/285 (21%), Positives = 107/285 (37%), Gaps = 36/285 (12%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIVN 61
+ ++ N+ + + P + + +E + + I I + +
Sbjct: 43 TLNNQKIVTFKNSTMRKL-PAALLDSFR-QVELLNLNDLQIEE-IDTYAFAYAHTIQKLY 99
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLP 120
+G N + P + L L LE N L S+P I + +L L + N L
Sbjct: 100 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIED 158
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
F TSL+ + L SN+LT V L +L + N S N L++ + + +
Sbjct: 159 DTFQATTSLQNLQLSSNRLTHVDLSLIPSLF---HANVSYNLLST-----LAIPIAVEEL 210
Query: 180 DFSMNNFSGVIP----------------TEIG---GLKNLEYLFLGYNRLQGSIPDSFGD 220
D S N+ + V T+ L + L YN L+ + F
Sbjct: 211 DASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVK 270
Query: 221 LISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265
+ L+ L +SNN L A+ + + L+ L+LS N L + R
Sbjct: 271 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 313
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 45/211 (21%), Positives = 85/211 (40%), Gaps = 14/211 (6%)
Query: 50 EISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRL 108
E L N IV + + L ++++ L L D ++E I + + +L
Sbjct: 40 EDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKL 98
Query: 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLP 167
+ N + P F N+ L ++ L N L+S+P F N + L+ S+N L
Sbjct: 99 YMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 158
Query: 168 LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFL 227
L + S N + V ++ + +L + + YN L + I+++ L
Sbjct: 159 DTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEEL 210
Query: 228 NLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
+ S+N+++ + + L L L N L
Sbjct: 211 DASHNSIN-VVRGPV--NVELTILKLQHNNL 238
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 42/222 (18%), Positives = 83/222 (37%), Gaps = 14/222 (6%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAEL 105
I + V++ + L + + +++ + +P + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 106 YRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTS 164
L+L+ ++ F+ +++ + +G N + +P F N+ + L N L+S
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 165 PLPLEI-GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIS 223
LP I N L + S NN + +L+ L L NRL + + S
Sbjct: 132 -LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPS 187
Query: 224 LKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265
L N+S N LS +L +E L+ S N + +
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGP 223
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 35/192 (18%), Positives = 69/192 (35%), Gaps = 6/192 (3%)
Query: 70 SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSL 129
I L + ++ + + L + + + A + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 130 RIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEI-GNLKVLIGIDFSMNNFS 187
+++L ++ + F I L N + LP + N+ +L + N+ S
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130
Query: 188 GVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 247
+ L L + N L+ D+F SL+ L LS+N L+ + SL +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPS 187
Query: 248 LENLNLSFNKLE 259
L + N+S+N L
Sbjct: 188 LFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 42/253 (16%), Positives = 89/253 (35%), Gaps = 47/253 (18%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
SL + LS+N L + + + SL + +S ++ ++
Sbjct: 162 QATTSLQNLQLSSNRLTHV----DLSLIP-SLFHANVSYNLLS-----TLAIPIAVEELD 211
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
N +N + + +L L L+ N L + + + L +DL N+L +
Sbjct: 212 ASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYH 266
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
F + L + + +N+L ++ L + + L+ S N L
Sbjct: 267 PFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH----------------- 309
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG----A 237
+ LE L+L +N + ++ +LK L LS+N+ A
Sbjct: 310 --------VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRA 358
Query: 238 IPASLEKLSYLEN 250
+ ++ + + +
Sbjct: 359 LFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 18/128 (14%), Positives = 41/128 (32%), Gaps = 1/128 (0%)
Query: 138 KLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGL 197
+ + +++ E L + F + + +
Sbjct: 9 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 68
Query: 198 KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 257
+ +E L L +++ +F +++ L + N + P + + L L L N
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 258 LEGEIPRG 265
L +PRG
Sbjct: 129 LS-SLPRG 135
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 67/325 (20%), Positives = 117/325 (36%), Gaps = 24/325 (7%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ + + + T G S+ + + + L + ++
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
NL NK+N L LQ L L N L + L ++ +DL N ++
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 121 ACFSNLTSLRIVSLGSNKLTSVP---------LTFWNLKDILNLNFSSNFL--------T 163
F L L+ + L N LT++ L+ L + +N ++N +
Sbjct: 356 QTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLEN 415
Query: 164 SPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSI-----PDS 217
+ + + L + + N FS + +LE LFLG N LQ + D
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475
Query: 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFE 277
F L L+ L L++N L+ P L+ L L+L+ N+L + N
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDIS 534
Query: 278 GNELLCGSPNLQVPPCKTSIHHTSW 302
N+LL +P++ V I H +
Sbjct: 535 RNQLLAPNPDVFVSLSVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-29
Identities = 58/283 (20%), Positives = 98/283 (34%), Gaps = 26/283 (9%)
Query: 2 SNCKSLTLIYLSNNPL-DGILPKTSVGNLSHSLEDFRMYNCNISG-GIPEEISNLTNSTI 59
L + L L D +L NL +L + I + L +
Sbjct: 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLK-ALTRLDLSKNQIRSLYLHPSFGKLNSLKS 152
Query: 60 VNLGGNKLNGSIPITLSKLQ--KLQGLGLEDNKLEGSIPDDICHLAELYR------LDLD 111
++ N++ L LQ L L N L + D +R LD+
Sbjct: 153 IDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS 212
Query: 112 GNKLSGSLPACFSN------------LTSLRIVSLGSNKLTSVPL-TFWNLKD--ILNLN 156
GN + + FSN + G + + TF L + +L+
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 157 FSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD 216
S F+ S LK L ++ + N + + GL NL+ L L YN L
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332
Query: 217 SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
+F L + +++L N+++ + + L L+ L+L N L
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 60/281 (21%), Positives = 108/281 (38%), Gaps = 29/281 (10%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIVNLGG 64
+ + LS N + + +S L L+ + + I +E NL N I++LG
Sbjct: 25 TTERLLLSFNYIRTV-TASSFPFLEQ-LQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSI--PDDICHLAELYRLDLDGNKLSG-SLPA 121
+K+ P L L L L L ++ +L L RLDL N++ L
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 122 CFSNLTSLRIVSLGSNKLTSVP-LTFWNL--KDILNLNFSSNFLTSPLPLEI-------- 170
F L SL+ + SN++ V L K + + ++N L S + ++
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202
Query: 171 ----------GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGD 220
GN + N S + ++ G++ ++ ++F
Sbjct: 203 NMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262
Query: 221 L--ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
L S++ L+LS+ + E L L+ LNL++NK+
Sbjct: 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 54/286 (18%), Positives = 103/286 (36%), Gaps = 34/286 (11%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGI--PEEISNLTNSTI 59
N +L ++ L ++ + + P G L + R+Y C +S + NL T
Sbjct: 70 RNLPNLRILDLGSSKIYFLHPDAFQGL--FHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 60 VNLGGNKLNG-SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLA--ELYRLDLDGNKLS 116
++L N++ + + KL L+ + N++ ++ L L L N L
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 117 GSLPACFSNL------TSLRIVSLGSNKLTSVP-------------LTFWNLKDILNLNF 157
+ + L I+ + N T + I+ F
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247
Query: 158 SSNFLTSP-----LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 212
+ + P L +++ L D S + LK+L+ L L YN++
Sbjct: 248 GFHNIKDPDQNTFAGLARSSVRHL---DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK 304
Query: 213 SIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
++F L +L+ LNLS N L ++ L + ++L N +
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 23/290 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
K L ++ L+ N ++ I + L +L+ + + L ++
Sbjct: 287 ETLKDLKVLNLAYNKINKI-ADEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYID 344
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L N + T L+KLQ L L DN L I + + + L GNKL +LP
Sbjct: 345 LQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPK 398
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLT--FWNLKDILNLNFSSNFLTS-PLPLEIGNLKVLIG 178
+ L N+L ++ + + + L + N +S L
Sbjct: 399 INLTANLIH---LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQ 455
Query: 179 IDFSMNNFSGVIPTEI-----GGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNN 233
+ N TE+ GL +L+ L+L +N L P F L +L+ L+L++N
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515
Query: 234 LSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC 283
L+ L + LE L++S N+L P F + S N+ +C
Sbjct: 516 LTVLSHNDL--PANLEILDISRNQL--LAPNPDVFVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 56/233 (24%), Positives = 85/233 (36%), Gaps = 25/233 (10%)
Query: 52 SNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICH-LAELYRLDL 110
L + + L N + + L++LQ L L +I + L L LDL
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 111 DGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL---TFWNLKDILNLNFSSNFLTS-PL 166
+K+ P F L L + L L+ L F NLK + L+ S N + S L
Sbjct: 81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 167 PLEIGNLKVLIGIDFSMNNFSGVIPTEIGGL--KNLEYLFLGYNRLQGSIPDSFGDL--- 221
G L L IDFS N V E+ L K L + L N L + +G
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 222 ---ISLKFLNLSNNNLSGAIPA------------SLEKLSYLENLNLSFNKLE 259
+ L+ L++S N + I SL ++ F+ ++
Sbjct: 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 28/117 (23%), Positives = 50/117 (42%), Gaps = 5/117 (4%)
Query: 155 LNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI 214
+ LT +P + + L S N V + L+ L+ L LG +I
Sbjct: 9 AFYRFCNLTQ-VPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 215 -PDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGN 270
++F +L +L+ L+L ++ + P + + L +L L L F L + + G F N
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 7e-31
Identities = 62/285 (21%), Positives = 107/285 (37%), Gaps = 36/285 (12%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIVN 61
+ ++ N+ + + P + + +E + + I I + +
Sbjct: 49 TLNNQKIVTFKNSTMRKL-PAALLDSFR-QVELLNLNDLQIEE-IDTYAFAYAHTIQKLY 105
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLP 120
+G N + P + L L LE N L S+P I + +L L + N L
Sbjct: 106 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIED 164
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
F TSL+ + L SN+LT V L +L + N S N L++ + + +
Sbjct: 165 DTFQATTSLQNLQLSSNRLTHVDLSLIPSLF---HANVSYNLLST-----LAIPIAVEEL 216
Query: 180 DFSMNNFSGVIP----------------TEIG---GLKNLEYLFLGYNRLQGSIPDSFGD 220
D S N+ + V T+ L + L YN L+ + F
Sbjct: 217 DASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276
Query: 221 LISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265
+ L+ L +SNN L A+ + + L+ L+LS N L + R
Sbjct: 277 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 319
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 58/284 (20%), Positives = 107/284 (37%), Gaps = 22/284 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
+ ++ +Y+ N + LP N+ L + ++S +P I N T +
Sbjct: 96 AYAHTIQKLYMGFNAIR-YLPPHVFQNVP-LLTVLVLERNDLSS-LPRGIFHNTPKLTTL 152
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
++ N L T LQ L L N+L + + + L+ ++ N LS
Sbjct: 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLST--- 206
Query: 121 ACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
+ ++ + N + V L L N LT L N L+ +
Sbjct: 207 --LAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLTDTAWLL--NYPGLVEV 259
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D S N ++ ++ LE L++ NRL ++ + +LK L+LS+N+L +
Sbjct: 260 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 317
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC 283
+ + LENL L N + + + + N+ C
Sbjct: 318 RNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDC 359
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 45/211 (21%), Positives = 85/211 (40%), Gaps = 14/211 (6%)
Query: 50 EISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRL 108
E L N IV + + L ++++ L L D ++E I + + +L
Sbjct: 46 EDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKL 104
Query: 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLP 167
+ N + P F N+ L ++ L N L+S+P F N + L+ S+N L
Sbjct: 105 YMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED 164
Query: 168 LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFL 227
L + S N + V ++ + +L + + YN L + I+++ L
Sbjct: 165 DTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEEL 216
Query: 228 NLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
+ S+N+++ + + L L L N L
Sbjct: 217 DASHNSIN-VVRGPV--NVELTILKLQHNNL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 5e-22
Identities = 34/191 (17%), Positives = 67/191 (35%), Gaps = 4/191 (2%)
Query: 70 SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSL 129
I L + ++ + + L + + + A + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 130 RIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSG 188
+++L ++ + F I L N + P N+ +L + N+ S
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137
Query: 189 VIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 248
+ L L + N L+ D+F SL+ L LS+N L+ + SL + L
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSL 194
Query: 249 ENLNLSFNKLE 259
+ N+S+N L
Sbjct: 195 FHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 6e-21
Identities = 42/253 (16%), Positives = 88/253 (34%), Gaps = 47/253 (18%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
SL + LS+N L + + + SL + +S ++ ++
Sbjct: 168 QATTSLQNLQLSSNRLTHV----DLSLIP-SLFHANVSYNLLS-----TLAIPIAVEELD 217
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
N +N + +L L L+ N L + + + L +DL N+L +
Sbjct: 218 ASHNSINV---VRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYH 272
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
F + L + + +N+L ++ L + + L+ S N L
Sbjct: 273 PFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH----------------- 315
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG----A 237
+ LE L+L +N + ++ +LK L LS+N+ A
Sbjct: 316 --------VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRA 364
Query: 238 IPASLEKLSYLEN 250
+ ++ + + +
Sbjct: 365 LFRNVARPAVDDA 377
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 18/128 (14%), Positives = 41/128 (32%), Gaps = 1/128 (0%)
Query: 138 KLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGL 197
+ + +++ E L + F + + +
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 74
Query: 198 KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 257
+ +E L L +++ +F +++ L + N + P + + L L L N
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 258 LEGEIPRG 265
L +PRG
Sbjct: 135 LS-SLPRG 141
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 59/260 (22%), Positives = 111/260 (42%), Gaps = 32/260 (12%)
Query: 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLG 63
+ + L+N L +S+ L LE +++ +PE +L + + N
Sbjct: 70 DRQAHELELNNLGL------SSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 64 GNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACF 123
L+ P L+ LG+ +N+LE +P ++ + + L +D+D N L LP
Sbjct: 123 LKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP 172
Query: 124 SNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSM 183
+L + + G+N+L +P NL + + +N L LP +L+ +
Sbjct: 173 PSLEFI---AAGNNQLEELP-ELQNLPFLTAIYADNNSLKK-LPDLPLSLESI---VAGN 224
Query: 184 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLE 243
N E+ L L ++ N L+ ++PD SL+ LN+ +N L+ +P +
Sbjct: 225 NILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQ 277
Query: 244 KLSYLENLNLSFNKLEGEIP 263
L++L+ F+ L P
Sbjct: 278 SLTFLDVSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 60/259 (23%), Positives = 105/259 (40%), Gaps = 38/259 (14%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ KSL + + L + P LE + N + +P E+ N + I+
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPP---------LLEYLGVSNNQLE-KLP-ELQNSSFLKII 158
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
++ N L +P L+ + +N+LE +P ++ +L L + D N L LP
Sbjct: 159 DVDNNSLK-KLPDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLP 211
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
+L S+ G+N L +P NL + + +N L + LP +L+ L +
Sbjct: 212 DLPLSLESI---VAGNNILEELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEAL---N 263
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
N + +P L L+ ++ L P +L +LN S+N + ++
Sbjct: 264 VRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCD 314
Query: 241 SLEKLSYLENLNLSFNKLE 259
LE LN+S NKL
Sbjct: 315 LPPS---LEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 61/258 (23%), Positives = 97/258 (37%), Gaps = 38/258 (14%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ N LT IY NN L ++ +L SLE + + ++ +PE +LT +
Sbjct: 233 LQNLPFLTTIYADNNLL------KTLPDLPPSLEALNVRDNYLTD-LPELPQSLTFLDVS 285
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+ L+ P L L N++ S+ D L EL ++ NKL LP
Sbjct: 286 ENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELP 333
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
A L L N L VP NLK L+ N L P +++ L
Sbjct: 334 ALPPRLERL---IASFNHLAEVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDL---- 382
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
MN+ +P NL+ L + N L+ PD S++ L +++ +
Sbjct: 383 -RMNSHLAEVPELPQ---NLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEF 434
Query: 241 SLEKLSYLENLNLSFNKL 258
+ E LE+ +
Sbjct: 435 AHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 54/241 (22%), Positives = 96/241 (39%), Gaps = 37/241 (15%)
Query: 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKL------------- 78
L++ ++ N++ +P E N+ + T ++ + P +
Sbjct: 12 FLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD 70
Query: 79 QKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNK 138
++ L L + L S+P+ HL L N L+ LP +L SL + +
Sbjct: 71 RQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA 125
Query: 139 LTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLK 198
L+ +P + L S+N L LP E+ N L ID N+ +P
Sbjct: 126 LSDLP------PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDLPP--- 173
Query: 199 NLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
+LE++ G N+L+ +P+ +L L + NN+L +P LE++ N L
Sbjct: 174 SLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNIL 227
Query: 259 E 259
E
Sbjct: 228 E 228
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 63/259 (24%), Positives = 102/259 (39%), Gaps = 40/259 (15%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ N LT IY NN L + +L SLE N + E+ NL T +
Sbjct: 191 LQNLPFLTAIYADNNSL------KKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTI 242
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
N L ++P L+ L + DN L +P+ L L + + LS P
Sbjct: 243 YADNNLLK-TLPDLPPSLEALN---VRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
+L ++ SN++ S+ +L++ LN S+N L LP L+ L
Sbjct: 298 -------NLYYLNASSNEIRSLCDLPPSLEE---LNVSNNKLIE-LPALPPRLERL---I 343
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
S N+ + +P NL+ L + YN L+ PD + L+ N+ +P
Sbjct: 344 ASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPE 393
Query: 241 SLEKLSYLENLNLSFNKLE 259
+ L + L++ N L
Sbjct: 394 LPQNL---KQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 40/210 (19%), Positives = 74/210 (35%), Gaps = 39/210 (18%)
Query: 78 LQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNL----------- 126
LQ + L +P + ++ ++ + P
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 127 --TSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN 184
+ L + L+S+P +L+ +L S N LT LP +LK L+ + ++
Sbjct: 69 LDRQAHELELNNLGLSSLPELPPHLE---SLVASCNSLTE-LPELPQSLKSLLVDNNNLK 124
Query: 185 NFSGVIPT---------------EIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNL 229
S + P E+ L+ + + N L+ +PD SL+F+
Sbjct: 125 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAA 180
Query: 230 SNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
NN L +P L+ L +L + N L+
Sbjct: 181 GNNQLE-ELP-ELQNLPFLTAIYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 33/152 (21%), Positives = 55/152 (36%), Gaps = 26/152 (17%)
Query: 125 NLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIG------ 178
+ T L+ S+ LT +P+ N+K + + P G + +
Sbjct: 9 SNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 179 -------IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSN 231
++ + S +P +LE L N L +P+ L SL N +
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 232 NNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
LS P LE L +S N+LE ++P
Sbjct: 124 KALSDLPPL-------LEYLGVSNNQLE-KLP 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 11/225 (4%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLE--GSIPDDICHLAE 104
+P I +++T + L NKL KL +L L L N L G
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 105 LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP--LTFWNLKDILNLNFSSNFL 162
L LDL N + ++ + F L L + + L + F +L++++ L+ S
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 163 TSPLPLEI-GNLKVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPDSFGD 220
I L L + + N+F +I L+NL +L L +L+ P +F
Sbjct: 139 RV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 221 LISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265
L SL+ LN+S+NN + L+ L+ L+ S N + +
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-28
Identities = 57/264 (21%), Positives = 106/264 (40%), Gaps = 32/264 (12%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG 64
+ L + N +L + + S ++ N+S +P+ + T++ +
Sbjct: 37 EKQALPGENRNEAVSLLKECLINQFSE----LQLNRLNLSS-LPDNL--PPQITVLEITQ 89
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFS 124
N L S+P + L+ L DN+L ++P+ L L D+D N+L+ LP +
Sbjct: 90 NAL-ISLPELPASLEYLD---ACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPA 140
Query: 125 NLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN 184
L + + +N+LT +P +L+ L+ +N LT LP +L+ L D S N
Sbjct: 141 LLEYI---NADNNQLTMLPELPTSLEV---LSVRNNQLTF-LPELPESLEAL---DVSTN 190
Query: 185 NFSGVIPTEIGGLKNLE----YLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
+P + E + NR+ IP++ L + L +N LS I
Sbjct: 191 LLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248
Query: 241 SLEKLSYLENLNLSFNKLEGEIPR 264
SL + + + + +
Sbjct: 249 SLSQQTAQPDYHGPRIYFSMSDGQ 272
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 7e-20
Identities = 52/216 (24%), Positives = 80/216 (37%), Gaps = 39/216 (18%)
Query: 70 SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG---NKLSGSLPACFSNL 126
SI + ++ L N + G+ D + + L G N+ L C +
Sbjct: 2 SIMLPINNNFSLSQN-SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 127 TSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNF 186
+ L L+S+P I L + N L S LP +L+ L D N
Sbjct: 59 NQFSELQLNRLNLSSLPDNL--PPQITVLEITQNALIS-LPELPASLEYL---DACDNRL 112
Query: 187 SGVIPTEIGGLK-----------------NLEYLFLGYNRLQGSIPDSFGDLISLKFLNL 229
S +P LK LEY+ N+L +P+ SL+ L++
Sbjct: 113 S-TLPELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLT-MLPELPT---SLEVLSV 167
Query: 230 SNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265
NN L+ +P E LE L++S N LE +P
Sbjct: 168 RNNQLT-FLPELPES---LEALDVSTNLLE-SLPAV 198
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 44/268 (16%), Positives = 81/268 (30%), Gaps = 41/268 (15%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
L I NN L T + L SLE + N ++ +PE +L +++ N
Sbjct: 141 LLEYINADNNQL------TMLPELPTSLEVLSVRNNQLTF-LPELPESLE---ALDVSTN 190
Query: 66 KLNGSIPITLSKLQKLQ----GLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L S+P + + +N++ IP++I L + L+ N LS S
Sbjct: 191 LLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIR 247
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+ + + G S+ N + + + ++ + +
Sbjct: 248 ESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEE 307
Query: 182 SMNNFSGV-------------------IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLI 222
N FS + + L L + +S D +
Sbjct: 308 HANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRV 367
Query: 223 SLKFLNLSNNNL-----SGAIPASLEKL 245
+L + NL L G L
Sbjct: 368 ALTWNNLRKTLLVHQASEGLFDNDTGAL 395
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 60/243 (24%), Positives = 93/243 (38%), Gaps = 13/243 (5%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAEL 105
+P+ I +N+ +NL N + T L L+ L L N + I LA L
Sbjct: 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125
Query: 106 YRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSS-NFLT 163
L+L N L+ F L+ LR + L +N + S+P F + ++ L+ L
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 164 SPLPLEI-GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLI 222
+ L L ++ M N + + L LE L + N P SF L
Sbjct: 186 Y-ISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLS 242
Query: 223 SLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG--GSFGNFSAESFEGNE 280
SLK L + N+ +S + + L+ L LNL+ N L +P N
Sbjct: 243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNP 301
Query: 281 LLC 283
C
Sbjct: 302 WNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 61/254 (24%), Positives = 105/254 (41%), Gaps = 11/254 (4%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
+ + + L + P+ + + + NI + +L + ++ LG N
Sbjct: 55 QFSKVVCTRRGLSEV-PQ----GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLPACFS 124
+ + L L L L DN L IP +L++L L L N + F+
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 125 NLTSLRIVSLGS-NKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
+ SL + LG KL + F L ++ LN + +P + L L ++ S
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMS 226
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242
N+F + P GL +L+ L++ +++ ++F L SL LNL++NNLS
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLF 286
Query: 243 EKLSYLENLNLSFN 256
L YL L+L N
Sbjct: 287 TPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 42/189 (22%), Positives = 80/189 (42%), Gaps = 10/189 (5%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
+ SL + L +N L I L + + N I IP + + + +
Sbjct: 120 NGLASLNTLELFDNWLTVIPSGAFEYL--SKLRELWLRNNPIE-SIPSYAFNRVPSLMRL 176
Query: 61 NLGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
+LG K I L L+ L L ++ +P ++ L L L++ GN
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIR 234
Query: 120 PACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEI-GNLKVLI 177
P F L+SL+ + + +++++ + F L ++ LN + N L+S LP ++ L+ L+
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLV 293
Query: 178 GIDFSMNNF 186
+ N +
Sbjct: 294 ELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 35/144 (24%), Positives = 50/144 (34%), Gaps = 30/144 (20%)
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
C + + V L+ VP +P N + L +
Sbjct: 52 CSNQFSK---VVCTRRGLSEVP--------------------QGIP---SNTRYL---NL 82
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
NN + L +LE L LG N ++ +F L SL L L +N L+ +
Sbjct: 83 MENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGA 142
Query: 242 LEKLSYLENLNLSFNKLEGEIPRG 265
E LS L L L N +E IP
Sbjct: 143 FEYLSKLRELWLRNNPIE-SIPSY 165
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 15/244 (6%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAEL 105
+P+ IS TN+ ++NL N++ + L+ L+ L L N + +I LA L
Sbjct: 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114
Query: 106 YRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSS-NFL 162
L+L N+L+ ++P F L+ L+ + L +N + S+P F + + L+ L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 163 TSPLPLEI-GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL 221
+ + L L ++ +M N IP + L L+ L L N L P SF L
Sbjct: 174 SY-ISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 222 ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG--GSFGNFSAESFEGN 279
+ L+ L + + + + + L L +NL+ N L +P + N
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
Query: 280 ELLC 283
C
Sbjct: 290 PWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 61/254 (24%), Positives = 111/254 (43%), Gaps = 11/254 (4%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
+ + L + P +S + ++ I +L + I+ L N
Sbjct: 44 QFSKVICVRKNLREV-PD----GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLPACFS 124
+ + L L L L DN+L +IP+ +L++L L L N + F+
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFN 157
Query: 125 NLTSLRIVSLGS-NKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
+ SLR + LG +L+ + F L ++ LN + L +P + L L +D S
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLS 215
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242
N+ S + P GL +L+ L++ +++Q ++F +L SL +NL++NNL+
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLF 275
Query: 243 EKLSYLENLNLSFN 256
L +LE ++L N
Sbjct: 276 TPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 10/189 (5%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
+ +L + L +N L I V L++ + N I IP + + + +
Sbjct: 109 NGLANLNTLELFDNRLTTIPNGAFVYL--SKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165
Query: 61 NLGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
+LG K I L L+ L L L IP ++ L +L LDL GN LS
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIR 223
Query: 120 PACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEI-GNLKVLI 177
P F L L+ + + +++ + F NL+ ++ +N + N LT LP ++ L L
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHHLE 282
Query: 178 GIDFSMNNF 186
I N +
Sbjct: 283 RIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 35/145 (24%), Positives = 51/145 (35%), Gaps = 7/145 (4%)
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
C + + V L VP + LN N + +L+ L +
Sbjct: 41 CSNQFSK---VICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
S N+ + GL NL L L NRL +F L LK L L NN + +
Sbjct: 96 SRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYA 155
Query: 242 LEKLSYLENLNLS-FNKLEGEIPRG 265
++ L L+L +L I G
Sbjct: 156 FNRIPSLRRLDLGELKRLS-YISEG 179
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 64/223 (28%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 52 SNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111
S + + VN L ++P L K L L +N L + L +L+LD
Sbjct: 7 SKVASHLEVNCDKRNL-TALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIG 171
+L+ L L L + L N+L S+PL L + L+ S N LTS LPL
Sbjct: 64 RAELT-KLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-LPLGA- 119
Query: 172 NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS-FGDLISLKFLNLS 230
G L L+ L+L N L+ ++P L+ L+L+
Sbjct: 120 --------------LRG--------LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLA 156
Query: 231 NNNLSGAIPASL-EKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
NNNL+ +PA L L L+ L L N L IP+ G FG+
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPK-GFFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 54/217 (24%), Positives = 78/217 (35%), Gaps = 39/217 (17%)
Query: 43 ISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHL 102
+ +P ++TI++L N L TL +L L L+ +L D L
Sbjct: 25 LPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TL 76
Query: 103 AELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNF 161
L LDL N+L SLP L +L ++ + N+LTS+PL L ++ L N
Sbjct: 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135
Query: 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPDS-FG 219
L + +P + LE L L N L +P
Sbjct: 136 LKT-------------------------LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLN 169
Query: 220 DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
L +L L L N+L IP L L N
Sbjct: 170 GLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-21
Identities = 52/236 (22%), Positives = 83/236 (35%), Gaps = 41/236 (17%)
Query: 2 SNCK-SLTLIYLSNNPLDGILPKTSV-GNLSHSLEDFRMYNCNISGGIPEEISNLTNSTI 59
+ S + L T++ +L + + + T T
Sbjct: 6 VSKVASHLEVNCDKRNL------TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 60 VNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
+NL +L + L L L L N+L+ S+P L L LD+ N+L+ SL
Sbjct: 60 LNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115
Query: 120 PA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177
P L L+ + L N+L ++P + L+ ++N LT
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE------------- 162
Query: 178 GIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNN 232
+P + GL+NL+ L L N L +IP F L F L N
Sbjct: 163 ------------LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 45/294 (15%), Positives = 92/294 (31%), Gaps = 24/294 (8%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEE-ISNLTNSTIV 60
SL + L NP + + NL+ +L+ R+ N I + LT+ +
Sbjct: 95 GPLSSLKYLNLMGNPYQTLGVTSLFPNLT-NLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+ L +L ++ + L L ++ + L+ + L+L L+
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213
Query: 121 ACFSNLTSLRIVSLGSNK-----------LTSVPLTFWNLKDILNLNFSSNFLTSPLPLE 169
+ + + + L + L ++ + + N L P E
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273
Query: 170 IGNLK--------VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL 221
+ + + + T L+ ++ + + +++ L
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHL 333
Query: 222 ISLKFLNLSNNNLSGAI---PASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
SL+FL+LS N + A L+ L LS N L G
Sbjct: 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 48/264 (18%), Positives = 92/264 (34%), Gaps = 18/264 (6%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+C L + + D + V ++ + + + + S L +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVT--IRRLHIPQFYLFYDLSTVYSLLEKVKRI 315
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDD---ICHLAELYRLDLDGNKLS- 116
+ +K+ L+ L+ L L +N + + L L L N L
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375
Query: 117 -GSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEI-GNLK 174
L +L + + N +P + + + LN SS + + I L+
Sbjct: 376 MQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQTLE 434
Query: 175 VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234
VL D S NN L L+ L++ N+L+ ++PD+ L + +S N L
Sbjct: 435 VL---DVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQL 485
Query: 235 SGAIPASLEKLSYLENLNLSFNKL 258
++L+ L+ + L N
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 43/278 (15%), Positives = 98/278 (35%), Gaps = 8/278 (2%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
+C + + + I L+ +++ + I+ ++ N ++ L
Sbjct: 3 SCDASGVCDGRSRSFTSIPS-----GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 63 GGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG-SLPA 121
+++N L L+ L L DN L L+ L L+L GN + +
Sbjct: 58 KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 122 CFSNLTSLRIVSLGS-NKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
F NLT+L+ + +G+ + + + F L + L + L + + +++ + +
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
++ + ++ L ++ YL L L + S
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFE 277
S +L L L +++E + G+F+ +
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 51/283 (18%), Positives = 105/283 (37%), Gaps = 32/283 (11%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ + + + L + +L ++ S+ + + N++ + S+ +
Sbjct: 169 KSIRDIHHLTLHLSESAFLLE--IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226
Query: 62 LGGNKLN-------GSIPITLSKLQKLQGLGLEDNKLEG------SIPDDICHLAE---- 104
+ + + L + +L + +D L G S D + L +
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286
Query: 105 -LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFL 162
+ RL + L L +S L ++ +++ ++K+ VP +LK + L+ S N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 163 TS---PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIG---GLKNLEYLFLGYNRLQGSIPD 216
G L + S N+ + LKNL L + N +PD
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404
Query: 217 SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
S ++FLNLS+ + + + LE L++S N L+
Sbjct: 405 SCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 49/299 (16%), Positives = 97/299 (32%), Gaps = 46/299 (15%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKT-SVGNLSHSLEDFRMYNCNISGG-------IPEEISN 53
S+ + L + L V +S ++ ++ + I
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252
Query: 54 LTNSTIVNLGGNKLNGSIPITLSKLQK--------LQGLGLEDNKLEGSIPDDICHLAEL 105
L+ + N L P + + ++ L + L + L ++
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312
Query: 106 YRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT----FWNLKDILNLNFSSNF 161
R+ ++ +K+ + +L SL + L N + L + L S N
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372
Query: 162 LTS--PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFG 219
L S + LK L +D S N F +P + + +L L ++ +
Sbjct: 373 LRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--C 428
Query: 220 DLISLKFLNLSNNNLSGAIPASLEKLSY-------------------LENLNLSFNKLE 259
+L+ L++SNNNL + L +L L + +S N+L+
Sbjct: 429 IPQTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 53/310 (17%), Positives = 106/310 (34%), Gaps = 43/310 (13%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVG-------NLSH---------------SLEDFRMY 39
C +L ++ L ++ ++ I +LS SL+ +
Sbjct: 47 RACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106
Query: 40 NCNISG-GIPEEISNLTNSTIVNLGGNKLNGSIP-ITLSKLQKLQGLGLEDNKLEGSIPD 97
G+ NLTN + +G + I I + L L L ++ L
Sbjct: 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166
Query: 98 DICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILN--- 154
+ + +++ L L ++ + L L+S+R + L L + + ++ +
Sbjct: 167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226
Query: 155 -LNFSSNFLTSP-------LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNL------ 200
L F + LT L I L + D ++N P+E + L
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286
Query: 201 --EYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
L + L + + L +K + + N+ + + + L LE L+LS N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 259 EGEIPRGGSF 268
E + +
Sbjct: 347 VEEYLKNSAC 356
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 42/215 (19%), Positives = 77/215 (35%), Gaps = 16/215 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEE---ISNLTNST 58
S + + I + N+ + + P + +L SLE + + + +
Sbjct: 307 SLLEKVKRITVENSKVFLV-PCSFSQHLK-SLEFLDLSENLMVEEYLKNSACKGAWPSLQ 364
Query: 59 IVNLGGNKLN--GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLS 116
+ L N L L L+ L L + N +PD ++ L+L +
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
Query: 117 GSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVL 176
+ C +L ++ + +N L S L L+ L S N L + LP + VL
Sbjct: 424 -VVKTC--IPQTLEVLDVSNNNLDSFSLFLPRLQ---ELYISRNKLKT-LP-DASLFPVL 475
Query: 177 IGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 211
+ + S N V L +L+ ++L N
Sbjct: 476 LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 63/217 (29%), Positives = 84/217 (38%), Gaps = 14/217 (6%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAEL 105
+P I S + L GN+++ + + L L L N L I LA L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82
Query: 106 YRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLT 163
+LDL N S+ F L L + L L + F L + L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 164 SPLPLEI----GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFG 219
+ LP + GNL L N S V GL +L+ L L NR+ P +F
Sbjct: 143 A-LPDDTFRDLGNLTHL---FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 220 DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
DL L L L NNLS +L L L+ L L+ N
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 6/211 (2%)
Query: 28 NLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLE 87
+ + + ++ IS N TI+ L N L + L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 88 DNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVP-L 144
DN S+ L L+ L LD L L F L +L+ + L N L ++P
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 145 TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLF 204
TF +L ++ +L N ++S L L + N + V P L L L+
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 205 LGYNRLQGSIP-DSFGDLISLKFLNLSNNNL 234
L N L ++P ++ L +L++L L++N
Sbjct: 208 LFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 33/163 (20%), Positives = 56/163 (34%), Gaps = 33/163 (20%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
L ++L L + + L +
Sbjct: 102 HGLGRLHTLHLDRCGL------QE---------------------LGPGLFRGLAALQYL 134
Query: 61 NLGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGS 118
L N L ++P T L L L L N++ S+P+ L L RL L N+++
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 119 LPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
P F +L L + L +N L+++P L+ + L + N
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 21/222 (9%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAEL 105
IP+ + ++ ++L N L + +LQ L L +++ +I D L+ L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 106 YRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLT 163
L L GN + SL FS L+SL+ + L S+ +LK + LN + N +
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 164 SPLPLE-----IGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEY----LFLGYNRLQGSI 214
S L + NL+ L D S N + T++ L + L L N + I
Sbjct: 138 S-FKLPEYFSNLTNLEHL---DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 215 PDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
I LK L L N L ++L+ L+ + L N
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-22
Identities = 49/221 (22%), Positives = 91/221 (41%), Gaps = 18/221 (8%)
Query: 24 TSV-GNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPI-TLSKLQKL 81
+ NL S ++ + + + +++L ++ +I L L
Sbjct: 20 YKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 82 QGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKL 139
L L N ++ S+ L+ L +L L+ SL +L +L+ +++ N +
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 140 TSVPL--TFWNLKDILNLNFSSNFLTSPLPLEI----GNLKVLIG-IDFSMNNFSGVIPT 192
S L F NL ++ +L+ SSN + S + + +L +D S+N + I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 193 EIGGLKNLEYLFLGYNRLQGSIPD-SFGDLISLKFLNLSNN 232
L+ L L N+L+ S+PD F L SL+ + L N
Sbjct: 195 GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 39/142 (27%), Positives = 57/142 (40%), Gaps = 10/142 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
S SL + L L +G+L +L++ + + I E SNLTN +
Sbjct: 97 SGLSSLQKLVAVETNLA-SLENFPIGHL-KTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 61 NLGGNKLNGSIPI-TLSKLQKLQG----LGLEDNKLEGSIPDDICHLAELYRLDLDGNKL 115
+L NK+ SI L L ++ L L N + I L L LD N+L
Sbjct: 155 DLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL 212
Query: 116 SGSLPACFSNLTSLRIVSLGSN 137
F LTSL+ + L +N
Sbjct: 213 KSVPDGIFDRLTSLQKIWLHTN 234
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 58/258 (22%), Positives = 97/258 (37%), Gaps = 29/258 (11%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
N S D I S L+ +L +N +I+ I LT T +
Sbjct: 18 DNFASEVAAAFEMQATDTI----SEEQLA-TLTSLDCHNSSITD--MTGIEKLTGLTKLI 70
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
N + + LS+ L L + NKL ++ + L +L L+ D NKL+ L
Sbjct: 71 CTSNNITT---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD- 122
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
S L ++ N LT + ++ + + L+ N + L + L +D
Sbjct: 123 -VSQNPLLTYLNCARNTLTEIDVS--HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
S N + + ++ K L L N + + I L FL+ S+N L+ I
Sbjct: 178 SFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID-- 228
Query: 242 LEKLSYLENLNLSFNKLE 259
+ L+ L + S N L
Sbjct: 229 VTPLTQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 54/277 (19%), Positives = 93/277 (33%), Gaps = 48/277 (17%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S +LT + +N L + V L+ L ++ ++S T +N
Sbjct: 82 SQNTNLTYLACDSNKLTNL----DVTPLT-KLTYLNCDTNKLT---KLDVSQNPLLTYLN 133
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
N L I +S +L L NK + D+ +L LD NK++ L
Sbjct: 134 CARNTLT---EIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT-ELD- 186
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
S L ++ +N +T + L + L+ SSN LT +++ L L D
Sbjct: 187 -VSQNKLLNRLNCDTNNITKLDLN--QNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDC 240
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS--------------------FGDL 221
S+N + + ++ L L L L I +
Sbjct: 241 SVNPLTEL---DVSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIKELDVTHN 296
Query: 222 ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
L L+ ++ L + L L L+ +L
Sbjct: 297 TQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 53/278 (19%), Positives = 97/278 (34%), Gaps = 48/278 (17%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
LT + ++N + + + + +L + ++ + ++ LT T +N
Sbjct: 61 EKLTGLTKLICTSNNITTL----DLSQNT-NLTYLACDSNKLTN-LD--VTPLTKLTYLN 112
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
NKL + +S+ L L N L I D+ H +L LD NK L
Sbjct: 113 CDTNKLT---KLDVSQNPLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKITKLD- 165
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+ T L + NK+T + ++ K + LN +N +T L++ L +D
Sbjct: 166 -VTPQTQLTTLDCSFNKITELDVS--QNKLLNRLNCDTNNITK---LDLNQNIQLTFLDC 219
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
S N + + ++ L L Y N L + S L L L+ +L I +
Sbjct: 220 SSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EIDLT 272
Query: 242 --------------------LEKLSYLENLNLSFNKLE 259
+ + L L+ +
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 37/259 (14%), Positives = 80/259 (30%), Gaps = 26/259 (10%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ LT + S N + + V L NI+ + ++ T ++
Sbjct: 167 TPQTQLTTLDCSFNKITEL----DVSQNK-LLNRLNCDTNNITK-LD--LNQNIQLTFLD 218
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
NKL I ++ L +L N L + + L++L L L +
Sbjct: 219 CSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID- 270
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
++ T L + L + + L+ + +T L++ L+ +
Sbjct: 271 -LTHNTQLIYFQAEGCRKIK-ELDVTHNTQLYLLDCQAAGITE---LDLSQNPKLVYLYL 325
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
+ + + ++ L+ L +Q S G + +L + +
Sbjct: 326 NNTELTEL---DVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKET 380
Query: 242 LEKLSYLENLNLSFNKLEG 260
L S ++ G
Sbjct: 381 LTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 37/187 (19%), Positives = 64/187 (34%), Gaps = 18/187 (9%)
Query: 73 ITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIV 132
E + LA L LD + ++ + LT L +
Sbjct: 15 FPDDNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKL 69
Query: 133 SLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPT 192
SN +T++ L+ ++ L SN LT+ L++ L L ++ N + +
Sbjct: 70 ICTSNNITTLDLS--QNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKL--- 121
Query: 193 EIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 252
++ L YL N L I L L+ N + + + L L+
Sbjct: 122 DVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLD 176
Query: 253 LSFNKLE 259
SFNK+
Sbjct: 177 CSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 41/243 (16%), Positives = 83/243 (34%), Gaps = 23/243 (9%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
++ LT + S+N L I V L+ L F ++ + +S L+ T +
Sbjct: 208 LNQNIQLTFLDCSSNKLTEI----DVTPLT-QLTYFDCSVNPLTE-LD--VSTLSKLTTL 259
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+ L I L+ +L E + + D+ H +LY LD ++ L
Sbjct: 260 HCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD 313
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
S L + L + +LT + ++ + + +L+ + + +G + L
Sbjct: 314 --LSQNPKLVYLYLNNTELTELDVS--HNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNF 367
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG---SIPDSFGDLISLKFLNLSNNNLSGA 237
+ + + + G +I G + ++ NLS
Sbjct: 368 EAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTD 427
Query: 238 IPA 240
PA
Sbjct: 428 NPA 430
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 45/226 (19%), Positives = 88/226 (38%), Gaps = 19/226 (8%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAEL 105
IP ++ ++L N++ L + LQ L L N + +I +D L L
Sbjct: 46 IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 106 YRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVP--LTFWNLKDILNLNFSSNFL 162
LDL N LS +L + F L+SL ++L N ++ F +L + L +
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 163 TSPLPLEI-GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD-SFGD 220
+ + + L L ++ ++ P + ++N+ +L L + + +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDV 220
Query: 221 LISLKFLNLSNNNLSG----AIPA----SLEKLSYLENLNLSFNKL 258
S++ L L + +L + SL K N+ ++ L
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 56/277 (20%), Positives = 113/277 (40%), Gaps = 26/277 (9%)
Query: 4 CKSLTLIYLSNNPLDGILPKTSV-GNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
C + S+ L S+ L+ +++ + N I+ ++ N + L
Sbjct: 30 CDRNGICKGSSGSL------NSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVL 83
Query: 63 GGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLP 120
N +N +I + S L L+ L L N L ++ L+ L L+L GN +L
Sbjct: 84 TSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLG 140
Query: 121 --ACFSNLTSLRIVSLGSN-KLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVL 176
+ FS+LT L+I+ +G+ T + F L + L ++ L S P + +++ +
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV 200
Query: 177 IGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG----SIP----DSFGDLISLKFLN 228
+ M ++ + ++E L L L + +S + + +
Sbjct: 201 SHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260
Query: 229 LSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265
+++ +L + L ++S L L S N+L+ +P G
Sbjct: 261 ITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDG 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 42/268 (15%), Positives = 98/268 (36%), Gaps = 22/268 (8%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIVNLGG 64
++ + LSNN + + + + + L+ + + I+ I E+ S+L + ++L
Sbjct: 53 AVKSLDLSNNRIT-YISNSDLQRCVN-LQALVLTSNGINT-IEEDSFSSLGSLEHLDLSY 109
Query: 65 NKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDIC--HLAELYRLDLDGNKLSGSLPA 121
N L ++ L L L L N + ++ + HL +L L + +
Sbjct: 110 NYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 122 -CFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
F+ LT L + + ++ L S + +++++ +L L + + + +
Sbjct: 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL 227
Query: 180 DFSMNNFSGVIPTEI--------GGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSN 231
+ + +E+ + + L + + L L S
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286
Query: 232 NNLSGAIPAS-LEKLSYLENLNLSFNKL 258
N L +P ++L+ L+ + L N
Sbjct: 287 NQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 46/247 (18%), Positives = 90/247 (36%), Gaps = 20/247 (8%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
C +L + L++N ++ + + S +L SLE + +S + L++ T +
Sbjct: 73 QRCVNLQALVLTSNGIN-TIEEDSFSSLG-SLEHLDLSYNYLSN-LSSSWFKPLSSLTFL 129
Query: 61 NLGGNKLNGSIP--ITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSG 117
NL GN ++ S L KLQ L + + I L L L++D + L
Sbjct: 130 NLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 118 SLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEI------ 170
P ++ ++ + L + + + + L L + E+
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
Query: 171 --GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS-FGDLISLKFL 227
+ + + + + + L L N+L+ S+PD F L SL+ +
Sbjct: 249 SLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKI 306
Query: 228 NLSNNNL 234
L N
Sbjct: 307 WLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 39/157 (24%), Positives = 57/157 (36%), Gaps = 29/157 (18%)
Query: 115 LSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLK 174
S + I S L S+P S L +K
Sbjct: 19 KEESSNQASLSCDRNGICKGSSGSLNSIP--------------------SGLT---EAVK 55
Query: 175 VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234
L D S N + + +++ NL+ L L N + DSF L SL+ L+LS N L
Sbjct: 56 SL---DLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 235 SGAIPASL-EKLSYLENLNLSFNKLEGEIPRGGSFGN 270
S + +S + LS L LNL N + + F +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 23/149 (15%), Positives = 54/149 (36%), Gaps = 15/149 (10%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
+ L + + + L S+ ++ ++ ++ + E ++ +
Sbjct: 171 AGLTFLEELEIDASDLQSY-EPKSLKSIQ-NVSHLILHMKQHIL-LLEIFVDVTSSVECL 227
Query: 61 NLGGNKLNG----SIPI----TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG 112
L L+ + +L K + + + D L + + ++ L L+
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286
Query: 113 NKLSGSLPA-CFSNLTSLRIVSLGSNKLT 140
N+L S+P F LTSL+ + L +N
Sbjct: 287 NQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 43/256 (16%), Positives = 92/256 (35%), Gaps = 8/256 (3%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSH-SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG 64
+L I + N IL + + S+ + ++ ++L +I +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFS 124
+ + + ++ LD N L+ ++
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345
Query: 125 NLTSLRIVSLGSNKLTSVPLT---FWNLKDILNLNFSSNFLTSPLPLEI-GNLKVLIGID 180
+LT L + L N+L + +K + L+ S N ++ K L+ ++
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
S N + I + ++ L L N+++ SIP L +L+ LN+++N L
Sbjct: 406 MSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDG 462
Query: 241 SLEKLSYLENLNLSFN 256
++L+ L+ + L N
Sbjct: 463 IFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-21
Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 16/242 (6%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNC--NISGGIPEEI-SNLTNSTI 59
++ +SN L G L SL+ ++ ++ G I +N I
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 60 VNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
N + + SK+ L +N L ++ ++ HL EL L L N+L L
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 120 PAC---FSNLTSLRIVSLGSNKLTSV--PLTFWNLKDILNLNFSSNFLTSPLPLEI-GNL 173
+ + SL+ + + N ++ K +L+LN SSN LT + + +
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI 423
Query: 174 KVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD-SFGDLISLKFLNLSNN 232
KVL D N IP ++ L+ L+ L + N+L+ S+PD F L SL+ + L N
Sbjct: 424 KVL---DLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
Query: 233 NL 234
Sbjct: 479 PW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 3e-17
Identities = 41/275 (14%), Positives = 79/275 (28%), Gaps = 23/275 (8%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG 64
+L + LS N D + GN+S L+ + ++ I++L S ++ + G
Sbjct: 90 VNLKHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFS 124
LQ L I ++ +L+ + + L
Sbjct: 149 ETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 125 NLT----------------SLRIVSLGSNKLTSVPLTFWNLK----DILNLNFSSNFLTS 164
+ +L + N + W+ I N+
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 165 PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISL 224
+LK L + F N+ + + +
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 225 KFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
L+ SNN L+ + + L+ LE L L N+L+
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 48/251 (19%), Positives = 87/251 (34%), Gaps = 19/251 (7%)
Query: 28 NLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLE 87
+LS + IS +I +L+ I+ + N++ Q+L+ L L
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77
Query: 88 DNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPAC--FSNLTSLRIVSLGSNKLTSVPLT 145
NKL I L LDL N +LP C F N++ L+ + L + L +
Sbjct: 78 HNKLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 146 -FWNLKDILNLNFSSNFLTSPLP---LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLE 201
+L L L+ N + L + + F ++ + + NLE
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193
Query: 202 YLFLGYNRLQGSIPDSFGDLISL------KFLNLSNNNLSGAIPASLEKL---SYLENLN 252
+ L L L L+N + + +L + + +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 253 LSFNKLEGEIP 263
+S KL+G++
Sbjct: 254 ISNVKLQGQLD 264
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 9/205 (4%)
Query: 56 NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKL 115
+ +V+ N L +P LS+ K L + N + DI L++L L + N++
Sbjct: 1 SEFLVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
Query: 116 SGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTS-PLPLEIGNLK 174
+ F L + L NKL + ++ +L+ S N + P+ E GN+
Sbjct: 58 QYLDISVFKFNQELEYLDLSHNKLVKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMS 115
Query: 175 VLIGIDFSMNNFSGVIPTEIGGLKNLE-YLFLGYNRLQGSIPDSFGDL--ISLKFLNLSN 231
L + S + I L + L LG + P+ D SL + +N
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 232 NNLSGAIPASLEKLSYLENLNLSFN 256
+ S++ ++ LE N+
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCV 200
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 40/214 (18%), Positives = 79/214 (36%), Gaps = 11/214 (5%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAEL 105
+P+++S +TI+N+ N ++ + L KL+ L + N+++ + + EL
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQEL 71
Query: 106 YRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT--FWNLKDILNLNFSSNFLT 163
LDL NKL + +L+ + L N ++P+ F N+ + L S+ L
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 164 SPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIS 223
L I +L + + + + GL++ L D+
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186
Query: 224 LKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 257
NL +N+ + + L N
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP 220
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 33/117 (28%), Positives = 55/117 (47%), Gaps = 9/117 (7%)
Query: 155 LNFSSNFLTSPLPLEI-GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 213
++ S N L +P ++ +L + S N S + ++I L L L + +NR+Q
Sbjct: 5 VDRSKNGLIH-VPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 214 IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGN 270
F L++L+LS+N L S L++L+LSFN + +P FGN
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGN 113
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 37/163 (22%), Positives = 67/163 (41%), Gaps = 9/163 (5%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNIS--GGIPEEISNLTNSTI 59
S + SNN L + + G+L+ LE + + I E + + +
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENC-GHLT-ELETLILQMNQLKELSKIAEMTTQMKSLQQ 378
Query: 60 VNLGGNKLNGSIP-ITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGS 118
+++ N ++ S + L L + N L +I C + LDL NK+ S
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIK-S 435
Query: 119 LPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
+P L +L+ +++ SN+L SVP F L + + +N
Sbjct: 436 IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 15/209 (7%)
Query: 51 ISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDL 110
L N+ + G + + +T + L + L + +I + +L L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70
Query: 111 DGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEI 170
N+++ L NLT + + L N L +V L+ I L+ +S +T PL
Sbjct: 71 KDNQIT-DLA-PLKNLTKITELELSGNPLKNVS-AIAGLQSIKTLDLTSTQITDVTPLA- 126
Query: 171 GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLS 230
L L + +N + + P + GL NL+YL +G ++ + +L L L
Sbjct: 127 -GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKAD 181
Query: 231 NNNLSGAIPASLEKLSYLENLNLSFNKLE 259
+N +S P L L L ++L N++
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 52/258 (20%), Positives = 107/258 (41%), Gaps = 19/258 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
++ +T + + I V L++ L + + I+ + NLT T +
Sbjct: 38 ADLDGITTLSAFGTGVTTI---EGVQYLNN-LIGLELKDNQITD--LAPLKNLTKITELE 91
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L GN L ++ ++ LQ ++ L L ++ P + L+ L L LD N+++ ++
Sbjct: 92 LSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP 146
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+ LT+L+ +S+G+ +++ + NL + L N ++ PL +L LI +
Sbjct: 147 -LAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHL 202
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
N S V P + NL + L + +L+ + + + PA+
Sbjct: 203 KNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPAT 258
Query: 242 LEKLSYLENLNLSFNKLE 259
+ + NL++N
Sbjct: 259 ISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 21/247 (8%)
Query: 12 LSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSI 71
++ I P L++ N++ ++L T ++ G + +I
Sbjct: 4 TQPTAINVIFP---DPALAN-AIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI 56
Query: 72 PITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRI 131
+ L L GL L+DN++ + + +L ++ L+L GN L ++ A + L S++
Sbjct: 57 EG-VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSA-IAGLQSIKT 111
Query: 132 VSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP 191
+ L S ++T V L ++ L N +T+ PL L L + S + P
Sbjct: 112 LDLTSTQITDVT-PLAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTP 168
Query: 192 TEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 251
+ L L L N++ I L +L ++L NN +S P L S L +
Sbjct: 169 --LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 252 NLSFNKL 258
L+ +
Sbjct: 223 TLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 34/174 (19%), Positives = 74/174 (42%), Gaps = 13/174 (7%)
Query: 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT 145
+ + PD LA ++ + ++ ++ ++L + +S +T++
Sbjct: 4 TQPTAINVIFPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIE-G 58
Query: 146 FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFL 205
L +++ L N +T PL+ NL + ++ S N V I GL++++ L L
Sbjct: 59 VQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGNPLKNVSA--IAGLQSIKTLDL 114
Query: 206 GYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
++ P L +L+ L L N ++ P L L+ L+ L++ ++
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 13/188 (6%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ +S+ + L++ + + T + LS +L+ + I+ ++ LTN ++
Sbjct: 104 AGLQSIKTLDLTSTQITDV---TPLAGLS-NLQVLYLDLNQITN--ISPLAGLTNLQYLS 157
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
+G +++ P L+ L KL L +DNK+ I + L L + L N++S P
Sbjct: 158 IGNAQVSDLTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP- 212
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+N ++L IV+L + +T+ P+ + N + N+ P I + +
Sbjct: 213 -LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV-VKGPSGAPIAPATISDNGTYASPNL 270
Query: 182 SMNNFSGV 189
+ N S +
Sbjct: 271 TWNLTSFI 278
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 6e-23
Identities = 49/277 (17%), Positives = 87/277 (31%), Gaps = 34/277 (12%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNST---- 58
L + K +E +YN I+ I E + +
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307
Query: 59 -IVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEG--SIPDDICHLAELYRLDLDGNKL 115
I ++ S S ++ L + + + L+ N
Sbjct: 308 MIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS--PSSFTFLNFTQNVF 365
Query: 116 SGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKV 175
+ S+ S L L+ + L N L + K++ +L L S L
Sbjct: 366 TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNS-LN-------- 416
Query: 176 LIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLS 235
S +++ L L N L GS+ +K L+L NN +
Sbjct: 417 -----------SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM 463
Query: 236 GAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
+IP + L L+ LN++ N+L+ +P G F +
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 48/242 (19%), Positives = 82/242 (33%), Gaps = 18/242 (7%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDF---RMYNCNISGGIPEEISNLTNSTI 59
+ + + + N + + + +L+ + N S I
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 60 VNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
L + + L N S+ L L L L N L +
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392
Query: 120 PACFSNLTSLRIVSLGSNKLTSVP------LTFWNLKDILNLNFSSNFLTSPLPLEI-GN 172
++ + L S+ W + IL LN SSN LT + +
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW-AESILVLNLSSNMLTGSVFRCLPPK 451
Query: 173 LKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD-SFGDLISLKFLNLSN 231
+KVL D N IP ++ L+ L+ L + N+L+ S+PD F L SL+++ L +
Sbjct: 452 VKVL---DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHD 506
Query: 232 NN 233
N
Sbjct: 507 NP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 57/284 (20%), Positives = 93/284 (32%), Gaps = 40/284 (14%)
Query: 4 CKSLTLIYLSNNPL----DGILPKTSVGNLSH----SLEDFRMYNCNISGGIPEEISNLT 55
+ +++ SN L + P+T +LS L +IS L+
Sbjct: 30 NELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELR-------------MPDISFLS 76
Query: 56 NSTIVNLGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNK 114
++ L N++ S+ Q L+ L + N+L+ +I +A L LDL N
Sbjct: 77 ELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFND 132
Query: 115 LSGSLPAC--FSNLTSLRIVSLGSNKLTSVPLTF----WNLKDILNLNFSSNFLTSPLPL 168
LP C F NLT L + L + K + L +L+L L
Sbjct: 133 FD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
Query: 169 EIGNLKVLIGID-----FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIS 223
+I N VL + FS+ V L N++ RL + +
Sbjct: 192 QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTL 251
Query: 224 LKFLNLSNNNLSGAIPASLE--KLSYLENLNLSFNKLEGEIPRG 265
L + +E LN+ + I R
Sbjct: 252 LNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 7e-15
Identities = 45/235 (19%), Positives = 83/235 (35%), Gaps = 10/235 (4%)
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDI 152
+P D+ L L N +S S L+ LR++ L N++ S+ F +D+
Sbjct: 45 HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102
Query: 153 LNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGV-IPTEIGGLKNLEYLFLGYNRLQ 211
L+ S N L + + + L +D S N+F + + E G L L +L L + +
Sbjct: 103 EYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 212 GSIPDSFGDL-ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL-EGEIPRGGSFG 269
L +S L+L + ++ G SL+ + L+L F+ + S
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTVLHLVFHPNSLFSVQVNMSVN 218
Query: 270 NFSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLRIVLPLSTTFMIVVIL 324
+L + + + N L I + +
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 46/273 (16%), Positives = 76/273 (27%), Gaps = 21/273 (7%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTI-VNLG 63
SL + LS N D + GNL+ L + +++L S I ++L
Sbjct: 121 ASLRHLDLSFNDFDVLPVCKEFGNLT-KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLV 179
Query: 64 GNKLNGSIPITLSKLQ-KLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPAC 122
+ G +L + L N L + + L L L KL+
Sbjct: 180 SYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS--VNALGHLQLSNIKLNDENCQR 237
Query: 123 FSNLT------------SLRIVSLGSNKLTSVPLTFWNLK----DILNLNFSSNFLTSPL 166
+L+ + + FW +I NL +
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297
Query: 167 PLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKF 226
LK L+ F + L + S F
Sbjct: 298 TYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTF 357
Query: 227 LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
LN + N + ++ L L+ L L N L+
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 11/120 (9%)
Query: 155 LNFSSNFLTSPLPLEI-GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 213
+++S+ LT +P ++ K L S N+ S + +I L L L L +NR++ S
Sbjct: 36 VDYSNRNLTH-VPKDLPPRTKAL---SLSQNSISELRMPDISFLSELRVLRLSHNRIR-S 90
Query: 214 IPDS-FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFS 272
+ F L++L++S+N L I ++ L +L+LSFN + +P FGN +
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLT 146
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 39/273 (14%), Positives = 80/273 (29%), Gaps = 22/273 (8%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSH-SLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ L + +S+N L + + +L H L +N + +E NLT T +
Sbjct: 98 FNQDLEYLDVSHNRLQN-ISCCPMASLRHLDL----SFNDFDVLPVCKEFGNLTKLTFLG 152
Query: 62 LGGNKLNGSIPITLSKLQ-KLQGLGLEDNKLEGSIPDDICHLA-ELYRLDLDGNKLSGSL 119
L K + ++ L L L ++G + + + L N L
Sbjct: 153 LSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 120 ------PACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNL 173
L+++++ +L + +LN+ T +++
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 174 KVLIGI---DFSMNNFSGVIPTEIGG-----LKNLEYLFLGYNRLQGSIPDSFGDLISLK 225
+ + + I E LK+L + S + +
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 226 FLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
LS ++ S LN + N
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 60/294 (20%), Positives = 103/294 (35%), Gaps = 34/294 (11%)
Query: 2 SNCKSLTLIYLSNNPL-DGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTI 59
+ +L ++ L+ L +L L+ SLE + + NI P N+ +
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNNIKKIQPASFFLNMRRFHV 158
Query: 60 VNLGGNKLNGSIPITLSKLQK--LQGLGLEDNKLEGSIPDDIC--------HLAELYRLD 109
++L NK+ L Q L L L+ + + LD
Sbjct: 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLD 218
Query: 110 LDGNKLSGSLPACFSNLTSL-------------RIVSLGSNKLTSVP-LTFWNLK--DIL 153
L GN S+ F + + S G TF L+ +
Sbjct: 219 LSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK 278
Query: 154 NLNFSSNFLTSPLPLEI-GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 212
+ S + + + L + + L + + N + + GL +L L L N L
Sbjct: 279 TCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS 337
Query: 213 SIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLSFNKLEGEIPRG 265
F +L L+ L+LS N++ A+ S L L+ L L N+L+ +P G
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDG 389
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 59/279 (21%), Positives = 98/279 (35%), Gaps = 54/279 (19%)
Query: 5 KSLTLIYLSNNPLDGI-------LPKTSVGNLS-HSLEDFRMYNCNISGGIPEEISNLTN 56
+ ++ L+ N + I L S+ M + T+
Sbjct: 154 RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213
Query: 57 STIVNLGGNKLNGSIP---ITLSKLQKLQGLGLEDNKLEG---------SIPDDICH--- 101
T ++L GN S+ K+Q L L ++ G +
Sbjct: 214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE 273
Query: 102 LAELYRLDLDGNKLSGSLPAC-FSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSS 159
+ + DL +K+ +L FS+ T L ++L N++ + FW L +L LN S
Sbjct: 274 ASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQ 332
Query: 160 NFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIP-DS 217
NFL S I + + L LE L L YN ++ ++ S
Sbjct: 333 NFLGS-------------------------IDSRMFENLDKLEVLDLSYNHIR-ALGDQS 366
Query: 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
F L +LK L L N L ++L+ L+ + L N
Sbjct: 367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 8e-20
Identities = 49/243 (20%), Positives = 88/243 (36%), Gaps = 20/243 (8%)
Query: 55 TNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAELYRLDLDGN 113
+ V+L N + + S+LQ LQ L +E I ++ L+ L L LD N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 114 KLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL---TFWNLKDILNLNFSSNFLTSPLPLE 169
+ L F+ L +L +++L L L F L + L N + P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 170 I-GNLKVLIGIDFSMNNFSGVIPTEIGGL--KNLEYLFLGYNRLQ--------GSIPDSF 218
N++ +D + N + ++ K+ L L LQ +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 219 GDLISLKFLNLSNNNLSGAIPA---SLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAES 275
S+ L+LS N ++ + +++L LS + G +F + +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 276 FEG 278
F+G
Sbjct: 269 FKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 45/294 (15%), Positives = 88/294 (29%), Gaps = 57/294 (19%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S + L + + ++ L++ I+
Sbjct: 51 SRLQDLQFLKVEQQTPGLVIR-------------------------NNTFRGLSSLIILK 85
Query: 62 LGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGS-IPDDI-CHLAELYRLDLDGNKLSGS 118
L N+ + + L L+ L L L+G+ + + L L L L N +
Sbjct: 86 LDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI 144
Query: 119 LPAC-FSNLTSLRIVSLGSNKLTSVP-----------LTFWNLKDILNLNFSSNFLTSPL 166
PA F N+ ++ L NK+ S+ T L I + + +L
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEK 204
Query: 167 PLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYL-------------FLGYNRLQGS 213
+ +D S N F + + G+ +
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264
Query: 214 IPDSFGDLI--SLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265
+F L +K +LS + + + + + LE L L+ N++ +I
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDN 317
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 35/195 (17%), Positives = 61/195 (31%), Gaps = 35/195 (17%)
Query: 70 SIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA-CFSNLTS 128
+P ++ + L N + L +L L ++ + F L+S
Sbjct: 27 ELPAHVNYVD------LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 129 LRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFS 187
L I+ L N+ + F L ++ L + L
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA---------------------- 118
Query: 188 GVIPTEI-GGLKNLEYLFLGYNRLQGSIPDS-FGDLISLKFLNLSNNNLSGAIPASLEKL 245
V+ L +LE L L N ++ P S F ++ L+L+ N + L
Sbjct: 119 -VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNF 177
Query: 246 --SYLENLNLSFNKL 258
+ L LS L
Sbjct: 178 QGKHFTLLRLSSITL 192
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 42/227 (18%), Positives = 83/227 (36%), Gaps = 46/227 (20%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNL-------- 54
S+T + LS N + K ++ + + + + + G +N
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 55 -----TNSTIVNLGGNKLNGSIPITL-SKLQKLQGLGLEDNKLEGSIPDDIC-HLAELYR 107
+ +L +K+ ++ ++ S L+ L L N++ I D+ L L +
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327
Query: 108 LDLDGNKLSGSLPAC-FSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSP 165
L+L N L S+ + F NL L ++ L N + ++ +F L ++ L +N L S
Sbjct: 328 LNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS- 385
Query: 166 LPLEIGNLKVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQ 211
+P I L +L+ ++L N
Sbjct: 386 ------------------------VPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 35/79 (44%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 348 WRTFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFES-FDV 406
+ FS EL A+D FS N++G+GGFG VYK RL D VAVK + + E F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 407 ECEMMKNIRHRNLIKILHG 425
E EM+ HRNL++ L G
Sbjct: 77 EVEMISMAVHRNLLR-LRG 94
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 3e-22
Identities = 47/252 (18%), Positives = 90/252 (35%), Gaps = 19/252 (7%)
Query: 7 LTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNK 66
+ + P+ I P + + +++ + + L + + +
Sbjct: 1 MGETITVSTPIKQIFP---DDAFAE-TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 54
Query: 67 LNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNL 126
+ S+ + L + L L NKL I + +L L L LD NK+ L + +L
Sbjct: 55 IK-SVQ-GIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDL 108
Query: 127 TSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNF 186
L+ +SL N ++ + +L + +L +N +T L L L + N
Sbjct: 109 KKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQI 165
Query: 187 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 246
S + + GL L+ L+L N + S + L +L L L + L
Sbjct: 166 SDI--VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221
Query: 247 YLENLNLSFNKL 258
+ + L
Sbjct: 222 VPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 3e-20
Identities = 56/258 (21%), Positives = 102/258 (39%), Gaps = 41/258 (15%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ S+ I +N+ + + + I L N T +
Sbjct: 40 NELNSIDQIIANNSDIKSV----------------------------QGIQYLPNVTKLF 71
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L GNKL I L+ L+ L L L++NK++ + + L +L L L+ N +S +
Sbjct: 72 LNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING 126
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+L L + LG+NK+T + L + L+ N ++ +PL L L +
Sbjct: 127 -LVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYL 182
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
S N+ S + + GLKNL+ L L + +L+ + ++ +L P
Sbjct: 183 SKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEI 238
Query: 242 LEKLSYLENLNLSFNKLE 259
+ E N+ ++ E
Sbjct: 239 ISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.3 bits (213), Expect = 4e-18
Identities = 41/179 (22%), Positives = 75/179 (41%), Gaps = 13/179 (7%)
Query: 81 LQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLT 140
+ ++ PDD AE + +L ++ ++ + L S+ + ++ +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 141 SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNL 200
SV L ++ L + N LT PL NLK L + N + + LK L
Sbjct: 57 SVQ-GIQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIKDLSS--LKDLKKL 111
Query: 201 EYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259
+ L L +N + I + L L+ L L NN ++ L +L+ L+ L+L N++
Sbjct: 112 KSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 40/203 (19%), Positives = 70/203 (34%), Gaps = 16/203 (7%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSH--SLEDFRMYNCNISGGIPEEISNLTNSTI 59
+ K L + L +N + + + L H LE + N I+ +S LT
Sbjct: 106 KDLKKLKSLSLEHNGI------SDINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDT 157
Query: 60 VNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL 119
++L N+++ I L+ L KLQ L L N + S + L L L+L +
Sbjct: 158 LSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKP 213
Query: 120 PACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
SNL V L + + + D N + + + I
Sbjct: 214 INHQSNLVVPNTVKNTDGSLVTPEIIS-DDGDYEKPNVKWHLPEFTNEVSF-IFYQPVTI 271
Query: 180 DFSMNNFSGVIPTEIGGLKNLEY 202
+ F G + + + + Y
Sbjct: 272 GKAKARFHGRVTQPLKEVYTVSY 294
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 65/214 (30%), Positives = 93/214 (43%), Gaps = 33/214 (15%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICH-LAEL 105
IP I ++ ++L NKL+ +L KL+ L L DNKL+ ++P I L L
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 106 YRLDLDGNKLSGSLPAC-FSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLT 163
L + NKL +LP F L +L + L N+L S+P F +L + L+ N L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 164 SPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS-FGDLI 222
S LP GV L +L+ L L N+L+ +P+ F L
Sbjct: 147 S-LP-------------------KGV----FDKLTSLKELRLYNNQLK-RVPEGAFDKLT 181
Query: 223 SLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
LK L L NN L + + L L+ L L N
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 34/176 (19%)
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDI 152
+IP +I A+ +LDL NKLS F LT LR++ L NKL ++P F LK++
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 153 LNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQ 211
L + N L + +P + L NL L L N+L+
Sbjct: 88 ETLWVTDNKLQA-------------------------LPIGVFDQLVNLAELRLDRNQLK 122
Query: 212 GSIPDS-FGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLSFNKLEGEIPRG 265
S+P F L L +L+L N L ++P + +KL+ L+ L L N+L+ +P G
Sbjct: 123 -SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEG 175
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELY 106
P++ + NL + T ++L + + ++ ++ S+ I +L +
Sbjct: 13 FPDDAF--AETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVR 66
Query: 107 RLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT-FWNLKDILNLNFSSNFLTSP 165
L L GNKL + A LT+L + L N+L S+P F L ++ L N L S
Sbjct: 67 YLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS- 123
Query: 166 LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS-FGDLISL 224
LP GV L NL YL L +N+LQ S+P F L +L
Sbjct: 124 LP-------------------DGVFDK----LTNLTYLNLAHNQLQ-SLPKGVFDKLTNL 159
Query: 225 KFLNLSNNNLSGAIPASL-EKLSYLENLNLSFNKLEGEIPRG 265
L+LS N L ++P + +KL+ L++L L N+L+ +P G
Sbjct: 160 TELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 62/205 (30%), Positives = 83/205 (40%), Gaps = 42/205 (20%)
Query: 53 NLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIP--DDICHLAELYRLDL 110
L + + + + I L ++ L L NKL I L L L L
Sbjct: 39 ELNSIDQIIANNSDIKSVQGI--QYLPNVRYLALGGNKLH-DISALK---ELTNLTYLIL 92
Query: 111 DGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPL 168
GN+L SLP F LT+L+ + L N+L S+P F L ++ LN + N L S LP
Sbjct: 93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LP- 149
Query: 169 EIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS-FGDLISLKFL 227
GV L NL L L YN+LQ S+P+ F L LK L
Sbjct: 150 ------------------KGVFDK----LTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDL 186
Query: 228 NLSNNNLSGAIP----ASLEKLSYL 248
L N L ++P L L Y+
Sbjct: 187 RLYQNQLK-SVPDGVFDRLTSLQYI 210
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 39/146 (26%), Positives = 57/146 (39%), Gaps = 17/146 (11%)
Query: 118 SLPA-CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVL 176
P F+ L +T T L I + +++ + S I L +
Sbjct: 12 IFPDDAFAETIKAN---LKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNV 65
Query: 177 IGIDFSMNNFSGVIPTEIG---GLKNLEYLFLGYNRLQGSIPDS-FGDLISLKFLNLSNN 232
+ N +I L NL YL L N+LQ S+P+ F L +LK L L N
Sbjct: 66 RYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119
Query: 233 NLSGAIPASLEKLSYLENLNLSFNKL 258
L +KL+ L LNL+ N+L
Sbjct: 120 QLQSLPDGVFDKLTNLTYLNLAHNQL 145
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 37/216 (17%), Positives = 74/216 (34%), Gaps = 7/216 (3%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAEL 105
IP ++ N+ + KL S L+ + + N + I D+ +L +L
Sbjct: 24 IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 106 YRLDL-DGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLT 163
+ + + N L P F NL +L+ + + + + +P + + + L+ N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141
Query: 164 SPLPLEI--GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL 221
+ G + + + N + + G + E N L+ D F
Sbjct: 142 HTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGA 201
Query: 222 ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 257
L++S + LE L L + K
Sbjct: 202 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 48/259 (18%), Positives = 84/259 (32%), Gaps = 57/259 (22%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S L I +S N + ++ NL L + R+ N + +
Sbjct: 51 SGFGDLEKIEISQNDVLEVIEADVFSNL-PKLHEIRIEKAN-------NLLYIN------ 96
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLP 120
P L LQ L + + ++ +PD H + LD+ N ++
Sbjct: 97 ----------PEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 121 A-CFSNLTS-LRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIG 178
F L+ I+ L N + + + +N + LN S N
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDN------------------ 187
Query: 179 IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD-SFGDLISLKFLNLSNNNLSGA 237
NN + G L + R+ S+P +L L+ + N
Sbjct: 188 -----NNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---K 238
Query: 238 IPASLEKLSYLENLNLSFN 256
+P +LEKL L +L++
Sbjct: 239 LP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 34/150 (22%), Positives = 57/150 (38%), Gaps = 5/150 (3%)
Query: 128 SLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFS 187
S R+ +K+T +P ++ + L F L L I+ S N+
Sbjct: 10 SNRVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 188 GVIPTEI-GGLKNLEYLFL-GYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKL 245
VI ++ L L + + N L P++F +L +L++L +SN +
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 246 SYLENLNLSFNKLEGEIPRGGSFGNFSAES 275
L++ N I R SF S ES
Sbjct: 128 LQKVLLDIQDNINIHTIER-NSFVGLSFES 156
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 36/164 (21%), Positives = 64/164 (39%), Gaps = 11/164 (6%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEE-ISNLT-NSTI 59
N +L + +SN + + + +L L D + N NI I L+ S I
Sbjct: 101 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ-DNINIHT-IERNSFVGLSFESVI 158
Query: 60 VNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAELYRLDLDGNKLSGS 118
+ L N + + Q + ++N LE +P+D+ + LD+ ++ S
Sbjct: 159 LWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-S 216
Query: 119 LPA-CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNF 161
LP+ NL LR S L +P T L ++ + +
Sbjct: 217 LPSYGLENLKKLRARST--YNLKKLP-TLEKLVALMEASLTYPS 257
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 27/94 (28%), Positives = 42/94 (44%), Gaps = 1/94 (1%)
Query: 332 RGKRPSNDANMPLVATWRTFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVK 391
+ ++ + ++L AT+ F LIG G FG VYK L D +VA+K
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 392 VFNLQCGRAFESFDVECEMMKNIRHRNLIKILHG 425
+ + E F+ E E + RH +L+ L G
Sbjct: 70 RRTPESSQGIEEFETEIETLSFCRHPHLVS-LIG 102
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 33/190 (17%), Positives = 64/190 (33%), Gaps = 11/190 (5%)
Query: 73 ITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIV 132
I S + L + + L + L ++ L +++ +
Sbjct: 17 IPDSTFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDL 71
Query: 133 SLGSNKLTSV-PLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP 191
++ + T+ P++ L ++ L +TS + L L +D S + I
Sbjct: 72 TINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 192 TEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 251
T+I L + + L YN I L LK LN+ + + +E L L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL 186
Query: 252 NLSFNKLEGE 261
+ G+
Sbjct: 187 YAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 29/188 (15%), Positives = 61/188 (32%), Gaps = 11/188 (5%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S K+ L + I + ++ SL + N N++ I N +
Sbjct: 20 STFKAYLNGLLGQSSTANI----TEAQMN-SLTYITLANINVTD--LTGIEYAHNIKDLT 72
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
+ P +S L L+ L + + ++ L L LD+ + S+
Sbjct: 73 INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+ L + + L N + + L ++ +LN + + +E + L +
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYA 188
Query: 182 SMNNFSGV 189
G
Sbjct: 189 FSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 31/164 (18%), Positives = 62/164 (37%), Gaps = 8/164 (4%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ SLT I L+N + + T + H+++D + N + + IS L+N +
Sbjct: 40 EAQMNSLTYITLANINVTDL---TGIEYA-HNIKDLTINNIHATN--YNPISGLSNLERL 93
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+ G + LS L L L + + + SI I L ++ +DL N +
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTS 164
L L+ +++ + + + + L S +
Sbjct: 154 P-LKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 23/142 (16%), Positives = 55/142 (38%), Gaps = 7/142 (4%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ ++ + ++N + LS +LE R+ +++ +S LT+ T++
Sbjct: 62 IEYAHNIKDLTINNIHATNY---NPISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
++ + + SI ++ L K+ + L N I + L EL L++ + +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG 176
Query: 121 ACFSNLTSLRIVSLGSNKLTSV 142
+ L + S +
Sbjct: 177 --IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 19/116 (16%), Positives = 43/116 (37%), Gaps = 7/116 (6%)
Query: 148 NLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGY 207
K LN + + ++ +L + + N + + T I N++ L +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYI---TLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 208 NRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
P L +L+ L + +++ +L L+ L L++S + + I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 51/250 (20%), Positives = 88/250 (35%), Gaps = 22/250 (8%)
Query: 30 SHSLEDF-RMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKL---QKLQGLG 85
SLE + + G +I + + + ++ I ++ LQ L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 86 LEDNKLEGSIPDDI--CHLAELYRLDLDGNKLSG---SLPACFSNL-TSLRIVSLGSNKL 139
LE+ ++ G+ P + +L L+L + L L L+++S+
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 140 TSVPLTFW-NLKDILNLNFSSNFLTSPLPLE-------IGNLKVLIGIDFSMNNFSGVIP 191
+ + L+ S N L L+VL + M SGV
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 192 TEIGGLKNLEYLFLGYNRLQGSIPD-SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLEN 250
L+ L L +N L+ + S L LNLS L +P L + L
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSV 278
Query: 251 LNLSFNKLEG 260
L+LS+N+L+
Sbjct: 279 LDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 43/263 (16%), Positives = 72/263 (27%), Gaps = 50/263 (19%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
L + L N + G P + L + N + + ++ L
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA-TRDAWLAELQQ------ 145
Query: 63 GGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP-- 120
L+ L + + + L LDL N G
Sbjct: 146 -------------WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
Query: 121 --ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIG 178
C +L++++L + + + L L G
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSAL--------------------AAARVQLQG 232
Query: 179 IDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGA 237
+D S N+ L L L + L+ +P L L+LS N L
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDR- 288
Query: 238 IPASLEKLSYLENLNLSFNKLEG 260
P+ E L + NL+L N
Sbjct: 289 NPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 42/243 (17%), Positives = 69/243 (28%), Gaps = 26/243 (10%)
Query: 41 CNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC 100
CN S P+ S ++ S+ L ++ D + + DI
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRV---------DTEADLGQFTDII 65
Query: 101 HLAELYRLDLDGNKLSGSLPAC------FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILN 154
L RL + ++ + S L L + +L PL D+
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 155 LNFSSNFLTSPLP----LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRL 210
LN + + L+ L + + + ++ L L L N
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 211 QGSIP----DSFGDLISLKFLNLSNNN---LSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
G +L+ L L N SG A L+ L+LS N L
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 264 RGG 266
Sbjct: 246 APS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 39/186 (20%), Positives = 62/186 (33%), Gaps = 14/186 (7%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ L L +S D L + L L+ + + E++ + +
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQ-QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 61 NLGGNKLNGSIPITLS----KLQKLQGLGLEDNKLE---GSIPDDICHLAELYRLDLDGN 113
+L N G + + K LQ L L + +E G +L LDL N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 114 KLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTS-PLPLEI 170
L + A + L ++L L VP L L+ S N L P P E+
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLDRNPSPDEL 295
Query: 171 GNLKVL 176
+ L
Sbjct: 296 PQVGNL 301
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 32/170 (18%), Positives = 54/170 (31%), Gaps = 16/170 (9%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGI-------PEEISNLTNS 57
L ++ ++ V +L + + G P + L
Sbjct: 149 PGLKVLSIAQAHSLNF-SCEQVRVFP-ALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206
Query: 58 TIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAELYRLDLDGNKLS 116
+ N G +G + +LQGL L N L + C ++L L+L L
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
Query: 117 GSLPAC-FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSP 165
+P + L+ L L N+L P L + NL+ N
Sbjct: 267 -QVPKGLPAKLSVL---DLSYNRLDRNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 46/251 (18%), Positives = 89/251 (35%), Gaps = 19/251 (7%)
Query: 8 TLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKL 67
+ P+ I + + +++ + L + + + +
Sbjct: 5 SETITVPTPIKQIFS---DDAFAE-TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI 58
Query: 68 NGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLT 127
S+ + L + L L NKL I + +L L L LD NK+ L + +L
Sbjct: 59 K-SVQ-GIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLK 112
Query: 128 SLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFS 187
L+ +SL N ++ + +L + +L +N +T L L L + N S
Sbjct: 113 KLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS 169
Query: 188 GVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 247
++P + GL L+ L+L N + + + L +L L L + L
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVV 225
Query: 248 LENLNLSFNKL 258
+ + L
Sbjct: 226 PNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 56/258 (21%), Positives = 102/258 (39%), Gaps = 41/258 (15%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ S+ I +N+ + + + I L N T +
Sbjct: 43 NELNSIDQIIANNSDIKSV----------------------------QGIQYLPNVTKLF 74
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L GNKL P L+ L+ L L L++NK++ + + L +L L L+ N +S +
Sbjct: 75 LNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING 129
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+L L + LG+NK+T + L + L+ N ++ +PL L L +
Sbjct: 130 -LVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYL 185
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
S N+ S + + GLKNL+ L L + +L+ + ++ +L P
Sbjct: 186 SKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEI 241
Query: 242 LEKLSYLENLNLSFNKLE 259
+ E N+ ++ E
Sbjct: 242 ISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 42/185 (22%), Positives = 77/185 (41%), Gaps = 13/185 (7%)
Query: 75 LSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSL 134
+ L+ + ++ L + ++ + + + S+ L ++ + L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 75
Query: 135 GSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI 194
NKLT + NLK++ L N + L+ +LK L + N S + +
Sbjct: 76 NGNKLTDIK-PLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGISDING--L 130
Query: 195 GGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 254
L LE L+LG N++ + L L L+L +N +S +P L L+ L+NL LS
Sbjct: 131 VHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186
Query: 255 FNKLE 259
N +
Sbjct: 187 KNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 36/166 (21%), Positives = 60/166 (36%), Gaps = 15/166 (9%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSH--SLEDFRMYNCNISGGIPEEISNLTNST 58
+ + K L + L +N + + + L H LE + N I+ +S LT
Sbjct: 108 LKDLKKLKSLSLEHNGI------SDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLD 159
Query: 59 IVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGS 118
++L N+++ I L+ L KLQ L L N + + + L L L+L +
Sbjct: 160 TLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNK 215
Query: 119 LPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTS 164
SNL V L + P + D N +
Sbjct: 216 PINHQSNLVVPNTVKNTDGSLVT-PEIISDDGDYEKPNVKWHLPEF 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 46/181 (25%), Positives = 73/181 (40%), Gaps = 40/181 (22%)
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLPA--CFSNLTSLRIVSLGSNKLTSVP-LTFWNLK 150
++P + + LDL N LS L A + LT+L + L N L + F +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88
Query: 151 DILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNR 209
++ L+ SSN L + + + L+ LE L L N
Sbjct: 89 NLRYLDLSSNHLHT-------------------------LDEFLFSDLQALEVLLLYNNH 123
Query: 210 LQGSIP-DSFGDLISLKFLNLSNNNLSGAIPA----SLEKLSYLENLNLSFNKLEGEIPR 264
+ + ++F D+ L+ L LS N +S P KL L L+LS NKL+ ++P
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL 180
Query: 265 G 265
Sbjct: 181 T 181
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 36/171 (21%), Positives = 68/171 (39%), Gaps = 12/171 (7%)
Query: 24 TSV-GNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIVNLGGNKLNGSIPI-TLSKLQK 80
+V +L + + N+S E + LTN + L N LN I +
Sbjct: 31 PNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 81 LQGLGLEDNKLEGSIPDDIC-HLAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNK 138
L+ L L N L ++ + + L L L L N + + F ++ L+ + L N+
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 139 LTSVPL-TFWN---LKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNN 185
++ P+ + L ++ L+ SSN L ++ L + ++N
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIVNLGG 64
L+ LS+N L + + + L++ L + + +++ I E + N ++L
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTN-LHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 65 NKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSLPA- 121
N L+ ++ S LQ L+ L L +N + + + +A+L +L L N++S P
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154
Query: 122 ---CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDI--LNLNFSSN 160
+ L L ++ L SNKL +PL L L +N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 32/164 (19%), Positives = 61/164 (37%), Gaps = 13/164 (7%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIVNLG 63
+L + LS+N L+ I + + +L + + ++ + E + S+L ++ L
Sbjct: 64 TNLHSLLLSHNHLNFI-SSEAFVPVP-NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY 120
Query: 64 GNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDI----CHLAELYRLDLDGNKLSGS 118
N + + + +LQ L L N++ P ++ L +L LDL NKL
Sbjct: 121 NNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 119 LPACFSNLTSL--RIVSLGSNKLTSVPLTFWNLKDILNLNFSSN 160
L + + L +N L + SS
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSV 222
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 39/211 (18%), Positives = 78/211 (36%), Gaps = 16/211 (7%)
Query: 49 EEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108
L N+ NLG + + ++ +L +Q +++ ++ S+ + L L
Sbjct: 13 FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSV-PLTFWNLKDILNLNFSSNFLTSPLP 167
L N++S L +LT L +S+ N+L ++ + L L +N L
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLDNNELRDTDS 123
Query: 168 LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFL 227
L +LK L + N ++ +G L LE L L N + + L + ++
Sbjct: 124 LI--HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWI 177
Query: 228 NLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
+L+ +L + +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-14
Identities = 36/248 (14%), Positives = 84/248 (33%), Gaps = 20/248 (8%)
Query: 12 LSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSI 71
P++ + P L++ + +++ L+ N + + S+
Sbjct: 4 QRPTPINQVFP---DPGLAN-AVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL 56
Query: 72 PITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRI 131
+ L+ L L N++ + + L +L L ++ N+L + L+ L
Sbjct: 57 A-GMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL-- 111
Query: 132 VSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP 191
L +N+L + +LK++ L+ +N L S + L L L +D N +
Sbjct: 112 -FLDNNELRDTD-SLIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEITNTGG 167
Query: 192 TEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 251
+ LK + ++ L + +L + + P + +
Sbjct: 168 --LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDG 223
Query: 252 NLSFNKLE 259
+ +
Sbjct: 224 CVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 35/188 (18%), Positives = 78/188 (41%), Gaps = 20/188 (10%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
M +L ++LS+N + + + + +L+ LE+ + + ++ + ++ +
Sbjct: 59 MQFFTNLKELHLSHNQISDL---SPLKDLTK-LEELSVNRNRLK-----NLNGIPSACLS 109
Query: 61 --NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGS 118
L N+L +L L+ L+ L + +NKL+ SI + L++L LDL GN+++ +
Sbjct: 110 RLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNT 165
Query: 119 LPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPL-PLEIGNLKVLI 177
+ L + + L K + P+ ++ N + + P I N +
Sbjct: 166 GG--LTRLKKVNWIDLTGQKCVNEPVK--YQPELYITNTVKDPDGRWISPYYISNGGSYV 221
Query: 178 GIDFSMNN 185
Sbjct: 222 DGCVLWEL 229
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-16
Identities = 37/165 (22%), Positives = 69/165 (41%), Gaps = 29/165 (17%)
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDI 152
IP ++ + + L+ N + P FS LR + L +N+++ + F L+ +
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 153 LNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 212
+L N +T LP + F G L +L+ L L N++
Sbjct: 83 NSLVLYGNKITE-LPKSL---------------FEG--------LFSLQLLLLNANKIN- 117
Query: 213 SIP-DSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
+ D+F DL +L L+L +N L + L ++ ++L+ N
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 7/121 (5%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAEL 105
IP + T + L N + P S +KL+ + L +N++ + D L L
Sbjct: 26 IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 106 YRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLT 163
L L GNK++ LP F L SL+++ L +NK+ + + F +L ++ L+ N L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 164 S 164
+
Sbjct: 142 T 142
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-11
Identities = 26/88 (29%), Positives = 38/88 (43%), Gaps = 3/88 (3%)
Query: 179 IDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAI 238
I N + P K L + L N++ PD+F L SL L L N ++ +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 239 PASL-EKLSYLENLNLSFNKLEGEIPRG 265
P SL E L L+ L L+ NK+ +
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVD 122
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 36/138 (26%), Positives = 48/138 (34%), Gaps = 30/138 (21%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S K L I LSNN + + P F L + +
Sbjct: 53 SPYKKLRRIDLSNNQISELAPDA-----------F---------------QGLRSLNSLV 86
Query: 62 LGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGNKLSGSL 119
L GNK+ +P L LQ L L NK+ + D L L L L NKL
Sbjct: 87 LYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIA 144
Query: 120 PACFSNLTSLRIVSLGSN 137
FS L +++ + L N
Sbjct: 145 KGTFSPLRAIQTMHLAQN 162
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 30/89 (33%), Positives = 43/89 (48%), Gaps = 16/89 (17%)
Query: 349 RTFSYLELFRATDEFSE------NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFE 402
+FS+ EL T+ F E N +G+GGFG VYK + + VAVK L
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKK--LAAMVDIT 69
Query: 403 S------FDVECEMMKNIRHRNLIKILHG 425
+ FD E ++M +H NL++ L G
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVE-LLG 97
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 39/212 (18%), Positives = 82/212 (38%), Gaps = 13/212 (6%)
Query: 52 SNLTNSTIVNLGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLD 109
S ++ + L L +IP S L + + + + + +L+++ ++
Sbjct: 28 SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86
Query: 110 LDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDIL-NLNFSSNFLTSPL 166
+ + + L L+ + + + L P LT DI L + N + +
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 167 PLEI--GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-DSFGDLIS 223
P+ G + + N F+ + L+ ++L N+ I D+FG + S
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205
Query: 224 -LKFLNLSNNNLSGAIPA-SLEKLSYLENLNL 253
L++S +++ A+P+ LE L L N
Sbjct: 206 GPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 38/238 (15%), Positives = 77/238 (32%), Gaps = 19/238 (7%)
Query: 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLG 63
C ++ + + +L S + ++ ++ SNL N + + +
Sbjct: 10 CHQEEDFRVTCKDI------QRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63
Query: 64 GNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAELYRLDLDGNKLSGSLPA 121
+ + + L K+ + + + + I D L L L + L P
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 122 C--FSNLTSLRIVSLGSN-KLTSVPL-TFWNLKDIL-NLNFSSNFLTSPLPLEIGNLKVL 176
+ I+ + N +TS+P+ F L + L +N TS + N L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKL 181
Query: 177 IGIDFSMNNFSGVIPTEI--GGLKNLEYLFLGYNRLQGSIP-DSFGDLISLKFLNLSN 231
+ + N + VI + G L + + ++P L L N
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 29/162 (17%), Positives = 62/162 (38%), Gaps = 10/162 (6%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEE--ISNLTNSTI 59
N +T I + N + ++ L L+ ++N + P+ + + I
Sbjct: 77 YNLSKVTHIEIRNTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFI 134
Query: 60 VNLGGNKLNGSIPI-TLSKLQK-LQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG 117
+ + N SIP+ L L L +N S+ + +L + L+ NK
Sbjct: 135 LEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193
Query: 118 SLPA-CFSNLTS-LRIVSLGSNKLTSVP-LTFWNLKDILNLN 156
+ F + S ++ + +T++P +LK+++ N
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 25/137 (18%), Positives = 41/137 (29%), Gaps = 6/137 (4%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV- 60
L + + N L T V + N ++ L N T+
Sbjct: 102 KELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICH--LAELYRLDLDGNKLSGS 118
L N S+ KL + L NK I D + LD+ ++ +
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-A 219
Query: 119 LPA-CFSNLTSLRIVSL 134
LP+ +L L +
Sbjct: 220 LPSKGLEHLKELIARNT 236
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 54/178 (30%), Positives = 77/178 (43%), Gaps = 29/178 (16%)
Query: 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLT 140
+ L L+ L L +L L+LD N+L +L A F +LT L + L +N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 141 SVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKN 199
S+P F +L + L N L S LP SGV L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LP-------------------SGVF----DRLTK 132
Query: 200 LEYLFLGYNRLQGSIPDS-FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
L+ L L N+LQ SIP F L +L+ L+LS N L + ++L L+ + L N
Sbjct: 133 LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 28/178 (15%)
Query: 3 NC--KSLTLI-----------YLSNNPLDGILPKTSVGNLSHSLEDFRMYNC--NISGGI 47
+C KSL + L + L + T L N N +
Sbjct: 20 DCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATF-----RGLTKLTWLNLDYNQLQTL 74
Query: 48 PEEI-SNLTNSTIVNLGGNKLNGSIPITL-SKLQKLQGLGLEDNKLEGSIPDDIC-HLAE 104
+ +LT + L N+L S+P+ + L +L L L N+L+ S+P + L +
Sbjct: 75 SAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK 132
Query: 105 LYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
L L L+ N+L S+PA F LT+L+ +SL +N+L SVP F L + + N
Sbjct: 133 LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 43/174 (24%), Positives = 66/174 (37%), Gaps = 54/174 (31%)
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDIL 153
S+P I A+ +LDL L+ A F LT L ++L N+L ++
Sbjct: 28 SVPSGI--PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS---------- 75
Query: 154 NLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 213
+GV L L L L N+L S
Sbjct: 76 ---------------------------------AGVF----DDLTELGTLGLANNQLA-S 97
Query: 214 IPDS-FGDLISLKFLNLSNNNLSGAIPASL-EKLSYLENLNLSFNKLEGEIPRG 265
+P F L L L L N L ++P+ + ++L+ L+ L L+ N+L+ IP G
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAG 149
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 76.3 bits (187), Expect = 6e-15
Identities = 29/195 (14%), Positives = 66/195 (33%), Gaps = 8/195 (4%)
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFS 124
+ ++L L K + ++ EL L+ + ++
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 125 NLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN 184
L L ++ L + L+ + + + + +
Sbjct: 394 ALDPLLYEKETLQYFST--LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451
Query: 185 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEK 244
+ + + + L + +L L +NRL+ ++P + L L+ L S+N L + +
Sbjct: 452 DLTVLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVAN 506
Query: 245 LSYLENLNLSFNKLE 259
L L+ L L N+L+
Sbjct: 507 LPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 49/218 (22%), Positives = 76/218 (34%), Gaps = 21/218 (9%)
Query: 48 PEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYR 107
+ + L K + L ++LQ L E+ +I I + L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDP 397
Query: 108 LDLDGNKLSGSLPACFSNLTSLRIVSLG------SNKLTSVPLTFWNLKDILNLNFSSNF 161
L + L FS L ++ + S L + D+ L+ +
Sbjct: 398 LLYEKETLQY-----FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL 221
LT LE L ++ +D S N +P + L+ LE L N L+ ++ +L
Sbjct: 453 LTVLCHLE--QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANL 507
Query: 222 ISLKFLNLSNNNLSG-AIPASLEKLSYLENLNLSFNKL 258
L+ L L NN L A L L LNL N L
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.5 bits (177), Expect = 1e-13
Identities = 42/252 (16%), Positives = 72/252 (28%), Gaps = 37/252 (14%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ + L LS + + LE + + + L
Sbjct: 346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETL 405
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
+ L P+ + L L+ L +N + A++ L L L+ L
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVL------KMEYADVRVLHLAHKDLT-VLCH 458
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
L + + L N+L ++P L+ + L S N L + +
Sbjct: 459 -LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-------------- 502
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD--SFGDLISLKFLNLSNNNLSGAIP 239
+ L L+ L L NRLQ L LNL N+L
Sbjct: 503 -----------GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550
Query: 240 ASLEKLSYLENL 251
L ++
Sbjct: 551 IQERLAEMLPSV 562
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 24/137 (17%), Positives = 47/137 (34%), Gaps = 38/137 (27%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ +T + LS+N L +P ++ L ++
Sbjct: 459 LEQLLLVTHLDLSHNRLR---------------------------ALPPALAALRCLEVL 491
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPD--DICHLAELYRLDLDGNKLS-- 116
N L ++ ++ L +LQ L L +N+L+ + L L+L GN L
Sbjct: 492 QASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQE 548
Query: 117 ----GSLPACFSNLTSL 129
L +++S+
Sbjct: 549 EGIQERLAEMLPSVSSI 565
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 17/73 (23%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEM 410
L+ + + +G FG V+KA+L + VAVK+F +Q ++++ + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 411 MKNIRHRNLIKIL 423
+ ++H N+++ +
Sbjct: 72 LPGMKHENILQFI 84
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 30/166 (18%)
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLP-ACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKD 151
IP+ I L L+ N+ + F L LR ++ +NK+T + F
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 152 ILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 211
+ + +SN L + + ++ F G L++L+ L L NR+
Sbjct: 83 VNEILLTSNRLEN-VQHKM---------------FKG--------LESLKTLMLRSNRIT 118
Query: 212 GSIP-DSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
+ DSF L S++ L+L +N ++ P + + L L LNL N
Sbjct: 119 -CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 34/139 (24%), Positives = 58/139 (41%), Gaps = 10/139 (7%)
Query: 131 IVSLGSNKLTSVPLTFWNL-KDILNLNFSSNFLTSPLPLEI-GNLKVLIGIDFSMNNFSG 188
V + KL +P ++ + L ++N T I L L I+FS N +
Sbjct: 15 TVDCSNQKLNKIPE---HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD 71
Query: 189 VIPTEIGGLKNLEYLFLGYNRLQGSIPDS-FGDLISLKFLNLSNNNLSGAIPA-SLEKLS 246
+ G + + L NRL+ ++ F L SLK L L +N ++ + S LS
Sbjct: 72 IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLS 129
Query: 247 YLENLNLSFNKLEGEIPRG 265
+ L+L N++ + G
Sbjct: 130 SVRLLSLYDNQIT-TVAPG 147
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 21/115 (18%), Positives = 43/115 (37%), Gaps = 8/115 (6%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLTNSTIV 60
L I SNN + I G S + + + + + + ++ L + +
Sbjct: 54 KKLPQLRKINFSNNKITDIEEGAFEG-ASG-VNEILLTSNRLEN-VQHKMFKGLESLKTL 110
Query: 61 NLGGNKLNGSIPI-TLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLDGN 113
L N++ + + L ++ L L DN++ ++ L L L+L N
Sbjct: 111 MLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-14
Identities = 33/118 (27%), Positives = 58/118 (49%), Gaps = 12/118 (10%)
Query: 46 GIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAE 104
GIP + T + L GN+ +P LS + L + L +N++ ++ + ++ +
Sbjct: 28 GIP------RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 105 LYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
L L L N+L +P F L SLR++SL N ++ VP F +L + +L +N
Sbjct: 80 LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 33/153 (21%), Positives = 54/153 (35%), Gaps = 52/153 (33%)
Query: 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLT 140
L L+ N+ +P ++ + L +DL N++S +L FSN+T L + L N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 141 SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNL 200
+P GLK+L
Sbjct: 92 CIP-------------------------------------------PRT----FDGLKSL 104
Query: 201 EYLFLGYNRLQGSIPD-SFGDLISLKFLNLSNN 232
L L N + +P+ +F DL +L L + N
Sbjct: 105 RLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 24/77 (31%), Positives = 35/77 (45%), Gaps = 3/77 (3%)
Query: 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 248
+P E+ K+L + L NR+ SF ++ L L LS N L IP + L L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSL 104
Query: 249 ENLNLSFNKLEGEIPRG 265
L+L N + +P G
Sbjct: 105 RLLSLHGNDIS-VVPEG 120
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 8/76 (10%)
Query: 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLE 249
IP ++ L+L N+ +P + L ++LSNN +S S ++ L
Sbjct: 29 IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 250 NLNLSFNKLEGEIPRG 265
L LS+N+L IP
Sbjct: 82 TLILSYNRLR-CIPPR 96
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 10/121 (8%)
Query: 46 GIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAE 104
GIP TN+ I+ L N++ P L L+ L L N+L ++P + L +
Sbjct: 37 GIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 105 LYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLT 163
L LDL N+L+ LP+ F L L+ + + NKLT +P L + +L N L
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLK 148
Query: 164 S 164
S
Sbjct: 149 S 149
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 28/164 (17%)
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDI 152
S+P I L L N+++ P F +L +L+ + LGSN+L ++P+ F +L +
Sbjct: 33 SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 153 LNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 212
L+ +N LT LP S V L +L+ LF+ N+L
Sbjct: 91 TVLDLGTNQLTV-LP-------------------SAVF----DRLVHLKELFMCCNKLT- 125
Query: 213 SIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
+P L L L L N L + ++LS L + L N
Sbjct: 126 ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 6/111 (5%)
Query: 53 NLTNSTIVNLGGNKLNGSIPITL-SKLQKLQGLGLEDNKLEGSIPDDIC-HLAELYRLDL 110
+L N + LG N+L ++P+ + L +L L L N+L +P + L L L +
Sbjct: 62 SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFM 119
Query: 111 DGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
NKL+ LP LT L ++L N+L S+P F L + + N
Sbjct: 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 3/87 (3%)
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
N + + P L NL+ L+LG N+L F L L L+L N L+ +P
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLP 104
Query: 240 ASL-EKLSYLENLNLSFNKLEGEIPRG 265
+++ ++L +L+ L + NKL E+PRG
Sbjct: 105 SAVFDRLVHLKELFMCCNKLT-ELPRG 130
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 8/71 (11%)
Query: 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 248
IPT N + L+L N++ P F LI+LK L L +N L A+P + + L+ L
Sbjct: 38 IPT------NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 249 ENLNLSFNKLE 259
L+L N+L
Sbjct: 91 TVLDLGTNQLT 101
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 22/75 (29%), Positives = 36/75 (48%), Gaps = 6/75 (8%)
Query: 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEM 410
+ E D LIG+G +G+VYK L +R VAVKVF+ ++F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFSFA---NRQNFINEKNI 58
Query: 411 MK--NIRHRNLIKIL 423
+ + H N+ + +
Sbjct: 59 YRVPLMEHDNIARFI 73
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-12
Identities = 30/120 (25%), Positives = 53/120 (44%), Gaps = 14/120 (11%)
Query: 46 GIPEEISNLTNSTIVNLGGNKLNGSIPIT--LSKLQKLQGLGLEDNKLEGSIPDDIC-HL 102
IP ++T + L N+L I +L L L L+ N+L I +
Sbjct: 26 DIP------LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA 77
Query: 103 AELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
+ + L L NK+ + F L L+ ++L N+++ V +F +L + +LN +SN
Sbjct: 78 SHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 38/183 (20%), Positives = 63/183 (34%), Gaps = 61/183 (33%)
Query: 56 NSTIVNLGGNKLN---GSIPITLSKLQKLQGLGLEDNKLEGSIPDDI-CHLAELYRLDLD 111
T V+ G L IP+ ++L L DN+L D + L L +L+L
Sbjct: 9 EGTTVDCTGRGLKEIPRDIPLHTTELL------LNDNELGRISSDGLFGRLPHLVKLELK 62
Query: 112 GNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEI 170
N+L+ + F + ++ + LG NK+ +
Sbjct: 63 RNQLT-GIEPNAFEGASHIQELQLGENKIKEIS--------------------------- 94
Query: 171 GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD-SFGDLISLKFLNL 229
+ + GL L+ L L N++ + SF L SL LNL
Sbjct: 95 ----------------NKM----FLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNL 133
Query: 230 SNN 232
++N
Sbjct: 134 ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 6/90 (6%)
Query: 179 IDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPDS-FGDLISLKFLNLSNNNLSG 236
+ + N + + G L +L L L N+L I + F ++ L L N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 237 AIPASL-EKLSYLENLNLSFNKLEGEIPRG 265
I + L L+ LNL N++ + G
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 39/166 (23%), Positives = 59/166 (35%), Gaps = 54/166 (32%)
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLPAC--FSNLTSLRIVSLGSNKLTSVPLTFWNLKD 151
IP DI L L+ N+L + + F L L + L N+LT +
Sbjct: 22 EIPRDI--PLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIE-------- 70
Query: 152 ILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 211
G +++ L LG N+++
Sbjct: 71 -----------------------------------PNAF----EGASHIQELQLGENKIK 91
Query: 212 GSIPD-SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
I + F L LK LNL +N +S +P S E L+ L +LNL+ N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 24/78 (30%), Positives = 32/78 (41%), Gaps = 10/78 (12%)
Query: 190 IPTEIGGLKNLEYLFLGYNRLQGSIPD-SFGDLISLKFLNLSNNNLSGAIPASL-EKLSY 247
IP + L L N L D FG L L L L N L+ I + E S+
Sbjct: 27 IPL------HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79
Query: 248 LENLNLSFNKLEGEIPRG 265
++ L L NK++ EI
Sbjct: 80 IQELQLGENKIK-EISNK 96
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 40/118 (33%), Positives = 59/118 (50%), Gaps = 11/118 (9%)
Query: 46 GIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAE 104
GIP +++T + L NKL KL +L L L N+++ S+PD + L +
Sbjct: 25 GIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 105 LYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
L L L NKL SLP F LT L+ ++L +N+L SVP F L + + +N
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-08
Identities = 40/128 (31%), Positives = 54/128 (42%), Gaps = 27/128 (21%)
Query: 107 RLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSP 165
RL+L+ NKL F LT L +SL N++ S+P F L + L N L S
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS- 90
Query: 166 LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD-SFGDLISL 224
LP +GV L L+ L L N+L+ S+PD F L SL
Sbjct: 91 LP-------------------NGVFDK----LTQLKELALDTNQLK-SVPDGIFDRLTSL 126
Query: 225 KFLNLSNN 232
+ + L N
Sbjct: 127 QKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 7e-08
Identities = 31/85 (36%), Positives = 40/85 (47%), Gaps = 3/85 (3%)
Query: 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLT 140
L LE NKL+ L +L +L L N++ SLP F LT L I+ L NKL
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 141 SVPL-TFWNLKDILNLNFSSNFLTS 164
S+P F L + L +N L S
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKS 114
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 248
IP+ + L L N+LQ F L L L+LS N + ++P + +KL+ L
Sbjct: 26 IPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 249 ENLNLSFNKLEGEIPRG 265
L L NKL+ +P G
Sbjct: 79 TILYLHENKLQ-SLPNG 94
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 26/74 (35%), Positives = 36/74 (48%), Gaps = 9/74 (12%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDR-MEVAVKVFNLQCGRA-------FESFDVECEMMK 412
+E IGKGGFG V+K RL VA+K L F+ F E +M
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 413 NIRHRNLIKILHGV 426
N+ H N++K L+G+
Sbjct: 79 NLNHPNIVK-LYGL 91
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 19/63 (30%), Positives = 30/63 (47%), Gaps = 3/63 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRN 418
+ + IG G FG+V++A +VAVK+ Q F E +MK +RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 419 LIK 421
++
Sbjct: 96 IVL 98
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-11
Identities = 40/122 (32%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 46 GIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAE 104
GIP +T ++L N L +L L L L NKL+ S+P+ + L
Sbjct: 25 GIP------AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 105 LYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFL 162
L L+L N+L SLP F LT L+ ++L +N+L S+P F L + +L N L
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136
Query: 163 TS 164
S
Sbjct: 137 KS 138
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-11
Identities = 42/112 (37%), Positives = 60/112 (53%), Gaps = 7/112 (6%)
Query: 53 NLTNSTIVNLGGNKLNGSIPITL-SKLQKLQGLGLEDNKLEGSIPDDIC-HLAELYRLDL 110
LT+ T + LGGNKL S+P + +KL L L L N+L+ S+P+ + L +L L L
Sbjct: 50 ELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELAL 107
Query: 111 DGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
+ N+L SLP F LT L+ + L N+L SVP F L + + N
Sbjct: 108 NTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 55/171 (32%), Positives = 73/171 (42%), Gaps = 29/171 (16%)
Query: 88 DNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TF 146
++ S+P I A+ LDL+ N L F LTSL + LG NKL S+P F
Sbjct: 15 YSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72
Query: 147 WNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLG 206
L + LN S+N L S LP +GV L L+ L L
Sbjct: 73 NKLTSLTYLNLSTNQLQS-LP-------------------NGVFDK----LTQLKELALN 108
Query: 207 YNRLQGSIPD-SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
N+LQ S+PD F L LK L L N L ++L+ L+ + L N
Sbjct: 109 TNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 51/154 (33%), Positives = 70/154 (45%), Gaps = 29/154 (18%)
Query: 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLT 140
L LE N L+ L L +L L GNKL SLP F+ LTSL ++L +N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 141 SVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKN 199
S+P F L + L ++N L S LP GV L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQS-LP-------------------DGVFDK----LTQ 125
Query: 200 LEYLFLGYNRLQGSIPD-SFGDLISLKFLNLSNN 232
L+ L L N+L+ S+PD F L SL+++ L +N
Sbjct: 126 LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 1/86 (1%)
Query: 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
D N+ + L +L L+LG N+LQ F L SL +LNLS N L
Sbjct: 34 DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPN 93
Query: 240 ASLEKLSYLENLNLSFNKLEGEIPRG 265
+KL+ L+ L L+ N+L+ +P G
Sbjct: 94 GVFDKLTQLKELALNTNQLQ-SLPDG 118
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 28/77 (36%), Positives = 38/77 (49%), Gaps = 5/77 (6%)
Query: 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 248
+PT I YL L N L+ F +L SL L L N L ++P + KL+ L
Sbjct: 22 VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 249 ENLNLSFNKLEGEIPRG 265
LNLS N+L+ +P G
Sbjct: 79 TYLNLSTNQLQ-SLPNG 94
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 13/65 (20%), Positives = 29/65 (44%), Gaps = 3/65 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRN 418
+ + + + G ++K R ++ VKV ++ R F+ EC ++ H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 419 LIKIL 423
++ +L
Sbjct: 69 VLPVL 73
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 18/63 (28%), Positives = 31/63 (49%), Gaps = 4/63 (6%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQ--CGRAFESFDVECEMMKNIRHRN 418
++ LIGKG FG VY R EVA+++ +++ ++F E + RH N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 419 LIK 421
++
Sbjct: 91 VVL 93
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 23/70 (32%), Positives = 33/70 (47%), Gaps = 6/70 (8%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC----GRAFESFDVECEMMKNIRH 416
E + +IG GGFG VY+A EVAVK + E+ E ++ ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 417 RNLIKILHGV 426
N+I L GV
Sbjct: 66 PNIIA-LRGV 74
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 27/109 (24%), Positives = 42/109 (38%), Gaps = 15/109 (13%)
Query: 328 RYQQRGKRPSNDANMPLVATWRTFSYLELFRATDEFSENNL-----IGKGGFGSVYKARL 382
+ P+ + A F + +F E +L +GKG FGSV R
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSAFEDRDPT----QFEERHLKFLQQLGKGNFGSVEMCRY 62
Query: 383 -----GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
VAVK F+ E E++K+++H N++K GV
Sbjct: 63 DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK-YKGV 110
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 19/68 (27%), Positives = 34/68 (50%), Gaps = 5/68 (7%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRN 418
+ + IG G FG+VYK + +VAVK+ N+ + ++F E +++ RH N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 419 LIKILHGV 426
++ G
Sbjct: 82 ILL-FMGY 88
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 17/63 (26%), Positives = 32/63 (50%), Gaps = 3/63 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
E ++G+G FG V KA+ + +VA+K + ++F VE + + H N++
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAK-DVAIKQIESE--SERKAFIVELRQLSRVNHPNIV 64
Query: 421 KIL 423
K+
Sbjct: 65 KLY 67
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 27/76 (35%), Positives = 36/76 (47%), Gaps = 12/76 (15%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL----GDRMEVAVKVFNLQCG--RAFESFDVECEM 410
N L +G+G FGSV + L G ++VAVK L R E F E
Sbjct: 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 411 MKNIRHRNLIKILHGV 426
MK+ H N+I++L GV
Sbjct: 90 MKDFSHPNVIRLL-GV 104
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 24/75 (32%), Positives = 35/75 (46%), Gaps = 11/75 (14%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL-----GDRMEVAVKVFNLQCGRAFESFDVECEMM 411
+F E +L +GKG FGSV R VAVK F+ E E++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 412 KNIRHRNLIKILHGV 426
K+++H N++K GV
Sbjct: 66 KSLQHDNIVK-YKGV 79
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 18/63 (28%), Positives = 28/63 (44%), Gaps = 6/63 (9%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEM--MKNIRHRN 418
+ IGKG +G V+ + +VAVKVF S+ E E+ +RH N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWRGE-KVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 419 LIK 421
++
Sbjct: 93 ILG 95
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 21/100 (21%), Positives = 33/100 (33%), Gaps = 1/100 (1%)
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPD-DICHLAELYRLDLDGNKLSGSLPACF 123
L + L L +E+ + + D+ L EL L + + L P F
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 124 SNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLT 163
L ++L N L S+ + L S N L
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 19/89 (21%), Positives = 29/89 (32%), Gaps = 9/89 (10%)
Query: 94 SIPDDICHLAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSV-PLTFWNLKD 151
+ L L ++ + L L LR +++ + L V P F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 152 ILNLNFSSNFLTS-------PLPLEIGNL 173
+ LN S N L S L L+ L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVL 110
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 8e-08
Identities = 24/93 (25%), Positives = 37/93 (39%), Gaps = 2/93 (2%)
Query: 167 PLEIGNLKVLIGIDFSMNNFSGVIPTE-IGGLKNLEYLFLGYNRLQGSIPDSFGDLISLK 225
+ + L + + + GL L L + + L+ PD+F L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 226 FLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258
LNLS N L +++ LS L+ L LS N L
Sbjct: 84 RLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 9/59 (15%), Positives = 15/59 (25%), Gaps = 2/59 (3%)
Query: 208 NRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLSFNKLEGEIPRG 265
+L L + N + L L L NL + + L +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 19/77 (24%), Positives = 35/77 (45%), Gaps = 6/77 (7%)
Query: 355 ELFRATDEFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQCG-RAFESFDVECE 409
+ + +IGKG FG VY +R++ A+K + + E+F E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 410 MMKNIRHRNLIKILHGV 426
+M+ + H N++ L G+
Sbjct: 75 LMRGLNHPNVLA-LIGI 90
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 25/86 (29%), Positives = 36/86 (41%), Gaps = 15/86 (17%)
Query: 355 ELFRATDEFSE---------NNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQCG-RA 400
EL +A N +IG+G FG VY L G ++ AVK N
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 401 FESFDVECEMMKNIRHRNLIKILHGV 426
F E +MK+ H N++ +L G+
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLL-GI 94
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 24/76 (31%), Positives = 34/76 (44%), Gaps = 12/76 (15%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL----GDRMEVAVKVFNLQCG--RAFESFDVECEM 410
E +GKG FGSV +A+L G ++VAVK+ E F E
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 411 MKNIRHRNLIKILHGV 426
MK H ++ K++ GV
Sbjct: 79 MKEFDHPHVAKLV-GV 93
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 4e-09
Identities = 17/58 (29%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
+G G FG V + + +VAVK+ + + + F E + M + H L+K +GV
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVK-FYGV 71
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 21/60 (35%), Positives = 30/60 (50%), Gaps = 2/60 (3%)
Query: 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
+G G FG V+ A +VAVK + E+F E +MK ++H L+K LH V
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK-LHAV 251
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 18/58 (31%), Positives = 31/58 (53%), Gaps = 2/58 (3%)
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
+G G FG V+ +VAVK Q + ++F E +MK ++H+ L++ L+ V
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR-LYAV 76
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 23/87 (26%), Positives = 34/87 (39%), Gaps = 13/87 (14%)
Query: 352 SYLELFRATD--EFSENNL-----IGKGGFGSVYKARL-----GDRMEVAVKVFNLQCGR 399
+ +L+ D F E +L +GKG FGSV R VAVK
Sbjct: 7 HHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD 66
Query: 400 AFESFDVECEMMKNIRHRNLIKILHGV 426
F E +++K + ++K GV
Sbjct: 67 QQRDFQREIQILKALHSDFIVK-YRGV 92
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 12/76 (15%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL-----GDRMEVAVKVFNLQCG-RAFESFDVECEM 410
F + L +G+G FG V G VAVK G + + E ++
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 411 MKNIRHRNLIKILHGV 426
++ + H ++IK G
Sbjct: 87 LRTLYHEHIIK-YKGC 101
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 16/57 (28%), Positives = 29/57 (50%), Gaps = 6/57 (10%)
Query: 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEM--MKNIRHRNLIK 421
+GKG +G V++ VAVK+F+ + +S+ E E+ +RH N++
Sbjct: 14 ECVGKGRYGEVWRGSWQGE-NVAVKIFSSR---DEKSWFRETELYNTVMLRHENILG 66
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 17/58 (29%), Positives = 32/58 (55%), Gaps = 2/58 (3%)
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
+G G FG V + + +VA+K+ + + + F E ++M N+ H L++ L+GV
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ-LYGV 87
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 21/65 (32%), Positives = 31/65 (47%), Gaps = 6/65 (9%)
Query: 367 NLIGKGGFGSVYKARL----GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIK 421
+IG+G FG VY L G ++ AVK N F E +MK+ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 422 ILHGV 426
+L G+
Sbjct: 155 LL-GI 158
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 20/76 (26%), Positives = 32/76 (42%), Gaps = 12/76 (15%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL-----GDRMEVAVKVFNLQCG-RAFESFDVECEM 410
F + L +G+G FG V R +VAVK + G E E+
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 411 MKNIRHRNLIKILHGV 426
++N+ H N++K G+
Sbjct: 77 LRNLYHENIVK-YKGI 91
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 38/265 (14%), Positives = 79/265 (29%), Gaps = 45/265 (16%)
Query: 32 SLEDFRMYNCNISG----GIPEEISNLTNSTIVNLGGNKLN--GSIPI--TLSKLQKLQG 83
S+E + I+ + + + + L GN + + + ++ + L+
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 84 LGLEDN---KLEGSIPDDICHLAE-------LYRLDLDGNKLSG----SLPACFSNLTSL 129
D +++ IP+ + L + L+ + L N L S T L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 130 RIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGV 189
+ L +N L + + + N L I N
Sbjct: 125 EHLYLHNNGLGPQAGAK----------IARALQELAVNKKAKNAPPLRSIICGRNRLENG 174
Query: 190 ----IPTEIGGLKNLEYLFLGYNRL-----QGSIPDSFGDLISLKFLNLSNNNLSG---- 236
+ L + + N + + + + LK L+L +N +
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 234
Query: 237 AIPASLEKLSYLENLNLSFNKLEGE 261
A+ +L+ L L L+ L
Sbjct: 235 ALAIALKSWPNLRELGLNDCLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 55/319 (17%), Positives = 99/319 (31%), Gaps = 65/319 (20%)
Query: 1 MSNCKSLTLIYLSNNPL--DGILPKTSVGNLSHSLEDFRMYNCNISGG----IPEEISNL 54
M+ S+ L + + + +V S+++ + I + E I++
Sbjct: 1 MAR-FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 55 TNSTIVNLGGNKLNGSIPIT----------LSKLQKLQGLGLEDNKLEGSIPDDICHLAE 104
+ I L K KL + L DN P L +
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG---PTAQEPLID 116
Query: 105 -------LYRLDLDGNK--------LSGSLPACFSNL-----TSLRIVSLGSNKLTSVPL 144
L L L N ++ +L N LR + G N+L + +
Sbjct: 117 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM 176
Query: 145 TFW-----NLKDILNLNFSSNFLTSP-----LPLEIGNLKVLIGIDFSMNNFSG----VI 190
W + + + + N + L + + L +D N F+ +
Sbjct: 177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 236
Query: 191 PTEIGGLKNLEYLFLGYNRLQG----SIPDSFGDL--ISLKFLNLSNNNLSG----AIPA 240
+ NL L L L ++ D+F L I L+ L L N + +
Sbjct: 237 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 296
Query: 241 SL-EKLSYLENLNLSFNKL 258
+ EK+ L L L+ N+
Sbjct: 297 VIDEKMPDLLFLELNGNRF 315
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 19/58 (32%), Positives = 31/58 (53%), Gaps = 2/58 (3%)
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
IG G FG V+ ++ +VA+K + + E F E E+M + H L++ L+GV
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ-LYGV 71
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 46/307 (14%), Positives = 94/307 (30%), Gaps = 50/307 (16%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSH---SLEDFRMYNCNIS----GGIPEEISNL 54
+L + L +N L + + L ++ + NC ++ G + + L
Sbjct: 53 RVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL 112
Query: 55 TNSTIVNLGGNKLNGSIPITLSKLQ-----KLQGLGLEDNKLEGSIPDDICHLAE----- 104
++L N L + L + +L+ L LE L LA
Sbjct: 113 PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS---AASCEPLASVLRAK 169
Query: 105 --LYRLDLDGNKLSGS-----LPACFSNLTSLRIVSLGSNKLT-----SVPLTFWNLKDI 152
L + N ++ + + L + L S +T + + +
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229
Query: 153 LNLNFSSNFLTSP-----LPLEIGNLKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYL 203
L SN L P + L + + + + ++L+ L
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289
Query: 204 FLGYNRLQGSIPDSFGDLI-----SLKFLNLSNNNLSG----AIPASLEKLSYLENLNLS 254
L N L + + L+ L + + + + + L + +L L +S
Sbjct: 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQIS 349
Query: 255 FNKLEGE 261
N+LE
Sbjct: 350 NNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 54/313 (17%), Positives = 103/313 (32%), Gaps = 64/313 (20%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSH-------SLEDFRMYNCNIS----GGIPE 49
+ +L ++LS+N L + L LE ++ C++S +
Sbjct: 109 LRTLPTLQELHLSDNLLGD----AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 164
Query: 50 EISNLTNSTIVNLGGNKLNGSIPITLSKLQK-----LQGLGLEDNKLEGSIPDDICHLAE 104
+ + + + N +N + L + K L+ L LE + D+ L
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCG 221
Query: 105 -------LYRLDLDGNKLSGS-----LPACFSNLTSLRIVSLGSNKLTSVPLTF-----W 147
L L L NKL P + LR + + +T+
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281
Query: 148 NLKDILNLNFSSN--------FLTSPLPLEIGNLKVLIGIDFSMNNFSGV----IPTEIG 195
+ + L+ + N L L L+ L +F+ + +
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL---WVKSCSFTAACCSHFSSVLA 338
Query: 196 GLKNLEYLFLGYNRLQGSIPDSFGDLI-----SLKFLNLSNNNLS----GAIPASLEKLS 246
+ L L + NRL+ + + L+ L L++ ++S ++ A+L
Sbjct: 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398
Query: 247 YLENLNLSFNKLE 259
L L+LS N L
Sbjct: 399 SLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 52/301 (17%), Positives = 89/301 (29%), Gaps = 66/301 (21%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ +SNN ++ V L L+ + +
Sbjct: 167 RAKPDFKELTVSNNDINE----AGVRVLCQGLK-----------------DSPCQLEALK 205
Query: 62 LGGNKLN----GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAE--------LYRLD 109
L + + ++ L+ L L NKL + L L L
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV---GMAELCPGLLHPSSRLRTLW 262
Query: 110 LDGNKLS----GSLPACFSNLTSLRIVSLGSNKLT-------SVPLTFWNLKDILNLNFS 158
+ ++ G L SL+ +SL N+L L + + +L
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ-LESLWVK 321
Query: 159 SNFLTS----PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIG-GLKN----LEYLFLGYNR 209
S T+ + + L+ + S N E+ GL L L+L
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381
Query: 210 LQ----GSIPDSFGDLISLKFLNLSNNNLSG----AIPASLEKLSY-LENLNLSFNKLEG 260
+ S+ + SL+ L+LSNN L + S+ + LE L L
Sbjct: 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441
Query: 261 E 261
E
Sbjct: 442 E 442
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 17/63 (26%), Positives = 27/63 (42%), Gaps = 1/63 (1%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN 418
+ + +G G FG VYKA+ A KV + E + VE E++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 419 LIK 421
++K
Sbjct: 78 IVK 80
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 17/76 (22%), Positives = 36/76 (47%), Gaps = 12/76 (15%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL-----GDRMEVAVKVFNLQCG-RAFESFDVECEM 410
F E L +G G FG+V+K ++ V +KV + G ++F++
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 411 MKNIRHRNLIKILHGV 426
+ ++ H ++++ L G+
Sbjct: 69 IGSLDHAHIVR-LLGL 83
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 21/60 (35%), Positives = 30/60 (50%), Gaps = 4/60 (6%)
Query: 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
IGKG FG V +VAVK ++ ++F E +M +RH NL++ L GV
Sbjct: 27 QTIGKGEFGDVMLGDYRGN-KVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQ-LLGV 82
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 18/55 (32%), Positives = 30/55 (54%), Gaps = 2/55 (3%)
Query: 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIK 421
IGKG FG V++ + EVAVK+F+ + R++ + E +RH N++
Sbjct: 48 ESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWF-REAEIYQTVMLRHENILG 100
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 2e-08
Identities = 74/491 (15%), Positives = 144/491 (29%), Gaps = 147/491 (29%)
Query: 1 MSNC-KS-LTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMY-----NCNISGGIPEEISN 53
+ K+ + L + + + F+++ NCN + E +
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMD-------------FKIFWLNLKNCNSPETVLEMLQK 204
Query: 54 LTNSTIVNLGGNKLNG-SIPITLSKLQ-KLQGLGLEDNKLEGS--IPDDICHLAELYRLD 109
L N + +I + + +Q +L+ L L+ E + ++ + +
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPYENCLLVLLNVQNAKAWNAFN 263
Query: 110 LDGNKLSGSLPACFSNLTSLRIVS----LGSNKLTSVPLTF--WNLKDILNLNFSSNFLT 163
L C LT+ R L + T + L L + +L
Sbjct: 264 LS----------CKILLTT-RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD 312
Query: 164 SP---LPLEI--GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSF 218
LP E+ N + L S+ + I + N +++ ++L I S
Sbjct: 313 CRPQDLPREVLTTNPRRL-----SI--IAESIRDGLATWDNWKHV--NCDKLTTIIESSL 363
Query: 219 GDLIS--LK--FLNLS----NNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGN 270
L + F LS + + IP L LS + + +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSAH----IPTIL--LSLI------WFDVIKSDVM------ 405
Query: 271 FSAESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLRIVLPLSTTFMIVVIL---LIL 327
L+ Q SI + L + + L + L ++
Sbjct: 406 VVVNKLHKYSLV----EKQPKESTISIPS------IYLELKVKLENEYA----LHRSIVD 451
Query: 328 RYQQRGKRPSNDANMPLVAT-WRTFSYL-------------ELFRA--TD-EFSENNLIG 370
Y S+D P + + +S++ LFR D F E +
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYF--YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRH 509
Query: 371 KG----GFGSV---------YKARLGD------RMEVAVKVFNLQCGRAFESFDVECEMM 411
GS+ YK + D R+ A+ F + E +
Sbjct: 510 DSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIE----------ENL 559
Query: 412 KNIRHRNLIKI 422
++ +L++I
Sbjct: 560 ICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 2e-07
Identities = 67/473 (14%), Positives = 143/473 (30%), Gaps = 125/473 (26%)
Query: 29 LSHSLEDF-RMYNCNISGGIPEEISNLTNST----IVNLGGNKLNGS---IPITLSK--- 77
LS + F ++C + + ++ + I+ + ++G+ LSK
Sbjct: 22 LSVFEDAFVDNFDCK---DVQDMPKSILSKEEIDHIIMSK-DAVSGTLRLFWTLLSKQEE 77
Query: 78 -LQKLQGLGLEDN--------KLEGSIPDDICHLAELYRLDLDGN------------KLS 116
+QK L N K E P + + R L + +
Sbjct: 78 MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137
Query: 117 GSLPACFSNLTSLRIVSL----GSNKLTSVPLT-----------------FWNLKDILNL 155
L L + V + GS K + + FW L
Sbjct: 138 LKLRQALLELRPAKNVLIDGVLGSGK--TW-VALDVCLSYKVQCKMDFKIFW-------L 187
Query: 156 NFSSNFLTSPLPLEIGNLKVLIGIDF-SMNNFSGVIPTEIGGLKN-LEYLFL--GYNR-L 210
N + + + L I ++ S ++ S I I ++ L L Y L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 211 -------QGSIPDSFGDLISLKFLNLSNN-NLSGAIPASLEKLSYLENLNLSFNKLEGEI 262
++F +S K L + ++ + A+ L++ +++ E +
Sbjct: 248 LVLLNVQNAKAWNAFN--LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK- 304
Query: 263 PRGGSFGNFSAESFEG--NELLCGSPNLQVPPCKTSIHH--TSWKNSLLLRIVLPLSTTF 318
+ + E+L +P ++ SI +W N + L+T
Sbjct: 305 ---SLLLKYLDCRPQDLPREVLTTNP-RRLSIIAESIRDGLATWDNWKHVNCD-KLTTI- 358
Query: 319 MIVVILLIL-------RYQQRGKRPSNDANMP---LVATWRTFSYLELFRATDEFSENNL 368
I L +L + + P A++P L W ++ ++ + +L
Sbjct: 359 -IESSLNVLEPAEYRKMFDRLSVFP-PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLI 420
+ K S + + +++ ++ HR+++
Sbjct: 417 VEKQPKESTI--SIPS----------IY-------LELKVKLENEYALHRSIV 450
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 7e-06
Identities = 75/471 (15%), Positives = 134/471 (28%), Gaps = 154/471 (32%)
Query: 84 LGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP 143
+ E + + D + + + + D + + S I+ + ++
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK-DAVSGTL 65
Query: 144 LTFWNL------------KDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP 191
FW L +++L +N+ FL SP+ E SM +
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINY--KFLMSPIKTEQ--------RQPSMMTRMYI-- 113
Query: 192 TEIGGLKNLEYLFLGYN--RLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS---LE--- 243
+ L N +F YN RLQ +L L L PA ++
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQ-------------PYLKL-RQALLELRPAKNVLIDGVL 159
Query: 244 ---KLSYLENLNLSFNKLEGEIPRGG---SFGNFSAESFEGNELLCGSPNLQVPPCKTSI 297
K +++ K++ ++ + N C SP +
Sbjct: 160 GSGK-TWVALDVCLSYKVQCKMDFKIFWLNLKN------------CNSPETVLEM----- 201
Query: 298 HHTSWKNSLLLRIVLPLSTTFMIVVILLILRYQQRGKRPSNDANMPLVATWRTFSYLELF 357
LL +I ++ R + +N+ L L
Sbjct: 202 -----LQKLLYQIDPNWTS------------------RSDHSSNIKLRIHSIQAELRRLL 238
Query: 358 RATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHR 417
++ EN L+ V L + V N +A+ +F++ C+++ R +
Sbjct: 239 KSKP--YENCLL-------V----LLN-------VQN---AKAWNAFNLSCKILLTTRFK 275
Query: 418 NLIKILHGVAVITFTVCLCLFHHSSA---SASASLVSSLT------LSRPAKGGGFRGCV 468
+ L T + L HHS SL+ L R R
Sbjct: 276 QVTDFLSAAT----TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 469 L-----------W----HVGVD-----FAAFVFVLEPGVE----VICFVFE 495
+ W HV D + + VLEP VF
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 21/58 (36%), Positives = 30/58 (51%), Gaps = 4/58 (6%)
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
IGKG FG V +VAVK ++ ++F E +M +RH NL++ L GV
Sbjct: 201 IGKGEFGDVMLGDYRGN-KVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQ-LLGV 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 16/66 (24%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFN-LQCGRAFESFDVECEMMKNIRHRN 418
+ ++++G+G +V++ R A+KVFN + R + E E++K + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 419 LIKILH 424
++K+
Sbjct: 69 IVKLFA 74
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 21/70 (30%), Positives = 30/70 (42%), Gaps = 3/70 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRN 418
++ IG+G FG V+ RL D VAVK F E ++K H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 419 LIKILHGVAV 428
+++ L GV
Sbjct: 174 IVR-LIGVCT 182
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 17/72 (23%), Positives = 34/72 (47%), Gaps = 7/72 (9%)
Query: 361 DEFSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNI 414
EF + ++G G FG+VYK ++ VA+K +A + E +M ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 415 RHRNLIKILHGV 426
+ ++ + L G+
Sbjct: 75 DNPHVCR-LLGI 85
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 2/66 (3%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
+ +G+G FG V+ VA+K + E+F E ++MK +RH L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 421 KILHGV 426
+ L+ V
Sbjct: 243 Q-LYAV 247
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 12/76 (15%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQCGRAFESFDVECEM 410
++ +G+G FG V+ A D+M VAVK A + F E E+
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 411 MKNIRHRNLIKILHGV 426
+ N++H +++K +GV
Sbjct: 71 LTNLQHEHIVK-FYGV 85
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 21/59 (35%), Positives = 30/59 (50%), Gaps = 3/59 (5%)
Query: 369 IGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
+G G +G VY+ + VAVK + E F E +MK I+H NL++ L GV
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ-LLGV 77
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 2/66 (3%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
+ +G+G FG V+ VA+K + E+F E ++MK +RH L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 421 KILHGV 426
+ L+ V
Sbjct: 326 Q-LYAV 330
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 23/73 (31%), Positives = 32/73 (43%), Gaps = 8/73 (10%)
Query: 361 DEFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFN---LQCGRAFESFDVECEMMKN 413
+ +G G FG V + G + VAVK L A + F E M +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 414 IRHRNLIKILHGV 426
+ HRNLI+ L+GV
Sbjct: 78 LDHRNLIR-LYGV 89
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 22/77 (28%), Positives = 31/77 (40%), Gaps = 13/77 (16%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQCG-RAFESFDVECE 409
EF NL +G+G FG V KA VAVK+ E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 410 MMKNIRHRNLIKILHGV 426
++K + H ++IK L+G
Sbjct: 79 VLKQVNHPHVIK-LYGA 94
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 9/66 (13%)
Query: 369 IGKGGFGSVYKARL--------GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
+G+G F ++K EV +KV + ESF MM + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 421 KILHGV 426
+GV
Sbjct: 76 L-NYGV 80
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 19/76 (25%), Positives = 35/76 (46%), Gaps = 12/76 (15%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQCGRAFESFDVECEM 410
++ +G+G FG V+ A D+M VAVK A + F E E+
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 411 MKNIRHRNLIKILHGV 426
+ ++H+++++ GV
Sbjct: 97 LTMLQHQHIVRFF-GV 111
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 17/63 (26%), Positives = 30/63 (47%), Gaps = 1/63 (1%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN 418
IG+G G V AR +VAVK+ +L+ + E E +M++ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 419 LIK 421
+++
Sbjct: 104 VVE 106
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 7e-08
Identities = 33/110 (30%), Positives = 50/110 (45%), Gaps = 12/110 (10%)
Query: 56 NSTIVNLGGNKLN---GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG 112
+ T+VN +L IP Q L L +N++ P HL L +L +
Sbjct: 13 DQTLVNCQNIRLASVPAGIPTDK------QRLWLNNNQITKLEPGVFDHLVNLQQLYFNS 66
Query: 113 NKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
NKL+ ++P F LT L + L N L S+P F NLK + ++ +N
Sbjct: 67 NKLT-AIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 9/77 (11%)
Query: 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 248
IPT + + L+L N++ P F L++L+ L ++N L+ AIP + +KL+ L
Sbjct: 31 IPT------DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83
Query: 249 ENLNLSFNKLEGEIPRG 265
L+L+ N L+ IPRG
Sbjct: 84 TQLDLNDNHLKS-IPRG 99
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 3/61 (4%)
Query: 367 NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHG 425
+ +G G +G VY+ + VAVK + E F E +MK I+H NL++ L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ-LLG 283
Query: 426 V 426
V
Sbjct: 284 V 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 19/77 (24%), Positives = 30/77 (38%), Gaps = 13/77 (16%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECE 409
E + + +G+G FG VY+ VA+K N R F E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 410 MMKNIRHRNLIKILHGV 426
+MK ++++ L GV
Sbjct: 81 VMKEFNCHHVVR-LLGV 96
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 17/63 (26%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN 418
+++ IG+G G+VY A + EVA++ NLQ E E +M+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 419 LIK 421
++
Sbjct: 79 IVN 81
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-08
Identities = 26/127 (20%), Positives = 45/127 (35%), Gaps = 7/127 (5%)
Query: 108 LDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLP 167
+ L + + A ++N R + L K+ + L ++FS N +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK--- 56
Query: 168 LE-IGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPDSFGDLISLK 225
L+ L+ L + + N + L +L L L N L D L SL
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 226 FLNLSNN 232
+L + N
Sbjct: 117 YLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-06
Identities = 21/107 (19%), Positives = 39/107 (36%), Gaps = 10/107 (9%)
Query: 49 EEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108
+ +N ++L G K+ I + L + + DN++ + D L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNL 155
++ N++ L L + L +N L L D+ L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV-------ELGDLDPL 109
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 2/63 (3%)
Query: 197 LKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
L + + N ++ + D F L LK L ++NN + + L L L L+ N
Sbjct: 41 LDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
Query: 257 KLE 259
L
Sbjct: 99 SLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 26/145 (17%), Positives = 50/145 (34%), Gaps = 32/145 (22%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+N + L + + NL +L+ F + +++ I
Sbjct: 15 YTNAVRDRELDLRGYKI------PVIENLGATLDQFDAI-------------DFSDNEIR 55
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLS--GS 118
L G L++L+ L + +N++ L +L L L N L G
Sbjct: 56 KLDG----------FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 105
Query: 119 LPACFSNLTSLRIVSLGSNKLTSVP 143
L ++L SL + + N +T+
Sbjct: 106 L-DPLASLKSLTYLCILRNPVTNKK 129
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-08
Identities = 40/110 (36%), Positives = 54/110 (49%), Gaps = 12/110 (10%)
Query: 56 NSTIVNLGGNKLN---GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG 112
+ T V+ G L IP T Q L L DN++ P L +L RLDLD
Sbjct: 10 SGTTVDCSGKSLASVPTGIPTTT------QVLYLYDNQITKLEPGVFDRLTQLTRLDLDN 63
Query: 113 NKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSN 160
N+L+ LPA F LT L +SL N+L S+P F NLK + ++ +N
Sbjct: 64 NQLT-VLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 9/77 (11%)
Query: 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL-EKLSYL 248
IPT + L+L N++ P F L L L+L NN L+ +PA + +KL+ L
Sbjct: 28 IPT------TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80
Query: 249 ENLNLSFNKLEGEIPRG 265
L+L+ N+L+ IPRG
Sbjct: 81 TQLSLNDNQLKS-IPRG 96
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 24/86 (27%), Positives = 37/86 (43%), Gaps = 6/86 (6%)
Query: 341 NMPLVATWRTFSYLELFRATD---EFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQ 396
+M + R+ ++L D F L+G G +G VYK R + A+KV ++
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 397 CGRAFESFDVECEMMKNI-RHRNLIK 421
G E E M+K HRN+
Sbjct: 61 -GDEEEEIKQEINMLKKYSHHRNIAT 85
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 16/66 (24%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFN-LQCGRAFESFDVECEMMKNIRHRN 418
+ ++++G+G +V++ R A+KVFN + R + E E++K + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 419 LIKILH 424
++K+
Sbjct: 69 IVKLFA 74
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 19/77 (24%), Positives = 34/77 (44%), Gaps = 13/77 (16%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQCG-RAFESFDVECE 409
E N+ +G G FG VY+ ++ ++VAVK C + F +E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 410 MMKNIRHRNLIKILHGV 426
++ H+N+++ GV
Sbjct: 86 IISKFNHQNIVR-CIGV 101
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 38/199 (19%), Positives = 63/199 (31%), Gaps = 42/199 (21%)
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGN---KLSGSLPAC 122
+ + K++ L +E + + L L L N K+S
Sbjct: 16 ERKSVVATEAEKVE----LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS----- 65
Query: 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
S + +LRI+SLG N + + + L S N + S +E
Sbjct: 66 LSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIE------------- 112
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQ--GSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
L NL L++ N++ G I D L L+ L L+ N L
Sbjct: 113 -------------KLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKE 158
Query: 241 SLEKLSYLENLNLSFNKLE 259
+ Y + L+
Sbjct: 159 NNATSEYRIEVVKRLPNLK 177
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 34/170 (20%), Positives = 67/170 (39%), Gaps = 32/170 (18%)
Query: 103 AELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSV-PLTFWNLKDILNLNFSSNF 161
AE L + + A S L + + ++L +N + + L+ ++++ L+ N
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLS--GMENLRILSLGRNL 81
Query: 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL 221
+ +I NL + LE L++ YN++ S+ L
Sbjct: 82 IK-----KIENLDAV--------------------ADTLEELWISYNQIA-SL-SGIEKL 114
Query: 222 ISLKFLNLSNNNLSGAIP-ASLEKLSYLENLNLSFNKLEGEIPRGGSFGN 270
++L+ L +SNN ++ L L LE+L L+ N L + +
Sbjct: 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 23/124 (18%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPIT----LSKLQKLQGLGLEDNKLEGSIPDDICHL 102
+ +S L + L N I LS ++ L+ L L N ++ I +L
Sbjct: 40 MDATLSTLKACKHLALSTNN------IEKISSLSGMENLRILSLGRNLIK-----KIENL 88
Query: 103 AELYR----LDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP--LTFWNLKDILNLN 156
+ L + N+++ SL L +LR++ + +NK+T+ L + +L
Sbjct: 89 DAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL 146
Query: 157 FSSN 160
+ N
Sbjct: 147 LAGN 150
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 16/68 (23%), Positives = 30/68 (44%), Gaps = 2/68 (2%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRH 416
R +F E ++G+G FG V KAR D A+K + E ++ ++ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNH 61
Query: 417 RNLIKILH 424
+ +++
Sbjct: 62 QYVVRYYA 69
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 15/59 (25%), Positives = 25/59 (42%), Gaps = 2/59 (3%)
Query: 369 IGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
+GKG FG K + +K +F E ++M+ + H N++K GV
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK-FIGV 75
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 17/72 (23%), Positives = 34/72 (47%), Gaps = 7/72 (9%)
Query: 361 DEFSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNI 414
EF + ++G G FG+VYK ++ VA+K +A + E +M ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 415 RHRNLIKILHGV 426
+ ++ + L G+
Sbjct: 75 DNPHVCR-LLGI 85
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 6/63 (9%)
Query: 369 IGKGGFGSVYKARL----GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKIL 423
IG+G FG V++ + VA+K E F E M+ H +++K L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK-L 81
Query: 424 HGV 426
GV
Sbjct: 82 IGV 84
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 22/63 (34%), Positives = 34/63 (53%), Gaps = 6/63 (9%)
Query: 369 IGKGGFGSVYKARL----GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKIL 423
+G+G FG VY+ G+++ VAVK C E F E +MKN+ H +++K L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK-L 78
Query: 424 HGV 426
G+
Sbjct: 79 IGI 81
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 23/77 (29%), Positives = 35/77 (45%), Gaps = 13/77 (16%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECE 409
E+ NN+ IG+G FG V++AR VAVK+ + F E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 410 MMKNIRHRNLIKILHGV 426
+M + N++K+L GV
Sbjct: 103 LMAEFDNPNIVKLL-GV 118
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 9/64 (14%)
Query: 369 IGKGGFGSVYKARL---GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKI 422
+G G FGSV + +++VA+KV L+ G E E ++M + + +++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVR- 400
Query: 423 LHGV 426
L GV
Sbjct: 401 LIGV 404
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 20/63 (31%), Positives = 25/63 (39%), Gaps = 6/63 (9%)
Query: 369 IGKGGFGSVYKARL----GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKIL 423
IG G G V RL + VA+K R F E +M H N+I+ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR-L 115
Query: 424 HGV 426
GV
Sbjct: 116 EGV 118
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 9/64 (14%)
Query: 369 IGKGGFGSVYKARL---GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKI 422
+G G FGSV + +++VA+KV L+ G E E ++M + + +++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVR- 74
Query: 423 LHGV 426
L GV
Sbjct: 75 LIGV 78
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 2/63 (3%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL-QCGRAFESFDVECEMMKNIRHRN 418
D++ +IG G V A + +VA+K NL +C + + E + M H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 419 LIK 421
++
Sbjct: 75 IVS 77
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 10/65 (15%)
Query: 369 IGKGGFGSVYKARL---GDRMEVAVKVFNLQCG----RAFESFDVECEMMKNIRHRNLIK 421
+G G FG+V K VAVK+ L+ + E +M+ + + +++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 422 ILHGV 426
+ G+
Sbjct: 83 -MIGI 86
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 19/77 (24%), Positives = 34/77 (44%), Gaps = 13/77 (16%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQCG-RAFESFDVECE 409
E N+ +G G FG VY+ ++ ++VAVK C + F +E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 410 MMKNIRHRNLIKILHGV 426
++ H+N+++ GV
Sbjct: 127 IISKFNHQNIVR-CIGV 142
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 19/63 (30%), Positives = 27/63 (42%), Gaps = 6/63 (9%)
Query: 369 IGKGGFGSVYKARL----GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKIL 423
+G G FG V RL + VA+K + + F E +M H N+I+ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR-L 111
Query: 424 HGV 426
GV
Sbjct: 112 EGV 114
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 20/75 (26%), Positives = 29/75 (38%), Gaps = 11/75 (14%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL----GDRMEVAVKVFNLQC-GRAFESFDVECEMM 411
E + IG+G FG V++ M VA+K E F E M
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 412 KNIRHRNLIKILHGV 426
+ H +++K L GV
Sbjct: 446 RQFDHPHIVK-LIGV 459
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRH 416
R +F E LIG GGFG V+KA+ D +K +A E + + + H
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63
Query: 417 RNLIK 421
N++
Sbjct: 64 VNIVH 68
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 1/58 (1%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILH 424
+G+GGF V L D A+K + E E +M + H N+++++
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 20/66 (30%), Positives = 33/66 (50%), Gaps = 4/66 (6%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFD---VECEMMKNIR 415
FS+ IG G FG+VY AR + + VA+K + ++ E + E ++ +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 416 HRNLIK 421
H N I+
Sbjct: 113 HPNTIQ 118
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 21/77 (27%), Positives = 32/77 (41%), Gaps = 13/77 (16%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECE 409
E S + + +G+ FG VYK L VA+K + G E F E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 410 MMKNIRHRNLIKILHGV 426
+ ++H N++ L GV
Sbjct: 65 LRARLQHPNVVC-LLGV 80
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 11/54 (20%), Positives = 23/54 (42%), Gaps = 2/54 (3%)
Query: 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRN 418
IG GG V++ + A+K NL+ + +S+ E + ++ +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 23/77 (29%), Positives = 35/77 (45%), Gaps = 15/77 (19%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL---GDRMEVAVKVFNLQCG---RAFESFDVECEM 410
N++ IG+G FG V KAR+ G RM+ A+K ++ F E E+
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEV 78
Query: 411 MKNI-RHRNLIKILHGV 426
+ + H N+I L G
Sbjct: 79 LCKLGHHPNIIN-LLGA 94
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 17/101 (16%), Positives = 29/101 (28%), Gaps = 6/101 (5%)
Query: 331 QRGKRPSNDANMPLVATWRTFSYLELFRATDEFSEN----NLIGKGGFGSVYKAR-LGDR 385
+ ND + W+ + + + +G G FG V++
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76
Query: 386 MEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
K N + E +M + H LI LH
Sbjct: 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN-LHDA 116
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 15/55 (27%), Positives = 33/55 (60%), Gaps = 1/55 (1%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIK 421
++GKG +G VY R L +++ +A+K + R + E + K+++H+N+++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ 83
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 11/54 (20%), Positives = 23/54 (42%), Gaps = 2/54 (3%)
Query: 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRN 418
IG GG V++ + A+K NL+ + +S+ E + ++ +
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 13/63 (20%), Positives = 27/63 (42%), Gaps = 5/63 (7%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRHRNLIKIL 423
+GKGGF ++ + A K+ L E +E + +++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG-F 106
Query: 424 HGV 426
HG
Sbjct: 107 HGF 109
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 16/64 (25%), Positives = 28/64 (43%), Gaps = 2/64 (3%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL-QCGRAFESFDVECEMMKNIRHR 417
+ F++ IGKG FG V+K + VA+K+ +L + E E ++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 418 NLIK 421
+ K
Sbjct: 81 YVTK 84
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 8e-07
Identities = 13/63 (20%), Positives = 27/63 (42%), Gaps = 5/63 (7%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRHRNLIKIL 423
+GKGGF ++ + A K+ L E +E + +++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG-F 80
Query: 424 HGV 426
HG
Sbjct: 81 HGF 83
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 21/64 (32%), Positives = 27/64 (42%), Gaps = 7/64 (10%)
Query: 369 IGKGGFGSVYKARL-----GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKI 422
IG G FG VYK L + VA+K + F E +M H N+I+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR- 110
Query: 423 LHGV 426
L GV
Sbjct: 111 LEGV 114
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 366 NNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL--QCGRAFESFDVECEMMKNIRHRNLIK 421
+ IG+G F +VYK +EVA + F E EM+K ++H N+++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 24/80 (30%), Positives = 34/80 (42%), Gaps = 16/80 (20%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL--------GDRMEVAVKVFNLQCG-RAFESFDVE 407
EF + L +G+G FG V A + + VAVK+ + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 408 CEMMKNI-RHRNLIKILHGV 426
EMMK I +H+N+I L G
Sbjct: 91 MEMMKMIGKHKNIIN-LLGA 109
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 15/68 (22%), Positives = 30/68 (44%), Gaps = 2/68 (2%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQ-CGRAFESFDVECEMMKNIR 415
+ + +G GGFG V + +VA+K + + E + +E ++MK +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 416 HRNLIKIL 423
H N++
Sbjct: 71 HPNVVSAR 78
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 11/54 (20%), Positives = 23/54 (42%), Gaps = 2/54 (3%)
Query: 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRN 418
IG GG V++ + A+K NL+ + +S+ E + ++ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 24/80 (30%), Positives = 34/80 (42%), Gaps = 16/80 (20%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL--------GDRMEVAVKVFNLQCG-RAFESFDVE 407
EF + L +G+G FG V A + + VAVK+ + E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 408 CEMMKNI-RHRNLIKILHGV 426
EMMK I +H+N+I L G
Sbjct: 137 MEMMKMIGKHKNIIN-LLGA 155
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 15/63 (23%), Positives = 33/63 (52%), Gaps = 5/63 (7%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRHRNLIKIL 423
L+GKG F VY+A + +EVA+K+ + + + E ++ ++H ++++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE-L 76
Query: 424 HGV 426
+
Sbjct: 77 YNY 79
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 2e-06
Identities = 30/165 (18%), Positives = 65/165 (39%), Gaps = 24/165 (14%)
Query: 117 GSLPACFSNLTSLRIVSL-GSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIG---- 171
L + L + + G+N L+ NLK +L S L + +I
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLK---SLEIISGGLPDSVVEDILGSDL 218
Query: 172 -NLKVLIGIDFSMNNFSGVIPTEI-------GGLKNLEYLFLGYNRLQGSIPDSFGD--- 220
NL+ L+ + + ++ + NL++L + Q + + F +
Sbjct: 219 PNLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 221 LISLKFLNLSNNNLSG----AIPASLEKLSYLENLNLSFNKLEGE 261
L L+ +++S L+ + ++K+ +L+ +N+ +N L E
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 4e-04
Identities = 28/189 (14%), Positives = 51/189 (26%), Gaps = 32/189 (16%)
Query: 68 NGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGS-----LPAC 122
+ L + L L ++ ++ L L++ L S L +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
NL L + + ++ L L +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDG-----DMNVFRPL------------FSKDRFPNLKWLGIV 260
Query: 183 MNNFSGVIPTEIGG---LKNLEYLFLGYNRLQGS----IPDSFGDLISLKFLNLSNNNLS 235
V+ L LE + + L + D + LKF+N+ N LS
Sbjct: 261 DAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
Query: 236 GAIPASLEK 244
+ L+K
Sbjct: 321 DEMKKELQK 329
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 17/66 (25%), Positives = 31/66 (46%), Gaps = 2/66 (3%)
Query: 362 EFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
S+ ++G G FG V+K +++A K+ + + E E +M + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 421 KILHGV 426
+ L+
Sbjct: 150 Q-LYDA 154
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 18/102 (17%), Positives = 35/102 (34%), Gaps = 6/102 (5%)
Query: 330 QQRGKRPSNDANMPLVATWRTFSYLELFRATDEFSE----NNLIGKGGFGSVYKAR-LGD 384
+ S++ + + W+ + + D + + +G G FG V++
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181
Query: 385 RMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
A K E+ E + M +RH L+ LH
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN-LHDA 222
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 15/63 (23%), Positives = 28/63 (44%), Gaps = 3/63 (4%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN 418
+ F +G+G +GSVYKA VA+K ++ + E +M+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 419 LIK 421
++K
Sbjct: 86 VVK 88
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 19/78 (24%), Positives = 31/78 (39%), Gaps = 14/78 (17%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECE 409
EF + L +G+G FG V +A VAVK+ + E +
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 410 MMKNI-RHRNLIKILHGV 426
++ +I H N++ L G
Sbjct: 83 ILIHIGHHLNVVN-LLGA 99
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 20/64 (31%), Positives = 33/64 (51%), Gaps = 5/64 (7%)
Query: 367 NLIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRHRNLIKI 422
+GKG FG+VY AR + +A+KV L+ E E+ ++RH N+++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR- 73
Query: 423 LHGV 426
L+G
Sbjct: 74 LYGY 77
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 17/69 (24%), Positives = 31/69 (44%), Gaps = 2/69 (2%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL-QCGRAFESFDVECEMMKNIR 415
R +F +G+GGFG V++A+ D A+K L A E E + + +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 416 HRNLIKILH 424
H +++ +
Sbjct: 63 HPGIVRYFN 71
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 17/66 (25%), Positives = 30/66 (45%), Gaps = 2/66 (3%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL-QCGRAFESFDVECEMMKNIR 415
R +F +G+GGFG V++A+ D A+K L A E E + + +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 416 HRNLIK 421
H +++
Sbjct: 62 HPGIVR 67
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 18/71 (25%), Positives = 36/71 (50%), Gaps = 10/71 (14%)
Query: 357 FRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVK-VFNLQC--GRAFESFDVECEMMKN 413
+ ++ +IG G FG V++A+L + EVA+K V + R E ++M+
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRI 88
Query: 414 IRHRNLIKILH 424
++H N++ +
Sbjct: 89 VKHPNVVDLKA 99
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 27/118 (22%), Positives = 39/118 (33%), Gaps = 18/118 (15%)
Query: 325 LILRYQQRGKRPSNDANMPLVATWRTFSYLELFRATD-EFSENNL-----IGKGGFGSVY 378
+ P+ + S EL E + L +G+G FG V
Sbjct: 28 YHHHHHHDYDIPTTENLYF-QGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVV 86
Query: 379 KARL--------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGV 426
A +VAVK+ + E EMMK I +H+N+I L G
Sbjct: 87 LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN-LLGA 143
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 23/78 (29%), Positives = 34/78 (43%), Gaps = 14/78 (17%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQCG-RAFESFDVECE 409
EF NL +G G FG V A G ++VAVK+ + E+ E +
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 410 MMKNI-RHRNLIKILHGV 426
MM + H N++ +L G
Sbjct: 101 MMTQLGSHENIVNLL-GA 117
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 22/65 (33%), Positives = 34/65 (52%), Gaps = 4/65 (6%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVK---VFNLQCGRAFESFDVECEMMKNIRH 416
F IG+G F VY+A L D + VA+K +F+L +A E +++K + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 417 RNLIK 421
N+IK
Sbjct: 92 PNVIK 96
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 13/64 (20%), Positives = 29/64 (45%), Gaps = 3/64 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHR 417
+++ IG+G FG + D + +K N+ + E E ++ N++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 418 NLIK 421
N+++
Sbjct: 84 NIVQ 87
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 11/67 (16%), Positives = 26/67 (38%), Gaps = 3/67 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHR 417
+++ IG G +G K R D + K + + E +++ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 418 NLIKILH 424
N+++
Sbjct: 66 NIVRYYD 72
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 7e-06
Identities = 8/77 (10%), Positives = 21/77 (27%), Gaps = 4/77 (5%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRHRNLIKIL 423
+ G V+ R + + A+KVF E + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 424 HGVAVITFTVCLCLFHH 440
++ + + +
Sbjct: 129 DRRRLLLPSDAVAVQSQ 145
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 21/78 (26%), Positives = 31/78 (39%), Gaps = 14/78 (17%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQCG-RAFESFDVECE 409
EF N L +G G FG V +A M VAVK+ E+ E +
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 410 MMKNI-RHRNLIKILHGV 426
++ + H N++ L G
Sbjct: 79 VLSYLGNHMNIVN-LLGA 95
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 4/64 (6%)
Query: 362 EFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLI 420
F +++G G G++ + D +VAVK +C F D E ++++ H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 421 KILH 424
+
Sbjct: 82 RYFC 85
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 6/112 (5%)
Query: 47 IPEEISNLTNSTI--VNLGGNKLN-GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLA 103
I E+ N T + + + L K N G I ++ L+ L L + L S+ ++ L
Sbjct: 14 IHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLP 71
Query: 104 ELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNL 155
+L +L+L N++ G L L +L ++L NKL + T LK + L
Sbjct: 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIS-TLEPLKKLECL 122
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 28/76 (36%), Positives = 36/76 (47%), Gaps = 2/76 (2%)
Query: 184 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLE 243
+ G I NLE+L L L S+ + L LK L LS N + G + E
Sbjct: 35 KSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAE 92
Query: 244 KLSYLENLNLSFNKLE 259
KL L +LNLS NKL+
Sbjct: 93 KLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 28/91 (30%), Positives = 38/91 (41%), Gaps = 9/91 (9%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSH--SLEDFRMYNCNISGGIPEEISNLTNSTI 59
+ +L + L N L SV NL L+ + I GG+ L N T
Sbjct: 46 AEFVNLEFLSLINVGL------ISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99
Query: 60 VNLGGNKLNG-SIPITLSKLQKLQGLGLEDN 89
+NL GNKL S L KL+ L+ L L +
Sbjct: 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 28/111 (25%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
+ + L + + SN LT ++ L+ + L S L L L ++ S
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAE-FVNLEFLSLINVGLISVSNLP--KLPKLKKLELS 79
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPDSFGDLISLKFLNLSNN 232
N G + L NL +L L N+L+ S + L LK L+L N
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 19/65 (29%), Positives = 31/65 (47%), Gaps = 3/65 (4%)
Query: 197 LKNLEYLFLGYNRLQ-GSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 255
+ L L + G I + ++L+FL+L N L ++L KL L+ L LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 256 NKLEG 260
N++ G
Sbjct: 81 NRIFG 85
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 4/88 (4%)
Query: 172 NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSN 231
++K L+ +D S +N G + + LE+L L SI + L LK L LS+
Sbjct: 18 DVKELV-LDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73
Query: 232 NNLSGAIPASLEKLSYLENLNLSFNKLE 259
N +SG + EK L +LNLS NK++
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 28/112 (25%), Positives = 50/112 (44%), Gaps = 6/112 (5%)
Query: 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLE-IGNLKVLIGIDF 181
S++ L + + SN+ LT +++ L+ + LTS + + L L ++
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDE-FEELEFLSTINVGLTS---IANLPKLNKLKKLEL 71
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPDSFGDLISLKFLNLSNN 232
S N SG + NL +L L N+++ S + L +LK L+L N
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-05
Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 9/91 (9%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSH--SLEDFRMYNCNISGGIPEEISNLTNSTI 59
+ L + N L TS+ NL L+ + + +SGG+ N T
Sbjct: 39 DEFEELEFLSTINVGL------TSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92
Query: 60 VNLGGNKLNG-SIPITLSKLQKLQGLGLEDN 89
+NL GNK+ S L KL+ L+ L L +
Sbjct: 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-05
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 6/112 (5%)
Query: 47 IPEEISNLTNSTI--VNLGGNKLN-GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLA 103
I E+ N T S + + L ++ N G + + ++L+ L + L SI ++ L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 104 ELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNL 155
+L +L+L N++SG L +L ++L NK+ T LK + NL
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD-LSTIEPLKKLENL 115
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 19/68 (27%), Positives = 34/68 (50%), Gaps = 3/68 (4%)
Query: 197 LKNLEYLFLGYNRLQ-GSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 255
+++ L L +R G + + L+FL+ N L+ A+L KL+ L+ L LS
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSD 73
Query: 256 NKLEGEIP 263
N++ G +
Sbjct: 74 NRVSGGLE 81
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 15/69 (21%), Positives = 26/69 (37%), Gaps = 6/69 (8%)
Query: 360 TDEFSENNLIGKGGFGSVYKARLGD------RMEVAVKVFNLQCGRAFESFDVECEMMKN 413
+ ++L+G+G F VY+A GD + + +KV F E +K
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 414 IRHRNLIKI 422
+K
Sbjct: 124 SMQHMFMKF 132
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 12/56 (21%), Positives = 24/56 (42%), Gaps = 1/56 (1%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKI 422
++G G F V+ + A+K S + E ++K I+H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 5/63 (7%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRHRNLIKIL 423
+GKG FG+VY AR ++ +A+KV L+ E E+ ++RH N+++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR-M 79
Query: 424 HGV 426
+
Sbjct: 80 YNY 82
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 14/78 (17%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECE 409
EF NNL +G G FG V +A ++VAVK+ E+ E +
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 410 MMKNI-RHRNLIKILHGV 426
+M ++ +H N++ L G
Sbjct: 102 IMSHLGQHENIVN-LLGA 118
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 19/68 (27%), Positives = 34/68 (50%), Gaps = 4/68 (5%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIR 415
+D + ++GKG FG V + E AVKV + ++ ES E +++K +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 416 HRNLIKIL 423
H N++K+
Sbjct: 85 HPNIMKLY 92
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 15/67 (22%), Positives = 22/67 (32%), Gaps = 5/67 (7%)
Query: 360 TDEFSENNLIGKG--GFGSVYKAR-LGDRMEVAVKVFNL--QCGRAFESFDVECEMMKNI 414
+ +IGKG +V AR V V+ NL E + K
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 415 RHRNLIK 421
H N++
Sbjct: 84 NHPNIVP 90
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 19/67 (28%), Positives = 34/67 (50%), Gaps = 3/67 (4%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQ--CGRAFESFDVECEMMKNIRH 416
+ ++ ++GKG FG V K + + E AVKV N + + E E++K + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 417 RNLIKIL 423
N++K+
Sbjct: 81 PNIMKLF 87
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 17/101 (16%), Positives = 33/101 (32%), Gaps = 7/101 (6%)
Query: 330 QQRGKRPSNDANMPLVATWRTFSYLELFRATDEFSEN----NLIGKGGFGSVYKAR-LGD 384
S N+ + + + SE +G G +G V R
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 385 RMEVAVKVFNLQ--CGRAFESFDVECEMMKNIRHRNLIKIL 423
+E A+K+ + E ++K + H N++K+
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 12/59 (20%), Positives = 22/59 (37%), Gaps = 5/59 (8%)
Query: 368 LIGKGGFGSVYKA---RLGDRMEVAVKVFNLQCGRAF-ESFDVECEMMKNIRHRNLIKI 422
I GG G +Y A + R V +K E + + + H ++++I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 14/61 (22%), Positives = 28/61 (45%), Gaps = 4/61 (6%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDV--ECEMMKNIRHRNLIKILHG 425
+GKG F V + + E A + N + A + + E + + ++H N+++ LH
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR-LHD 77
Query: 426 V 426
Sbjct: 78 S 78
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 11/56 (19%), Positives = 21/56 (37%), Gaps = 6/56 (10%)
Query: 367 NLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIK 421
+G+G FG V++ + + AVK L+ R E + ++
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP 114
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 19/74 (25%), Positives = 36/74 (48%), Gaps = 8/74 (10%)
Query: 360 TDEFSEN----NLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQ--CGRAFESFDVECEMMK 412
+ +FS+N +GKG F V + +E A K+ N + R F+ + E + +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 413 NIRHRNLIKILHGV 426
++H N+++ LH
Sbjct: 61 KLQHPNIVR-LHDS 73
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 21/73 (28%), Positives = 34/73 (46%), Gaps = 7/73 (9%)
Query: 357 FRATDEFSEN----NLIGKGGFGSVYKAR-LGDRMEVAVKVFN--LQCGRAFESFDVECE 409
F+E ++GKG FG V K + + E AVKV N + + E E
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 410 MMKNIRHRNLIKI 422
++K + H N++K+
Sbjct: 74 LLKKLDHPNIMKL 86
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 52/306 (16%), Positives = 90/306 (29%), Gaps = 69/306 (22%)
Query: 1 MSNCKSLTLIYLSNNPL--DGILPKTSV-GNLSHSLEDFRMYNCNISGGIPEEI-----S 52
S +T + LS N L + N S+ + ++ +E+ +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 53 NLTNSTIVNLGGNKLNGSIPITLSKL-----QKLQGLGLEDNKLEGSIPDDICHLAE--- 104
N T +NL GN L+ L K + L L N +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS---SKSSSEFKQAFS 134
Query: 105 -----LYRLDLDGNK--------LSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKD 151
+ L+L GN L L A +N+ SL L N L S
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLN---LRGNNLASK--------- 182
Query: 152 ILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIG-GLKN----LEYLFLG 206
+ L L ++ L D S N E+ + + L L
Sbjct: 183 ------NCAELAKFLASIPASVTSL---DLSANLLGLKSYAELAYIFSSIPNHVVSLNLC 233
Query: 207 YNRLQGS----IPDSFGDLISLKFLNLSNNNLSG-------AIPASLEKLSYLENLNLSF 255
N L G + L L+ + L + + A+ A+ + + ++ +
Sbjct: 234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNG 293
Query: 256 NKLEGE 261
++
Sbjct: 294 KEIHPS 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 52/261 (19%), Positives = 89/261 (34%), Gaps = 19/261 (7%)
Query: 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLG 63
+L + + P + LS + FR + + E S +
Sbjct: 43 ASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSN 102
Query: 64 GNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG-NKLS-GSLPA 121
++ LS+ KLQ L LE +L I + + + L RL+L G + S +L
Sbjct: 103 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT 162
Query: 122 CFSNLTSLRIVSLGS-NKLTSVPLTFW------NLKDILNLNFSSNFLT-SPLPLEIGNL 173
S+ + L ++L T + + LNL+ L S L +
Sbjct: 163 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ-LNLSGYRKNLQKSDLSTLVRRC 221
Query: 174 KVLIGIDFSM-NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD----SFGDLISLKFLN 228
L+ +D S E L L++L L I G++ +LK L
Sbjct: 222 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD---IIPETLLELGEIPTLKTLQ 278
Query: 229 LSNNNLSGAIPASLEKLSYLE 249
+ G + E L +L+
Sbjct: 279 VFGIVPDGTLQLLKEALPHLQ 299
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 20/78 (25%), Positives = 37/78 (47%), Gaps = 8/78 (10%)
Query: 356 LFRATDEFSEN----NLIGKGGFGSVYKAR-LGDRMEVAVKVFN--LQCGRAFESFDVEC 408
+ A+ +FS+N +GKG F V + +E A K+ N R F+ + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 409 EMMKNIRHRNLIKILHGV 426
+ + ++H N+++ LH
Sbjct: 80 RICRKLQHPNIVR-LHDS 96
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 12/63 (19%), Positives = 25/63 (39%), Gaps = 4/63 (6%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECE-MMKNIRHRNL 419
+ ++G G G+V VAVK + + +E + + ++ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 420 IKI 422
I+
Sbjct: 72 IRY 74
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 14/59 (23%), Positives = 25/59 (42%), Gaps = 3/59 (5%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
+G+G FG V++ + K ++ G E ++ RHRN++ LH
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILH-LHES 69
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 19/59 (32%), Positives = 29/59 (49%), Gaps = 2/59 (3%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
IG+G +G V A G R+ A K + F E E+MK++ H N+I+ L+
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR-LYET 74
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 6/60 (10%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDV-----ECEMMKNIRHRNLIKI 422
IG+G +G V A R A+K+ N R DV E +MK + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 18/63 (28%), Positives = 28/63 (44%), Gaps = 9/63 (14%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDV-----ECEMMKNIRHRNL 419
+G G G V A +VA+K+ + G A E+ E E++K + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 420 IKI 422
IKI
Sbjct: 78 IKI 80
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 17/63 (26%), Positives = 28/63 (44%), Gaps = 9/63 (14%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDV-----ECEMMKNIRHRNL 419
+G G G V A +VA+++ + G A E+ E E++K + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 420 IKI 422
IKI
Sbjct: 203 IKI 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 20/72 (27%), Positives = 37/72 (51%), Gaps = 11/72 (15%)
Query: 357 FRATDEFSENNLIGKGGFGSVYKARLGDRME-VAVK-VFNLQ--CGRAFESFDVECEMMK 412
+++ +IG G FG VY+A+L D E VA+K V + R E ++M+
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMR 102
Query: 413 NIRHRNLIKILH 424
+ H N++++ +
Sbjct: 103 KLDHCNIVRLRY 114
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 21/79 (26%), Positives = 32/79 (40%), Gaps = 12/79 (15%)
Query: 359 ATDEFSEN---------NLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVEC 408
+TD FS +++G+G V L E AVK+ Q G E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 409 EMMKNIR-HRNLIKILHGV 426
EM+ + HRN+++ L
Sbjct: 62 EMLYQCQGHRNVLE-LIEF 79
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 20/74 (27%), Positives = 31/74 (41%), Gaps = 8/74 (10%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFN------LQCGRAFESFDVECEMMK 412
D + +G G F V K R ++ A K + G + E + E ++K
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 413 NIRHRNLIKILHGV 426
I+H N+I LH V
Sbjct: 70 EIQHPNVIT-LHEV 82
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 2e-04
Identities = 28/167 (16%), Positives = 48/167 (28%), Gaps = 24/167 (14%)
Query: 350 TFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKV--------FNLQCGRAF 401
FS+ T++ IG+G FG V++ D VA+K+ N + F
Sbjct: 12 PFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 402 ESFDVECEMMKNI---------RHRNLIKILHGVAVI-TFTVCLCLFHHSSASASASLVS 451
E E + K + R I + V ++ L S S
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 452 SLTLSRPAKGGGFRGCVLWHVGVDFAAFVFVLEPGVEVICFVFEILL 498
+ + F G+D L + ++
Sbjct: 128 RPDFFKDDQ--LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTA 172
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 10/75 (13%), Positives = 27/75 (36%), Gaps = 19/75 (25%)
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFN---LQCGRAFESFDV--------------ECEMM 411
+ +G F + ++ A+K + L+ R F + E +++
Sbjct: 39 LNQGKFNKIILCEKDNK-FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 412 KNIRHRNLIKILHGV 426
+I++ + G+
Sbjct: 98 TDIKNEYCLT-CEGI 111
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 20/65 (30%), Positives = 29/65 (44%), Gaps = 8/65 (12%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFN------LQCGRAFESFDVECEMMKNIRHRNLIK 421
+G G F V K R G E A K + G + E + E +++ IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 422 ILHGV 426
LH +
Sbjct: 73 -LHDI 76
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 15/56 (26%), Positives = 27/56 (48%), Gaps = 2/56 (3%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIK 421
++ +GGF VY+A+ +G E A+K + E MK + H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 16/61 (26%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNL-QCGRAFESFDVECEMMKNIRHRNLIKILHG 425
+G+G +G V A VAVK+ ++ + E+ E + K + H N++K +G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK-FYG 72
Query: 426 V 426
Sbjct: 73 H 73
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 18/65 (27%), Positives = 27/65 (41%), Gaps = 8/65 (12%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFN------LQCGRAFESFDVECEMMKNIRHRNLIK 421
+G G F V K R +E A K + G E + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 422 ILHGV 426
LH V
Sbjct: 80 -LHDV 83
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 18/68 (26%), Positives = 29/68 (42%), Gaps = 4/68 (5%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEM---MKN 413
R T EF E IG G FGSV+K D A+K + + + E+
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 414 IRHRNLIK 421
+H ++++
Sbjct: 68 GQHSHVVR 75
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 15/64 (23%), Positives = 30/64 (46%), Gaps = 6/64 (9%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN----LQCGRAFESFDVECEMMKNIRHRNLIKI 422
L+G+G +G V + AVK+ + + E ++++ +RH+N+I+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ- 70
Query: 423 LHGV 426
L V
Sbjct: 71 LVDV 74
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 16/61 (26%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNL-QCGRAFESFDVECEMMKNIRHRNLIKILHG 425
+G+G +G V A VAVK+ ++ + E+ E + K + H N++K +G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK-FYG 72
Query: 426 V 426
Sbjct: 73 H 73
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 17/56 (30%), Positives = 28/56 (50%), Gaps = 2/56 (3%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFN-LQCGRAFESFDVECEMMKNIRHRNLIKI 422
+G G FG V+ +E +K N + E + E E++K++ H N+IKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 8/55 (14%), Positives = 16/55 (29%), Gaps = 1/55 (1%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIK 421
++G+ + +A V V + E + +R IK
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 35/276 (12%), Positives = 85/276 (30%), Gaps = 25/276 (9%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPK--TSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNST 58
+ + L G + T + N L+ +S ++ L +
Sbjct: 80 LKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVS---DLDLDRLAKAR 136
Query: 59 IVNLGGNKLNGSIPIT-------LSKLQKLQGLGLEDNKLEGSIPDDICHLAE----LYR 107
+L KL+ T ++ +K++ L +E++ + LA+ L
Sbjct: 137 ADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEV 196
Query: 108 LDLDGNKLSG-------SLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSN 160
L+ + + ++ +L S+++ +L NL++ + + +
Sbjct: 197 LNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNED 256
Query: 161 FLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPDSFG 219
+ + + L + S + +P + L L Y L+
Sbjct: 257 IGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQ 315
Query: 220 DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 255
+L+ L N + + L+ L +
Sbjct: 316 KCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 14/68 (20%), Positives = 22/68 (32%), Gaps = 4/68 (5%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECE---MMKN 413
F + +G G +G V+K R D AVK + E K
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 414 IRHRNLIK 421
+H ++
Sbjct: 114 GQHPCCVR 121
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 4/59 (6%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRHRNLIKI 422
+G G FG V +VAVK+ N ++ E + +K RH ++IK+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 15/64 (23%), Positives = 26/64 (40%), Gaps = 7/64 (10%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKV-----FNLQCGRAFESFDVECEMMKNIRHRNLIKI 422
IGKG F V + + AVK+ F G + E E + ++H ++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE- 90
Query: 423 LHGV 426
L
Sbjct: 91 LLET 94
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 21/67 (31%), Positives = 34/67 (50%), Gaps = 11/67 (16%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN----LQCGRAFESFDV--ECEMMKNIR----H 416
L+GKGGFG+V+ L DR++VA+KV L +S E ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 417 RNLIKIL 423
+I++L
Sbjct: 98 PGVIRLL 104
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 18/65 (27%), Positives = 28/65 (43%), Gaps = 8/65 (12%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFN------LQCGRAFESFDVECEMMKNIRHRNLIK 421
+G G F V K R +E A K + G + E + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 422 ILHGV 426
LH V
Sbjct: 80 -LHDV 83
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 16/78 (20%), Positives = 30/78 (38%), Gaps = 14/78 (17%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKV-------------FNLQCGRAFESFD 405
+ + + +G G +G V + E A+KV N + E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 406 VECEMMKNIRHRNLIKIL 423
E ++K++ H N+IK+
Sbjct: 95 NEISLLKSLDHPNIIKLF 112
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 18/63 (28%), Positives = 31/63 (49%), Gaps = 5/63 (7%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRHRNLIKIL 423
+G+G FG V A + +VA+K + L+ + E +K +RH ++IK L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK-L 74
Query: 424 HGV 426
+ V
Sbjct: 75 YDV 77
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 17/65 (26%), Positives = 26/65 (40%), Gaps = 9/65 (13%)
Query: 369 IGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDV-----ECEMMKNIRHRNL 419
+G G FG V+ A EV VK + E + E ++ + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 420 IKILH 424
IK+L
Sbjct: 92 IKVLD 96
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 5/63 (7%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRHRNLIKIL 423
+G G FG V + +VAVK+ N ++ E + +K RH ++IK L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK-L 81
Query: 424 HGV 426
+ V
Sbjct: 82 YQV 84
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 17/65 (26%), Positives = 28/65 (43%), Gaps = 9/65 (13%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDV------ECEMMKNIRHR--N 418
L+G GGFGSVY + D + VA+K + E ++K +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 419 LIKIL 423
+I++L
Sbjct: 110 VIRLL 114
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 499 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 100.0 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.98 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.98 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.98 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.98 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.98 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.98 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.98 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.98 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.98 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.98 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.94 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.93 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.93 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.93 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.93 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.92 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.92 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.9 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.89 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.89 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.89 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.89 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.89 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.87 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.86 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.86 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.86 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.86 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.86 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.86 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.85 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.85 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.85 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.83 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.82 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.81 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.81 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.81 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.8 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.8 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.79 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.79 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.79 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.75 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.75 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.74 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.74 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.74 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.74 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.74 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.74 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.74 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.74 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.73 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.73 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.73 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.73 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.73 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.73 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.72 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.72 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.72 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.72 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.71 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.71 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.71 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.71 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.71 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.71 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.71 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.71 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.71 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.71 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.7 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.7 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.7 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.7 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.7 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.7 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.69 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.69 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.69 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.69 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.69 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.69 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.69 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.69 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.69 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.69 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.69 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.69 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.69 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.69 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.68 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.68 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.68 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.68 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.68 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.68 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.68 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.68 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.68 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.68 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.68 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.68 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.68 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.68 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.68 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.68 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.68 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.68 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.68 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.68 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.68 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.67 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.67 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.67 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.67 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.67 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.67 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.67 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.67 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.67 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.67 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.67 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.67 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.67 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.67 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.67 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.67 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.67 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.67 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.67 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.67 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.66 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.66 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.66 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.66 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.66 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.66 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.66 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.66 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.66 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.66 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.66 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.66 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.66 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.66 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.66 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.66 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.66 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.65 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.65 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.65 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.65 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.65 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.65 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.65 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.65 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.65 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.65 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.65 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.65 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.65 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.65 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.65 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.65 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.65 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.65 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.65 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.65 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.65 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.65 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.64 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.64 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.64 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.64 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.64 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.64 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.64 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.64 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.64 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.64 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.64 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.64 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.64 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.64 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.64 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.64 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.64 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.64 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.64 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.64 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.64 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.64 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.64 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.64 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.63 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.63 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.63 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.63 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.63 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.63 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.63 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.63 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.63 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.63 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.63 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.63 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.63 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.63 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.62 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.62 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.62 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.62 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.62 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.62 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.62 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.62 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.62 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.62 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.62 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.62 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.62 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.62 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.61 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.61 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.61 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.61 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.61 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.61 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.61 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.61 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.61 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.6 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.6 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.6 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.6 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.6 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.6 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.6 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.6 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.6 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.59 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.59 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.59 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.59 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.59 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.58 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.58 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.58 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.58 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.58 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.58 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.57 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.57 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.57 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.56 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.55 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.55 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.55 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.55 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.54 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.54 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.54 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.53 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.53 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.53 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.52 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.52 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.51 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.51 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.5 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.49 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.49 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.49 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.48 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.48 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.46 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.44 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.41 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.37 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.32 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.15 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.01 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.98 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.64 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.64 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.44 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.3 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.25 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.09 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.72 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.64 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.27 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.23 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 94.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 91.69 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 89.9 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.56 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 86.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 85.79 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 85.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 85.59 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 83.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 82.16 | |
| 2lz0_A | 100 | Uncharacterized protein; hypothetical leucine rich | 81.45 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 80.9 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.21 Aligned_cols=289 Identities=34% Similarity=0.584 Sum_probs=265.1
Q ss_pred CCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCe
Q 010856 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQG 83 (499)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 83 (499)
+++|++|++++|.+++..|. .+..++ +|++|++++|.+++..|..|..+++|++|++++|.+++..|..+..+++|++
T Consensus 393 ~~~L~~L~L~~n~l~~~~p~-~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 470 (768)
T 3rgz_A 393 KNTLQELYLQNNGFTGKIPP-TLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470 (768)
T ss_dssp TCCCCEEECCSSEEEEECCG-GGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred cCCccEEECCCCccccccCH-HHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceE
Confidence 67899999999999888887 788888 8999999999999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC-CCccccCCCCCcEEEcCCCcC
Q 010856 84 LGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l 162 (499)
|++++|++++..|..+..+++|++|++++|++++..|..+..+++|++|++++|+++. +|..+..+++|+.|++++|.+
T Consensus 471 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 550 (768)
T 3rgz_A 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEE
T ss_pred EEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCcc
Confidence 9999999998999999999999999999999999999999999999999999999985 888999999999999999988
Q ss_pred CCCCccc----------------------------------------------------------------------ccC
Q 010856 163 TSPLPLE----------------------------------------------------------------------IGN 172 (499)
Q Consensus 163 ~~~~~~~----------------------------------------------------------------------~~~ 172 (499)
++.+|.. +..
T Consensus 551 ~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~ 630 (768)
T 3rgz_A 551 NGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630 (768)
T ss_dssp ESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSS
T ss_pred CCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhc
Confidence 7655533 344
Q ss_pred CCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEE
Q 010856 173 LKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 252 (499)
Q Consensus 173 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 252 (499)
+++|+.|++++|++++.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|||++|++++.+|..+..+++|+.||
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcCcccCCCCCCCCCccccccCCCcCCCCCCCCCCCCCCCCc
Q 010856 253 LSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSI 297 (499)
Q Consensus 253 l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~~~~~~~~~~~~~ 297 (499)
+++|+++|.+|....+..+....+.|||.+||.|. ++|....
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~ 752 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSN 752 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCc
Confidence 99999999999998899999999999999999753 3776533
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.74 Aligned_cols=138 Identities=20% Similarity=0.202 Sum_probs=121.6
Q ss_pred CCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeC
Q 010856 150 KDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNL 229 (499)
Q Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l 229 (499)
++|++|++++|.+++..+..+..+++|+.|++++|++++..+..|.++++|++|++++|.+++..+..|..+++|+.|++
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 46677777777777777788889999999999999999888889999999999999999999888899999999999999
Q ss_pred CCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcCCCCCCC
Q 010856 230 SNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 230 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~~c~~~~ 287 (499)
++|++++..|..|..+++|++|++++|++++..+.. ..++.++.+++.+|++.|+|+.
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 999999888999999999999999999999766544 4678899999999999998874
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=311.60 Aligned_cols=281 Identities=23% Similarity=0.274 Sum_probs=219.8
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++++.|+|++|++++..+. .+..++ +|++|+|++|.++++.|.+|.++++|++|+|++|.++...+..|.++++|++|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~-~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 109 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQD-EFASFP-HLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKL 109 (477)
T ss_dssp TTCSEEECCSSCCCEECTT-TTTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEE
T ss_pred CCCcEEECCCCccceECHh-HccCCC-CCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEE
Confidence 4677888888888777665 667777 78888888888877777778888888888888888776666667777888888
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCCCCCcEEEcCCCcCC
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~ 163 (499)
+|++|.+....+..|..+++|++|++++|.+++..+..|..+++|+.|++++|+++.++. .+..+++|+.|++++|.+.
T Consensus 110 ~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~ 189 (477)
T 2id5_A 110 DISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189 (477)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCC
T ss_pred ECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCc
Confidence 888888777777777777788888888887777777777777777777777777777654 4666777777777777766
Q ss_pred CCCcccccCCC------------------------CccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCcccc
Q 010856 164 SPLPLEIGNLK------------------------VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFG 219 (499)
Q Consensus 164 ~~~~~~~~~l~------------------------~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~ 219 (499)
+..+..|..++ +|+.|++++|+++...+..+..+++|++|+|++|.+++..+..|.
T Consensus 190 ~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (477)
T 2id5_A 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH 269 (477)
T ss_dssp EECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCT
T ss_pred EeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhcc
Confidence 65555555544 455555666667665556788899999999999999988888899
Q ss_pred CCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcCCCCCCC
Q 010856 220 DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 220 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~~c~~~~ 287 (499)
.+++|+.|++++|++++..+..|..+++|+.|++++|++++..+.. ..+++++.+++.+|||.|+|..
T Consensus 270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 270 ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp TCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred ccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 9999999999999999888999999999999999999999766543 4567889999999999998854
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=297.22 Aligned_cols=254 Identities=32% Similarity=0.552 Sum_probs=240.5
Q ss_pred cccEEEcccCCCcc--cCCccccCCCCCCEEeccC-CcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEE
Q 010856 32 SLEDFRMYNCNISG--GIPEEISNLTNSTIVNLGG-NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108 (499)
Q Consensus 32 ~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 108 (499)
++++|+|++|.+++ .+|..|.++++|++|++++ |.+.+..|..|.++++|++|+|++|.+++..|..|..+++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 79999999999998 8899999999999999995 99998999999999999999999999998999999999999999
Q ss_pred eeecCCCCCcCCccccCCccCCeeeccccCCC-CCCccccCCC-CCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcc
Q 010856 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLT-SVPLTFWNLK-DILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNF 186 (499)
Q Consensus 109 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 186 (499)
++++|.+++..|..+..+++|++|++++|+++ .+|..+..++ +|++|++++|.+++..|..+..++ |+.|++++|.+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 99999999999999999999999999999999 5899999998 999999999999988899999887 99999999999
Q ss_pred cccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCC
Q 010856 187 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG 266 (499)
Q Consensus 187 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 266 (499)
++..|..|..+++|+.|++++|.+++..+. +..+++|++|++++|++++..|..+..+++|+.|++++|++++.+|...
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 999999999999999999999999966655 8889999999999999999999999999999999999999999999988
Q ss_pred CCCCccccccCCCcCCCCCCC
Q 010856 267 SFGNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 267 ~~~~l~~~~l~~N~~~c~~~~ 287 (499)
.++.+..+++.+|+++|+.|.
T Consensus 289 ~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS
T ss_pred cccccChHHhcCCCCccCCCC
Confidence 899999999999999998753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.26 Aligned_cols=251 Identities=35% Similarity=0.557 Sum_probs=215.2
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
+|++|++++|.+++..|..|.++++|++|++++|.+++..|..+..+++|+.|++++|.+.+..|..+..+++|++|+++
T Consensus 395 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 474 (768)
T 3rgz_A 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474 (768)
T ss_dssp CCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred CccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence 67777888887777888888888888888888888888888888888888888888888888888888888889999999
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCC-CCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccC
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI 190 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 190 (499)
+|++++..|..+..+++|+.|++++|+++. +|..+..+++|++|++++|.+++..|..+..+++|+.|++++|++++.+
T Consensus 475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i 554 (768)
T 3rgz_A 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence 999888888888888899999999998885 7888888899999999999988888888888999999999998887655
Q ss_pred ccc----------------------------------------------------------------------ccCCcCC
Q 010856 191 PTE----------------------------------------------------------------------IGGLKNL 200 (499)
Q Consensus 191 ~~~----------------------------------------------------------------------l~~l~~L 200 (499)
|.. +..+++|
T Consensus 555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L 634 (768)
T 3rgz_A 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634 (768)
T ss_dssp CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence 543 2335678
Q ss_pred ceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCC
Q 010856 201 EYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGN 279 (499)
Q Consensus 201 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N 279 (499)
+.|++++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|||++|+++|.+|.. ..++.++.+++++|
T Consensus 635 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 88999999999999999999999999999999999999999999999999999999999888875 45677888999988
Q ss_pred cCC
Q 010856 280 ELL 282 (499)
Q Consensus 280 ~~~ 282 (499)
+..
T Consensus 715 ~l~ 717 (768)
T 3rgz_A 715 NLS 717 (768)
T ss_dssp EEE
T ss_pred ccc
Confidence 854
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.09 Aligned_cols=284 Identities=21% Similarity=0.228 Sum_probs=231.3
Q ss_pred CCCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCC
Q 010856 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQK 80 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 80 (499)
|.++++|++|+|++|.+++..|. .+.+++ +|++|+|++|.++.+.+..|.++++|++|+|++|.+++..+..|.++++
T Consensus 52 ~~~l~~L~~L~L~~n~i~~~~~~-~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 129 (477)
T 2id5_A 52 FASFPHLEELELNENIVSAVEPG-AFNNLF-NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129 (477)
T ss_dssp TTTCTTCCEEECTTSCCCEECTT-TTTTCT-TCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred ccCCCCCCEEECCCCccCEeChh-hhhCCc-cCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHcccccc
Confidence 45788888888888888887776 777777 8888888888888777777888888888888888888777778888888
Q ss_pred CCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCC----------
Q 010856 81 LQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNL---------- 149 (499)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l---------- 149 (499)
|++|++++|.+++..+..|.++++|++|++++|++++..+..+..+++|+.|++++|.+..++. .+..+
T Consensus 130 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 209 (477)
T 2id5_A 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209 (477)
T ss_dssp CCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEEC
T ss_pred CCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCC
Confidence 8888888888887777778888888888888888876666667777777777777776665332 33333
Q ss_pred --------------CCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCC
Q 010856 150 --------------KDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 215 (499)
Q Consensus 150 --------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 215 (499)
.+|++|++++|.++.+.+..+..+++|+.|++++|.+++..+..|..+++|++|+|++|++++..+
T Consensus 210 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 289 (477)
T 2id5_A 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289 (477)
T ss_dssp CTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECT
T ss_pred CccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECH
Confidence 366677777777877666778999999999999999999888899999999999999999999999
Q ss_pred ccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCCC
Q 010856 216 DSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 286 (499)
Q Consensus 216 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~~ 286 (499)
..|..+++|+.|++++|++++..+..|..+++|+.|++++|++.+..+..+.+.......+.++...|..|
T Consensus 290 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 290 YAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp TTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred HHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 99999999999999999999988889999999999999999999765543333334446677788888664
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=306.62 Aligned_cols=283 Identities=22% Similarity=0.263 Sum_probs=249.3
Q ss_pred CCCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCC-ccccCCC
Q 010856 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIP-ITLSKLQ 79 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~ 79 (499)
|+++++|++|++++|.++.. |. .+..++ +|++|++++|.+++..|..+..+++|++|++++|.+.+..+ ..+..++
T Consensus 274 ~~~l~~L~~L~l~~n~l~~l-p~-~l~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 274 FHCFSGLQELDLTATHLSEL-PS-GLVGLS-TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTCTTCSEEECTTSCCSCC-CS-SCCSCT-TCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred hccccCCCEEeccCCccCCC-Ch-hhcccc-cCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 45688999999999999844 44 567777 89999999999998888889999999999999998875444 4588999
Q ss_pred CCCeEecccccccccC--CccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCC-C-ccccCCCCCcEE
Q 010856 80 KLQGLGLEDNKLEGSI--PDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSV-P-LTFWNLKDILNL 155 (499)
Q Consensus 80 ~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~~l~~L~~L 155 (499)
+|++|++++|.+++.. +..+..+++|++|++++|++.+..+..|..+++|+.|++++|+++.. + ..+..+++|++|
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence 9999999999998765 67889999999999999999988889999999999999999999874 3 348889999999
Q ss_pred EcCCCcCCCCCcccccCCCCccEEEccCCccccc---CcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCC
Q 010856 156 NFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGV---IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNN 232 (499)
Q Consensus 156 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N 232 (499)
++++|.+++..+..+..+++|+.|++++|++++. .+..+..+++|++|++++|++++..|..|..+++|+.|++++|
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 510 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence 9999999988888999999999999999999863 3356889999999999999999998999999999999999999
Q ss_pred cCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcCCCCCCC
Q 010856 233 NLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 233 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~~c~~~~ 287 (499)
++++..|..+..+++| .|++++|++++.+|.. ..++.++.+++.+|||.|+|+.
T Consensus 511 ~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 511 RLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred ccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 9999999999999999 9999999999877754 4467889999999999998853
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.01 Aligned_cols=141 Identities=23% Similarity=0.246 Sum_probs=98.5
Q ss_pred CCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccc-cCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCE
Q 010856 148 NLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSG-VIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKF 226 (499)
Q Consensus 148 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 226 (499)
.+++|++|++++|.+++..+..+..+++|+.|++++|.+++ ..|..+..+++|++|++++|++++..|..|..+++|+.
T Consensus 422 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 501 (606)
T 3vq2_A 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501 (606)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCE
Confidence 34444444444444444445555666666666666666665 35666777777778888888777777777888888888
Q ss_pred EeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCC-CccccccCCCcCCCCCCCC
Q 010856 227 LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFG-NFSAESFEGNELLCGSPNL 288 (499)
Q Consensus 227 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~-~l~~~~l~~N~~~c~~~~~ 288 (499)
|++++|++++..|..+..+++|+.|++++|++++..+....++ +++.+++.+|||.|+|+..
T Consensus 502 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp EECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred EECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 8888888887777888888888888888888875444434454 4788888888888888643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=294.92 Aligned_cols=264 Identities=22% Similarity=0.267 Sum_probs=219.9
Q ss_pred CCCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCc--cccCC
Q 010856 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPI--TLSKL 78 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l 78 (499)
|+++++|++|+|++|.+.+..+...+..++ +|++|+|++|.+++..|..|.++++|++|++++|.+++..+. .|..+
T Consensus 50 ~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l 128 (455)
T 3v47_A 50 FSRLQDLQFLKVEQQTPGLVIRNNTFRGLS-SLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128 (455)
T ss_dssp TSSCTTCCEEECCCCSTTCEECTTTTTTCT-TCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTC
T ss_pred hccCccccEEECcCCcccceECcccccccc-cCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCc
Confidence 467888888888888887554444677777 888888888888888888888888888888888888764443 37888
Q ss_pred CCCCeEecccccccccCCcc-ccCcccccEEeeecCCCCCcCCccccCC-------------------------------
Q 010856 79 QKLQGLGLEDNKLEGSIPDD-ICHLAELYRLDLDGNKLSGSLPACFSNL------------------------------- 126 (499)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l------------------------------- 126 (499)
++|++|+|++|.+++..|.. +..+++|++|++++|++++..+..+..+
T Consensus 129 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~ 208 (455)
T 3v47_A 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208 (455)
T ss_dssp TTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCT
T ss_pred ccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccc
Confidence 88888888888888776665 7788888888888888876665544332
Q ss_pred ---ccCCee---------------------------------------------------------------eccccCCC
Q 010856 127 ---TSLRIV---------------------------------------------------------------SLGSNKLT 140 (499)
Q Consensus 127 ---~~L~~L---------------------------------------------------------------~L~~n~l~ 140 (499)
++|+.| ++++|+++
T Consensus 209 ~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 288 (455)
T 3v47_A 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288 (455)
T ss_dssp TTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCC
T ss_pred cccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCcccc
Confidence 344444 44444444
Q ss_pred C-CCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCcccc
Q 010856 141 S-VPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFG 219 (499)
Q Consensus 141 ~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~ 219 (499)
. .|..+..+++|++|++++|.+++..+..|..+++|+.|++++|.+++..+..|..+++|++|++++|++++..|..|.
T Consensus 289 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 368 (455)
T 3v47_A 289 ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred ccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcc
Confidence 4 355688899999999999999998899999999999999999999998899999999999999999999998899999
Q ss_pred CCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC
Q 010856 220 DLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265 (499)
Q Consensus 220 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 265 (499)
.+++|++|++++|++++..+..+..+++|+.|++++|++++.+|..
T Consensus 369 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred ccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 9999999999999999888888999999999999999999988854
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=286.92 Aligned_cols=274 Identities=21% Similarity=0.230 Sum_probs=173.7
Q ss_pred CCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCe
Q 010856 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQG 83 (499)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 83 (499)
+++++.|++++|.++.+.+. .+..++ +|++|++++|.++++.+.+|..+++|++|+|++|.+++..|..|.++++|++
T Consensus 44 l~~l~~l~l~~~~l~~l~~~-~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAA-LLDSFR-QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GCCCSEEEEESCEESEECTH-HHHHCC-CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCceEEEecCCchhhCChh-Hhcccc-cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 35555666666655544333 444555 5666666666665555555566666666666666665555555555666666
Q ss_pred EecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCcc-c----------------
Q 010856 84 LGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT-F---------------- 146 (499)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~---------------- 146 (499)
|++++|+++...+..|..+++|++|++++|++++..+..+..+++|+.|++++|+++.++.. +
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEE
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeeccccccccc
Confidence 66666665544434445556666666666666555555555555666666665555543210 0
Q ss_pred ---------------------cCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeC
Q 010856 147 ---------------------WNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFL 205 (499)
Q Consensus 147 ---------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 205 (499)
...++|+.|++++|.+++. ..+..+++|+.|++++|.+++..|..|..+++|++|++
T Consensus 202 ~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 279 (390)
T 3o6n_A 202 AIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279 (390)
T ss_dssp ECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEEC
T ss_pred CCCCcceEEECCCCeeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEEC
Confidence 1124566666666666643 45677778888888888887777777888888888888
Q ss_pred cCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCC
Q 010856 206 GYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS 285 (499)
Q Consensus 206 ~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~ 285 (499)
++|++++ .+..+..+++|+.|++++|+++ ..|..+..+++|+.|++++|++++.. ...++.++.+++.+|++.|.+
T Consensus 280 ~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~~ 355 (390)
T 3o6n_A 280 SNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNS 355 (390)
T ss_dssp CSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred CCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccchh
Confidence 8888874 3455567788888888888887 34555677788888888888887543 345677888888888887754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=283.55 Aligned_cols=250 Identities=30% Similarity=0.436 Sum_probs=234.5
Q ss_pred CCCCEEECcCCCCCc--cCChhccccccccccEEEccc-CCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCC
Q 010856 5 KSLTLIYLSNNPLDG--ILPKTSVGNLSHSLEDFRMYN-CNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKL 81 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~--~~~~~~~~~l~~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 81 (499)
.+++.|+|++|.+++ ..|. .+..++ +|++|++++ |.+.+.+|..|.++++|++|+|++|.+++..|..|.++++|
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~-~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 127 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPS-SLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCG-GGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred ceEEEEECCCCCccCCcccCh-hHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCC
Confidence 579999999999998 7787 888898 999999995 99999999999999999999999999998999999999999
Q ss_pred CeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCc-cCCeeeccccCCCC-CCccccCCCCCcEEEcCC
Q 010856 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLT-SLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSS 159 (499)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~ 159 (499)
++|++++|.+++..|..+..+++|++|++++|++++..|..+..++ +|+.|++++|+++. +|..+..++ |++|++++
T Consensus 128 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~ 206 (313)
T 1ogq_A 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSR 206 (313)
T ss_dssp CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCS
T ss_pred CEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcC
Confidence 9999999999999999999999999999999999988999999998 99999999999995 888888887 99999999
Q ss_pred CcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCc
Q 010856 160 NFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239 (499)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 239 (499)
|.+++..+..+..+++|+.|++++|.+++..+. +..+++|++|++++|++++..|..+..+++|+.|++++|++++.+|
T Consensus 207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip 285 (313)
T 1ogq_A 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp SEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred CcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence 999998999999999999999999999976665 8889999999999999999999999999999999999999998888
Q ss_pred ccccCCCCCCEEEccCCcCc
Q 010856 240 ASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 240 ~~~~~l~~L~~L~l~~N~l~ 259 (499)
.. ..+++|+.+++++|+..
T Consensus 286 ~~-~~l~~L~~l~l~~N~~l 304 (313)
T 1ogq_A 286 QG-GNLQRFDVSAYANNKCL 304 (313)
T ss_dssp CS-TTGGGSCGGGTCSSSEE
T ss_pred CC-ccccccChHHhcCCCCc
Confidence 76 88999999999999943
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=303.38 Aligned_cols=289 Identities=23% Similarity=0.242 Sum_probs=238.0
Q ss_pred CCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCc--ccCCccccCC--CCCCEEeccCCcCCccCCccccC
Q 010856 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNIS--GGIPEEISNL--TNSTIVNLGGNKLNGSIPITLSK 77 (499)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~--~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~ 77 (499)
+.+++|++|++++|.+++..+. .+..++ +|++|++++|.+. ...+..|..+ ++|+.|++++|++++..|..|..
T Consensus 326 ~~l~~L~~L~l~~n~l~~~~~~-~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 326 QWLKCLEHLNMEDNDIPGIKSN-MFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTCTTCCEEECCSCCBCCCCTT-TTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred ccCCCCCEEECCCCccCCCChh-Hhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 3466677777777777665554 566666 6777777776533 2223334332 46777777888888888888999
Q ss_pred CCCCCeEecccccccccCC-ccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCC---CCCccccCCCCCc
Q 010856 78 LQKLQGLGLEDNKLEGSIP-DDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLT---SVPLTFWNLKDIL 153 (499)
Q Consensus 78 l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~l~~L~ 153 (499)
+++|+.|++++|.+.+.++ ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++ .+|..+..+++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 9999999999999976554 67889999999999999999888889999999999999999886 3688899999999
Q ss_pred EEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCc--------ccccCCcCCceeeCcCCcCCCCCCccccCCCCCC
Q 010856 154 NLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP--------TEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLK 225 (499)
Q Consensus 154 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--------~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 225 (499)
.|++++|.++++.+..|.++++|+.|++++|++++..+ ..|.++++|++|++++|+++.+.+..|..+++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence 99999999999888889999999999999999986532 2378899999999999999977777899999999
Q ss_pred EEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCC--CCCCccccccCCCcCCCCCCC-CCCCC
Q 010856 226 FLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG--SFGNFSAESFEGNELLCGSPN-LQVPP 292 (499)
Q Consensus 226 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~~l~~~~l~~N~~~c~~~~-~~~~~ 292 (499)
.|++++|++++..+..|..+++|+.|++++|++++..+... .+++++.+++.+|||.|+|+. .++..
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~ 633 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEEC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHH
Confidence 99999999998888889999999999999999998766532 467899999999999999974 44433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=309.84 Aligned_cols=272 Identities=23% Similarity=0.235 Sum_probs=233.0
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|++|++++|.+.+..+. .+..++ +|+.|+|++|.+++..|.+|..+++|++|+|++|.+++..+..|..+++|+.|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~-~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 343 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSR-VFETLK-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343 (844)
T ss_dssp SCCCEEECTTCCCCEECSC-CSSSCC-CCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEE
T ss_pred CCccEEECCCCcccccChh-hhhcCC-CCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEE
Confidence 7899999999999988776 788888 89999999999999999999999999999999999998889999999999999
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCcc-------------------
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT------------------- 145 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------------------- 145 (499)
++++|.+....+..|..+++|++|++++|.+++.. .+++|+.|++++|+++.+|..
T Consensus 344 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~ 418 (844)
T 3j0a_A 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDI 418 (844)
T ss_dssp ECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTT
T ss_pred ECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCcccccccccccceeecccCccccCch
Confidence 99999999888888999999999999999988532 255666666666666554432
Q ss_pred ---ccCCCCCcEEEcCCCcCCCCCcc-cccCCCCccEEEccCCccc-----ccCcccccCCcCCceeeCcCCcCCCCCCc
Q 010856 146 ---FWNLKDILNLNFSSNFLTSPLPL-EIGNLKVLIGIDFSMNNFS-----GVIPTEIGGLKNLEYLFLGYNRLQGSIPD 216 (499)
Q Consensus 146 ---~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~-----~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 216 (499)
+..+++|+.|++++|++++..+. .+..+++|+.|++++|.++ +..+..|.++++|+.|+|++|++++..+.
T Consensus 419 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 498 (844)
T 3j0a_A 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498 (844)
T ss_dssp HHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTT
T ss_pred hhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChh
Confidence 34788899999999988865433 4566788999999999987 34456688999999999999999999999
Q ss_pred cccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCCCC
Q 010856 217 SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 217 ~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~~~ 287 (499)
.|..+++|+.|+|++|++++..+..+. ++|+.|++++|++++..|.. ++.+..+++.+|||.|+|+.
T Consensus 499 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 499 VFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSC
T ss_pred HccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccccc
Confidence 999999999999999999988777776 89999999999999988865 67899999999999998863
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=298.51 Aligned_cols=271 Identities=21% Similarity=0.230 Sum_probs=174.8
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++++.|++++|.+..+++. .+..++ +|++|+|++|.++++.|..|..+++|++|+|++|.+++..|..|.++++|++|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~-~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAA-LLDSFR-QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp CCCSEEEESSCEESEECTH-HHHHCC-CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCCCCCcCHH-HHccCC-CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 3444444444444443332 334444 44444444444444444444444444444444444444444444444444444
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCC---------------------
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP--------------------- 143 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--------------------- 143 (499)
+|++|.++...+..|..+++|++|+|++|.+++..|..|..+++|+.|++++|.++.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~ 208 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 208 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEE
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcccccc
Confidence 44444444333333444444444444444444444444444444444444444444322
Q ss_pred -------------------ccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceee
Q 010856 144 -------------------LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLF 204 (499)
Q Consensus 144 -------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 204 (499)
..+ .++|+.|++++|.+++ +..+..+++|+.|++++|.+++..|..|..+++|+.|+
T Consensus 209 ~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 284 (597)
T 3oja_B 209 IPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 284 (597)
T ss_dssp CCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred CCchhheeeccCCccccccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEE
Confidence 111 2467777777777775 35678899999999999999998899999999999999
Q ss_pred CcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCC
Q 010856 205 LGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG 284 (499)
Q Consensus 205 L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~ 284 (499)
|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++.. ...++.+..+++.+|+|.|.
T Consensus 285 Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 285 ISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCCh
Confidence 99999986 4666778999999999999999 56677888999999999999998653 44578899999999999997
Q ss_pred C
Q 010856 285 S 285 (499)
Q Consensus 285 ~ 285 (499)
+
T Consensus 361 ~ 361 (597)
T 3oja_B 361 S 361 (597)
T ss_dssp H
T ss_pred h
Confidence 6
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.14 Aligned_cols=118 Identities=25% Similarity=0.361 Sum_probs=101.7
Q ss_pred ccCCCCccEEEccCCcc-cccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCC
Q 010856 170 IGNLKVLIGIDFSMNNF-SGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 248 (499)
Q Consensus 170 ~~~l~~L~~L~l~~n~l-~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 248 (499)
+..++.|+.|++++|.+ ....|..|..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|
T Consensus 465 ~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 544 (635)
T 4g8a_A 465 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 544 (635)
T ss_dssp TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTC
T ss_pred cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCC
Confidence 34456677777777764 34567788899999999999999999999999999999999999999999999999999999
Q ss_pred CEEEccCCcCcccCCCCC-CC-CCccccccCCCcCCCCCCC
Q 010856 249 ENLNLSFNKLEGEIPRGG-SF-GNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 249 ~~L~l~~N~l~~~~~~~~-~~-~~l~~~~l~~N~~~c~~~~ 287 (499)
+.|++++|+|++..|... .+ ++++.+++++|||.|+|..
T Consensus 545 ~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 545 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 999999999999888753 34 5789999999999999853
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=269.10 Aligned_cols=268 Identities=23% Similarity=0.296 Sum_probs=234.0
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEe
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLG 85 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 85 (499)
+++.++++++.++.+... ++++|++|++++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 32 ~l~~l~~~~~~l~~lp~~-----~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKD-----LPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp ETTEEECTTSCCCSCCCS-----CCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCeEEEecCCCccccCcc-----CCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 789999999999865332 234899999999999988888999999999999999999988899999999999999
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC---CCccccCCCCCcEEEcCCCcC
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS---VPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~~~~~~~l~~L~~L~l~~n~l 162 (499)
+++|.++. +|..+. ++|++|++++|.+++..+..|..+++|+.|++++|.++. .+..+..+++|++|++++|.+
T Consensus 107 Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 107 LSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 99999984 444443 799999999999998888889999999999999999974 466788999999999999999
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
+.+ |..+. ++|+.|++++|.+++..+..+..+++|++|++++|.+++..+..+..+++|+.|++++|+++ ..|..+
T Consensus 184 ~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l 259 (330)
T 1xku_A 184 TTI-PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259 (330)
T ss_dssp CSC-CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred ccC-Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhh
Confidence 864 33332 89999999999999988999999999999999999999888889999999999999999999 677789
Q ss_pred cCCCCCCEEEccCCcCcccCCCCC-------CCCCccccccCCCcCCCCC
Q 010856 243 EKLSYLENLNLSFNKLEGEIPRGG-------SFGNFSAESFEGNELLCGS 285 (499)
Q Consensus 243 ~~l~~L~~L~l~~N~l~~~~~~~~-------~~~~l~~~~l~~N~~~c~~ 285 (499)
..+++|+.|++++|++++..+... ..+.+..+++.+||+.+..
T Consensus 260 ~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~ 309 (330)
T 1xku_A 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309 (330)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred ccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccc
Confidence 999999999999999997654432 2356778899999987643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.89 Aligned_cols=142 Identities=27% Similarity=0.348 Sum_probs=104.7
Q ss_pred ccCCCCCcEEEcCCCcCCCCCc-ccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCC-CCCCccccCCCC
Q 010856 146 FWNLKDILNLNFSSNFLTSPLP-LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ-GSIPDSFGDLIS 223 (499)
Q Consensus 146 ~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~ 223 (499)
+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.+..+..+.++++|++|++++|.++ +..|..+..+++
T Consensus 392 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~ 471 (570)
T 2z63_A 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471 (570)
T ss_dssp EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccC
Confidence 3344555555555555554433 35666777777777777777777777777888888888888876 456777888888
Q ss_pred CCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcCCCCCCC
Q 010856 224 LKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 224 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~~c~~~~ 287 (499)
|+.|++++|++++..|..+..+++|+.|++++|++++..|.. ..++.++.+++.+|++.|.|+.
T Consensus 472 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 888888888888777888888888888888888888776653 4567788888888888888764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=290.05 Aligned_cols=139 Identities=22% Similarity=0.246 Sum_probs=80.0
Q ss_pred cCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccC--cccccCCcCCceeeCcCCcCCC-CCCccccCCCC
Q 010856 147 WNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI--PTEIGGLKNLEYLFLGYNRLQG-SIPDSFGDLIS 223 (499)
Q Consensus 147 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~ 223 (499)
..+++|++|++++|.+++..|..+..+++|+.|++++|++++.. |..+..+++|++|++++|++++ ..+..+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 45567777777777777666666777777777777777776532 3456666777777777777665 33333555555
Q ss_pred CCEEeCCCCcCCccC---------------------cccccCCCCCCEEEccCCcCcccCCC-CCCCCCccccccCCCcC
Q 010856 224 LKFLNLSNNNLSGAI---------------------PASLEKLSYLENLNLSFNKLEGEIPR-GGSFGNFSAESFEGNEL 281 (499)
Q Consensus 224 L~~L~l~~N~l~~~~---------------------~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~~~l~~N~~ 281 (499)
|+.|++++|++++.. |..+..+++|+.|++++|++++..+. ...++.++.+++++|||
T Consensus 430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~ 509 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCB
T ss_pred CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCc
Confidence 555555555444333 33333555555555555555533332 23445555555666665
Q ss_pred CCCC
Q 010856 282 LCGS 285 (499)
Q Consensus 282 ~c~~ 285 (499)
.|+|
T Consensus 510 ~c~c 513 (562)
T 3a79_B 510 DCTC 513 (562)
T ss_dssp CCCH
T ss_pred CCCc
Confidence 5554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=268.64 Aligned_cols=266 Identities=24% Similarity=0.269 Sum_probs=231.7
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEe
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLG 85 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 85 (499)
+++.++++++.++.++.. + +++|++|++++|.+++..+.+|.++++|++|++++|.+++..|..|.++++|++|+
T Consensus 34 ~l~~l~~~~~~l~~ip~~--~---~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKE--I---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp ETTEEECCSSCCSSCCSC--C---CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred cCCEEECCCCCccccCCC--C---CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 699999999999855432 2 34899999999999988888999999999999999999988899999999999999
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC---CCccccCCCCCcEEEcCCCcC
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS---VPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~~~~~~~l~~L~~L~l~~n~l 162 (499)
+++|.++. +|..+. ++|++|++++|+++...+..|..+++|+.|++++|.++. .+..+..+ +|++|++++|.+
T Consensus 109 L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 109 ISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred CCCCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 99999984 444443 899999999999998888889999999999999999974 45566666 999999999999
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
+++ |..+. ++|+.|++++|.+++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|+++ .+|..+
T Consensus 185 ~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l 260 (332)
T 2ft3_A 185 TGI-PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260 (332)
T ss_dssp SSC-CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred Ccc-Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence 874 43333 78999999999999988889999999999999999999888889999999999999999999 677789
Q ss_pred cCCCCCCEEEccCCcCcccCCCCC-------CCCCccccccCCCcCCCC
Q 010856 243 EKLSYLENLNLSFNKLEGEIPRGG-------SFGNFSAESFEGNELLCG 284 (499)
Q Consensus 243 ~~l~~L~~L~l~~N~l~~~~~~~~-------~~~~l~~~~l~~N~~~c~ 284 (499)
..+++|+.|++++|++++..+... ..+.+..+++.+||+.+.
T Consensus 261 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp GGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred hcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 999999999999999997654431 145678899999998753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=287.10 Aligned_cols=132 Identities=23% Similarity=0.235 Sum_probs=80.4
Q ss_pred cCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccc--cCcccccCCcCCceeeCcCCcCCCCCC-ccccCCCC
Q 010856 147 WNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSG--VIPTEIGGLKNLEYLFLGYNRLQGSIP-DSFGDLIS 223 (499)
Q Consensus 147 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~ 223 (499)
..+++|++|++++|.+++..|..+..+++|+.|++++|++++ ..|..+..+++|++|++++|.+++..| ..+..+++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 456778888888888877777777778888888888888775 334567777777777777777776333 33556666
Q ss_pred CCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCc
Q 010856 224 LKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNE 280 (499)
Q Consensus 224 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~ 280 (499)
|+.|++++|++++..+..+. ++|+.|++++|+++...+....++.++.+++++|.
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~ 455 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred CCEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCc
Confidence 66666666665544443332 34555555555554222222234444444444444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-32 Score=264.55 Aligned_cols=267 Identities=20% Similarity=0.247 Sum_probs=221.7
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|+.|+|++|++++..+. .+..++ +|++|++++|.++++.|.+|..+++|++|++++|.++.. |..+. ++|++|
T Consensus 52 ~~l~~L~L~~n~i~~~~~~-~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l-~~~~~--~~L~~L 126 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDG-DFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL-PEKMP--KTLQEL 126 (330)
T ss_dssp TTCCEEECCSSCCCCBCTT-TTTTCT-TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBC-CSSCC--TTCCEE
T ss_pred CCCeEEECCCCcCCEeChh-hhccCC-CCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCcc-Chhhc--ccccEE
Confidence 5789999999999987765 678888 899999999999988888999999999999999999844 44333 789999
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCC--cCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcC
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG--SLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l 162 (499)
++++|.+++..+..|..+++|++|++++|.+.. ..+..+..+++|+.|++++|+++.+|..+. ++|++|++++|.+
T Consensus 127 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l 204 (330)
T 1xku_A 127 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKI 204 (330)
T ss_dssp ECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCC
T ss_pred ECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcC
Confidence 999999988777788999999999999999864 667788889999999999999998887654 8899999999999
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
++..+..+..+++|+.|++++|.+++..+..+..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..|
T Consensus 205 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence 9888888999999999999999999888888899999999999999998 667788899999999999999998777777
Q ss_pred cC------CCCCCEEEccCCcCccc--CCC-CCCCCCccccccCCC
Q 010856 243 EK------LSYLENLNLSFNKLEGE--IPR-GGSFGNFSAESFEGN 279 (499)
Q Consensus 243 ~~------l~~L~~L~l~~N~l~~~--~~~-~~~~~~l~~~~l~~N 279 (499)
.. .+.++.+++++|++... .|. ......++.+++++|
T Consensus 284 ~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred CCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 54 37888999999998742 222 123455667777766
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=299.09 Aligned_cols=276 Identities=24% Similarity=0.362 Sum_probs=224.9
Q ss_pred CCCCCCCCEEECcCCCCCcc-----------------CChhccc--cccccccEEEcccCCCcccCCccccCCCCCCEEe
Q 010856 1 MSNCKSLTLIYLSNNPLDGI-----------------LPKTSVG--NLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~~-----------------~~~~~~~--~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 61 (499)
|+++++|++|+|++|.+++. .|. .+. +++ +|++|++++|.+.+.+|..|.++++|++|+
T Consensus 202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 279 (636)
T 4eco_A 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLK-DLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279 (636)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCT-TCCEEEEECCTTCSSCCTTTTTCSSCCEEE
T ss_pred HhcccCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccC-CCCEEEecCCcCCccChHHHhcCCCCCEEE
Confidence 35788999999999999984 565 666 888 899999999999999999999999999999
Q ss_pred ccCCc-CCc-cCCccccCC------CCCCeEecccccccccCCc--cccCcccccEEeeecCCCCCcCCccccCCccCCe
Q 010856 62 LGGNK-LNG-SIPITLSKL------QKLQGLGLEDNKLEGSIPD--DICHLAELYRLDLDGNKLSGSLPACFSNLTSLRI 131 (499)
Q Consensus 62 L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 131 (499)
+++|+ +++ ..|..+..+ ++|++|++++|+++ .+|. .+..+++|++|++++|++++.+| .+..+++|+.
T Consensus 280 Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~ 357 (636)
T 4eco_A 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLAS 357 (636)
T ss_dssp CTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESE
T ss_pred CcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCE
Confidence 99998 887 677777665 89999999999998 6777 88999999999999999997777 8888889999
Q ss_pred eeccccCCCCCCccccCCCC-CcEEEcCCCcCCCCCcccccCCC--CccEEEccCCcccccCccccc-------CCcCCc
Q 010856 132 VSLGSNKLTSVPLTFWNLKD-ILNLNFSSNFLTSPLPLEIGNLK--VLIGIDFSMNNFSGVIPTEIG-------GLKNLE 201 (499)
Q Consensus 132 L~L~~n~l~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~l~-------~l~~L~ 201 (499)
|++++|+++.+|..+..+++ |++|++++|.++ .+|..+..++ +|+.|++++|.+++..|..+. .+++|+
T Consensus 358 L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~ 436 (636)
T 4eco_A 358 LNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436 (636)
T ss_dssp EECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEE
T ss_pred EECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCC
Confidence 99999988888888888888 999999999888 4666666654 788888888888888887777 777888
Q ss_pred eeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCC-------CCCEEEccCCcCcccCCCC-C--CCCCc
Q 010856 202 YLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS-------YLENLNLSFNKLEGEIPRG-G--SFGNF 271 (499)
Q Consensus 202 ~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~-------~L~~L~l~~N~l~~~~~~~-~--~~~~l 271 (499)
+|++++|.+++..+..+..+++|+.|++++|+++...+..+.... +|+.|++++|+++. +|.. . .++.+
T Consensus 437 ~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~l~~L 515 (636)
T 4eco_A 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYL 515 (636)
T ss_dssp EEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCB-CCGGGSTTTCTTC
T ss_pred EEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCc-cChhhhhccCCCc
Confidence 888888888866555667788888888888888855444444333 78888888888884 4433 3 56778
Q ss_pred cccccCCCcCC
Q 010856 272 SAESFEGNELL 282 (499)
Q Consensus 272 ~~~~l~~N~~~ 282 (499)
+.+++++|...
T Consensus 516 ~~L~Ls~N~l~ 526 (636)
T 4eco_A 516 VGIDLSYNSFS 526 (636)
T ss_dssp CEEECCSSCCS
T ss_pred CEEECCCCCCC
Confidence 88888888743
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=287.78 Aligned_cols=278 Identities=18% Similarity=0.181 Sum_probs=190.2
Q ss_pred CCCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCC
Q 010856 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQK 80 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 80 (499)
|+++++|++|+|++|.++++.|. .+..++ +|++|++++|.+++..|.+|.++++|++|++++|.+++..+..|.++++
T Consensus 53 ~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~ 130 (606)
T 3t6q_A 53 FSRLINLTFLDLTRCQIYWIHED-TFQSQH-RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130 (606)
T ss_dssp STTCTTCSEEECTTCCCCEECTT-TTTTCT-TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTT
T ss_pred hccCccceEEECCCCccceeChh-hccCcc-ccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCc
Confidence 46788888888888888887776 777777 8888888888888888888888888888888888888766777788888
Q ss_pred CCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCC--eeeccccCC-------------------
Q 010856 81 LQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLR--IVSLGSNKL------------------- 139 (499)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~n~l------------------- 139 (499)
|++|++++|.+++.....+..+++|++|++++|.+++..+..|..+++|+ .|++++|++
T Consensus 131 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~ 210 (606)
T 3t6q_A 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFG 210 (606)
T ss_dssp CCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECT
T ss_pred ccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccC
Confidence 88888888887765444445577777777777776655555454444444 444444433
Q ss_pred --------------------------------------------------------CCCCc-cccCCCCCcEEEcCCCcC
Q 010856 140 --------------------------------------------------------TSVPL-TFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 140 --------------------------------------------------------~~~~~-~~~~l~~L~~L~l~~n~l 162 (499)
+.++. .+..+++|++|++++|.+
T Consensus 211 ~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 290 (606)
T 3t6q_A 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290 (606)
T ss_dssp TCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCC
T ss_pred CchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCcc
Confidence 33222 255567777777777777
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCC-CccccCCCCCCEEeCCCCcCCccC--c
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI-PDSFGDLISLKFLNLSNNNLSGAI--P 239 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~l~~N~l~~~~--~ 239 (499)
+. +|..+..+++|++|++++|.+++..|..+..+++|++|++++|.+.+.. +..+..+++|+.|++++|++++.. +
T Consensus 291 ~~-lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 369 (606)
T 3t6q_A 291 SE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369 (606)
T ss_dssp SC-CCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEEST
T ss_pred CC-CChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcc
Confidence 63 5556677777777777777777666666777777777777777666433 334666677777777777666544 5
Q ss_pred ccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcC
Q 010856 240 ASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNEL 281 (499)
Q Consensus 240 ~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~ 281 (499)
..+..+++|+.|++++|++++..|.. ...+.++.+++.+|..
T Consensus 370 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 412 (606)
T 3t6q_A 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412 (606)
T ss_dssp TTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCE
T ss_pred hhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcC
Confidence 56666666777777766666555443 3355666666666654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=292.55 Aligned_cols=273 Identities=24% Similarity=0.273 Sum_probs=230.8
Q ss_pred CCCCCCEEECcCCCCCccCChhccccccccccEEEcccCC-Ccc-cCCccccCC------CCCCEEeccCCcCCccCCc-
Q 010856 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCN-ISG-GIPEEISNL------TNSTIVNLGGNKLNGSIPI- 73 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~-i~~-~~~~~~~~l------~~L~~L~L~~n~l~~~~~~- 73 (499)
++++|++|+|++|.+.+..|. .+.+++ +|++|++++|+ +++ .+|..+..+ ++|++|++++|+++ .+|.
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~-~l~~l~-~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~ 323 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPT-FLKALP-EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVE 323 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCT-TTTTCS-SCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCH
T ss_pred ccCCCCEEEecCCcCCccChH-HHhcCC-CCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCch
Confidence 799999999999999999887 888898 89999999998 988 788888776 99999999999999 6777
Q ss_pred -cccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCcc-CCeeeccccCCCCCCccccCCC-
Q 010856 74 -TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTS-LRIVSLGSNKLTSVPLTFWNLK- 150 (499)
Q Consensus 74 -~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~l~- 150 (499)
.+.++++|++|++++|.+++.+| .+..+++|++|++++|+++ .+|..+..+++ |+.|++++|+++.+|..+..++
T Consensus 324 ~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l 401 (636)
T 4eco_A 324 TSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSV 401 (636)
T ss_dssp HHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCS
T ss_pred hhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchhhhhccc
Confidence 89999999999999999997888 8999999999999999999 67778999999 9999999999999998777654
Q ss_pred -CCcEEEcCCCcCCCCCccccc-------CCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCC
Q 010856 151 -DILNLNFSSNFLTSPLPLEIG-------NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLI 222 (499)
Q Consensus 151 -~L~~L~l~~n~l~~~~~~~~~-------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 222 (499)
+|++|++++|.+++..|..+. .+++|+.|++++|+++...+..+..+++|++|++++|+++.+.+..+....
T Consensus 402 ~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~ 481 (636)
T 4eco_A 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481 (636)
T ss_dssp SCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETT
T ss_pred CccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccc
Confidence 899999999999988888887 778899999999999866555667788899999999988855444444433
Q ss_pred -------CCCEEeCCCCcCCccCccccc--CCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcC
Q 010856 223 -------SLKFLNLSNNNLSGAIPASLE--KLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281 (499)
Q Consensus 223 -------~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~ 281 (499)
+|+.|++++|+++ .+|..+. .+++|+.|++++|++++.......++.++.+++++|+.
T Consensus 482 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ 548 (636)
T 4eco_A 482 ENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRD 548 (636)
T ss_dssp EECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBC
T ss_pred ccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcc
Confidence 8888999998888 5666665 88888999999998887333345677888888876653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-32 Score=262.63 Aligned_cols=267 Identities=21% Similarity=0.254 Sum_probs=201.9
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|++|++++|.+++..+. .+..++ +|++|++++|.+++..|.+|.++++|++|++++|.++.. |..+. ++|++|
T Consensus 54 ~~l~~L~l~~n~i~~~~~~-~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l-~~~~~--~~L~~L 128 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKD-DFKGLQ-HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEI-PPNLP--SSLVEL 128 (332)
T ss_dssp TTCCEEECCSSCCCEECTT-TTTTCT-TCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSC-CSSCC--TTCCEE
T ss_pred CCCeEEECCCCcCCccCHh-HhhCCC-CCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCcc-Ccccc--ccCCEE
Confidence 5688888888888877665 677777 788888888888877788888888888888888888744 33333 678888
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCC--cCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcC
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG--SLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l 162 (499)
++++|.++...+..|..+++|++|++++|.++. ..+..+..+ +|+.|++++|+++.+|..+. ++|++|++++|.+
T Consensus 129 ~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i 205 (332)
T 2ft3_A 129 RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKI 205 (332)
T ss_dssp ECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCC
T ss_pred ECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcccc--CCCCEEECCCCcC
Confidence 888888887766678888888888888888853 566677777 88888888888888776554 6788888888888
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
++..+..+..+++|+.|++++|++++..+..+..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..|
T Consensus 206 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~ 284 (332)
T 2ft3_A 206 QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284 (332)
T ss_dssp CCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSS
T ss_pred CccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHc
Confidence 8777778888888888888888888777777888888888888888888 566678888888888888888887776666
Q ss_pred cC------CCCCCEEEccCCcCc--ccCCCC-CCCCCccccccCCCc
Q 010856 243 EK------LSYLENLNLSFNKLE--GEIPRG-GSFGNFSAESFEGNE 280 (499)
Q Consensus 243 ~~------l~~L~~L~l~~N~l~--~~~~~~-~~~~~l~~~~l~~N~ 280 (499)
.. .++|+.|++++|++. +..|.. ...+.++.+++++|.
T Consensus 285 ~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 54 356788888888886 333322 335566666766653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=273.38 Aligned_cols=246 Identities=22% Similarity=0.171 Sum_probs=177.9
Q ss_pred ccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEE
Q 010856 29 LSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108 (499)
Q Consensus 29 l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 108 (499)
++ +++.|++++|.++.+.+..|..+++|++|++++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|++|
T Consensus 44 l~-~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 44 LN-NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GC-CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cC-CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 45 89999999999998877778999999999999999998888899999999999999999998888889999999999
Q ss_pred eeecCCCCCcCCccccCCccCCeeeccccCCCCCC-ccccCCCCCcEEEcCCCcCCCCCcccccCC--------------
Q 010856 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNL-------------- 173 (499)
Q Consensus 109 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-------------- 173 (499)
++++|+++...+..|..+++|++|++++|+++.++ ..+..+++|++|++++|.+++.....+.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~ 202 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 202 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEE
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccC
Confidence 99999999777777899999999999999999864 468899999999999999987543333222
Q ss_pred --CCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEE
Q 010856 174 --KVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 251 (499)
Q Consensus 174 --~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 251 (499)
+.|+.|++++|.++... . ...++|+.|++++|.+++. ..+..+++|+.|++++|.+++..|..|..+++|+.|
T Consensus 203 ~~~~L~~L~l~~n~l~~~~-~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 277 (390)
T 3o6n_A 203 IPIAVEELDASHNSINVVR-G--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277 (390)
T ss_dssp CCSSCSEEECCSSCCCEEE-C--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred CCCcceEEECCCCeeeecc-c--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEE
Confidence 22333333333333221 1 1123555555555555532 345555555555555555555555555555555555
Q ss_pred EccCCcCcccCCCCCCCCCccccccCCCc
Q 010856 252 NLSFNKLEGEIPRGGSFGNFSAESFEGNE 280 (499)
Q Consensus 252 ~l~~N~l~~~~~~~~~~~~l~~~~l~~N~ 280 (499)
++++|++++..+....++.++.+++++|.
T Consensus 278 ~L~~n~l~~~~~~~~~l~~L~~L~L~~n~ 306 (390)
T 3o6n_A 278 YISNNRLVALNLYGQPIPTLKVLDLSHNH 306 (390)
T ss_dssp ECCSSCCCEEECSSSCCTTCCEEECCSSC
T ss_pred ECCCCcCcccCcccCCCCCCCEEECCCCc
Confidence 55555555443333344555555555554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=269.72 Aligned_cols=278 Identities=20% Similarity=0.189 Sum_probs=238.2
Q ss_pred CCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCe
Q 010856 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQG 83 (499)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 83 (499)
|+.....+++++.++.++.. ++++|++|++++|+++++.+..|.++++|++|++++|.+++..+..|.++++|++
T Consensus 30 C~~~~~c~~~~~~l~~iP~~-----~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 30 CDRNGICKGSSGSLNSIPSG-----LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp ECTTSEEECCSTTCSSCCTT-----CCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCeEeeCCCCCccccccc-----ccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 45666789999999966442 2348999999999999888889999999999999999999888889999999999
Q ss_pred EecccccccccCCccccCcccccEEeeecCCCCCcCC-ccccCCccCCeeecccc-CCCCC-CccccCCCCCcEEEcCCC
Q 010856 84 LGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP-ACFSNLTSLRIVSLGSN-KLTSV-PLTFWNLKDILNLNFSSN 160 (499)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~l~~L~~L~l~~n 160 (499)
|++++|++++..+..|.++++|++|++++|+++...+ ..+..+++|++|++++| .++.+ +..+..+++|++|++++|
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 9999999997666669999999999999999997655 58899999999999999 57775 457889999999999999
Q ss_pred cCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCcccc---CCCCCCEEeCCCCcCCc-
Q 010856 161 FLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFG---DLISLKFLNLSNNNLSG- 236 (499)
Q Consensus 161 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~---~l~~L~~L~l~~N~l~~- 236 (499)
.+++..+..+..+++|+.|++++|.++...+..+..+++|++|++++|.+++..+..+. ..+.++.++++++.+++
T Consensus 185 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp TCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred CcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 99998899999999999999999999866555566789999999999999976655443 46778999999998875
Q ss_pred ---cCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcCCCCCC
Q 010856 237 ---AIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP 286 (499)
Q Consensus 237 ---~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~~c~~~ 286 (499)
..|..+..+++|+.|++++|+++...+.. ..+++++.+++.+|++.|+|+
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred chhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 35677889999999999999999544443 568899999999999999875
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=283.04 Aligned_cols=120 Identities=19% Similarity=0.263 Sum_probs=72.2
Q ss_pred CCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCcc-CCccccCCCC
Q 010856 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGS-IPITLSKLQK 80 (499)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~ 80 (499)
+++++|++|+|++|++++..+. .+..++ +|++|++++|.+++..+..|.++++|++|++++|.+++. .|..+.++++
T Consensus 47 ~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~ 124 (549)
T 2z81_A 47 RACANLQVLILKSSRINTIEGD-AFYSLG-SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124 (549)
T ss_dssp SSCTTCCEEECTTSCCCEECTT-TTTTCT-TCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTT
T ss_pred hcCCcccEEECCCCCcCccChh-hccccc-cCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCC
Confidence 4566666666666666665554 555565 666666666666666555566666666666666666642 3445666666
Q ss_pred CCeEeccccc-ccccCCccccCcccccEEeeecCCCCCcCCccc
Q 010856 81 LQGLGLEDNK-LEGSIPDDICHLAELYRLDLDGNKLSGSLPACF 123 (499)
Q Consensus 81 L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 123 (499)
|++|++++|. +....+..|.++++|++|++++|.+++..|..+
T Consensus 125 L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 168 (549)
T 2z81_A 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168 (549)
T ss_dssp CCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTT
T ss_pred ccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhh
Confidence 6666666665 333333455666666666666666655444444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-31 Score=270.39 Aligned_cols=249 Identities=23% Similarity=0.272 Sum_probs=177.4
Q ss_pred CCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEec
Q 010856 7 LTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGL 86 (499)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 86 (499)
...++.+++.++.++.. +++++++|+|++|+++++.+..|.++++|++|+|++|.++++.+..|.++++|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~-----~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQG-----IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SCEEECCSSCCSSCCSC-----CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CcEEEECCCCcCccCCC-----CCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 45677777777644321 2347777777777777777777777777777777777777777777777777777777
Q ss_pred ccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccc-cCCCCCCc-cccCCCCCcEEEcCCCcCCC
Q 010856 87 EDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGS-NKLTSVPL-TFWNLKDILNLNFSSNFLTS 164 (499)
Q Consensus 87 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~-~~~~l~~L~~L~l~~n~l~~ 164 (499)
++|+++...+..|..+++|++|+|++|+++...+..|..+++|+.|++++ |.+..++. .+..+++|++|++++|.+++
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 77777766666677777777777777777766666777777777777777 34444544 46667777777777777765
Q ss_pred CCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccC
Q 010856 165 PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEK 244 (499)
Q Consensus 165 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 244 (499)
. | .+..+++|+.|++++|.+++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|++++..+..|..
T Consensus 211 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 211 M-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp C-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred c-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 4 2 4666777777777777777777777777777777777777777766777777777777777777777666666777
Q ss_pred CCCCCEEEccCCcCcccC
Q 010856 245 LSYLENLNLSFNKLEGEI 262 (499)
Q Consensus 245 l~~L~~L~l~~N~l~~~~ 262 (499)
+++|+.|++++|++.+..
T Consensus 289 l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 289 LRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp CTTCCEEECCSSCEECST
T ss_pred ccCCCEEEccCCCcCCCC
Confidence 777777777777766543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-31 Score=268.44 Aligned_cols=246 Identities=24% Similarity=0.264 Sum_probs=130.9
Q ss_pred CEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecc
Q 010856 8 TLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLE 87 (499)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 87 (499)
+.++.+++.++.++.. ++.+++.|+|++|+++.+.+..|.++++|++|+|++|.++.+.+..|.++++|++|+|+
T Consensus 46 ~~v~c~~~~l~~iP~~-----~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 46 SKVICVRKNLREVPDG-----ISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp CEEECCSCCCSSCCSC-----CCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CEEEeCCCCcCcCCCC-----CCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4455555555533221 12355555555555555555555555555555555555555555555555555555555
Q ss_pred cccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecccc-CCCCCCc-cccCCCCCcEEEcCCCcCCCC
Q 010856 88 DNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSN-KLTSVPL-TFWNLKDILNLNFSSNFLTSP 165 (499)
Q Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~-~~~~l~~L~~L~l~~n~l~~~ 165 (499)
+|+++...+..|..+++|++|+|++|+++...+..|..+++|+.|++++| .+..++. .+..+++|++|++++|.++.+
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 200 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence 55555444445555555555555555555555555555555555555552 3333332 344555555555555555532
Q ss_pred CcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCC
Q 010856 166 LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKL 245 (499)
Q Consensus 166 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 245 (499)
| .+..+++|+.|++++|++++..+..|.++++|++|++++|++++..+..|..+++|+.|+|++|++++..+..|..+
T Consensus 201 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 201 -P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp -C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred -c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 2 34455555555555555555555555555555555555555555555555555555555555555555554555555
Q ss_pred CCCCEEEccCCcCcc
Q 010856 246 SYLENLNLSFNKLEG 260 (499)
Q Consensus 246 ~~L~~L~l~~N~l~~ 260 (499)
++|+.|+|++|++.+
T Consensus 279 ~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 279 HHLERIHLHHNPWNC 293 (440)
T ss_dssp TTCCEEECCSSCEEC
T ss_pred cCCCEEEcCCCCccC
Confidence 555555555555543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=263.47 Aligned_cols=250 Identities=20% Similarity=0.185 Sum_probs=198.2
Q ss_pred CEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccC--CccccCCCCCCeEe
Q 010856 8 TLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSI--PITLSKLQKLQGLG 85 (499)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~ 85 (499)
+.++++++.++.++.. ++++|++|++++|+++.+.+..|.++++|++|+|++|.++... +..+..+++|++|+
T Consensus 10 ~~l~c~~~~l~~ip~~-----~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTG-----IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp TEEECCSSCCSSCCSC-----CCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred CEEEcCCCCcccCCCC-----CCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 5788888888755432 2347889999999888766667888889999999998887432 45666788888899
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCC-ccccCCccCCeeeccccCCCC-CCccccCCCCCcEEEcCCCcCC
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP-ACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~ 163 (499)
+++|.++. ++..+..+++|++|++++|++++..+ ..+..+++|++|++++|.++. .+..+..+++|++|++++|.++
T Consensus 85 Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 85 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp CCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 98888874 55668888888888888888886655 577888888888888888876 4556777888888888888887
Q ss_pred C-CCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 164 S-PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 164 ~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
+ ..|..+..+++|+.|++++|.+++..|..+..+++|++|++++|++++..+..+..+++|+.|++++|++++..+..+
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 5 467778888888888888888887777888888888888888888887777778888888888888888888888888
Q ss_pred cCCC-CCCEEEccCCcCcccCC
Q 010856 243 EKLS-YLENLNLSFNKLEGEIP 263 (499)
Q Consensus 243 ~~l~-~L~~L~l~~N~l~~~~~ 263 (499)
..++ +|+.|++++|++++..+
T Consensus 244 ~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CCCCTTCCEEECTTCCEECSGG
T ss_pred HhhhccCCEEEccCCCeecccC
Confidence 8774 88888888888876543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-31 Score=259.23 Aligned_cols=260 Identities=25% Similarity=0.377 Sum_probs=165.5
Q ss_pred CCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCC
Q 010856 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKL 81 (499)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 81 (499)
..+++|++|++++|.+++..+ +..++ +|++|++++|.+++. ++|..+++|++|++++|.+++..+ +..+++|
T Consensus 63 ~~~~~L~~L~l~~n~i~~~~~---~~~l~-~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L 134 (347)
T 4fmz_A 63 EYLTNLEYLNLNGNQITDISP---LSNLV-KLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKM 134 (347)
T ss_dssp GGCTTCCEEECCSSCCCCCGG---GTTCT-TCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTC
T ss_pred hhcCCccEEEccCCccccchh---hhcCC-cCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCchh--hccCCce
Confidence 467889999999998886533 66677 899999999888854 368888899999999888885433 7788888
Q ss_pred CeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCc
Q 010856 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNF 161 (499)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~ 161 (499)
++|++++|...... ..+..+++|++|++++|.+.+..+ +..+++|+.|++++|.++.++. +..+++|+.|++++|.
T Consensus 135 ~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~ 210 (347)
T 4fmz_A 135 YSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQ 210 (347)
T ss_dssp CEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSC
T ss_pred eEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc-ccCCCccceeecccCC
Confidence 88888888554333 347777777888887777775433 6667777777777777776654 5555666666666666
Q ss_pred CCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCccc
Q 010856 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241 (499)
Q Consensus 162 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~ 241 (499)
+++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|++++. ..
T Consensus 211 l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~ 282 (347)
T 4fmz_A 211 ITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SV 282 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GG
T ss_pred CCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hh
Confidence 554332 4555556666666665554332 55555555555555555532 3455555555555555555543 23
Q ss_pred ccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcC
Q 010856 242 LEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNEL 281 (499)
Q Consensus 242 ~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~ 281 (499)
+..+++|+.|++++|++++..+.. ..+++++.+++++|++
T Consensus 283 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 323 (347)
T 4fmz_A 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323 (347)
T ss_dssp GGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSC
T ss_pred hcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcc
Confidence 455555555555555555443321 2344555555555553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-31 Score=268.26 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=227.4
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
....++.+++.++ .+|..+. ++++.|+|++|+++.+.+..|.++++|++|+|++|.++...+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 5678999999998 4555554 689999999999999888999999999999999999998888999999999999999
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCCCCCcEEEcCC-CcCCCCCcccccCCCCccEEEccCCccccc
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSS-NFLTSPLPLEIGNLKVLIGIDFSMNNFSGV 189 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (499)
+|+++...+..|..+++|++|++++|+++.++. .+..+++|++|++++ |.+..+.+..|.++++|+.|++++|.++..
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 200 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence 999998888899999999999999999999765 688899999999999 456666667899999999999999999855
Q ss_pred CcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCC
Q 010856 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSF 268 (499)
Q Consensus 190 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~ 268 (499)
| .+..+++|++|+|++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+.. ..+
T Consensus 201 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 201 -P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp -C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred -c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 3 5889999999999999999999999999999999999999999999999999999999999999999766654 457
Q ss_pred CCccccccCCCcCCCCCCC
Q 010856 269 GNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 269 ~~l~~~~l~~N~~~c~~~~ 287 (499)
+.++.+++.+|||.|+|..
T Consensus 279 ~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 279 HHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TTCCEEECCSSCEECSSTT
T ss_pred cCCCEEEcCCCCccCCCCc
Confidence 8899999999999999854
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-31 Score=290.16 Aligned_cols=274 Identities=20% Similarity=0.222 Sum_probs=152.4
Q ss_pred CCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCcc--ccCCC
Q 010856 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPIT--LSKLQ 79 (499)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~ 79 (499)
+++++|++|+|++|...+..+...+.+++ +|++|+|++|.+++..|++|.++++|++|+|++|.+++..+.. |.+++
T Consensus 45 ~~l~~L~~LdLs~n~~~~~i~~~~f~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~ 123 (844)
T 3j0a_A 45 PFLEQLQLLELGSQYTPLTIDKEAFRNLP-NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123 (844)
T ss_dssp SSCCSCSEEEECTTCCCCEECTTTTSSCT-TCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCS
T ss_pred cccccCeEEeCCCCCCccccCHHHhcCCC-CCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccC
Confidence 34445555555554332222112444454 5555555555555555555555555555555555555433322 55555
Q ss_pred CCCeEecccccccccCC-ccccCcccccEEeeecCCCCCcCCccccCC--cc----------------------------
Q 010856 80 KLQGLGLEDNKLEGSIP-DDICHLAELYRLDLDGNKLSGSLPACFSNL--TS---------------------------- 128 (499)
Q Consensus 80 ~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~---------------------------- 128 (499)
+|++|+|++|.+++..+ ..|.++++|++|++++|.+++..+..+..+ ++
T Consensus 124 ~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~ 203 (844)
T 3j0a_A 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203 (844)
T ss_dssp SCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTT
T ss_pred CCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCcccc
Confidence 55555555555544332 345555555555555555544443333322 22
Q ss_pred --CCeeeccccCCCC-CCccc------------------------------------cC--CCCCcEEEcCCCcCCCCCc
Q 010856 129 --LRIVSLGSNKLTS-VPLTF------------------------------------WN--LKDILNLNFSSNFLTSPLP 167 (499)
Q Consensus 129 --L~~L~L~~n~l~~-~~~~~------------------------------------~~--l~~L~~L~l~~n~l~~~~~ 167 (499)
|+.|++++|.++. .+..+ .. .++|+.|++++|.+.+..+
T Consensus 204 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~ 283 (844)
T 3j0a_A 204 MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283 (844)
T ss_dssp CCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECS
T ss_pred CceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccCh
Confidence 3333333332221 11000 00 1456666666666666666
Q ss_pred ccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCC
Q 010856 168 LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 247 (499)
Q Consensus 168 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 247 (499)
..|..+++|+.|++++|++++..+..|.++++|++|++++|.+++..+..|..+++|+.|++++|++....+..|..+++
T Consensus 284 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 363 (844)
T 3j0a_A 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363 (844)
T ss_dssp CCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCC
T ss_pred hhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCC
Confidence 66777777777777777777776777777777777777777777666777777777777777777777666667777777
Q ss_pred CCEEEccCCcCcccCCCCCCCCCccccccCCCc
Q 010856 248 LENLNLSFNKLEGEIPRGGSFGNFSAESFEGNE 280 (499)
Q Consensus 248 L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~ 280 (499)
|+.|++++|.+++... ++.+..+.+.+|.
T Consensus 364 L~~L~Ls~N~l~~i~~----~~~L~~L~l~~N~ 392 (844)
T 3j0a_A 364 LQTLDLRDNALTTIHF----IPSIPDIFLSGNK 392 (844)
T ss_dssp CCEEEEETCCSCCCSS----CCSCSEEEEESCC
T ss_pred CCEEECCCCCCCcccC----CCCcchhccCCCC
Confidence 7777777777764321 3344444444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-31 Score=268.94 Aligned_cols=251 Identities=24% Similarity=0.240 Sum_probs=227.6
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
....++.+++.++. +|..+. ++|++|+|++|+++++.+..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 46789999999984 555554 689999999999999989999999999999999999998888999999999999999
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCCCCCcEEEcCC-CcCCCCCcccccCCCCccEEEccCCccccc
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSS-NFLTSPLPLEIGNLKVLIGIDFSMNNFSGV 189 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (499)
+|+++...+..|..+++|++|++++|+++.++. .+..+++|++|++++ |.+..+.+..|.++++|+.|++++|++++.
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 999998888889999999999999999999765 688999999999999 566666667899999999999999999865
Q ss_pred CcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCC
Q 010856 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSF 268 (499)
Q Consensus 190 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~ 268 (499)
..+..+++|++|+|++|.+++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+.. ..+
T Consensus 212 --~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 --PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp --CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred --ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 35889999999999999999999999999999999999999999999999999999999999999999766654 457
Q ss_pred CCccccccCCCcCCCCCCC
Q 010856 269 GNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 269 ~~l~~~~l~~N~~~c~~~~ 287 (499)
+++..+++.+|||.|+|..
T Consensus 290 ~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTCCEEECCSSCEECSTTT
T ss_pred cCCCEEEccCCCcCCCCCc
Confidence 8899999999999999864
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-31 Score=280.49 Aligned_cols=253 Identities=25% Similarity=0.250 Sum_probs=204.4
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
+++++|+|++|.+++..+. .+.+++ +|++|++++|.+++..|.+|.++++|++|+|++|.++.+.+..|.++++|++|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~-~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 102 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAA-NFTRYS-QLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTEL 102 (680)
T ss_dssp TTCSEEECCSSCCCCCCGG-GGGGGT-TCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEE
T ss_pred CCCcEEECCCCCCCCcCHH-HHhCCC-cCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEE
Confidence 5789999999999977665 788888 89999999999998889999999999999999999997777789999999999
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCcc---ccCCCCCcEEEcCCCc
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT---FWNLKDILNLNFSSNF 161 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~l~~L~~L~l~~n~ 161 (499)
++++|.+++..+..|.++++|++|++++|.+++..+..+..+++|++|++++|.++.++.. ...+++|++|++++|.
T Consensus 103 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~ 182 (680)
T 1ziw_A 103 HLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182 (680)
T ss_dssp ECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCC
T ss_pred ECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCc
Confidence 9999999877778899999999999999999988888888999999999999999886543 3356889999999998
Q ss_pred CCCCCcccccCC---------------------------CCccEEEccCCcccccCcccccCCcC--CceeeCcCCcCCC
Q 010856 162 LTSPLPLEIGNL---------------------------KVLIGIDFSMNNFSGVIPTEIGGLKN--LEYLFLGYNRLQG 212 (499)
Q Consensus 162 l~~~~~~~~~~l---------------------------~~L~~L~l~~n~l~~~~~~~l~~l~~--L~~L~L~~n~l~~ 212 (499)
+++..+..+..+ ++|+.|++++|.+++..+..|.+++. |++|++++|.+++
T Consensus 183 l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~ 262 (680)
T 1ziw_A 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262 (680)
T ss_dssp CCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCE
T ss_pred ccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCc
Confidence 888777655543 45666777777777777777776654 8888888887777
Q ss_pred CCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCc
Q 010856 213 SIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 213 ~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|...
T Consensus 263 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~ 309 (680)
T 1ziw_A 263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309 (680)
T ss_dssp ECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCC
T ss_pred cCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhh
Confidence 77777777778888888888777766666666666666666655443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-31 Score=274.96 Aligned_cols=269 Identities=21% Similarity=0.212 Sum_probs=169.4
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|++|+|++|.+++..+. .+..++ +|++|++++|++++..|.+|.++++|++|+|++|+++. +|.. .+++|++|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~-~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L 95 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTS-DILSLS-KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHL 95 (520)
T ss_dssp TTCSEEECCSSCCCCCCHH-HHTTCT-TCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEE
T ss_pred ccccEEECCCCcccccChh-hccccc-cccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEE
Confidence 4677777777777766554 566666 67777777777777767777777777777777777774 3333 66777777
Q ss_pred eccccccccc-CCccccCcccccEEeeecCCCCCcCCccccCCccC--CeeeccccCC--CC-CCccccCC---------
Q 010856 85 GLEDNKLEGS-IPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSL--RIVSLGSNKL--TS-VPLTFWNL--------- 149 (499)
Q Consensus 85 ~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~-~~~~~~~l--------- 149 (499)
+|++|.+++. .|..|..+++|++|++++|.+++ ..+..+++| +.|++++|.+ .. .|..+..+
T Consensus 96 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l 172 (520)
T 2z7x_B 96 DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172 (520)
T ss_dssp ECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEEC
T ss_pred eccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEe
Confidence 7777777652 45667777777777777666653 122333333 3333333333 11 11111110
Q ss_pred --------------------------------------------------------------------------CCCcEE
Q 010856 150 --------------------------------------------------------------------------KDILNL 155 (499)
Q Consensus 150 --------------------------------------------------------------------------~~L~~L 155 (499)
++|++|
T Consensus 173 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp CSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred ccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 123333
Q ss_pred EcCCCcCCCCCccc-----------------------------------------------------ccCCCCccEEEcc
Q 010856 156 NFSSNFLTSPLPLE-----------------------------------------------------IGNLKVLIGIDFS 182 (499)
Q Consensus 156 ~l~~n~l~~~~~~~-----------------------------------------------------~~~l~~L~~L~l~ 182 (499)
++++|.+++..|.. +..+++|++|+++
T Consensus 253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls 332 (520)
T 2z7x_B 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332 (520)
T ss_dssp EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECC
T ss_pred EeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeE
Confidence 33333322211111 1566778888888
Q ss_pred CCcccccCcccccCCcCCceeeCcCCcCCC--CCCccccCCCCCCEEeCCCCcCCc-cCcccccCCCCCCEEEccCCcCc
Q 010856 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQG--SIPDSFGDLISLKFLNLSNNNLSG-AIPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 183 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
+|++++..|..+..+++|++|++++|++++ ..|..+..+++|+.|++++|++++ ..+..+..+++|+.|++++|+++
T Consensus 333 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~ 412 (520)
T 2z7x_B 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412 (520)
T ss_dssp SSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCC
T ss_pred CCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCC
Confidence 888887777778888888888888888875 334667788888888888888876 33345777788888888888887
Q ss_pred ccCCCCCCCCCccccccCCCcCC
Q 010856 260 GEIPRGGSFGNFSAESFEGNELL 282 (499)
Q Consensus 260 ~~~~~~~~~~~l~~~~l~~N~~~ 282 (499)
+..|.... +.++.+++++|...
T Consensus 413 ~~~~~~l~-~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 413 DTIFRCLP-PRIKVLDLHSNKIK 434 (520)
T ss_dssp GGGGGSCC-TTCCEEECCSSCCC
T ss_pred cchhhhhc-ccCCEEECCCCccc
Confidence 66655422 57777888877654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-31 Score=274.41 Aligned_cols=269 Identities=19% Similarity=0.165 Sum_probs=199.7
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|++|+|++|.+++..+. .+..++ +|++|++++|.++++.|++|.++++|++|+|++|+++.+ |.. .+++|++|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~-~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~--~l~~L~~L 126 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMP-DISFLS-ELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI-SCC--PMASLRHL 126 (562)
T ss_dssp TTCCEEECCSSCCCCCCGG-GTTTCT-TCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEE-CSC--CCTTCSEE
T ss_pred CCcCEEECCCCCccccChh-hhccCC-CccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCcc-Ccc--ccccCCEE
Confidence 5677888888888766655 677777 788888888888777777788888888888888887743 333 67778888
Q ss_pred eccccccccc-CCccccCcccccEEeeecCCCCCcCCccccCCccC--CeeeccccCC--CC-CCccccCC---------
Q 010856 85 GLEDNKLEGS-IPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSL--RIVSLGSNKL--TS-VPLTFWNL--------- 149 (499)
Q Consensus 85 ~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~-~~~~~~~l--------- 149 (499)
++++|++++. .|..|.++++|++|++++|++++. .+..+++| +.|++++|++ +. .|..+..+
T Consensus 127 ~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l 203 (562)
T 3a79_B 127 DLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203 (562)
T ss_dssp ECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEE
T ss_pred ECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEe
Confidence 8888887753 346777788888888888777642 33444444 6677766666 32 22222221
Q ss_pred ------------------------------------------------------------------------CCCcEEEc
Q 010856 150 ------------------------------------------------------------------------KDILNLNF 157 (499)
Q Consensus 150 ------------------------------------------------------------------------~~L~~L~l 157 (499)
++|++|++
T Consensus 204 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l 283 (562)
T 3a79_B 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283 (562)
T ss_dssp CSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEE
T ss_pred cCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEE
Confidence 15666666
Q ss_pred CCCcCCCCCcccc-----------------------------------------------------cCCCCccEEEccCC
Q 010856 158 SSNFLTSPLPLEI-----------------------------------------------------GNLKVLIGIDFSMN 184 (499)
Q Consensus 158 ~~n~l~~~~~~~~-----------------------------------------------------~~l~~L~~L~l~~n 184 (499)
++|.+++.+|..+ ..+++|++|++++|
T Consensus 284 ~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n 363 (562)
T 3a79_B 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363 (562)
T ss_dssp EEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred eccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCC
Confidence 6666665444433 67889999999999
Q ss_pred cccccCcccccCCcCCceeeCcCCcCCCCC--CccccCCCCCCEEeCCCCcCCc-cCcccccCCCCCCEEEccCCcCccc
Q 010856 185 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSI--PDSFGDLISLKFLNLSNNNLSG-AIPASLEKLSYLENLNLSFNKLEGE 261 (499)
Q Consensus 185 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~--~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~ 261 (499)
.+++..|..+..+++|++|++++|++++.. |..+..+++|+.|++++|++++ ..+..+..+++|+.|++++|++++.
T Consensus 364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 443 (562)
T 3a79_B 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443 (562)
T ss_dssp CCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGG
T ss_pred ccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcc
Confidence 999988999999999999999999999743 4678999999999999999998 5555688889999999999999877
Q ss_pred CCCCCCCCCccccccCCCcCC
Q 010856 262 IPRGGSFGNFSAESFEGNELL 282 (499)
Q Consensus 262 ~~~~~~~~~l~~~~l~~N~~~ 282 (499)
.|.... +.++.+++++|...
T Consensus 444 ~~~~l~-~~L~~L~L~~N~l~ 463 (562)
T 3a79_B 444 VFRCLP-PKVKVLDLHNNRIM 463 (562)
T ss_dssp GGSSCC-TTCSEEECCSSCCC
T ss_pred hhhhhc-CcCCEEECCCCcCc
Confidence 665432 57888888888654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-31 Score=286.70 Aligned_cols=271 Identities=22% Similarity=0.246 Sum_probs=213.5
Q ss_pred CCCCCCEEECcCCCCCccCChhccccccccccEEEcccCC-Ccc-cCCccccCCC-------CCCEEeccCCcCCccCCc
Q 010856 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCN-ISG-GIPEEISNLT-------NSTIVNLGGNKLNGSIPI 73 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~-i~~-~~~~~~~~l~-------~L~~L~L~~n~l~~~~~~ 73 (499)
++++|++|+|++|.+.+..|. .+.+++ +|++|+|++|+ +++ .+|..+..++ +|++|+|++|.++ .+|.
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~-~l~~L~-~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~ 565 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPD-FLYDLP-ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA 565 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCG-GGGGCS-SCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred cCCCCCEEECcCCCCCccChH-HHhCCC-CCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence 799999999999999999997 888998 99999999998 887 7777666554 9999999999999 6777
Q ss_pred --cccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCcc-CCeeeccccCCCCCCccccCCC
Q 010856 74 --TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTS-LRIVSLGSNKLTSVPLTFWNLK 150 (499)
Q Consensus 74 --~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~l~ 150 (499)
.|.++++|+.|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|++++|+++.+|..+..++
T Consensus 566 ~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~ 642 (876)
T 4ecn_A 566 SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKS 642 (876)
T ss_dssp HHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCSCCCTTC
T ss_pred hhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCchhhhccc
Confidence 8999999999999999999 667 8999999999999999999 77888999998 9999999999999988776665
Q ss_pred C--CcEEEcCCCcCCCCCcccc---c--CCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCC--
Q 010856 151 D--ILNLNFSSNFLTSPLPLEI---G--NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL-- 221 (499)
Q Consensus 151 ~--L~~L~l~~n~l~~~~~~~~---~--~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l-- 221 (499)
. |+.|++++|.+++.+|... . .+++|+.|++++|.++...+..+..+++|+.|+|++|+++.+.+..+...
T Consensus 643 ~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~ 722 (876)
T 4ecn_A 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722 (876)
T ss_dssp SSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTS
T ss_pred cCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccc
Confidence 4 8889999988877544322 2 33478888888888875444444577788888888887774433333322
Q ss_pred -----CCCCEEeCCCCcCCccCccccc--CCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCc
Q 010856 222 -----ISLKFLNLSNNNLSGAIPASLE--KLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNE 280 (499)
Q Consensus 222 -----~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~ 280 (499)
++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++..+....+++++.+++++|+
T Consensus 723 ~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~ 787 (876)
T 4ecn_A 723 NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR 787 (876)
T ss_dssp CCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCB
T ss_pred cccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCC
Confidence 27788888888777 4555665 7778888888888887643334456677777777765
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=278.66 Aligned_cols=119 Identities=22% Similarity=0.237 Sum_probs=91.9
Q ss_pred CCCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCC
Q 010856 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQK 80 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 80 (499)
|+++++|++|+|++|.++++.|. .+.+++ +|++|+|++|.+++..|.+|.++++|++|++++|.+++..+..+.++++
T Consensus 52 ~~~l~~L~~L~Ls~n~l~~i~~~-~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 129 (606)
T 3vq2_A 52 FSNFSELQWLDLSRCEIETIEDK-AWHGLH-HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129 (606)
T ss_dssp TTTCTTCCEEECTTCCCCEECTT-TTTTCT-TCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTT
T ss_pred ccCCccCcEEeCCCCcccccCHH-Hhhchh-hcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCC
Confidence 45677888888888888877665 667777 7888888888888777788888888888888888887776677888888
Q ss_pred CCeEecccccccc-cCCccccCcccccEEeeecCCCCCcCCc
Q 010856 81 LQGLGLEDNKLEG-SIPDDICHLAELYRLDLDGNKLSGSLPA 121 (499)
Q Consensus 81 L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 121 (499)
|++|++++|.+.+ .+|..|.++++|++|++++|++++..+.
T Consensus 130 L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred CCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 8888888888775 3577788888888888888877655443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=289.28 Aligned_cols=275 Identities=24% Similarity=0.330 Sum_probs=234.1
Q ss_pred CCCCCCCCEEECcCCCCCc-----------------cCChhccc--cccccccEEEcccCCCcccCCccccCCCCCCEEe
Q 010856 1 MSNCKSLTLIYLSNNPLDG-----------------ILPKTSVG--NLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~-----------------~~~~~~~~--~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 61 (499)
|++|++|++|+|++|.+++ ..|. .++ +++ +|++|+|++|.+.+.+|..|.++++|++|+
T Consensus 444 l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~-~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~ 521 (876)
T 4ecn_A 444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLK-DLTDVELYNCPNMTQLPDFLYDLPELQSLN 521 (876)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCT-TCCEEEEESCTTCCSCCGGGGGCSSCCEEE
T ss_pred HhcCCCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCC-CCCEEECcCCCCCccChHHHhCCCCCCEEE
Confidence 3578999999999999998 2565 555 888 899999999999999999999999999999
Q ss_pred ccCCc-CCc-cCCccccC-------CCCCCeEecccccccccCCc--cccCcccccEEeeecCCCCCcCCccccCCccCC
Q 010856 62 LGGNK-LNG-SIPITLSK-------LQKLQGLGLEDNKLEGSIPD--DICHLAELYRLDLDGNKLSGSLPACFSNLTSLR 130 (499)
Q Consensus 62 L~~n~-l~~-~~~~~~~~-------l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 130 (499)
|++|+ +++ ..|..+.. +++|+.|+|++|.++ .+|. .+..+++|+.|+|++|+++ .+| .|..+++|+
T Consensus 522 Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~ 598 (876)
T 4ecn_A 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLT 598 (876)
T ss_dssp CTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEES
T ss_pred CcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcce
Confidence 99998 887 66765544 459999999999999 7777 8999999999999999999 666 899999999
Q ss_pred eeeccccCCCCCCccccCCCC-CcEEEcCCCcCCCCCcccccCCCC--ccEEEccCCcccccCcccc---c--CCcCCce
Q 010856 131 IVSLGSNKLTSVPLTFWNLKD-ILNLNFSSNFLTSPLPLEIGNLKV--LIGIDFSMNNFSGVIPTEI---G--GLKNLEY 202 (499)
Q Consensus 131 ~L~L~~n~l~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~~~l---~--~l~~L~~ 202 (499)
.|++++|+++.+|..+..+++ |+.|++++|.++ .+|..+..++. |+.|++++|++++..|... . .+++|+.
T Consensus 599 ~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~ 677 (876)
T 4ecn_A 599 DLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677 (876)
T ss_dssp EEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEE
T ss_pred EEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCE
Confidence 999999999999999999999 999999999999 56777777654 9999999999987665332 2 3458999
Q ss_pred eeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCC-------CCCCEEEccCCcCcccCCCC-C--CCCCcc
Q 010856 203 LFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKL-------SYLENLNLSFNKLEGEIPRG-G--SFGNFS 272 (499)
Q Consensus 203 L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l-------~~L~~L~l~~N~l~~~~~~~-~--~~~~l~ 272 (499)
|++++|.++.+.+..+..+++|+.|+|++|+++...+..+... ++|+.|+|++|+++. +|.. . .+++++
T Consensus 678 L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~-lp~~l~~~~l~~L~ 756 (876)
T 4ecn_A 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLS 756 (876)
T ss_dssp EECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCC-CCGGGSTTTCTTCC
T ss_pred EEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCcc-chHHhhhccCCCcC
Confidence 9999999995554556689999999999999995544444433 399999999999994 5543 3 688999
Q ss_pred ccccCCCcCC
Q 010856 273 AESFEGNELL 282 (499)
Q Consensus 273 ~~~l~~N~~~ 282 (499)
.+++++|...
T Consensus 757 ~L~Ls~N~L~ 766 (876)
T 4ecn_A 757 NMDVSYNCFS 766 (876)
T ss_dssp EEECCSSCCS
T ss_pred EEEeCCCCCC
Confidence 9999999754
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=276.13 Aligned_cols=248 Identities=22% Similarity=0.200 Sum_probs=179.0
Q ss_pred ccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEE
Q 010856 29 LSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108 (499)
Q Consensus 29 l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 108 (499)
++ +++.|++++|.+..+.+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|
T Consensus 50 l~-~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 50 LN-NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GC-CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CC-CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 44 89999999999998888889999999999999999999888899999999999999999999888889999999999
Q ss_pred eeecCCCCCcCCccccCCccCCeeeccccCCCCCC-ccccCCCCCcEEEcCCCcCCCCCcccccCC--------------
Q 010856 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNL-------------- 173 (499)
Q Consensus 109 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-------------- 173 (499)
+|++|.+++.++..|..+++|++|++++|.++.++ ..+..+++|++|++++|.+++.....+.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~ 208 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 208 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEE
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcccccc
Confidence 99999999888888899999999999999999965 468899999999999999987543333222
Q ss_pred --C---------------------CccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCC
Q 010856 174 --K---------------------VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLS 230 (499)
Q Consensus 174 --~---------------------~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 230 (499)
+ +|+.|++++|.+++ +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|+
T Consensus 209 ~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 286 (597)
T 3oja_B 209 IPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286 (597)
T ss_dssp CCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECT
T ss_pred CCchhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECC
Confidence 1 23333333333332 2334455555555555555555555555555555555555
Q ss_pred CCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCc
Q 010856 231 NNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNE 280 (499)
Q Consensus 231 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~ 280 (499)
+|.+++ .|..+..+++|+.|+|++|++++..+....++.+..+++.+|+
T Consensus 287 ~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~N~ 335 (597)
T 3oja_B 287 NNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNS 335 (597)
T ss_dssp TSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSC
T ss_pred CCCCCC-CCcccccCCCCcEEECCCCCCCccCcccccCCCCCEEECCCCC
Confidence 555553 2333444555555555555555332222334455555555554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=252.93 Aligned_cols=250 Identities=24% Similarity=0.221 Sum_probs=133.6
Q ss_pred CEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecc
Q 010856 8 TLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLE 87 (499)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 87 (499)
++++++++.++.++.. ++++|++|++++|.++++.+..|..+++|++|++++|.+++..+..|..+++|++|+++
T Consensus 14 ~~~~c~~~~l~~ip~~-----~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 88 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVG-----IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88 (285)
T ss_dssp CEEECCSSCCSSCCTT-----CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred eEEEcCcCCcccCCcC-----CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCC
Confidence 3455555555543221 12255556665555555555555555555555555555555555555555555555555
Q ss_pred ccc-ccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCC
Q 010856 88 DNK-LEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPL 166 (499)
Q Consensus 88 ~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (499)
+|. ++...+..|..+++|++|++++|++++..+..+..+++|++|++++|+++. ..
T Consensus 89 ~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~~ 145 (285)
T 1ozn_A 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-----------------------LP 145 (285)
T ss_dssp SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-----------------------CC
T ss_pred CCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccc-----------------------cC
Confidence 554 444444455555555555555555554444444445555555555554444 44
Q ss_pred cccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCC
Q 010856 167 PLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 246 (499)
Q Consensus 167 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 246 (499)
+..+..+++|+.|++++|++++..+..+..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..+..++
T Consensus 146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence 44455555555555555555544444555556666666666666555555566666666666666666655555566666
Q ss_pred CCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCC
Q 010856 247 YLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS 285 (499)
Q Consensus 247 ~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~ 285 (499)
+|+.|++++|++.+..+....+..+.......+...|..
T Consensus 226 ~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~ 264 (285)
T 1ozn_A 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL 264 (285)
T ss_dssp TCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred ccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCC
Confidence 666666666666554433222223333444445545543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=253.05 Aligned_cols=227 Identities=23% Similarity=0.235 Sum_probs=180.5
Q ss_pred CEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecccc
Q 010856 58 TIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSN 137 (499)
Q Consensus 58 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 137 (499)
++++.+++.++.+ |..+ .++|++|++++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~~i-p~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQAV-PVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSSC-CTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcccC-CcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 4555666555532 3222 345666666666666555556666666666666666666666666777777777777777
Q ss_pred C-CCCC-CccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCC
Q 010856 138 K-LTSV-PLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 215 (499)
Q Consensus 138 ~-l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 215 (499)
. ++.+ +..+..+++|++|++++|.+++..+..+..+++|++|++++|++++..+..|..+++|++|++++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 5 6665 5567777888888888888887778888999999999999999998888889999999999999999998888
Q ss_pred ccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCC-CCCCCCccccccCCCcCCCCCCC
Q 010856 216 DSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGSPN 287 (499)
Q Consensus 216 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~~~l~~N~~~c~~~~ 287 (499)
..|..+++|+.|++++|++++..+..+..+++|+.|++++|++++..+. ...++.++.+++.+|++.|+|+.
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence 8899999999999999999999899999999999999999999976654 35678899999999999998864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=264.42 Aligned_cols=257 Identities=16% Similarity=0.164 Sum_probs=225.0
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|++|++++|.++++.+. .+..++ +|++|++++|.+++..+.+|.++++|++|++++|++++..+..|.++++|++|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~-~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 129 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNS-DLQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFL 129 (353)
T ss_dssp TTCCEEECTTSCCCEECTT-TTTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEE
T ss_pred ccCcEEECCCCcCcccCHH-HhccCC-CCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEE
Confidence 5899999999999987765 788888 99999999999999989999999999999999999997766679999999999
Q ss_pred ecccccccccCC-ccccCcccccEEeeecC-CCCCcCCccccCCccCCeeeccccCCCCC-CccccCCCCCcEEEcCCCc
Q 010856 85 GLEDNKLEGSIP-DDICHLAELYRLDLDGN-KLSGSLPACFSNLTSLRIVSLGSNKLTSV-PLTFWNLKDILNLNFSSNF 161 (499)
Q Consensus 85 ~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~l~~n~ 161 (499)
++++|+++...+ ..+..+++|++|++++| .+....+..|..+++|+.|++++|+++.+ |..+..+++|++|++++|.
T Consensus 130 ~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 130 NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp ECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSC
T ss_pred ECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCc
Confidence 999999996555 57899999999999999 57777788999999999999999999984 7789999999999999999
Q ss_pred CCCCCcccccCCCCccEEEccCCcccccCccccc---CCcCCceeeCcCCcCCC----CCCccccCCCCCCEEeCCCCcC
Q 010856 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIG---GLKNLEYLFLGYNRLQG----SIPDSFGDLISLKFLNLSNNNL 234 (499)
Q Consensus 162 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~---~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~l~~N~l 234 (499)
++......+..+++|+.|++++|.+++..+..+. ..+.++.++++++.+.+ .+|..+..+++|+.|++++|++
T Consensus 210 l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l 289 (353)
T 2z80_A 210 HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQL 289 (353)
T ss_dssp STTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCC
T ss_pred cccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCC
Confidence 9865555566789999999999999987655443 45678889999888875 3567789999999999999999
Q ss_pred CccCcccccCCCCCCEEEccCCcCcccCC
Q 010856 235 SGAIPASLEKLSYLENLNLSFNKLEGEIP 263 (499)
Q Consensus 235 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 263 (499)
+...+..|..+++|++|++++|++++..|
T Consensus 290 ~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 290 KSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 96666667999999999999999998765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=253.19 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=223.1
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccC--CccccCcccccEEe
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSI--PDDICHLAELYRLD 109 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~ 109 (499)
.-+.++++++.++. +|..+. ++|++|+|++|+++.+.+..|.++++|++|+|++|.++... +..+..+++|++|+
T Consensus 8 ~~~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 8 SGTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp ETTEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred CCCEEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 35679999999984 454443 68999999999999777777899999999999999998442 56677899999999
Q ss_pred eecCCCCCcCCccccCCccCCeeeccccCCCCCCc--cccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCccc
Q 010856 110 LDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL--TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFS 187 (499)
Q Consensus 110 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (499)
+++|.++. .+..+..+++|++|++++|+++.++. .+..+++|++|++++|.+++..+..+..+++|+.|++++|.++
T Consensus 85 Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 85 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp CCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 99999994 56668899999999999999999764 7889999999999999999888888999999999999999998
Q ss_pred c-cCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-
Q 010856 188 G-VIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG- 265 (499)
Q Consensus 188 ~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~- 265 (499)
+ ..|..+..+++|++|++++|.+++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|++++..|..
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 7 57888999999999999999999888999999999999999999999888888999999999999999999887765
Q ss_pred CCC-CCccccccCCCcCCCCCC
Q 010856 266 GSF-GNFSAESFEGNELLCGSP 286 (499)
Q Consensus 266 ~~~-~~l~~~~l~~N~~~c~~~ 286 (499)
..+ +.+..+++.+|++.|+|.
T Consensus 244 ~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CCCCTTCCEEECTTCCEECSGG
T ss_pred HhhhccCCEEEccCCCeecccC
Confidence 345 489999999999999875
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=253.79 Aligned_cols=258 Identities=23% Similarity=0.397 Sum_probs=195.8
Q ss_pred CCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCC
Q 010856 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQ 82 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 82 (499)
.+++|++|++++|.+... + .+..++ +|++|++++|.+++..+ |..+++|++|++++|.++.. ..+..+++|+
T Consensus 42 ~l~~L~~L~l~~~~i~~~-~--~~~~~~-~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~ 113 (347)
T 4fmz_A 42 ELESITKLVVAGEKVASI-Q--GIEYLT-NLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR 113 (347)
T ss_dssp HHTTCSEEECCSSCCCCC-T--TGGGCT-TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred hcccccEEEEeCCccccc-h--hhhhcC-CccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence 457788888888888754 2 355666 78888888888875543 78888888888888888753 3578888888
Q ss_pred eEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcC
Q 010856 83 GLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l 162 (499)
+|++++|.+++..+ +..+++|++|++++|......+ .+..+++|++|++++|.+..++. +..+++|++|++++|.+
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l 189 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQI 189 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCC
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCcc
Confidence 88888888875433 7788888888888886554433 47788888888888888887665 77788888888888888
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++. ..+
T Consensus 190 ~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~ 261 (347)
T 4fmz_A 190 EDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAV 261 (347)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGG
T ss_pred ccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhH
Confidence 76433 7778888888888888876544 7778888888888888875533 77888888888888888754 467
Q ss_pred cCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcC
Q 010856 243 EKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281 (499)
Q Consensus 243 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~ 281 (499)
..+++|+.|++++|++++. +....+++++.+++.+|+.
T Consensus 262 ~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 262 KDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp TTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCC
T ss_pred hcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcC
Confidence 7888888888888888754 4455667788888888864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=276.52 Aligned_cols=273 Identities=19% Similarity=0.148 Sum_probs=194.6
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|++|+|++|++++..+. .+..++ +|++|++++|.+++..|++|.++++|++|++++|.+++..+..|.++++|++|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~-~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 103 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHG-DLRACA-NLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYL 103 (549)
T ss_dssp TTCCEEECCSSCCCEECSS-TTSSCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEE
T ss_pred CCccEEECcCCccCccChh-hhhcCC-cccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEE
Confidence 5899999999999988776 788888 89999999999999999999999999999999999998888889999999999
Q ss_pred eccccccccc-CCccccCcccccEEeeecCC-CCCcCCccccCCccCCeeeccccCCCC-CCccccC-------------
Q 010856 85 GLEDNKLEGS-IPDDICHLAELYRLDLDGNK-LSGSLPACFSNLTSLRIVSLGSNKLTS-VPLTFWN------------- 148 (499)
Q Consensus 85 ~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~------------- 148 (499)
++++|.+++. .|..+.++++|++|++++|. +....+..|.++++|++|++++|+++. .|..+..
T Consensus 104 ~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 104 NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp ECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB
T ss_pred ECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc
Confidence 9999999864 46789999999999999998 554555789999999999999999987 5555544
Q ss_pred -----------CCCCcEEEcCCCcCCCCC--cc-cccCC-----------------------------------------
Q 010856 149 -----------LKDILNLNFSSNFLTSPL--PL-EIGNL----------------------------------------- 173 (499)
Q Consensus 149 -----------l~~L~~L~l~~n~l~~~~--~~-~~~~l----------------------------------------- 173 (499)
+++|++|++++|.+++.. +. ....+
T Consensus 184 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~ 263 (549)
T 2z81_A 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263 (549)
T ss_dssp STTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEE
T ss_pred ccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccc
Confidence 456666666666665421 00 00011
Q ss_pred ----------------------------------------------CCccEEEccCCcccccCcccc-cCCcCCceeeCc
Q 010856 174 ----------------------------------------------KVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLG 206 (499)
Q Consensus 174 ----------------------------------------------~~L~~L~l~~n~l~~~~~~~l-~~l~~L~~L~L~ 206 (499)
.+|+.|++++|.++. .|..+ ..+++|++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~-ip~~~~~~l~~L~~L~Ls 342 (549)
T 2z81_A 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLS 342 (549)
T ss_dssp ECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC-CCHHHHHHCTTCCEEECC
T ss_pred cccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCcccc-CCHHHHhcCccccEEEcc
Confidence 123333333333331 22222 346666666666
Q ss_pred CCcCCCCCC---ccccCCCCCCEEeCCCCcCCccCc--ccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCc
Q 010856 207 YNRLQGSIP---DSFGDLISLKFLNLSNNNLSGAIP--ASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNE 280 (499)
Q Consensus 207 ~n~l~~~~~---~~l~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~ 280 (499)
+|++++..+ ..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|++++..+.....+.++.+++++|.
T Consensus 343 ~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~ 421 (549)
T 2z81_A 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTG 421 (549)
T ss_dssp SSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSC
T ss_pred CCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCC
Confidence 666665432 235566667777777776664432 34666677777777777776433333445566666666665
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=250.07 Aligned_cols=224 Identities=20% Similarity=0.247 Sum_probs=195.6
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
+++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..+..+++|++|+++
T Consensus 82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 7888888888888 55667777888888888888888 67777888888888888888888 667788888888888888
Q ss_pred cCCCCCcCCccccC---------CccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEcc
Q 010856 112 GNKLSGSLPACFSN---------LTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182 (499)
Q Consensus 112 ~n~l~~~~~~~~~~---------l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 182 (499)
+|++.+..|..+.. +++|++|++++|+++.+|..+..+++|++|++++|.+++ .|..+..+++|+.|+++
T Consensus 159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls 237 (328)
T 4fcg_A 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLR 237 (328)
T ss_dssp EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECT
T ss_pred CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECc
Confidence 88877777776654 899999999999999999889999999999999999986 45578899999999999
Q ss_pred CCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCc
Q 010856 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 183 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
+|.+.+..|..+..+++|++|++++|.+.+..|..+..+++|+.|++++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 99998889999999999999999999988889999999999999999999999999999999999999999988765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=269.86 Aligned_cols=116 Identities=20% Similarity=0.239 Sum_probs=90.5
Q ss_pred CCCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCC
Q 010856 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQK 80 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 80 (499)
|.++++|++|+|++|+++++.+. .+..++ +|++|++++|.+++..|.+|.++++|++|++++|.++...+..+.++++
T Consensus 48 ~~~l~~L~~L~Ls~n~i~~i~~~-~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~ 125 (570)
T 2z63_A 48 FFSFPELQVLDLSRCEIQTIEDG-AYQSLS-HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125 (570)
T ss_dssp TTTCSSCCEEECTTCCCCEECTT-TTTTCT-TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTT
T ss_pred hhCCCCceEEECCCCcCCccCcc-cccCch-hCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCcccccccc
Confidence 45677888888888888776665 677777 7888888888888777778888888888888888887666666888888
Q ss_pred CCeEeccccccccc-CCccccCcccccEEeeecCCCCCc
Q 010856 81 LQGLGLEDNKLEGS-IPDDICHLAELYRLDLDGNKLSGS 118 (499)
Q Consensus 81 L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~ 118 (499)
|++|++++|.+++. .|..|.++++|++|++++|++++.
T Consensus 126 L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~ 164 (570)
T 2z63_A 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (570)
T ss_dssp CCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE
T ss_pred ccEEecCCCccceecChhhhcccCCCCEEeCcCCcccee
Confidence 88888888888763 577788888888888888876644
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=250.55 Aligned_cols=226 Identities=19% Similarity=0.265 Sum_probs=182.7
Q ss_pred CCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCe
Q 010856 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQG 83 (499)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 83 (499)
.++++.|+|++|.++.+ |. .+..++ +|++|+|++|.++ .+|..|..+++|++|+|++|.++ .+|..+.++++|++
T Consensus 80 ~~~l~~L~L~~n~l~~l-p~-~l~~l~-~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~ 154 (328)
T 4fcg_A 80 QPGRVALELRSVPLPQF-PD-QAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE 154 (328)
T ss_dssp STTCCEEEEESSCCSSC-CS-CGGGGT-TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCE
T ss_pred ccceeEEEccCCCchhc-Ch-hhhhCC-CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCE
Confidence 46788888888888844 44 466677 7888888888888 67777888888888888888888 56777888888888
Q ss_pred EecccccccccCCccccC---------cccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcE
Q 010856 84 LGLEDNKLEGSIPDDICH---------LAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILN 154 (499)
Q Consensus 84 L~L~~n~l~~~~~~~~~~---------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~ 154 (499)
|++++|++.+..|..+.. +++|++|++++|+++ .+|..+..+++|+.|++++|+++.+|..+..+++|++
T Consensus 155 L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~ 233 (328)
T 4fcg_A 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEE 233 (328)
T ss_dssp EEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCE
T ss_pred EECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCE
Confidence 888887777777766543 888888888888888 5667788888888888888888888878888888888
Q ss_pred EEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcC
Q 010856 155 LNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234 (499)
Q Consensus 155 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l 234 (499)
|++++|.+.+..|..+..+++|+.|++++|.+.+..|..+..+++|++|++++|++.+.+|..+..+++|+.+++..+.+
T Consensus 234 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp EECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred EECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 88888888888888888888888888888888888888888888888888888888888888888888888888877765
Q ss_pred C
Q 010856 235 S 235 (499)
Q Consensus 235 ~ 235 (499)
.
T Consensus 314 ~ 314 (328)
T 4fcg_A 314 A 314 (328)
T ss_dssp C
T ss_pred H
Confidence 5
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=260.67 Aligned_cols=259 Identities=28% Similarity=0.410 Sum_probs=155.1
Q ss_pred CCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCC---------
Q 010856 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIP--------- 72 (499)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--------- 72 (499)
.++++|++|++++|.+++..+ +..++ +|++|++++|.+++..+ +..+++|++|++++|.+++...
T Consensus 87 ~~l~~L~~L~l~~n~l~~~~~---~~~l~-~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~ 160 (466)
T 1o6v_A 87 KNLTKLVDILMNNNQIADITP---LANLT-NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQ 160 (466)
T ss_dssp TTCTTCCEEECCSSCCCCCGG---GTTCT-TCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSE
T ss_pred hccccCCEEECCCCccccChh---hcCCC-CCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccE
Confidence 467777888888877775533 55666 77777777777775533 6777777777777776654211
Q ss_pred ----------ccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCC
Q 010856 73 ----------ITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSV 142 (499)
Q Consensus 73 ----------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 142 (499)
..+.++++|++|++++|.++.. ..+..+++|++|++++|.+++..+ +..+++|+.|++++|+++.+
T Consensus 161 L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 236 (466)
T 1o6v_A 161 LSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI 236 (466)
T ss_dssp EEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred eecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc
Confidence 1255667777778887777643 346677777777777777775543 55566666666666666665
Q ss_pred CccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCC
Q 010856 143 PLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLI 222 (499)
Q Consensus 143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 222 (499)
+ .+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +..++
T Consensus 237 ~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~ 309 (466)
T 1o6v_A 237 G-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLK 309 (466)
T ss_dssp G-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCT
T ss_pred h-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCC
Confidence 3 35556666666666666655433 5555666666666666654432 5555555555555555554322 45555
Q ss_pred CCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCc
Q 010856 223 SLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNE 280 (499)
Q Consensus 223 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~ 280 (499)
+|+.|++++|++++..+ +..+++|+.|++++|++++. +....++.++.+++.+|+
T Consensus 310 ~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 310 NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQ 364 (466)
T ss_dssp TCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSC
T ss_pred CCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCc
Confidence 55555555555554433 44555555555555555543 233334444555555544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-30 Score=258.99 Aligned_cols=255 Identities=30% Similarity=0.399 Sum_probs=149.8
Q ss_pred CCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCC
Q 010856 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQ 82 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 82 (499)
.+++|++|+|++|.+++..+ +..++ +|++|++++|.+++..+ +.++++|++|++++|.+++..+ +..+++|+
T Consensus 66 ~l~~L~~L~Ls~n~l~~~~~---~~~l~-~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 137 (466)
T 1o6v_A 66 YLNNLTQINFSNNQLTDITP---LKNLT-KLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLN 137 (466)
T ss_dssp GCTTCCEEECCSSCCCCCGG---GTTCT-TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCS
T ss_pred hhcCCCEEECCCCccCCchh---hhccc-cCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCC
Confidence 46677777777777765532 55555 67777777777765544 6777777777777777765433 66777777
Q ss_pred eEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcC
Q 010856 83 GLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l 162 (499)
+|++++|.+.+. + .+..+++|++|+++ |.+.+. ..+..+++|+.|++++|.++.++ .+..+++|++|++++|.+
T Consensus 138 ~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l 211 (466)
T 1o6v_A 138 RLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDISSNKVSDIS-VLAKLTNLESLIATNNQI 211 (466)
T ss_dssp EEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCC--GGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCC
T ss_pred EEECCCCccCCC-h-hhccCCcccEeecC-CcccCc--hhhccCCCCCEEECcCCcCCCCh-hhccCCCCCEEEecCCcc
Confidence 777777776643 1 24444444444443 222222 12556666677777777666654 355666666666666666
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
++..+ +..+++|+.|++++|.+++. ..+..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +
T Consensus 212 ~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~ 283 (466)
T 1o6v_A 212 SDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L 283 (466)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--G
T ss_pred ccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--c
Confidence 65433 45566666666666666543 345556666666666666654432 5555666666666666654333 5
Q ss_pred cCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCc
Q 010856 243 EKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNE 280 (499)
Q Consensus 243 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~ 280 (499)
..+++|+.|++++|++++..+ ...+++++.+++.+|.
T Consensus 284 ~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~ 320 (466)
T 1o6v_A 284 AGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNN 320 (466)
T ss_dssp TTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSC
T ss_pred cCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCc
Confidence 555666666666666554333 3344555555555554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-29 Score=265.04 Aligned_cols=114 Identities=24% Similarity=0.249 Sum_probs=99.9
Q ss_pred CCCcEEEcCCCcC-CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEe
Q 010856 150 KDILNLNFSSNFL-TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLN 228 (499)
Q Consensus 150 ~~L~~L~l~~n~l-~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 228 (499)
++|+.|++++|.+ ....|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 3455555555542 234567788999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCCccCcccccCC-CCCCEEEccCCcCcccCC
Q 010856 229 LSNNNLSGAIPASLEKL-SYLENLNLSFNKLEGEIP 263 (499)
Q Consensus 229 l~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~ 263 (499)
|++|+|++..|..+..+ ++|+.|++++|++.+...
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999999999999988 689999999999998654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-31 Score=254.59 Aligned_cols=244 Identities=17% Similarity=0.201 Sum_probs=143.6
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCc-ccCCcccc-------CCCCCCEEeccCCcCCccCCccc-
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNIS-GGIPEEIS-------NLTNSTIVNLGGNKLNGSIPITL- 75 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~-~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~~- 75 (499)
++|++|++++|.+ ..|. .+. ..|+.|++++|.++ ...|..+. ++++|++|+|++|.+++..|..+
T Consensus 43 ~~L~~l~l~~n~l--~~p~-~~~---~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 43 RSLEYLLKRVDTE--ADLG-QFT---DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EECTTHHHHCCTT--CCCH-HHH---HHHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred CCceeEeeccccc--ccHH-HHH---HHHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 4566666666666 3333 221 23666666666663 23343333 56666666666666666555554
Q ss_pred -cCCCCCCeEecccccccccCCccccCc-----ccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC---CCccc
Q 010856 76 -SKLQKLQGLGLEDNKLEGSIPDDICHL-----AELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS---VPLTF 146 (499)
Q Consensus 76 -~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~~~~~ 146 (499)
..+++|++|+|++|++++. |..+..+ ++|++|++++|++++..+..|..+++|++|++++|++.. ++..+
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 195 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence 6666666666666666655 5555555 666666666666666666666666666666666666543 22222
Q ss_pred --cCCCCCcEEEcCCCcCCCC---CcccccCCCCccEEEccCCcccccCc-ccccCCcCCceeeCcCCcCCCCCCccccC
Q 010856 147 --WNLKDILNLNFSSNFLTSP---LPLEIGNLKVLIGIDFSMNNFSGVIP-TEIGGLKNLEYLFLGYNRLQGSIPDSFGD 220 (499)
Q Consensus 147 --~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~l~~ 220 (499)
..+++|++|++++|.+++. ....+..+++|+.|++++|++++..| ..+..+++|++|++++|+++ .+|..+.
T Consensus 196 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~- 273 (312)
T 1wwl_A 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP- 273 (312)
T ss_dssp CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-
T ss_pred HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-
Confidence 5566666666666666531 11233455666666666666665443 33445566666666666666 3444443
Q ss_pred CCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcc
Q 010856 221 LISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 221 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 260 (499)
++|+.|++++|++++. |. +..+++|++|++++|++++
T Consensus 274 -~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 -AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred -CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5666666666666654 33 6666666666666666653
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=248.71 Aligned_cols=251 Identities=22% Similarity=0.213 Sum_probs=210.1
Q ss_pred CCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCC
Q 010856 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQ 82 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 82 (499)
++++|++|++++|.+++. | .+..++ +|++|++++|+++++ | +..+++|++|++++|.+++. + +.++++|+
T Consensus 40 ~l~~L~~L~Ls~n~l~~~-~--~l~~l~-~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~ 109 (457)
T 3bz5_A 40 QLATLTSLDCHNSSITDM-T--GIEKLT-GLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLT 109 (457)
T ss_dssp HHTTCCEEECCSSCCCCC-T--TGGGCT-TCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCC
T ss_pred HcCCCCEEEccCCCcccC-h--hhcccC-CCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCC
Confidence 578999999999999976 4 467787 899999999999975 3 88999999999999999975 3 88999999
Q ss_pred eEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccC-CCCCCccccCCCCCcEEEcCCCc
Q 010856 83 GLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNK-LTSVPLTFWNLKDILNLNFSSNF 161 (499)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~l~~L~~L~l~~n~ 161 (499)
+|++++|++++. + +..+++|++|++++|++++. .+..+++|+.|++++|+ +..+ .+..+++|++|++++|.
T Consensus 110 ~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~ 181 (457)
T 3bz5_A 110 YLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNK 181 (457)
T ss_dssp EEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCc
Confidence 999999999864 3 88999999999999999975 37889999999999994 5446 47789999999999999
Q ss_pred CCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCccc
Q 010856 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPAS 241 (499)
Q Consensus 162 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~ 241 (499)
++++ + +..+++|+.|++++|++++. .+..+++|++|++++|+++++ | +..+++|+.|++++|++++..+..
T Consensus 182 l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~~~~~~ 252 (457)
T 3bz5_A 182 ITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTELDVST 252 (457)
T ss_dssp CCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCCCTT
T ss_pred ccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCCcCHHH
Confidence 9974 3 78899999999999999876 488899999999999999974 4 888999999999999999876555
Q ss_pred ccCCC-------CCCEEEccCCcCcccCCCCCCCCCccccccCCCcC
Q 010856 242 LEKLS-------YLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281 (499)
Q Consensus 242 ~~~l~-------~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~ 281 (499)
+..+. +|+.|++++|++.+.+|. ..++.++.+++++|+.
T Consensus 253 l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~-~~l~~L~~L~Ls~n~~ 298 (457)
T 3bz5_A 253 LSKLTTLHCIQTDLLEIDLTHNTQLIYFQA-EGCRKIKELDVTHNTQ 298 (457)
T ss_dssp CTTCCEEECTTCCCSCCCCTTCTTCCEEEC-TTCTTCCCCCCTTCTT
T ss_pred CCCCCEEeccCCCCCEEECCCCccCCcccc-cccccCCEEECCCCcc
Confidence 54443 455666666666666653 3567888888888864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=246.93 Aligned_cols=237 Identities=21% Similarity=0.191 Sum_probs=188.4
Q ss_pred CCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCC
Q 010856 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKL 81 (499)
Q Consensus 2 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 81 (499)
+.+++|++|+|++|.++++ .+..++ +|++|++++|.+++. + +.++++|++|++++|++++. + +..+++|
T Consensus 61 ~~l~~L~~L~Ls~n~l~~~----~~~~l~-~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L 129 (457)
T 3bz5_A 61 EKLTGLTKLICTSNNITTL----DLSQNT-NLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLL 129 (457)
T ss_dssp GGCTTCSEEECCSSCCSCC----CCTTCT-TCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTC
T ss_pred cccCCCCEEEccCCcCCeE----ccccCC-CCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcC
Confidence 5688999999999999986 266777 899999999999975 3 88999999999999999864 3 8899999
Q ss_pred CeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCc
Q 010856 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNF 161 (499)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~ 161 (499)
++|++++|++++. .+..+++|++|++++|+..+.. .+..+++|+.|++++|+++.+| +..+++|+.|++++|.
T Consensus 130 ~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~ 202 (457)
T 3bz5_A 130 TYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNN 202 (457)
T ss_dssp CEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC--CTTCTTCCEEECCSSC
T ss_pred CEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec--cccCCCCCEEECcCCc
Confidence 9999999999875 3788899999999999655444 4778899999999999999887 7788999999999999
Q ss_pred CCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCC-------CCCEEeCCCCcC
Q 010856 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLI-------SLKFLNLSNNNL 234 (499)
Q Consensus 162 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~-------~L~~L~l~~N~l 234 (499)
+++. .+..+++|+.|++++|++++. | +..+++|+.|++++|++++..+..+..+. +|+.|++++|.+
T Consensus 203 l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~ 276 (457)
T 3bz5_A 203 ITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQ 276 (457)
T ss_dssp CSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTT
T ss_pred CCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCcc
Confidence 9875 478889999999999999874 4 78889999999999999876544444332 334444444444
Q ss_pred CccCcccccCCCCCCEEEccCCcCcccCCC
Q 010856 235 SGAIPASLEKLSYLENLNLSFNKLEGEIPR 264 (499)
Q Consensus 235 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 264 (499)
.+..| +..+++|+.|++++|+..+.+|.
T Consensus 277 ~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~ 304 (457)
T 3bz5_A 277 LIYFQ--AEGCRKIKELDVTHNTQLYLLDC 304 (457)
T ss_dssp CCEEE--CTTCTTCCCCCCTTCTTCCEEEC
T ss_pred CCccc--ccccccCCEEECCCCcccceecc
Confidence 43333 35667777788887777665553
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=248.93 Aligned_cols=258 Identities=18% Similarity=0.170 Sum_probs=203.1
Q ss_pred CCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEec
Q 010856 7 LTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGL 86 (499)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 86 (499)
++.++++.+.+...... .+..++ +|++|++++|.+++..|..|..+++|++|+|++|.+++..+ +..+++|++|++
T Consensus 12 l~i~~ls~~~l~~~~~~-~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 12 YKIEKVTDSSLKQALAS-LRQSAW-NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp EEEESCCTTTHHHHHHH-HHTTGG-GCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred eeEeeccccchhhhHHH-HhccCC-CCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 44556666666543332 344445 89999999999998888889999999999999999986554 889999999999
Q ss_pred ccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCC-ccccCCCCCcEEEcCCCcCCCC
Q 010856 87 EDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSP 165 (499)
Q Consensus 87 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~ 165 (499)
++|.+++.. ..++|++|++++|++++..+.. +++|+.|++++|+++.++ ..+..+++|++|++++|.+++.
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence 999987442 3489999999999998765543 578999999999999864 4777889999999999999887
Q ss_pred Ccccc-cCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccC
Q 010856 166 LPLEI-GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEK 244 (499)
Q Consensus 166 ~~~~~-~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 244 (499)
.+..+ ..+++|++|++++|.+++.. ....+++|++|++++|++++..+ .+..+++|+.|++++|+++. +|..+..
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~-l~~~~~~ 235 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRF 235 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred cHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccc-hhhHhhc
Confidence 66666 47899999999999998662 33458999999999999996544 58889999999999999994 5677888
Q ss_pred CCCCCEEEccCCcCc-ccCCCC-CCCCCccccccCCCc
Q 010856 245 LSYLENLNLSFNKLE-GEIPRG-GSFGNFSAESFEGNE 280 (499)
Q Consensus 245 l~~L~~L~l~~N~l~-~~~~~~-~~~~~l~~~~l~~N~ 280 (499)
+++|+.|++++|+++ +.+|.. ..++.++.+++.+++
T Consensus 236 l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~ 273 (317)
T 3o53_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273 (317)
T ss_dssp CTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred CCCCCEEEccCCCccCcCHHHHHhccccceEEECCCch
Confidence 999999999999998 333322 235556666666443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=243.55 Aligned_cols=242 Identities=22% Similarity=0.224 Sum_probs=210.6
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
+++.++++.+.+.......+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..+ +..+++|++|+++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 46677788888876666777788899999999999998888899999999999999999986654 8999999999999
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCc
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP 191 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (499)
+|++++.. ..++|+.|++++|+++.++.. .+++|++|++++|.+++..+..+..+++|+.|++++|.+++..+
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~--~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEEC--CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCcc--ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 99998543 348999999999999987643 46899999999999999888899999999999999999998877
Q ss_pred ccc-cCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCC
Q 010856 192 TEI-GGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGN 270 (499)
Q Consensus 192 ~~l-~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 270 (499)
..+ ..+++|++|++++|.+++. .....+++|+.|++++|++++..+ .+..+++|+.|++++|++++..+....++.
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~--~~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~ 238 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQN 238 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEE--ECCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTT
T ss_pred HHHhhccCcCCEEECCCCcCccc--ccccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccchhhHhhcCCC
Confidence 776 4789999999999999966 233458999999999999996555 488999999999999999976555567789
Q ss_pred ccccccCCCcCCCCC
Q 010856 271 FSAESFEGNELLCGS 285 (499)
Q Consensus 271 l~~~~l~~N~~~c~~ 285 (499)
++.+++.+|++.|++
T Consensus 239 L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 239 LEHFDLRGNGFHCGT 253 (317)
T ss_dssp CCEEECTTCCCBHHH
T ss_pred CCEEEccCCCccCcC
Confidence 999999999998864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-28 Score=228.17 Aligned_cols=208 Identities=26% Similarity=0.303 Sum_probs=126.7
Q ss_pred CCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecc
Q 010856 56 NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLG 135 (499)
Q Consensus 56 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 135 (499)
+|++|++++|.+++..+..|.++++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 44444554444444444444444455555555554444444444455555555555555554444455555555555555
Q ss_pred ccCCCCCCc-cccCCCCCcEEEcCCCcCCCC-CcccccCCCCccEEEccCCcccccCcccccCCcCCc----eeeCcCCc
Q 010856 136 SNKLTSVPL-TFWNLKDILNLNFSSNFLTSP-LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLE----YLFLGYNR 209 (499)
Q Consensus 136 ~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~----~L~L~~n~ 209 (499)
+|+++.++. .+..+++|++|++++|.+++. .|..+..+++|+.|++++|++++..+..+..+++|+ +|++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 555555433 355555566666666655543 355666666666777777766666666666666666 78888888
Q ss_pred CCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCC
Q 010856 210 LQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR 264 (499)
Q Consensus 210 l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 264 (499)
+++..+..+.. .+|+.|++++|++++..+..|..+++|+.|++++|++++..+.
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 87665555544 4788888888888877777778888888888888888876654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=255.38 Aligned_cols=241 Identities=20% Similarity=0.196 Sum_probs=201.7
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
+|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.+++.. ..++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence 79999999999999888999999999999999999987655 899999999999999998543 33899999999
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCC-CccccCCCCCcEEEcCCCcCCCCCccccc-CCCCccEEEccCCccccc
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSV-PLTFWNLKDILNLNFSSNFLTSPLPLEIG-NLKVLIGIDFSMNNFSGV 189 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~ 189 (499)
+|.+++..+. .+++|+.|++++|.++.+ |..+..+++|+.|++++|.+++..|..+. .+++|+.|+|++|.+++.
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 9999977654 357899999999999985 55788899999999999999987777776 789999999999999876
Q ss_pred CcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcc-cCCC-CCC
Q 010856 190 IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG-EIPR-GGS 267 (499)
Q Consensus 190 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~-~~~ 267 (499)
. .+..+++|+.|+|++|.+++..+ .+..+++|+.|++++|.+++ +|..+..+++|+.|++++|++.+ .+|. ...
T Consensus 185 ~--~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 K--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp E--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred c--ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 3 34468999999999999997655 48899999999999999995 56678899999999999999983 3322 233
Q ss_pred CCCccccccC-------CCcCCCCCC
Q 010856 268 FGNFSAESFE-------GNELLCGSP 286 (499)
Q Consensus 268 ~~~l~~~~l~-------~N~~~c~~~ 286 (499)
++.+..+.+. +|++.|.++
T Consensus 261 l~~L~~l~~~~~~~~~~~~~~~c~~~ 286 (487)
T 3oja_A 261 NQRVQTVAKQTVKKLTGQNEEECTVP 286 (487)
T ss_dssp CHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred CCCCcEEeccccccccCCCcccccCC
Confidence 4555555554 778777664
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-28 Score=227.37 Aligned_cols=223 Identities=19% Similarity=0.177 Sum_probs=198.9
Q ss_pred EEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEeccc
Q 010856 9 LIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLED 88 (499)
Q Consensus 9 ~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 88 (499)
..+..+..++.++.. ++++|++|++++|.+++..+..|.++++|++|++++|.+++..+..|.++++|++|++++
T Consensus 11 ~~~c~~~~l~~ip~~-----l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 85 (276)
T 2z62_A 11 TYQCMELNFYKIPDN-----LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (276)
T ss_dssp EEECTTSCCSSCCSS-----SCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred eEEecCCCccccCCC-----CCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCC
Confidence 567777777754332 345899999999999988888999999999999999999988888999999999999999
Q ss_pred ccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC--CCccccCCCCCcEEEcCCCcCCCCC
Q 010856 89 NKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS--VPLTFWNLKDILNLNFSSNFLTSPL 166 (499)
Q Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (499)
|.+++..+..|.++++|++|++++|.+.+..+..+..+++|++|++++|+++. +|..+..+++|++|++++|++++..
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~ 165 (276)
T 2z62_A 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (276)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred CccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCC
Confidence 99998888899999999999999999998888789999999999999999998 6889999999999999999999887
Q ss_pred cccccCCCCcc----EEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCcc
Q 010856 167 PLEIGNLKVLI----GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGA 237 (499)
Q Consensus 167 ~~~~~~l~~L~----~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 237 (499)
+..+..+++|+ .|++++|.+++..+..+.. .+|++|++++|++++..+..|..+++|+.|++++|+++..
T Consensus 166 ~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp GGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred HHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 77887777776 8999999999777666654 4899999999999988888889999999999999999843
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=255.23 Aligned_cols=222 Identities=24% Similarity=0.238 Sum_probs=191.6
Q ss_pred CCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCee
Q 010856 53 NLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIV 132 (499)
Q Consensus 53 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 132 (499)
.+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.+++..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34589999999999998888899999999999999999986654 8899999999999999985432 3899999
Q ss_pred eccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCccccc-CCcCCceeeCcCCcCC
Q 010856 133 SLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIG-GLKNLEYLFLGYNRLQ 211 (499)
Q Consensus 133 ~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-~l~~L~~L~L~~n~l~ 211 (499)
++++|.++.++.. .+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..|..+. .+++|++|+|++|.++
T Consensus 105 ~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 105 HAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp ECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred ECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 9999999987643 468899999999999998888899999999999999999988888776 7899999999999998
Q ss_pred CCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCCC
Q 010856 212 GSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 286 (499)
Q Consensus 212 ~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~~ 286 (499)
+.. .+..+++|+.|+|++|.+++.++. +..+++|+.|++++|.+++.++....++.+..+++.+|++.|++.
T Consensus 183 ~~~--~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~ 254 (487)
T 3oja_A 183 DVK--GQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTL 254 (487)
T ss_dssp EEE--CCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHH
T ss_pred ccc--ccccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcch
Confidence 763 344689999999999999976554 889999999999999999866665667889999999999998764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=244.41 Aligned_cols=247 Identities=21% Similarity=0.226 Sum_probs=207.1
Q ss_pred cccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCc-cCCcccc-------CCCCCCeEecccccccccCCc
Q 010856 26 VGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNG-SIPITLS-------KLQKLQGLGLEDNKLEGSIPD 97 (499)
Q Consensus 26 ~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~ 97 (499)
+.... +|++|++++|.+ .+|..+... |+.|+|++|.++. ..|..+. ++++|++|+|++|++++..|.
T Consensus 39 ~~~~~-~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGR-SLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEE-ECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCC-CceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 34445 799999999999 567666544 9999999999953 4455444 789999999999999988888
Q ss_pred cc--cCcccccEEeeecCCCCCcCCccccCC-----ccCCeeeccccCCCCCC-ccccCCCCCcEEEcCCCcCCCC--Cc
Q 010856 98 DI--CHLAELYRLDLDGNKLSGSLPACFSNL-----TSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSP--LP 167 (499)
Q Consensus 98 ~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~--~~ 167 (499)
.+ ..+++|++|++++|++++. |..+..+ ++|++|++++|+++.++ ..+..+++|++|++++|++.+. .+
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 76 8999999999999999987 7777777 89999999999999976 7899999999999999998753 22
Q ss_pred ccc--cCCCCccEEEccCCccccc---CcccccCCcCCceeeCcCCcCCCCCC-ccccCCCCCCEEeCCCCcCCccCccc
Q 010856 168 LEI--GNLKVLIGIDFSMNNFSGV---IPTEIGGLKNLEYLFLGYNRLQGSIP-DSFGDLISLKFLNLSNNNLSGAIPAS 241 (499)
Q Consensus 168 ~~~--~~l~~L~~L~l~~n~l~~~---~~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~l~~N~l~~~~~~~ 241 (499)
..+ ..+++|++|++++|++++. ....+..+++|++|++++|++++..| ..+..+++|+.|++++|+++ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 333 8899999999999999842 22445678999999999999998764 56777899999999999999 55665
Q ss_pred ccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCC
Q 010856 242 LEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL 282 (499)
Q Consensus 242 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~ 282 (499)
+. ++|+.|++++|++++. |....++.++.+++.+|++.
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTT
T ss_pred cc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCC
Confidence 55 8999999999999977 66777889999999999864
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-27 Score=223.45 Aligned_cols=203 Identities=25% Similarity=0.199 Sum_probs=134.1
Q ss_pred ccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCC
Q 010856 51 ISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLR 130 (499)
Q Consensus 51 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 130 (499)
+.++++++++++++|.++.+ |..+. ++++.|+|++|.+++..+..|..+++|++|++++|.+++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 56778888888888888744 33332 5788888888888777777788888888888888888754332 5677777
Q ss_pred eeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcC
Q 010856 131 IVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRL 210 (499)
Q Consensus 131 ~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 210 (499)
.|++++|+++.+|..+..+++|++|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++
T Consensus 81 ~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 77777777777776666777777777777777666556666666666666666666655555555666666666666666
Q ss_pred CCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCc
Q 010856 211 QGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 211 ~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
++..+..|..+++|+.|++++|+++ .+|..+..+++|+.+++++|++.
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 6555555555666666666666665 33334444445555555544444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-26 Score=215.76 Aligned_cols=183 Identities=27% Similarity=0.326 Sum_probs=101.3
Q ss_pred CCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCCCCCcEEEcC
Q 010856 80 KLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFS 158 (499)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~l~ 158 (499)
+|++|++++|+++...+..|..+++|++|++++|+++...+..|..+++|++|++++|+++.++. .+..+++|++|+++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 34444444444443333344444444444444444444333444444445555555554444332 23444555555555
Q ss_pred CCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccC
Q 010856 159 SNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAI 238 (499)
Q Consensus 159 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 238 (499)
+|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 55555544555555666666666666666555555666666666666666666655556666667777777777666655
Q ss_pred cccccCCCCCCEEEccCCcCcccC
Q 010856 239 PASLEKLSYLENLNLSFNKLEGEI 262 (499)
Q Consensus 239 ~~~~~~l~~L~~L~l~~N~l~~~~ 262 (499)
+..|..+++|+.|++++|++.+..
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCSS
T ss_pred HHHhccccCCCEEEecCCCeeCCC
Confidence 556666666666666666665443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-26 Score=216.32 Aligned_cols=202 Identities=26% Similarity=0.288 Sum_probs=140.2
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
+.+.+++++++++. +|..+. ++|++|+|++|+++...+..|.++++|++|++++|.++...+..|..+++|++|+++
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 45666666666663 333332 456666666666665555566666666666666666665555556666667777777
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccC
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI 190 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 190 (499)
+|++++..+..|..+++|++|++++|+++.++. .+..+++|++|++++|.+++..+..|..+++|+.|++++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 777666666666667777777777777766543 3566777777777777777666666777778888888888877776
Q ss_pred cccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCc
Q 010856 191 PTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG 236 (499)
Q Consensus 191 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 236 (499)
+..|..+++|++|++++|++++..+..|..+++|+.|++++|++..
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 6677788888888888888887766677888888888888888763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-26 Score=219.41 Aligned_cols=206 Identities=27% Similarity=0.267 Sum_probs=123.6
Q ss_pred ccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcE
Q 010856 75 LSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILN 154 (499)
Q Consensus 75 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~ 154 (499)
+.++++++++++++|.++. +|..+. ++++.|++++|.+++..+..|..+++|+.|++++|+++.++.. ..+++|++
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~~ 81 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGT 81 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCE
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCCE
Confidence 4455566666666666653 333332 4566666666666655555666666666666666666665433 45666666
Q ss_pred EEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcC
Q 010856 155 LNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234 (499)
Q Consensus 155 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l 234 (499)
|++++|.++. +|..+..+++|+.|++++|++++..+..|.++++|++|++++|++++..+..|..+++|+.|++++|++
T Consensus 82 L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 6666666653 444555666666666666666655555666666666666666666655555566666666666666666
Q ss_pred CccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCC
Q 010856 235 SGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS 285 (499)
Q Consensus 235 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~ 285 (499)
++..+..|..+++|+.|++++|+++...+.......++.+++.+|||.|+|
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 655555556666666666666666644433344445566666666666655
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-25 Score=227.23 Aligned_cols=248 Identities=29% Similarity=0.374 Sum_probs=156.6
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|++|++++|.+++ .| .+..++ +|++|++++|++++ +|..+ ++|++|++++|++++ .| .+.++++|++|
T Consensus 131 ~~L~~L~L~~n~l~~-lp--~~~~l~-~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L 200 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP--ELQNSS-FLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAI 200 (454)
T ss_dssp TTCCEEECCSSCCSS-CC--CCTTCT-TCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEE
T ss_pred CCCCEEECcCCCCCC-Cc--ccCCCC-CCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEE
Confidence 578888888888876 34 366676 78888888888875 34332 477888888888775 34 47777888888
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCC
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTS 164 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (499)
++++|++++ +|.. .++|++|++++|.++ .+| .+..+++|+.|++++|+++.+|.. +++|+.|++++|.+++
T Consensus 201 ~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~ 271 (454)
T 1jl5_A 201 YADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD 271 (454)
T ss_dssp ECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC
T ss_pred ECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc
Confidence 888877774 3322 246777777777777 344 366777777777777777766642 2566666666666665
Q ss_pred CCcccccCCCCccEEEccCCccccc--Cccc-------------ccCC-cCCceeeCcCCcCCCCCCccccCCCCCCEEe
Q 010856 165 PLPLEIGNLKVLIGIDFSMNNFSGV--IPTE-------------IGGL-KNLEYLFLGYNRLQGSIPDSFGDLISLKFLN 228 (499)
Q Consensus 165 ~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~-------------l~~l-~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 228 (499)
+ |.. .++|+.|++++|++++. .|.. +..+ ++|++|++++|++++ +|.. +++|+.|+
T Consensus 272 l-~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~ 343 (454)
T 1jl5_A 272 L-PEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLI 343 (454)
T ss_dssp C-CCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred c-Ccc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEE
Confidence 2 221 24555555555555441 1111 1123 589999999999986 4443 58899999
Q ss_pred CCCCcCCccCcccccCCCCCCEEEccCCcCcc--cCCCCC-CC-------------CCccccccCCCcCCC
Q 010856 229 LSNNNLSGAIPASLEKLSYLENLNLSFNKLEG--EIPRGG-SF-------------GNFSAESFEGNELLC 283 (499)
Q Consensus 229 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~-~~-------------~~l~~~~l~~N~~~c 283 (499)
+++|++++ +|. .+++|+.|++++|++++ .+|... .+ ++++.+++++|+...
T Consensus 344 L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 344 ASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE 410 (454)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred CCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence 99999995 444 47899999999999998 555442 22 678889999998654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-25 Score=222.41 Aligned_cols=182 Identities=23% Similarity=0.299 Sum_probs=84.0
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|++|++++|.++++ |. .. + +|++|++++|+++++. . + .++|++|++++|++++ .| .|.++++|++|
T Consensus 91 ~~L~~L~l~~n~l~~l-p~-~~---~-~L~~L~l~~n~l~~l~-~-~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L 158 (454)
T 1jl5_A 91 PHLESLVASCNSLTEL-PE-LP---Q-SLKSLLVDNNNLKALS-D-L--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKII 158 (454)
T ss_dssp TTCSEEECCSSCCSSC-CC-CC---T-TCCEEECCSSCCSCCC-S-C--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEE
T ss_pred CCCCEEEccCCcCCcc-cc-cc---C-CCcEEECCCCccCccc-C-C--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEE
Confidence 4566666666666653 22 11 2 4555555555544321 1 0 1345555555555553 23 35555555555
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCc-------------------c
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-------------------T 145 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-------------------~ 145 (499)
++++|++++ +|.. ..+|++|++++|++++ .| .+..+++|+.|++++|+++.+|. .
T Consensus 159 ~l~~N~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~~~L~~L~l~~n~l~~lp~ 232 (454)
T 1jl5_A 159 DVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 232 (454)
T ss_dssp ECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCC
T ss_pred ECCCCcCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCcCcccEEECcCCcCCcccc
Confidence 555555543 2221 1244555555555543 22 34444444444444444444432 2
Q ss_pred ccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCC
Q 010856 146 FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 212 (499)
Q Consensus 146 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 212 (499)
+..+++|++|++++|++++. |. .+++|+.|++++|++++. |.. .++|++|++++|++++
T Consensus 233 ~~~l~~L~~L~l~~N~l~~l-~~---~~~~L~~L~l~~N~l~~l-~~~---~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 233 LQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTDL-PEL---PQSLTFLDVSENIFSG 291 (454)
T ss_dssp CTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSE
T ss_pred cCCCCCCCEEECCCCcCCcc-cc---cccccCEEECCCCccccc-Ccc---cCcCCEEECcCCccCc
Confidence 44455555555555555432 11 124455555555555432 221 2455555555555553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-25 Score=229.35 Aligned_cols=240 Identities=23% Similarity=0.209 Sum_probs=120.5
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEe
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLG 85 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 85 (499)
+++.|++++|.++.+ |. .+. ++|++|++++|.++.+ |. .+++|++|+|++|+++.+ |. .+++|++|+
T Consensus 41 ~l~~L~ls~n~L~~l-p~-~l~---~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~ 107 (622)
T 3g06_A 41 GNAVLNVGESGLTTL-PD-CLP---AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLTSL-PV---LPPGLLELS 107 (622)
T ss_dssp CCCEEECCSSCCSCC-CS-CCC---TTCSEEEECSCCCSCC-CC---CCTTCCEEEECSCCCSCC-CC---CCTTCCEEE
T ss_pred CCcEEEecCCCcCcc-Ch-hhC---CCCcEEEecCCCCCCC-CC---cCCCCCEEEcCCCcCCcC-CC---CCCCCCEEE
Confidence 355566666666533 22 111 2566666666655532 22 345555566665555532 22 445555555
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccc-----------------cC
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTF-----------------WN 148 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-----------------~~ 148 (499)
+++|.+++. |. .+++|+.|++++|+++.. |.. +++|++|++++|+++.+|..+ ..
T Consensus 108 Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~ 179 (622)
T 3g06_A 108 IFSNPLTHL-PA---LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPML 179 (622)
T ss_dssp ECSCCCCCC-CC---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCC
T ss_pred CcCCcCCCC-CC---CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCccc
Confidence 555555532 21 334444555555544432 211 244444444444444433211 22
Q ss_pred CCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEe
Q 010856 149 LKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLN 228 (499)
Q Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 228 (499)
+++|+.|++++|.++++. . .+++|+.|++++|.++.. |. .+++|+.|++++|.++++ | ..+++|+.|+
T Consensus 180 ~~~L~~L~Ls~N~l~~l~-~---~~~~L~~L~L~~N~l~~l-~~---~~~~L~~L~Ls~N~L~~l-p---~~l~~L~~L~ 247 (622)
T 3g06_A 180 PSGLQELSVSDNQLASLP-T---LPSELYKLWAYNNRLTSL-PA---LPSGLKELIVSGNRLTSL-P---VLPSELKELM 247 (622)
T ss_dssp CTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSSC-CC---CCTTCCEEECCSSCCSCC-C---CCCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCCC-C---ccchhhEEECcCCccccc-CC---CCCCCCEEEccCCccCcC-C---CCCCcCcEEE
Confidence 355566666666655422 1 124455555555555432 21 235666666666666642 3 3446667777
Q ss_pred CCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCC
Q 010856 229 LSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL 282 (499)
Q Consensus 229 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~ 282 (499)
+++|+|+... . .+++|+.|++++|+|+...+....++++..+++.+|++.
T Consensus 248 Ls~N~L~~lp-~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 248 VSGNRLTSLP-M---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp CCSSCCSCCC-C---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCC
T ss_pred CCCCCCCcCC-c---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCC
Confidence 7777666432 2 456667777777777633323344566666667776643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-26 Score=210.26 Aligned_cols=196 Identities=17% Similarity=0.217 Sum_probs=126.9
Q ss_pred CCCEEeccCCcCCccCCccccCCCCCCeEeccccc-ccccCCccccCcccccEEeeec-CCCCCcCCccccCCccCCeee
Q 010856 56 NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNK-LEGSIPDDICHLAELYRLDLDG-NKLSGSLPACFSNLTSLRIVS 133 (499)
Q Consensus 56 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 133 (499)
+|++|++++|+++++.+..|.++++|++|++++|+ ++...+..|.++++|++|++++ |+++...+..|.++++|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666666555566666666666666665 6655555666666666666666 666665556666666677777
Q ss_pred ccccCCCCCCccccCCCCCc---EEEcCCC-cCCCCCcccccCCCCcc-EEEccCCcccccCcccccCCcCCceeeCcCC
Q 010856 134 LGSNKLTSVPLTFWNLKDIL---NLNFSSN-FLTSPLPLEIGNLKVLI-GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYN 208 (499)
Q Consensus 134 L~~n~l~~~~~~~~~l~~L~---~L~l~~n-~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n 208 (499)
+++|+++.+|. +..+++|+ +|++++| .++++.+..|..+++|+ .|++++|+++.+.+..+.. ++|++|++++|
T Consensus 112 l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n 189 (239)
T 2xwt_C 112 IFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN 189 (239)
T ss_dssp EEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred CCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence 77776666664 55566665 6677666 66665555666677777 7777777766444444444 66777777777
Q ss_pred c-CCCCCCccccCC-CCCCEEeCCCCcCCccCcccccCCCCCCEEEccCC
Q 010856 209 R-LQGSIPDSFGDL-ISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256 (499)
Q Consensus 209 ~-l~~~~~~~l~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 256 (499)
+ ++++.+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 4 666656666666 7777777777777644333 4556666766654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=217.52 Aligned_cols=221 Identities=23% Similarity=0.257 Sum_probs=178.4
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
++..+++..+.+.+. ..+..+++|+.|++++|.++.. ..+..+++|++|++++|.+++. ..+..+++|++|+++
T Consensus 20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence 456667777776644 2356678888888888887732 3477788888888888888753 467888888888888
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCcc-ccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccC
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT-FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI 190 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 190 (499)
+|.+++..+..|..+++|++|++++|+++.++.. +..+++|++|++++|.+++..+..+..+++|+.|++++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 8888877777788888888888888888886554 677888888888888888877777888889999999999988877
Q ss_pred cccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC
Q 010856 191 PTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265 (499)
Q Consensus 191 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 265 (499)
+..+..+++|++|++++|++++..+..+..+++|+.|++++|++.+ .+++|+.++++.|.++|.+|..
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCT
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCc
Confidence 7778888999999999999988888788889999999999998773 3567888899999999888765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=209.87 Aligned_cols=225 Identities=25% Similarity=0.303 Sum_probs=192.2
Q ss_pred CEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecc
Q 010856 8 TLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLE 87 (499)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 87 (499)
..+++..+.+.+.. ....++ +|+.|++++|.++.. ..+..+++|++|++++|.+++. ..+..+++|++|+++
T Consensus 22 ~~l~l~~~~~~~~~---~~~~l~-~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 22 IKANLKKKSVTDAV---TQNELN-SIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHTCSCTTSEE---CHHHHT-TCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred HHHHhcCccccccc---cccccc-ceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence 34455666666543 344556 899999999998843 3588899999999999999853 478899999999999
Q ss_pred cccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCcc-ccCCCCCcEEEcCCCcCCCCC
Q 010856 88 DNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT-FWNLKDILNLNFSSNFLTSPL 166 (499)
Q Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~ 166 (499)
+|.+++..+..|..+++|++|++++|++++..+..|..+++|++|++++|+++.++.. +..+++|++|++++|.+++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 9999988888889999999999999999988888899999999999999999987654 678999999999999999888
Q ss_pred cccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCC
Q 010856 167 PLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 246 (499)
Q Consensus 167 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 246 (499)
+..+..+++|+.|++++|++++..+..+..+++|++|++++|.+.+ .+++|+.|+++.|.+++.+|..++.++
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccC
Confidence 8888999999999999999999888889999999999999998874 356799999999999999998887665
Q ss_pred C
Q 010856 247 Y 247 (499)
Q Consensus 247 ~ 247 (499)
.
T Consensus 247 ~ 247 (272)
T 3rfs_A 247 P 247 (272)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-28 Score=251.04 Aligned_cols=276 Identities=17% Similarity=0.140 Sum_probs=169.8
Q ss_pred CCCCCCEEECcCCCCCccC----ChhccccccccccEEEcccCCCcccCCccc-cCCC----CCCEEeccCCcCCc----
Q 010856 3 NCKSLTLIYLSNNPLDGIL----PKTSVGNLSHSLEDFRMYNCNISGGIPEEI-SNLT----NSTIVNLGGNKLNG---- 69 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~----~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~-~~l~----~L~~L~L~~n~l~~---- 69 (499)
.+++|++|+|++|.+++.. +. .+..++ +|++|++++|.+++..+..+ ..++ +|++|+|++|.++.
T Consensus 26 ~~~~L~~L~L~~~~l~~~~~~~l~~-~l~~~~-~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~ 103 (461)
T 1z7x_W 26 LLQQCQVVRLDDCGLTEARCKDISS-ALRVNP-ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 103 (461)
T ss_dssp HHTTCSEEEEESSCCCHHHHHHHHH-HHHTCT-TCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred hcCCccEEEccCCCCCHHHHHHHHH-HHHhCC-CcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence 4577888888888776432 22 344455 78888888887765444333 2344 58888888887774
Q ss_pred cCCccccCCCCCCeEecccccccccCCcccc-----CcccccEEeeecCCCCCcC----CccccCCccCCeeeccccCCC
Q 010856 70 SIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-----HLAELYRLDLDGNKLSGSL----PACFSNLTSLRIVSLGSNKLT 140 (499)
Q Consensus 70 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~ 140 (499)
..+..+..+++|++|++++|.++...+..+. ..++|++|++++|++++.. +..+..+++|+.|++++|.++
T Consensus 104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 183 (461)
T 1z7x_W 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183 (461)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence 3366677777888888888877644333222 2456777888777777533 344555677777777777766
Q ss_pred CC-Ccccc-----CCCCCcEEEcCCCcCCCC----CcccccCCCCccEEEccCCcccccC-----cccccCCcCCceeeC
Q 010856 141 SV-PLTFW-----NLKDILNLNFSSNFLTSP----LPLEIGNLKVLIGIDFSMNNFSGVI-----PTEIGGLKNLEYLFL 205 (499)
Q Consensus 141 ~~-~~~~~-----~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~-----~~~l~~l~~L~~L~L 205 (499)
.. +..+. ..++|++|++++|.+++. ++..+..+++|+.|++++|.+++.. +..+..+++|++|++
T Consensus 184 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L 263 (461)
T 1z7x_W 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263 (461)
T ss_dssp HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEEC
Confidence 52 11111 245777777777777653 2445566677777777777766432 222234677777777
Q ss_pred cCCcCCCC----CCccccCCCCCCEEeCCCCcCCccCcccccC-----CCCCCEEEccCCcCcccC----CCC-CCCCCc
Q 010856 206 GYNRLQGS----IPDSFGDLISLKFLNLSNNNLSGAIPASLEK-----LSYLENLNLSFNKLEGEI----PRG-GSFGNF 271 (499)
Q Consensus 206 ~~n~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~~----~~~-~~~~~l 271 (499)
++|.+++. .+..+..+++|+.|++++|.+++..+..+.. .++|+.|++++|.+++.. +.. ...+++
T Consensus 264 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 343 (461)
T 1z7x_W 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343 (461)
T ss_dssp TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC
T ss_pred cCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCc
Confidence 77777643 3455566777777777777776443333322 257777777777766431 111 123566
Q ss_pred cccccCCCc
Q 010856 272 SAESFEGNE 280 (499)
Q Consensus 272 ~~~~l~~N~ 280 (499)
+.+++++|.
T Consensus 344 ~~L~Ls~n~ 352 (461)
T 1z7x_W 344 LELQISNNR 352 (461)
T ss_dssp CEEECCSSB
T ss_pred cEEEccCCc
Confidence 667776664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-24 Score=224.89 Aligned_cols=226 Identities=22% Similarity=0.178 Sum_probs=162.6
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
++|++|+|++|.++.+.+ .++ +|++|+|++|+++++ |. .+++|++|+|++|.+++..+ .+++|+.|
T Consensus 61 ~~L~~L~L~~N~l~~lp~-----~l~-~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L 126 (622)
T 3g06_A 61 AHITTLVIPDNNLTSLPA-----LPP-ELRTLEVSGNQLTSL-PV---LPPGLLELSIFSNPLTHLPA----LPSGLCKL 126 (622)
T ss_dssp TTCSEEEECSCCCSCCCC-----CCT-TCCEEEECSCCCSCC-CC---CCTTCCEEEECSCCCCCCCC----CCTTCCEE
T ss_pred CCCcEEEecCCCCCCCCC-----cCC-CCCEEEcCCCcCCcC-CC---CCCCCCEEECcCCcCCCCCC----CCCCcCEE
Confidence 467777777777775433 233 777777777777743 33 55677777777777764322 34556666
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCC--ccc--------------cCCccCCeeeccccCCCCCCccccC
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP--ACF--------------SNLTSLRIVSLGSNKLTSVPLTFWN 148 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~--------------~~l~~L~~L~L~~n~l~~~~~~~~~ 148 (499)
++++|+++. +|.. +++|++|++++|++++... ..+ ..+++|+.|++++|+++.+|..
T Consensus 127 ~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~l~~~--- 199 (622)
T 3g06_A 127 WIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLASLPTL--- 199 (622)
T ss_dssp ECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCC---
T ss_pred ECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCCCCCc---
Confidence 666666553 2221 2555555555555553211 111 2237899999999999988754
Q ss_pred CCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEe
Q 010856 149 LKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLN 228 (499)
Q Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 228 (499)
+++|+.|++++|.++.+. . .+++|+.|++++|.++++ | ..+++|+.|++++|.++.+ |. .+++|+.|+
T Consensus 200 ~~~L~~L~L~~N~l~~l~-~---~~~~L~~L~Ls~N~L~~l-p---~~l~~L~~L~Ls~N~L~~l-p~---~~~~L~~L~ 267 (622)
T 3g06_A 200 PSELYKLWAYNNRLTSLP-A---LPSGLKELIVSGNRLTSL-P---VLPSELKELMVSGNRLTSL-PM---LPSGLLSLS 267 (622)
T ss_dssp CTTCCEEECCSSCCSSCC-C---CCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEE
T ss_pred cchhhEEECcCCcccccC-C---CCCCCCEEEccCCccCcC-C---CCCCcCcEEECCCCCCCcC-Cc---ccccCcEEe
Confidence 488999999999998643 2 358899999999999964 3 5568999999999999954 44 678999999
Q ss_pred CCCCcCCccCcccccCCCCCCEEEccCCcCcccCCC
Q 010856 229 LSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR 264 (499)
Q Consensus 229 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 264 (499)
+++|+|+ .+|..+..+++|+.|++++|++++..|.
T Consensus 268 Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 268 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred CCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 9999999 5678899999999999999999976554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-27 Score=233.58 Aligned_cols=251 Identities=19% Similarity=0.178 Sum_probs=194.8
Q ss_pred EEECcCCCCCccCChhccccccccccEEEcccCCCcccCC----ccccCCC-CCCEEeccCCcCCccCCccccCC-----
Q 010856 9 LIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIP----EEISNLT-NSTIVNLGGNKLNGSIPITLSKL----- 78 (499)
Q Consensus 9 ~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l----- 78 (499)
.+++++|++++..|. ++. .+.+|++|+|++|.+++..+ .+|..++ +|++|+|++|.++...+..+..+
T Consensus 2 ~~~ls~n~~~~~~~~-~~~-~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~ 79 (362)
T 3goz_A 2 NYKLTLHPGSNPVEE-FTS-IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79 (362)
T ss_dssp EEECCCCTTCCHHHH-HHT-SCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred ccccccccchHHHHH-HHh-CCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccC
Confidence 468899999987775 444 45479999999999998777 7888898 89999999999998777766664
Q ss_pred CCCCeEecccccccccCCcccc----Cc-ccccEEeeecCCCCCcCCccc----cC-CccCCeeeccccCCCC-----CC
Q 010856 79 QKLQGLGLEDNKLEGSIPDDIC----HL-AELYRLDLDGNKLSGSLPACF----SN-LTSLRIVSLGSNKLTS-----VP 143 (499)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~----~l-~~L~~L~L~~n~l~~~~~~~~----~~-l~~L~~L~L~~n~l~~-----~~ 143 (499)
++|++|+|++|.+++..+..+. .+ ++|++|++++|++++..+..+ .. .++|++|++++|++++ ++
T Consensus 80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 159 (362)
T 3goz_A 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI 159 (362)
T ss_dssp TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence 8999999999999877666444 34 899999999999987665544 33 3699999999999984 34
Q ss_pred ccccCCC-CCcEEEcCCCcCCCCCcccc----cCC-CCccEEEccCCcccccC----cccccC-CcCCceeeCcCCcCCC
Q 010856 144 LTFWNLK-DILNLNFSSNFLTSPLPLEI----GNL-KVLIGIDFSMNNFSGVI----PTEIGG-LKNLEYLFLGYNRLQG 212 (499)
Q Consensus 144 ~~~~~l~-~L~~L~l~~n~l~~~~~~~~----~~l-~~L~~L~l~~n~l~~~~----~~~l~~-l~~L~~L~L~~n~l~~ 212 (499)
..+..++ +|++|++++|.+++..+..+ ..+ ++|+.|++++|.+++.. +..+.. .++|++|+|++|.+++
T Consensus 160 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 239 (362)
T 3goz_A 160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239 (362)
T ss_dssp HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence 4455565 89999999999987665443 344 58999999999998643 334444 4589999999999987
Q ss_pred CCC----ccccCCCCCCEEeCCCCcCCccC-------cccccCCCCCCEEEccCCcCccc
Q 010856 213 SIP----DSFGDLISLKFLNLSNNNLSGAI-------PASLEKLSYLENLNLSFNKLEGE 261 (499)
Q Consensus 213 ~~~----~~l~~l~~L~~L~l~~N~l~~~~-------~~~~~~l~~L~~L~l~~N~l~~~ 261 (499)
..+ ..+..+++|+.|++++|.+.+.. +..+..+++|+.||+++|++...
T Consensus 240 ~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 240 PSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp CCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 654 33567789999999999855433 33567788899999999998754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-25 Score=204.26 Aligned_cols=199 Identities=20% Similarity=0.214 Sum_probs=176.0
Q ss_pred ccccccEEEcccCCCcccCCccccCCCCCCEEeccCCc-CCccCCccccCCCCCCeEeccc-ccccccCCccccCccccc
Q 010856 29 LSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNK-LNGSIPITLSKLQKLQGLGLED-NKLEGSIPDDICHLAELY 106 (499)
Q Consensus 29 l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~ 106 (499)
++.+|++|++++|+++++.+.+|.++++|++|++++|+ ++.+.+..|.++++|++|++++ |+++...+..|.++++|+
T Consensus 29 ~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~ 108 (239)
T 2xwt_C 29 LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK 108 (239)
T ss_dssp CCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCC
T ss_pred CCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCC
Confidence 34589999999999998888899999999999999997 9888888899999999999998 999988888899999999
Q ss_pred EEeeecCCCCCcCCccccCCccCC---eeecccc-CCCCCCc-cccCCCCCc-EEEcCCCcCCCCCcccccCCCCccEEE
Q 010856 107 RLDLDGNKLSGSLPACFSNLTSLR---IVSLGSN-KLTSVPL-TFWNLKDIL-NLNFSSNFLTSPLPLEIGNLKVLIGID 180 (499)
Q Consensus 107 ~L~L~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~-~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~ 180 (499)
+|++++|++++ .|. |..+++|+ .|++++| +++.++. .+..+++|+ +|++++|.++.+.+..|.. ++|+.|+
T Consensus 109 ~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~ 185 (239)
T 2xwt_C 109 FLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVY 185 (239)
T ss_dssp EEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEE
T ss_pred EEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEE
Confidence 99999999997 454 88888898 9999999 9999775 488899999 9999999999766666666 8999999
Q ss_pred ccCCc-ccccCcccccCC-cCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCc
Q 010856 181 FSMNN-FSGVIPTEIGGL-KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNN 233 (499)
Q Consensus 181 l~~n~-l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~ 233 (499)
+++|+ +++..+..|.++ ++|+.|++++|++++..+. .+++|+.|+++++.
T Consensus 186 L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp CTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred cCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence 99995 998888889999 9999999999999965444 67789999998763
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-28 Score=245.87 Aligned_cols=275 Identities=18% Similarity=0.153 Sum_probs=203.9
Q ss_pred CCCEEECcCCCCCcc----CChhccccccccccEEEcccCCCcccCCcccc-----CCCCCCEEeccCCcCCccC----C
Q 010856 6 SLTLIYLSNNPLDGI----LPKTSVGNLSHSLEDFRMYNCNISGGIPEEIS-----NLTNSTIVNLGGNKLNGSI----P 72 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~----~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~----~ 72 (499)
+|++|+|++|.+++. .+. .+..++ +|++|++++|.+++..+..+. ..++|++|++++|+++... +
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~-~l~~~~-~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSS-TLRTLP-TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHH-HTTSCT-TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHH-HHccCC-ceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 799999999998853 244 677777 899999999998765444333 3568999999999988643 4
Q ss_pred ccccCCCCCCeEecccccccccCCcccc-----CcccccEEeeecCCCCCc----CCccccCCccCCeeeccccCCCCC-
Q 010856 73 ITLSKLQKLQGLGLEDNKLEGSIPDDIC-----HLAELYRLDLDGNKLSGS----LPACFSNLTSLRIVSLGSNKLTSV- 142 (499)
Q Consensus 73 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~- 142 (499)
..+..+++|++|++++|.++...+..+. ..++|++|++++|.++.. ++..+..+++|++|++++|+++..
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 5566778999999999998755444443 256899999999998864 356677788999999999988762
Q ss_pred -----CccccCCCCCcEEEcCCCcCCCC----CcccccCCCCccEEEccCCcccccCcccccC-----CcCCceeeCcCC
Q 010856 143 -----PLTFWNLKDILNLNFSSNFLTSP----LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGG-----LKNLEYLFLGYN 208 (499)
Q Consensus 143 -----~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~-----l~~L~~L~L~~n 208 (499)
+..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++..+..+.. .++|++|++++|
T Consensus 244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 323 (461)
T 1z7x_W 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCC
Confidence 22233578999999999988763 4556667889999999999887654444432 368999999999
Q ss_pred cCCCC----CCccccCCCCCCEEeCCCCcCCccCcccccC-----CCCCCEEEccCCcCcc----cCCCC-CCCCCcccc
Q 010856 209 RLQGS----IPDSFGDLISLKFLNLSNNNLSGAIPASLEK-----LSYLENLNLSFNKLEG----EIPRG-GSFGNFSAE 274 (499)
Q Consensus 209 ~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~----~~~~~-~~~~~l~~~ 274 (499)
.+++. .+..+..+++|+.|++++|++++..+..+.. .++|+.|++++|++++ .+|.. ...++++.+
T Consensus 324 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L 403 (461)
T 1z7x_W 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403 (461)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred CCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEE
Confidence 88865 3455677789999999999887655544432 6789999999998884 33322 346778888
Q ss_pred ccCCCcCC
Q 010856 275 SFEGNELL 282 (499)
Q Consensus 275 ~l~~N~~~ 282 (499)
++++|+..
T Consensus 404 ~l~~N~i~ 411 (461)
T 1z7x_W 404 DLSNNCLG 411 (461)
T ss_dssp ECCSSSCC
T ss_pred ECCCCCCC
Confidence 88888753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=216.50 Aligned_cols=222 Identities=17% Similarity=0.188 Sum_probs=122.7
Q ss_pred ccEEEcccCCCcccCCc---cccCCCCCCEEeccCCcCCccCCccc--cCCCCCCeEecccccccccCC----ccccCcc
Q 010856 33 LEDFRMYNCNISGGIPE---EISNLTNSTIVNLGGNKLNGSIPITL--SKLQKLQGLGLEDNKLEGSIP----DDICHLA 103 (499)
Q Consensus 33 L~~L~l~~n~i~~~~~~---~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l~ 103 (499)
++.|.+.++.++..... .+..+++|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..++
T Consensus 66 l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~ 145 (310)
T 4glp_A 66 VRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKP 145 (310)
T ss_dssp CCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCS
T ss_pred eeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhcc
Confidence 55666666555421100 11223456666666666666666555 666666666666666664333 2334566
Q ss_pred cccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC---CC--ccccCCCCCcEEEcCCCcCCCCCcc---cccCCCC
Q 010856 104 ELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS---VP--LTFWNLKDILNLNFSSNFLTSPLPL---EIGNLKV 175 (499)
Q Consensus 104 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~~--~~~~~l~~L~~L~l~~n~l~~~~~~---~~~~l~~ 175 (499)
+|++|++++|++++..+..|..+++|++|++++|++.. ++ ..+..+++|++|++++|+++..... .+..+++
T Consensus 146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~ 225 (310)
T 4glp_A 146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQ 225 (310)
T ss_dssp CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCC
T ss_pred CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCC
Confidence 66666666666666666666666666666666666543 22 1224556666666666666532111 2345566
Q ss_pred ccEEEccCCcccccCcccccCC---cCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEE
Q 010856 176 LIGIDFSMNNFSGVIPTEIGGL---KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLN 252 (499)
Q Consensus 176 L~~L~l~~n~l~~~~~~~l~~l---~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 252 (499)
|++|++++|++++..|..+..+ ++|++|++++|+++ .+|..+. ++|+.|++++|++++. |. +..+++|+.|+
T Consensus 226 L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~ 300 (310)
T 4glp_A 226 PHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLT 300 (310)
T ss_dssp CSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEE
T ss_pred CCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEE
Confidence 6666666666665555444444 46666666666666 3344332 5666666666666643 22 45556666666
Q ss_pred ccCCcCc
Q 010856 253 LSFNKLE 259 (499)
Q Consensus 253 l~~N~l~ 259 (499)
+++|+++
T Consensus 301 L~~N~l~ 307 (310)
T 4glp_A 301 LDGNPFL 307 (310)
T ss_dssp CSSTTTS
T ss_pred CcCCCCC
Confidence 6666655
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=213.20 Aligned_cols=225 Identities=16% Similarity=0.172 Sum_probs=185.6
Q ss_pred CCCEEECcCCCCCccCChh--ccccccccccEEEcccCCCcccCCccc--cCCCCCCEEeccCCcCCccCC----ccccC
Q 010856 6 SLTLIYLSNNPLDGILPKT--SVGNLSHSLEDFRMYNCNISGGIPEEI--SNLTNSTIVNLGGNKLNGSIP----ITLSK 77 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~--~~~~l~~~L~~L~l~~n~i~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~ 77 (499)
.++.|.+.++.++...... ....++ +|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYS-RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHS-CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccC-ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4677888877775321110 112234 69999999999999999888 899999999999999997554 34567
Q ss_pred CCCCCeEecccccccccCCccccCcccccEEeeecCCCCCc---C-CccccCCccCCeeeccccCCCCCCcc----ccCC
Q 010856 78 LQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGS---L-PACFSNLTSLRIVSLGSNKLTSVPLT----FWNL 149 (499)
Q Consensus 78 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~---~-~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~l 149 (499)
+++|++|+|++|++.+..+..|..+++|++|+|++|++.+. . +..+..+++|++|++++|+++.++.. +..+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 99999999999999988889999999999999999998642 2 23347889999999999999876652 5678
Q ss_pred CCCcEEEcCCCcCCCCCcccccCC---CCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCE
Q 010856 150 KDILNLNFSSNFLTSPLPLEIGNL---KVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKF 226 (499)
Q Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 226 (499)
++|++|++++|.+++..|..+..+ ++|++|++++|+++. +|..+. ++|++|+|++|++++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 999999999999998877777766 699999999999994 566553 8999999999999965 33 788899999
Q ss_pred EeCCCCcCCc
Q 010856 227 LNLSNNNLSG 236 (499)
Q Consensus 227 L~l~~N~l~~ 236 (499)
|++++|++++
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999974
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=209.75 Aligned_cols=194 Identities=24% Similarity=0.347 Sum_probs=107.2
Q ss_pred cCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCe
Q 010856 52 SNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRI 131 (499)
Q Consensus 52 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 131 (499)
..+++|++|++++|.++.. + .+..+++|++|++++|.+++..+ +..+++|++|++++|++++. ..+..+++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 3445555555555555432 2 34555555555555555553322 55555555555555555532 23555555555
Q ss_pred eeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCC
Q 010856 132 VSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 211 (499)
Q Consensus 132 L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 211 (499)
|++++|+++.++. +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.++
T Consensus 112 L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 112 LDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp EECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 5555555555543 5555566666666665554332 5555666666666666654332 556666666666666665
Q ss_pred CCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcc
Q 010856 212 GSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 212 ~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 260 (499)
+..+ +..+++|+.|++++|++++.. .+..+++|+.|++++|++++
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 4322 556666666666666666443 25666666666666666654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=206.35 Aligned_cols=208 Identities=19% Similarity=0.330 Sum_probs=178.0
Q ss_pred ECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEeccccc
Q 010856 11 YLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNK 90 (499)
Q Consensus 11 ~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 90 (499)
.+..+.+++... ...++ +|++|++++|.++.. + .+..+++|++|++++|.+++..+ +..+++|++|++++|+
T Consensus 25 ~l~~~~~~~~~~---~~~l~-~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 25 AAGKSNVTDTVT---QADLD-GITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (308)
T ss_dssp HTTCSSTTSEEC---HHHHH-TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HhCCCCcCceec---HHHcC-CcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence 445555655433 33466 899999999999864 4 68899999999999999986555 8999999999999999
Q ss_pred ccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccc
Q 010856 91 LEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEI 170 (499)
Q Consensus 91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 170 (499)
+++. ..+..+++|++|++++|++++.. .+..+++|+.|++++|+++.++. +..+++|++|++++|.+++..+ +
T Consensus 97 l~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l 169 (308)
T 1h6u_A 97 LKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--L 169 (308)
T ss_dssp CSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred CCCc--hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh--h
Confidence 9864 46899999999999999999653 38899999999999999999875 8899999999999999997544 8
Q ss_pred cCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCcc
Q 010856 171 GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGA 237 (499)
Q Consensus 171 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 237 (499)
..+++|+.|++++|++++..+ +..+++|++|++++|++++.. .+..+++|+.|++++|++++.
T Consensus 170 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 899999999999999987644 889999999999999999664 489999999999999999853
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-26 Score=221.40 Aligned_cols=249 Identities=21% Similarity=0.215 Sum_probs=149.7
Q ss_pred CCEEECcCCCCCccCChhccccc--cccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCcc-CCccccCCCCCCe
Q 010856 7 LTLIYLSNNPLDGILPKTSVGNL--SHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGS-IPITLSKLQKLQG 83 (499)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~~l--~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~ 83 (499)
++.+++++|.+.. . .+..+ + +++.|++++|.+.+..+. +..+++|++|++++|.+++. .+..+..+++|++
T Consensus 49 ~~~l~l~~~~~~~---~-~~~~~~~~-~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~ 122 (336)
T 2ast_B 49 WQTLDLTGKNLHP---D-VTGRLLSQ-GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 122 (336)
T ss_dssp SSEEECTTCBCCH---H-HHHHHHHT-TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred heeeccccccCCH---H-HHHhhhhc-cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence 5667777766652 2 33333 3 677777777777655544 44567777777777776644 5555666777777
Q ss_pred EecccccccccCCccccCcccccEEeeecC-CCCCc-CCccccCCccCCeeecccc-CCCC--CCccccCCC-CCcEEEc
Q 010856 84 LGLEDNKLEGSIPDDICHLAELYRLDLDGN-KLSGS-LPACFSNLTSLRIVSLGSN-KLTS--VPLTFWNLK-DILNLNF 157 (499)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n-~l~~--~~~~~~~l~-~L~~L~l 157 (499)
|++++|.+++..+..+..+++|++|++++| .+++. .+..+..+++|++|++++| .++. ++..+..++ +|++|++
T Consensus 123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l 202 (336)
T 2ast_B 123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202 (336)
T ss_dssp EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence 777777766656666666777777777777 45532 3444566677777777777 6664 455566666 7777777
Q ss_pred CCC--cCC-CCCcccccCCCCccEEEccCCc-ccccCcccccCCcCCceeeCcCCc-CCCCCCccccCCCCCCEEeCCCC
Q 010856 158 SSN--FLT-SPLPLEIGNLKVLIGIDFSMNN-FSGVIPTEIGGLKNLEYLFLGYNR-LQGSIPDSFGDLISLKFLNLSNN 232 (499)
Q Consensus 158 ~~n--~l~-~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~l~~N 232 (499)
++| .++ ...+..+..+++|+.|++++|. +++..+..+..+++|++|++++|. +.......+..+++|+.|++++|
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 776 343 2234445566677777777776 555555566666777777777664 22222224566667777777766
Q ss_pred cCCccCcccccCCCCCCEEEccCCcCcccCCC
Q 010856 233 NLSGAIPASLEKLSYLENLNLSFNKLEGEIPR 264 (499)
Q Consensus 233 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 264 (499)
++......+. .++..|++++|++++..|.
T Consensus 283 -i~~~~~~~l~--~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 283 -VPDGTLQLLK--EALPHLQINCSHFTTIARP 311 (336)
T ss_dssp -SCTTCHHHHH--HHSTTSEESCCCSCCTTCS
T ss_pred -cCHHHHHHHH--hhCcceEEecccCccccCC
Confidence 3322212221 2244455666666665554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-23 Score=195.68 Aligned_cols=177 Identities=25% Similarity=0.285 Sum_probs=96.1
Q ss_pred ccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeec
Q 010856 33 LEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG 112 (499)
Q Consensus 33 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 112 (499)
.++++++++.++. +|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|++++
T Consensus 16 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 4445555555442 222222 3455555555555544444455555555555555555544444455555555555555
Q ss_pred CCCCCcCCccccCCccCCeeeccccCCCCCCcc-ccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCc
Q 010856 113 NKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT-FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP 191 (499)
Q Consensus 113 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (499)
|++++..+..|..+++|++|++++|+++.++.. +..+++|++|++++|.++++.+..|..+++|+.|++++|++++..+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 555544445555555555555555555554433 3455556666666666655555556666666666666666665555
Q ss_pred ccccCCcCCceeeCcCCcCCC
Q 010856 192 TEIGGLKNLEYLFLGYNRLQG 212 (499)
Q Consensus 192 ~~l~~l~~L~~L~L~~n~l~~ 212 (499)
..|..+++|+.|++++|++..
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCT
T ss_pred HHHhCCCCCCEEEeeCCceeC
Confidence 566666666666666666654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-26 Score=230.74 Aligned_cols=237 Identities=23% Similarity=0.253 Sum_probs=175.2
Q ss_pred ccccccccccEEEcccCCCcccCC----ccccCCCCCCEEeccCCcCC---ccCCccc-------cCCCCCCeEeccccc
Q 010856 25 SVGNLSHSLEDFRMYNCNISGGIP----EEISNLTNSTIVNLGGNKLN---GSIPITL-------SKLQKLQGLGLEDNK 90 (499)
Q Consensus 25 ~~~~l~~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~---~~~~~~~-------~~l~~L~~L~L~~n~ 90 (499)
.+..++ +|++|+|++|.++...+ ..+..+++|++|+|++|.+. +..|..+ ..+++|++|+|++|.
T Consensus 27 ~l~~~~-~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 27 VLLEDD-SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHHCS-CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHhcCC-CccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 455566 79999999998886533 34678889999999886443 3344433 678889999999998
Q ss_pred ccc----cCCccccCcccccEEeeecCCCCCcCCcccc----CC---------ccCCeeeccccCCCC--CC---ccccC
Q 010856 91 LEG----SIPDDICHLAELYRLDLDGNKLSGSLPACFS----NL---------TSLRIVSLGSNKLTS--VP---LTFWN 148 (499)
Q Consensus 91 l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l---------~~L~~L~L~~n~l~~--~~---~~~~~ 148 (499)
++. .++..+..+++|++|+|++|.++...+..+. .+ ++|++|++++|+++. ++ ..+..
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 185 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence 886 3566778888899999999988744333333 33 788899999988873 44 45667
Q ss_pred CCCCcEEEcCCCcCCC-----CCcccccCCCCccEEEccCCccc----ccCcccccCCcCCceeeCcCCcCCCC----CC
Q 010856 149 LKDILNLNFSSNFLTS-----PLPLEIGNLKVLIGIDFSMNNFS----GVIPTEIGGLKNLEYLFLGYNRLQGS----IP 215 (499)
Q Consensus 149 l~~L~~L~l~~n~l~~-----~~~~~~~~l~~L~~L~l~~n~l~----~~~~~~l~~l~~L~~L~L~~n~l~~~----~~ 215 (499)
+++|++|++++|.++. ..+..+..+++|+.|+|++|.++ ...|..+..+++|++|+|++|.+++. ++
T Consensus 186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 265 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265 (386)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence 8888899998888873 23336778888888888888885 45667778888888888888888764 34
Q ss_pred cccc--CCCCCCEEeCCCCcCCc----cCcccc-cCCCCCCEEEccCCcCcccC
Q 010856 216 DSFG--DLISLKFLNLSNNNLSG----AIPASL-EKLSYLENLNLSFNKLEGEI 262 (499)
Q Consensus 216 ~~l~--~l~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~ 262 (499)
..+. .+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|++++..
T Consensus 266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 5553 37888888888888886 356555 56788888888888887543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-23 Score=194.50 Aligned_cols=180 Identities=24% Similarity=0.302 Sum_probs=104.1
Q ss_pred CCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecc
Q 010856 56 NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLG 135 (499)
Q Consensus 56 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 135 (499)
..++++++++.++. +|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|+++
T Consensus 15 ~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 34556666666653 232222 355555555555555555555555555555555555555444445555555555555
Q ss_pred ccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCC
Q 010856 136 SNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 215 (499)
Q Consensus 136 ~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 215 (499)
+|+++ +..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+
T Consensus 92 ~n~l~-----------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 148 (251)
T 3m19_A 92 NNQLA-----------------------SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA 148 (251)
T ss_dssp TSCCC-----------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCccc-----------------------ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence 55444 4444445555555555555555555555555666666666666666665555
Q ss_pred ccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCccc
Q 010856 216 DSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGE 261 (499)
Q Consensus 216 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 261 (499)
..|..+++|+.|++++|++++..+..+..+++|+.|++++|++++.
T Consensus 149 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 5666666667777777766666666666667777777777776654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-26 Score=227.37 Aligned_cols=236 Identities=21% Similarity=0.215 Sum_probs=191.6
Q ss_pred CCCCCCEEECcCCCCCccCChh---ccccccccccEEEcccCCC---cccCCccc-------cCCCCCCEEeccCCcCCc
Q 010856 3 NCKSLTLIYLSNNPLDGILPKT---SVGNLSHSLEDFRMYNCNI---SGGIPEEI-------SNLTNSTIVNLGGNKLNG 69 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~---~~~~l~~~L~~L~l~~n~i---~~~~~~~~-------~~l~~L~~L~L~~n~l~~ 69 (499)
.+++|++|+|++|.+++..+.. .+..++ +|++|+|++|.+ ++.+|..+ ..+++|++|+|++|.++.
T Consensus 30 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~-~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 108 (386)
T 2ca6_A 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 108 (386)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCT-TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred cCCCccEEECCCCCCCHHHHHHHHHHHHhCC-CccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCH
Confidence 5789999999999998764431 355677 899999999644 44555554 789999999999999987
Q ss_pred ----cCCccccCCCCCCeEecccccccccCCccc----cCc---------ccccEEeeecCCCCC-cCC---ccccCCcc
Q 010856 70 ----SIPITLSKLQKLQGLGLEDNKLEGSIPDDI----CHL---------AELYRLDLDGNKLSG-SLP---ACFSNLTS 128 (499)
Q Consensus 70 ----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----~~l---------~~L~~L~L~~n~l~~-~~~---~~~~~l~~ 128 (499)
.++..+..+++|++|+|++|.++...+..+ ..+ ++|++|++++|+++. ..+ ..+..+++
T Consensus 109 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~ 188 (386)
T 2ca6_A 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 188 (386)
T ss_dssp TTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCC
Confidence 356678899999999999999975444433 334 899999999999973 333 35677899
Q ss_pred CCeeeccccCCCC------CCccccCCCCCcEEEcCCCcCC----CCCcccccCCCCccEEEccCCccccc----Ccccc
Q 010856 129 LRIVSLGSNKLTS------VPLTFWNLKDILNLNFSSNFLT----SPLPLEIGNLKVLIGIDFSMNNFSGV----IPTEI 194 (499)
Q Consensus 129 L~~L~L~~n~l~~------~~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l 194 (499)
|+.|++++|+++. ++..+..+++|+.|+|++|.++ ..++..+..+++|+.|+|++|.+++. ++..+
T Consensus 189 L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l 268 (386)
T 2ca6_A 189 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 268 (386)
T ss_dssp CCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHH
T ss_pred cCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHH
Confidence 9999999999983 3447889999999999999996 45677888999999999999999865 45556
Q ss_pred c--CCcCCceeeCcCCcCCC----CCCccc-cCCCCCCEEeCCCCcCCccCc
Q 010856 195 G--GLKNLEYLFLGYNRLQG----SIPDSF-GDLISLKFLNLSNNNLSGAIP 239 (499)
Q Consensus 195 ~--~l~~L~~L~L~~n~l~~----~~~~~l-~~l~~L~~L~l~~N~l~~~~~ 239 (499)
. .+++|++|+|++|.+++ .++..+ ..+++|+.|++++|++++..+
T Consensus 269 ~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 269 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred hhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 3 38999999999999997 366666 668999999999999997663
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.7e-23 Score=200.71 Aligned_cols=199 Identities=14% Similarity=0.108 Sum_probs=106.4
Q ss_pred CEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCcc-CCccccCCCCCCe-Ee
Q 010856 8 TLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGS-IPITLSKLQKLQG-LG 85 (499)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~-L~ 85 (499)
++++.++++++.+ |. . ++.++++|+|++|+|+.+.+++|.++++|++|+|++|++.+. .+.+|.++++|++ +.
T Consensus 12 ~~v~C~~~~Lt~i-P~-~---l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 12 RVFLCQESKVTEI-PS-D---LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp TEEEEESTTCCSC-CT-T---CCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred CEEEecCCCCCcc-Cc-C---cCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 4566666666644 32 1 233666677777766665556666666777777766665443 3345666666554 44
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccc-cCCCCCCc-cccCC-CCCcEEEcCCCcC
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGS-NKLTSVPL-TFWNL-KDILNLNFSSNFL 162 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~-~~~~l-~~L~~L~l~~n~l 162 (499)
+++|+++.+.+..|..+++|++|++++|+++...+..+....++..|++.+ +++..++. .+..+ ..++.|++++|+|
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i 166 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence 455666656566666666666666666666655555555555555566543 34554433 23332 2345555555555
Q ss_pred CCCCcccccCCCCccEEEccC-CcccccCcccccCCcCCceeeCcCCcCCC
Q 010856 163 TSPLPLEIGNLKVLIGIDFSM-NNFSGVIPTEIGGLKNLEYLFLGYNRLQG 212 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 212 (499)
+.+.+..| ...+|+.|++++ |.++.+.+..|.++++|++|++++|+|+.
T Consensus 167 ~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 167 QEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp CEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred cCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc
Confidence 54333222 223444444442 34443333444445555555555555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-25 Score=218.39 Aligned_cols=247 Identities=20% Similarity=0.201 Sum_probs=196.8
Q ss_pred EEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCC----ccccCCC-CCCeEecccccccccCCccccCc-----cc
Q 010856 35 DFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIP----ITLSKLQ-KLQGLGLEDNKLEGSIPDDICHL-----AE 104 (499)
Q Consensus 35 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~ 104 (499)
.+++++|.+++.+|..+...++|++|+|++|.++...+ ..|..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46889999999888877777789999999999997776 6788888 99999999999998877777765 99
Q ss_pred ccEEeeecCCCCCcCCccc----cCC-ccCCeeeccccCCCCCCc-----cccC-CCCCcEEEcCCCcCCCCCccc----
Q 010856 105 LYRLDLDGNKLSGSLPACF----SNL-TSLRIVSLGSNKLTSVPL-----TFWN-LKDILNLNFSSNFLTSPLPLE---- 169 (499)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~----~~l-~~L~~L~L~~n~l~~~~~-----~~~~-l~~L~~L~l~~n~l~~~~~~~---- 169 (499)
|++|+|++|++++..+..+ ..+ ++|+.|++++|+++..+. .+.. .++|++|++++|.+++.....
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999997766644 444 899999999999988553 2334 369999999999998644433
Q ss_pred ccCCC-CccEEEccCCcccccCccccc----CC-cCCceeeCcCCcCCCCC----CccccC-CCCCCEEeCCCCcCCccC
Q 010856 170 IGNLK-VLIGIDFSMNNFSGVIPTEIG----GL-KNLEYLFLGYNRLQGSI----PDSFGD-LISLKFLNLSNNNLSGAI 238 (499)
Q Consensus 170 ~~~l~-~L~~L~l~~n~l~~~~~~~l~----~l-~~L~~L~L~~n~l~~~~----~~~l~~-l~~L~~L~l~~N~l~~~~ 238 (499)
+..++ +|++|++++|++++..+..+. .+ ++|++|+|++|.+++.. +..+.. .++|+.|++++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 34555 999999999999987765544 44 59999999999998643 344544 469999999999998765
Q ss_pred c----ccccCCCCCCEEEccCCcCcccCC--------CCCCCCCccccccCCCcC
Q 010856 239 P----ASLEKLSYLENLNLSFNKLEGEIP--------RGGSFGNFSAESFEGNEL 281 (499)
Q Consensus 239 ~----~~~~~l~~L~~L~l~~N~l~~~~~--------~~~~~~~l~~~~l~~N~~ 281 (499)
+ ..+..+++|+.|++++|.+.+..+ .....+.+..+++++|+.
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l 296 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcC
Confidence 5 445778999999999999553322 223456678889999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-25 Score=208.93 Aligned_cols=135 Identities=18% Similarity=0.169 Sum_probs=107.2
Q ss_pred hhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+ ..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--PL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--EE
Confidence 56888999999999999999853 47889999998765555678999999999999999999999998743 44
Q ss_pred eeeecccC-CCccccccc-----------------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEE
Q 010856 435 LCLFHHSS-ASASASLVS-----------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVI 490 (499)
Q Consensus 435 ~~l~~~~~-~~~~~~l~~-----------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~ 490 (499)
++++||+. |++.+.++. .+.....++.|||+||+|||+ |+||.|+|++.++.+|++
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence 56777775 455444432 223344567999999999876 899999999999999999
Q ss_pred EEEEeec
Q 010856 491 CFVFEIL 497 (499)
Q Consensus 491 ~f~~~~~ 497 (499)
|||+++.
T Consensus 171 DFGla~~ 177 (299)
T 4asz_A 171 DFGMSRD 177 (299)
T ss_dssp CCSCHHH
T ss_pred Cccccee
Confidence 9999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-25 Score=210.00 Aligned_cols=136 Identities=19% Similarity=0.185 Sum_probs=104.8
Q ss_pred hhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|.+.+.||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|...+ ..
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR--PL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence 56788899999999999999853 47899999998765555788999999999999999999999997643 44
Q ss_pred eeeecccCCC-ccccccc-------------------cccccccccccccccceeecc------CCCcccEEEeeCCCeE
Q 010856 435 LCLFHHSSAS-ASASLVS-------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVE 488 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~-------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~ 488 (499)
++++||+.++ +.+.++. .+.....++.|||+||+|||+ |+||.|||++.++.+|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 5677777554 4333322 122234557899999999765 8999999999999999
Q ss_pred EEEEEEeecc
Q 010856 489 VICFVFEILL 498 (499)
Q Consensus 489 ~~~f~~~~~~ 498 (499)
++|||+++.+
T Consensus 199 i~DFGla~~~ 208 (329)
T 4aoj_A 199 IGDFGMSRDI 208 (329)
T ss_dssp ECCCC-----
T ss_pred Ecccccceec
Confidence 9999998754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-23 Score=200.92 Aligned_cols=223 Identities=17% Similarity=0.129 Sum_probs=183.9
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcc-cCCccccCCCCCCE-EeccCCcCCccCCccccCCCCCC
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISG-GIPEEISNLTNSTI-VNLGGNKLNGSIPITLSKLQKLQ 82 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~ 82 (499)
+++++|+|++|+|+.+.+. .|.+++ +|++|+|++|++.+ +.+.+|.++++|++ +.+++|+++.+.|..|..+++|+
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~-~f~~l~-~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~ 107 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKG-AFSGFG-DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ 107 (350)
T ss_dssp TTCSEEEEESCCCSEECTT-SSTTCT-TCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCC
T ss_pred CCCCEEEccCCcCCCcCHH-HHcCCC-CCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccc
Confidence 5799999999999977665 788898 99999999999865 44567999998876 66778999988899999999999
Q ss_pred eEecccccccccCCccccCcccccEEeeec-CCCCCcCCccccCCc-cCCeeeccccCCCCCCccccCCCCCcEEEcCC-
Q 010856 83 GLGLEDNKLEGSIPDDICHLAELYRLDLDG-NKLSGSLPACFSNLT-SLRIVSLGSNKLTSVPLTFWNLKDILNLNFSS- 159 (499)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~- 159 (499)
+|++++|++....+..+....++..|++.+ +++....+..|..+. .++.|++++|+|+.++...+...+|++|++++
T Consensus 108 ~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~ 187 (350)
T 4ay9_X 108 YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDN 187 (350)
T ss_dssp EEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTC
T ss_pred cccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccC
Confidence 999999999977777777888899999976 678877777787775 68999999999999998888888999999975
Q ss_pred CcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCc
Q 010856 160 NFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNN 233 (499)
Q Consensus 160 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~ 233 (499)
|.++.+.+..|..+++|+.|++++|+|+.+.+..|.++++|+.+++ +.++ ..| .+..+++|+.++++++.
T Consensus 188 n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 188 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp TTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred CcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCc
Confidence 7788777778999999999999999999776665555544444433 2344 444 47788889999887653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-24 Score=201.71 Aligned_cols=137 Identities=15% Similarity=0.187 Sum_probs=106.8
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|++.+.||+|+||+||+|+. .+|+.||+|++++.. ....+.+.+|++++++++|||||++++++...+ ..+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD--EII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEE
Confidence 47899999999999999999995 579999999997653 233567999999999999999999999987743 445
Q ss_pred eeecccCCCccccccccccc----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASASASLVSSLTL----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~~~~----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++||++|++.+.+...... .+.++.|++.||+|||+ |+||+||+++.++.++++|||+++..
T Consensus 90 ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 67788888877766543333 34446899999999876 89999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-24 Score=207.53 Aligned_cols=136 Identities=17% Similarity=0.176 Sum_probs=111.6
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
..|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+ ..++++|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEe
Confidence 4588999999999999999996 579999999998766566678999999999999999999999998744 4456788
Q ss_pred ccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|+.|+.+..+.. .+...+.++.||+.||+|||+ |+||+|||++.++.+|++|||+++.+
T Consensus 152 y~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 152 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceec
Confidence 886654433322 223344556899999999976 89999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-24 Score=207.78 Aligned_cols=137 Identities=12% Similarity=0.107 Sum_probs=104.9
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG--SLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--EEEE
Confidence 36799999999999999999996 579999999997654 234577999999999999999999999987643 3455
Q ss_pred eecccC-CCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHSS-ASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~-~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++||+. |++.+.+... +.....++.||+.||+|||+ |+||+|||++.++.+|++|||+++.+
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 677775 5555555322 22234456899999999876 89999999999999999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-24 Score=205.47 Aligned_cols=136 Identities=18% Similarity=0.126 Sum_probs=105.2
Q ss_pred hhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
+++.+.+.||+|+||+||+|++ .+++.||||+++... ....++|.+|+.++++++|||||+++|+|...+ .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~--~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ--P 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--S
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC--E
Confidence 4567778999999999999985 246789999997554 344678999999999999999999999997633 3
Q ss_pred eeeeecccCC-Ccccccccc--------------------ccccccccccccccceeecc------CCCcccEEEeeCCC
Q 010856 434 CLCLFHHSSA-SASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG 486 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~ 486 (499)
..+++||+.+ ++.+.+... +.....++.|||+||+|||+ |+||.|||+++++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 4556777754 544444221 11233457899999999876 89999999999999
Q ss_pred eEEEEEEEeecc
Q 010856 487 VEVICFVFEILL 498 (499)
Q Consensus 487 ~~~~~f~~~~~~ 498 (499)
+|++|||+++.+
T Consensus 184 ~Ki~DFGlar~~ 195 (308)
T 4gt4_A 184 VKISDLGLFREV 195 (308)
T ss_dssp EEECCSCCBCGG
T ss_pred EEECCcccceec
Confidence 999999998754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9.3e-25 Score=212.33 Aligned_cols=233 Identities=15% Similarity=0.158 Sum_probs=193.3
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCccc-CCccccCCCCCCEEeccCCcCCccCCccccCCCCCCe
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGG-IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQG 83 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 83 (499)
++++.|++++|.+.+..+. +..++ +|++|++++|.+++. .+..+..+++|++|++++|.+++..+..+..+++|++
T Consensus 70 ~~l~~L~l~~n~l~~~~~~--~~~~~-~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~ 146 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE--HFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 146 (336)
T ss_dssp TTCSEEECTTCEECSCCCS--CCCCB-CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSE
T ss_pred ccceEEEcCCccccccchh--hccCC-CCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCE
Confidence 7899999999999988765 44577 899999999999865 7778999999999999999998878888999999999
Q ss_pred Eecccc-ccccc-CCccccCcccccEEeeecC-CCCCc-CCccccCCc-cCCeeecccc--CCCC--CCccccCCCCCcE
Q 010856 84 LGLEDN-KLEGS-IPDDICHLAELYRLDLDGN-KLSGS-LPACFSNLT-SLRIVSLGSN--KLTS--VPLTFWNLKDILN 154 (499)
Q Consensus 84 L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~L~~n--~l~~--~~~~~~~l~~L~~ 154 (499)
|++++| .+++. .+..+..+++|++|++++| .+++. .+..+..++ +|++|++++| .++. ++..+..+++|++
T Consensus 147 L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~ 226 (336)
T 2ast_B 147 LNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 226 (336)
T ss_dssp EECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSE
T ss_pred EECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCE
Confidence 999999 67753 5566888999999999999 88854 466678899 9999999999 5553 6777888999999
Q ss_pred EEcCCCc-CCCCCcccccCCCCccEEEccCCc-ccccCcccccCCcCCceeeCcCCcCCCCCCccccCC-CCCCEEeCCC
Q 010856 155 LNFSSNF-LTSPLPLEIGNLKVLIGIDFSMNN-FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDL-ISLKFLNLSN 231 (499)
Q Consensus 155 L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~l~~ 231 (499)
|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|++|++++| ++.. .+..+ .++..|++++
T Consensus 227 L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~ 302 (336)
T 2ast_B 227 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINC 302 (336)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESC
T ss_pred EeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEec
Confidence 9999999 777777788999999999999995 33332336788999999999999 5433 33333 2366677999
Q ss_pred CcCCccCcccccC
Q 010856 232 NNLSGAIPASLEK 244 (499)
Q Consensus 232 N~l~~~~~~~~~~ 244 (499)
|++++..|..+..
T Consensus 303 n~l~~~~~~~~~~ 315 (336)
T 2ast_B 303 SHFTTIARPTIGN 315 (336)
T ss_dssp CCSCCTTCSSCSS
T ss_pred ccCccccCCcccc
Confidence 9999888877654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-24 Score=203.26 Aligned_cols=137 Identities=13% Similarity=0.132 Sum_probs=111.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++.+.+ ..+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEE
Confidence 35799999999999999999996 579999999997643 344678999999999999999999999988744 345
Q ss_pred eeecccC-CCcccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSS-ASASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~-~~~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++||+. |++.+.+..... ..+.++.||+.||+|||+ |+||+|||++.++.+|++|||+++.+
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 5677764 555555543333 344456899999999876 89999999999999999999999865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.6e-24 Score=209.19 Aligned_cols=136 Identities=17% Similarity=0.176 Sum_probs=112.0
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
..|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||+++++|...+ ..++++|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--EEEEEEe
Confidence 5699999999999999999996 579999999998776666778999999999999999999999998744 4556778
Q ss_pred ccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|+.|+.+..+.. .+.....++.||+.||+|||+ |+||+|||++.++.+|++|||+++.+
T Consensus 229 y~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 229 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred CCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 886654443322 223344556899999999876 89999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-23 Score=199.68 Aligned_cols=139 Identities=16% Similarity=0.173 Sum_probs=104.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEcccc------
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITF------ 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~------ 431 (499)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++...+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 45799999999999999999996 5799999999976543 335679999999999999999999999865332
Q ss_pred ----ceeeeeecccCCC-cccccccccc-------ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEE
Q 010856 432 ----TVCLCLFHHSSAS-ASASLVSSLT-------LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFV 493 (499)
Q Consensus 432 ----~~~~~l~~~~~~~-~~~~l~~~~~-------~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~ 493 (499)
...++++||+.|+ +.+.+..... ....++.|+++||+|||+ |+||+||+++.++.+|++|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 1235567777554 4333332221 123456899999999766 899999999999999999999
Q ss_pred Eeecc
Q 010856 494 FEILL 498 (499)
Q Consensus 494 ~~~~~ 498 (499)
+++.+
T Consensus 164 la~~~ 168 (299)
T 4g31_A 164 LVTAM 168 (299)
T ss_dssp CC---
T ss_pred cceec
Confidence 98764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-22 Score=179.76 Aligned_cols=162 Identities=23% Similarity=0.225 Sum_probs=83.3
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
+|++|++++|+++++.+..|..+++|++|++++|+++...+..|..+++|++|++++|++++..+..|..+++|++|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 45555555555554444445555555555555555554444444555555555555555544433344444555555555
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCc
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP 191 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (499)
+|++++..+..|.. +++|++|++++|.+++..+..+..+++|+.|++++|.+.+
T Consensus 109 ~N~l~~~~~~~~~~-----------------------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--- 162 (208)
T 2o6s_A 109 TNQLQSLPDGVFDK-----------------------LTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--- 162 (208)
T ss_dssp SSCCCCCCTTTTTT-----------------------CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC---
T ss_pred CCcCcccCHhHhcc-----------------------CCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec---
Confidence 55444444444444 4555555555555554444445555555555555554432
Q ss_pred ccccCCcCCceeeCcCCcCCCCCCccccCCCC
Q 010856 192 TEIGGLKNLEYLFLGYNRLQGSIPDSFGDLIS 223 (499)
Q Consensus 192 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 223 (499)
.+++|++|+++.|++++.+|..++.++.
T Consensus 163 ----~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ----TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 2345666666666666666655555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=7e-22 Score=178.16 Aligned_cols=179 Identities=25% Similarity=0.281 Sum_probs=133.8
Q ss_pred EEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccC
Q 010856 59 IVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNK 138 (499)
Q Consensus 59 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 138 (499)
.++++++.++.+ |..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|+
T Consensus 11 ~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 445555555422 2222 2356666666666665555556666666666666666666555566777777777777777
Q ss_pred CCCCCcc-ccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCcc
Q 010856 139 LTSVPLT-FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDS 217 (499)
Q Consensus 139 l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 217 (499)
++.++.. +..+++|++|++++|.+++..+..+..+++|+.|++++|++++..+..+..+++|++|++++|.+.+
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----- 162 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----- 162 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-----
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-----
Confidence 7776543 5677888888888888887777778999999999999999998888789999999999999998764
Q ss_pred ccCCCCCCEEeCCCCcCCccCcccccCCCC
Q 010856 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSY 247 (499)
Q Consensus 218 l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 247 (499)
.+++|+.|+++.|++++.+|..++.++.
T Consensus 163 --~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 --TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp --CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred --CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 4578999999999999999998887765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-23 Score=199.06 Aligned_cols=134 Identities=19% Similarity=0.233 Sum_probs=105.1
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.+++.+.+.||+|+||+||+|++++ .||||+++... ....+.|.+|++++++++|||||+++|++... . .+++
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~-~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD--N-LAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--S-CEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC--e-EEEE
Confidence 4567788999999999999998743 69999997543 23457899999999999999999999987542 2 3456
Q ss_pred ecccCC-Cccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSSA-SASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+||+.| ++.+.++. .+.....++.|||+||+|||+ |+||.|||+++++.+|++|||+++.+
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 777754 44444432 222344557899999999977 89999999999999999999999764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=186.27 Aligned_cols=170 Identities=25% Similarity=0.342 Sum_probs=88.2
Q ss_pred CCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEc
Q 010856 78 LQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNF 157 (499)
Q Consensus 78 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l 157 (499)
+++|+.|++++|.+... ..+..+++|++|++++|++++..+ +..+++|+.|++++|+++.++. +..+++|++|++
T Consensus 45 l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L 119 (291)
T 1h6t_A 45 LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS-LKDLKKLKSLSL 119 (291)
T ss_dssp HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGGG-GTTCTTCCEEEC
T ss_pred cCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCChh-hccCCCCCEEEC
Confidence 34444444444444322 123444444444444444443322 4444444444444444444332 444555555555
Q ss_pred CCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCcc
Q 010856 158 SSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGA 237 (499)
Q Consensus 158 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 237 (499)
++|.+++. ..+..+++|+.|++++|++++. ..+..+++|++|++++|++++..+ +..+++|+.|++++|++++.
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l 193 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 193 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC
Confidence 55555442 2344555555555555555543 345566666666666666664433 66666666666666666643
Q ss_pred CcccccCCCCCCEEEccCCcCcc
Q 010856 238 IPASLEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 238 ~~~~~~~l~~L~~L~l~~N~l~~ 260 (499)
+ .+..+++|+.|++++|+++.
T Consensus 194 -~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 194 -R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -G-GGTTCTTCSEEEEEEEEEEC
T ss_pred -h-hhccCCCCCEEECcCCcccC
Confidence 2 35666666666666666653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.3e-23 Score=192.86 Aligned_cols=135 Identities=17% Similarity=0.180 Sum_probs=103.8
Q ss_pred ccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcc--ccceeeeee
Q 010856 364 SENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVI--TFTVCLCLF 438 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~--~~~~~~~l~ 438 (499)
...+.||+|+||+||+|+. .+++.||+|++.... ....+.|.+|++++++++|||||+++++|... .....++++
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999996 468999999997654 23456799999999999999999999998652 122345577
Q ss_pred cccCC-Ccccccccc----ccccccccccccccceeecc--------CCCcccEEEee-CCCeEEEEEEEeecc
Q 010856 439 HHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV--------GVDFAAFVFVL-EPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~--------~~~p~~~l~~~-~~~~~~~~f~~~~~~ 498 (499)
||+.| ++.+.+... +.....++.||+.||+|||+ |+||+|||+++ ++.+|++|||++++.
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 77755 444444332 22344556899999998865 78999999985 678999999998753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-21 Score=199.05 Aligned_cols=180 Identities=27% Similarity=0.294 Sum_probs=92.9
Q ss_pred CCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecc
Q 010856 56 NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLG 135 (499)
Q Consensus 56 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 135 (499)
+|+.|+|++|.+++ +|..+ +++|++|+|++|+++ .+| ..+++|++|++++|++++ +|. +.. +|+.|+++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 55555555555554 23222 245555555555555 233 234555555555555554 333 332 55556666
Q ss_pred ccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCC
Q 010856 136 SNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 215 (499)
Q Consensus 136 ~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 215 (499)
+|+++.+|. .+++|+.|++++|.++++ |. .+++|+.|++++|++++ +|. |. ++|+.|+|++|+|+ .+|
T Consensus 129 ~N~l~~lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp 196 (571)
T 3cvr_A 129 NNQLTMLPE---LPALLEYINADNNQLTML-PE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP 196 (571)
T ss_dssp SSCCSCCCC---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred CCcCCCCCC---cCccccEEeCCCCccCcC-CC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence 665555554 445556666666655542 22 34555566666665554 233 33 55666666666655 233
Q ss_pred ccccCCCCC-------CEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccC
Q 010856 216 DSFGDLISL-------KFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEI 262 (499)
Q Consensus 216 ~~l~~l~~L-------~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 262 (499)
. +.. +| +.|+|++|+|+. +|..+..+++|+.|++++|++++.+
T Consensus 197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~ 246 (571)
T 3cvr_A 197 A-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRI 246 (571)
T ss_dssp C-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHH
T ss_pred h-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcC
Confidence 3 332 44 666666666653 3444444666666666666665543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.5e-23 Score=195.56 Aligned_cols=135 Identities=13% Similarity=0.125 Sum_probs=102.6
Q ss_pred hhcccccccccCCcceEEEEEe----CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
++|++.+.||+|+||+||+|+. .+++.||+|++++.. ......+.+|++++++++|||||++++++.+.+ ..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG--KL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT--EE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EE
Confidence 5799999999999999999985 247899999997653 233457889999999999999999999987743 44
Q ss_pred eeeecccC-CCccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSS-ASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~-~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++||+. |++.+.+.... ...+.++.|++.||+|||+ |+||+|+|++.++.+|++|||+++.
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 55677775 45545444322 2344556899999999976 8999999999999999999999975
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.6e-21 Score=174.85 Aligned_cols=150 Identities=22% Similarity=0.352 Sum_probs=70.3
Q ss_pred EEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCc
Q 010856 107 RLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNN 185 (499)
Q Consensus 107 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 185 (499)
.++++++.++.+ |..+. ++|+.|++++|+++.++. .+..+++|++|+|++|.++++.+..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~~i-P~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLTEI-PTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCSSC-CSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcCcC-CCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 445555555422 22222 345555555555554332 34444455555555555544444444444455555555554
Q ss_pred ccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCc
Q 010856 186 FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 186 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
++...+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 44444444444444444444444444444444444444444444444444444444444444444444444443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=190.87 Aligned_cols=155 Identities=25% Similarity=0.276 Sum_probs=77.5
Q ss_pred CCEEeccCCcCCccCCcccc-CCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecc
Q 010856 57 STIVNLGGNKLNGSIPITLS-KLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLG 135 (499)
Q Consensus 57 L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 135 (499)
++.|+|++|+|++..+..|. ++++|++|+|++|+|+...+..|..+++|++|+|++|+++...+..|..+++|+.|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 44444444444444444443 44444444444444444444444444445555555555444444444444555555555
Q ss_pred ccCCCCC-CccccCCCCCcEEEcCCCcCCCCCcccc---cCCCCccEEEccCCcccccCcccccCCcC--CceeeCcCCc
Q 010856 136 SNKLTSV-PLTFWNLKDILNLNFSSNFLTSPLPLEI---GNLKVLIGIDFSMNNFSGVIPTEIGGLKN--LEYLFLGYNR 209 (499)
Q Consensus 136 ~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~~~l~~l~~--L~~L~L~~n~ 209 (499)
+|+++.+ +..+..+++|+.|+|++|.++++.+..| ..+++|+.|+|++|+|+...+..+..++. |+.|+|++|.
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 5555443 3344445555555555555554333333 34556666666666666555555555555 3666666666
Q ss_pred CC
Q 010856 210 LQ 211 (499)
Q Consensus 210 l~ 211 (499)
+.
T Consensus 201 ~~ 202 (361)
T 2xot_A 201 LE 202 (361)
T ss_dssp EE
T ss_pred cc
Confidence 65
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-21 Score=196.08 Aligned_cols=189 Identities=26% Similarity=0.369 Sum_probs=159.8
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
+|+.|+|++|++++ +|..+ .++|++|+|++|.|+ .+| ..+++|+.|+|++|++++ +|. +.. +|++|+++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 79999999999997 55545 378999999999999 455 457899999999999997 555 655 99999999
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCc
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP 191 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (499)
+|++++ +|. .+++|+.|++++|+++.+|. .+++|++|++++|.+++ +|. +. ++|+.|++++|+|+. +|
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~-lp 196 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLES-LP 196 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSS-CC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCc-hh
Confidence 999997 444 67999999999999999987 57899999999999998 444 65 899999999999994 44
Q ss_pred ccccCCcCC-------ceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCC
Q 010856 192 TEIGGLKNL-------EYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 247 (499)
Q Consensus 192 ~~l~~l~~L-------~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 247 (499)
. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..+..++.
T Consensus 197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 4 554 77 99999999999 56777777999999999999999988888776543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.5e-23 Score=201.15 Aligned_cols=138 Identities=20% Similarity=0.174 Sum_probs=112.8
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcc----ccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVI----TFTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~----~~~~ 433 (499)
++|.+.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++... +...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4699999999999999999996 579999999997543 23456789999999999999999999987542 2234
Q ss_pred eeeeecccCCCccccccccccc----cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHSSASASASLVSSLTL----SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~~~~~----~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++++||++|++...+...... .+.++.||+.||+|||+ |+||+|||++.++.++++|||+++.+
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 5678889988877666543333 44556899999999877 89999999999999999999998753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=177.89 Aligned_cols=154 Identities=25% Similarity=0.314 Sum_probs=111.3
Q ss_pred EEeeecCCCCCcCCccccCCccCCeeeccccCCCCCC--ccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCC
Q 010856 107 RLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP--LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN 184 (499)
Q Consensus 107 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 184 (499)
.+++++|.++. +|..+. ..++.|++++|+++.++ ..+..+++|++|++++|.++++.+..|.++++|++|++++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 55666666653 233332 34566666666666652 23566777777777777777666667777777778888888
Q ss_pred cccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCC
Q 010856 185 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263 (499)
Q Consensus 185 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 263 (499)
++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|++.+..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 7777777777788888888888888887777788888888888888888887778888888888888888888876554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=203.50 Aligned_cols=193 Identities=20% Similarity=0.294 Sum_probs=133.0
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
++..+.+..+.+.+..+ +..+++|+.|++++|.+... + .+..+++|+.|+|++|++++..+ +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 45555666666664433 45667777777777777643 2 46777777777777777775543 6777777777777
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCc
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP 191 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (499)
+|.+++. ..+..+++|+.|+|++|+++.++ .+..+++|+.|+|++|.++++ ..+..+++|+.|+|++|.+++..|
T Consensus 96 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 96 ENKIKDL--SSLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SSCCCCC--TTSTTCTTCCEEECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCCCC--hhhccCCCCCEEEecCCCCCCCc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 7777743 25677777777777777777764 466777777777777777764 456677777777777777776544
Q ss_pred ccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCc
Q 010856 192 TEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239 (499)
Q Consensus 192 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 239 (499)
+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|++.....
T Consensus 171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence 67777777777777777754 356777777777777777765433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.2e-23 Score=199.19 Aligned_cols=147 Identities=16% Similarity=0.127 Sum_probs=111.8
Q ss_pred cCHHHHHHHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCC-CCcccc
Q 010856 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRH-RNLIKI 422 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H-~niv~l 422 (499)
+....++...++|++.+.||+|+||+||+|++. .++.||||+++.... ...+.|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 445566667788999999999999999999852 246899999976543 345679999999999965 899999
Q ss_pred ceeEEccccceeeeeecccC-CCcccccccc--------------------ccccccccccccccceeecc------CCC
Q 010856 423 LHGVAVITFTVCLCLFHHSS-ASASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GVD 475 (499)
Q Consensus 423 ~~~~~~~~~~~~~~l~~~~~-~~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~~ 475 (499)
+|+|...+. ..++++||+. |++.+.++.. +.....++.|||+||+|||+ |+|
T Consensus 134 ~g~~~~~~~-~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK 212 (353)
T 4ase_A 134 LGACTKPGG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 212 (353)
T ss_dssp EEEECCTTS-CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEecCC-EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence 999876332 3345667765 4544444321 11223446899999999866 899
Q ss_pred cccEEEeeCCCeEEEEEEEeecc
Q 010856 476 FAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 476 p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|.|||+++++.+|++|||+++.+
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~ 235 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDI 235 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCT
T ss_pred ccceeeCCCCCEEECcchhhhhc
Confidence 99999999999999999999754
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-21 Score=181.73 Aligned_cols=187 Identities=27% Similarity=0.368 Sum_probs=156.8
Q ss_pred EECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccc
Q 010856 10 IYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDN 89 (499)
Q Consensus 10 L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 89 (499)
+.+..+.+++..+ ...++ +|++|++++|.++.. + .+..+++|++|++++|++++..+ +..+++|++|++++|
T Consensus 29 ~~l~~~~~~~~~~---~~~l~-~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 29 DNLKKKSVTDAVT---QNELN-SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHTTCSCTTSEEC---HHHHH-TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHhcCCCcccccc---hhhcC-cccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence 3456666665433 34566 899999999999865 3 48889999999999999986555 889999999999999
Q ss_pred cccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCccc
Q 010856 90 KLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLE 169 (499)
Q Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 169 (499)
.+++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|+++.+ ..+..+++|+.|++++|.+++..+
T Consensus 101 ~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-- 173 (291)
T 1h6t_A 101 KVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-- 173 (291)
T ss_dssp CCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred cCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--
Confidence 99853 3488999999999999999864 4688899999999999999988 578889999999999999987655
Q ss_pred ccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCC
Q 010856 170 IGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 213 (499)
Q Consensus 170 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 213 (499)
+..+++|+.|++++|.+++. ..+..+++|+.|++++|+++..
T Consensus 174 l~~l~~L~~L~L~~N~i~~l--~~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 174 LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEEEEEEEEECC
T ss_pred hcCCCccCEEECCCCcCCCC--hhhccCCCCCEEECcCCcccCC
Confidence 88999999999999999865 3488999999999999998854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-22 Score=191.93 Aligned_cols=135 Identities=16% Similarity=0.082 Sum_probs=102.0
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccc--ceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITF--TVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~--~~~~~l~ 438 (499)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... ....+.+|+..+.+++|||||+++|+|...+. ...++++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4588889999999999999998 688999999975431 11223455666678999999999999976432 2456678
Q ss_pred cccCCC-ccccccc---cccccccccccccccceeec--------------cCCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSAS-ASASLVS---SLTLSRPAKGGGFRGCVLWH--------------VGVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~-~~~~l~~---~~~~~~~~~~~i~~gl~yLH--------------~~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
||+.|+ +.+.++. .+.....++.|+++||+||| +|+||.|||++.++.+|++|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 888654 4444432 22234455789999999885 57999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-22 Score=193.07 Aligned_cols=132 Identities=14% Similarity=0.110 Sum_probs=104.9
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.+.|...+.||+|+||+||+|+. .+|+.||||+++.... ..+|++++++++|||||++++++.+.+ ..++++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~--~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP--WVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEE
Confidence 45688889999999999999996 5799999999976432 247999999999999999999987643 345577
Q ss_pred cccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEeecc
Q 010856 439 HHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~~~ 498 (499)
||+.| ++.+.+... +.....++.||+.||+|||+ |+||+|||++.++ .+|++|||+++.+
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 77755 554444332 23344556899999999977 8999999998876 5999999999764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=175.76 Aligned_cols=153 Identities=25% Similarity=0.309 Sum_probs=71.3
Q ss_pred eeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcC
Q 010856 131 IVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRL 210 (499)
Q Consensus 131 ~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 210 (499)
.++++++.++.+|..+. ++|+.|++++|.++++.+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++
T Consensus 15 ~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 15 IVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 34444444444443332 3444444444444444444444444444444444444444444444444444444444444
Q ss_pred CCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCC-CCCCCCccccccCCCcCCCCC
Q 010856 211 QGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGS 285 (499)
Q Consensus 211 ~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~l~~~~l~~N~~~c~~ 285 (499)
+.+.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+. ...++.++.+++.+|+|.|+|
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 444444444444444444444444444444444444444444444444443332 122344444444444444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=170.53 Aligned_cols=157 Identities=23% Similarity=0.225 Sum_probs=142.3
Q ss_pred CCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCc-ccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcC
Q 010856 129 LRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLP-LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGY 207 (499)
Q Consensus 129 L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~ 207 (499)
-+.+++++|.++.+|..+. +.+++|++++|.+++..+ ..|..+++|+.|++++|++++..+..|.++++|++|+|++
T Consensus 13 ~~~l~~s~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 13 GTTVDCSNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TTEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEeEeCCCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 3589999999999997663 467899999999998754 5689999999999999999998888999999999999999
Q ss_pred CcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCCcCCCCCC
Q 010856 208 NRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP 286 (499)
Q Consensus 208 n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N~~~c~~~ 286 (499)
|++++..+..|..+++|+.|++++|++++..|..|..+++|+.|++++|++++..|.. ..+++++.+++.+|+|.|+|+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999988888999999999999999999999999999999999999999999886654 457889999999999999875
Q ss_pred C
Q 010856 287 N 287 (499)
Q Consensus 287 ~ 287 (499)
.
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.2e-21 Score=186.15 Aligned_cols=177 Identities=25% Similarity=0.252 Sum_probs=90.1
Q ss_pred CEEeccCCcCCccCCccccCCCCCCeEecccccccccCCcccc-CcccccEEeeecCCCCCcCCccccCCccCCeeeccc
Q 010856 58 TIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC-HLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGS 136 (499)
Q Consensus 58 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 136 (499)
+.+++++|.++. +|..+. +.++.|+|++|++++..+..|. .+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 456666666653 333222 2355556665555555444444 555555555555555554444555555555555555
Q ss_pred cCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCc
Q 010856 137 NKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPD 216 (499)
Q Consensus 137 n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 216 (499)
|+++. +.+..|..+++|+.|+|++|+|+...+..|.++++|++|+|++|++++..+.
T Consensus 98 N~l~~-----------------------~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 154 (361)
T 2xot_A 98 NHLHT-----------------------LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154 (361)
T ss_dssp SCCCE-----------------------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred CcCCc-----------------------CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence 55544 3333444444455555555555444444555555555555555555543333
Q ss_pred cc---cCCCCCCEEeCCCCcCCccCcccccCCCC--CCEEEccCCcCcc
Q 010856 217 SF---GDLISLKFLNLSNNNLSGAIPASLEKLSY--LENLNLSFNKLEG 260 (499)
Q Consensus 217 ~l---~~l~~L~~L~l~~N~l~~~~~~~~~~l~~--L~~L~l~~N~l~~ 260 (499)
.| ..+++|+.|+|++|+|+...+..+..++. ++.|++++|++.+
T Consensus 155 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp GTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred HhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 33 34555666666666665554455555554 2555555555543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-20 Score=192.40 Aligned_cols=188 Identities=27% Similarity=0.365 Sum_probs=124.8
Q ss_pred EEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEeccc
Q 010856 9 LIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLED 88 (499)
Q Consensus 9 ~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 88 (499)
.+.+..+.+.+..+ +..++ +|+.|++++|.+..+ + .+..+++|+.|+|++|.+++..+ +..+++|+.|+|++
T Consensus 25 ~l~l~~~~i~~~~~---~~~L~-~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 25 KDNLKKKSVTDAVT---QNELN-SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHTTCSCTTSEEC---HHHHT-TCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHhccCCCcccccc---hhcCC-CCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 34455555554433 23444 677777777777643 2 46677777777777777765444 66777777777777
Q ss_pred ccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcc
Q 010856 89 NKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPL 168 (499)
Q Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 168 (499)
|.+.+. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|+++.+ ..+..+++|+.|+|++|.+++..+
T Consensus 97 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 97 NKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP- 170 (605)
T ss_dssp SCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred CCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh-
Confidence 777642 2566777777777777777753 3466677777777777777766 456677777777777777776544
Q ss_pred cccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCC
Q 010856 169 EIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 213 (499)
Q Consensus 169 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 213 (499)
+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|++.+.
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred -hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 66777777777777777654 3466777777777777776654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=7e-20 Score=167.48 Aligned_cols=154 Identities=25% Similarity=0.237 Sum_probs=115.4
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
+-+.++++++.++. +|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|+++...+..|..+++|++|+|+
T Consensus 20 s~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 20 SGTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred eCCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 56677887777774 343333 678888888888887777778888888888888888876666667778888888888
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccc
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSG 188 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 188 (499)
+|++++..+..|..+++|+.|+|++|+++.+|..+..+++|++|++++|.+++..+..|..+++|+.|++++|.+..
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 88888777777777888888888888888877777777777777777777776666666667777777777776653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.8e-20 Score=167.15 Aligned_cols=154 Identities=25% Similarity=0.301 Sum_probs=98.2
Q ss_pred ccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCC-CccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccC
Q 010856 105 LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSV-PLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSM 183 (499)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 183 (499)
-+.++.+++.++.+ |..+. ++|+.|+|++|+++.+ +..+..+++|++|+|++|.++.+.+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~~i-p~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHASV-PAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCSSC-CSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcCcc-CCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 34566666666633 33332 5666777777776664 44566666677777777766665555566666666777766
Q ss_pred CcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccC
Q 010856 184 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEI 262 (499)
Q Consensus 184 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 262 (499)
|++++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|++++|++++..+..|..+++|+.|++++|++.+..
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 6666665555666666666666666666 44556666666666666666666655556666666666666666666544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.7e-23 Score=216.07 Aligned_cols=274 Identities=11% Similarity=0.061 Sum_probs=132.2
Q ss_pred CCCCCCEEECcCCCCCccCCh---hccccccccccEEEcccCCCcc----cCCccccCCCCCCEEeccCCcCCccCCccc
Q 010856 3 NCKSLTLIYLSNNPLDGILPK---TSVGNLSHSLEDFRMYNCNISG----GIPEEISNLTNSTIVNLGGNKLNGSIPITL 75 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~---~~~~~l~~~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 75 (499)
++++|++|+|++|.+++.... .....++ +|++|++++|.+++ ..+..+.++++|++|++++|.+.+ .+..+
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~-~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~ 239 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNT-SLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFF 239 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCC-CCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHH
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCC-CccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHH
Confidence 467788888888876654322 1233455 67777777777752 233344566777777777776543 22333
Q ss_pred cCCCCCCeEec---------------------------ccccccccCCccccCcccccEEeeecCCCCCcCC-ccccCCc
Q 010856 76 SKLQKLQGLGL---------------------------EDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP-ACFSNLT 127 (499)
Q Consensus 76 ~~l~~L~~L~L---------------------------~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~ 127 (499)
..+++|++|++ +++.. ...+..+..+++|++|++++|.+++... ..+..++
T Consensus 240 ~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~ 318 (592)
T 3ogk_B 240 KAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCP 318 (592)
T ss_dssp HHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCT
T ss_pred hhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCc
Confidence 33333333333 33221 1334455566777777777777553222 2235556
Q ss_pred cCCeeeccccCCCC--CCccccCCCCCcEEEcCC-----------CcCCCCCc-ccccCCCCccEEEccCCcccccCccc
Q 010856 128 SLRIVSLGSNKLTS--VPLTFWNLKDILNLNFSS-----------NFLTSPLP-LEIGNLKVLIGIDFSMNNFSGVIPTE 193 (499)
Q Consensus 128 ~L~~L~L~~n~l~~--~~~~~~~l~~L~~L~l~~-----------n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~ 193 (499)
+|+.|+++ +.+.. ++.....+++|++|++++ |.+++... .....+++|++|+++.|.+++..+..
T Consensus 319 ~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~ 397 (592)
T 3ogk_B 319 NLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES 397 (592)
T ss_dssp TCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHH
T ss_pred CCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHH
Confidence 66666665 22222 222223445555555551 33332111 11222444444444444444333333
Q ss_pred c----------------------------------cCCcCCceeeCcCCc--CCCCCCccc-cCCCCCCEEeCCCCcCCc
Q 010856 194 I----------------------------------GGLKNLEYLFLGYNR--LQGSIPDSF-GDLISLKFLNLSNNNLSG 236 (499)
Q Consensus 194 l----------------------------------~~l~~L~~L~L~~n~--l~~~~~~~l-~~l~~L~~L~l~~N~l~~ 236 (499)
+ .++++|++|++++|. +++.....+ ..+++|+.|++++|++++
T Consensus 398 l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~ 477 (592)
T 3ogk_B 398 IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESD 477 (592)
T ss_dssp HHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSH
T ss_pred HHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCH
Confidence 3 334445555544321 332222222 225556666666666553
Q ss_pred c-CcccccCCCCCCEEEccCCcCcccC-CC-CCCCCCccccccCCCc
Q 010856 237 A-IPASLEKLSYLENLNLSFNKLEGEI-PR-GGSFGNFSAESFEGNE 280 (499)
Q Consensus 237 ~-~~~~~~~l~~L~~L~l~~N~l~~~~-~~-~~~~~~l~~~~l~~N~ 280 (499)
. .+..+..+++|+.|++++|++++.. +. ...+++++.+++++|.
T Consensus 478 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 478 EGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 2 2333455566666666666654321 11 1124555566666555
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=7e-21 Score=177.89 Aligned_cols=149 Identities=20% Similarity=0.263 Sum_probs=61.1
Q ss_pred ccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcE
Q 010856 75 LSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILN 154 (499)
Q Consensus 75 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~ 154 (499)
+..+++|+.|++++|.++.. + .+..+++|++|++++|++++..+ +..+++|+.|++++|+++.++.... ++|++
T Consensus 37 ~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~~~~--~~L~~ 110 (263)
T 1xeu_A 37 QKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPS--ACLSR 110 (263)
T ss_dssp HHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTTCCC--SSCCE
T ss_pred hhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCcccc--CcccE
Confidence 33444444444444444322 1 33444444444444444443322 4444444444444444444332111 44444
Q ss_pred EEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcC
Q 010856 155 LNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234 (499)
Q Consensus 155 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l 234 (499)
|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++
T Consensus 111 L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~ 184 (263)
T 1xeu_A 111 LFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKC 184 (263)
T ss_dssp EECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEE
T ss_pred EEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcc
Confidence 44444444432 1233344444444444444332 1233444444444444444433 3334444444444444444
Q ss_pred C
Q 010856 235 S 235 (499)
Q Consensus 235 ~ 235 (499)
+
T Consensus 185 ~ 185 (263)
T 1xeu_A 185 V 185 (263)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.2e-20 Score=162.68 Aligned_cols=154 Identities=16% Similarity=0.243 Sum_probs=105.5
Q ss_pred ccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCC
Q 010856 51 ISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLR 130 (499)
Q Consensus 51 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 130 (499)
...+++|++|++++|.++. .| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 3556677777777777763 33 46677777777777776552 24566777777777777777766666777777777
Q ss_pred eeeccccCCCC-CCccccCCCCCcEEEcCCCc-CCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCC
Q 010856 131 IVSLGSNKLTS-VPLTFWNLKDILNLNFSSNF-LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYN 208 (499)
Q Consensus 131 ~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n 208 (499)
+|++++|+++. .+..+..+++|++|++++|. ++.. + .+..+++|+.|++++|++++.. .+..+++|++|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCc
Confidence 77777777775 55567777777777777776 6543 3 5677777888888887777542 6677788888888888
Q ss_pred cCCC
Q 010856 209 RLQG 212 (499)
Q Consensus 209 ~l~~ 212 (499)
++.+
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 7653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-20 Score=172.99 Aligned_cols=171 Identities=20% Similarity=0.255 Sum_probs=145.4
Q ss_pred CCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEE
Q 010856 77 KLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLN 156 (499)
Q Consensus 77 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~ 156 (499)
.+.++..+++++|.+++.. .+..+++|++|++++|.++.. + .+..+++|+.|++++|++++++. +..+++|++|+
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~ 91 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEE
Confidence 4566778888888887553 578899999999999999854 3 68889999999999999999887 88999999999
Q ss_pred cCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCc
Q 010856 157 FSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG 236 (499)
Q Consensus 157 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 236 (499)
+++|++++..+ +.. ++|+.|++++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++
T Consensus 92 L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCcc
Confidence 99999987543 223 8999999999999865 4588999999999999999865 368889999999999999987
Q ss_pred cCcccccCCCCCCEEEccCCcCccc
Q 010856 237 AIPASLEKLSYLENLNLSFNKLEGE 261 (499)
Q Consensus 237 ~~~~~~~~l~~L~~L~l~~N~l~~~ 261 (499)
. ..+..+++|+.|++++|++++.
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h--HHhccCCCCCEEeCCCCcccCC
Confidence 6 6788899999999999999865
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-22 Score=210.27 Aligned_cols=190 Identities=23% Similarity=0.200 Sum_probs=113.6
Q ss_pred cCCCCCCEEeccCCcCCccCCccccCCCCCCeEeccccc-------------ccccCCccccCcccccEEe-eecCCCCC
Q 010856 52 SNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNK-------------LEGSIPDDICHLAELYRLD-LDGNKLSG 117 (499)
Q Consensus 52 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-------------l~~~~~~~~~~l~~L~~L~-L~~n~l~~ 117 (499)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+..|..+..+++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 56788888888888887 567778888888888887664 3445555666677777776 454432
Q ss_pred cCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCC
Q 010856 118 SLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGL 197 (499)
Q Consensus 118 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 197 (499)
..|+.+.+++|.++.++. ..|+.|++++|.++++ |. +..+++|+.|+|++|.++ .+|..+..+
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY-----ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH-----TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred ---------chhhhhhhhcccccccCc-----cCceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 223333444444443321 2355566666665542 33 555566666666666665 345555666
Q ss_pred cCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccC-cccccCCCCCCEEEccCCcCcccCC
Q 010856 198 KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAI-PASLEKLSYLENLNLSFNKLEGEIP 263 (499)
Q Consensus 198 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~ 263 (499)
++|+.|+|++|++++ +| .+..+++|+.|+|++|+|++.. |..+..+++|+.|++++|++++.+|
T Consensus 486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 666666666666654 33 5556666666666666666554 5556666666666666666665544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=161.75 Aligned_cols=154 Identities=18% Similarity=0.219 Sum_probs=105.7
Q ss_pred cCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEE
Q 010856 100 CHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179 (499)
Q Consensus 100 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 179 (499)
..+++|++|++++|.++. .+ .+..+++|++|++++|.++.++ .+..+++|++|++++|.+++..+..+..+++|+.|
T Consensus 41 ~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 445566666666666663 23 4556666666666666555544 56667777777777777766556667777778888
Q ss_pred EccCCcccccCcccccCCcCCceeeCcCCc-CCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcC
Q 010856 180 DFSMNNFSGVIPTEIGGLKNLEYLFLGYNR-LQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258 (499)
Q Consensus 180 ~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 258 (499)
++++|++++..+..+..+++|++|++++|. ++.. + .+..+++|+.|++++|++++.. .+..+++|+.|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCccc
Confidence 888887776667777788888888888887 6533 3 5777888888888888887533 677788888888888887
Q ss_pred cc
Q 010856 259 EG 260 (499)
Q Consensus 259 ~~ 260 (499)
.+
T Consensus 194 ~~ 195 (197)
T 4ezg_A 194 GG 195 (197)
T ss_dssp --
T ss_pred CC
Confidence 53
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=7e-20 Score=162.61 Aligned_cols=155 Identities=26% Similarity=0.346 Sum_probs=92.0
Q ss_pred CeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcc-cccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCC
Q 010856 130 RIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPL-EIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYN 208 (499)
Q Consensus 130 ~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n 208 (499)
+.+++++|+++.+|..+.. +|++|++++|.++++.+. .|..+++|++|++++|++++..|..|.++++|++|+|++|
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4555666666555554432 566666666666554443 3566666666666666666666666666666666666666
Q ss_pred cCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCCC
Q 010856 209 RLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 286 (499)
Q Consensus 209 ~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~~ 286 (499)
++++..+..|..+++|+.|++++|++++..|..|..+++|+.|++++|++++..+.......+....+.++...|+.|
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 666666666666666777777777766666666666677777777777766554432111122223344444455543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=4e-22 Score=205.93 Aligned_cols=203 Identities=20% Similarity=0.156 Sum_probs=168.7
Q ss_pred cccccccEEEcccCCCcccCCccccCCCCCCEEeccCCc-------------CCccCCccccCCCCCCeEe-cccccccc
Q 010856 28 NLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNK-------------LNGSIPITLSKLQKLQGLG-LEDNKLEG 93 (499)
Q Consensus 28 ~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~-------------l~~~~~~~~~~l~~L~~L~-L~~n~l~~ 93 (499)
..+ +|+.|+|++|.++ .+|..++++++|+.|++++|. +.+..|..+..+++|+.|+ ++.|.+
T Consensus 347 ~~~-~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 347 TDE-QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp TTT-TSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred cCc-cceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 345 7999999999998 678889999999999997775 4556677788888899888 666654
Q ss_pred cCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCC
Q 010856 94 SIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNL 173 (499)
Q Consensus 94 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 173 (499)
.+|+.+.+++|.++...+ ..|+.|++++|+++.+|. +..+++|+.|+|++|.++ .+|..+..+
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred ---------chhhhhhhhcccccccCc------cCceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 456677788888774432 258899999999999986 899999999999999999 567899999
Q ss_pred CCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCC-CccccCCCCCCEEeCCCCcCCccCcc---cccCCCCCC
Q 010856 174 KVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI-PDSFGDLISLKFLNLSNNNLSGAIPA---SLEKLSYLE 249 (499)
Q Consensus 174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~l~~N~l~~~~~~---~~~~l~~L~ 249 (499)
++|+.|+|++|++++ +| .+..+++|+.|+|++|++++.. |..+..+++|+.|+|++|++++.++. .+..+++|+
T Consensus 486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~ 563 (567)
T 1dce_A 486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563 (567)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCS
T ss_pred CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccC
Confidence 999999999999997 45 7899999999999999999876 89999999999999999999876553 234588999
Q ss_pred EEEc
Q 010856 250 NLNL 253 (499)
Q Consensus 250 ~L~l 253 (499)
.|++
T Consensus 564 ~L~l 567 (567)
T 1dce_A 564 SILT 567 (567)
T ss_dssp EEEC
T ss_pred ccCC
Confidence 8875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-20 Score=192.89 Aligned_cols=137 Identities=16% Similarity=0.187 Sum_probs=109.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.++|.+.+.||+|+||+||+|+. .+|+.||+|++........+.+.+|+++|+.++|||||++++++...+ ..++++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS--EEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEE
Confidence 36799999999999999999996 579999999998765555678999999999999999999999987643 445567
Q ss_pred cccC-CCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeC--CCeEEEEEEEeecc
Q 010856 439 HHSS-ASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE--PGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~-~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~--~~~~~~~f~~~~~~ 498 (499)
||+. |++.+.+.. .+...+.++.||+.||+|||+ |+||.|++++.+ +.++++|||+++.+
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 7775 455444432 122344556899999999876 899999999854 78999999999764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-20 Score=183.10 Aligned_cols=137 Identities=16% Similarity=0.105 Sum_probs=106.6
Q ss_pred HHHhhhcccccccccCCcceEEEEEe----CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEcccc
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITF 431 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~ 431 (499)
....+.|++.+.||+|+||+||+|+. .+++.||+|++.+.. ...++.+|+++++.+ +|||||++++++...+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~- 93 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND- 93 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT-
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC-
Confidence 34457799999999999999999984 247889999986543 346788999999988 7999999999987744
Q ss_pred ceeeeeecccCCC-cccccc-ccccccccccccccccceeecc------CCCcccEEEeeC-CCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSAS-ASASLV-SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE-PGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~~-~~~~l~-~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~-~~~~~~~f~~~~~ 497 (499)
..++++||+.|+ +.+.+. ......+.++.|++.||+|||+ |+||+|||++.+ +.++++|||+++.
T Consensus 94 -~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 94 -HVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp -EEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred -EEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 445677777654 433332 2233455567899999998876 899999999876 6899999999864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.7e-20 Score=197.14 Aligned_cols=218 Identities=22% Similarity=0.250 Sum_probs=115.2
Q ss_pred cccEEEcccCCCcccCCccccCCCCCC-----EEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCccccc
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNST-----IVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELY 106 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~-----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 106 (499)
.++.|+|.+|.+... +..+.....|. .++++.|.+. ..+..|..+++|+.|+|++|.+. .+|..+..+++|+
T Consensus 174 ~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~ 250 (727)
T 4b8c_D 174 LTPKIELFANGKDEA-NQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLT 250 (727)
T ss_dssp --------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCS
T ss_pred ccceEEeeCCCCCcc-hhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCC
Confidence 567777777776643 32222222222 2233344444 55677888888999999998888 5566666888899
Q ss_pred EEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcc
Q 010856 107 RLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNF 186 (499)
Q Consensus 107 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 186 (499)
+|+|++|.++ .+|..|..+++|+.|+|++|+|+.+|..+..+++|++|+|++|.|+. +|..|..+++|+.|+|++|.+
T Consensus 251 ~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 251 RLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVTT-LPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp CCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCCC-CCSSTTSCTTCCCEECTTSCC
T ss_pred EEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCCc-cChhhhcCCCccEEeCCCCcc
Confidence 9999999888 66778888899999999999998888888888999999999998874 566688899999999999999
Q ss_pred cccCcccccCCcC-CceeeCcCCcCCCCCCccccCCCCCCEEeCCCC--------cCCccCcccccCCCCCCEEEccCCc
Q 010856 187 SGVIPTEIGGLKN-LEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNN--------NLSGAIPASLEKLSYLENLNLSFNK 257 (499)
Q Consensus 187 ~~~~~~~l~~l~~-L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N--------~l~~~~~~~~~~l~~L~~L~l~~N~ 257 (499)
++..|..+..+.. +..|+|++|.+++..|. .|+.|+++.| .+.+..+..+..+..+....+++|-
T Consensus 329 ~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Ni 402 (727)
T 4b8c_D 329 EKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNT 402 (727)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C-----------------------------------------C
T ss_pred CCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecccccccccCCccccccchhhcccccceeeeeccc
Confidence 8887777755432 23478889988877665 4556666666 3444444455566666777777777
Q ss_pred Ccc
Q 010856 258 LEG 260 (499)
Q Consensus 258 l~~ 260 (499)
+.+
T Consensus 403 l~~ 405 (727)
T 4b8c_D 403 LCQ 405 (727)
T ss_dssp CCG
T ss_pred ccc
Confidence 753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-20 Score=190.76 Aligned_cols=137 Identities=15% Similarity=0.088 Sum_probs=106.0
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHH---HHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVE---CEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E---~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
.++|.+.++||+|+||+||+|+. .+|+.||||++++.. ......+.+| +++++.++|||||++++++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~-- 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-- 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--
Confidence 47899999999999999999996 479999999997643 2223334444 56778899999999999988744
Q ss_pred eeeeeecccC-CCccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 433 VCLCLFHHSS-ASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 433 ~~~~l~~~~~-~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
..++++||+. |++...+.... ...+.++.||+.||+|||+ |+||+|||++.++.++++|||+++.+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 3445677765 55555554332 3344556899999999877 89999999999999999999998754
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-21 Score=202.33 Aligned_cols=257 Identities=18% Similarity=0.149 Sum_probs=155.3
Q ss_pred CCCCCCEEECcCCCCCccCCh---hccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcC------------
Q 010856 3 NCKSLTLIYLSNNPLDGILPK---TSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKL------------ 67 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~---~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l------------ 67 (499)
++++|++|++++|.+++.... ..+..++ +|++|++++|.+.+ .+..+..+++|++|++++...
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~-~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~ 267 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCR-SLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV 267 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCT-TCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCC-CCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhh
Confidence 467888888888888643221 1234555 78888888877654 334444444444444432110
Q ss_pred --------------CccCCccccCCCCCCeEecccccccccCC-ccccCc------------------------ccccEE
Q 010856 68 --------------NGSIPITLSKLQKLQGLGLEDNKLEGSIP-DDICHL------------------------AELYRL 108 (499)
Q Consensus 68 --------------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l------------------------~~L~~L 108 (499)
....|..+..+++|++|+|++|.+++... ..+..+ ++|++|
T Consensus 268 ~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L 347 (592)
T 3ogk_B 268 FPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRL 347 (592)
T ss_dssp CCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEE
T ss_pred ccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEE
Confidence 11223334455666666666666543221 123344 445555
Q ss_pred eeec-----------CCCCCcC-CccccCCccCCeeeccccCCCC-CCccccC-CCCCcEEEcC----CCcCCCC-----
Q 010856 109 DLDG-----------NKLSGSL-PACFSNLTSLRIVSLGSNKLTS-VPLTFWN-LKDILNLNFS----SNFLTSP----- 165 (499)
Q Consensus 109 ~L~~-----------n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~-l~~L~~L~l~----~n~l~~~----- 165 (499)
++++ |.+++.. +.....+++|++|+++.|+++. .+..+.. +++|+.|+++ .|.+++.
T Consensus 348 ~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~ 427 (592)
T 3ogk_B 348 RIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNG 427 (592)
T ss_dssp EEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHH
T ss_pred EeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHH
Confidence 5552 3333211 1112335666666666666654 2223333 6778888885 5666653
Q ss_pred CcccccCCCCccEEEccCCc--ccccCccccc-CCcCCceeeCcCCcCCCC-CCccccCCCCCCEEeCCCCcCCcc-Ccc
Q 010856 166 LPLEIGNLKVLIGIDFSMNN--FSGVIPTEIG-GLKNLEYLFLGYNRLQGS-IPDSFGDLISLKFLNLSNNNLSGA-IPA 240 (499)
Q Consensus 166 ~~~~~~~l~~L~~L~l~~n~--l~~~~~~~l~-~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~l~~N~l~~~-~~~ 240 (499)
.+..+.++++|+.|++++|. +++..+..+. .+++|++|++++|++++. .+..+..+++|+.|++++|++++. .+.
T Consensus 428 ~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 507 (592)
T 3ogk_B 428 VRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAA 507 (592)
T ss_dssp HHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHH
T ss_pred HHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHH
Confidence 22235567888888887543 5544444443 489999999999999863 345568899999999999998754 344
Q ss_pred cccCCCCCCEEEccCCcCccc
Q 010856 241 SLEKLSYLENLNLSFNKLEGE 261 (499)
Q Consensus 241 ~~~~l~~L~~L~l~~N~l~~~ 261 (499)
....+++|+.|++++|+++..
T Consensus 508 ~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 508 AVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHCSSCCEEEEESCBCCTT
T ss_pred HHHhcCccCeeECcCCcCCHH
Confidence 456799999999999998854
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=173.69 Aligned_cols=102 Identities=12% Similarity=0.089 Sum_probs=69.7
Q ss_pred CCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCc-eeeCcCCcCCCCCCccccCCCCCCEE
Q 010856 149 LKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLE-YLFLGYNRLQGSIPDSFGDLISLKFL 227 (499)
Q Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~-~L~L~~n~l~~~~~~~l~~l~~L~~L 227 (499)
+++|+.|++++|.++.+....|.++++|+.|++.+| ++.+.+..|.++++|+ .+++.+ .++.+.+..|.++++|+.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 566777777776666666666777777777777666 6656666677777776 777766 5655666667777777777
Q ss_pred eCCCCcCCccCcccccCCCCCCEEE
Q 010856 228 NLSNNNLSGAIPASLEKLSYLENLN 252 (499)
Q Consensus 228 ~l~~N~l~~~~~~~~~~l~~L~~L~ 252 (499)
++++|+++.+.+.+|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 7777777666666777777776665
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-17 Score=163.89 Aligned_cols=244 Identities=12% Similarity=0.073 Sum_probs=202.9
Q ss_pred CCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCe
Q 010856 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQG 83 (499)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 83 (499)
+..++.+.+.+ .++.+... +|.+ . +|+.+.+..+ ++.+...+|.++ +|+.+.+.. .++.+.+.+|.++++|+.
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~-aF~~-~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKD-AFRN-S-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKK 184 (401)
T ss_dssp CSSCSEEECCT-TCCEECTT-TTTT-C-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCE
T ss_pred cCCccEEEECC-ccCEehHh-hccc-C-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCe
Confidence 46777888874 46656555 6665 3 6999999876 777888899885 799999986 777788889999999999
Q ss_pred EecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCC
Q 010856 84 LGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~ 163 (499)
+++++|+++.+....|. ..+|+.+.+..+ ++.+...+|.++++|+.+++..+ ++.++...+.-.+|+.+.+. +.++
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~~~L~~i~lp-~~i~ 260 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRESGITTVKLP-NGVT 260 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTTCCCSEEEEE-TTCC
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccccccccCCccEEEeC-CCcc
Confidence 99999999977777777 589999999854 77788899999999999999875 66666544444899999994 5577
Q ss_pred CCCcccccCCCCccEEEccCCccc-----ccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccC
Q 010856 164 SPLPLEIGNLKVLIGIDFSMNNFS-----GVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAI 238 (499)
Q Consensus 164 ~~~~~~~~~l~~L~~L~l~~n~l~-----~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 238 (499)
.+....|.++++|+.+++.+|.+. .+.+..|.++++|+.+.+. +.++.+....|.++++|+.+++..| ++.+.
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 778889999999999999988775 5677889999999999999 4588788889999999999999655 77788
Q ss_pred cccccCCCCCCEEEccCCcCccc
Q 010856 239 PASLEKLSYLENLNLSFNKLEGE 261 (499)
Q Consensus 239 ~~~~~~l~~L~~L~l~~N~l~~~ 261 (499)
..+|.++ +|+.+++++|.+...
T Consensus 339 ~~aF~~~-~L~~l~l~~n~~~~l 360 (401)
T 4fdw_A 339 FSAFNNT-GIKEVKVEGTTPPQV 360 (401)
T ss_dssp TTSSSSS-CCCEEEECCSSCCBC
T ss_pred HHhCCCC-CCCEEEEcCCCCccc
Confidence 8999999 999999999987643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=152.33 Aligned_cols=173 Identities=21% Similarity=0.277 Sum_probs=120.0
Q ss_pred cEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCcc--ccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccC
Q 010856 106 YRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT--FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSM 183 (499)
Q Consensus 106 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 183 (499)
+++++++|+++. +|..+. .+|+.|++++|+++.++.. +..+++|++|++++|.+++..|..|.++++|+.|++++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 466666666653 333333 2677777777777776543 67778888888888888877778888888888888888
Q ss_pred CcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcc-cccCCCCCCEEEccCCcCcccC
Q 010856 184 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA-SLEKLSYLENLNLSFNKLEGEI 262 (499)
Q Consensus 184 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~ 262 (499)
|++++..+..|.++++|++|+|++|++++..|..|..+++|+.|++++|+++...+. ++.. .++...+..+...+..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~--~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE--WLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHH--HHHHHCCSGGGCBBCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHH--HHHHcCCCCCCCCCCC
Confidence 888888887888888888888888888888888888888999999999988754331 1111 1222233445555444
Q ss_pred CCCCCCCCccccccCCCcCCCCC
Q 010856 263 PRGGSFGNFSAESFEGNELLCGS 285 (499)
Q Consensus 263 ~~~~~~~~l~~~~l~~N~~~c~~ 285 (499)
|.. +......++..+.+.|..
T Consensus 166 P~~--l~~~~l~~l~~~~~~C~~ 186 (192)
T 1w8a_A 166 PSK--VRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp STT--TTTSBGGGSCTTTCCCCC
T ss_pred ChH--HcCCChhhCcHhhcCcCC
Confidence 443 334445566677777754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=168.11 Aligned_cols=149 Identities=19% Similarity=0.175 Sum_probs=117.4
Q ss_pred cccccCHHHHHHHhhh----------cccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCC
Q 010856 347 TWRTFSYLELFRATDE----------FSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIR 415 (499)
Q Consensus 347 ~~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~ 415 (499)
....++.+++..++.. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 3456788888877764 777789999999999999975 79999999998766666788999999999999
Q ss_pred CCCccccceeEEccccceeeeeecccCCCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCC
Q 010856 416 HRNLIKILHGVAVITFTVCLCLFHHSSASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP 485 (499)
Q Consensus 416 H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~ 485 (499)
||||+++++++...+ ..++++|++.|+.+..+.. .+.....++.|++.||+|||+ +++|.||+++.++
T Consensus 101 h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 101 HFNVVEMYKSYLVGE--ELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp CTTBCCEEEEEEETT--EEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred CCCcceEEEEEEECC--EEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 999999999987643 4566788886654443322 222344456899999998876 8999999999999
Q ss_pred CeEEEEEEEeec
Q 010856 486 GVEVICFVFEIL 497 (499)
Q Consensus 486 ~~~~~~f~~~~~ 497 (499)
.++++|||++..
T Consensus 179 ~~kl~Dfg~~~~ 190 (321)
T 2c30_A 179 RVKLSDFGFCAQ 190 (321)
T ss_dssp CEEECCCTTCEE
T ss_pred cEEEeeeeeeee
Confidence 999999998764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-19 Score=173.31 Aligned_cols=145 Identities=23% Similarity=0.268 Sum_probs=114.8
Q ss_pred cCHHHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccc
Q 010856 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
++..++...+++|...+.||+|+||.||+|+.++++.||+|++........+.+.+|+++++.++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44445556778999999999999999999998889999999987766566788999999999999999999999886533
Q ss_pred cceeeeeecccCC-Ccccccccc--------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 431 FTVCLCLFHHSSA-SASASLVSS--------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 431 ~~~~~~l~~~~~~-~~~~~l~~~--------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
..+++++++.+ .+.+.+... +.....++.|+++||+|||+ +++|.||+++.++.++++|||++
T Consensus 109 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 109 --EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp --CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred --eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 34556777754 444433221 12233456899999998876 89999999999999999999987
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 187 ~~ 188 (321)
T 2qkw_B 187 KK 188 (321)
T ss_dssp EE
T ss_pred cc
Confidence 63
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=1e-18 Score=169.12 Aligned_cols=140 Identities=15% Similarity=0.163 Sum_probs=107.4
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccc-----
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF----- 431 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~----- 431 (499)
..++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++...+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3567999999999999999999975 79999999997654 3456789999999999999999999998855321
Q ss_pred --------------------------------------------------ceeeeeecccCCCccc-ccccccc------
Q 010856 432 --------------------------------------------------TVCLCLFHHSSASASA-SLVSSLT------ 454 (499)
Q Consensus 432 --------------------------------------------------~~~~~l~~~~~~~~~~-~l~~~~~------ 454 (499)
...++++|++.|+.+. .+.....
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 1145567777654333 3222111
Q ss_pred -ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 455 -LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 455 -~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
....++.|++.||+|||+ ++||.||+++.++.++++|||++...
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence 123456899999998876 89999999999999999999987643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.2e-18 Score=151.83 Aligned_cols=130 Identities=30% Similarity=0.410 Sum_probs=91.2
Q ss_pred CeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCc
Q 010856 130 RIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNR 209 (499)
Q Consensus 130 ~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 209 (499)
+.+++++|+++.+|..+. ++|++|++++|.++. +|..|.++++|+.|++++|.|++..+..|.++++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 456666666666665432 466677777776663 44566667777777777777776666667777777777777777
Q ss_pred CCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccC
Q 010856 210 LQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEI 262 (499)
Q Consensus 210 l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 262 (499)
++++.+..|..+++|+.|+|++|+|+...+..|..+++|+.|++++|++.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 77777777777777777777777777666667777777888887777776543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.74 E-value=4.2e-20 Score=193.66 Aligned_cols=179 Identities=12% Similarity=0.035 Sum_probs=105.1
Q ss_pred CcccccEEeeecCCCCCcC-CccccCCccCCeeeccccCCCC--CCccccCCCCCcEEEcCC---------CcCCCCCcc
Q 010856 101 HLAELYRLDLDGNKLSGSL-PACFSNLTSLRIVSLGSNKLTS--VPLTFWNLKDILNLNFSS---------NFLTSPLPL 168 (499)
Q Consensus 101 ~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~l~~L~~L~l~~---------n~l~~~~~~ 168 (499)
.+++|++|++++|.+++.. ...+..+++|+.|++++| ++. ++.....+++|++|++.+ +.+++....
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~ 365 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence 5678899999888866432 223457788888888887 432 222233477888887733 344332222
Q ss_pred cc-cCCCCccEEEccCCcccccCccccc-CCcCCceeeCc--C----CcCCCCCC-----ccccCCCCCCEEeCCCCcCC
Q 010856 169 EI-GNLKVLIGIDFSMNNFSGVIPTEIG-GLKNLEYLFLG--Y----NRLQGSIP-----DSFGDLISLKFLNLSNNNLS 235 (499)
Q Consensus 169 ~~-~~l~~L~~L~l~~n~l~~~~~~~l~-~l~~L~~L~L~--~----n~l~~~~~-----~~l~~l~~L~~L~l~~N~l~ 235 (499)
.+ ..+++|+.|.++.|.+++.....+. .+++|++|+++ + +.+++... ..+..+++|+.|++++ .++
T Consensus 366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~ 444 (594)
T 2p1m_B 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT 444 (594)
T ss_dssp HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence 22 2367777777777777655444443 46777777777 3 44542211 1245566777777765 555
Q ss_pred ccCcccccC-CCCCCEEEccCCcCcccCCCC--CCCCCccccccCCCcC
Q 010856 236 GAIPASLEK-LSYLENLNLSFNKLEGEIPRG--GSFGNFSAESFEGNEL 281 (499)
Q Consensus 236 ~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~--~~~~~l~~~~l~~N~~ 281 (499)
+..+..+.. +++|+.|++++|.+++..... ..+++++.+++.+|+.
T Consensus 445 ~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 444444443 667777777777765432211 1256667777776664
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=9.6e-19 Score=166.66 Aligned_cols=136 Identities=17% Similarity=0.191 Sum_probs=109.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
..+|...+.||+|+||+||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..++++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC--EEEEEE
Confidence 45799999999999999999995 579999999998766566778999999999999999999999987643 445677
Q ss_pred cccCCCcccc-ccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASAS-LVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~-l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|++.|+.+.. +.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence 7775544333 221 222344556899999998876 8999999999999999999998754
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-16 Score=157.55 Aligned_cols=237 Identities=12% Similarity=0.071 Sum_probs=186.8
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
.++.+.+.+ .++.+...+|.++ +|+.+.+..| ++.+...+|.++ +|+.+.+.. .++.+...+|.++++|+.+++.
T Consensus 114 ~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~ 188 (401)
T 4fdw_A 114 GYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLS 188 (401)
T ss_dssp SCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECT
T ss_pred CccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecC
Confidence 788888765 4666778888885 7999998876 777778888884 699999986 6776777889999999999999
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCC-ccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccC
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI 190 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 190 (499)
+|.++.+....|. ..+|+.+.+..+ ++.++ ..|.++++|+.+++..| ++.+....|.+ .+|+.+.+ .+.++.+.
T Consensus 189 ~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~ 263 (401)
T 4fdw_A 189 KTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIA 263 (401)
T ss_dssp TSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEEC
T ss_pred CCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEC
Confidence 9999987777887 589999999854 77654 46778899999999875 66677777877 78999999 45577777
Q ss_pred cccccCCcCCceeeCcCCcCC-----CCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC
Q 010856 191 PTEIGGLKNLEYLFLGYNRLQ-----GSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG 265 (499)
Q Consensus 191 ~~~l~~l~~L~~L~L~~n~l~-----~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 265 (499)
...|.++++|+.+++.+|.+. .+....|.++++|+.+++. +.++.+...+|.++++|+.+++..| ++...+..
T Consensus 264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~a 341 (401)
T 4fdw_A 264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSA 341 (401)
T ss_dssp TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTS
T ss_pred hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHh
Confidence 888999999999999888765 4667889999999999998 4588788889999999999999655 65443333
Q ss_pred CCCCCccccccCCCc
Q 010856 266 GSFGNFSAESFEGNE 280 (499)
Q Consensus 266 ~~~~~l~~~~l~~N~ 280 (499)
-.-..+..+.+.+|.
T Consensus 342 F~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 342 FNNTGIKEVKVEGTT 356 (401)
T ss_dssp SSSSCCCEEEECCSS
T ss_pred CCCCCCCEEEEcCCC
Confidence 222267778887775
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.74 E-value=8.6e-18 Score=145.76 Aligned_cols=132 Identities=23% Similarity=0.269 Sum_probs=94.1
Q ss_pred ccccEEEcccCCCc-ccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEe
Q 010856 31 HSLEDFRMYNCNIS-GGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLD 109 (499)
Q Consensus 31 ~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 109 (499)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++..|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 36777777777776 45566667777777777777777754 5667777777777777777765666666677777777
Q ss_pred eecCCCCCcCC-ccccCCccCCeeeccccCCCCCCc----cccCCCCCcEEEcCCCcCCC
Q 010856 110 LDGNKLSGSLP-ACFSNLTSLRIVSLGSNKLTSVPL----TFWNLKDILNLNFSSNFLTS 164 (499)
Q Consensus 110 L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~----~~~~l~~L~~L~l~~n~l~~ 164 (499)
+++|.+++... ..+..+++|+.|++++|.++.++. .+..+++|++|++++|.+..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 77777775432 567777777777777777777665 56677777777777777654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5.8e-19 Score=169.36 Aligned_cols=137 Identities=15% Similarity=0.195 Sum_probs=109.1
Q ss_pred HhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
..++|...+.||+|+||+||+|+..+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER--CLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS--CEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC--EEEE
Confidence 346799999999999999999998889999999996543 233567899999999999999999999987633 4456
Q ss_pred eecccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|++.+++...+... ......++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 7888887765544322 22234456899999998876 8999999999999999999998865
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-19 Score=179.33 Aligned_cols=144 Identities=13% Similarity=0.076 Sum_probs=111.6
Q ss_pred CHHHHHHHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEE
Q 010856 352 SYLELFRATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVA 427 (499)
Q Consensus 352 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~ 427 (499)
.+.++....++|...++||+|+||+||+|+.+ +++.||+|++++.. ....+.+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555666789999999999999999999975 58899999997532 223345889999999999999999999987
Q ss_pred ccccceeeeeecccC-CCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 428 VITFTVCLCLFHHSS-ASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 428 ~~~~~~~~~l~~~~~-~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
..+ ..++++||+. |++...+.. .+...+.++.|++.||+|||+ ++||.||+++.++.++++|||++
T Consensus 145 ~~~--~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 145 DDN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp CSS--EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eCC--EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 743 4456777774 454444432 122234456888999988765 89999999999999999999988
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
+.
T Consensus 223 ~~ 224 (437)
T 4aw2_A 223 LK 224 (437)
T ss_dssp EE
T ss_pred hh
Confidence 64
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-18 Score=164.78 Aligned_cols=138 Identities=16% Similarity=0.163 Sum_probs=105.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--------------------------ccHHHHHHHHHHHh
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--------------------------RAFESFDVECEMMK 412 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~il~ 412 (499)
.++|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999996 5789999999975431 11356899999999
Q ss_pred cCCCCCccccceeEEccccceeeeeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEe
Q 010856 413 NIRHRNLIKILHGVAVITFTVCLCLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV 482 (499)
Q Consensus 413 ~l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~ 482 (499)
+++||||+++++++........++++|++.++....+... +.....++.|+++||+|||+ +++|.||+++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 9999999999999876434455667888866554443222 22234446899999998876 8999999999
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
.++.++++|||++..
T Consensus 172 ~~~~~kl~Dfg~~~~ 186 (298)
T 2zv2_A 172 EDGHIKIADFGVSNE 186 (298)
T ss_dssp TTSCEEECCCTTCEE
T ss_pred CCCCEEEecCCCccc
Confidence 999999999998764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.2e-20 Score=192.38 Aligned_cols=275 Identities=14% Similarity=0.094 Sum_probs=180.2
Q ss_pred CCCCCCEEECcCCCCCccCChhccc-cccccccEEEcccC-CCccc-CCccccCCCCCCEEeccCCcCCccCCccc----
Q 010856 3 NCKSLTLIYLSNNPLDGILPKTSVG-NLSHSLEDFRMYNC-NISGG-IPEEISNLTNSTIVNLGGNKLNGSIPITL---- 75 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~~~~~-~l~~~L~~L~l~~n-~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---- 75 (499)
.+++|++|+|++|.+++..+. .+. .++ +|++|++++| .++.. .+..+.++++|++|+|++|.+++..+..+
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~-~l~~~~~-~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~ 180 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLE-LIAKSFK-NFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP 180 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHH-HHHHHCT-TCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC
T ss_pred hCCCCCeEEeeCcEEcHHHHH-HHHHhCC-CCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh
Confidence 467899999999888766554 333 566 8999999888 55432 33344578888888888888775444333
Q ss_pred cCCCCCCeEeccccc--cccc-CCccccCcccccEEeeecCC--------------------------------------
Q 010856 76 SKLQKLQGLGLEDNK--LEGS-IPDDICHLAELYRLDLDGNK-------------------------------------- 114 (499)
Q Consensus 76 ~~l~~L~~L~L~~n~--l~~~-~~~~~~~l~~L~~L~L~~n~-------------------------------------- 114 (499)
..+++|++|++++|. +... ....+..+++|++|++++|.
T Consensus 181 ~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~ 260 (594)
T 2p1m_B 181 DTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVA 260 (594)
T ss_dssp TTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHH
T ss_pred hcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHH
Confidence 356688888888876 2211 11112345777777777661
Q ss_pred ------------CCCc----CCccccCCccCCeeeccccCCCC--CCccccCCCCCcEEEcCCCcCCCC-CcccccCCCC
Q 010856 115 ------------LSGS----LPACFSNLTSLRIVSLGSNKLTS--VPLTFWNLKDILNLNFSSNFLTSP-LPLEIGNLKV 175 (499)
Q Consensus 115 ------------l~~~----~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~ 175 (499)
+... .+..+..+++|+.|++++|.++. +...+..+++|++|++++| +++. .+.....+++
T Consensus 261 l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~ 339 (594)
T 2p1m_B 261 LSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKD 339 (594)
T ss_dssp HHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTT
T ss_pred HhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCC
Confidence 1111 11122256899999999999775 3334668899999999988 4321 1222235789
Q ss_pred ccEEEccC---------CcccccCcccc-cCCcCCceeeCcCCcCCCCCCcccc-CCCCCCEEeCC--C----CcCCccC
Q 010856 176 LIGIDFSM---------NNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPDSFG-DLISLKFLNLS--N----NNLSGAI 238 (499)
Q Consensus 176 L~~L~l~~---------n~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~l~--~----N~l~~~~ 238 (499)
|+.|++++ +.+++.....+ .++++|++|.++.|.+++.....+. .+++|+.|+++ + |.+++..
T Consensus 340 L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~ 419 (594)
T 2p1m_B 340 LRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEP 419 (594)
T ss_dssp CCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCC
T ss_pred CCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCc
Confidence 99999843 45554333333 3489999999999998865555554 58999999999 4 5666322
Q ss_pred -----cccccCCCCCCEEEccCCcCcccCCCC-C-CCCCccccccCCCcC
Q 010856 239 -----PASLEKLSYLENLNLSFNKLEGEIPRG-G-SFGNFSAESFEGNEL 281 (499)
Q Consensus 239 -----~~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~~l~~~~l~~N~~ 281 (499)
+..+..+++|+.|++++ .+++..+.. . ..++++.+++.+|..
T Consensus 420 ~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i 468 (594)
T 2p1m_B 420 LDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGD 468 (594)
T ss_dssp THHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCS
T ss_pred hhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCC
Confidence 22367789999999987 565432211 1 256788899988763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-18 Score=165.95 Aligned_cols=135 Identities=16% Similarity=0.192 Sum_probs=109.9
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
++|+..+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEEE
Confidence 4689999999999999999996 468999999997654 23357789999999999999999999998763 345668
Q ss_pred ecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|++.+++...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 88888876554432 222344556899999998876 8999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-18 Score=167.95 Aligned_cols=137 Identities=16% Similarity=0.215 Sum_probs=95.8
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
..++|+..+.||+|+||.||+|+. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN--KLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT--EEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC--eEEE
Confidence 346799999999999999999996 469999999997654 334577899999999999999999999987633 4556
Q ss_pred eecccCCCcccccccc----------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVSS----------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~----------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|++.|++.+.+... ......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 7888887765544321 12233345799999998876 8999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=7e-19 Score=170.01 Aligned_cols=150 Identities=31% Similarity=0.360 Sum_probs=116.9
Q ss_pred cccccCHHHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCcccccee
Q 010856 347 TWRTFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHG 425 (499)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~ 425 (499)
....++.+++....++|...+.||+|+||.||+|+..+|+.||+|++.... ......+.+|+++++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 456789999999999999999999999999999998789999999997654 2233478999999999999999999999
Q ss_pred EEccccceeeeeecccCC-Ccccccccc--------ccccccccccccccceeecc---------CCCcccEEEeeCCCe
Q 010856 426 VAVITFTVCLCLFHHSSA-SASASLVSS--------LTLSRPAKGGGFRGCVLWHV---------GVDFAAFVFVLEPGV 487 (499)
Q Consensus 426 ~~~~~~~~~~~l~~~~~~-~~~~~l~~~--------~~~~~~~~~~i~~gl~yLH~---------~~~p~~~l~~~~~~~ 487 (499)
+...+ ..+++++++.+ ++.+.+... +.....++.|++.||+|||+ +++|.||+++.++.+
T Consensus 96 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 96 CMTPT--ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp ECCSS--CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EecCC--ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 87643 33456777755 443333221 12234456888888877765 689999999999999
Q ss_pred EEEEEEEeecc
Q 010856 488 EVICFVFEILL 498 (499)
Q Consensus 488 ~~~~f~~~~~~ 498 (499)
+++|||++...
T Consensus 174 kl~Dfg~~~~~ 184 (326)
T 3uim_A 174 VVGDFGLAKLM 184 (326)
T ss_dssp EECCCSSCEEC
T ss_pred EeccCcccccc
Confidence 99999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.73 E-value=6.9e-19 Score=167.52 Aligned_cols=138 Identities=18% Similarity=0.137 Sum_probs=108.7
Q ss_pred hhhcccccccccCCcceEEEEEe-----CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.++|+..+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++...+....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 3688999999976655556789999999999999999999999866443345
Q ss_pred eeeecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++++.+ ++.+.+... +.....++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 567777754 544433221 12233456899999999876 8999999999999999999999865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.1e-19 Score=170.24 Aligned_cols=138 Identities=18% Similarity=0.206 Sum_probs=110.1
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
...++|...+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~ 89 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK--TL 89 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EE
Confidence 4467899999999999999999996 689999999997653 234567889999999999999999999987633 45
Q ss_pred eeeecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|++.| ++.+.+... ......++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 567788754 444443322 22334556899999999876 8999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.73 E-value=8.4e-19 Score=177.67 Aligned_cols=139 Identities=17% Similarity=0.166 Sum_probs=103.2
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc---cce
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT---FTV 433 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~---~~~ 433 (499)
.++|...+.||+|+||+||+|+. .+++.||||++.... ....+++.+|++++++++|||||++++++...+ ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36799999999999999999995 479999999996543 234577899999999999999999999985432 234
Q ss_pred eeeeecccCCCccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHSSASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++++|++++++...+.... ...+.++.||+.||+|||+ ++||.|||++.++.++++|||+++..
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 56678888887666554332 2244456899999999876 89999999999999999999998753
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-17 Score=144.42 Aligned_cols=133 Identities=23% Similarity=0.222 Sum_probs=68.2
Q ss_pred CCCCEEeccCCcCC-ccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeee
Q 010856 55 TNSTIVNLGGNKLN-GSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVS 133 (499)
Q Consensus 55 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 133 (499)
++|++|++++|.++ +..|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++..|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45555555555554 33344445555555555555555433 3444455555555555555443444444444444444
Q ss_pred ccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCc---ccccCCcCCceeeCcCCcC
Q 010856 134 LGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIP---TEIGGLKNLEYLFLGYNRL 210 (499)
Q Consensus 134 L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~---~~l~~l~~L~~L~L~~n~l 210 (499)
+++|+++.++ .+..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+
T Consensus 102 Ls~N~l~~~~----------------------~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 102 LSGNKLKDIS----------------------TLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CBSSSCCSSG----------------------GGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred ccCCccCcch----------------------hHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 4444444433 11445555555666666665554433 3556666666666666665
Q ss_pred C
Q 010856 211 Q 211 (499)
Q Consensus 211 ~ 211 (499)
.
T Consensus 160 ~ 160 (168)
T 2ell_A 160 Q 160 (168)
T ss_dssp C
T ss_pred h
Confidence 5
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.73 E-value=1e-18 Score=168.99 Aligned_cols=136 Identities=16% Similarity=0.162 Sum_probs=111.3
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|.+.+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT--DIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEE
Confidence 46899999999999999999996 679999999997542 233467899999999999999999999987743 455
Q ss_pred eeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++||++|++.+.+... +.....++.|++.||+|||+ +++|.||++++++.++++|||++..
T Consensus 86 lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 86 MVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 67888888776655432 22344556899999999876 8999999999999999999998864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=9.4e-19 Score=186.33 Aligned_cols=220 Identities=22% Similarity=0.191 Sum_probs=124.4
Q ss_pred CCCCEEECcCCCCCccCChhcccccc---ccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCC
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLS---HSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKL 81 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 81 (499)
+.++.|+|.+|.+...... .+..+. .++..+++..|.+. ..++.|..++.|+.|+|++|.+. .+|..+..+++|
T Consensus 173 ~~~~~l~L~~n~~~~~~~~-~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQA-LLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCcchhh-HhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 4578899999988764222 111110 01222333334444 56888999999999999999998 556666699999
Q ss_pred CeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCc
Q 010856 82 QGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNF 161 (499)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~ 161 (499)
++|+|++|.|+ .+|..|..+++|++|+|++|.++ .+|..|..+++|++|+|++|.|+.+|..+..+++|+.|+|++|.
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSC
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCc
Confidence 99999999999 77889999999999999999999 66888999999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCC-ccEEEccCCcccccCcccccCCcCCceeeCcCC--------cCCCCCCccccCCCCCCEEeCCCC
Q 010856 162 LTSPLPLEIGNLKV-LIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYN--------RLQGSIPDSFGDLISLKFLNLSNN 232 (499)
Q Consensus 162 l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n--------~l~~~~~~~l~~l~~L~~L~l~~N 232 (499)
+++.+|..+..+.. +..+++++|.+++..|. .|+.|+++.| .+.+..+..+..+..+....+++|
T Consensus 328 l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~N 401 (727)
T 4b8c_D 328 LEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYN 401 (727)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C-----------------------------------------
T ss_pred cCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecccccccccCCccccccchhhcccccceeeeecc
Confidence 99888777655432 23478999999877665 4556667766 344444445566667777788888
Q ss_pred cCC
Q 010856 233 NLS 235 (499)
Q Consensus 233 ~l~ 235 (499)
-+.
T Consensus 402 il~ 404 (727)
T 4b8c_D 402 TLC 404 (727)
T ss_dssp CCC
T ss_pred ccc
Confidence 765
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=4.5e-17 Score=142.49 Aligned_cols=133 Identities=26% Similarity=0.271 Sum_probs=107.7
Q ss_pred CCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCC
Q 010856 129 LRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYN 208 (499)
Q Consensus 129 L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n 208 (499)
.+.+++++|+++.+|..+. ++|++|++++|.+++..+..+..+++|++|++++|.+++..+..|..+++|++|++++|
T Consensus 9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 4567777777777775443 67888888888888776677788888888888888888777777888888899999988
Q ss_pred cCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCC
Q 010856 209 RLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263 (499)
Q Consensus 209 ~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 263 (499)
.+++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|++++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 8887777778888899999999999887777777888899999999998887655
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=4e-18 Score=164.83 Aligned_cols=223 Identities=16% Similarity=0.118 Sum_probs=149.1
Q ss_pred cccEEEcccCCCc--ccCCccccCCCCCCEEeccCCcCCccCCccccC--------CCCCCeEecccccccccCCccccC
Q 010856 32 SLEDFRMYNCNIS--GGIPEEISNLTNSTIVNLGGNKLNGSIPITLSK--------LQKLQGLGLEDNKLEGSIPDDICH 101 (499)
Q Consensus 32 ~L~~L~l~~n~i~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--------l~~L~~L~L~~n~l~~~~~~~~~~ 101 (499)
+|+.|+|++|++. ...+..+ +.+..+.+..|. +.+.+|.+ +++|+.|+|.+ .++.+.+.+|.+
T Consensus 50 ~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~ 122 (329)
T 3sb4_A 50 SLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKG 122 (329)
T ss_dssp TCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTT
T ss_pred cCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhc
Confidence 5666666666665 2221111 123334444442 33456666 77777777777 666666667777
Q ss_pred cccccEEeeecCCCCCcCCccccCCccCCeeeccccC----CCCC-CccccCCCCCc-EEEc------------------
Q 010856 102 LAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNK----LTSV-PLTFWNLKDIL-NLNF------------------ 157 (499)
Q Consensus 102 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~----l~~~-~~~~~~l~~L~-~L~l------------------ 157 (499)
+++|+.|++.+|.+..+.+.+|.++.++..+.+..+. ...+ ...|.++..|+ .+.+
T Consensus 123 ~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~ 202 (329)
T 3sb4_A 123 CDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPR 202 (329)
T ss_dssp CTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGG
T ss_pred CcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCcc
Confidence 7777777777777776777777776666666655421 1111 12233444444 2322
Q ss_pred -------CCCcCCCCCcccc-cCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCC-EEe
Q 010856 158 -------SSNFLTSPLPLEI-GNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLK-FLN 228 (499)
Q Consensus 158 -------~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~-~L~ 228 (499)
.++- .......+ ..+++|+.+++++|+++.+.+..|.++++|++|++.+| ++.+.+..|.++++|+ .++
T Consensus 203 ~~~~l~~~~~l-~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~ 280 (329)
T 3sb4_A 203 DINFLTIEGKL-DNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLE 280 (329)
T ss_dssp GCSEEEEEECC-CHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccceEEEeeee-cHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEE
Confidence 2221 00000001 13789999999999999888899999999999999998 8878888999999999 999
Q ss_pred CCCCcCCccCcccccCCCCCCEEEccCCcCcccCCC
Q 010856 229 LSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPR 264 (499)
Q Consensus 229 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 264 (499)
+.+ .++.+.+.+|.++++|+.+++++|.++...+.
T Consensus 281 l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~ 315 (329)
T 3sb4_A 281 LPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDE 315 (329)
T ss_dssp ECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTT
T ss_pred Ecc-cceEEchhhhhCCccCCEEEeCCCccCccchh
Confidence 998 88888889999999999999999999865543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.7e-18 Score=164.65 Aligned_cols=136 Identities=15% Similarity=0.120 Sum_probs=108.9
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.++|...+.||+|+||+||+|+. .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..++++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--RLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC--eeEEEE
Confidence 46789999999999999999996 469999999986655556678999999999999999999999987633 445577
Q ss_pred cccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++ +.+.+.. .+.....++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 777554 4333322 122234456899999998876 8999999999999999999998864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-18 Score=175.83 Aligned_cols=138 Identities=16% Similarity=0.102 Sum_probs=110.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc----cc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT----FT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----~~ 432 (499)
.++|...+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++++.++|||||++++++...+ ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46799999999999999999995 578999999997643 234567899999999999999999999986532 23
Q ss_pred eeeeeecccCCCcccccccc--ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVSS--LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~~--~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++|++.+++...+... +.....++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 45678899988866554322 22344556899999999876 8999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-18 Score=173.10 Aligned_cols=143 Identities=13% Similarity=0.068 Sum_probs=111.4
Q ss_pred HHHHHHHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEc
Q 010856 353 YLELFRATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAV 428 (499)
Q Consensus 353 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~ 428 (499)
..++....++|...+.||+|+||+||+|+.+ +++.||+|++++.. ....+.+.+|+++++.++|||||++++++..
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556788999999999999999999964 68999999997532 2334568899999999999999999999876
Q ss_pred cccceeeeeecccCCC-ccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 429 ITFTVCLCLFHHSSAS-ASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~~-~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+ ..++++||+.|+ +...+.. .+...+.++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 141 ~~--~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 141 DR--YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SS--EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CC--EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 33 445678888554 4333221 223344556899999998876 8999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-18 Score=165.74 Aligned_cols=135 Identities=17% Similarity=0.207 Sum_probs=108.8
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|...+.||+|+||.||+|+..+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--eEEEEE
Confidence 4688999999999999999998789999999996543 233477899999999999999999999987643 455678
Q ss_pred cccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|++.+++...+... ......++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 88887654443321 22234456899999999876 8999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-18 Score=169.76 Aligned_cols=136 Identities=18% Similarity=0.195 Sum_probs=101.6
Q ss_pred hhcccccccccCCcceEEEEEeC----CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.+|...+.||+|+||.||+|+.. ++..||||+++... ....+.|.+|++++++++||||+++++++...+ ..+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 122 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK--PVM 122 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SCE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--ceE
Confidence 57889999999999999999853 57789999997653 234567999999999999999999999987633 445
Q ss_pred eeecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++|++.+ .+.+.+... +.....++.|+++||+|||+ +++|.||+++.++.++++|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 67788754 444333221 12234456899999998876 89999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.3e-18 Score=168.20 Aligned_cols=137 Identities=15% Similarity=0.100 Sum_probs=108.1
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|+++++.++|||||++++++...+ ..+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~ 91 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE--DMF 91 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEE
Confidence 46799999999999999999996 468999999997543 344678899999999999999999999887643 345
Q ss_pred eeecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++++.|+ +...+... ......++.|++.||+|||+ ++||.||+++.++.++++|||++..+
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 567777554 43333322 22334456899999998876 89999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=4e-18 Score=164.56 Aligned_cols=137 Identities=18% Similarity=0.158 Sum_probs=106.3
Q ss_pred hhhcccccccccCCcceEEEEEeC----CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.++|.+.+.||+|+||.||+|+.. .+..||||+++... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR--LA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG--CC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--cc
Confidence 356888999999999999999963 34569999997653 334567999999999999999999999986633 44
Q ss_pred eeeecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++|++.| ++.+.+... ......++.|++.||+|||+ +++|.||+++.++.++++|||+++..
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 567787755 443333221 22234456899999998876 89999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-18 Score=170.51 Aligned_cols=140 Identities=15% Similarity=0.103 Sum_probs=104.5
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCC-CCCccccceeEEccccce
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTV 433 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~ 433 (499)
...++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++++. ||||+++++++...+...
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999995 579999999996542 234567889999999997 999999999987655545
Q ss_pred eeeeecccCCCcccccccc---ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSASASASLVSS---LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~~---~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+++++++.+++...+... ......++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 86 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 6678899988765544321 12233446899999998876 8999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=3.9e-18 Score=165.13 Aligned_cols=136 Identities=15% Similarity=0.141 Sum_probs=108.2
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||+||+|+. .+|+.||+|++++.. ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC--EEE
Confidence 46799999999999999999996 479999999997642 344677899999999999999999999887643 445
Q ss_pred eeecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++||+.|+ +...+... +...+.++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 577777654 43333222 22334456899999999876 8999999999999999999998763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.6e-18 Score=164.68 Aligned_cols=136 Identities=15% Similarity=0.154 Sum_probs=105.4
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..+++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--eEEEE
Confidence 467999999999999999999964 79999999997554 233466889999999999999999999987633 34456
Q ss_pred ecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|++.| ++.+.+... +.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence 777755 444444332 22344556899999998876 8999999999999999999998864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=8.4e-18 Score=164.30 Aligned_cols=136 Identities=16% Similarity=0.167 Sum_probs=107.1
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG------RAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
.+.|...+.||+|+||.||+|+. .+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-- 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT-- 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--
Confidence 45699999999999999999996 4799999999976542 13578999999999999999999999987633
Q ss_pred eeeeeecccC-CCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCC----CeEEEEEEEeec
Q 010856 433 VCLCLFHHSS-ASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP----GVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~-~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~----~~~~~~f~~~~~ 497 (499)
..++++|++. |++.+.+... +.....++.|++.||+|||+ +++|.||++.+++ .++++|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 4456777774 5554444322 22334456899999998876 8999999998776 699999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-18 Score=171.92 Aligned_cols=144 Identities=13% Similarity=0.064 Sum_probs=112.1
Q ss_pred CHHHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEE
Q 010856 352 SYLELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVA 427 (499)
Q Consensus 352 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~ 427 (499)
.+++.....++|...+.||+|+||+||+|+. .+|+.||+|++++.. ....+.+.+|+.++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4455556678999999999999999999996 479999999997542 223455889999999999999999999887
Q ss_pred ccccceeeeeecccC-CCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 428 VITFTVCLCLFHHSS-ASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 428 ~~~~~~~~~l~~~~~-~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
..+ ..++++||+. |++...+... +...+.++.|++.||+|||+ ++||.||+++.++.++++|||++
T Consensus 132 ~~~--~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 132 DEN--YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp CSS--EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eCC--EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 643 4456777774 4544444321 22234456889999998865 89999999999999999999988
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 210 ~~ 211 (412)
T 2vd5_A 210 LK 211 (412)
T ss_dssp EE
T ss_pred ee
Confidence 64
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-18 Score=165.12 Aligned_cols=138 Identities=16% Similarity=0.115 Sum_probs=106.7
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.|.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+....++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56899999999999999999964 69999999997644 34467789999999999999999999998765444455677
Q ss_pred cccCC-Cccccccc-------cccccccccccccccceeecc------CCCcccEEE----eeCCCeEEEEEEEeecc
Q 010856 439 HHSSA-SASASLVS-------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVF----VLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~-~~~~~l~~-------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~----~~~~~~~~~~f~~~~~~ 498 (499)
|++.+ ++...+.. .+.....++.|++.||+|||+ +++|.||++ +.++.++++|||+++..
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 88755 44333322 122234456899999998876 899999998 44456999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=5.6e-18 Score=162.78 Aligned_cols=136 Identities=15% Similarity=0.125 Sum_probs=108.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||+||+|+. .+|+.||+|++++.. ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--EEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC--EEE
Confidence 46799999999999999999996 479999999997643 244677889999999999999999999987633 445
Q ss_pred eeecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|++.| ++...+... +.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCccee
Confidence 67777755 444443322 22334456899999998876 8999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.1e-18 Score=168.27 Aligned_cols=136 Identities=19% Similarity=0.199 Sum_probs=104.8
Q ss_pred hhhcccccccccCCcceEEEEEe--------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL--------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
.++|...+.||+|+||.||+|+. .++..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46799999999999999999984 235679999997654 23456799999999999 899999999998763
Q ss_pred ccceeeeeecccCC-Cccccccccc--------------------cccccccccccccceeecc------CCCcccEEEe
Q 010856 430 TFTVCLCLFHHSSA-SASASLVSSL--------------------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFV 482 (499)
Q Consensus 430 ~~~~~~~l~~~~~~-~~~~~l~~~~--------------------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~ 482 (499)
+ ..++++||+.| ++.+.+.... .....++.|+++||+|||+ ++||.||+++
T Consensus 160 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 160 G--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp S--SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred C--CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 3 34456777755 4444333211 1123346899999999876 8999999999
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
.++.++++|||+++.
T Consensus 238 ~~~~~kl~DFG~a~~ 252 (370)
T 2psq_A 238 ENNVMKIADFGLARD 252 (370)
T ss_dssp TTCCEEECCCSSCEE
T ss_pred CCCCEEEccccCCcc
Confidence 999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.6e-18 Score=172.51 Aligned_cols=139 Identities=15% Similarity=0.170 Sum_probs=112.4
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc---ce
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF---TV 433 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~---~~ 433 (499)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+. ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46799999999999999999996 468999999997543 2345779999999999999999999998866432 34
Q ss_pred eeeeecccCCCccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHSSASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++++|++++++...+.... ...+.++.|+++||+|||+ ++||.||+++.++.++++|||+++..
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 56678899887766554332 2344556899999999876 89999999999999999999998753
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-16 Score=141.62 Aligned_cols=127 Identities=24% Similarity=0.303 Sum_probs=107.9
Q ss_pred cEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCc
Q 010856 106 YRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNN 185 (499)
Q Consensus 106 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 185 (499)
+.+++++|+++.+ |..+. ++|+.|++++|+++.+|..+..+++|+.|++++|.|+++.+..|.++++|+.|+|++|+
T Consensus 13 ~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVL-PKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSC-CSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcC-CCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4677777777743 43332 57888888888888888888888899999999999988888889999999999999999
Q ss_pred ccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCC
Q 010856 186 FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLS 235 (499)
Q Consensus 186 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~ 235 (499)
+++..+..|.++++|++|+|++|+++...+..|..+++|+.|++++|++.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 99888888999999999999999999777778999999999999999886
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.7e-18 Score=159.42 Aligned_cols=135 Identities=17% Similarity=0.113 Sum_probs=107.2
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|+..+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++...+ ..+++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--ceEEEEE
Confidence 46789999999999999999998788899999997654 23567999999999999999999999987633 3456778
Q ss_pred ccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.++ +.+.+.. .......++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccc
Confidence 77655 3333322 122233446899999998876 8999999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.4e-18 Score=166.94 Aligned_cols=146 Identities=10% Similarity=0.089 Sum_probs=114.9
Q ss_pred CHHHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCc-----------cHHHHHHHHHHHhcCCCCCcc
Q 010856 352 SYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR-----------AFESFDVECEMMKNIRHRNLI 420 (499)
Q Consensus 352 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~H~niv 420 (499)
..+++....++|...+.||+|+||.||+|...+|+.||+|++...... ..+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456777888999999999999999999999878999999999543211 136799999999999999999
Q ss_pred ccceeEEccc---cceeeeeecccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCC
Q 010856 421 KILHGVAVIT---FTVCLCLFHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG 486 (499)
Q Consensus 421 ~l~~~~~~~~---~~~~~~l~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~ 486 (499)
++++++...+ ....+++++++.|++...+... ......++.|++.||+|||+ +++|.||+++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 9999986532 2245668888888766655422 22234456899999999876 89999999999999
Q ss_pred eEEEEEEEeec
Q 010856 487 VEVICFVFEIL 497 (499)
Q Consensus 487 ~~~~~f~~~~~ 497 (499)
++++|||++..
T Consensus 173 ~kl~Dfg~~~~ 183 (362)
T 3pg1_A 173 ITICDFNLARE 183 (362)
T ss_dssp EEECCTTC---
T ss_pred EEEEecCcccc
Confidence 99999998853
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.5e-18 Score=169.56 Aligned_cols=138 Identities=16% Similarity=0.180 Sum_probs=108.2
Q ss_pred HHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
...++|...+.||+|+||.||+|+.. +++.||||+++.... ...++|.+|++++++++||||+++++++...+ ..+
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--PIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS--SCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC--CcE
Confidence 44567999999999999999999975 789999999975432 23456889999999999999999999987633 345
Q ss_pred eeecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|++.+ ++.+.+... ......++.|+++||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 67777754 444443321 22234456899999998866 8999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=5.4e-18 Score=162.35 Aligned_cols=140 Identities=21% Similarity=0.180 Sum_probs=104.4
Q ss_pred HHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 355 ELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 355 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
++....++|...+.||+|+||.||+|+. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-- 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 3344567899999999999999999987 67899999997654 233567899999999999999999999987643
Q ss_pred eeeeeecccCC-Ccccccccc-------ccccccccccccccceeecc--------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 433 VCLCLFHHSSA-SASASLVSS-------LTLSRPAKGGGFRGCVLWHV--------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~~-------~~~~~~~~~~i~~gl~yLH~--------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
..+++++++.+ ++.+.+... +.....++.|++.||+|||+ +++|.||+++.++.++++|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 34557777755 443333321 12233456889999987765 679999999999999999999986
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
.
T Consensus 188 ~ 188 (309)
T 3p86_A 188 L 188 (309)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=9.4e-18 Score=160.58 Aligned_cols=148 Identities=24% Similarity=0.321 Sum_probs=116.2
Q ss_pred cccccCHHHHHHHhhhcccc------cccccCCcceEEEEEeCCCCEEEEEEeeccC----CccHHHHHHHHHHHhcCCC
Q 010856 347 TWRTFSYLELFRATDEFSEN------NLIGKGGFGSVYKARLGDRMEVAVKVFNLQC----GRAFESFDVECEMMKNIRH 416 (499)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~H 416 (499)
....|++.++..++.+|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999998877 8899999999999987 67899999996532 2345779999999999999
Q ss_pred CCccccceeEEccccceeeeeecccCC-Cccccccc-------cccccccccccccccceeecc------CCCcccEEEe
Q 010856 417 RNLIKILHGVAVITFTVCLCLFHHSSA-SASASLVS-------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV 482 (499)
Q Consensus 417 ~niv~l~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~-------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~ 482 (499)
|||+++++++...+ ..+++++++.+ .+.+.+.. .+.....++.|++.||+|||+ +++|.||+++
T Consensus 90 ~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 90 ENLVELLGFSSDGD--DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD 167 (307)
T ss_dssp TTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred CCeEEEEEEEecCC--ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc
Confidence 99999999887633 34456777744 44333321 122233456889999998866 8999999999
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
.++.++++|||+++.
T Consensus 168 ~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 168 EAFTAKISDFGLARA 182 (307)
T ss_dssp TTCCEEECCCTTCEE
T ss_pred CCCcEEEeecccccc
Confidence 999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.69 E-value=6.6e-18 Score=164.45 Aligned_cols=136 Identities=15% Similarity=0.124 Sum_probs=108.4
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||.||+|+. .+|+.||+|++.+.. ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~ 117 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC--EEE
Confidence 46799999999999999999996 479999999997643 344678899999999999999999999887633 445
Q ss_pred eeecccC-CCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSS-ASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~-~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|++. |++...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccccee
Confidence 6777775 454444432 222344456899999998876 8999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.69 E-value=5.5e-18 Score=165.39 Aligned_cols=137 Identities=18% Similarity=0.226 Sum_probs=106.2
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
.+.|...+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+++++.++||||+++++++...+ .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG--M 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--E
Confidence 35799999999999999999996 479999999996532 224678999999999999999999999987633 4
Q ss_pred eeeeecccCCC-ccccccc--------cccccccccccccccceeecc------CCCcccEEEeeCCC---eEEEEEEEe
Q 010856 434 CLCLFHHSSAS-ASASLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG---VEVICFVFE 495 (499)
Q Consensus 434 ~~~l~~~~~~~-~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~---~~~~~f~~~ 495 (499)
.++++|++.|+ +...+.. .+.....++.|++.||+|||+ ++||.||+++.++. ++++|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 45677777654 4333321 222334456899999999876 89999999987654 999999998
Q ss_pred ecc
Q 010856 496 ILL 498 (499)
Q Consensus 496 ~~~ 498 (499)
+..
T Consensus 181 ~~~ 183 (351)
T 3c0i_A 181 IQL 183 (351)
T ss_dssp EEC
T ss_pred eEe
Confidence 653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7.8e-18 Score=169.87 Aligned_cols=136 Identities=18% Similarity=0.100 Sum_probs=107.6
Q ss_pred HHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
...++|...+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|++++++++|||||++++++...+. ..+++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS-CEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC-ceEEE
Confidence 3457789999999999999999998 47799999997643 45789999999999999999999999876433 34456
Q ss_pred ecccCC-Ccccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|++.+ ++.+.+... ......++.|+++||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 777754 554444322 12234456899999998866 8999999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=5.2e-18 Score=165.22 Aligned_cols=135 Identities=21% Similarity=0.215 Sum_probs=108.4
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
..|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++...+ ..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--eEEE
Confidence 4588899999999999999995 5799999999976542 23467899999999999999999999987633 4556
Q ss_pred eecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|++.|++.+.+.. .+.....++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 788888776554421 122234456899999999876 8999999999999999999998764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.1e-17 Score=138.43 Aligned_cols=125 Identities=20% Similarity=0.154 Sum_probs=56.9
Q ss_pred cCCeeeccccCCC--CCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeC
Q 010856 128 SLRIVSLGSNKLT--SVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFL 205 (499)
Q Consensus 128 ~L~~L~L~~n~l~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 205 (499)
+|+.|++++|.++ .+|..+..+++|++|++++|.+++. ..+..+++|++|++++|.+++..|..+..+++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 3334444444433 2333333444444444444444432 33444444444444444444434444444555555555
Q ss_pred cCCcCCCC-CCccccCCCCCCEEeCCCCcCCccCc---ccccCCCCCCEEEcc
Q 010856 206 GYNRLQGS-IPDSFGDLISLKFLNLSNNNLSGAIP---ASLEKLSYLENLNLS 254 (499)
Q Consensus 206 ~~n~l~~~-~~~~l~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~ 254 (499)
++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.|+++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 55555432 12445555555555555555554433 345555555555544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.69 E-value=7.8e-18 Score=170.16 Aligned_cols=138 Identities=19% Similarity=0.192 Sum_probs=109.7
Q ss_pred HHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
....++|...+.||+|+||+||+|...++..||||+++... ...+.|.+|++++++++|||||++++++.. . ..++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~-~~~l 259 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--E-PIYI 259 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS--S-SCEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC--C-ccEE
Confidence 34557799999999999999999998888899999997654 346789999999999999999999998753 2 3445
Q ss_pred eecccCC-Ccccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHSSA-SASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++|++.+ ++.+.+... ......++.|++.||+|||+ +++|.||+++.++.++++|||+++..
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 6777754 554444321 11233456899999999876 89999999999999999999998753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-17 Score=159.93 Aligned_cols=137 Identities=18% Similarity=0.133 Sum_probs=104.3
Q ss_pred hhcccccccccCCcceEEEEEe-----CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
..|+..+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+....
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999983 368899999997544 3446789999999999999999999999877543445
Q ss_pred eeeecccCC-Cccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSA-SASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++++.+ ++.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 567777755 44333321 122234456899999998876 8999999999999999999998764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.6e-17 Score=138.14 Aligned_cols=130 Identities=21% Similarity=0.216 Sum_probs=112.4
Q ss_pred CcccccEEeeecCCCC-CcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEE
Q 010856 101 HLAELYRLDLDGNKLS-GSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179 (499)
Q Consensus 101 ~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 179 (499)
..++|+.|++++|.++ +..|..+..+++|+.|++++|.++.+ ..+..+++|++|++++|.+++..|..+..+++|++|
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 4578999999999998 67777888999999999999999988 678889999999999999998778888889999999
Q ss_pred EccCCccccc-CcccccCCcCCceeeCcCCcCCCCCC---ccccCCCCCCEEeCCC
Q 010856 180 DFSMNNFSGV-IPTEIGGLKNLEYLFLGYNRLQGSIP---DSFGDLISLKFLNLSN 231 (499)
Q Consensus 180 ~l~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~---~~l~~l~~L~~L~l~~ 231 (499)
++++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999874 34778899999999999999987766 5788899999998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.9e-18 Score=169.22 Aligned_cols=147 Identities=16% Similarity=0.135 Sum_probs=111.4
Q ss_pred ccCHHHHHHHhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCccc
Q 010856 350 TFSYLELFRATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNI-RHRNLIK 421 (499)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~H~niv~ 421 (499)
.+....+....++|...+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 455666777788999999999999999999973 3468999999976542 3356799999999999 8999999
Q ss_pred cceeEEccccceeeeeecccCC-Ccccccccc------------------------------------------------
Q 010856 422 ILHGVAVITFTVCLCLFHHSSA-SASASLVSS------------------------------------------------ 452 (499)
Q Consensus 422 l~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~~------------------------------------------------ 452 (499)
+++++...+.. .++++|++.| ++.+.+...
T Consensus 91 ~~~~~~~~~~~-~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 91 LLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEEEECSTTSC-CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeecCCCc-eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99998764332 3456666654 433332211
Q ss_pred ----------------------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 453 ----------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 453 ----------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.....++.|+++||+|||+ ++||.||+++.++.++++|||++..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 242 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 242 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceee
Confidence 11122335789999999876 8999999999999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.1e-18 Score=169.06 Aligned_cols=135 Identities=19% Similarity=0.177 Sum_probs=101.2
Q ss_pred hhccc-ccccccCCcceEEEEEeC---CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSE-NNLIGKGGFGSVYKARLG---DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~-~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
+.|.. .++||+|+||.||+|+.+ +++.||+|++.... ..+.+.+|++++++++|||||++++++...+....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34655 568999999999999954 57899999997543 2357889999999999999999999997644556677
Q ss_pred eecccCCCcccccc-------------ccccccccccccccccceeecc------CCCcccEEE----eeCCCeEEEEEE
Q 010856 437 LFHHSSASASASLV-------------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVF----VLEPGVEVICFV 493 (499)
Q Consensus 437 l~~~~~~~~~~~l~-------------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~----~~~~~~~~~~f~ 493 (499)
+++|+.+++...+. ..+.....++.|++.||+|||+ ++||.||++ ..++.++++|||
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 88998887655443 2222344556899999999876 899999999 566799999999
Q ss_pred Eeec
Q 010856 494 FEIL 497 (499)
Q Consensus 494 ~~~~ 497 (499)
+++.
T Consensus 178 ~a~~ 181 (405)
T 3rgf_A 178 FARL 181 (405)
T ss_dssp CCC-
T ss_pred Ccee
Confidence 9864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.69 E-value=8.5e-18 Score=159.85 Aligned_cols=135 Identities=14% Similarity=0.168 Sum_probs=106.4
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++...+ ..++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~l 88 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD--CYYL 88 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS--EEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC--eEEE
Confidence 5699999999999999999995 4789999999965432 23467899999999999999999999987633 4456
Q ss_pred eecccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|++.|+ +.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 77777654 4333322 222334456899999998876 8999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.9e-18 Score=164.96 Aligned_cols=138 Identities=16% Similarity=0.138 Sum_probs=107.0
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFT 432 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~ 432 (499)
...++|...+.||+|+||+||+|+. .+|+.||+|++++.. ....+.+.+|+++++.+ +||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~-- 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD-- 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Confidence 3457899999999999999999996 468999999997642 23456788999999988 7999999999887643
Q ss_pred eeeeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++||+.| ++...+.. .+...+.++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 34557777765 44333332 222344456899999999876 8999999999999999999998763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-17 Score=160.60 Aligned_cols=137 Identities=16% Similarity=0.193 Sum_probs=107.0
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG------RAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
.+.|...+.||+|+||.||+|+. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence 35699999999999999999996 4699999999976532 13578999999999999999999999987633
Q ss_pred eeeeeecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCC----CeEEEEEEEeec
Q 010856 433 VCLCLFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP----GVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~----~~~~~~f~~~~~ 497 (499)
..++++|++.| ++.+.+... +.....++.|++.||+|||+ +++|.||++.+++ .++++|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 44556777754 444433322 22334456899999999876 8999999998776 799999998865
Q ss_pred c
Q 010856 498 L 498 (499)
Q Consensus 498 ~ 498 (499)
.
T Consensus 168 ~ 168 (326)
T 2y0a_A 168 I 168 (326)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-17 Score=168.12 Aligned_cols=137 Identities=17% Similarity=0.179 Sum_probs=108.9
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~--~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS--DIF 92 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEE
Confidence 467999999999999999999964 79999999997543 233567899999999999999999999987643 445
Q ss_pred eeecccC-CCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSS-ASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~-~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++|++. |++.+.+... +.....++.|++.||+|||+ +++|.||+++.++.++++|||++...
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 5777774 4544444322 22334456899999999876 89999999999999999999998653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=8.4e-18 Score=162.49 Aligned_cols=138 Identities=16% Similarity=0.086 Sum_probs=109.9
Q ss_pred hhhcccccccccCCcceEEEEEe-----CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.++|+..+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++...+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35789999999999999999983 3688999999987655556779999999999999999999998876444555
Q ss_pred eeeecccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|++.++ +.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 6678888554 4333322 222334456899999998876 8999999999999999999998864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=9.1e-18 Score=163.92 Aligned_cols=138 Identities=16% Similarity=0.191 Sum_probs=109.8
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc------
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT------ 430 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~------ 430 (499)
.++|...+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|++++++++||||+++++++...+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999996 579999999986544 233567889999999999999999999987632
Q ss_pred cceeeeeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 FTVCLCLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 ~~~~~~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
....++++|++.+++...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 123556788888765544332 222344556899999999876 8999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=7e-18 Score=167.45 Aligned_cols=138 Identities=16% Similarity=0.115 Sum_probs=106.6
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.|.+.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+....++++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56899999999999999999964 69999999997544 34467788999999999999999999998765444455677
Q ss_pred cccCC-Ccccccccc-------ccccccccccccccceeecc------CCCcccEEE----eeCCCeEEEEEEEeecc
Q 010856 439 HHSSA-SASASLVSS-------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVF----VLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~-~~~~~l~~~-------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~----~~~~~~~~~~f~~~~~~ 498 (499)
|++.| ++...+... +.....++.|++.||+|||+ ++||.||++ +.++.++++|||+++.+
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 87755 443333321 22234456899999998876 899999998 44456999999998753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.68 E-value=8.7e-18 Score=163.02 Aligned_cols=138 Identities=16% Similarity=0.222 Sum_probs=103.9
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--------CccHHHHHHHHHHHhcCC---------CCCcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--------GRAFESFDVECEMMKNIR---------HRNLIKI 422 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~---------H~niv~l 422 (499)
.++|...+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 78999999997653 123478899999998885 7777777
Q ss_pred ceeEEcc----------------------------ccceeeeeecccCCC-ccccccc---cccccccccccccccceee
Q 010856 423 LHGVAVI----------------------------TFTVCLCLFHHSSAS-ASASLVS---SLTLSRPAKGGGFRGCVLW 470 (499)
Q Consensus 423 ~~~~~~~----------------------------~~~~~~~l~~~~~~~-~~~~l~~---~~~~~~~~~~~i~~gl~yL 470 (499)
.+++... +....++++||+.++ +.+.+.. .....+.++.|++.||+||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 7654310 123455677776544 5555432 2233455568999999999
Q ss_pred c-c------CCCcccEEEeeCC--------------------CeEEEEEEEeecc
Q 010856 471 H-V------GVDFAAFVFVLEP--------------------GVEVICFVFEILL 498 (499)
Q Consensus 471 H-~------~~~p~~~l~~~~~--------------------~~~~~~f~~~~~~ 498 (499)
| + |+||.||+++.++ .++++|||+++..
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~ 232 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence 8 4 8999999999886 8999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-17 Score=162.23 Aligned_cols=140 Identities=17% Similarity=0.213 Sum_probs=107.3
Q ss_pred HHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCccccceeEEcc
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIRHRNLIKILHGVAVI 429 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~ 429 (499)
+....++|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445667899999999999999999996 578999999997542 34467899999999999999999999998763
Q ss_pred ccceeeeeecccCC-Cccccccc--------------------------------------------ccccccccccccc
Q 010856 430 TFTVCLCLFHHSSA-SASASLVS--------------------------------------------SLTLSRPAKGGGF 464 (499)
Q Consensus 430 ~~~~~~~l~~~~~~-~~~~~l~~--------------------------------------------~~~~~~~~~~~i~ 464 (499)
+ ...+++|++.| ++.+.+.. .+.....++.|++
T Consensus 101 ~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 101 Q--YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp S--EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred C--eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 3 44556777754 44333321 1111233567999
Q ss_pred ccceeecc------CCCcccEEEeeCC--CeEEEEEEEeec
Q 010856 465 RGCVLWHV------GVDFAAFVFVLEP--GVEVICFVFEIL 497 (499)
Q Consensus 465 ~gl~yLH~------~~~p~~~l~~~~~--~~~~~~f~~~~~ 497 (499)
.||+|||+ +++|.||+++.++ .++++|||++..
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~ 219 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEE
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeecccccc
Confidence 99998876 8999999997665 899999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.68 E-value=9.9e-18 Score=164.39 Aligned_cols=138 Identities=17% Similarity=0.160 Sum_probs=98.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcc----ccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVI----TFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~----~~~ 432 (499)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++... +..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46799999999999999999995 579999999996543 23456788999999999999999999998652 223
Q ss_pred eeeeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++++++++++...+.. .......++.|+++||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 4566788887766554432 122234456899999999876 8999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=7.7e-18 Score=166.18 Aligned_cols=137 Identities=11% Similarity=0.100 Sum_probs=106.2
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~ 433 (499)
...+|...+.||+|+||+||+|+.+ +++.||+|++++.. ....+.+.+|..++.++ +|||||++++++...+ .
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--R 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS--E
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC--E
Confidence 3568999999999999999999964 68899999998653 23345688999999876 8999999999887633 4
Q ss_pred eeeeecccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++++||+.|+ +...+.. .+...+.++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 45677777654 4333332 223344556899999999876 8999999999999999999998763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-17 Score=156.05 Aligned_cols=136 Identities=17% Similarity=0.108 Sum_probs=107.8
Q ss_pred HhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
..++|...+.||+|+||.||+|+..++..||+|++.... ...+++.+|++++++++||||+++++++.... ..++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY--PIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--ceEEEE
Confidence 346799999999999999999998888899999997654 23567999999999999999999999886532 345677
Q ss_pred cccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++ +.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 777555 4333322 222334456899999998876 8999999999999999999998864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-17 Score=171.56 Aligned_cols=138 Identities=10% Similarity=0.098 Sum_probs=108.5
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
..++|...+.||+|+||.||+|+. .+|+.||+|++.+.. ......+.+|+++++.++|||||++++++...+ ..
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--AL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC--EE
Confidence 346799999999999999999996 479999999997643 334567899999999999999999999887643 45
Q ss_pred eeeecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++||+.| ++...+.. .+.....++.||+.||+|||+ ++||.||+++.++.++++|||++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 567787755 44333322 122234446899999998876 89999999999999999999998643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-17 Score=160.33 Aligned_cols=137 Identities=18% Similarity=0.142 Sum_probs=104.9
Q ss_pred HhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccc--ceeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITF--TVCLC 436 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~--~~~~~ 436 (499)
...+|+..+.||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++..... ...++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3467999999999999999999874 7899999996543 234456779999999999999999999876432 23456
Q ss_pred eecccCC-Cccccccc---cccccccccccccccceeecc----------------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 437 LFHHSSA-SASASLVS---SLTLSRPAKGGGFRGCVLWHV----------------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~----------------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++|++.+ ++.+.+.. .+.....++.|+++||+|||+ ++||.||+++.++.++++|||+++
T Consensus 100 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 7777755 44433322 223344556888898877764 589999999999999999999986
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
.
T Consensus 180 ~ 180 (322)
T 3soc_A 180 K 180 (322)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-17 Score=165.32 Aligned_cols=138 Identities=17% Similarity=0.126 Sum_probs=103.8
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccc-----
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVIT----- 430 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----- 430 (499)
.....+|...+.||+|+||+||+|+. .+|+.||+|++..... ...+|+++++.++|||||++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999995 5799999999975432 2337999999999999999999885421
Q ss_pred -------------------------------cceeeeeecccCCCccccccc--------cccccccccccccccceeec
Q 010856 431 -------------------------------FTVCLCLFHHSSASASASLVS--------SLTLSRPAKGGGFRGCVLWH 471 (499)
Q Consensus 431 -------------------------------~~~~~~l~~~~~~~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH 471 (499)
.....+++|++.+++.+.+.. .+.....++.|+++||+|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 123556888988775444331 12234445689999999887
Q ss_pred c------CCCcccEEEe-eCCCeEEEEEEEeecc
Q 010856 472 V------GVDFAAFVFV-LEPGVEVICFVFEILL 498 (499)
Q Consensus 472 ~------~~~p~~~l~~-~~~~~~~~~f~~~~~~ 498 (499)
+ ++||.||+++ .++.++++|||++..+
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 192 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEEC
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCccc
Confidence 6 8999999998 5678999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-17 Score=162.46 Aligned_cols=136 Identities=12% Similarity=0.092 Sum_probs=106.9
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHHhcC-CCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~ 434 (499)
.++|...+.||+|+||.||+|+. .+++.||+|++.+... ...+.+.+|++++.++ +||||+++++++...+ ..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC--EE
Confidence 46799999999999999999996 4689999999986542 2345688999999987 8999999999987633 44
Q ss_pred eeeecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|++.| ++...+... +...+.++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 567777755 443333322 22344456899999999876 8999999999999999999998763
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-17 Score=162.45 Aligned_cols=138 Identities=15% Similarity=0.270 Sum_probs=107.4
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
...++|...+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~ 103 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FH 103 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EE
Confidence 3456899999999999999999996 4699999999976542 33567899999999999999999999987633 44
Q ss_pred eeeecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCC---CeEEEEEEEeec
Q 010856 435 LCLFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~~f~~~~~ 497 (499)
++++|++.| .+.+.+... +.....++.|++.||+|||+ +++|.||+++.++ .++++|||+++.
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 557777755 444443322 22234456899999999876 8999999997654 499999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.3e-17 Score=156.20 Aligned_cols=135 Identities=19% Similarity=0.246 Sum_probs=106.0
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH--NMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC--eEEEEE
Confidence 5799999999999999999996 468999999997654 344678999999999999999999999987633 455677
Q ss_pred cccCC-Ccccccc--------ccccccccccccccccceeecc------CCCcccEEEee---CCCeEEEEEEEeec
Q 010856 439 HHSSA-SASASLV--------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---EPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~-~~~~~l~--------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---~~~~~~~~f~~~~~ 497 (499)
|++.+ ++.+.+. ........++.|+++||+|||+ +++|.||++.+ ++.++++|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 77765 4433332 1222344556899999998876 89999999943 46799999999864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=4.1e-16 Score=136.32 Aligned_cols=129 Identities=26% Similarity=0.307 Sum_probs=66.1
Q ss_pred ccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeec
Q 010856 33 LEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG 112 (499)
Q Consensus 33 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 112 (499)
.+.+++++++++.+ |..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 34444555544422 2211 13455555555555544444445555555555555555544444455555555555555
Q ss_pred CCCCCcCCccccCCccCCeeeccccCCCCCCcc-ccCCCCCcEEEcCCCcCCC
Q 010856 113 NKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT-FWNLKDILNLNFSSNFLTS 164 (499)
Q Consensus 113 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~ 164 (499)
|++++..+..|..+++|+.|++++|+++.+|.. +..+++|++|++++|.+.+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 555554444555555555555555555555443 3445566666666665554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9.6e-18 Score=171.19 Aligned_cols=137 Identities=18% Similarity=0.166 Sum_probs=108.6
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
...+|...+.||+|+||.||+|+.. ++..||||+++... ...++|.+|++++++++|||||+++++|...+ ..+++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC--cEEEE
Confidence 4567899999999999999999975 48899999997654 34678999999999999999999999987633 44567
Q ss_pred ecccC-CCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSS-ASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~-~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+|++. |++.+.+... ......++.|++.||+|||+ +++|.||+++.++.++++|||+++..
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 77776 4544444321 12233446899999998866 89999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-17 Score=162.28 Aligned_cols=135 Identities=18% Similarity=0.181 Sum_probs=105.3
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
..++|...+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++...+ ..+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC--EEEEE
Confidence 3467999999999999999999964 799999999976542 3467889999999999999999999987643 44567
Q ss_pred ecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCC--eEEEEEEEee
Q 010856 438 FHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG--VEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~--~~~~~f~~~~ 496 (499)
++|+.| ++...+.. .......++.|++.||+|||+ ++||.||+++.++. ++++|||+++
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 777754 44333322 223344556899999998876 89999999976654 9999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.3e-18 Score=165.13 Aligned_cols=135 Identities=15% Similarity=0.166 Sum_probs=105.5
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|...+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++...+ ..++++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS--CEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC--EEEEEe
Confidence 46889999999999999999964 789999999965432 22234568999999999999999999987633 445678
Q ss_pred cccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|++.|++...+... ......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 88888765554322 12234446899999998876 8999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-17 Score=160.76 Aligned_cols=138 Identities=17% Similarity=0.195 Sum_probs=106.0
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccc--e
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFT--V 433 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~--~ 433 (499)
.++|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++...+.. .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36799999999999999999995 5789999999976542 2245789999999999999999999988653322 2
Q ss_pred eeeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++++|++.| .+.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 2557777755 44333322 222344556899999999876 8999999999999999999998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4.7e-18 Score=167.65 Aligned_cols=138 Identities=12% Similarity=0.030 Sum_probs=105.0
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHH---HHHhcCCCCCccccc-------ee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVEC---EMMKNIRHRNLIKIL-------HG 425 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~---~il~~l~H~niv~l~-------~~ 425 (499)
.++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999995 579999999997542 34467899999 556667899999998 44
Q ss_pred EEcccc---------------ceeeeeecccCCCccccccccc-----------cccccccccccccceeecc------C
Q 010856 426 VAVITF---------------TVCLCLFHHSSASASASLVSSL-----------TLSRPAKGGGFRGCVLWHV------G 473 (499)
Q Consensus 426 ~~~~~~---------------~~~~~l~~~~~~~~~~~l~~~~-----------~~~~~~~~~i~~gl~yLH~------~ 473 (499)
+..... ...++++|+++|++.+.+.... .....++.|++.||+|||+ +
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 432210 0244577888877666554322 2233456899999999876 8
Q ss_pred CCcccEEEeeCCCeEEEEEEEeec
Q 010856 474 VDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 474 ~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+||.||+++.++.++++|||+++.
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~ 255 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVR 255 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEE
T ss_pred CCHHHEEEcCCCCEEEEechhhee
Confidence 999999999999999999998863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=9.8e-18 Score=162.76 Aligned_cols=139 Identities=14% Similarity=0.167 Sum_probs=108.0
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEcccc
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITF 431 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~ 431 (499)
....++|...+.||+|+||+||+|+. .+|+.||+|++++.. ....+.+.+|.+++..+ +||||+++++++...+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~- 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE- 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-
Confidence 35567899999999999999999996 468999999997643 33456788999999876 9999999999887643
Q ss_pred ceeeeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++||+.| ++...+.. .+.....++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 92 -~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 92 -NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred -EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 44567777754 54443332 222344456899999999876 8999999999999999999998763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=6.8e-18 Score=165.65 Aligned_cols=138 Identities=14% Similarity=0.133 Sum_probs=102.6
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc----cc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT----FT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----~~ 432 (499)
.+.|...+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|+++++.++||||+++++++...+ ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999996 579999999996543 223567899999999999999999999986532 23
Q ss_pred eeeeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++++++++++...+.. .......++.|+++||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 4466788886655443322 122234456899999999876 8999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-17 Score=156.73 Aligned_cols=137 Identities=13% Similarity=0.091 Sum_probs=105.2
Q ss_pred HHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
...++|...+.||+|+||.||+|...++..||+|++.... ...+++.+|++++++++||||+++++++...+ ..+++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 97 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR--PIFII 97 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC--CeEEE
Confidence 3456799999999999999999998888899999997654 23477999999999999999999999886533 34567
Q ss_pred ecccCC-Cccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.+ .+.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 777754 44333322 122234456899999998876 8999999999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-17 Score=164.46 Aligned_cols=138 Identities=15% Similarity=0.076 Sum_probs=108.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc----c
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF----T 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~----~ 432 (499)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+. .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999996 478999999997643 2335678899999999999999999999865332 2
Q ss_pred eeeeeecccCCCccccccc--cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVS--SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~--~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++|++.+++...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 4567889988876554432 222334456899999999876 8999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=9.7e-18 Score=160.81 Aligned_cols=135 Identities=13% Similarity=0.047 Sum_probs=104.8
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC--ccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG--RAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|...+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+..+.++ +||||+++++++... ...++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEE
Confidence 57999999999999999999975 799999999865432 2334556666665554 999999999998763 34566
Q ss_pred eecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|++++++...+.. .+.....++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 888888776554432 222344556899999999876 8999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-17 Score=163.61 Aligned_cols=133 Identities=16% Similarity=0.191 Sum_probs=97.9
Q ss_pred ccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecccC
Q 010856 364 SENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
...+.||+|+||.||+|+. .+|+.||+|+++.......+.+.+|++++++++||||+++++++...+ ..++++|++.
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN--DIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEEeCCC
Confidence 3357899999999999996 579999999998765455678999999999999999999999987643 4556778876
Q ss_pred CC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEee--CCCeEEEEEEEeecc
Q 010856 443 AS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL--EPGVEVICFVFEILL 498 (499)
Q Consensus 443 ~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~--~~~~~~~~f~~~~~~ 498 (499)
++ +.+.+.. .+.....++.|+++||+|||+ +++|.||++.+ ++.++++|||+++..
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 54 3333321 122233446799999998876 89999999854 457999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-17 Score=159.76 Aligned_cols=136 Identities=13% Similarity=0.170 Sum_probs=106.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.++|...+.||+|+||.||+|+. .+++.||+|.+.... ...+.+.+|+++++.++||||+++++++...+ ..++++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME--ELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC--EEEEEE
Confidence 36799999999999999999996 468999999987543 34567889999999999999999999987643 445677
Q ss_pred cccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEee--CCCeEEEEEEEeecc
Q 010856 439 HHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL--EPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~--~~~~~~~~f~~~~~~ 498 (499)
|++.| ++.+.+... +.....++.|++.||+|||+ +++|.||+++. ++.++++|||+++..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 77755 444433321 22234456899999999876 89999999986 679999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-17 Score=161.05 Aligned_cols=136 Identities=13% Similarity=0.125 Sum_probs=99.6
Q ss_pred hhhcccccccccCCcceEEEEEe----CCCCEEEEEEeeccC----CccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQC----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
.++|...+.||+|+||.||+|+. .+|+.||+|++++.. ......+.+|++++++++||||+++++++...+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG- 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence 46799999999999999999996 468999999997643 223456889999999999999999999987633
Q ss_pred ceeeeeecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++|++.|+ +...+... ......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 -KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred -EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 345577777544 43333222 22233446899999998876 8999999999999999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=8.2e-18 Score=162.68 Aligned_cols=142 Identities=15% Similarity=0.169 Sum_probs=105.2
Q ss_pred HHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc
Q 010856 354 LELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 354 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
.......++|...+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 33445667899999999999999999995 578999999997544 223456889999999999999999999987633
Q ss_pred cceeeeeecccCCCccccccccc----cccccccccccccceeecc------CCCcccEEEeeCC-----CeEEEEEEEe
Q 010856 431 FTVCLCLFHHSSASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-----GVEVICFVFE 495 (499)
Q Consensus 431 ~~~~~~l~~~~~~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-----~~~~~~f~~~ 495 (499)
..++++|++.|++.+.+.... .....++.|++.||+|||+ ++||.||++..++ .++++|||++
T Consensus 107 --~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 107 --RLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp --EEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred --EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 456678888887655544322 2234456899999999876 8999999995443 4999999987
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
+.
T Consensus 185 ~~ 186 (329)
T 3gbz_A 185 RA 186 (329)
T ss_dssp HH
T ss_pred cc
Confidence 53
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-17 Score=162.97 Aligned_cols=137 Identities=15% Similarity=0.130 Sum_probs=107.0
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.+.|...+.||+|+||.||+|.. .+|+.||+|++..........+.+|++++++++||||+++++++... ...++++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEEEEEE
Confidence 35799999999999999999996 47899999999866544556789999999999999999999998763 3445577
Q ss_pred cccCC-Cccccccc-----cccccccccccccccceeecc------CCCcccEEEee--CCCeEEEEEEEeecc
Q 010856 439 HHSSA-SASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL--EPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~-~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~--~~~~~~~~f~~~~~~ 498 (499)
|++.| ++.+.+.. .+.....++.|++.||+|||+ +++|.||+++. ++.++++|||++..+
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 77755 44343332 122234456899999999876 89999999974 357999999998653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-17 Score=159.93 Aligned_cols=139 Identities=19% Similarity=0.146 Sum_probs=107.8
Q ss_pred hhhcccccccccCCcceEEEEEe-----CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.++|...+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++...+....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46689999999999999999983 3688999999987655566789999999999999999999998866443344
Q ss_pred eeeecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++++++.+ ++.+.+... +.....++.|+++||+|||+ +++|.||+++.++.++++|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 567777755 443333221 12233446899999998876 89999999999999999999988653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-17 Score=165.89 Aligned_cols=138 Identities=15% Similarity=0.214 Sum_probs=105.9
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
...++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|||||++++++...+ ..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~ 85 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG--HH 85 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS--EE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC--EE
Confidence 3457799999999999999999995 579999999997654 234567899999999999999999999987633 44
Q ss_pred eeeecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEee---CCCeEEEEEEEeec
Q 010856 435 LCLFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---EPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---~~~~~~~~f~~~~~ 497 (499)
++++|++.| ++.+.+.... .....++.|++.||+|||+ ++||.||+++. ++.++++|||+++.
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 556777755 4444443222 2234456899999999876 89999999984 46799999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-17 Score=160.23 Aligned_cols=140 Identities=20% Similarity=0.201 Sum_probs=98.5
Q ss_pred HHhhhcccccccccCCcceEEEEEeC-CC---CEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG-DR---MEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
...++|...+.||+|+||.||+|+.. ++ ..||+|+++... ....+.+.+|++++++++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 34567999999999999999999964 33 379999997653 3446789999999999999999999999876432
Q ss_pred c----eeeeeecccCC-Ccccccc----------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEE
Q 010856 432 T----VCLCLFHHSSA-SASASLV----------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVI 490 (499)
Q Consensus 432 ~----~~~~l~~~~~~-~~~~~l~----------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~ 490 (499)
. ..+.+++++.+ ++...+. ..+.....++.|+++||+|||+ ++||.||+++.++.++++
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 2 12456666655 4433332 1222334456899999999876 899999999999999999
Q ss_pred EEEEeec
Q 010856 491 CFVFEIL 497 (499)
Q Consensus 491 ~f~~~~~ 497 (499)
|||+++.
T Consensus 180 Dfg~a~~ 186 (323)
T 3qup_A 180 DFGLSRK 186 (323)
T ss_dssp CCCC---
T ss_pred ecccccc
Confidence 9999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-17 Score=168.17 Aligned_cols=136 Identities=19% Similarity=0.171 Sum_probs=107.9
Q ss_pred HHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
...++|...+.||+|+||.||+|...++..||||+++... ...++|.+|++++++++||||+++++++.. + ..+++
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~--~~~iv 256 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIYIV 256 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--SCEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C--ceEEE
Confidence 4456789999999999999999998777889999997654 345789999999999999999999998865 2 34457
Q ss_pred ecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|++.+ ++.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 777755 54444432 112234456899999998876 8999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-17 Score=163.90 Aligned_cols=140 Identities=16% Similarity=0.107 Sum_probs=110.8
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccc---cce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVIT---FTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~---~~~ 433 (499)
..+.|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++.... ...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 345799999999999999999996 4788999999975442 33467899999999999999999999886532 134
Q ss_pred eeeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.+++++++.+++...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||+++..
T Consensus 105 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 566888888876554432 222344456899999998876 89999999999999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-17 Score=157.06 Aligned_cols=136 Identities=15% Similarity=0.121 Sum_probs=106.3
Q ss_pred hhhcccccccccCCcceEEEEEeC-CC-------CEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DR-------MEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
.++|...+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|++++++++||||+++++++...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD- 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence 357899999999999999999853 34 579999997766566788999999999999999999999987633
Q ss_pred ceeeeeecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCC--------eEEEE
Q 010856 432 TVCLCLFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG--------VEVIC 491 (499)
Q Consensus 432 ~~~~~l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~--------~~~~~ 491 (499)
..++++|++.| ++.+.+... ......++.|++.||+|||+ +++|.||+++.++. ++++|
T Consensus 86 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 86 -ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp -CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred -CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 33457777764 444433322 12234456899999999876 89999999988876 99999
Q ss_pred EEEeec
Q 010856 492 FVFEIL 497 (499)
Q Consensus 492 f~~~~~ 497 (499)
||++..
T Consensus 165 fg~~~~ 170 (289)
T 4fvq_A 165 PGISIT 170 (289)
T ss_dssp CCSCTT
T ss_pred Cccccc
Confidence 998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=9.8e-18 Score=164.58 Aligned_cols=135 Identities=15% Similarity=0.178 Sum_probs=102.3
Q ss_pred hhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
.++|...+.||+|+||+||+|+. .+++.||||+++... .....++.+|+.++++++|||||++++++...+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-- 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 35789999999999999999994 246789999997543 334567899999999999999999999987633
Q ss_pred eeeeeecccCC-Cccccccccc-----------cccccccccccccceeecc------CCCcccEEEeeCC---CeEEEE
Q 010856 433 VCLCLFHHSSA-SASASLVSSL-----------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVIC 491 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~~~-----------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~~ 491 (499)
..++++|++.| ++.+.+.... .....++.|++.||+|||+ ++||.||+++.++ .++++|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 33456777754 5444333211 1223456899999999876 8999999998554 499999
Q ss_pred EEEee
Q 010856 492 FVFEI 496 (499)
Q Consensus 492 f~~~~ 496 (499)
||+++
T Consensus 228 FG~a~ 232 (367)
T 3l9p_A 228 FGMAR 232 (367)
T ss_dssp CHHHH
T ss_pred Ccccc
Confidence 99875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-17 Score=164.78 Aligned_cols=136 Identities=20% Similarity=0.202 Sum_probs=105.1
Q ss_pred hhhcccccccccCCcceEEEEEe--------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL--------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
.++|...+.||+|+||.||+|+. ..+..||+|+++... ....+++.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 46789999999999999999984 123579999997654 23457799999999999 999999999998763
Q ss_pred ccceeeeeecccCC-Cccccccc--------------------cccccccccccccccceeecc------CCCcccEEEe
Q 010856 430 TFTVCLCLFHHSSA-SASASLVS--------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV 482 (499)
Q Consensus 430 ~~~~~~~l~~~~~~-~~~~~l~~--------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~ 482 (499)
+ ..++++|++.+ ++.+.+.. .+.....++.|++.||+|||+ ++||.||+++
T Consensus 148 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 148 G--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp S--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred C--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 3 34556777755 44433322 112233446899999999876 8999999999
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
.++.++++|||+++.
T Consensus 226 ~~~~~kL~DFG~a~~ 240 (382)
T 3tt0_A 226 EDNVMKIADFGLARD 240 (382)
T ss_dssp TTCCEEECSCSCCCC
T ss_pred CCCcEEEcccCcccc
Confidence 999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-17 Score=162.74 Aligned_cols=138 Identities=15% Similarity=0.194 Sum_probs=102.6
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-----ccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-----RAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
...++|...+.||+|+||.||+|+. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 85 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS- 85 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC-
Confidence 3456799999999999999999996 4699999999975431 11356889999999999999999999986633
Q ss_pred ceeeeeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++++++.+++...+.. .......++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 86 -~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 -NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp -CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred -ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 4456788888765444332 222334456899999998876 8999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.8e-17 Score=157.24 Aligned_cols=135 Identities=16% Similarity=0.133 Sum_probs=105.8
Q ss_pred cccccccccCCcceEEEEEe-----CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-----GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
|...+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|++++++++||||+++++++...+....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999999874 2588999999976542 34567999999999999999999999988754445566
Q ss_pred eecccCCC-ccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSAS-ASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.++ +.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 78887654 4333322 222334456899999998866 8999999999999999999998864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.3e-17 Score=154.31 Aligned_cols=136 Identities=18% Similarity=0.233 Sum_probs=108.3
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.+.|...+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++... ...++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeEEEEE
Confidence 467999999999999999999964 6889999999876656678899999999999999999999998763 3445677
Q ss_pred cccCCC-ccccccc----cccccccccccccccceeecc------CCCcccEEE---eeCCCeEEEEEEEeec
Q 010856 439 HHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVF---VLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~---~~~~~~~~~~f~~~~~ 497 (499)
+++.++ +.+.+.. .+.....++.|++.||+|||+ +++|.||++ ..++.++++|||++..
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 777554 3333322 222344556899999998876 899999999 6678999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.67 E-value=7.8e-18 Score=162.67 Aligned_cols=136 Identities=17% Similarity=0.125 Sum_probs=99.2
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCE----EEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRME----VAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
.++|...+.||+|+||.||+|+. .+++. ||+|.+.... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS--E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--e
Confidence 35699999999999999999995 34544 5777775433 345678999999999999999999999998643 3
Q ss_pred eeeeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++++++.+|++.+.+.. .+.....++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 444445555555544432 122234456899999999876 8999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-17 Score=163.78 Aligned_cols=136 Identities=14% Similarity=0.101 Sum_probs=107.2
Q ss_pred HhhhcccccccccC--CcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 359 ATDEFSENNLIGKG--GFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
..++|+..+.||+| +||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++...+ .
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--E 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--E
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC--E
Confidence 44679999999999 99999999964 79999999997654 233567889999999999999999999987633 4
Q ss_pred eeeeecccCCCccc-cccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 434 CLCLFHHSSASASA-SLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 434 ~~~l~~~~~~~~~~-~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.+++++++.++.+. .+.. .+.....++.|++.||+|||+ ++||.||+++.++.++++|||.+.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 55677777654333 3221 122234456899999998876 899999999999999999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-17 Score=159.41 Aligned_cols=138 Identities=16% Similarity=0.132 Sum_probs=105.9
Q ss_pred HHhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
....+|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3456799999999999999999984 245789999997654 234577899999999999999999999886633
Q ss_pred cceeeeeecccC-CCcccccccc----------------------------ccccccccccccccceeecc------CCC
Q 010856 431 FTVCLCLFHHSS-ASASASLVSS----------------------------LTLSRPAKGGGFRGCVLWHV------GVD 475 (499)
Q Consensus 431 ~~~~~~l~~~~~-~~~~~~l~~~----------------------------~~~~~~~~~~i~~gl~yLH~------~~~ 475 (499)
..+++++++. +++.+.+... ......++.|+++||+|||+ +++
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 100 --PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp --SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred --ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 3455677775 4443333221 11223446899999998876 899
Q ss_pred cccEEEeeCCCeEEEEEEEeec
Q 010856 476 FAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 476 p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|.||+++.++.++++|||+++.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~ 199 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRD 199 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEE
T ss_pred hheEEEcCCCCEEEcccccccc
Confidence 9999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-17 Score=158.76 Aligned_cols=135 Identities=19% Similarity=0.222 Sum_probs=107.3
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
++|...+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR--RLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC--eEEEE
Confidence 57899999999999999999964 699999999865542 22567889999999999999999999987633 44567
Q ss_pred ecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.++....+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL 151 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence 88887765443321 122344556899999998876 8999999999999999999998864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-17 Score=168.27 Aligned_cols=137 Identities=14% Similarity=0.173 Sum_probs=107.2
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||+||+|+. .+|+.||+|++.+.. ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT--DLC 261 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC--EEE
Confidence 36788899999999999999997 479999999997643 234567899999999999999999999887633 445
Q ss_pred eeecccCCCcc-ccccc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASAS-ASLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~-~~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++|+.|+.+ ..+.. .+.....++.||+.||+|||+ ++||.||+++.++.++++|||+++.+
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 67777765433 33221 112233446899999998876 89999999999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-17 Score=158.85 Aligned_cols=139 Identities=20% Similarity=0.238 Sum_probs=106.5
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-----CccHHHHHHHHHHHhcCC---CCCccccceeEEcc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIR---HRNLIKILHGVAVI 429 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~---H~niv~l~~~~~~~ 429 (499)
..++|...+.||+|+||+||+|+. .+++.||+|++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999995 579999999996432 122456788888887765 99999999998763
Q ss_pred cc---ceeeeeecccCCCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEE
Q 010856 430 TF---TVCLCLFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 430 ~~---~~~~~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
+. ....++++++.+++...+... +.....++.|++.||+|||+ +++|.||+++.++.++++|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 32 235567888888765554332 22344556899999999876 8999999999999999999998
Q ss_pred eec
Q 010856 495 EIL 497 (499)
Q Consensus 495 ~~~ 497 (499)
+..
T Consensus 167 a~~ 169 (308)
T 3g33_A 167 ARI 169 (308)
T ss_dssp TTT
T ss_pred ccc
Confidence 764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-17 Score=161.46 Aligned_cols=139 Identities=19% Similarity=0.140 Sum_probs=107.1
Q ss_pred HHHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEcc
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVI 429 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~ 429 (499)
....++|...+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999999999999963 348899999976542 3356799999999999999999999998763
Q ss_pred ccceeeeeecccCC-Ccccccccc----------------------------ccccccccccccccceeecc------CC
Q 010856 430 TFTVCLCLFHHSSA-SASASLVSS----------------------------LTLSRPAKGGGFRGCVLWHV------GV 474 (499)
Q Consensus 430 ~~~~~~~l~~~~~~-~~~~~l~~~----------------------------~~~~~~~~~~i~~gl~yLH~------~~ 474 (499)
+ ..++++|++.+ ++.+.+... +.....++.|+++||+|||+ ++
T Consensus 123 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 123 K--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp S--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred C--ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 3 34556777755 443333221 11123346899999999876 89
Q ss_pred CcccEEEeeCCCeEEEEEEEeec
Q 010856 475 DFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 475 ~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|.||+++.++.++++|||++..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~ 223 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRN 223 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHH
T ss_pred CcceEEECCCCeEEEeecCCCcc
Confidence 99999999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-17 Score=171.15 Aligned_cols=139 Identities=19% Similarity=0.163 Sum_probs=110.0
Q ss_pred HHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
+....++|.+.+.||+|+||.||+|...++..||||+++... ...++|.+|+++|++++|||||++++++.. + ..+
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~--~~~ 337 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIY 337 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--SCE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c--cce
Confidence 344567799999999999999999998777889999997654 345789999999999999999999998865 2 344
Q ss_pred eeecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++|++.+ ++.+.+.. .......++.|+++||+|||+ +++|.||+++.++.++++|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 57777755 44444432 122234556899999999876 89999999999999999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.66 E-value=3.2e-17 Score=154.58 Aligned_cols=138 Identities=17% Similarity=0.203 Sum_probs=108.1
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
.+.++|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 83 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--R 83 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--E
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC--E
Confidence 3567899999999999999999996 468899999996543 233567899999999999999999999987633 4
Q ss_pred eeeeecccCCCc-cccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSASA-SASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~~~-~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+++++++.++. ...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence 456777776543 333322 222334456899999999877 8999999999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-17 Score=157.65 Aligned_cols=138 Identities=12% Similarity=0.157 Sum_probs=108.1
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC----CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46799999999999999999996 578999999997543 2345779999999999999999999999865444455
Q ss_pred eeeecccCCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|++.+++...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 66788887764443322 112233446899999998866 8999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-17 Score=162.61 Aligned_cols=135 Identities=19% Similarity=0.127 Sum_probs=98.9
Q ss_pred hcccccccccCCcceEEEEEeC--C--CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARLG--D--RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.|...+.||+|+||.||+|+.. + +..||+|.++... ....+++.+|+.++++++||||+++++++...+...+ +
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~-l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-V 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE-E
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE-E
Confidence 4677789999999999999852 3 2468999987543 3446789999999999999999999998865443333 4
Q ss_pred eecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|++.+ ++.+.+... ......++.|+++||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccc
Confidence 6666654 554444321 11233445899999999876 8999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-17 Score=160.10 Aligned_cols=135 Identities=15% Similarity=0.179 Sum_probs=107.3
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCC--CCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRH--RNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H--~niv~l~~~~~~~~~~~~~ 435 (499)
...|...+.||+|+||.||+|...+++.||+|++..... ...+.+.+|++++++++| |||+++++++...+ ..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~--~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC--EEE
Confidence 356899999999999999999988899999999976542 234678999999999976 99999999987643 445
Q ss_pred eeecccCCCcccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|+.++++.+.+..... ....++.|++.||+|||+ ++||.||+++ ++.++++|||+++.
T Consensus 86 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 86 MVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 5677777776555543222 234456899999998876 8999999995 67899999998864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-17 Score=156.48 Aligned_cols=136 Identities=16% Similarity=0.188 Sum_probs=106.9
Q ss_pred HHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
...++|...+.||+|+||.||+|+..++..||+|++.... ...+.+.+|++++++++||||+++++++... ..+++
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~v 85 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYII 85 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC---CcEEE
Confidence 3456799999999999999999998888899999997544 3457899999999999999999999987542 23456
Q ss_pred ecccC-CCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSS-ASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~-~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++. +++.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 77774 454443332 122234456899999998876 8999999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.4e-17 Score=161.74 Aligned_cols=137 Identities=17% Similarity=0.144 Sum_probs=98.4
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHH-HhcCCCCCccccceeEEccccce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEM-MKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~i-l~~l~H~niv~l~~~~~~~~~~~ 433 (499)
..++|...+.||+|+||+||+|+.+ +++.||+|++++.. ....+.+.+|..+ ++.++||||+++++++...+ .
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~--~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--K 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS--E
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC--E
Confidence 3467999999999999999999964 68999999997654 2234567788877 57799999999999887643 4
Q ss_pred eeeeecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++++||+.| ++...+... +...+.++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 4557777755 443333322 22334456899999998876 8999999999999999999999763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.66 E-value=9.1e-18 Score=161.83 Aligned_cols=145 Identities=19% Similarity=0.188 Sum_probs=110.8
Q ss_pred cCHHHHHHHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccc
Q 010856 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKIL 423 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~ 423 (499)
+..+++....++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455566788999999999999999999853 367899999975542 3356789999999999999999999
Q ss_pred eeEEccccceeeeeecccCC-Cccccccc--------------cccccccccccccccceeecc------CCCcccEEEe
Q 010856 424 HGVAVITFTVCLCLFHHSSA-SASASLVS--------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV 482 (499)
Q Consensus 424 ~~~~~~~~~~~~~l~~~~~~-~~~~~l~~--------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~ 482 (499)
+++...+ ..+++++++.+ ++.+.+.. .......++.|++.||+|||+ +++|.||+++
T Consensus 95 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 95 GVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred EEEccCC--ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence 9986633 34556777755 54443332 112233446899999998876 8999999999
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
.++.++++|||+++.
T Consensus 173 ~~~~~kl~Dfg~~~~ 187 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRD 187 (322)
T ss_dssp TTCCEEECCTTCCCG
T ss_pred CCCeEEECcCccccc
Confidence 999999999998763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-17 Score=167.39 Aligned_cols=137 Identities=15% Similarity=0.133 Sum_probs=100.0
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
..++|...+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+++++.++||||+++++++...+ ..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT--EE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--EE
Confidence 346799999999999999999996 579999999997542 233466889999999999999999999987643 45
Q ss_pred eeeecccCCCcc-ccccc----cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASAS-ASLVS----SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~-~~l~~----~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++||+.|+.+ ..+.. .......++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 567888866543 33322 222344456899999999885 7999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-17 Score=157.72 Aligned_cols=139 Identities=14% Similarity=0.014 Sum_probs=106.6
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcc--ccceee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVI--TFTVCL 435 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~--~~~~~~ 435 (499)
..++|...+.||+|+||.||+|+. .+++.||+|++........+.+.+|+++++.++||||+++++++... .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346799999999999999999996 57999999999765555567899999999999999999999998642 122445
Q ss_pred eeecccCC-Cccccccc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++++.+ ++.+.+.. .+.....++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 56777755 44333322 122234456899999998876 8999999999999999999997653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-17 Score=166.03 Aligned_cols=134 Identities=16% Similarity=0.173 Sum_probs=101.9
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcc----ccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVI----TFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~----~~~~~~ 435 (499)
..|...+.||+|+||+||+|+. .+|+.||||++.... +...+|++++++++|||||++++++... +.....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4588999999999999999997 469999999996543 2234799999999999999999988542 122345
Q ss_pred eeecccCCCccccccc--------cccccccccccccccceeecc------CCCcccEEEeeCCC-eEEEEEEEeecc
Q 010856 436 CLFHHSSASASASLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG-VEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~-~~~~~f~~~~~~ 498 (499)
++++|+.+++...+.. .+.....++.|+++||+|||+ ++||.||+++.+++ ++++|||+++.+
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 6788888765443321 112234456899999999876 89999999986654 699999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.66 E-value=4e-17 Score=157.86 Aligned_cols=135 Identities=16% Similarity=0.163 Sum_probs=106.9
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|+..+.||+|+||.||+|+. .+++.||+|+++.. ..+.+.+|++++++++ ||||+++++++........+++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999995 57899999999743 3577999999999997 9999999999876444445567
Q ss_pred ecccCCCccccccc--cccccccccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEeec
Q 010856 438 FHHSSASASASLVS--SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~--~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~~ 497 (499)
++++.++.+..+.. .......++.|++.||+|||+ +++|.||+++.++ .++++|||++..
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 78876654443322 222344556899999998876 8999999998766 799999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.3e-17 Score=162.13 Aligned_cols=134 Identities=14% Similarity=0.175 Sum_probs=106.1
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCC--CCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIR--HRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~--H~niv~l~~~~~~~~~~~~~~ 436 (499)
..|...+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+ ..++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~--~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ--YIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC--EEEE
Confidence 4599999999999999999998779999999997654 234577999999999996 599999999887744 3455
Q ss_pred eecccCCCcccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|+.++++.+.+..... ....++.||+.||+|||+ ++||.||++ +++.++++|||+++.
T Consensus 134 v~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll-~~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 134 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQ 203 (390)
T ss_dssp EEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE-SSSCEEECCCSSSCC
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE-ECCeEEEEecCcccc
Confidence 677776666554433222 234456899999999876 899999999 568999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.4e-17 Score=154.63 Aligned_cols=136 Identities=14% Similarity=0.098 Sum_probs=98.9
Q ss_pred HhhhcccccccccCCcceEEEEEeC----CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
..++|...+.||+|+||.||+|+.. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.. . .
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~-~ 89 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--N-P 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S-S
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--C-c
Confidence 3467999999999999999999963 24579999987543 2345679999999999999999999998743 2 2
Q ss_pred eeeeecccCC-Cccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSA-SASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.+++++++.+ ++.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 3456677655 44333321 122233446899999998876 8999999999999999999998864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=138.75 Aligned_cols=134 Identities=20% Similarity=0.180 Sum_probs=87.1
Q ss_pred ccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCce
Q 010856 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEY 202 (499)
Q Consensus 123 ~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 202 (499)
+..+.+|+.|++++|+++.++......++|++|++++|.+++. ..+..+++|++|++++|.+++..+..+..+++|++
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92 (176)
T ss_dssp EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCCcCCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence 3445556666666666665543222223666666666666654 45666777777777777777655555577777777
Q ss_pred eeCcCCcCCCCCCc--cccCCCCCCEEeCCCCcCCccCcc---cccCCCCCCEEEccCCcCc
Q 010856 203 LFLGYNRLQGSIPD--SFGDLISLKFLNLSNNNLSGAIPA---SLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 203 L~L~~n~l~~~~~~--~l~~l~~L~~L~l~~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~ 259 (499)
|++++|+++. .|. .+..+++|+.|++++|+++...+. .+..+++|+.||+++|.+.
T Consensus 93 L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 93 LILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 7777777763 333 677777888888888877743322 3777788888888877765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.65 E-value=6.5e-17 Score=155.40 Aligned_cols=135 Identities=16% Similarity=0.111 Sum_probs=104.8
Q ss_pred hhcccc-cccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeee
Q 010856 361 DEFSEN-NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l 437 (499)
+.|.+. +.||+|+||.||+|+. .+++.||||++........+.+.+|++++.++ +||||+++++++...+ ..+++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~--~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED--RFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--EEEEE
Confidence 457764 7899999999999995 57999999999876655677899999999884 7999999999987633 45567
Q ss_pred ecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCC---eEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG---VEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~---~~~~~f~~~~~ 497 (499)
+|++.| .+.+.+... ......++.|++.||+|||+ +++|.||+++.++. ++++|||++..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 777754 444433322 22334456899999999876 89999999987766 99999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.65 E-value=6.1e-17 Score=161.78 Aligned_cols=137 Identities=14% Similarity=0.120 Sum_probs=103.3
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--------ccHHHHHHHHHHHhcCCCCCccccceeEEc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--------RAFESFDVECEMMKNIRHRNLIKILHGVAV 428 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~H~niv~l~~~~~~ 428 (499)
...++|...+.||+|+||+||+|+. .+++.||+|++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3456799999999999999999996 5689999999975431 112358899999999999999999998754
Q ss_pred cccceeeeeecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCC---CeEEEEEEE
Q 010856 429 ITFTVCLCLFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVICFVF 494 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~~f~~ 494 (499)
.+ .++++|++.+ ++.+.+.... .....++.|++.||+|||+ ++||.||++..++ .++++|||+
T Consensus 212 ~~---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 ED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SE---EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred Cc---eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 32 3456777754 5444443322 2234446899999999876 8999999997654 499999998
Q ss_pred eec
Q 010856 495 EIL 497 (499)
Q Consensus 495 ~~~ 497 (499)
++.
T Consensus 289 a~~ 291 (419)
T 3i6u_A 289 SKI 291 (419)
T ss_dssp TTS
T ss_pred cee
Confidence 764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-17 Score=158.08 Aligned_cols=137 Identities=15% Similarity=0.144 Sum_probs=103.0
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcc----------
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVI---------- 429 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~---------- 429 (499)
++|...+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57899999999999999999974 5899999999866555567899999999999999999999987431
Q ss_pred --ccceeeeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEee-CCCeEEEEEEEeec
Q 010856 430 --TFTVCLCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL-EPGVEVICFVFEIL 497 (499)
Q Consensus 430 --~~~~~~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~-~~~~~~~~f~~~~~ 497 (499)
+....+++++++.|++.+.+.. .......++.|++.||+|||+ +++|.||+++. ++.++++|||+++.
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~ 170 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBC
T ss_pred ccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccc
Confidence 2234566788888765544432 122234456899999999876 89999999974 55889999998864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.6e-17 Score=159.44 Aligned_cols=135 Identities=14% Similarity=0.179 Sum_probs=96.7
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
..+.|...+.||+|+||.||+|+.. +++.||+|+++... ..+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT--EISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS--EEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC--eEEEE
Confidence 3467999999999999999999974 68899999997543 3456889999999999999999999987633 44557
Q ss_pred ecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEee---CCCeEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---EPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---~~~~~~~~f~~~~~ 497 (499)
+|++.| .+.+.+... +.....++.|++.||+|||+ +++|.||++.. ++.++++|||++..
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 777754 443433322 22334456899999999876 89999999975 77899999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=3e-17 Score=156.28 Aligned_cols=135 Identities=18% Similarity=0.144 Sum_probs=102.2
Q ss_pred hcccccccccCCcceEEEEEe-CC---CCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GD---RMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~---~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.|...+.||+|+||+||+|+. .+ +..||+|.+..... ...+.+.+|++++++++||||+++++++...+...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~- 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV- 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE-
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE-
Confidence 355668999999999999984 23 33799999975442 3457899999999999999999999998765544444
Q ss_pred eeccc-CCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHS-SASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~-~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++ ++++.+.+... ......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 45555 55554444321 12233445799999998876 8999999999999999999998863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.5e-17 Score=158.40 Aligned_cols=137 Identities=18% Similarity=0.200 Sum_probs=107.9
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCc--cHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGR--AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..++|...+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++... ...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CEEE
Confidence 3467999999999999999999964 6999999999665422 245688999999999999999999998763 3455
Q ss_pred eeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++++.++....+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 173 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence 6788887775554321 122344556899999998876 8999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-17 Score=159.26 Aligned_cols=135 Identities=16% Similarity=0.140 Sum_probs=101.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCE----EEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRME----VAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
++|...+.||+|+||+||+|+. .+++. ||+|.+.... ....+.+.+|+.++++++||||+++++++.. ...+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CccE
Confidence 5688999999999999999995 35554 7777775433 2334567899999999999999999998854 2233
Q ss_pred eeeeccc-CCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHS-SASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~-~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.+++++ +|++.+.+... +.....++.|++.||+|||+ ++||.||+++.++.++++|||+++..
T Consensus 91 -~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 -LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp -EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred -EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 455555 45554444321 22234446899999999876 89999999999999999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.8e-17 Score=156.84 Aligned_cols=142 Identities=20% Similarity=0.196 Sum_probs=102.0
Q ss_pred HHHHhhhcccccccccCCcceEEEEEeC----CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcc
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVI 429 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~ 429 (499)
+....++|...+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3345577899999999999999999852 35589999997553 23356799999999999999999999998764
Q ss_pred ccc---eeeeeecccCC-Ccccccc----------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEE
Q 010856 430 TFT---VCLCLFHHSSA-SASASLV----------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEV 489 (499)
Q Consensus 430 ~~~---~~~~l~~~~~~-~~~~~l~----------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~ 489 (499)
+.. ..+++++++.+ ++...+. ..+.....++.|+++||+|||+ +++|.||+++.++.+++
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 322 23456677655 4433331 1122234456899999999877 89999999999999999
Q ss_pred EEEEEeec
Q 010856 490 ICFVFEIL 497 (499)
Q Consensus 490 ~~f~~~~~ 497 (499)
+|||++..
T Consensus 189 ~Dfg~~~~ 196 (313)
T 3brb_A 189 ADFGLSKK 196 (313)
T ss_dssp CSCSCC--
T ss_pred eecCccee
Confidence 99998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=8.8e-17 Score=153.27 Aligned_cols=134 Identities=16% Similarity=0.180 Sum_probs=102.2
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhc--CCCCCccccceeEEcc--ccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKN--IRHRNLIKILHGVAVI--TFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~H~niv~l~~~~~~~--~~~~~~ 435 (499)
.++|...+.||+|+||+||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... .....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999988 7889999999653 34556677777665 8999999999987652 123345
Q ss_pred eeecccCC-Cccccccc---cccccccccccccccceeec--------c------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVS---SLTLSRPAKGGGFRGCVLWH--------V------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~---~~~~~~~~~~~i~~gl~yLH--------~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|++.+ ++.+.+.. .+.....++.|++.||+||| + ++||.||+++.++.++++|||+++.
T Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp EEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 67777765 44333321 22233445689999999998 4 8999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.9e-17 Score=160.24 Aligned_cols=133 Identities=14% Similarity=0.078 Sum_probs=104.8
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|...+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++...+ ..++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK--YNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--EEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--ccEEEE
Confidence 5799999999999999999995 5799999999975432 34688999999999 9999999999887633 445677
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCC-----eEEEEEEEeec
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG-----VEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~-----~~~~~f~~~~~ 497 (499)
+++++++.+.+.. .+.....++.|++.||+|||+ ++||.||+++.++. ++++|||+++.
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 7776665544432 222344556899999998876 89999999988776 99999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=8.2e-17 Score=154.26 Aligned_cols=137 Identities=18% Similarity=0.119 Sum_probs=102.0
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
..++|...+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--EL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--cE
Confidence 446799999999999999999996 579999999997543 233567899999999999999999999987633 44
Q ss_pred eeeecccCCC-ccccccc--------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSAS-ASASLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++++.++ +.+.+.. .......++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 5677777664 3333221 122233456899999999876 8999999999999999999998764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-17 Score=160.53 Aligned_cols=138 Identities=16% Similarity=0.138 Sum_probs=109.3
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEccc---ccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVIT---FTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~---~~~~ 434 (499)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++.... ....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46799999999999999999996 4789999999975432 33567889999999999999999999875421 2345
Q ss_pred eeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++++.+++...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 90 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 66888888776544332 222344556899999998876 8999999999999999999998864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=139.37 Aligned_cols=109 Identities=20% Similarity=0.198 Sum_probs=51.7
Q ss_pred ccCCCCCCEEeccCCcCCccCCccccCCC-CCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccC
Q 010856 51 ISNLTNSTIVNLGGNKLNGSIPITLSKLQ-KLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSL 129 (499)
Q Consensus 51 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 129 (499)
+.++++|++|++++|.++.. +. +..+. +|+.|++++|.+++. ..+..+++|++|++++|++++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 44445555555555555532 22 22222 555555555555433 344455555555555555554433333445555
Q ss_pred CeeeccccCCCCCCc--cccCCCCCcEEEcCCCcCC
Q 010856 130 RIVSLGSNKLTSVPL--TFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 130 ~~L~L~~n~l~~~~~--~~~~l~~L~~L~l~~n~l~ 163 (499)
+.|++++|+++.+|. .+..+++|+.|++++|.++
T Consensus 91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence 555555555544443 3444444444444444443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=149.50 Aligned_cols=137 Identities=15% Similarity=0.161 Sum_probs=108.2
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
..++|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++... ...++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEEE
Confidence 3467999999999999999999964 78999999997654 34457899999999999999999999988763 24455
Q ss_pred eecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|++.+ ++.+.+.... .....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 6777755 4444443221 2234456899999998866 8999999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-17 Score=159.24 Aligned_cols=147 Identities=16% Similarity=0.131 Sum_probs=111.2
Q ss_pred ccCHHHHHHHhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCccc
Q 010856 350 TFSYLELFRATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNI-RHRNLIK 421 (499)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~H~niv~ 421 (499)
.+....+....++|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+++++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345556666678999999999999999999983 3568999999976542 3356789999999999 7999999
Q ss_pred cceeEEccccceeeeeecccCC-Ccccccccc--------------------ccccccccccccccceeecc------CC
Q 010856 422 ILHGVAVITFTVCLCLFHHSSA-SASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GV 474 (499)
Q Consensus 422 l~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~ 474 (499)
+++++...+. ..+++++++.+ ++.+.+... ......++.|++.||+|||+ ++
T Consensus 96 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~di 174 (316)
T 2xir_A 96 LLGACTKPGG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174 (316)
T ss_dssp EEEEECCTTS-CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecCCC-ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccC
Confidence 9999876433 24456677654 443333221 11223345799999998877 89
Q ss_pred CcccEEEeeCCCeEEEEEEEeec
Q 010856 475 DFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 475 ~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|.||+++.++.++++|||+++.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~ 197 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARD 197 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSC
T ss_pred ccceEEECCCCCEEECCCccccc
Confidence 99999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.65 E-value=3.3e-17 Score=158.77 Aligned_cols=137 Identities=19% Similarity=0.204 Sum_probs=104.2
Q ss_pred HhhhcccccccccCCcceEEEEEe--------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL--------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAV 428 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~ 428 (499)
..++|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 347899999999999999999985 246789999997654 23456789999999999 99999999999876
Q ss_pred cccceeeeeecccCC-Cccccccccc--------------------cccccccccccccceeecc------CCCcccEEE
Q 010856 429 ITFTVCLCLFHHSSA-SASASLVSSL--------------------TLSRPAKGGGFRGCVLWHV------GVDFAAFVF 481 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~-~~~~~l~~~~--------------------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~ 481 (499)
.+ ..+++++++.+ ++.+.+.... .....++.|++.||+|||+ +++|.||++
T Consensus 113 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 DG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp SS--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CC--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 33 34556777755 4433332211 1123345799999998876 899999999
Q ss_pred eeCCCeEEEEEEEeec
Q 010856 482 VLEPGVEVICFVFEIL 497 (499)
Q Consensus 482 ~~~~~~~~~~f~~~~~ 497 (499)
+.++.++++|||+++.
T Consensus 191 ~~~~~~kL~Dfg~~~~ 206 (334)
T 2pvf_A 191 TENNVMKIADFGLARD 206 (334)
T ss_dssp CTTCCEEECCCTTCEE
T ss_pred cCCCCEEEcccccccc
Confidence 9999999999998764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3e-17 Score=161.49 Aligned_cols=138 Identities=14% Similarity=0.101 Sum_probs=108.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccccc----
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITFT---- 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~---- 432 (499)
.+.|...+.||+|+||.||+|+. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46789999999999999999996 4799999999976432 2356789999999999999999999998764322
Q ss_pred eeeeeecccCCCccccccc--cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVS--SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~--~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++++++.+++...+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 121 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 2356788888776544332 223344556899999999876 8999999999999999999998864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.5e-17 Score=152.87 Aligned_cols=137 Identities=16% Similarity=0.283 Sum_probs=107.7
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
..++|...+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN--YV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS--EE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC--eE
Confidence 456799999999999999999996 579999999997543 233577999999999999999999999987633 44
Q ss_pred eeeecccCCCccc-cccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASA-SLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~-~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|++.++.+. .+.. .......++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 5677777554333 2221 122334456899999998876 8999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.3e-17 Score=157.46 Aligned_cols=137 Identities=18% Similarity=0.134 Sum_probs=101.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCE----EEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRME----VAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
.++|...+.||+|+||.||+|+. .+++. ||+|.+.... ....+.+.+|++++++++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--c
Confidence 35799999999999999999995 45554 4677665433 345678999999999999999999999988643 3
Q ss_pred eeeeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++++++.+|++.+.+.. .......++.|++.||+|||+ ++||.||+++.++.++++|||++...
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 444445555555544432 122234456899999998876 89999999999999999999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-17 Score=157.35 Aligned_cols=137 Identities=18% Similarity=0.153 Sum_probs=107.5
Q ss_pred HHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
....+|+..+.||+|+||.||+|+.. ++..||+|.+.... ...+.+.+|++++++++||||+++++++...+ ..++
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 86 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PFYI 86 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CEEE
Confidence 45678999999999999999999964 58899999997543 34678999999999999999999999886533 3455
Q ss_pred eecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.| ++.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 7777764 44333321 112233445799999998876 8999999999999999999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.6e-17 Score=154.77 Aligned_cols=135 Identities=17% Similarity=0.231 Sum_probs=105.8
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
..+.|...+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC--eEEEE
Confidence 3467999999999999999999974 68999999997666566788999999999999999999999987633 44567
Q ss_pred ecccCCCcccccc------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 438 FHHSSASASASLV------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 438 ~~~~~~~~~~~l~------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
++++.++....+. ........++.|++.||+|||+ +++|.||+++.++.++++|||++
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 7887665443321 1222334456899999998876 89999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.6e-17 Score=170.19 Aligned_cols=134 Identities=14% Similarity=0.175 Sum_probs=103.0
Q ss_pred hccccc-ccccCCcceEEEEEeC---CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 362 EFSENN-LIGKGGFGSVYKARLG---DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++.... .||+|+||.||+|.++ ++..||||+++... ....++|.+|++++++++|||||++++++.. + ..++
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~--~~~l 412 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E--ALML 412 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S--SEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C--CeEE
Confidence 344444 7999999999999853 46679999997654 3456889999999999999999999999865 2 2445
Q ss_pred eecccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++|++.++ +.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||+++.+
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 67777554 4333321 122344556899999999876 89999999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.64 E-value=8.8e-17 Score=154.87 Aligned_cols=136 Identities=16% Similarity=0.166 Sum_probs=106.6
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG------RAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
.+.|...+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT-- 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence 467999999999999999999964 699999999976532 13577999999999999999999999987633
Q ss_pred eeeeeecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCC----CeEEEEEEEeec
Q 010856 433 VCLCLFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP----GVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~----~~~~~~f~~~~~ 497 (499)
..++++|++.| ++.+.+... ......++.|++.||+|||+ +++|.||++++++ .++++|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 44567777754 444433322 22334556899999998866 8999999998877 799999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4e-17 Score=160.24 Aligned_cols=135 Identities=14% Similarity=0.123 Sum_probs=103.6
Q ss_pred HHhhhcccccccccCCcceEEEEE------eCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC---CCCccccceeEEc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKAR------LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR---HRNLIKILHGVAV 428 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---H~niv~l~~~~~~ 428 (499)
...++|...+.||+|+||+||+|. ..+++.||+|+++.. ...++.+|++++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345679999999999999999994 356889999999753 3467888888888876 9999999999876
Q ss_pred cccceeeeeecccC-CCccccccc---------cccccccccccccccceeecc------CCCcccEEEee---------
Q 010856 429 ITFTVCLCLFHHSS-ASASASLVS---------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL--------- 483 (499)
Q Consensus 429 ~~~~~~~~l~~~~~-~~~~~~l~~---------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~--------- 483 (499)
.+ ..++++||+. |++.+.+.. .+.....++.|+++||+|||+ ++||.||+++.
T Consensus 139 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 QN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred CC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 44 3345677775 444444431 122244556899999998877 89999999988
Q ss_pred --CCCeEEEEEEEeec
Q 010856 484 --EPGVEVICFVFEIL 497 (499)
Q Consensus 484 --~~~~~~~~f~~~~~ 497 (499)
++.++++|||+++.
T Consensus 217 ~~~~~~kl~DFG~a~~ 232 (365)
T 3e7e_A 217 DLSAGLALIDLGQSID 232 (365)
T ss_dssp --CTTEEECCCTTCEE
T ss_pred cccCCEEEeeCchhhh
Confidence 89999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-17 Score=151.92 Aligned_cols=135 Identities=16% Similarity=0.083 Sum_probs=107.3
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|...+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++...+ ..+++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--CeEEEEe
Confidence 467899999999999999999988888999999976542 3478999999999999999999999887633 3456777
Q ss_pred ccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++.+ .+.+.+... ......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 7755 443333221 22233446899999998876 8999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=6.7e-17 Score=152.36 Aligned_cols=139 Identities=12% Similarity=0.130 Sum_probs=108.5
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..++|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 356899999999999999999996 479999999997654 23456799999999999999999999988654444556
Q ss_pred eeecccCC-Cccccccc--------cccccccccccccccceeec-----------cCCCcccEEEeeCCCeEEEEEEEe
Q 010856 436 CLFHHSSA-SASASLVS--------SLTLSRPAKGGGFRGCVLWH-----------VGVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH-----------~~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
+++|++.+ ++.+.+.. .+.....++.|++.||+||| .+++|.||+++.++.++++|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 67888865 44333321 22233445688999998765 478999999999999999999987
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 164 ~~ 165 (279)
T 2w5a_A 164 RI 165 (279)
T ss_dssp HH
T ss_pred ee
Confidence 54
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=6.4e-17 Score=156.83 Aligned_cols=136 Identities=13% Similarity=0.174 Sum_probs=107.8
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--FVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--eEE
Confidence 467999999999999999999964 68899999997653 234567899999999999999999999987633 455
Q ss_pred eeecccCCCccccc-cc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASL-VS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l-~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|++.++.+..+ .. .+.....++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 67888865543332 21 222344456899999998876 8999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.2e-17 Score=161.85 Aligned_cols=147 Identities=16% Similarity=0.156 Sum_probs=113.5
Q ss_pred ccccCHHHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-----CCCccc
Q 010856 348 WRTFSYLELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-----HRNLIK 421 (499)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----H~niv~ 421 (499)
...+++++.....++|...+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|+++++.+. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34455555556678899999999999999999996 578999999997432 33466788999999886 999999
Q ss_pred cceeEEccccceeeeeecccCCCcccccccc------ccccccccccccccceeecc------CCCcccEEEee------
Q 010856 422 ILHGVAVITFTVCLCLFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL------ 483 (499)
Q Consensus 422 l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~------ 483 (499)
+++++...+ ..+++++++++++.+.+... ......++.|++.||+|||+ ++||.||+++.
T Consensus 101 ~~~~~~~~~--~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 101 YHGKFMYYD--HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEEEETT--EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred ccceeeECC--eeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 999987743 45567788877665554322 12234456899999998876 89999999964
Q ss_pred -------------------CCCeEEEEEEEeec
Q 010856 484 -------------------EPGVEVICFVFEIL 497 (499)
Q Consensus 484 -------------------~~~~~~~~f~~~~~ 497 (499)
++.++++|||++..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~ 211 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEE
T ss_pred ccchhcccccccccccccCCCCEEEEeccCcee
Confidence 78999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=4.3e-17 Score=155.23 Aligned_cols=136 Identities=18% Similarity=0.111 Sum_probs=102.8
Q ss_pred hhcccccccccCCcceEEEEEeCC----CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGD----RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..|...+.||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|++++++++||||+++++++...+...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~- 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL- 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE-
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE-
Confidence 458888999999999999998532 3368999987544 2345779999999999999999999998766443333
Q ss_pred eeecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++++.+ ++.+.+... ......++.|++.||+|||+ +++|.||++++++.++++|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 46677655 444333221 12233445799999998876 8999999999999999999998864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=6.6e-17 Score=153.66 Aligned_cols=136 Identities=13% Similarity=0.173 Sum_probs=107.5
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--FVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC--EEE
Confidence 467899999999999999999964 68899999997653 234567899999999999999999999987633 445
Q ss_pred eeecccCCCcccccc-c----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLV-S----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~-~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|++.++....+. . .+.....++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 677888655433322 1 222334456899999998876 8999999999999999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.7e-17 Score=158.50 Aligned_cols=138 Identities=16% Similarity=0.135 Sum_probs=109.3
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCccccceeEEc------ccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIKILHGVAV------ITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~------~~~ 431 (499)
..+|...+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.+++++. ||||+++++++.. .+.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45799999999999999999996 478999999997665555678999999999996 9999999998853 122
Q ss_pred ceeeeeecccCCCccccccc-------cccccccccccccccceeecc--------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 432 TVCLCLFHHSSASASASLVS-------SLTLSRPAKGGGFRGCVLWHV--------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~-------~~~~~~~~~~~i~~gl~yLH~--------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
...+++++++.|++.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++.
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 34567888888876554432 222334456889999987765 679999999999999999999876
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
.
T Consensus 187 ~ 187 (337)
T 3ll6_A 187 T 187 (337)
T ss_dssp C
T ss_pred e
Confidence 4
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4e-17 Score=158.12 Aligned_cols=138 Identities=17% Similarity=0.174 Sum_probs=106.2
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--------ccHHHHHHHHHHHhcCCCCCccccceeEEcc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--------RAFESFDVECEMMKNIRHRNLIKILHGVAVI 429 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~ 429 (499)
..++|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456799999999999999999995 5789999999976531 1234678899999999999999999998763
Q ss_pred ccceeeeeeccc-CC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 430 TFTVCLCLFHHS-SA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 430 ~~~~~~~l~~~~-~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+ ..+++++++ .| ++...+... +.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 102 ~--~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 102 G--FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp S--EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred C--EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 3 344566655 44 333333222 22334456899999998876 8999999999999999999998864
Q ss_pred c
Q 010856 498 L 498 (499)
Q Consensus 498 ~ 498 (499)
.
T Consensus 180 ~ 180 (335)
T 3dls_A 180 L 180 (335)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3e-17 Score=157.44 Aligned_cols=138 Identities=16% Similarity=0.144 Sum_probs=106.5
Q ss_pred HHhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCccccceeEEcc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCG-RAFESFDVECEMMKNI-RHRNLIKILHGVAVI 429 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~ 429 (499)
...++|...+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3446799999999999999999984 3578999999976542 3457799999999999 999999999998763
Q ss_pred ccceeeeeecccCC-Ccccccccc----------------------ccccccccccccccceeecc------CCCcccEE
Q 010856 430 TFTVCLCLFHHSSA-SASASLVSS----------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFV 480 (499)
Q Consensus 430 ~~~~~~~l~~~~~~-~~~~~l~~~----------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l 480 (499)
+ ..++++|++.+ ++.+.+... +.....++.|+++||+|||+ +++|.||+
T Consensus 100 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 100 G--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp S--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred C--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 3 34556777755 444333221 12233445899999999876 89999999
Q ss_pred EeeCCCeEEEEEEEeec
Q 010856 481 FVLEPGVEVICFVFEIL 497 (499)
Q Consensus 481 ~~~~~~~~~~~f~~~~~ 497 (499)
++.++.++++|||++..
T Consensus 178 ~~~~~~~kl~Dfg~~~~ 194 (313)
T 1t46_A 178 LTHGRITKICDFGLARD 194 (313)
T ss_dssp EETTTEEEECCCGGGSC
T ss_pred EcCCCCEEEcccccccc
Confidence 99999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=3.5e-17 Score=159.32 Aligned_cols=139 Identities=17% Similarity=0.187 Sum_probs=105.0
Q ss_pred HHHhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEc
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAV 428 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~ 428 (499)
....++|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34557899999999999999999995 245689999997543 33457899999999999 99999999999876
Q ss_pred cccceeeeeecccCC-Ccccccccc---------------------------ccccccccccccccceeecc------CC
Q 010856 429 ITFTVCLCLFHHSSA-SASASLVSS---------------------------LTLSRPAKGGGFRGCVLWHV------GV 474 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~-~~~~~l~~~---------------------------~~~~~~~~~~i~~gl~yLH~------~~ 474 (499)
.+ ..+++++++.+ ++.+.+... +.....++.|++.||+|||+ ++
T Consensus 121 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 121 SG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred CC--ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 33 34556777754 544433221 11223346899999998876 89
Q ss_pred CcccEEEeeCCCeEEEEEEEeec
Q 010856 475 DFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 475 ~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|.||+++.++.++++|||++..
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~ 221 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARD 221 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSC
T ss_pred ChhhEEEcCCCcEEeCCCccCcc
Confidence 99999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=4.4e-17 Score=152.80 Aligned_cols=136 Identities=14% Similarity=0.157 Sum_probs=106.9
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|...+.||+|+||.||+|+. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+....+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 45789999999999999999998 48899999997654 2335679999999999999999999999877533445567
Q ss_pred ecccCC-Ccccccccc------ccccccccccccccceeecc--------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 438 FHHSSA-SASASLVSS------LTLSRPAKGGGFRGCVLWHV--------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~--------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++++.+ ++.+.+... +.....++.|+++||+|||+ +++|.||+++.++.++++||||..
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 777765 554444332 22234456899999998886 579999999989999999998864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-17 Score=158.56 Aligned_cols=138 Identities=14% Similarity=0.098 Sum_probs=109.3
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEcccc----c
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVITF----T 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~----~ 432 (499)
.++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++...+. .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35789999999999999999996 4799999999975432 235678999999999999999999999876432 2
Q ss_pred eeeeeecccCCCccccccc--cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVS--SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~--~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++++++.+++...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 3456788888776554432 222344556899999999876 8999999999999999999998753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.8e-17 Score=152.72 Aligned_cols=135 Identities=19% Similarity=0.108 Sum_probs=102.7
Q ss_pred HhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
..++|+..+.||+|+||.||+|+. +|+.||+|+++... ..+.+.+|++++++++||||+++++++...+. ..++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC-ceEEEE
Confidence 356799999999999999999987 57899999997543 45789999999999999999999998765332 344567
Q ss_pred cccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.+ ++.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccc
Confidence 77765 44443332 122234556899999998876 8999999999999999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=9.1e-17 Score=157.38 Aligned_cols=135 Identities=13% Similarity=0.107 Sum_probs=106.6
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT--EEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC--EEEEE
Confidence 367999999999999999999964 78999999997653 233567999999999999999999999887633 45567
Q ss_pred ecccCC-Ccccccccc----ccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 438 FHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
++++.| ++.+.+... ......++.|++.||+|||+ +++|.||+++.++.++++|||++.
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence 888865 443333322 22234456888999888764 789999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=151.88 Aligned_cols=133 Identities=17% Similarity=0.184 Sum_probs=101.1
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
|.....||+|+||.||+|+. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+ ...++++++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~ 101 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQV 101 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEECC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC--cEEEEEEeC
Confidence 44456899999999999995 578999999998766555678999999999999999999999987633 445567777
Q ss_pred CCC-cccccccc-------ccccccccccccccceeecc------CCCcccEEEee-CCCeEEEEEEEeec
Q 010856 442 SAS-ASASLVSS-------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL-EPGVEVICFVFEIL 497 (499)
Q Consensus 442 ~~~-~~~~l~~~-------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~-~~~~~~~~f~~~~~ 497 (499)
.++ +.+.+... +.....++.|++.||+|||+ +++|.||+++. ++.++++|||++..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 544 33333221 11223345799999998876 89999999987 78999999998764
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=4.3e-17 Score=155.33 Aligned_cols=136 Identities=21% Similarity=0.260 Sum_probs=105.6
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 79 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYL 79 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCC--ceEE
Confidence 357899999999999999999964 78999999986543 233467899999999999999999999987633 4556
Q ss_pred eecccCCCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|++.+++.+.+... ......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 80 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 152 (299)
T 2r3i_A 80 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152 (299)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred EEEcccCCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhh
Confidence 7888877655444322 12233456899999999876 8999999999999999999998653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-17 Score=158.03 Aligned_cols=138 Identities=12% Similarity=0.072 Sum_probs=107.7
Q ss_pred HHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFT 432 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~ 432 (499)
...++|...+.||+|+||+||+|+.+ +|+.||+|++++.. ....+.+.+|.+++..+ +||||+++++++...+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~-- 94 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-- 94 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS--
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC--
Confidence 34578999999999999999999975 58899999997643 34467789999999988 8999999999887643
Q ss_pred eeeeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++||+.| ++...+.. .+.....++.|++.||+|||+ ++||.||+++.++.++++|||++..
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 44557777755 44444332 222334456899999998876 8999999999999999999998763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=7.6e-17 Score=152.68 Aligned_cols=135 Identities=15% Similarity=0.185 Sum_probs=103.1
Q ss_pred hhccccc-ccccCCcceEEEEEeC---CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENN-LIGKGGFGSVYKARLG---DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
++|.... .||+|+||.||+|... ++..||+|+++... ....+.+.+|++++++++||||+++++++.. + ..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E--ALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S--SEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C--CcE
Confidence 4566665 8999999999999853 57889999997654 3346779999999999999999999999843 2 244
Q ss_pred eeecccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++++.++ +.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||+++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 567777654 3333321 122334456899999998876 89999999999999999999988643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.9e-16 Score=155.32 Aligned_cols=141 Identities=14% Similarity=0.191 Sum_probs=109.0
Q ss_pred HHHHHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCc--------cHHHHHHHHHHHhcC-CCCCccccce
Q 010856 355 ELFRATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGR--------AFESFDVECEMMKNI-RHRNLIKILH 424 (499)
Q Consensus 355 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l-~H~niv~l~~ 424 (499)
......++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33455678999999999999999999974 7999999999765421 145678999999998 8999999999
Q ss_pred eEEccccceeeeeecccCCCcc-ccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEE
Q 010856 425 GVAVITFTVCLCLFHHSSASAS-ASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFV 493 (499)
Q Consensus 425 ~~~~~~~~~~~~l~~~~~~~~~-~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~ 493 (499)
++... ...++++|++.|+.+ +.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||
T Consensus 168 ~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 168 SYESS--SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEEBS--SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEeeC--CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 88763 345567888866433 33221 222344456899999998876 899999999999999999999
Q ss_pred Eeec
Q 010856 494 FEIL 497 (499)
Q Consensus 494 ~~~~ 497 (499)
++..
T Consensus 246 ~~~~ 249 (365)
T 2y7j_A 246 FSCH 249 (365)
T ss_dssp TCEE
T ss_pred cccc
Confidence 8764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-16 Score=163.40 Aligned_cols=136 Identities=18% Similarity=0.216 Sum_probs=106.2
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.+.|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG--YFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEE
Confidence 467999999999999999999964 79999999997653 345678999999999999999999999987633 344
Q ss_pred eeeccc-CCCccccccccc----cccccccccccccceeecc------CCCcccEEEe---eCCCeEEEEEEEeec
Q 010856 436 CLFHHS-SASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFV---LEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~-~~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~---~~~~~~~~~f~~~~~ 497 (499)
++++++ +|++.+.+.... .....++.|++.||+|||+ +++|.||++. .++.++++|||++..
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 566666 445444443222 2234456899999999876 8999999994 567899999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.2e-16 Score=163.15 Aligned_cols=136 Identities=12% Similarity=0.163 Sum_probs=101.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.+.|...+.||+|+||+||+|+. .++..||+|++.... ....+.+.+|+++++.++|||||++++++.... ..++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR--NYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EEEE
Confidence 45699999999999999999996 478999999997654 334577999999999999999999999987633 4455
Q ss_pred eecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCC---CeEEEEEEEeec
Q 010856 437 LFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~~f~~~~~ 497 (499)
+++|+.| ++.+.+... +.....++.|++.||+|||+ ++||.||++...+ .++++|||++..
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 6777755 443433322 22334456899999999876 8999999997643 499999998764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-16 Score=156.21 Aligned_cols=135 Identities=10% Similarity=0.104 Sum_probs=106.6
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCc---c--------------HHHHHHHHHHHhcCCCCCcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR---A--------------FESFDVECEMMKNIRHRNLIKI 422 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~--------------~~~~~~E~~il~~l~H~niv~l 422 (499)
.++|...+.||+|+||.||+|+. +|+.||+|++...... . .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999999754311 1 1789999999999999999999
Q ss_pred ceeEEccccceeeeeecccCC-Ccccc------ccc------cccccccccccccccceeecc-------CCCcccEEEe
Q 010856 423 LHGVAVITFTVCLCLFHHSSA-SASAS------LVS------SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFV 482 (499)
Q Consensus 423 ~~~~~~~~~~~~~~l~~~~~~-~~~~~------l~~------~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~ 482 (499)
++++...+ ..++++|++.+ ++.+. +.. .+.....++.|++.||+|||+ +++|.||+++
T Consensus 109 ~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSS--EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEeeCC--eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 99987743 45567777766 44333 221 111233446889999988885 7999999999
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
.++.++++|||++..
T Consensus 187 ~~~~~kl~dfg~~~~ 201 (348)
T 2pml_X 187 KNGRVKLSDFGESEY 201 (348)
T ss_dssp TTSCEEECCCTTCEE
T ss_pred CCCcEEEeccccccc
Confidence 999999999998864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-16 Score=149.95 Aligned_cols=135 Identities=18% Similarity=0.183 Sum_probs=106.1
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG------RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
++|...+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+ .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT--D 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC--e
Confidence 56999999999999999999974 699999999976431 23678999999999999999999999987633 4
Q ss_pred eeeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCC----CeEEEEEEEeec
Q 010856 434 CLCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP----GVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~----~~~~~~f~~~~~ 497 (499)
.+++++++.+ .+.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++ .++++|||++..
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 4567777754 44333322 222344556899999998876 8999999998776 799999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-16 Score=151.37 Aligned_cols=135 Identities=18% Similarity=0.184 Sum_probs=107.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
+.|...+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+ ..++++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--eEEEEE
Confidence 4588999999999999999995 578999999997654 344678999999999999999999999887633 445677
Q ss_pred cccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++.++.+..+... ......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 100 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 100 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168 (303)
T ss_dssp ECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeeccccee
Confidence 87766543332221 22234456899999998876 8999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=151.25 Aligned_cols=135 Identities=18% Similarity=0.186 Sum_probs=105.0
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccc-------
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVIT------- 430 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~------- 430 (499)
...+|...+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++...+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999974 79999999997543 45779999999999999999999875421
Q ss_pred -------cceeeeeecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEE
Q 010856 431 -------FTVCLCLFHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVI 490 (499)
Q Consensus 431 -------~~~~~~l~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~ 490 (499)
....++++|++.+ .+.+.+.. .+.....++.|++.||+|||+ +++|.||++++++.++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 2234567788766 44333321 122233456899999998876 899999999999999999
Q ss_pred EEEEeec
Q 010856 491 CFVFEIL 497 (499)
Q Consensus 491 ~f~~~~~ 497 (499)
|||++..
T Consensus 165 Dfg~~~~ 171 (284)
T 2a19_B 165 DFGLVTS 171 (284)
T ss_dssp CCTTCEE
T ss_pred cchhhee
Confidence 9998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-16 Score=151.46 Aligned_cols=136 Identities=15% Similarity=0.282 Sum_probs=104.9
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC--EEEE
Confidence 46799999999999999999996 468999999997654 233567889999999999999999999987633 3455
Q ss_pred eecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCC---eEEEEEEEeec
Q 010856 437 LFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG---VEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~---~~~~~f~~~~~ 497 (499)
+++++.|+ +...+... ......++.|++.||+|||+ +++|.||+++.++. ++++|||++..
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 67777654 33333222 22234456889999998876 89999999976554 99999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-16 Score=163.52 Aligned_cols=137 Identities=18% Similarity=0.231 Sum_probs=106.4
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..+.|...+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS--SFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--EEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC--EEE
Confidence 346799999999999999999996 479999999997543 345678999999999999999999999987633 445
Q ss_pred eeecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEee---CCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---EPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---~~~~~~~~f~~~~~ 497 (499)
++++++.| ++.+.+... ......++.|++.||+|||+ ++||.||++.. ++.++++|||++..
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 56777654 444443322 22344556899999999876 89999999954 44699999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-16 Score=149.69 Aligned_cols=136 Identities=16% Similarity=0.152 Sum_probs=107.7
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT--DFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--eEE
Confidence 467999999999999999999974 79999999997543 234567899999999999999999999987633 445
Q ss_pred eeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++++.+ .+.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence 67777755 44333322 222334456899999999876 8999999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.63 E-value=6.4e-17 Score=160.32 Aligned_cols=135 Identities=16% Similarity=0.160 Sum_probs=102.9
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccc----cceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVIT----FTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----~~~~~ 435 (499)
...|...+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++.... .....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346999999999999999999986666699998865432 1237999999999999999999986532 22345
Q ss_pred eeecccCCCccccccc--------cccccccccccccccceeecc------CCCcccEEEe-eCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASASASLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV-LEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~-~~~~~~~~~f~~~~~~ 498 (499)
+++||+.+++...+.. .......++.|+++||+|||+ ++||.||+++ .++.++++|||+++.+
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 6788888775443321 112234456899999998876 8999999998 6788999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.63 E-value=8.7e-17 Score=152.42 Aligned_cols=137 Identities=12% Similarity=0.008 Sum_probs=99.0
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-cc-HHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RA-FESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~-~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..++|...+.||+|+||.||+|+. .+|+.||+|++..... .. .+.+.+|...++.++||||+++++++...+ ..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~--~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG--DVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--SEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--CEE
Confidence 346799999999999999999996 5799999999975532 22 233445555688899999999999987633 445
Q ss_pred eeecccCCCccccccc--------cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSASASASLVS--------SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++|++.|++.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 6788888765443321 222334556899999988875 6899999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.4e-17 Score=153.39 Aligned_cols=137 Identities=12% Similarity=0.132 Sum_probs=104.3
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
..+.|...+.||+|+||.||+|+. .+|+.||+|+++.......+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT--HYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS--EEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC--EEEEE
Confidence 346799999999999999999996 479999999998665445567899999999999999999999987633 44567
Q ss_pred ecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEE---eeCCCeEEEEEEEeec
Q 010856 438 FHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVF---VLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~---~~~~~~~~~~f~~~~~ 497 (499)
+|++.| ++.+.+... ......++.|++.||+|||+ +++|.||++ ++++.++++|||++..
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 777755 443433222 22234456899999998876 899999999 5678899999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=150.70 Aligned_cols=136 Identities=17% Similarity=0.210 Sum_probs=107.1
Q ss_pred hhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK--RIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC--EEE
Confidence 467999999999999999999964 68899999996542 233567999999999999999999999987633 445
Q ss_pred eeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++++.+ .+.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 67777755 44333332 222334456899999998877 8999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-16 Score=162.38 Aligned_cols=137 Identities=13% Similarity=0.184 Sum_probs=104.0
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-------------ccHHHHHHHHHHHhcCCCCCccccce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-------------RAFESFDVECEMMKNIRHRNLIKILH 424 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~H~niv~l~~ 424 (499)
..+.|...+.||+|+||+||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 356799999999999999999996 4689999999975431 23567899999999999999999999
Q ss_pred eEEccccceeeeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCC---CeEEE
Q 010856 425 GVAVITFTVCLCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVI 490 (499)
Q Consensus 425 ~~~~~~~~~~~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~ 490 (499)
++...+ ..+++++++.| ++.+.+.. .+.....++.|++.||+|||+ +++|.||++..++ .++++
T Consensus 114 ~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 114 VFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEECSS--EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEcCC--EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 987633 44567777755 44444332 223344556899999998876 8999999998765 59999
Q ss_pred EEEEeec
Q 010856 491 CFVFEIL 497 (499)
Q Consensus 491 ~f~~~~~ 497 (499)
|||++..
T Consensus 192 Dfg~a~~ 198 (504)
T 3q5i_A 192 DFGLSSF 198 (504)
T ss_dssp CCTTCEE
T ss_pred ECCCCEE
Confidence 9998864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.62 E-value=5.9e-17 Score=158.31 Aligned_cols=136 Identities=14% Similarity=0.134 Sum_probs=105.9
Q ss_pred hhhcccccccccCCcceEEEEEe----CCCCEEEEEEeeccC----CccHHHHHHHHHHHhcC-CCCCccccceeEEccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQC----GRAFESFDVECEMMKNI-RHRNLIKILHGVAVIT 430 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~ 430 (499)
.++|...+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46799999999999999999996 368999999996532 23346678899999999 6999999999887633
Q ss_pred cceeeeeecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 FTVCLCLFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 ~~~~~~l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++||+.+ .+.+.+... ......++.|++.||+|||+ ++||.||+++.++.++++|||+++.
T Consensus 133 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 --KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 44567788765 443333322 22233446799999999876 8999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-16 Score=151.47 Aligned_cols=138 Identities=14% Similarity=0.094 Sum_probs=107.1
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccc-------
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVIT------- 430 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~------- 430 (499)
..++|+..+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356799999999999999999996 479999999996532 34567899999999999999999999876421
Q ss_pred ----cceeeeeecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEE
Q 010856 431 ----FTVCLCLFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 431 ----~~~~~~l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
....++++|++.| ++.+.+... ......++.|+++||+|||+ +++|.||+++.++.++++|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 2344557777755 444433321 12233456899999999876 8999999999999999999998
Q ss_pred eec
Q 010856 495 EIL 497 (499)
Q Consensus 495 ~~~ 497 (499)
+..
T Consensus 163 ~~~ 165 (303)
T 1zy4_A 163 AKN 165 (303)
T ss_dssp CSC
T ss_pred hhh
Confidence 754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.1e-17 Score=157.99 Aligned_cols=140 Identities=13% Similarity=0.054 Sum_probs=102.9
Q ss_pred HhhhcccccccccCCcceEEEEEeCC------CCEEEEEEeeccCCc-----------cHHHHHHHHHHHhcCCCCCccc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGD------RMEVAVKVFNLQCGR-----------AFESFDVECEMMKNIRHRNLIK 421 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~H~niv~ 421 (499)
..++|...+.||+|+||.||+|.... ++.||+|++...... ....+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34579999999999999999998643 478999998765311 1123456677788899999999
Q ss_pred cceeEEcccc--ceeeeeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEe--eCCC
Q 010856 422 ILHGVAVITF--TVCLCLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV--LEPG 486 (499)
Q Consensus 422 l~~~~~~~~~--~~~~~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~--~~~~ 486 (499)
+++++...+. ...+++++++++++.+.+.. .+.....++.|++.||+|||+ ++||.||+++ .++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9999876321 33456777776555444332 223344556899999998875 8999999999 7889
Q ss_pred eEEEEEEEeecc
Q 010856 487 VEVICFVFEILL 498 (499)
Q Consensus 487 ~~~~~f~~~~~~ 498 (499)
++++|||+++.+
T Consensus 193 ~kl~DFG~a~~~ 204 (364)
T 3op5_A 193 VYLVDYGLAYRY 204 (364)
T ss_dssp EEECCCTTCEES
T ss_pred EEEEECCcceec
Confidence 999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-16 Score=152.96 Aligned_cols=131 Identities=15% Similarity=0.138 Sum_probs=100.1
Q ss_pred hcccc---cccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeee
Q 010856 362 EFSEN---NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 362 ~~~~~---~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~ 436 (499)
+|+.. +.||+|+||.||+|+. .+++.||+|++... ....+.+|+++++.+. ||||+++++++...+ ..++
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~--~~~l 83 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL--HTFL 83 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC--EEEE
Confidence 45543 7899999999999996 46899999999753 3467889999999997 999999999987633 4456
Q ss_pred eecccCC-Ccccccccc----ccccccccccccccceeecc------CCCcccEEEeeCC---CeEEEEEEEeec
Q 010856 437 LFHHSSA-SASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~~f~~~~~ 497 (499)
++|++.| ++.+.+... +.....++.|++.||+|||+ +++|.||++..++ .++++|||++..
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 7777755 444444322 22344556899999998876 8999999998765 799999998864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-16 Score=149.49 Aligned_cols=137 Identities=17% Similarity=0.057 Sum_probs=105.9
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcC-CCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~ 434 (499)
..++|...+.||+|+||.||+|+.. +++.||+|++.... .....++.+|+..+..+ +||||+++++++...+ ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~--~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD--HM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT--EE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eE
Confidence 4578999999999999999999974 79999999997653 33456788999999998 9999999999987633 44
Q ss_pred eeeecccCC-Cccccccc--------cccccccccccccccceeecc------CCCcccEEEeeC---------------
Q 010856 435 LCLFHHSSA-SASASLVS--------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE--------------- 484 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~--------------- 484 (499)
++++|++.| ++.+.+.. .+.....++.|++.||+|||+ +++|.||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 567777755 54444332 222344556899999998876 899999999743
Q ss_pred ----CCeEEEEEEEeec
Q 010856 485 ----PGVEVICFVFEIL 497 (499)
Q Consensus 485 ----~~~~~~~f~~~~~ 497 (499)
..++++|||.+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~ 183 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTR 183 (289)
T ss_dssp ---CCCEEECCCTTCEE
T ss_pred cCCceEEEEcccccccc
Confidence 4799999998764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-16 Score=156.75 Aligned_cols=144 Identities=13% Similarity=0.052 Sum_probs=100.1
Q ss_pred HHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccc-
Q 010856 354 LELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITF- 431 (499)
Q Consensus 354 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~- 431 (499)
.......++|...+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 44567778999999999999999999996 479999999986543 233567788888899999999999999865321
Q ss_pred ----ceeeeeecccCCCccccccc--------cccccccccccccccceeec--c------CCCcccEEEee-CCCeEEE
Q 010856 432 ----TVCLCLFHHSSASASASLVS--------SLTLSRPAKGGGFRGCVLWH--V------GVDFAAFVFVL-EPGVEVI 490 (499)
Q Consensus 432 ----~~~~~l~~~~~~~~~~~l~~--------~~~~~~~~~~~i~~gl~yLH--~------~~~p~~~l~~~-~~~~~~~ 490 (499)
...+++++++.+++...+.. .......++.|++.|++||| + ++||.||+++. ++.++++
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 22556788888875443221 11223344678899998888 4 89999999986 7899999
Q ss_pred EEEEeecc
Q 010856 491 CFVFEILL 498 (499)
Q Consensus 491 ~f~~~~~~ 498 (499)
|||+++..
T Consensus 175 Dfg~a~~~ 182 (360)
T 3e3p_A 175 DFGSAKKL 182 (360)
T ss_dssp CCTTCBCC
T ss_pred eCCCceec
Confidence 99998653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.62 E-value=1e-16 Score=155.14 Aligned_cols=135 Identities=18% Similarity=0.176 Sum_probs=101.4
Q ss_pred hhcccccccccCCcceEEEEEeC-C----CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-D----RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
..|...+.||+|+||.||+|+.. + +..||+|+++... ......+.+|++++++++||||+++++++... ...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--CCc
Confidence 45777899999999999999853 2 3469999997654 23456789999999999999999999998653 344
Q ss_pred eeeecccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|++.++ +.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 5677877664 4333322 122234456899999998876 8999999999999999999999865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=150.76 Aligned_cols=133 Identities=22% Similarity=0.244 Sum_probs=100.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCc-------cHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGR-------AFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
.++|...+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|++++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36799999999999999999996 57999999999654321 1267899999999999999999999886533
Q ss_pred ceeeeeecccC-CCcccccccc-----ccccccccccccccceeecc--------CCCcccEEEeeCCC-----eEEEEE
Q 010856 432 TVCLCLFHHSS-ASASASLVSS-----LTLSRPAKGGGFRGCVLWHV--------GVDFAAFVFVLEPG-----VEVICF 492 (499)
Q Consensus 432 ~~~~~l~~~~~-~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~--------~~~p~~~l~~~~~~-----~~~~~f 492 (499)
.++++++. +++...+... +.....++.|++.||+|||+ +++|.||++..++. ++++||
T Consensus 97 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 ---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp ---EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred ---eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 24666665 4443433221 22234456888888876655 67999999987766 999999
Q ss_pred EEee
Q 010856 493 VFEI 496 (499)
Q Consensus 493 ~~~~ 496 (499)
|++.
T Consensus 174 g~~~ 177 (287)
T 4f0f_A 174 GLSQ 177 (287)
T ss_dssp TTCB
T ss_pred Cccc
Confidence 9875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-16 Score=153.01 Aligned_cols=131 Identities=18% Similarity=0.213 Sum_probs=98.9
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|+..+.||+|+||.||+|+. .++.||+|++... ...+.+.+|++++++++||||+++++++.. ..++++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEEEEE
Confidence 35788999999999999999997 4678999998643 345789999999999999999999998753 2345677
Q ss_pred ccCC-Cccccccccc-------cccccccccccccceeecc---------CCCcccEEEeeCCC-eEEEEEEEeec
Q 010856 440 HSSA-SASASLVSSL-------TLSRPAKGGGFRGCVLWHV---------GVDFAAFVFVLEPG-VEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~-~~~~~l~~~~-------~~~~~~~~~i~~gl~yLH~---------~~~p~~~l~~~~~~-~~~~~f~~~~~ 497 (499)
++.| .+.+.+.... .....++.|+++||+|||+ +++|.||+++.++. ++++|||++..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 7755 4433333221 1123345788999998876 79999999988876 69999998753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.3e-16 Score=149.11 Aligned_cols=132 Identities=9% Similarity=-0.086 Sum_probs=101.6
Q ss_pred hhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGR---AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
+.|...+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|++++++++||||+++++++...+ ..++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA--GGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC--cEEE
Confidence 56999999999999999999964 5899999999765422 2477999999999999999999999987633 4456
Q ss_pred eecccCCCcccccccccc---ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEE
Q 010856 437 LFHHSSASASASLVSSLT---LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 437 l~~~~~~~~~~~l~~~~~---~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
++||+.|+.+..+..... ....++.|++.||+|||+ ++||.||++++++.++++++|.
T Consensus 109 v~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~ 175 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT 175 (286)
T ss_dssp EEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC
T ss_pred EEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc
Confidence 778876544333222111 123346899999999876 8999999999888888876553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.7e-17 Score=156.00 Aligned_cols=139 Identities=16% Similarity=0.163 Sum_probs=91.9
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
....++|...+.||+|+||.||+|+. .+++.||+|++.... ....+++.+|++++++++||||+++++++...+ ..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--EL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS--CE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--Cc
Confidence 34457899999999999999999995 478999999986543 334567889999999999999999999987644 34
Q ss_pred eeeecccCCC-cccccc------------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 435 LCLFHHSSAS-ASASLV------------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~------------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
+++++++.|+ +.+.+. ........++.|++.||+|||+ +++|.||+++.++.++++|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 5577777554 333332 1122334456899999998876 89999999999999999999986
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 169 ~~ 170 (303)
T 2vwi_A 169 AF 170 (303)
T ss_dssp HH
T ss_pred he
Confidence 43
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-16 Score=152.30 Aligned_cols=137 Identities=13% Similarity=0.064 Sum_probs=104.9
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
..++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG--QL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC--eE
Confidence 3577999999999999999999964 789999999975432 22467899999999999999999999987633 44
Q ss_pred eeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|++.| .+.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 557777765 44333322 222334556899999998876 8999999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=7.7e-17 Score=152.97 Aligned_cols=138 Identities=12% Similarity=0.102 Sum_probs=103.4
Q ss_pred HHhhhccccc-ccccCCcceEEEEEe---CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 358 RATDEFSENN-LIGKGGFGSVYKARL---GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 358 ~~~~~~~~~~-~lg~G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
.....|...+ .||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+++++.++||||+++++++.. .
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--E 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--S
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC--C
Confidence 3346788877 999999999999964 347889999997543 2235779999999999999999999998843 2
Q ss_pred ceeeeeecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 432 TVCLCLFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 432 ~~~~~l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
..+++++++.++ +.+.+... ......++.|++.||+|||+ +++|.||+++.++.++++|||++...
T Consensus 91 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 -SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp -SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 334567777544 43333222 22234456899999998876 89999999999999999999987643
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.9e-18 Score=151.56 Aligned_cols=112 Identities=21% Similarity=0.210 Sum_probs=49.4
Q ss_pred cccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCc
Q 010856 74 TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDIL 153 (499)
Q Consensus 74 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~ 153 (499)
.+..+++|++|++++|.+++ +| .+..+++|++|++++|.++ .+|..+..+++|+.|++++|+++.+| .+..+++|+
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~ 118 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLS-GIEKLVNLR 118 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCHH-HHHHHHHSS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcCC-ccccCCCCC
Confidence 34444444444444444443 22 3444444444444444444 22333333444444444444444443 334444444
Q ss_pred EEEcCCCcCCCCCc-ccccCCCCccEEEccCCccccc
Q 010856 154 NLNFSSNFLTSPLP-LEIGNLKVLIGIDFSMNNFSGV 189 (499)
Q Consensus 154 ~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~ 189 (499)
+|++++|.+++..+ ..+..+++|+.|++++|.+++.
T Consensus 119 ~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred EEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 44444444443211 2344455555555555555433
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-16 Score=152.20 Aligned_cols=136 Identities=15% Similarity=0.145 Sum_probs=101.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--------ccHHHHHHHHHHHhcCCCCCccccceeEEccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--------RAFESFDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
.++|...+.||+|+||.||+|+. .+++.||||++..... .....+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999996 4689999999965421 12345889999999999999999999886533
Q ss_pred cceeeeeecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCC---eEEEEEEEee
Q 010856 431 FTVCLCLFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG---VEVICFVFEI 496 (499)
Q Consensus 431 ~~~~~~l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~---~~~~~f~~~~ 496 (499)
.+++++++.+ ++.+.+.... .....++.|++.||+|||+ +++|.||+++.++. ++++|||++.
T Consensus 89 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 ---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp ---EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred ---eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 3456777755 4433333222 2233446899999998876 89999999987654 9999999886
Q ss_pred cc
Q 010856 497 LL 498 (499)
Q Consensus 497 ~~ 498 (499)
..
T Consensus 166 ~~ 167 (322)
T 2ycf_A 166 IL 167 (322)
T ss_dssp EC
T ss_pred ec
Confidence 53
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-16 Score=154.28 Aligned_cols=140 Identities=19% Similarity=0.223 Sum_probs=107.3
Q ss_pred HHhhhcccccccccCCcceEEEEEe--CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcC---CCCCccccceeEEcc-
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL--GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNI---RHRNLIKILHGVAVI- 429 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~H~niv~l~~~~~~~- 429 (499)
...++|...+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+++++.+ +||||+++++++...
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4557899999999999999999996 468899999996543 22234577888887765 899999999988631
Q ss_pred --ccceeeeeecccCCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 430 --TFTVCLCLFHHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 430 --~~~~~~~l~~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
+....+++++++.|++...+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 2334566788888776554432 122234456899999998876 89999999999999999999987
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 168 ~~ 169 (326)
T 1blx_A 168 RI 169 (326)
T ss_dssp CC
T ss_pred cc
Confidence 64
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.9e-16 Score=152.91 Aligned_cols=134 Identities=18% Similarity=0.187 Sum_probs=101.8
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEE--EEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEV--AVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~v--avK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~ 435 (499)
++|...+.||+|+||.||+|+. .++..+ |+|.+.... ....+.+.+|+++++++ +||||+++++++...+ ..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--EEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC--ceE
Confidence 6789999999999999999995 456654 999987543 33456799999999999 9999999999987633 445
Q ss_pred eeecccCC-Ccccccccc--------------------ccccccccccccccceeecc------CCCcccEEEeeCCCeE
Q 010856 436 CLFHHSSA-SASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVE 488 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~ 488 (499)
+++|++.+ ++.+.+... +.....++.|+++||+|||+ +++|.||+++.++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 67777754 444433221 11233446899999998876 8999999999999999
Q ss_pred EEEEEEee
Q 010856 489 VICFVFEI 496 (499)
Q Consensus 489 ~~~f~~~~ 496 (499)
++|||++.
T Consensus 183 L~Dfg~~~ 190 (327)
T 1fvr_A 183 IADFGLSR 190 (327)
T ss_dssp ECCTTCEE
T ss_pred EcccCcCc
Confidence 99999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-16 Score=147.65 Aligned_cols=135 Identities=19% Similarity=0.196 Sum_probs=98.8
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC----CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC----GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|...+.||+|+||.||+|+. .++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP--NLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----CE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC--ceE
Confidence 35789999999999999999997 47899999986543 223577899999999999999999999987633 345
Q ss_pred eeecccCCCcccccccc----ccccccccccccccceeec---------cCCCcccEEEee--------CCCeEEEEEEE
Q 010856 436 CLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWH---------VGVDFAAFVFVL--------EPGVEVICFVF 494 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH---------~~~~p~~~l~~~--------~~~~~~~~f~~ 494 (499)
++++++.|+.+..+... +.....++.|+++||+||| .+++|.||++.. ++.++++|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 67777765544433222 2223445688999999875 477999999975 67799999998
Q ss_pred eec
Q 010856 495 EIL 497 (499)
Q Consensus 495 ~~~ 497 (499)
+..
T Consensus 163 ~~~ 165 (271)
T 3dtc_A 163 ARE 165 (271)
T ss_dssp ---
T ss_pred ccc
Confidence 764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-16 Score=150.59 Aligned_cols=136 Identities=18% Similarity=0.217 Sum_probs=103.4
Q ss_pred HhhhcccccccccCCcceEEEEEeC----CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
..++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--PT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS--SC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CC
Confidence 4567999999999999999999852 23469999997653 23467799999999999999999999987542 22
Q ss_pred eeeeecccCC-Cccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSA-SASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.+++++.+ ++.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 88 -~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 -WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp -EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred -EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 346666654 44333322 112233445799999998876 8999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.1e-17 Score=156.29 Aligned_cols=146 Identities=18% Similarity=0.201 Sum_probs=110.8
Q ss_pred cCHHHHHHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEc
Q 010856 351 FSYLELFRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAV 428 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~ 428 (499)
++..++....+.|...+.||+|+||.||+|+. .+|+.||+|++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33444456678899999999999999999996 579999999997543 3457799999999998 89999999999876
Q ss_pred cc----cceeeeeecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEE
Q 010856 429 IT----FTVCLCLFHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVIC 491 (499)
Q Consensus 429 ~~----~~~~~~l~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~ 491 (499)
.. ....++++|++.+ .+.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 32 2344567788766 44333322 112233456899999999876 8999999999999999999
Q ss_pred EEEeec
Q 010856 492 FVFEIL 497 (499)
Q Consensus 492 f~~~~~ 497 (499)
||++..
T Consensus 173 fg~~~~ 178 (326)
T 2x7f_A 173 FGVSAQ 178 (326)
T ss_dssp CTTTC-
T ss_pred CcCcee
Confidence 998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-16 Score=154.99 Aligned_cols=133 Identities=16% Similarity=0.155 Sum_probs=101.8
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~ 436 (499)
..++|...+.||+|+||+||+|+. .+|+.||+|++++... ...+|++++.++ +||||+++++++...+ ..++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGK--YVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSS--EEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCC--EEEE
Confidence 457799999999999999999996 4689999999976542 245788888887 7999999999987633 4456
Q ss_pred eecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCC----eEEEEEEEeec
Q 010856 437 LFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG----VEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~----~~~~~f~~~~~ 497 (499)
++|++.| ++.+.+.... .....++.|++.||+|||+ ++||.||++.++++ ++++|||++..
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 7777754 5444443322 2334456899999998876 89999999966543 99999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-16 Score=150.95 Aligned_cols=134 Identities=19% Similarity=0.255 Sum_probs=98.7
Q ss_pred HhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
..++|+..+.||+|+||.||+|+.. ..||+|+++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~l 96 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAI 96 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC---ccEE
Confidence 3467999999999999999999863 359999997554 23357799999999999999999999865432 2344
Q ss_pred eecccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++++.++ +...+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 66666544 3333321 112233456899999998876 8999999999999999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-16 Score=159.01 Aligned_cols=135 Identities=19% Similarity=0.187 Sum_probs=105.0
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC------CCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI------RHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~H~niv~l~~~~~~~~~~ 432 (499)
..+|...+.||+|+||+||+|+. .+++.||||++.... ...+.+.+|+++++.+ .|+||+++++++... .
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--N 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--T
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--C
Confidence 35699999999999999999996 468999999997532 2345677888887765 677999999988763 3
Q ss_pred eeeeeecccCCCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeCCC--eEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG--VEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~--~~~~~f~~~~~ 497 (499)
...++++++.+++.+.+... +.....++.|++.||+|||+ ++||.||+++.++. ++++|||++..
T Consensus 173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 45567888887765554322 22345567899999998876 89999999988776 99999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.5e-16 Score=149.91 Aligned_cols=138 Identities=15% Similarity=0.177 Sum_probs=106.4
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---------ccHHHHHHHHHHHhcCC-CCCccccceeE
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---------RAFESFDVECEMMKNIR-HRNLIKILHGV 426 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~-H~niv~l~~~~ 426 (499)
...++|...+.||+|+||.||+|+. .+|+.||+|+++.... ...+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3456799999999999999999996 4689999999975431 12456889999999995 99999999998
Q ss_pred EccccceeeeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 427 AVITFTVCLCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 427 ~~~~~~~~~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
... ...+++++++.+ .+.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++
T Consensus 94 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 94 ETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp ECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 763 344567777765 44333332 222334456899999998766 89999999999999999999987
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 172 ~~ 173 (298)
T 1phk_A 172 CQ 173 (298)
T ss_dssp EE
T ss_pred hh
Confidence 64
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.1e-16 Score=155.38 Aligned_cols=137 Identities=11% Similarity=0.008 Sum_probs=93.3
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHH---HHHhcCCCCCccccc-------ee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVEC---EMMKNIRHRNLIKIL-------HG 425 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~il~~l~H~niv~l~-------~~ 425 (499)
...|...+.||+|+||.||+|+. .+|+.||+|++..... ...+.+.+|+ ++++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 34588999999999999999996 4799999999987542 2345677885 55566 799988755 33
Q ss_pred EEcccc---------------ceeeeeecccCCCcccccccc-----cccc------ccccccccccceeecc------C
Q 010856 426 VAVITF---------------TVCLCLFHHSSASASASLVSS-----LTLS------RPAKGGGFRGCVLWHV------G 473 (499)
Q Consensus 426 ~~~~~~---------------~~~~~l~~~~~~~~~~~l~~~-----~~~~------~~~~~~i~~gl~yLH~------~ 473 (499)
+..... ...++++||+.|++.+.+... .... ..++.|+++||+|||+ +
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 322110 235667888887776655431 1112 2344899999998876 8
Q ss_pred CCcccEEEeeCCCeEEEEEEEeec
Q 010856 474 VDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 474 ~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+||.||+++.++.++++|||+++.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~ 243 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWK 243 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEE
T ss_pred CCHHHEEECCCCCEEEEecceeee
Confidence 999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.1e-16 Score=150.37 Aligned_cols=134 Identities=13% Similarity=0.063 Sum_probs=105.4
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|...+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|+++++.+ +|+|++++++++.. ....+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEE
Confidence 35699999999999999999995 579999999986543 234688999999999 89999999988865 3344567
Q ss_pred ecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCC-----eEEEEEEEeec
Q 010856 438 FHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG-----VEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~-----~~~~~f~~~~~ 497 (499)
++++++++.+.+.. .......++.|++.||+|||+ +++|.||+++.++. ++++|||+++.
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 78776666554432 222344556899999998877 89999999987665 99999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.1e-16 Score=150.51 Aligned_cols=135 Identities=16% Similarity=0.160 Sum_probs=101.3
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
..+.|...+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|++++++++||||+++++++...+ ..+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT--DLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--EEEEE
Confidence 4467999999999999999999964 69999999997643 3467999999999999999999999987633 44567
Q ss_pred ecccCCCccc-ccc-----ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASA-SLV-----SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~-~l~-----~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.++.+. .+. ........++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 7877664333 222 1222234456889999998876 8999999999999999999998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.4e-16 Score=166.35 Aligned_cols=138 Identities=13% Similarity=0.090 Sum_probs=107.2
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCccccceeEEccccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFT 432 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~ 432 (499)
...++|...+.||+|+||+||+|+. .+++.||||++++.. ....+.+.+|.+++..+ +||+|+++++++...+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~-- 415 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-- 415 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS--
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC--
Confidence 3457899999999999999999996 468999999997642 34457788999999987 7999999998876533
Q ss_pred eeeeeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++||+.| ++...+.. .+.....++.||+.||+|||+ ++||.|||++.++.++++|||++..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 44557777755 44434332 222344556899999998876 8999999999999999999998763
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=8.7e-17 Score=155.73 Aligned_cols=140 Identities=16% Similarity=0.103 Sum_probs=106.7
Q ss_pred HHHHhhhcccccccccCCcceEEEEEeC-CC-----CEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCccccceeEE
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARLG-DR-----MEVAVKVFNLQCG-RAFESFDVECEMMKNI-RHRNLIKILHGVA 427 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~H~niv~l~~~~~ 427 (499)
+....++|...+.||+|+||.||+|... ++ ..||+|.+..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678999999999999999999953 23 4799999976542 3456799999999999 8999999999987
Q ss_pred ccccceeeeeecccCC-Cccccccc------------------cccccccccccccccceeecc------CCCcccEEEe
Q 010856 428 VITFTVCLCLFHHSSA-SASASLVS------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV 482 (499)
Q Consensus 428 ~~~~~~~~~l~~~~~~-~~~~~l~~------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~ 482 (499)
..+ ..+++++++.+ ++.+.+.. .......++.|++.||+|||+ +++|.||+++
T Consensus 121 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 121 HGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSS--SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred cCC--ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 633 34556777755 44333322 111233445799999998876 8999999999
Q ss_pred eCCCeEEEEEEEeec
Q 010856 483 LEPGVEVICFVFEIL 497 (499)
Q Consensus 483 ~~~~~~~~~f~~~~~ 497 (499)
.++.++++|||+++.
T Consensus 199 ~~~~~kl~Dfg~~~~ 213 (333)
T 2i1m_A 199 NGHVAKIGDFGLARD 213 (333)
T ss_dssp GGGEEEBCCCGGGCC
T ss_pred CCCeEEECccccccc
Confidence 999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=3.5e-16 Score=151.02 Aligned_cols=145 Identities=9% Similarity=0.049 Sum_probs=109.1
Q ss_pred cCHHHHHHHhhhcccc-cccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcC-CCCCcccccee
Q 010856 351 FSYLELFRATDEFSEN-NLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNI-RHRNLIKILHG 425 (499)
Q Consensus 351 ~~~~~~~~~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~H~niv~l~~~ 425 (499)
..++......+.|... +.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++..+ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444455556678777 88999999999999964 69999999997654 23367899999999998 56999999999
Q ss_pred EEccccceeeeeecccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEee---CCCeEE
Q 010856 426 VAVITFTVCLCLFHHSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---EPGVEV 489 (499)
Q Consensus 426 ~~~~~~~~~~~l~~~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---~~~~~~ 489 (499)
+...+ ..++++|++.|+ +...+.. .+.....++.|++.||+|||+ +++|.||+++. ++.+++
T Consensus 98 ~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 98 YENTS--EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp EECSS--EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EEeCC--eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEE
Confidence 87633 445567777554 4333321 112234456899999998866 89999999987 689999
Q ss_pred EEEEEeec
Q 010856 490 ICFVFEIL 497 (499)
Q Consensus 490 ~~f~~~~~ 497 (499)
+|||+++.
T Consensus 176 ~Dfg~a~~ 183 (327)
T 3lm5_A 176 VDFGMSRK 183 (327)
T ss_dssp CCGGGCEE
T ss_pred eeCccccc
Confidence 99998865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.1e-16 Score=165.63 Aligned_cols=129 Identities=13% Similarity=0.117 Sum_probs=99.9
Q ss_pred cccccCCcceEEEEEe---CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARL---GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||.||+|.+ .+++.||||+++... ....+++.+|++++++++|||||++++++... ..++++|++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEEEcc
Confidence 4799999999999964 346789999997643 23467899999999999999999999988642 234567777
Q ss_pred CCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 442 SAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 442 ~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++ +.+.+... +.....++.||+.||+|||+ ++||.||+++.++.++++|||+++.+
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 554 43333322 22234556899999999876 89999999999999999999987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=5.4e-16 Score=146.83 Aligned_cols=137 Identities=18% Similarity=0.248 Sum_probs=106.2
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
..++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 97 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFY 97 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--CeEE
Confidence 3467999999999999999999964 78999999997643 34567899999999999999999999998763 3445
Q ss_pred eeecccCC-Cccccccc----cccccccccccccccceeecc------CCCcccEEEeeCC---CeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~~f~~~~~ 497 (499)
++++++.+ .+.+.+.. .......++.|++.||+|||+ +++|.||+++.++ .++++|||++..
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 56777754 44333322 222344556899999998876 8999999997543 699999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.3e-16 Score=151.29 Aligned_cols=136 Identities=11% Similarity=0.099 Sum_probs=103.8
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-ccHHHHHHHHH-HHhcCCCCCccccceeEEccccceeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-RAFESFDVECE-MMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~-il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ....++.+|+. +++.++||||+++++++...+ ..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~--~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG--DCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS--EEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC--ceEE
Confidence 46788999999999999999996 4799999999976542 23445666766 778899999999999987643 4556
Q ss_pred eecccCCCccccccc---------cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLVS---------SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~~---------~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++|++.+++...+.. .+.....++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 788888765433321 122234456888898887765 7999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=4e-16 Score=151.81 Aligned_cols=138 Identities=12% Similarity=0.018 Sum_probs=99.5
Q ss_pred hhcccccccccCCcceEEEEEeC----CCCEEEEEEeeccCCc-----------cHHHHHHHHHHHhcCCCCCcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQCGR-----------AFESFDVECEMMKNIRHRNLIKILHG 425 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~H~niv~l~~~ 425 (499)
++|...+.||+|+||.||+|+.. ++..||+|++...... ..+.+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999964 5788999999765321 12347788999999999999999998
Q ss_pred EEcc--ccceeeeeecccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCC--CeEEEE
Q 010856 426 VAVI--TFTVCLCLFHHSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP--GVEVIC 491 (499)
Q Consensus 426 ~~~~--~~~~~~~l~~~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~--~~~~~~ 491 (499)
+... +....++++|++++++.+.+... +.....++.|++.||+|||+ +++|.||+++.++ .++++|
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~D 196 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLAD 196 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECC
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEe
Confidence 8762 12344557777766655444332 22344556899999998877 8999999998777 999999
Q ss_pred EEEeecc
Q 010856 492 FVFEILL 498 (499)
Q Consensus 492 f~~~~~~ 498 (499)
||+++.+
T Consensus 197 fg~a~~~ 203 (345)
T 2v62_A 197 YGLSYRY 203 (345)
T ss_dssp CTTCEES
T ss_pred CCCceec
Confidence 9998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.9e-16 Score=148.01 Aligned_cols=136 Identities=17% Similarity=0.191 Sum_probs=103.2
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcc--ccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVI--TFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~--~~~~~~~ 436 (499)
.|...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++... +....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 377788999999999999996 568899999997654 23456789999999999999999999988652 2233556
Q ss_pred eecccCC-Cccccccc----cccccccccccccccceeecc--------CCCcccEEEe-eCCCeEEEEEEEeec
Q 010856 437 LFHHSSA-SASASLVS----SLTLSRPAKGGGFRGCVLWHV--------GVDFAAFVFV-LEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~-~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~--------~~~p~~~l~~-~~~~~~~~~f~~~~~ 497 (499)
+++++.+ .+.+.+.. .......++.|++.||+|||+ +++|.||+++ .++.++++|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 7788755 44333332 122234456888999987765 6799999997 678999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.2e-16 Score=166.31 Aligned_cols=136 Identities=12% Similarity=0.067 Sum_probs=105.0
Q ss_pred hhcccccccccCCcceEEEEEeC--CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccc---ee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG--DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT---VC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~---~~ 434 (499)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++...+.. ..
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67999999999999999999964 68999999986543 23456789999999999999999999998764331 13
Q ss_pred eeeecccCCCcccccc---ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLV---SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~---~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|++.|+.+.... ..+.....++.|++.||+|||+ ++||.||+++. +.++++|||++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~-~~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-SCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-CcEEEEecccchh
Confidence 5678888765544332 1222344556899999998876 89999999976 5999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2e-16 Score=152.76 Aligned_cols=136 Identities=15% Similarity=0.178 Sum_probs=100.1
Q ss_pred HhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
..++|...+.||+|+||.||+|+. .+++.||+|++.... .....++.+|+.++++++||||+++++++...+
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL- 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-
Confidence 346799999999999999999983 357799999997543 234567899999999999999999999987633
Q ss_pred ceeeeeecccC-CCccccccccc-----------cccccccccccccceeecc------CCCcccEEEeeC---CCeEEE
Q 010856 432 TVCLCLFHHSS-ASASASLVSSL-----------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE---PGVEVI 490 (499)
Q Consensus 432 ~~~~~l~~~~~-~~~~~~l~~~~-----------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~---~~~~~~ 490 (499)
..+++++++. +++.+.+.... .....++.|++.||+|||+ +++|.||+++.+ ..++++
T Consensus 107 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 107 -PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred -CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 3355677774 44444333211 1123346899999998876 899999999843 459999
Q ss_pred EEEEee
Q 010856 491 CFVFEI 496 (499)
Q Consensus 491 ~f~~~~ 496 (499)
|||+++
T Consensus 186 Dfg~~~ 191 (327)
T 2yfx_A 186 DFGMAR 191 (327)
T ss_dssp CCHHHH
T ss_pred cccccc
Confidence 999864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=5.6e-18 Score=151.17 Aligned_cols=132 Identities=19% Similarity=0.272 Sum_probs=73.7
Q ss_pred cccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCc
Q 010856 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLE 201 (499)
Q Consensus 122 ~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 201 (499)
.+..+++|++|++++|+++.+| .+..+++|++|++++|.++. +|..+..+++|+.|++++|++++. | .+..+++|+
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~l-~-~~~~l~~L~ 118 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL-S-GIEKLVNLR 118 (198)
T ss_dssp HHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCCH-H-HHHHHHHSS
T ss_pred HHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCccc-ccchhhcCCcCCEEECcCCcCCcC-C-ccccCCCCC
Confidence 4444445555555555554444 44444555555555555542 333444445566666666665542 2 455666677
Q ss_pred eeeCcCCcCCCCCC-ccccCCCCCCEEeCCCCcCCccCcc----------cccCCCCCCEEEccCCcCc
Q 010856 202 YLFLGYNRLQGSIP-DSFGDLISLKFLNLSNNNLSGAIPA----------SLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 202 ~L~L~~n~l~~~~~-~~l~~l~~L~~L~l~~N~l~~~~~~----------~~~~l~~L~~L~l~~N~l~ 259 (499)
+|++++|++++..+ ..+..+++|+.|++++|++++..|. .+..+++|+.|| +|+++
T Consensus 119 ~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 77777776664322 3566677777777777776654433 266677777765 55554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-15 Score=147.75 Aligned_cols=138 Identities=18% Similarity=0.135 Sum_probs=102.8
Q ss_pred HHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcC--CCCCccccceeEEcccc--
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNI--RHRNLIKILHGVAVITF-- 431 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~H~niv~l~~~~~~~~~-- 431 (499)
-....++|...+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++.....
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445578999999999999999999974 889999999643 234556677766654 99999999998876421
Q ss_pred ceeeeeecccCC-Cccccccc---cccccccccccccccceeec--------------cCCCcccEEEeeCCCeEEEEEE
Q 010856 432 TVCLCLFHHSSA-SASASLVS---SLTLSRPAKGGGFRGCVLWH--------------VGVDFAAFVFVLEPGVEVICFV 493 (499)
Q Consensus 432 ~~~~~l~~~~~~-~~~~~l~~---~~~~~~~~~~~i~~gl~yLH--------------~~~~p~~~l~~~~~~~~~~~f~ 493 (499)
...++++|++.+ ++.+.+.. .+.....++.|++.||+||| +++||.||+++.++.++++|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 345567788765 44443322 22223445688899988876 3699999999999999999999
Q ss_pred Eeec
Q 010856 494 FEIL 497 (499)
Q Consensus 494 ~~~~ 497 (499)
+++.
T Consensus 188 ~a~~ 191 (337)
T 3mdy_A 188 LAVK 191 (337)
T ss_dssp TCEE
T ss_pred Ccee
Confidence 8754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-16 Score=153.30 Aligned_cols=145 Identities=14% Similarity=0.156 Sum_probs=110.5
Q ss_pred ccCHHHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCC--CCCcccccee
Q 010856 350 TFSYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIR--HRNLIKILHG 425 (499)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~--H~niv~l~~~ 425 (499)
.+.++.+.....+|...+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 344444455567799999999999999999998789999999997654 234577899999999997 5999999999
Q ss_pred EEccccceeeeeecccCCCccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEe
Q 010856 426 VAVITFTVCLCLFHHSSASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFE 495 (499)
Q Consensus 426 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~ 495 (499)
+...+ ..++++|+.++++.+.+.... .....++.|+++||+|||+ +++|.||+++ ++.++++|||++
T Consensus 97 ~~~~~--~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~ 173 (313)
T 3cek_A 97 EITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173 (313)
T ss_dssp EECSS--EEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred eecCC--EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccc
Confidence 87643 345567777766655443322 2234456899999999876 8999999994 589999999987
Q ss_pred ec
Q 010856 496 IL 497 (499)
Q Consensus 496 ~~ 497 (499)
..
T Consensus 174 ~~ 175 (313)
T 3cek_A 174 NQ 175 (313)
T ss_dssp CC
T ss_pred cc
Confidence 64
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.58 E-value=5.4e-16 Score=153.83 Aligned_cols=133 Identities=11% Similarity=0.088 Sum_probs=99.8
Q ss_pred hhhcccc-cccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHh-cCCCCCccccceeEEcc--cccee
Q 010856 360 TDEFSEN-NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMK-NIRHRNLIKILHGVAVI--TFTVC 434 (499)
Q Consensus 360 ~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~-~l~H~niv~l~~~~~~~--~~~~~ 434 (499)
.++|... +.||+|+||+||+|+. .+|+.||||+++. ...+.+|++++. ..+||||+++++++... +....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567665 6899999999999996 4799999999963 245778998874 56899999999987541 12334
Q ss_pred eeeecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEee---CCCeEEEEEEEeec
Q 010856 435 LCLFHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---EPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---~~~~~~~~f~~~~~ 497 (499)
++++||+.| ++.+.+.. .+.....++.|++.||+|||+ ++||.||+++. ++.++++|||+++.
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 567777755 44444432 222344556899999999876 89999999987 67899999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=5e-16 Score=155.90 Aligned_cols=131 Identities=13% Similarity=0.048 Sum_probs=99.3
Q ss_pred cccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeeeccc
Q 010856 363 FSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++... ...++++|++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~lv~E~~ 91 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD--RFLYIALELC 91 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEEECCC
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CeEEEEEecC
Confidence 4456889999999998766668999999999753 245678999999876 899999999887653 3455678888
Q ss_pred CCCcccccccccc-----------ccccccccccccceeecc------CCCcccEEEeeC-------------CCeEEEE
Q 010856 442 SASASASLVSSLT-----------LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE-------------PGVEVIC 491 (499)
Q Consensus 442 ~~~~~~~l~~~~~-----------~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~-------------~~~~~~~ 491 (499)
+|++.+.+..... ....++.|++.||+|||+ ++||.||+++.+ ..++++|
T Consensus 92 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 7765554432211 112356899999999876 899999999754 3799999
Q ss_pred EEEeecc
Q 010856 492 FVFEILL 498 (499)
Q Consensus 492 f~~~~~~ 498 (499)
||++..+
T Consensus 172 FG~a~~~ 178 (434)
T 2rio_A 172 FGLCKKL 178 (434)
T ss_dssp CTTCEEC
T ss_pred cccceec
Confidence 9988653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-15 Score=147.75 Aligned_cols=138 Identities=17% Similarity=0.141 Sum_probs=106.8
Q ss_pred HHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhc--CCCCCccccceeEEcccc--
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKN--IRHRNLIKILHGVAVITF-- 431 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~H~niv~l~~~~~~~~~-- 431 (499)
-....++|...+.||+|+||.||+|+. +|+.||+|++... ..+.+.+|++++.. ++||||+++++++...+.
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344557899999999999999999998 5889999999643 34678889999887 799999999999876432
Q ss_pred ceeeeeecccCC-Cccccccc---cccccccccccccccceeec--------c------CCCcccEEEeeCCCeEEEEEE
Q 010856 432 TVCLCLFHHSSA-SASASLVS---SLTLSRPAKGGGFRGCVLWH--------V------GVDFAAFVFVLEPGVEVICFV 493 (499)
Q Consensus 432 ~~~~~l~~~~~~-~~~~~l~~---~~~~~~~~~~~i~~gl~yLH--------~------~~~p~~~l~~~~~~~~~~~f~ 493 (499)
...+++++++.+ ++.+.+.. .+.....++.|++.||+||| + +++|.||+++.++.++++|||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 244567777765 44443322 22223445689999999888 4 899999999999999999999
Q ss_pred Eeec
Q 010856 494 FEIL 497 (499)
Q Consensus 494 ~~~~ 497 (499)
+++.
T Consensus 193 ~~~~ 196 (342)
T 1b6c_B 193 LAVR 196 (342)
T ss_dssp TCEE
T ss_pred Ccee
Confidence 8764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-15 Score=147.81 Aligned_cols=135 Identities=22% Similarity=0.268 Sum_probs=99.2
Q ss_pred HhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHH--HhcCCCCCccccceeEEcc---ccce
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEM--MKNIRHRNLIKILHGVAVI---TFTV 433 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~i--l~~l~H~niv~l~~~~~~~---~~~~ 433 (499)
..++|...+.||+|+||.||+|+. +++.||||++.... .+.+..|.++ +..++||||+++++++... +...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 356799999999999999999987 68899999997532 3445555555 4468999999999866432 2223
Q ss_pred eeeeecccCC-Cccccccc---cccccccccccccccceeecc---------------CCCcccEEEeeCCCeEEEEEEE
Q 010856 434 CLCLFHHSSA-SASASLVS---SLTLSRPAKGGGFRGCVLWHV---------------GVDFAAFVFVLEPGVEVICFVF 494 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~---------------~~~p~~~l~~~~~~~~~~~f~~ 494 (499)
.++++|++.+ ++.+.+.. .+.....++.|+++||+|||+ ++||.||+++.++.++++|||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 4567788755 44433322 122234456889999988774 5899999999999999999999
Q ss_pred eec
Q 010856 495 EIL 497 (499)
Q Consensus 495 ~~~ 497 (499)
+..
T Consensus 167 a~~ 169 (336)
T 3g2f_A 167 SMR 169 (336)
T ss_dssp CEE
T ss_pred eee
Confidence 864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.7e-16 Score=148.14 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=96.3
Q ss_pred hhhcccccccccCCcceEEEEEe--CCCC--EEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL--GDRM--EVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~--~~~~--~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
.++|...+.||+|+||.||+|+. .+++ .||+|+++... ....+.+.+|++++++++||||+++++++...+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 35799999999999999999985 2333 68999987543 234578999999999999999999999887633
Q ss_pred eeeeeecccC-CCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSS-ASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~-~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
...+++++. +.+.+.+.. .......++.|++.||+|||+ +++|.||+++.++.++++|||++..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 334566664 454443322 122334456899999998876 8999999999999999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=6e-16 Score=162.81 Aligned_cols=137 Identities=15% Similarity=0.098 Sum_probs=104.5
Q ss_pred HHhhhcccccccccCCcceEEEEEeC----CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG----DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
...++|...+.||+|+||.||+|+.. .+..||+|.++... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~ 464 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NP 464 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cc
Confidence 34467888999999999999999863 25679999987543 2335779999999999999999999998843 22
Q ss_pred eeeeeecccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++++|++.+ ++.+.+... +.....++.|++.||+|||+ +++|.||+++.++.++++|||+++.
T Consensus 465 -~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 465 -VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp -CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred -eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 3456777754 443333221 12233446899999999876 8999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-16 Score=155.41 Aligned_cols=125 Identities=15% Similarity=0.169 Sum_probs=96.2
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC--------CCCccccceeEEcc-
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR--------HRNLIKILHGVAVI- 429 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------H~niv~l~~~~~~~- 429 (499)
.++|...+.||+|+||+||+|+. .+++.||+|++.... ...+.+.+|+++++.++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36799999999999999999995 578999999997432 33567889999999885 78899999988632
Q ss_pred -ccceeeeeecccCCCcccccccc------ccccccccccccccceeecc-------CCCcccEEEeeCC
Q 010856 430 -TFTVCLCLFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEP 485 (499)
Q Consensus 430 -~~~~~~~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~ 485 (499)
+....+++++++++++...+... ......++.|++.||+|||+ ++||.||++..++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 23355668888888876654322 22344556899999988876 5899999998664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.4e-15 Score=143.11 Aligned_cols=138 Identities=14% Similarity=0.084 Sum_probs=101.5
Q ss_pred CHHHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCC------------------ccHHHHHHHHHHHhc
Q 010856 352 SYLELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG------------------RAFESFDVECEMMKN 413 (499)
Q Consensus 352 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~ 413 (499)
....+......|...+.||+|+||.||+|+..+|+.||+|.++.... .....+.+|++++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34444555556777899999999999999997799999999964321 124568999999999
Q ss_pred CCCCCccccceeEEccccceeeeeecccCCCccccccccccccccccccccccceeecc------CCCcccEEEeeCCCe
Q 010856 414 IRHRNLIKILHGVAVITFTVCLCLFHHSSASASASLVSSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGV 487 (499)
Q Consensus 414 l~H~niv~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~ 487 (499)
++ | +++.+++.. ...++++|++.|+.+..+.. .....++.|+++||+|||+ ++||.||+++ ++.+
T Consensus 161 l~--~-~~v~~~~~~---~~~~lvmE~~~g~~L~~l~~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW---EGNAVLMELIDAKELYRVRV--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp TT--T-SSSCCEEEE---ETTEEEEECCCCEEGGGCCC--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred cc--C-CCcCeEEec---cceEEEEEecCCCcHHHcch--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 98 5 666665533 22356788886654443422 2344567899999998765 8999999999 8999
Q ss_pred EEEEEEEeecc
Q 010856 488 EVICFVFEILL 498 (499)
Q Consensus 488 ~~~~f~~~~~~ 498 (499)
+++|||+++..
T Consensus 232 kl~DFG~a~~~ 242 (282)
T 1zar_A 232 WIIDFPQSVEV 242 (282)
T ss_dssp EECCCTTCEET
T ss_pred EEEECCCCeEC
Confidence 99999998743
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.56 E-value=2.4e-14 Score=124.01 Aligned_cols=89 Identities=21% Similarity=0.205 Sum_probs=50.8
Q ss_pred CCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEc
Q 010856 174 KVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNL 253 (499)
Q Consensus 174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 253 (499)
++|+.|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 34445555555555444555555555555555555555555555555666666666666666555555666666666666
Q ss_pred cCCcCcccC
Q 010856 254 SFNKLEGEI 262 (499)
Q Consensus 254 ~~N~l~~~~ 262 (499)
++|++++..
T Consensus 110 ~~N~~~c~c 118 (170)
T 3g39_A 110 LNNPWDCAC 118 (170)
T ss_dssp CSSCBCTTB
T ss_pred CCCCCCCCc
Confidence 666665443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.5e-16 Score=150.96 Aligned_cols=141 Identities=21% Similarity=0.203 Sum_probs=97.2
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC------ccHHHHHHHHHHHhcC----CCCCcccccee
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG------RAFESFDVECEMMKNI----RHRNLIKILHG 425 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l----~H~niv~l~~~ 425 (499)
....++|...+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|++++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44557799999999999999999996 5789999999975432 1233466799998888 89999999998
Q ss_pred EEccccceeeeeeccc-CCCccccccc----cccccccccccccccceeecc------CCCcccEEEe-eCCCeEEEEEE
Q 010856 426 VAVITFTVCLCLFHHS-SASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV-LEPGVEVICFV 493 (499)
Q Consensus 426 ~~~~~~~~~~~l~~~~-~~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~-~~~~~~~~~f~ 493 (499)
+...+. .++++++++ ++++.+.+.. .+.....++.|++.||+|||+ +++|.||+++ .++.++++|||
T Consensus 107 ~~~~~~-~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 107 FETQEG-FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp C------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EecCCe-EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 866432 233333424 4444443332 222344456899999998876 8999999998 67889999999
Q ss_pred Eeecc
Q 010856 494 FEILL 498 (499)
Q Consensus 494 ~~~~~ 498 (499)
+++..
T Consensus 186 ~~~~~ 190 (312)
T 2iwi_A 186 SGALL 190 (312)
T ss_dssp SCEEC
T ss_pred hhhhc
Confidence 87653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-15 Score=144.40 Aligned_cols=134 Identities=11% Similarity=0.090 Sum_probs=101.1
Q ss_pred hhhcccc-cccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHH-hcCCCCCccccceeEEc--ccccee
Q 010856 360 TDEFSEN-NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMM-KNIRHRNLIKILHGVAV--ITFTVC 434 (499)
Q Consensus 360 ~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~H~niv~l~~~~~~--~~~~~~ 434 (499)
.++|... +.||+|+||.||+|+. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. .+....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 7899999999999996 5789999999964 24677899887 66799999999998864 112344
Q ss_pred eeeecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEee---CCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---EPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---~~~~~~~~f~~~~~~ 498 (499)
+++++++.| ++.+.+.. .+.....++.|++.||+|||+ +++|.||+++. ++.++++|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 567777755 54444332 122234456899999998876 89999999987 678999999988653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.2e-16 Score=154.12 Aligned_cols=131 Identities=10% Similarity=0.018 Sum_probs=99.6
Q ss_pred hhcccccccccCCcceEEEEEeC---------CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccc----------
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG---------DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIK---------- 421 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~---------- 421 (499)
++|...+.||+|+||.||+|+.. +++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57999999999999999999964 3789999999754 46889999999999999998
Q ss_pred -----cceeEEccccceeeeeecccCCCcccccccc------ccccccccccccccceeecc------CCCcccEEEeeC
Q 010856 422 -----ILHGVAVITFTVCLCLFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE 484 (499)
Q Consensus 422 -----l~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~ 484 (499)
+++++... ....++++|++++++.+.+... +.....++.|++.||+|||+ +++|.||+++.+
T Consensus 117 ~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 117 LAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred cCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 44455432 2344557777766655544322 22334456899999999876 899999999887
Q ss_pred C--CeEEEEEEEeec
Q 010856 485 P--GVEVICFVFEIL 497 (499)
Q Consensus 485 ~--~~~~~~f~~~~~ 497 (499)
+ .++++|||+++.
T Consensus 196 ~~~~~kl~Dfg~a~~ 210 (352)
T 2jii_A 196 DQSQVTLAGYGFAFR 210 (352)
T ss_dssp EEEEEEECCGGGCBC
T ss_pred CCceEEEecCcceee
Confidence 7 899999999864
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.55 E-value=2.8e-14 Score=123.56 Aligned_cols=108 Identities=26% Similarity=0.224 Sum_probs=95.5
Q ss_pred cCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcC
Q 010856 128 SLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGY 207 (499)
Q Consensus 128 ~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~ 207 (499)
..+.+++++|+++.+|..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 10 ~~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 10 SGTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp ETTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 45789999999999987663 8899999999999988888899999999999999999988888889999999999999
Q ss_pred CcCCCCCCccccCCCCCCEEeCCCCcCCcc
Q 010856 208 NRLQGSIPDSFGDLISLKFLNLSNNNLSGA 237 (499)
Q Consensus 208 n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 237 (499)
|++++..+..|..+++|+.|+|++|+++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 999988777899999999999999998744
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=8.2e-16 Score=153.93 Aligned_cols=134 Identities=15% Similarity=0.123 Sum_probs=100.8
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
..+|...+.||+|+||+||.....+|+.||||++..... +.+.+|+++++++ +|||||++++++...+ ..++++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQ--FQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETT--EEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCC--EEEEEE
Confidence 345888899999999997655456889999999965432 2356899999998 8999999998887633 446678
Q ss_pred cccCCCccccccccc-----cccccccccccccceeecc------CCCcccEEEeeC-----CCeEEEEEEEeecc
Q 010856 439 HHSSASASASLVSSL-----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE-----PGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~~~~~l~~~~-----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~-----~~~~~~~f~~~~~~ 498 (499)
|++.|++.+.+.... .....++.|+++||+|||+ ++||.||++..+ ..++++|||++..+
T Consensus 98 E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 888877655543321 1223456899999999876 899999999532 25789999998753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-15 Score=145.56 Aligned_cols=137 Identities=10% Similarity=0.055 Sum_probs=95.6
Q ss_pred HHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCc-c-HHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGR-A-FESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
...++|...+.||+|+||.||+|+.. +|+.||+|++...... . .+.+..+..+++.++||||+++++++...+ ..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~~ 99 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT--DV 99 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--EE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--cE
Confidence 34577999999999999999999974 7999999999765422 2 233445556788899999999999987643 44
Q ss_pred eeeecccCCCccccccc------cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++|++++ ....+.. .......++.|+++||+|||+ +++|.||+++.++.++++|||++..
T Consensus 100 ~lv~e~~~~-~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 100 FIAMELMGT-CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEECCCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEeccCC-cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 567788743 3232221 122233456889999988875 6999999999999999999998753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.1e-15 Score=152.59 Aligned_cols=135 Identities=17% Similarity=0.138 Sum_probs=102.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+++++.++|++.+..+.++... ....++++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~-~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVE-GDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEee-CCEEEEEE
Confidence 36799999999999999999995 5799999999875542 24588999999999886666655555432 33445677
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEE---eeCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVF---VLEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~---~~~~~~~~~~f~~~~~ 497 (499)
+++++.+.+.+.. .+.....++.||+.||+|||+ ++||.||++ +.++.++++|||+++.
T Consensus 83 e~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 8887666554432 223344556899999998876 899999999 5778999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-15 Score=145.35 Aligned_cols=136 Identities=16% Similarity=0.128 Sum_probs=101.9
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
..++|...+.||+|+||.||+|+. .+++.||+|++..... .+.+.+|+++++.++|++++..++++...+ ...+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEET-TEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCC-CceEEE
Confidence 446799999999999999999995 5789999998765432 245889999999999999998888775533 334557
Q ss_pred ecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEE---eeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVF---VLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~---~~~~~~~~~~f~~~~~ 497 (499)
++++++++.+.+.. .......++.|++.||+|||+ +++|.||++ ++++.++++|||+++.
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 77776665554431 222344556899999998876 899999999 6788999999998864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.8e-15 Score=143.79 Aligned_cols=135 Identities=16% Similarity=0.124 Sum_probs=105.2
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.++|...+.||+|+||.||+|+. .+|+.||+|++..... .+.+.+|+++++.++|++++..++++...+ ...++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEET-TEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCC-CceEEEE
Confidence 46799999999999999999995 5799999999876442 346899999999999999888887765533 3445577
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEe---eCCCeEEEEEEEeec
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV---LEPGVEVICFVFEIL 497 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~---~~~~~~~~~f~~~~~ 497 (499)
|++++++.+.+.. .......++.|++.||+|||+ +++|.||++. +++.++++|||++..
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 7776665554431 222334456899999999876 8999999994 778999999998764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.8e-14 Score=122.56 Aligned_cols=104 Identities=26% Similarity=0.268 Sum_probs=48.2
Q ss_pred CeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCc
Q 010856 130 RIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNR 209 (499)
Q Consensus 130 ~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 209 (499)
+.+++++|+++.+|..+. ++|++|+|++|.++++.+..|.++++|+.|+|++|+|+++.+..|..+++|++|+|++|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 455555555555554332 445555555555554444444444444444444444444333334444444444444444
Q ss_pred CCCCCCccccCCCCCCEEeCCCCcCC
Q 010856 210 LQGSIPDSFGDLISLKFLNLSNNNLS 235 (499)
Q Consensus 210 l~~~~~~~l~~l~~L~~L~l~~N~l~ 235 (499)
|++..+..|..+++|+.|++++|++.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cceeCHHHhccccCCCEEEeCCCCcc
Confidence 44333333444444444444444443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=5.7e-16 Score=160.59 Aligned_cols=138 Identities=16% Similarity=0.145 Sum_probs=102.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcc----ccce
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVI----TFTV 433 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~----~~~~ 433 (499)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++... +...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999996 568999999987543 33456799999999999999999999886441 1223
Q ss_pred eeeeecccCC-Cccccccc-------cccccccccccccccceeecc------CCCcccEEEeeCCC---eEEEEEEEee
Q 010856 434 CLCLFHHSSA-SASASLVS-------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG---VEVICFVFEI 496 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~-------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~---~~~~~f~~~~ 496 (499)
.+++++++.| ++...+.. .+.....++.|++.||+|||+ +++|.||+++.+++ ++++|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 4457777754 44333322 222334456899999999876 89999999987765 8999999986
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
.
T Consensus 173 ~ 173 (676)
T 3qa8_A 173 E 173 (676)
T ss_dssp B
T ss_pred c
Confidence 5
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.6e-16 Score=149.59 Aligned_cols=139 Identities=17% Similarity=0.252 Sum_probs=102.7
Q ss_pred HHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc
Q 010856 354 LELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF 431 (499)
Q Consensus 354 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~ 431 (499)
+++....++|...+.||+|+||.||+|+... .||+|+++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 102 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP- 102 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-
Confidence 3344456789999999999999999998743 49999987543 233456889999999999999999999987643
Q ss_pred ceeeeeecccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 432 TVCLCLFHHSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 432 ~~~~~l~~~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+++++++.|+ +.+.+.. .......++.|++.||+|||+ +++|.||+++ ++.++++|||++..
T Consensus 103 -~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 -HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp -CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred -ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 345567777544 3333322 122334456899999998876 8999999996 68999999998653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-15 Score=146.98 Aligned_cols=140 Identities=17% Similarity=0.193 Sum_probs=104.3
Q ss_pred HHHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCc------cHHHHHHHHHHHhcCC--CCCccccceeEE
Q 010856 357 FRATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGR------AFESFDVECEMMKNIR--HRNLIKILHGVA 427 (499)
Q Consensus 357 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--H~niv~l~~~~~ 427 (499)
....++|...+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|++++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34456799999999999999999995 57899999999765321 2345778999999986 599999999987
Q ss_pred ccccceeeeeecccC--CCccccccc----cccccccccccccccceeecc------CCCcccEEEe-eCCCeEEEEEEE
Q 010856 428 VITFTVCLCLFHHSS--ASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV-LEPGVEVICFVF 494 (499)
Q Consensus 428 ~~~~~~~~~l~~~~~--~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~-~~~~~~~~~f~~ 494 (499)
..+ ..+++++++. +++.+.+.. .......++.|++.||+|||+ +++|.||+++ +++.++++|||+
T Consensus 119 ~~~--~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 119 RPD--SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp CSS--EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cCC--cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 643 3344555554 444333332 222334456899999998866 8999999998 678999999998
Q ss_pred eecc
Q 010856 495 EILL 498 (499)
Q Consensus 495 ~~~~ 498 (499)
+...
T Consensus 197 ~~~~ 200 (320)
T 3a99_A 197 GALL 200 (320)
T ss_dssp CEEC
T ss_pred cccc
Confidence 7653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.7e-14 Score=121.24 Aligned_cols=109 Identities=23% Similarity=0.266 Sum_probs=91.4
Q ss_pred CcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCC
Q 010856 152 ILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSN 231 (499)
Q Consensus 152 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~ 231 (499)
-+.+++++|.++. +|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 3688999999875 444443 7889999999999988888899999999999999999987777788899999999999
Q ss_pred CcCCccCcccccCCCCCCEEEccCCcCcccCC
Q 010856 232 NNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263 (499)
Q Consensus 232 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 263 (499)
|+|++..+..|..+++|+.|++++|++.+..+
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 99997777778889999999999998886543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-15 Score=146.15 Aligned_cols=135 Identities=16% Similarity=0.188 Sum_probs=104.4
Q ss_pred hhhcccccccccCCcceEEEEEe--CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC------ccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL--GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN------LIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~n------iv~l~~~~~~~~~ 431 (499)
.++|...+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|+++++.++|++ |+++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~- 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG- 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC-
Confidence 35799999999999999999985 368899999997532 33567889999998877654 899998887633
Q ss_pred ceeeeeecccCCCccccccccc------cccccccccccccceeecc------CCCcccEEEee----------------
Q 010856 432 TVCLCLFHHSSASASASLVSSL------TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---------------- 483 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~~------~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---------------- 483 (499)
..++++|++++++.+.+.... .....++.|++.||+|||+ +++|.||+++.
T Consensus 91 -~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 91 -HICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp -EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred -cEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 455678888777665554322 2234456899999998876 89999999976
Q ss_pred ---CCCeEEEEEEEeec
Q 010856 484 ---EPGVEVICFVFEIL 497 (499)
Q Consensus 484 ---~~~~~~~~f~~~~~ 497 (499)
++.++++|||++..
T Consensus 170 ~~~~~~~kl~Dfg~~~~ 186 (339)
T 1z57_A 170 TLINPDIKVVDFGSATY 186 (339)
T ss_dssp EESCCCEEECCCSSCEE
T ss_pred cccCCCceEeeCccccc
Confidence 55799999998764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.4e-15 Score=155.30 Aligned_cols=128 Identities=10% Similarity=-0.041 Sum_probs=90.6
Q ss_pred cccCCcceEEEEE-eCCCCEEEEEEeeccC----------CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceeee
Q 010856 369 IGKGGFGSVYKAR-LGDRMEVAVKVFNLQC----------GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 369 lg~G~~g~v~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~~ 436 (499)
.+.|+.|.+..++ +-.|+.||||++.+.. ....++|.+|+++|+++ .|+||+++++++.+ ....++
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEEE
Confidence 5566666666555 2358899999997542 12346799999999999 79999999998876 335566
Q ss_pred eecccCCCccc-cccccccc-cccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHSSASASA-SLVSSLTL-SRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~~~~~~-~l~~~~~~-~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++||+.|+.+. .+...... .++++.||+.||+|+|+ |+||+|||+++++.+|++|||+++.+
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 78888665444 33333222 34567899999999876 99999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.50 E-value=2.3e-15 Score=148.06 Aligned_cols=137 Identities=12% Similarity=0.122 Sum_probs=103.8
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-----------CCCccccceeEE
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-----------HRNLIKILHGVA 427 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------H~niv~l~~~~~ 427 (499)
.++|...+.||+|+||+||+|+. .+++.||+|++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999996 578999999997432 23567889999998876 899999999886
Q ss_pred ccc--cceeeeeecccCCCccccccc------cccccccccccccccceeecc-------CCCcccEEEeeCC------C
Q 010856 428 VIT--FTVCLCLFHHSSASASASLVS------SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEP------G 486 (499)
Q Consensus 428 ~~~--~~~~~~l~~~~~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~------~ 486 (499)
..+ ....+++++++++++.+.+.. .......++.|++.||+|||+ +++|.||++..++ .
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 532 234566778887666554432 112234456888998888775 6999999996433 6
Q ss_pred eEEEEEEEeec
Q 010856 487 VEVICFVFEIL 497 (499)
Q Consensus 487 ~~~~~f~~~~~ 497 (499)
++++|||++..
T Consensus 177 ~kl~Dfg~a~~ 187 (373)
T 1q8y_A 177 IKIADLGNACW 187 (373)
T ss_dssp EEECCCTTCEE
T ss_pred EEEcccccccc
Confidence 99999998864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4.2e-15 Score=146.69 Aligned_cols=137 Identities=17% Similarity=0.222 Sum_probs=104.0
Q ss_pred HHhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CC-----CccccceeEEccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HR-----NLIKILHGVAVIT 430 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~-----niv~l~~~~~~~~ 430 (499)
...++|...+.||+|+||+||+|+. .+++.||||+++... ...+++.+|+++++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4457899999999999999999996 468899999997432 23466788999888774 55 4888888887633
Q ss_pred cceeeeeecccCCCcccccccc------ccccccccccccccceeec--------cCCCcccEEEee--CCCeEEEEEEE
Q 010856 431 FTVCLCLFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWH--------VGVDFAAFVFVL--EPGVEVICFVF 494 (499)
Q Consensus 431 ~~~~~~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH--------~~~~p~~~l~~~--~~~~~~~~f~~ 494 (499)
...+++|++.+++.+.+... +.....++.|++.||+||| +++||.||++.. ++.++++|||+
T Consensus 130 --~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 --HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp --EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred --ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 45567888888766554322 2234455689999998886 389999999954 56799999999
Q ss_pred eec
Q 010856 495 EIL 497 (499)
Q Consensus 495 ~~~ 497 (499)
++.
T Consensus 208 a~~ 210 (382)
T 2vx3_A 208 SCQ 210 (382)
T ss_dssp CEE
T ss_pred cee
Confidence 864
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=2e-14 Score=147.70 Aligned_cols=126 Identities=12% Similarity=-0.001 Sum_probs=88.1
Q ss_pred ccccccccCCcceEEEEEeCCCCEEEEEEeeccCCc--------cHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 364 SENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGR--------AFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
...+.||+|+||.||+|.. .++.+|+|+....... ..+++.+|++++++++||||+++..++...+ ..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NKR 415 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TTE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--ccE
Confidence 4457899999999999954 5778999987543211 1355899999999999999996666555432 335
Q ss_pred eeecccC-CCccccccccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSS-ASASASLVSSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~-~~~~~~l~~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++||+. +++.+.+.. ...++.|+++||+|||+ |+||.||++++ .++++|||+++..
T Consensus 416 lVmE~~~ggsL~~~l~~----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEEECCCSEEHHHHSTT----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHH----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 6778876 444333333 45667899999998876 89999999987 9999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4.1e-15 Score=145.13 Aligned_cols=135 Identities=16% Similarity=0.153 Sum_probs=104.3
Q ss_pred hhhcccccccccCCcceEEEEEeC-CC-CEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC------ccccceeEEcccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLG-DR-MEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN------LIKILHGVAVITF 431 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~n------iv~l~~~~~~~~~ 431 (499)
.++|...+.||+|+||+||+|+.. ++ +.||+|+++... ...+.+.+|++++++++|++ ++.+++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~- 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG- 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC-
Confidence 367999999999999999999963 44 789999997532 33567889999999888766 888887776533
Q ss_pred ceeeeeecccCCCcccccccc------ccccccccccccccceeecc------CCCcccEEE------------------
Q 010856 432 TVCLCLFHHSSASASASLVSS------LTLSRPAKGGGFRGCVLWHV------GVDFAAFVF------------------ 481 (499)
Q Consensus 432 ~~~~~l~~~~~~~~~~~l~~~------~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~------------------ 481 (499)
..++++|++++++...+... ......++.|++.||+|||+ +++|.||++
T Consensus 96 -~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 96 -HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp -EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred -eEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 45567888888776654322 22344556899999998877 899999999
Q ss_pred -eeCCCeEEEEEEEeec
Q 010856 482 -VLEPGVEVICFVFEIL 497 (499)
Q Consensus 482 -~~~~~~~~~~f~~~~~ 497 (499)
+.++.++++|||++..
T Consensus 175 ~~~~~~~kl~Dfg~~~~ 191 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATF 191 (355)
T ss_dssp EESCCCEEECCCTTCEE
T ss_pred ccCCCcEEEeecCcccc
Confidence 5678999999998764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.48 E-value=5.4e-15 Score=147.36 Aligned_cols=139 Identities=12% Similarity=-0.017 Sum_probs=96.0
Q ss_pred HhhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCC-CCcccccee--------
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRH-RNLIKILHG-------- 425 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H-~niv~l~~~-------- 425 (499)
....|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+++.++| +|......+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345578889999999999999995 579999999987443 2235789999999999987 332221111
Q ss_pred -E------------Eccc---cceeeeeecccCCCcccccc-----------ccccccccccccccccceeecc------
Q 010856 426 -V------------AVIT---FTVCLCLFHHSSASASASLV-----------SSLTLSRPAKGGGFRGCVLWHV------ 472 (499)
Q Consensus 426 -~------------~~~~---~~~~~~l~~~~~~~~~~~l~-----------~~~~~~~~~~~~i~~gl~yLH~------ 472 (499)
+ .... ....+.+++.+.+++.+.+. ..+.....++.|+++||+|||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1 0000 12334456666666554432 1112233445899999998876
Q ss_pred CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 473 GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 473 ~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+||.||+++.++.++++|||+++.
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~ 260 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVR 260 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEE
T ss_pred CcccceEEEecCCeEEEEeccceee
Confidence 8999999999999999999999764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-14 Score=140.07 Aligned_cols=134 Identities=12% Similarity=0.078 Sum_probs=95.8
Q ss_pred Hhhhcccc-cccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHH-HHHhcCCCCCccccceeEEccc--cce
Q 010856 359 ATDEFSEN-NLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVEC-EMMKNIRHRNLIKILHGVAVIT--FTV 433 (499)
Q Consensus 359 ~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~il~~l~H~niv~l~~~~~~~~--~~~ 433 (499)
..++|... +.||+|+||.||+|+.. +|+.||+|++.... ...+|+ ..++.+.||||+++++++.... ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 44678884 46999999999999964 79999999996532 223333 3456779999999999886522 223
Q ss_pred eeeeecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeCC---CeEEEEEEEeec
Q 010856 434 CLCLFHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---GVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---~~~~~~f~~~~~ 497 (499)
.++++|++.| ++.+.+.. .+.....++.|++.||+|||+ +++|.||+++.++ .++++|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 4557777765 44443322 122334456899999999876 8999999997644 499999998764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-12 Score=129.51 Aligned_cols=244 Identities=16% Similarity=0.103 Sum_probs=157.8
Q ss_pred CCCCCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCC---------------
Q 010856 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN--------------- 65 (499)
Q Consensus 1 l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n--------------- 65 (499)
|.+|++|+++.+.. .++.+... +|.++. +|+.+++..+ ++.+...+|.++++|+.+.+..+
T Consensus 67 F~~c~~L~~i~lp~-~i~~I~~~-aF~~c~-~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~ 142 (394)
T 4fs7_A 67 FQGCRKVTEIKIPS-TVREIGEF-AFENCS-KLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFK 142 (394)
T ss_dssp TTTCTTEEEEECCT-TCCEECTT-TTTTCT-TCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCS
T ss_pred hhCCCCceEEEeCC-CccCcchh-HhhCCC-CCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeeccccc
Confidence 56788999999974 47766554 788887 8999999755 66677778888888877766533
Q ss_pred ------cCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccC-
Q 010856 66 ------KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNK- 138 (499)
Q Consensus 66 ------~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~- 138 (499)
.+..+...+|.++++|+.+.+.++. ..+....|.++.+|+.+++..+ ++.+...+|.++..|+.+.+..+.
T Consensus 143 ~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~ 220 (394)
T 4fs7_A 143 EITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLY 220 (394)
T ss_dssp EEECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCC
T ss_pred ccccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCce
Confidence 1112334567888899999997654 3366677888889999988766 555666677777777776664431
Q ss_pred -----------CCC--CC--------ccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCC
Q 010856 139 -----------LTS--VP--------LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGL 197 (499)
Q Consensus 139 -----------l~~--~~--------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 197 (499)
++. +| ..+..+..|+.+.+..+... +....|..+..++.+....+.+. ...|.++
T Consensus 221 ~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~ 296 (394)
T 4fs7_A 221 YLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGC 296 (394)
T ss_dssp EECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTC
T ss_pred EeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccc
Confidence 111 12 24566788888888776432 44556666666666665554332 2345556
Q ss_pred cCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCC
Q 010856 198 KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256 (499)
Q Consensus 198 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 256 (499)
.+|+.+.+..+ ++.+....|.++.+|+.+++.++ ++.+...+|.++++|+.+++..|
T Consensus 297 ~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 297 SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 66666666543 44455555666666666666533 55555556666666666666544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.2e-12 Score=126.52 Aligned_cols=251 Identities=14% Similarity=0.077 Sum_probs=172.0
Q ss_pred CCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccc-------
Q 010856 17 LDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDN------- 89 (499)
Q Consensus 17 l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n------- 89 (499)
++.+... +|.++. +|+++.+.. .++.+...+|.++++|+.++|..+ ++.+...+|.++.+|+.+.+..+
T Consensus 59 VtsIg~~-AF~~c~-~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~ 134 (394)
T 4fs7_A 59 VVSIGYA-AFQGCR-KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVE 134 (394)
T ss_dssp EEEECTT-TTTTCT-TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTT
T ss_pred EeEhHHH-HhhCCC-CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecce
Confidence 4444444 787777 899999975 488788889999999999999865 66677788999888888776533
Q ss_pred --------------cccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCC-ccccCCCCCcE
Q 010856 90 --------------KLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP-LTFWNLKDILN 154 (499)
Q Consensus 90 --------------~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~l~~L~~ 154 (499)
.+......+|.++++|+.+.+.++. ..+....|.++.+|+.+.+..+ ++.++ ..+.++..|+.
T Consensus 135 aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~ 212 (394)
T 4fs7_A 135 AFKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLEN 212 (394)
T ss_dssp TTTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCB
T ss_pred eeecccccccccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccce
Confidence 1112234568888999999997654 4477789999999999999876 44432 24555555555
Q ss_pred EEcCCCc---------------------CCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCC
Q 010856 155 LNFSSNF---------------------LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 213 (499)
Q Consensus 155 L~l~~n~---------------------l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 213 (499)
+.+..+. ++.+....|..+..|+.+.+..+... +....|..+..++.+....+.+
T Consensus 213 i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i--- 288 (394)
T 4fs7_A 213 MEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV--- 288 (394)
T ss_dssp CCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---
T ss_pred eecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---
Confidence 5444332 12233345556666676666655432 5556666777777776665543
Q ss_pred CCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCC-CCCCCccccccCCC
Q 010856 214 IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSAESFEGN 279 (499)
Q Consensus 214 ~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~l~~~~l~~N 279 (499)
....|..+.+|+.+.+.++ ++.+...+|.++++|+.+++..+ ++..-... ....+|+.+.+..|
T Consensus 289 ~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 289 PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 3356888999999999765 77777889999999999999754 55333222 22345666666444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-15 Score=148.64 Aligned_cols=181 Identities=17% Similarity=0.123 Sum_probs=100.4
Q ss_pred CCCCeEecccccccccCCccccC-----cccccEEeeecCCCCCcCCccc-cCCccCCeeeccccCCCCCC-----ccc-
Q 010856 79 QKLQGLGLEDNKLEGSIPDDICH-----LAELYRLDLDGNKLSGSLPACF-SNLTSLRIVSLGSNKLTSVP-----LTF- 146 (499)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~-----~~~- 146 (499)
+.|+.|+|++|.++......+.. .++|++|+|++|.++......+ ..+++|+.|+|++|.+++.. ..+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 34555555555554332222221 1455555555555543222222 22345666666666665421 111
Q ss_pred cCCCCCcEEEcCCCcCCCC----CcccccCCCCccEEEccCCcccccC----cccccCCcCCceeeCcCCcCCCCC----
Q 010856 147 WNLKDILNLNFSSNFLTSP----LPLEIGNLKVLIGIDFSMNNFSGVI----PTEIGGLKNLEYLFLGYNRLQGSI---- 214 (499)
Q Consensus 147 ~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~~---- 214 (499)
...++|++|+|++|.+++. ++..+..+++|++|+|++|.+++.. +..+...++|++|+|++|.|++..
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 2346677777777766542 2233456677777777777776432 445666778888888888887532
Q ss_pred CccccCCCCCCEEeCCCCcCCccCcccccCCCC-----CCEEE--ccCCcCc
Q 010856 215 PDSFGDLISLKFLNLSNNNLSGAIPASLEKLSY-----LENLN--LSFNKLE 259 (499)
Q Consensus 215 ~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-----L~~L~--l~~N~l~ 259 (499)
...+...++|+.|+|++|.|+......+..+.. |+.+. +..|.++
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 234556788999999999988655555544321 55665 5666554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=5.5e-15 Score=144.59 Aligned_cols=159 Identities=19% Similarity=0.180 Sum_probs=121.6
Q ss_pred cccccEEeeecCCCCCcCCccccC-----CccCCeeeccccCCCC--CCccccCCCCCcEEEcCCCcCCCCCcccc----
Q 010856 102 LAELYRLDLDGNKLSGSLPACFSN-----LTSLRIVSLGSNKLTS--VPLTFWNLKDILNLNFSSNFLTSPLPLEI---- 170 (499)
Q Consensus 102 l~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---- 170 (499)
++.|++|+|++|.++......+.. .++|+.|+|++|.++. +..-...+++|+.|+|++|.+++.....+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 467999999999998644443332 3699999999999976 22223345689999999999976443333
Q ss_pred -cCCCCccEEEccCCccccc----CcccccCCcCCceeeCcCCcCCCCC----CccccCCCCCCEEeCCCCcCCccC---
Q 010856 171 -GNLKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFLGYNRLQGSI----PDSFGDLISLKFLNLSNNNLSGAI--- 238 (499)
Q Consensus 171 -~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~l~~N~l~~~~--- 238 (499)
...++|+.|+|++|.++.. ++..+..+++|++|+|++|.+++.. ...+...++|+.|+|++|.|++..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 3568899999999999753 3344577899999999999998532 455677889999999999998543
Q ss_pred -cccccCCCCCCEEEccCCcCcc
Q 010856 239 -PASLEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 239 -~~~~~~l~~L~~L~l~~N~l~~ 260 (499)
...+...++|++|+|++|+|+.
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHHhCCCCCEEeccCCCCCH
Confidence 3445567999999999999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=4.6e-14 Score=131.11 Aligned_cols=131 Identities=12% Similarity=0.039 Sum_probs=89.6
Q ss_pred hcccccccccCCcceEEEEEe-CCCCE--EEEEEeeccCCc------------------------cHHHHHHHHHHHhcC
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRME--VAVKVFNLQCGR------------------------AFESFDVECEMMKNI 414 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~il~~l 414 (499)
-|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 366788999999999999997 68888 999997543210 013688999999999
Q ss_pred CCCCccccceeEEccccceeeeeecccCC-C-cccccc---cc--ccccccccccccccceeec-c------CCCcccEE
Q 010856 415 RHRNLIKILHGVAVITFTVCLCLFHHSSA-S-ASASLV---SS--LTLSRPAKGGGFRGCVLWH-V------GVDFAAFV 480 (499)
Q Consensus 415 ~H~niv~l~~~~~~~~~~~~~~l~~~~~~-~-~~~~l~---~~--~~~~~~~~~~i~~gl~yLH-~------~~~p~~~l 480 (499)
.|+++.-..-+.. ...++++||+++ + ....+. .. ......++.|++.||+||| + |++|.||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NIL 203 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIM 203 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence 9887532221111 123457777743 1 111111 11 2233455688888888888 4 89999999
Q ss_pred EeeCCCeEEEEEEEeecc
Q 010856 481 FVLEPGVEVICFVFEILL 498 (499)
Q Consensus 481 ~~~~~~~~~~~f~~~~~~ 498 (499)
+.+ .+++||||+++..
T Consensus 204 l~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 204 YID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ESS--SEEECCCTTCEET
T ss_pred EcC--cEEEEECcccccC
Confidence 977 9999999998753
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=8.5e-13 Score=128.32 Aligned_cols=103 Identities=19% Similarity=0.151 Sum_probs=62.0
Q ss_pred eeecccc-CCCCCCccccCCCCCcEEEcCC-CcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCC
Q 010856 131 IVSLGSN-KLTSVPLTFWNLKDILNLNFSS-NFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYN 208 (499)
Q Consensus 131 ~L~L~~n-~l~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n 208 (499)
.++++++ +++.+|. +..+++|+.|+|++ |.++++.+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 3455555 5666665 66666666666664 6666555555666666666666666666665656666666666666666
Q ss_pred cCCCCCCccccCCCCCCEEeCCCCcCC
Q 010856 209 RLQGSIPDSFGDLISLKFLNLSNNNLS 235 (499)
Q Consensus 209 ~l~~~~~~~l~~l~~L~~L~l~~N~l~ 235 (499)
+|+++.+..|..++ |+.|+|.+|++.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 66655444454444 666666666655
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.6e-11 Score=118.89 Aligned_cols=247 Identities=13% Similarity=0.154 Sum_probs=134.0
Q ss_pred CCCCC-CCCEEECcCCCCCccCChhccccccccccEEEcccCC---CcccCCccccCCCCCCEEeccCCcCCccCCcccc
Q 010856 1 MSNCK-SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCN---ISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLS 76 (499)
Q Consensus 1 l~~l~-~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~---i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 76 (499)
|.+++ .|+.+.+..+ ++.+... +|.++. +|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++.+...+|.
T Consensus 59 F~~~~~~L~sI~iP~s-vt~Ig~~-AF~~C~-~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 59 FCNYKYVLTSVQIPDT-VTEIGSN-AFYNCT-SLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTCCSCCCEEEECTT-CCEECTT-TTTTCT-TCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred ccCCCCcCEEEEECCC-eeEEhHH-HhhCCc-cCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 34553 5888888754 6656555 777777 78888887653 66666777888888888777654 4546666777
Q ss_pred CCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccc----------------------cCCccCCeeec
Q 010856 77 KLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACF----------------------SNLTSLRIVSL 134 (499)
Q Consensus 77 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----------------------~~l~~L~~L~L 134 (499)
.+.+|+.+.+..+ +..+....|....+|+.+.+..+ ++.+...+| ..+.+++....
T Consensus 135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l~~~~~ 212 (394)
T 4gt6_A 135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAKVTRIGTNAFSECFALSTITS 212 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTCCEEEE
T ss_pred hhcccccccccce-eeeecccceecccccccccccce-eeEeccccccccceeEEEECCcccccccchhhhccccceecc
Confidence 7778887777643 33344556666666666666543 222333333 33333333322
Q ss_pred cccCCCC-----------------------------CC--------ccccCCCCCcEEEcCCCcCCCCCcccccCCCCcc
Q 010856 135 GSNKLTS-----------------------------VP--------LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLI 177 (499)
Q Consensus 135 ~~n~l~~-----------------------------~~--------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 177 (499)
..+.... +| ..|.++..|+.+.+..+.. .+....|.+++.|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~ 291 (394)
T 4gt6_A 213 DSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQ 291 (394)
T ss_dssp CCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCC
T ss_pred cccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccc-eecCcccccccccc
Confidence 2211111 11 1233444555555543322 23344455555555
Q ss_pred EEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCc
Q 010856 178 GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 257 (499)
Q Consensus 178 ~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 257 (499)
.+.+. +.++.+....|.++.+|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++.+...+|.++++|+.+++.+|.
T Consensus 292 ~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 292 DIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp EEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred cccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 55553 2344444455555555555555433 44344455555555555555432 444445555555555555555543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=9.8e-13 Score=127.88 Aligned_cols=131 Identities=23% Similarity=0.198 Sum_probs=106.0
Q ss_pred cEEEcCCC-cCCCCCcccccCCCCccEEEccC-CcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCC
Q 010856 153 LNLNFSSN-FLTSPLPLEIGNLKVLIGIDFSM-NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLS 230 (499)
Q Consensus 153 ~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 230 (499)
..++++++ .++. +|. +..+++|+.|+|++ |.|++..+..|.++++|+.|+|++|+|+++.+..|..+++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35788888 8986 555 99999999999996 99999988999999999999999999999999999999999999999
Q ss_pred CCcCCccCcccccCCCCCCEEEccCCcCcccCCCCC--CCCCccccccCCCcCCCCCC
Q 010856 231 NNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG--SFGNFSAESFEGNELLCGSP 286 (499)
Q Consensus 231 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~~l~~~~l~~N~~~c~~~ 286 (499)
+|+|++..+..|..++ |+.|+|.+|++.+...... .+.......+..+...|..+
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence 9999988888887776 9999999999986543211 01111223344566677654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.32 E-value=9.1e-11 Score=115.99 Aligned_cols=131 Identities=15% Similarity=0.145 Sum_probs=99.3
Q ss_pred ccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCc---CCccCCccccCCCCCCeEecccccccccCCccccC
Q 010856 25 SVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNK---LNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICH 101 (499)
Q Consensus 25 ~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~---l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 101 (499)
+|.+....|+.+.+-.+ ++.+...+|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++.+....|..
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~ 135 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH 135 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhh
Confidence 66665436999999754 777888999999999999998874 77677889999999999988765 55566778999
Q ss_pred cccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCC
Q 010856 102 LAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSS 159 (499)
Q Consensus 102 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~ 159 (499)
+.+|+.+.+..+ +..+....|..+.+|+.+.+..+ ++.+....+...+|+.+.+..
T Consensus 136 c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~ 191 (394)
T 4gt6_A 136 CEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPA 191 (394)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECT
T ss_pred hcccccccccce-eeeecccceecccccccccccce-eeEeccccccccceeEEEECC
Confidence 999999999754 45477788999999999988654 444433333334555555543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.15 E-value=2e-09 Score=105.74 Aligned_cols=107 Identities=14% Similarity=0.062 Sum_probs=56.9
Q ss_pred ccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCC
Q 010856 146 FWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLK 225 (499)
Q Consensus 146 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 225 (499)
+....+|+.+.+..+ +..+....|.++..|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++.+....|.++++|+
T Consensus 213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~ 289 (379)
T 4h09_A 213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT 289 (379)
T ss_dssp TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence 334455555555433 33334445555566666665544 44444455555556666655432 3334445555566666
Q ss_pred EEeCCCCcCCccCcccccCCCCCCEEEccC
Q 010856 226 FLNLSNNNLSGAIPASLEKLSYLENLNLSF 255 (499)
Q Consensus 226 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 255 (499)
.+.+.++.++.+...+|.++.+|+.+++..
T Consensus 290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 290 KVVMDNSAIETLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp EEEECCTTCCEECTTTTTTCTTCCEEECCT
T ss_pred cccccccccceehhhhhcCCCCCCEEEcCc
Confidence 666655555555555566666666666543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.08 E-value=9e-12 Score=120.39 Aligned_cols=142 Identities=11% Similarity=-0.030 Sum_probs=87.0
Q ss_pred HHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCC--------------ccHHHHHHHHHHHhcCCCCCc
Q 010856 354 LELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG--------------RAFESFDVECEMMKNIRHRNL 419 (499)
Q Consensus 354 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~il~~l~H~ni 419 (499)
..+...-.-|.+...||+|+||.||+|..++|+.||||+++.... ........++++.....|+|+
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 444444445889999999999999999988899999999854210 111222333333333334444
Q ss_pred cccceeEEc----cccceeeeeecccCCCccccccccccccccccccccccceeecc------CCCcccEEEeeCC----
Q 010856 420 IKILHGVAV----ITFTVCLCLFHHSSASASASLVSSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP---- 485 (499)
Q Consensus 420 v~l~~~~~~----~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~---- 485 (499)
++++..... .+.....++++++.|.....+.. ....+.+..|++.||.|||+ |+||.|||+.+++
T Consensus 168 ~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~-~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS-VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp HHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCC-CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred HHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcc-cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 433321110 01112246788887765444332 22234455788888877655 8999999998765
Q ss_pred ------CeEEEEEEEee
Q 010856 486 ------GVEVICFVFEI 496 (499)
Q Consensus 486 ------~~~~~~f~~~~ 496 (499)
++.+|||+-++
T Consensus 247 ~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTSEEEEEEECCCTTCE
T ss_pred ccccccceEEEEeCCcc
Confidence 38899998554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.2e-11 Score=117.98 Aligned_cols=154 Identities=17% Similarity=0.128 Sum_probs=88.3
Q ss_pred ccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCC-Cccc--cCCCCCcEEEcCC--CcCC-CC----Ccc
Q 010856 99 ICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSV-PLTF--WNLKDILNLNFSS--NFLT-SP----LPL 168 (499)
Q Consensus 99 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~--~~l~~L~~L~l~~--n~l~-~~----~~~ 168 (499)
+..+++|+.|+|++|.-... +. +. +++|+.|++..|.++.- ...+ ..+|+|++|+|+. |... +. +..
T Consensus 168 l~~~P~L~~L~L~g~~~l~l-~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~ 244 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLSI-GK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP 244 (362)
T ss_dssp HHTCTTCCEEEEECCBTCBC-CS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG
T ss_pred HhcCCCCcEEEEeCCCCcee-cc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHH
Confidence 34455555565555521111 11 22 45666666666555431 1112 2456666666532 1111 10 001
Q ss_pred cc--cCCCCccEEEccCCcccccCccccc---CCcCCceeeCcCCcCCCCC----CccccCCCCCCEEeCCCCcCCccCc
Q 010856 169 EI--GNLKVLIGIDFSMNNFSGVIPTEIG---GLKNLEYLFLGYNRLQGSI----PDSFGDLISLKFLNLSNNNLSGAIP 239 (499)
Q Consensus 169 ~~--~~l~~L~~L~l~~n~l~~~~~~~l~---~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~l~~N~l~~~~~ 239 (499)
.+ ..+++|+.|+|.+|.+.+..+..+. .+++|++|+|+.|.+++.. +..+..+++|+.|++++|.|+....
T Consensus 245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~ 324 (362)
T 2ra8_A 245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK 324 (362)
T ss_dssp GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH
T ss_pred HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH
Confidence 12 2467888888888887643333332 4788999999999888642 2333556899999999999886555
Q ss_pred ccccC-CCCCCEEEccCCc
Q 010856 240 ASLEK-LSYLENLNLSFNK 257 (499)
Q Consensus 240 ~~~~~-l~~L~~L~l~~N~ 257 (499)
..+.. + ...+++++++
T Consensus 325 ~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 325 KELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHC--CSEEECCSBC
T ss_pred HHHHHHc--CCEEEecCCc
Confidence 54543 3 4678998887
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.01 E-value=9.2e-11 Score=113.68 Aligned_cols=159 Identities=16% Similarity=0.153 Sum_probs=105.6
Q ss_pred cCcccccEEeeecCCCC---------CcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccc
Q 010856 100 CHLAELYRLDLDGNKLS---------GSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEI 170 (499)
Q Consensus 100 ~~l~~L~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 170 (499)
..+++|+.|.+.++... +.+...+..+|+|+.|++++|.-..++. + .+++|+.|++..+.++......+
T Consensus 136 ~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l 213 (362)
T 2ra8_A 136 EKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGK-K-PRPNLKSLEIISGGLPDSVVEDI 213 (362)
T ss_dssp HHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCBCCS-C-BCTTCSEEEEECSBCCHHHHHHH
T ss_pred hhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCceecc-c-cCCCCcEEEEecCCCChHHHHHH
Confidence 34566666666544321 1233455678999999999884233443 3 37899999999988764332333
Q ss_pred c--CCCCccEEEccC--Cccccc-----Ccccc--cCCcCCceeeCcCCcCCCCCCccc---cCCCCCCEEeCCCCcCCc
Q 010856 171 G--NLKVLIGIDFSM--NNFSGV-----IPTEI--GGLKNLEYLFLGYNRLQGSIPDSF---GDLISLKFLNLSNNNLSG 236 (499)
Q Consensus 171 ~--~l~~L~~L~l~~--n~l~~~-----~~~~l--~~l~~L~~L~L~~n~l~~~~~~~l---~~l~~L~~L~l~~N~l~~ 236 (499)
. .+++|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+.+..+..+ ..+++|+.|+|+.|.+.+
T Consensus 214 ~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp HHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred HHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 3 689999999863 221111 11122 257899999999998875332233 257899999999999986
Q ss_pred cC----cccccCCCCCCEEEccCCcCcc
Q 010856 237 AI----PASLEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 237 ~~----~~~~~~l~~L~~L~l~~N~l~~ 260 (499)
.. +..+..+++|+.|++++|.++.
T Consensus 294 ~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 294 EGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp HHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred HHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 43 3334567999999999998874
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.98 E-value=4.2e-08 Score=96.24 Aligned_cols=108 Identities=18% Similarity=0.226 Sum_probs=65.4
Q ss_pred cccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCC
Q 010856 145 TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISL 224 (499)
Q Consensus 145 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 224 (499)
.+.++..|+.+.+..+ ++.+....|.++..|+.+.+..+ +..+....|.++++|+.+.+.++.++.+....|.++.+|
T Consensus 235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L 312 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL 312 (379)
T ss_dssp TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence 3455666666666554 44455556666666666666443 444455566666666666666666665556666666666
Q ss_pred CEEeCCCCcCCccCcccccCCCCCCEEEccC
Q 010856 225 KFLNLSNNNLSGAIPASLEKLSYLENLNLSF 255 (499)
Q Consensus 225 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 255 (499)
+.++|..+ ++.+...+|.++++|+.+.+..
T Consensus 313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 313 SSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred CEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 66666543 5555556666666666665543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.64 E-value=4.2e-09 Score=92.07 Aligned_cols=87 Identities=17% Similarity=0.153 Sum_probs=46.3
Q ss_pred CCCccEEEccCCccccc----CcccccCCcCCceeeCcCCcCCCC----CCccccCCCCCCEEeC--CCCcCCcc----C
Q 010856 173 LKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFLGYNRLQGS----IPDSFGDLISLKFLNL--SNNNLSGA----I 238 (499)
Q Consensus 173 l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~l--~~N~l~~~----~ 238 (499)
.++|++|+|++|.|... +...+...++|++|+|++|.|++. +...+...++|+.|+| ++|.|... +
T Consensus 64 ~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l 143 (185)
T 1io0_A 64 NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI 143 (185)
T ss_dssp CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH
T ss_pred CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHH
Confidence 34444444444444321 122233445566666666666542 2334555566777777 66666643 2
Q ss_pred cccccCCCCCCEEEccCCcCc
Q 010856 239 PASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 239 ~~~~~~l~~L~~L~l~~N~l~ 259 (499)
...+...++|++|++++|.+.
T Consensus 144 ~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 144 ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEeccCCCCC
Confidence 234445567777777777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.64 E-value=4e-09 Score=92.21 Aligned_cols=89 Identities=11% Similarity=0.072 Sum_probs=47.5
Q ss_pred cCCCCCcEEEcCCCcCCCC----CcccccCCCCccEEEccCCccccc----CcccccCCcCCceeeC--cCCcCCCCC--
Q 010856 147 WNLKDILNLNFSSNFLTSP----LPLEIGNLKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFL--GYNRLQGSI-- 214 (499)
Q Consensus 147 ~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L--~~n~l~~~~-- 214 (499)
...++|++|+|++|.+.+. +...+...+.|++|+|++|.|... +...+...++|++|+| ++|.++...
T Consensus 62 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~ 141 (185)
T 1io0_A 62 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 141 (185)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred HhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHH
Confidence 3344455555555544431 112233344555555555555532 2344555666777777 667766432
Q ss_pred --CccccCCCCCCEEeCCCCcCC
Q 010856 215 --PDSFGDLISLKFLNLSNNNLS 235 (499)
Q Consensus 215 --~~~l~~l~~L~~L~l~~N~l~ 235 (499)
...+...++|+.|++++|.+.
T Consensus 142 ~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 142 EIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCcCEEeccCCCCC
Confidence 234455577788888777765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.50 E-value=7.8e-09 Score=95.02 Aligned_cols=79 Identities=22% Similarity=0.302 Sum_probs=45.4
Q ss_pred cCCCCCCeEeccccccccc--CCccccCcccccEEeeecCCCCCcCCccccCCc--cCCeeeccccCCCC-CC-------
Q 010856 76 SKLQKLQGLGLEDNKLEGS--IPDDICHLAELYRLDLDGNKLSGSLPACFSNLT--SLRIVSLGSNKLTS-VP------- 143 (499)
Q Consensus 76 ~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~L~~n~l~~-~~------- 143 (499)
.++++|+.|+|++|+|++. ++..+..+++|+.|+|++|++++. ..+..+. +|+.|+|++|.+.. +|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 3456666666666666652 234455666666666666666644 2222233 66777777776654 33
Q ss_pred ccccCCCCCcEEE
Q 010856 144 LTFWNLKDILNLN 156 (499)
Q Consensus 144 ~~~~~l~~L~~L~ 156 (499)
..+..+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 1245567777665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.44 E-value=3e-08 Score=91.07 Aligned_cols=57 Identities=26% Similarity=0.302 Sum_probs=26.5
Q ss_pred ccCCcCCceeeCcCCcCCCCCCccccCCC--CCCEEeCCCCcCCccCc-------ccccCCCCCCEEE
Q 010856 194 IGGLKNLEYLFLGYNRLQGSIPDSFGDLI--SLKFLNLSNNNLSGAIP-------ASLEKLSYLENLN 252 (499)
Q Consensus 194 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~--~L~~L~l~~N~l~~~~~-------~~~~~l~~L~~L~ 252 (499)
+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|++.+..| ..+..+|+|+.||
T Consensus 192 ~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 192 VQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp HHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred HhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 33444555555555554432 1122222 55555565555554332 2344556666554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.6e-07 Score=84.55 Aligned_cols=88 Identities=14% Similarity=0.035 Sum_probs=63.6
Q ss_pred HHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCccccceeEEcccccee
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~ 434 (499)
+......|......+.|+.+.||++.. .++.+++|+...........+.+|+++++.+. |..+.++++++... ...
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~ 85 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWS 85 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--Cce
Confidence 344556788888899999999999975 36789999987533223346889999998874 67778888776542 234
Q ss_pred eeeecccCCCcc
Q 010856 435 LCLFHHSSASAS 446 (499)
Q Consensus 435 ~~l~~~~~~~~~ 446 (499)
+.+++++.|...
T Consensus 86 ~lv~e~i~G~~l 97 (263)
T 3tm0_A 86 NLLMSEADGVLC 97 (263)
T ss_dssp EEEEECCSSEEH
T ss_pred EEEEEecCCeeh
Confidence 457788877643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.25 E-value=2.7e-07 Score=78.64 Aligned_cols=85 Identities=13% Similarity=0.033 Sum_probs=47.7
Q ss_pred CCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCc-ccccCcccccCC----cCCceeeCcCCc-CCCCCCccccCCC
Q 010856 149 LKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNN-FSGVIPTEIGGL----KNLEYLFLGYNR-LQGSIPDSFGDLI 222 (499)
Q Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~l~~l----~~L~~L~L~~n~-l~~~~~~~l~~l~ 222 (499)
-..|++||++++.+++..-..+.++++|+.|+|++|. +++..-..+..+ ++|++|+|++|. +++..-..+..++
T Consensus 60 ~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 60 KYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred CceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 3456777777776665444555666666666666664 544333334432 356666666653 5544334455556
Q ss_pred CCCEEeCCCCc
Q 010856 223 SLKFLNLSNNN 233 (499)
Q Consensus 223 ~L~~L~l~~N~ 233 (499)
+|+.|+++++.
T Consensus 140 ~L~~L~L~~c~ 150 (176)
T 3e4g_A 140 NLKYLFLSDLP 150 (176)
T ss_dssp TCCEEEEESCT
T ss_pred CCCEEECCCCC
Confidence 66666666553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.22 E-value=2.7e-07 Score=78.58 Aligned_cols=84 Identities=15% Similarity=0.112 Sum_probs=47.7
Q ss_pred CCccEEEccCCcccccCcccccCCcCCceeeCcCCc-CCCCCCccccCC----CCCCEEeCCCCc-CCccCcccccCCCC
Q 010856 174 KVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNR-LQGSIPDSFGDL----ISLKFLNLSNNN-LSGAIPASLEKLSY 247 (499)
Q Consensus 174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~l----~~L~~L~l~~N~-l~~~~~~~~~~l~~ 247 (499)
..|+.||++++.++...-..+.++++|++|+|++|. +++.....+..+ ++|++|+|++|. |++..-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 346666666666655544555566666666666663 554333344443 356666666653 55544445556666
Q ss_pred CCEEEccCCc
Q 010856 248 LENLNLSFNK 257 (499)
Q Consensus 248 L~~L~l~~N~ 257 (499)
|+.|++++++
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.09 E-value=1.3e-06 Score=80.54 Aligned_cols=83 Identities=11% Similarity=-0.031 Sum_probs=54.9
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC--ccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN--LIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~n--iv~l~~~~~~~~~~~~~~l 437 (499)
...+......+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++.... ...+++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEE
Confidence 3445544444566679999998777888999987543 2245789999998886545 44577665442 224567
Q ss_pred ecccCCCccc
Q 010856 438 FHHSSASASA 447 (499)
Q Consensus 438 ~~~~~~~~~~ 447 (499)
++++.|....
T Consensus 94 ~e~i~G~~l~ 103 (264)
T 1nd4_A 94 LGEVPGQDLL 103 (264)
T ss_dssp EECCSSEETT
T ss_pred EEecCCcccC
Confidence 8888776543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.72 E-value=8.9e-06 Score=70.59 Aligned_cols=88 Identities=18% Similarity=0.090 Sum_probs=45.2
Q ss_pred cCCCCccEEEccCCcccccC----cccccCCcCCceeeCcCCcCCCC----CCccccCCCCCCEEeCCCC---cCCc---
Q 010856 171 GNLKVLIGIDFSMNNFSGVI----PTEIGGLKNLEYLFLGYNRLQGS----IPDSFGDLISLKFLNLSNN---NLSG--- 236 (499)
Q Consensus 171 ~~l~~L~~L~l~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~l~~N---~l~~--- 236 (499)
..-+.|+.|+|++|+|.+.. ...+..-+.|++|+|++|.|.+. +.+.+..-+.|+.|+|++| .+..
T Consensus 67 ~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~ 146 (197)
T 1pgv_A 67 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE 146 (197)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred hhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHH
Confidence 33444555555555554322 22233445666666666666542 1233445556777777654 2332
Q ss_pred -cCcccccCCCCCCEEEccCCcC
Q 010856 237 -AIPASLEKLSYLENLNLSFNKL 258 (499)
Q Consensus 237 -~~~~~~~~l~~L~~L~l~~N~l 258 (499)
.+...+...++|+.|+++.|.+
T Consensus 147 ~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 147 MDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHhCCCcCeEeccCCCc
Confidence 1234455566777777765543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.64 E-value=9.1e-06 Score=70.54 Aligned_cols=62 Identities=11% Similarity=0.003 Sum_probs=30.1
Q ss_pred CCCccEEEccCCccccc----CcccccCCcCCceeeCcCCc---CCC----CCCccccCCCCCCEEeCCCCcC
Q 010856 173 LKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFLGYNR---LQG----SIPDSFGDLISLKFLNLSNNNL 234 (499)
Q Consensus 173 l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~---l~~----~~~~~l~~l~~L~~L~l~~N~l 234 (499)
-+.|+.|+|++|.|... +...+..-+.|++|+|++|. +.. .+...+..-++|+.|+++.|.+
T Consensus 97 N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 97 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred CCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 34455555555554432 12233444556666666442 221 1223345556677777766644
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00042 Score=56.05 Aligned_cols=38 Identities=16% Similarity=0.213 Sum_probs=19.4
Q ss_pred cccccEEEcccCCCcccCCccccCCCCCCEEeccCCcC
Q 010856 30 SHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKL 67 (499)
Q Consensus 30 ~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 67 (499)
|.+|++|+|++|+|+.+.++.|..+++|++|+|++|.+
T Consensus 30 p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 30 PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 33455555555555544444455555555555555544
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00017 Score=69.68 Aligned_cols=80 Identities=8% Similarity=0.010 Sum_probs=50.9
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEee--ccC-CccHHHHHHHHHHHhcCC--CCCccccceeEEcccc-ceeeeeec
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFN--LQC-GRAFESFDVECEMMKNIR--HRNLIKILHGVAVITF-TVCLCLFH 439 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~il~~l~--H~niv~l~~~~~~~~~-~~~~~l~~ 439 (499)
.+.++.|.++.||+....+ ..+++|+.. ... ......+.+|.++++.+. +..+.++++++...+. ...+.+++
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999998754 578888776 332 123456889999999886 4557787777654321 12345788
Q ss_pred ccCCCcc
Q 010856 440 HSSASAS 446 (499)
Q Consensus 440 ~~~~~~~ 446 (499)
++.|...
T Consensus 122 ~v~G~~l 128 (359)
T 3dxp_A 122 FVSGRVL 128 (359)
T ss_dssp CCCCBCC
T ss_pred ecCCeec
Confidence 8877644
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00066 Score=54.87 Aligned_cols=56 Identities=29% Similarity=0.382 Sum_probs=31.4
Q ss_pred eeeCcCCcCC-CCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCc
Q 010856 202 YLFLGYNRLQ-GSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 202 ~L~L~~n~l~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|++.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5556666655 12232222 25667777777776666666666666666655544443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=91.69 E-value=0.11 Score=48.55 Aligned_cols=74 Identities=5% Similarity=-0.041 Sum_probs=46.8
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCC---CccccceeEEccccceeeeeecccC
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHR---NLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~---niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
...++.|....||+. |..+++|+-.. ......+.+|.++++.+.+. -+.+.+.+....+... +++++++.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~-~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP-FVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE-EEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce-EEEEeccC
Confidence 345788888899987 45678887421 12346789999999988653 2445554443222223 35777777
Q ss_pred CCcc
Q 010856 443 ASAS 446 (499)
Q Consensus 443 ~~~~ 446 (499)
|...
T Consensus 97 G~~l 100 (306)
T 3tdw_A 97 GQIL 100 (306)
T ss_dssp SEEC
T ss_pred CeEC
Confidence 7643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.02 E-value=0.027 Score=56.09 Aligned_cols=60 Identities=12% Similarity=0.062 Sum_probs=17.6
Q ss_pred cccccccCCcceEEEEEeCC-CCEEEE------EEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEE
Q 010856 365 ENNLIGKGGFGSVYKARLGD-RMEVAV------KVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVA 427 (499)
Q Consensus 365 ~~~~lg~G~~g~v~~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~ 427 (499)
+.+.+| ||.||+|.+.. ...||+ |..+... ......|.+|..+++..+|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345666 99999999743 467888 6665432 233457899999999999999999988754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=89.90 E-value=0.05 Score=50.79 Aligned_cols=75 Identities=13% Similarity=0.119 Sum_probs=43.7
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCc--cccceeEEcccc-ceeeeeeccc
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNI-RHRNL--IKILHGVAVITF-TVCLCLFHHS 441 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~H~ni--v~l~~~~~~~~~-~~~~~l~~~~ 441 (499)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+ .+..+ .+.++.....+. ...+.+++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3558899999999763 45788875432 2356789999999877 33332 333322211111 1123456777
Q ss_pred CCCcc
Q 010856 442 SASAS 446 (499)
Q Consensus 442 ~~~~~ 446 (499)
.|...
T Consensus 99 ~G~~l 103 (304)
T 3sg8_A 99 KGVPL 103 (304)
T ss_dssp CCEEC
T ss_pred CCeEC
Confidence 66543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.56 E-value=0.29 Score=30.34 Aligned_cols=17 Identities=29% Similarity=0.360 Sum_probs=6.6
Q ss_pred hhhHHHHHHHHHHhhhc
Q 010856 316 TTFMIVVILLILRYQQR 332 (499)
Q Consensus 316 ~~~~~~~~~~~~~~~~~ 332 (499)
.++++++.+.++++.||
T Consensus 21 v~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 21 LLLLLVVALGIGLFMRR 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhhh
Confidence 33333333443444333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.93 E-value=0.47 Score=29.32 Aligned_cols=16 Identities=19% Similarity=0.287 Sum_probs=6.1
Q ss_pred hhhHHHHHHHHHHhhh
Q 010856 316 TTFMIVVILLILRYQQ 331 (499)
Q Consensus 316 ~~~~~~~~~~~~~~~~ 331 (499)
.++++++.+.++++.|
T Consensus 20 v~~v~ii~~~~~~~~R 35 (44)
T 2l2t_A 20 LFILVIVGLTFAVYVR 35 (44)
T ss_dssp HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhh
Confidence 3333333344344433
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=85.79 E-value=1.4 Score=40.37 Aligned_cols=53 Identities=15% Similarity=0.079 Sum_probs=42.1
Q ss_pred cccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC
Q 010856 363 FSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR 415 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~ 415 (499)
..-...+|.|..+.||+.+..+|+.|.+|+-..........|.+|.+.|+.+.
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLG 69 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence 44456789999999999999999999999876544444457889999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=85.61 E-value=0.67 Score=41.98 Aligned_cols=71 Identities=14% Similarity=0.014 Sum_probs=44.6
Q ss_pred cccCCcc-eEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeeeeecccCCC
Q 010856 369 IGKGGFG-SVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLCLFHHSSAS 444 (499)
Q Consensus 369 lg~G~~g-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~l~~~~~~~ 444 (499)
+..|..+ .||+.... ++..+.+|+-... ....+.+|.++++.+. +--+.++++++...+ ..+++++++.|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--DAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--eEEEEEEeeCCc
Confidence 4445555 68987754 5677889986543 3456889999988763 223556666665432 334567777664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=83.66 E-value=0.56 Score=45.38 Aligned_cols=74 Identities=9% Similarity=0.111 Sum_probs=45.1
Q ss_pred ccccccCCcceEEEEEeC-CCCEEEEEEeeccCC-------ccHHHHHHHHHHHhcCCC--CC-ccccceeEEcccccee
Q 010856 366 NNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCG-------RAFESFDVECEMMKNIRH--RN-LIKILHGVAVITFTVC 434 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~H--~n-iv~l~~~~~~~~~~~~ 434 (499)
.+.+|.|.++.||++... +++.+++|....... ...+++.+|.++++.+.. |. +.+++.+ ..+ ..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~--~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE--MA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT--TT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC--cc
Confidence 457899999999999753 467899998653211 123567889998887632 33 3344432 222 23
Q ss_pred eeeecccCC
Q 010856 435 LCLFHHSSA 443 (499)
Q Consensus 435 ~~l~~~~~~ 443 (499)
+++++++.|
T Consensus 111 ~lvmE~l~g 119 (397)
T 2olc_A 111 VTVMEDLSH 119 (397)
T ss_dssp EEEECCCTT
T ss_pred EEEEEeCCC
Confidence 456777765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=82.16 E-value=1.6 Score=40.60 Aligned_cols=95 Identities=11% Similarity=-0.015 Sum_probs=65.2
Q ss_pred ccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC---CCCccccceeEEccccceeeeeecccC
Q 010856 366 NNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR---HRNLIKILHGVAVITFTVCLCLFHHSS 442 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---H~niv~l~~~~~~~~~~~~~~l~~~~~ 442 (499)
.+.++.|.+..+|+... ++..+.+|+.... ....+.+|.+.++.+. ..-+.+.+++.... ...+.+++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEecc
Confidence 45689999999999886 4668888987643 3567889999888773 24567777665442 23456788887
Q ss_pred CCccccccccccccccccccccccceeeccCCC
Q 010856 443 ASASASLVSSLTLSRPAKGGGFRGCVLWHVGVD 475 (499)
Q Consensus 443 ~~~~~~l~~~~~~~~~~~~~i~~gl~yLH~~~~ 475 (499)
|.... ...+.+++++|+-||+...
T Consensus 115 G~~~~---------~~~~~~lG~~LA~LH~~~~ 138 (312)
T 3jr1_A 115 KSKNK---------QSSFTIFAEKIAQLHQIQG 138 (312)
T ss_dssp CCCCC---------TTHHHHHHHHHHHHHHCCC
T ss_pred CCCCC---------chhHHHHHHHHHHHHcCCC
Confidence 76321 1234567788889998543
|
| >2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} | Back alignment and structure |
|---|
Probab=81.45 E-value=4.2 Score=30.46 Aligned_cols=48 Identities=15% Similarity=-0.022 Sum_probs=31.1
Q ss_pred CCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccc
Q 010856 41 CNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDN 89 (499)
Q Consensus 41 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 89 (499)
..++.+...+|.++++|+.+.|-.+ ++.+...+|.++.+|+.+.+...
T Consensus 6 ~~vt~I~~~aF~~c~~L~~i~iP~~-v~~Ig~~aF~~C~~L~~i~~~~~ 53 (100)
T 2lz0_A 6 EPVVGMDKSLFAGNTVIREITVQPN-IGLLYDGMFSGCTALEKLILTGE 53 (100)
T ss_dssp CCCCSSCSCTTTTCTTCCCEEECTT-SSCCCTTSSTTCTTCCCEEECCS
T ss_pred CccCEecHHHhcCCCCCcEEEcCCc-hheEcHHHHhccCCccEEEEcCC
Confidence 3455555667777777777777654 44466666777777777776553
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=80.90 E-value=0.93 Score=27.97 Aligned_cols=7 Identities=14% Similarity=0.316 Sum_probs=2.8
Q ss_pred HHhhhcC
Q 010856 327 LRYQQRG 333 (499)
Q Consensus 327 ~~~~~~~ 333 (499)
++.+||+
T Consensus 33 ~~~RRR~ 39 (44)
T 2jwa_A 33 ILIKRRQ 39 (44)
T ss_dssp HHHHHHC
T ss_pred hheehhh
Confidence 3344443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 499 | ||||
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-14 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-13 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-13 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-12 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-12 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-12 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-12 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-12 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-12 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-11 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-11 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-11 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-11 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-11 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-11 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-11 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-11 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-11 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-11 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-11 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-11 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-11 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-10 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-10 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-10 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-10 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-10 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-10 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-10 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-10 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-10 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-10 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-09 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-09 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-09 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-09 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-09 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-09 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-09 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-09 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-04 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-09 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-08 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-08 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-08 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-08 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-08 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-08 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-08 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-08 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-08 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-08 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-07 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-07 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-07 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-06 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-06 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 |
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.4 bits (241), Expect = 1e-22
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 15/229 (6%)
Query: 28 NLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLE 87
L++ R+ + ++ LTN + N+++ P+ + L L L
Sbjct: 170 PLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLN 227
Query: 88 DNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFW 147
N+L+ + L L LDL N++S P S LT L + LG+N+++++
Sbjct: 228 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS-PLA 282
Query: 148 NLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGY 207
L + NL + N L P I NLK L + NN S + P + L L+ LF
Sbjct: 283 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN 338
Query: 208 NRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFN 256
N++ S +L ++ +L+ +N +S P L L+ + L L+
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 82.0 bits (201), Expect = 1e-17
Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 13/188 (6%)
Query: 76 SKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLG 135
+KL L+ L +N++ P I L L L+GN+L ++LT+L + L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 136 SNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIG 195
+N+++++ L + L +N +++ PL L L ++ + N + P
Sbjct: 250 NNQISNLA-PLSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQLEDISPISN- 305
Query: 196 GLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSF 255
LKNL YL L +N + P L L+ L +NN +S +SL L+ + L+
Sbjct: 306 -LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 256 NKLEGEIP 263
N++ P
Sbjct: 361 NQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.2 bits (142), Expect = 3e-10
Identities = 52/276 (18%), Positives = 91/276 (32%), Gaps = 28/276 (10%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
+ L + + +T + ++ + I + + L N T +N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTT----LQADRLGIKS--IDGVEYLNNLTQIN 72
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYR----LDLDGNKLSG 117
N+L P L L KL + + +N++ P D + L
Sbjct: 73 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130
Query: 118 SLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGN----- 172
L+S I + + + + +L +N T N
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190
Query: 173 -----LKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFL 227
L L + + N S + P I NL+ L L N+L+ + L +L L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 228 NLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
+L+NN +S P L L+ L L L N++ P
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.1 bits (139), Expect = 9e-10
Identities = 53/289 (18%), Positives = 94/289 (32%), Gaps = 36/289 (12%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ +LT I SNN L I P ++ L L + ++ LT
Sbjct: 62 VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 121
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGS-- 118
+ L + +L + S+ L
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181
Query: 119 -------LPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIG 171
+ + LT+L + +N+++ + L ++ L+ + N L L
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGTL--A 238
Query: 172 NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP---------------- 215
+L L +D + N S + P + GL L L LG N++ P
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296
Query: 216 ----DSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEG 260
+L +L +L L NN+S P + L+ L+ L + NK+
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 45/244 (18%), Positives = 91/244 (37%), Gaps = 23/244 (9%)
Query: 52 SNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111
+ L LG + ++ + L ++ L + ++ SI D + +L L +++
Sbjct: 19 TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 74
Query: 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPL--- 168
N+L+ P NLT L + + +N++ + F++
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 169 ----------EIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFL-GYNRLQGSIPDS 217
I ++ L G+ G T++ L NL L + + S
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 218 FGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFE 277
L +L+ L +NN +S P + + L+ L+L+ N+L+ I S N +
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-IGTLASLTNLTDLDLA 249
Query: 278 GNEL 281
N++
Sbjct: 250 NNQI 253
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 15/64 (23%), Positives = 30/64 (46%), Gaps = 6/64 (9%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S+ L ++ +NN + + +S+ NL+ ++ + IS P ++NLT T +
Sbjct: 326 SSLTKLQRLFFANNKVSDV---SSLANLT-NINWLSAGHNQISDLTP--LANLTRITQLG 379
Query: 62 LGGN 65
L
Sbjct: 380 LNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.8 bits (229), Expect = 2e-21
Identities = 55/261 (21%), Positives = 96/261 (36%), Gaps = 12/261 (4%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG 64
L+ L NN + I NL + L + N IS P + L + L
Sbjct: 31 PDTALLDLQNNKITEI-KDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSK 88
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFS 124
N+L LQ+L+ E K+ S+ + + + + L + K SG F
Sbjct: 89 NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQ 147
Query: 125 NLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN 184
+ L + + +T++P + L+ N +T + L L + S N
Sbjct: 148 GMKKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 185 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG------AI 238
+ S V + +L L L N+L +P D ++ + L NNN+S
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 239 PASLEKLSYLENLNLSFNKLE 259
P K + ++L N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.6 bits (213), Expect = 2e-19
Identities = 53/246 (21%), Positives = 88/246 (35%), Gaps = 5/246 (2%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELY 106
+P+++ ++ +++L NK+ L+ L L L +NK+ P L +L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 107 RLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPL 166
RL L N+L L LR+ K+ N ++ L + +
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 167 PLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKF 226
+K L I + N + + G +L L L N++ S L +L
Sbjct: 143 NGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 227 LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 286
L LS N++S SL +L L+L+ NKL N +
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGS 259
Query: 287 NLQVPP 292
N PP
Sbjct: 260 NDFCPP 265
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.5 bits (210), Expect = 5e-19
Identities = 53/232 (22%), Positives = 87/232 (37%), Gaps = 6/232 (2%)
Query: 56 NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKL 115
+ +V L +P L L L++NK+ D +L L+ L L NK+
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 116 SGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKV 175
S P F+ L L + L N+L +P L ++ + N +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 176 LIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLS 235
++ + + SG+ G+K L Y+ + + +IP SL L+L N ++
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184
Query: 236 GAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 287
ASL+ L+ L L LSFN + + E N L P
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.0 bits (136), Expect = 1e-09
Identities = 29/151 (19%), Positives = 49/151 (32%), Gaps = 5/151 (3%)
Query: 155 LNFSSNFLTSPLPLEIG-NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 213
+ S L +P ++ + +L D N + + + LKNL L L N++
Sbjct: 15 VQCSDLGLEK-VPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 214 IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSA 273
P +F L+ L+ L LS N L + L L K+ + G +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 274 ESFEGNELLCGSPNLQVPPCKTSIHHTSWKN 304
+ K S + N
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 30/150 (20%), Positives = 54/150 (36%), Gaps = 12/150 (8%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
K L+ I +++ + I L SL + + I+ + L N +
Sbjct: 146 FQGMKKLSYIRIADTNITTIPQ-----GLPPSLTELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSG--- 117
L N ++ +L+ L+ L L +NKL +P + + + L N +S
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 259
Query: 118 ---SLPACFSNLTSLRIVSLGSNKLTSVPL 144
P + S VSL SN + +
Sbjct: 260 NDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 89.8 bits (221), Expect = 2e-20
Identities = 72/293 (24%), Positives = 115/293 (39%), Gaps = 28/293 (9%)
Query: 2 SNCKSLTLIYLSNNPLDGILP-KTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ + + LS L P +S+ NL + + N+ G IP I+ LT +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
+ ++G+IP LS+++ L L N L G++P I L L + DGN++SG++P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
+ + + L S + + L S + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
N ++G KNL L L NR+ G++P L L LN+S NNL
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC----- 281
Query: 241 SLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC 293
GEIP+GG+ F ++ N+ LCGSP +P C
Sbjct: 282 -------------------GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 46.3 bits (108), Expect = 4e-06
Identities = 39/141 (27%), Positives = 62/141 (43%), Gaps = 4/141 (2%)
Query: 97 DDICHLAELYRLDLDGNKLSG--SLPACFSNLTSLRIVSLGS--NKLTSVPLTFWNLKDI 152
D + LDL G L +P+ +NL L + +G N + +P L +
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 153 LNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 212
L + ++ +P + +K L+ +DFS N SG +P I L NL + NR+ G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 213 SIPDSFGDLISLKFLNLSNNN 233
+IPDS+G L + N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN 184
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.1 bits (105), Expect = 1e-05
Identities = 19/73 (26%), Positives = 30/73 (41%), Gaps = 3/73 (4%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
+ K+L + L NN + G LP+ + L L + N+ G IP + NL +
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQ-GLTQLK-FLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 61 NLGGNKLNGSIPI 73
NK P+
Sbjct: 297 AYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 37.8 bits (86), Expect = 0.002
Identities = 22/82 (26%), Positives = 32/82 (39%), Gaps = 3/82 (3%)
Query: 178 GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQG--SIPDSFGDLISLKFLNLSNN-NL 234
D + GV+ + L L L IP S +L L FL + NL
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 235 SGAIPASLEKLSYLENLNLSFN 256
G IP ++ KL+ L L ++
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHT 111
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (205), Expect = 1e-18
Identities = 54/257 (21%), Positives = 89/257 (34%), Gaps = 6/257 (2%)
Query: 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGG 64
+ I+L N + + P S + + N +
Sbjct: 32 AASQRIFLHGNRISHV-PAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 65 NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFS 124
+L P T L +L L L+ L+ P LA L L L N L F
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 125 NLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSM 183
+L +L + L N+++SVP F L + L N + P +L L+ +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 184 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLE 243
NN S + + L+ L+YL L N + L+ S++ + ++P L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 244 KLSYLENLNLSFNKLEG 260
L+ N L+G
Sbjct: 270 GRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (165), Expect = 2e-13
Identities = 61/242 (25%), Positives = 88/242 (36%), Gaps = 4/242 (1%)
Query: 47 IPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELY 106
+P I S + L GN+++ + + L L L N L LA L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 107 RLDLDGNKLSGSL-PACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNF-SSNFLTS 164
+LDL N S+ PA F L L + L L + + L + N L +
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 165 PLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISL 224
+L L + N S V GL +L+ L L NR+ P +F DL L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 225 KFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG 284
L L NNLS +L L L+ L L+ N + + +E+ C
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263
Query: 285 SP 286
P
Sbjct: 264 LP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 3e-11
Identities = 33/188 (17%), Positives = 61/188 (32%), Gaps = 5/188 (2%)
Query: 1 MSNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIV 60
L ++L L + + +L+ + + + + +L N T +
Sbjct: 101 FHGLGRLHTLHLDRCGLQEL--GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158
Query: 61 NLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP 120
L GN+++ L L L L N++ P L L L L N LS
Sbjct: 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
+ L +L+ + L N + SS+ + LP + +
Sbjct: 219 EALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLK---R 275
Query: 181 FSMNNFSG 188
+ N+ G
Sbjct: 276 LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 2e-05
Identities = 36/231 (15%), Positives = 60/231 (25%), Gaps = 28/231 (12%)
Query: 120 PACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGI 179
AC S L +VP+ + N ++ + L +
Sbjct: 4 GACVCYNEPKVTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61
Query: 180 DFSMNNFSGVI-------------------------PTEIGGLKNLEYLFLGYNRLQGSI 214
N + + P GL L L L LQ
Sbjct: 62 WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121
Query: 215 PDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRG-GSFGNFSA 273
P F L +L++L L +N L + L L +L L N++ R +
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 274 ESFEGNELLCGSPNLQVPPCKTSIHHTSWKNSLLLRIVLPLSTTFMIVVIL 324
N + P+ + + N L + + L
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 70.9 bits (173), Expect = 4e-14
Identities = 20/89 (22%), Positives = 32/89 (35%), Gaps = 14/89 (15%)
Query: 350 TFSYLELFRATDEFSEN---------NLIGKGGFGSVYKARL----GDRMEVAVKVFNLQ 396
F++ + A EF++ +IG G FG V L + VA+K
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 397 -CGRAFESFDVECEMMKNIRHRNLIKILH 424
+ F E +M H N+I +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEG 94
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 3e-13
Identities = 18/66 (27%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
+ +G G FG V+ +VAVK Q + ++F E +MK ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 421 KILHGV 426
+ L+ V
Sbjct: 72 R-LYAV 76
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.6 bits (162), Expect = 6e-13
Identities = 22/81 (27%), Positives = 36/81 (44%), Gaps = 2/81 (2%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
E + IG G FG V+ ++ +VA+K + E F E E+M + H L+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63
Query: 421 KILHGVAVITFTVCLCLFHHS 441
+ L+GV + +CL
Sbjct: 64 Q-LYGVCLEQAPICLVFEFME 83
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.2 bits (161), Expect = 2e-12
Identities = 16/86 (18%), Positives = 36/86 (41%), Gaps = 5/86 (5%)
Query: 354 LELFRATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAF-ESFDVECEMM 411
+EL D+F + + +G G G V+K + +A K+ +L+ A E +++
Sbjct: 1 MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 412 KNIRHRNLIKILHGVAVITFTVCLCL 437
++ +G + +C+
Sbjct: 59 HECNSPYIVG-FYGAFYSDGEISICM 83
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (158), Expect = 2e-12
Identities = 17/81 (20%), Positives = 38/81 (46%), Gaps = 2/81 (2%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
+ + +G G FG V + + +VA+K+ + + + F E ++M N+ H L+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 421 KILHGVAVITFTVCLCLFHHS 441
+ L+GV + + + +
Sbjct: 63 Q-LYGVCTKQRPIFIITEYMA 82
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (158), Expect = 3e-12
Identities = 16/63 (25%), Positives = 29/63 (46%), Gaps = 1/63 (1%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
+ +G+G FG V+ VA+K + E+F E ++MK +RH L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 421 KIL 423
++
Sbjct: 76 QLY 78
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.2 bits (156), Expect = 5e-12
Identities = 18/65 (27%), Positives = 34/65 (52%), Gaps = 4/65 (6%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRN 418
+ + IG G FG+VYK + +VAVK+ N+ + ++F E +++ RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 419 LIKIL 423
++ +
Sbjct: 66 ILLFM 70
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 64.2 bits (156), Expect = 5e-12
Identities = 23/82 (28%), Positives = 37/82 (45%), Gaps = 5/82 (6%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL---QCGRAFESFDVECEMMKNIR 415
FS+ IG G FG+VY AR + + VA+K + Q ++ E ++ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 416 HRNLIKILHGVAVITFTVCLCL 437
H N I+ G + T L +
Sbjct: 74 HPNTIQ-YRGCYLREHTAWLVM 94
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.0 bits (155), Expect = 6e-12
Identities = 19/65 (29%), Positives = 31/65 (47%), Gaps = 2/65 (3%)
Query: 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNL 419
+ + + +G G +G VY+ + VAVK E F E +MK I+H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 420 IKILH 424
+++L
Sbjct: 76 VQLLG 80
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (152), Expect = 1e-11
Identities = 18/70 (25%), Positives = 27/70 (38%), Gaps = 6/70 (8%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGD-----RMEVAVKVFNLQCG-RAFESFDVECEMMKNI 414
+ +IG G FG VYK L + VA+K + F E +M
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 415 RHRNLIKILH 424
H N+I++
Sbjct: 67 SHHNIIRLEG 76
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.7 bits (152), Expect = 1e-11
Identities = 20/64 (31%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLI 420
E IGKG FG V +VAVK ++F E +M +RH NL+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 421 KILH 424
++L
Sbjct: 64 QLLG 67
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (152), Expect = 2e-11
Identities = 17/74 (22%), Positives = 35/74 (47%), Gaps = 5/74 (6%)
Query: 355 ELFRATDEFS-ENNLIGKGGFGSVYKARL---GDRMEVAVKVFNLQCGRAF-ESFDVECE 409
+LF D + +G G FGSV + +++VA+KV +A E E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 410 MMKNIRHRNLIKIL 423
+M + + +++++
Sbjct: 62 IMHQLDNPYIVRLI 75
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (150), Expect = 4e-11
Identities = 17/77 (22%), Positives = 37/77 (48%), Gaps = 7/77 (9%)
Query: 354 LELFRATDEFSENNLIGKGGFGSVYKARLGD-----RMEVAVKVFNL-QCGRAFESFDVE 407
L + + T+ F + ++G G FG+VYK ++ VA+K +A + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 408 CEMMKNIRHRNLIKILH 424
+M ++ + ++ ++L
Sbjct: 62 AYVMASVDNPHVCRLLG 78
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.2 bits (150), Expect = 4e-11
Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 10/98 (10%)
Query: 350 TFSYLELFRATDEFSEN----NLIGKGGFGSVYKAR-LGDRMEVAVKVFN--LQCGRAFE 402
TF EL + E E + +G G +GSV A + VAVK + Q +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 403 SFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440
E ++K+++H N+I +L V T L F+
Sbjct: 63 RTYRELRLLKHMKHENVIGLLD---VFTPARSLEEFND 97
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.2 bits (150), Expect = 4e-11
Identities = 16/72 (22%), Positives = 35/72 (48%), Gaps = 2/72 (2%)
Query: 355 ELFRATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAF-ESFDVECEMMK 412
++F ++ + IG+G +G V A +++ VA+K + + + + E +++
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 413 NIRHRNLIKILH 424
RH N+I I
Sbjct: 62 RFRHENIIGIND 73
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.2 bits (148), Expect = 5e-11
Identities = 18/66 (27%), Positives = 32/66 (48%), Gaps = 1/66 (1%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN 418
+++ IG+G G+VY A + EVA++ NLQ E E +M+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 419 LIKILH 424
++ L
Sbjct: 79 IVNYLD 84
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (146), Expect = 8e-11
Identities = 19/70 (27%), Positives = 32/70 (45%), Gaps = 3/70 (4%)
Query: 369 IGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAV 428
IGKG FG V++ + EVAVK+F+ + R++ + E +RH N++
Sbjct: 11 IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWF-REAEIYQTVMLRHENILG-FIAADN 67
Query: 429 ITFTVCLCLF 438
L+
Sbjct: 68 KDNGTWTQLW 77
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.4 bits (146), Expect = 8e-11
Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 1/66 (1%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN 418
D + +G G FG VYKA+ + A KV + + E + VE +++ + H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 419 LIKILH 424
++K+L
Sbjct: 71 IVKLLD 76
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.4 bits (146), Expect = 8e-11
Identities = 15/70 (21%), Positives = 30/70 (42%), Gaps = 4/70 (5%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKN 413
+ ++F ++G+G F +V AR L E A+K+ + E ++M
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 414 IRHRNLIKIL 423
+ H +K+
Sbjct: 65 LDHPFFVKLY 74
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (146), Expect = 8e-11
Identities = 21/64 (32%), Positives = 30/64 (46%), Gaps = 5/64 (7%)
Query: 366 NNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQCGRAF-ESFDVECEMMKNIRHRNLI 420
N +IG+G FG VY L G ++ AVK N F E +MK+ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 421 KILH 424
+L
Sbjct: 92 SLLG 95
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (145), Expect = 8e-11
Identities = 20/70 (28%), Positives = 29/70 (41%), Gaps = 7/70 (10%)
Query: 361 DEFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFN---LQCGRAFESFDVECEMMKN 413
+ +G G FG V + G + VAVK L A + F E M +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 414 IRHRNLIKIL 423
+ HRNLI++
Sbjct: 68 LDHRNLIRLY 77
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (145), Expect = 9e-11
Identities = 13/65 (20%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 365 ENNLIGKGGFGSVYKARLGDR---MEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNL 419
E+ +G G FG+V K + VAVK+ + + E +M+ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 420 IKILH 424
++++
Sbjct: 71 VRMIG 75
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (146), Expect = 1e-10
Identities = 16/63 (25%), Positives = 33/63 (52%), Gaps = 5/63 (7%)
Query: 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIK 421
+++ +IG G FG VY+A+L VA+K + E ++M+ + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 422 ILH 424
+ +
Sbjct: 78 LRY 80
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 59.8 bits (144), Expect = 1e-10
Identities = 17/69 (24%), Positives = 29/69 (42%), Gaps = 4/69 (5%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGR---AFESFDVECEMMKNIR 415
+D + ++G GG V+ AR L +VAVKV R + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 416 HRNLIKILH 424
H ++ +
Sbjct: 66 HPAIVAVYD 74
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 59.5 bits (143), Expect = 2e-10
Identities = 20/82 (24%), Positives = 37/82 (45%), Gaps = 3/82 (3%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRN 418
+++ IG+G +G VYKA+ A+K L+ + E ++K ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 419 LIKILHGVAVITFTVCLCLFHH 440
++K L+ V + L H
Sbjct: 62 IVK-LYDVIHTKKRLVLVFEHL 82
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 60.1 bits (145), Expect = 2e-10
Identities = 17/78 (21%), Positives = 26/78 (33%), Gaps = 2/78 (2%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNL 419
D + +G G FG V++ K N + E +M + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 420 IKILHGVAVITFTVCLCL 437
I LH + + L L
Sbjct: 89 IN-LHDAFEDKYEMVLIL 105
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 60.1 bits (145), Expect = 2e-10
Identities = 14/65 (21%), Positives = 24/65 (36%), Gaps = 1/65 (1%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNL 419
D + + +G G FG V++ A K E+ E + M +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 420 IKILH 424
+ +
Sbjct: 86 VNLHD 90
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.5 bits (143), Expect = 2e-10
Identities = 14/71 (19%), Positives = 28/71 (39%), Gaps = 3/71 (4%)
Query: 357 FRATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR 415
R + + IG G FG +Y + EVA+K+ ++ +E ++ K ++
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQ 60
Query: 416 HRNLIKILHGV 426
I +
Sbjct: 61 GGVGIPTIRWC 71
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 2e-10
Identities = 39/207 (18%), Positives = 59/207 (28%), Gaps = 26/207 (12%)
Query: 74 TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVS 133
+SK+ + + L ++P D+ + L L N L A T L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 134 LGSNKLTSVPLTFWNLKDILNLNFSSNF----------------------LTSPLPLEIG 171
L +LT + + + LTS +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 172 NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSN 231
L L + N + P + LE L L N L L +L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 232 NNLSGAIPASLEKLSYLENLNLSFNKL 258
N+L IP L L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 2e-09
Identities = 40/233 (17%), Positives = 65/233 (27%), Gaps = 32/233 (13%)
Query: 2 SNCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVN 61
S S + L + P +L + + + T T +N
Sbjct: 7 SKVASHLEVNCDKRNLTALPP-----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 62 LGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA 121
L +L L L LDL N+L
Sbjct: 62 LDRAELT--------------------------KLQVDGTLPVLGTLDLSHNQLQSLPLL 95
Query: 122 CFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDF 181
+ + + + L ++ L N L + P + L +
Sbjct: 96 GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155
Query: 182 SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234
+ NN + + + GL+NL+ L L N L +IP F L F L N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.5 bits (143), Expect = 3e-10
Identities = 19/81 (23%), Positives = 33/81 (40%), Gaps = 7/81 (8%)
Query: 351 FSYLELFRATDEFSEN----NLIGKGGFGSVYKAR-LGDRMEVAVKVFN--LQCGRAFES 403
F E+ + E +G G +G+V A +VA+K Q +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 404 FDVECEMMKNIRHRNLIKILH 424
E ++K++RH N+I +L
Sbjct: 64 AYRELRLLKHMRHENVIGLLD 84
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.5 bits (141), Expect = 3e-10
Identities = 18/79 (22%), Positives = 34/79 (43%), Gaps = 3/79 (3%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL-QCGRAFESFDVECEMMKNIRHRN 418
+++ +G+G +G V A VAVK+ ++ + E+ E + K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 419 LIKILHGVAVITFTVCLCL 437
++K +G L L
Sbjct: 65 VVK-FYGHRREGNIQYLFL 82
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (141), Expect = 4e-10
Identities = 21/69 (30%), Positives = 35/69 (50%), Gaps = 5/69 (7%)
Query: 361 DEFSENNLIGKGGFGSVYKARL---GDRMEVAVKVFNLQCGR-AFESFDVECEMMKNI-R 415
++ ++IG+G FG V KAR+ G RM+ A+K + F E E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 416 HRNLIKILH 424
H N+I +L
Sbjct: 70 HPNIINLLG 78
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.7 bits (139), Expect = 7e-10
Identities = 17/80 (21%), Positives = 33/80 (41%), Gaps = 3/80 (3%)
Query: 360 TDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFE-SFDVECEMMKNIRHR 417
D + +++G G F V A + VA+K + E S + E ++ I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 418 NLIKILHGVAVITFTVCLCL 437
N++ L + + L +
Sbjct: 68 NIVA-LDDIYESGGHLYLIM 86
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (137), Expect = 9e-10
Identities = 15/68 (22%), Positives = 28/68 (41%), Gaps = 5/68 (7%)
Query: 361 DEFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQCGRAF-ESFDVECEMMKNIR 415
+ IG+G FG V++ + VA+K + E F E M+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 416 HRNLIKIL 423
H +++K++
Sbjct: 67 HPHIVKLI 74
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 57.0 bits (137), Expect = 1e-09
Identities = 15/67 (22%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRH 416
+F +G G FG V+ R + A+KV + + E + E M+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 417 RNLIKIL 423
+I++
Sbjct: 64 PFIIRMW 70
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (136), Expect = 1e-09
Identities = 19/67 (28%), Positives = 34/67 (50%), Gaps = 4/67 (5%)
Query: 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRH 416
++F +GKG FG+VY AR + +A+KV L+ E E+ ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 417 RNLIKIL 423
N++++
Sbjct: 66 PNILRLY 72
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (136), Expect = 2e-09
Identities = 23/84 (27%), Positives = 34/84 (40%), Gaps = 8/84 (9%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL------QCGRAFESFDVECEMMKN 413
D + +G G F V K R ++ A K + G + E + E ++K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 414 IRHRNLIKILHGVAVITFTVCLCL 437
I+H N+I LH V V L L
Sbjct: 70 IQHPNVIT-LHEVYENKTDVILIL 92
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.2 bits (135), Expect = 2e-09
Identities = 11/67 (16%), Positives = 26/67 (38%), Gaps = 3/67 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHR 417
+++ IG G +G K R D + K + + E +++ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 418 NLIKILH 424
N+++
Sbjct: 64 NIVRYYD 70
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (136), Expect = 2e-09
Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 4/68 (5%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRA---FESFDVECEMMKNIRH 416
++F L+GKG FG V R A+K+ + A E +++N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 417 RNLIKILH 424
L + +
Sbjct: 65 PFLTALKY 72
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 2e-09
Identities = 19/65 (29%), Positives = 31/65 (47%), Gaps = 3/65 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHR 417
+ F + IG+G +G VYKAR VA+K L + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 418 NLIKI 422
N++K+
Sbjct: 62 NIVKL 66
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (135), Expect = 3e-09
Identities = 16/71 (22%), Positives = 30/71 (42%), Gaps = 7/71 (9%)
Query: 361 DEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCG-RAFESFDVECEMMKN 413
++ + + +G+G FG VY+ VA+K N R F E +MK
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 414 IRHRNLIKILH 424
+++++L
Sbjct: 80 FNCHHVVRLLG 90
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 4e-09
Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 5/124 (4%)
Query: 130 RIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGV 189
R++ L LT + L + +L+ S N L + P + L+ L + S N V
Sbjct: 1 RVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 190 IPTEIGGLKNLEYLFLGYNRLQG-SIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 248
L+ L L NRLQ + L LNL N+L L
Sbjct: 59 DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 249 ENLN 252
+++
Sbjct: 117 PSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 2e-06
Identities = 24/125 (19%), Positives = 45/125 (36%), Gaps = 8/125 (6%)
Query: 84 LGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP 143
L L L ++ + L + LDL N+L P + L L ++ N L +V
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 144 LTFWNLKDILNLNFSSNFLTS-PLPLEIGNLKVLIGIDFSMNNFS---GVIPTEIGGLKN 199
NL + L +N L + + L+ ++ N+ G+ L +
Sbjct: 60 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 200 LEYLF 204
+ +
Sbjct: 119 VSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 3e-06
Identities = 30/108 (27%), Positives = 41/108 (37%), Gaps = 6/108 (5%)
Query: 155 LNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI 214
L+ + LT L L ++ +D S N + P + L+ LE L +
Sbjct: 3 LHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 215 PDSFGDLISLKFLNLSNNNL-SGAIPASLEKLSYLENLNLSFNKLEGE 261
D +L L+ L L NN L A L L LNL N L E
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 1e-05
Identities = 25/115 (21%), Positives = 47/115 (40%), Gaps = 6/115 (5%)
Query: 40 NCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDI 99
+ +++ + + L T ++L N+L P L+ L+ L+ L DN D +
Sbjct: 7 HKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENVDGV 61
Query: 100 CHLAELYRLDLDGNKL-SGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDIL 153
+L L L L N+L + + L +++L N L L ++L
Sbjct: 62 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.9 bits (134), Expect = 4e-09
Identities = 14/71 (19%), Positives = 29/71 (40%), Gaps = 7/71 (9%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNL------QCGRAFESFDVECEMMKN 413
++FS + +IG+GGFG VY R A+K + Q + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 414 IRHRNLIKILH 424
++ + +
Sbjct: 64 GDCPFIVCMSY 74
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 5e-09
Identities = 39/214 (18%), Positives = 74/214 (34%), Gaps = 21/214 (9%)
Query: 47 IPEEIS------NLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDIC 100
+P I + NL + +T ++L + + ++ ++ I
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQ 65
Query: 101 HLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSN 160
+L + +L L+GNKL+ L +L+ + V + S
Sbjct: 66 YLPNVTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 161 FLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGD 220
+ +L L + N + + L L+ L L N++ +P
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAG 176
Query: 221 LISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 254
L L+ L LS N++S +L L L+ L L
Sbjct: 177 LTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 9e-04
Identities = 33/204 (16%), Positives = 69/204 (33%), Gaps = 17/204 (8%)
Query: 61 NLGGNKLNGSIPI----TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLS 116
LG + PI + + L+ + ++ + L + ++ + + +
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59
Query: 117 GSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVL 176
L ++ + L NKLT + + NL ++ +
Sbjct: 60 SVQG--IQYLPNVTKLFLNGNKLTDIK-------PLANLKNLGWLFLDENKVKDLSSLKD 110
Query: 177 IGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG 236
+ S++ I G + + L + + L L L+L +N +S
Sbjct: 111 LKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD 170
Query: 237 AIPASLEKLSYLENLNLSFNKLEG 260
+P L L+ L+NL LS N +
Sbjct: 171 IVP--LAGLTKLQNLYLSKNHISD 192
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.2 bits (132), Expect = 5e-09
Identities = 18/77 (23%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 367 NLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC-----GRAFESFDVECEMMKNIRHRNLI 420
+ +G+G F +VYKAR VA+K L + E ++++ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 421 KILHGVAVITFTVCLCL 437
L + L
Sbjct: 64 G-LLDAFGHKSNISLVF 79
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 6e-09
Identities = 43/219 (19%), Positives = 74/219 (33%), Gaps = 27/219 (12%)
Query: 53 NLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG 112
L N+ + G + + +T + L + L + + + +L L L+L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 113 NKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGN 172
N+++ A NLT + + L N L +V S+ + N
Sbjct: 73 NQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 173 LKVLIGIDF-----------------SMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 215
L+VL S+ N T + L L L N++ P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 216 DSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 254
L +L ++L NN +S P L S L + L+
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 2e-07
Identities = 28/229 (12%), Positives = 60/229 (26%), Gaps = 19/229 (8%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
+ I + + + + + ++ + ++ E + L N + L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITT----LSAFGTGVTT--IEGVQYLNNLIGLEL 70
Query: 63 GGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPAC 122
N++ P+ L K +I + + +
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
L L + S + NL L +
Sbjct: 131 LQVL---------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSN 231
N S + P + L NL + L N++ P + +L + L+N
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (131), Expect = 8e-09
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 8/88 (9%)
Query: 361 DEFSENNLIGKGGFGSVYKARLGDRME----VAVKVFN----LQCGRAFESFDVECEMMK 412
+ F ++G G +G V+ R + A+KV +Q + E E ++++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 413 NIRHRNLIKILHGVAVITFTVCLCLFHH 440
+IR + LH + L L +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYI 111
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (130), Expect = 1e-08
Identities = 14/70 (20%), Positives = 30/70 (42%), Gaps = 5/70 (7%)
Query: 355 ELFRATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKN 413
EL+ +++ +G+G FG V++ + K ++ G E ++
Sbjct: 2 ELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNI 57
Query: 414 IRHRNLIKIL 423
RHRN++ +
Sbjct: 58 ARHRNILHLH 67
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (129), Expect = 1e-08
Identities = 19/76 (25%), Positives = 33/76 (43%), Gaps = 4/76 (5%)
Query: 366 NNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQ--CGRAFESFDVECEMMKNIRHRNLIKI 422
+ IG+G F +VYK +EVA + + F E EM+K ++H N+++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR- 72
Query: 423 LHGVAVITFTVCLCLF 438
+ T C+
Sbjct: 73 FYDSWESTVKGKKCIV 88
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.4 bits (130), Expect = 1e-08
Identities = 20/85 (23%), Positives = 36/85 (42%), Gaps = 9/85 (10%)
Query: 361 DEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCGRAF-ESFDVECEMMKN 413
+ ++G G FG V A G ++VAVK+ + + E+ E +MM
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 414 I-RHRNLIKILHGVAVITFTVCLCL 437
+ H N++ L G ++ + L
Sbjct: 97 LGSHENIVN-LLGACTLSGPIYLIF 120
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.1 bits (129), Expect = 1e-08
Identities = 21/75 (28%), Positives = 35/75 (46%), Gaps = 12/75 (16%)
Query: 362 EFSENNL-----IGKGGFGSVYKARL------GDRMEVAVKVFNLQCGRAFES-FDVECE 409
E+ NN+ IG+G FG V++AR VAVK+ + ++ F E
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 410 MMKNIRHRNLIKILH 424
+M + N++K+L
Sbjct: 69 LMAEFDNPNIVKLLG 83
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 54.0 bits (129), Expect = 1e-08
Identities = 13/84 (15%), Positives = 30/84 (35%), Gaps = 4/84 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECEMMKNIRH 416
D+F +G G FG V + A+K+ + + + E E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 417 RNLIKILHGVAVITFTVCLCLFHH 440
L+K+ + + +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVA 124
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (128), Expect = 2e-08
Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 8/72 (11%)
Query: 361 DEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQCGRAF-ESFDVECEMMKN 413
+ S +G G FG V +A M VAVK+ E+ E +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 414 I-RHRNLIKILH 424
+ H N++ +L
Sbjct: 83 LGNHMNIVNLLG 94
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 2e-08
Identities = 24/92 (26%), Positives = 32/92 (34%), Gaps = 9/92 (9%)
Query: 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT 145
N I L L++ NKL LPA L L N L VP
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAEVPEL 322
Query: 146 FWNLKDILNLNFSSNFLTS--PLPLEIGNLKV 175
NLK L+ N L +P + +L++
Sbjct: 323 PQNLK---QLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 4e-08
Identities = 21/88 (23%), Positives = 33/88 (37%), Gaps = 8/88 (9%)
Query: 113 NKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGN 172
N S + + SL +++ +NKL +P L+ L S N L +P N
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAE-VPELPQN 325
Query: 173 LKVLIGIDFSMNNFSGVIPTEIGGLKNL 200
LK L N P +++L
Sbjct: 326 LKQL---HVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 1e-07
Identities = 21/83 (25%), Positives = 37/83 (44%), Gaps = 9/83 (10%)
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240
+ +N S I + +LE L + N+L +P L+ L S N+L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321
Query: 241 SLEKLSYLENLNLSFNKLEGEIP 263
+ L + L++ +N L E P
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 4e-07
Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 9/104 (8%)
Query: 145 TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLF 204
F L ++ + N ++ + L ++ S N +P LE L
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLI 310
Query: 205 LGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYL 248
+N L +P+ +LK L++ N L P E + L
Sbjct: 311 ASFNHLA-EVPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 7e-05
Identities = 17/80 (21%), Positives = 30/80 (37%), Gaps = 11/80 (13%)
Query: 3 NCKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNL 62
SL + +SNN L + L LE +++ +PE NL +++
Sbjct: 282 LPPSLEELNVSNNKL------IELPALPPRLERLIASFNHLA-EVPELPQNLKQ---LHV 331
Query: 63 GGNKLNGSIPITLSKLQKLQ 82
N L P ++ L+
Sbjct: 332 EYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 2e-04
Identities = 25/78 (32%), Positives = 30/78 (38%), Gaps = 7/78 (8%)
Query: 204 FLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263
N I SL+ LN+SNN L +PA + LE L SFN L E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320
Query: 264 RGGSFGNFSAESFEGNEL 281
N E N L
Sbjct: 321 --ELPQNLKQLHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 4e-04
Identities = 17/51 (33%), Positives = 24/51 (47%), Gaps = 4/51 (7%)
Query: 100 CHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLK 150
C + + L+L+ LS SLP +L SL N LT +P +LK
Sbjct: 35 CLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLTELPELPQSLK 81
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.002
Identities = 16/66 (24%), Positives = 25/66 (37%), Gaps = 5/66 (7%)
Query: 198 KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 257
+ L L L S+P+ L+ L S N+L+ +P + L L N +
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 258 LEGEIP 263
L P
Sbjct: 93 LSDLPP 98
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.6 bits (125), Expect = 4e-08
Identities = 16/67 (23%), Positives = 34/67 (50%), Gaps = 3/67 (4%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHR 417
++ + IG+G +G+V+KA+ VA+K L S E ++K ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 418 NLIKILH 424
N++++
Sbjct: 62 NIVRLHD 68
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.6 bits (125), Expect = 4e-08
Identities = 16/87 (18%), Positives = 29/87 (33%), Gaps = 7/87 (8%)
Query: 361 DEFSENNLIGKGGFGSVYKAR------LGDRMEVAVKVFNLQCGRA-FESFDVECEMMKN 413
D +G+G FG V +A VAVK+ + + E +++ +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 414 IRHRNLIKILHGVAVITFTVCLCLFHH 440
I H + L G + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEF 99
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.1 bits (124), Expect = 5e-08
Identities = 12/60 (20%), Positives = 23/60 (38%), Gaps = 3/60 (5%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
IG+G FG +++ L + +VA+K + E K + I ++
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (125), Expect = 5e-08
Identities = 15/86 (17%), Positives = 29/86 (33%), Gaps = 6/86 (6%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFN---LQCGRAFESFDVECE-MMKNIR 415
++F + ++GKG FG V+ A A+K + E VE +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 416 HRNLIKILHGVAVITFTVCLCLFHHS 441
H L + + + + +
Sbjct: 62 HPFLTH-MFCTFQTKENLFFVMEYLN 86
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 50.9 bits (121), Expect = 5e-08
Identities = 12/68 (17%), Positives = 19/68 (27%), Gaps = 10/68 (14%)
Query: 367 NLIGKGGFGSVYKARLGDRMEVAVKVFNL----------QCGRAFESFDVECEMMKNIRH 416
L+G+G +V+ E VK + + F V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 417 RNLIKILH 424
R L K+
Sbjct: 66 RALQKLQG 73
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.8 bits (123), Expect = 6e-08
Identities = 15/70 (21%), Positives = 35/70 (50%), Gaps = 3/70 (4%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNI 414
++ + IG+G FG V+KAR +VA+K ++ + E ++++ +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 415 RHRNLIKILH 424
+H N++ ++
Sbjct: 67 KHENVVNLIE 76
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 51.8 bits (123), Expect = 7e-08
Identities = 15/79 (18%), Positives = 38/79 (48%), Gaps = 5/79 (6%)
Query: 348 WRTFSYLELFRATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDV 406
W S++ + D++ +G+G + V++A + + +V VK+ + +
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR--- 78
Query: 407 ECEMMKNIR-HRNLIKILH 424
E ++++N+R N+I +
Sbjct: 79 EIKILENLRGGPNIITLAD 97
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (117), Expect = 1e-07
Identities = 30/155 (19%), Positives = 55/155 (35%), Gaps = 5/155 (3%)
Query: 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPL 168
+L ++ L S +L L S P + LN S+ + L +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAAT-LRI 59
Query: 169 EIGNLKVLIGIDFSMNNFSGV--IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKF 226
N+ L+ ++ S N + + + + NL+ L L N L+ + L+
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 227 LNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGE 261
L L N+LS +S + +L+G
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 13/74 (17%), Positives = 30/74 (40%), Gaps = 2/74 (2%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGV 426
+G G F +V+ A+ + + VA+K+ E+ + E ++++ + + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 427 AVITFTVCLCLFHH 440
A + H
Sbjct: 79 ANHILKLLDHFNHK 92
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (122), Expect = 1e-07
Identities = 18/71 (25%), Positives = 28/71 (39%), Gaps = 3/71 (4%)
Query: 357 FRATDEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFN--LQCGRAFESFDVECEMMKN 413
F + IG G G V A VA+K + Q + E +MK
Sbjct: 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 414 IRHRNLIKILH 424
+ H+N+I +L+
Sbjct: 73 VNHKNIISLLN 83
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (121), Expect = 1e-07
Identities = 19/74 (25%), Positives = 35/74 (47%), Gaps = 7/74 (9%)
Query: 358 RATDEFSENNLIGKGGFGSVYKAR--LGDRMEVAVKVFNLQCG--RAFESFDVECEMMKN 413
RA ++ IG+G +G V+KAR VA+K +Q G S E ++++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 414 I---RHRNLIKILH 424
+ H N++++
Sbjct: 64 LETFEHPNVVRLFD 77
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.4 bits (116), Expect = 2e-07
Identities = 40/160 (25%), Positives = 62/160 (38%), Gaps = 3/160 (1%)
Query: 128 SLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEI-GNLKVLIGIDFSMNNF 186
V L +P L + N L + G L L+ ++ N
Sbjct: 9 EGTTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 187 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLS 246
+G+ P G +++ L LG N+++ F L LK LNL +N +S +P S E L+
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 247 YLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 286
L +LNL+ N +S G CG+P
Sbjct: 127 SLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 3/94 (3%)
Query: 93 GSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDI 152
L +L L+L N++S +P F +L SL ++L SN W + +
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWL 151
Query: 153 LNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNF 186
+ + P ++ ++++ D + F
Sbjct: 152 RKKSLNGGAARCGAPSKVRDVQIK---DLPHSEF 182
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 2e-07
Identities = 44/264 (16%), Positives = 85/264 (32%), Gaps = 19/264 (7%)
Query: 12 LSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNG-S 70
L+ L P + LS + FR + + E S ++L + + +
Sbjct: 7 LTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 71 IPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDG--NKLSGSLPACFSNLTS 128
+ LS+ KLQ L LE +L I + + + L RL+L G +L S+ +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 129 LRIVSLGSNKLTSVPLTFWNLKD--------ILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
L ++L + + L+ + + L ++
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGY-NRLQGSIPDSFGDLISLKFLNLSNNNLSGAIP 239
E L L++L L + G++ +LK L + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 240 ASLEKLSYLENLNLSFNKLEGEIP 263
E L +L ++ +
Sbjct: 243 LLKEALP---HLQINCSHFTTIAR 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.9 bits (118), Expect = 3e-07
Identities = 21/74 (28%), Positives = 30/74 (40%), Gaps = 10/74 (13%)
Query: 361 DEFSENNLIGKGGFGSVYKARL--------GDRMEVAVKVFNLQCG-RAFESFDVECEMM 411
D +G+G FG V A +VAVK+ + E EMM
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 412 KNI-RHRNLIKILH 424
K I +H+N+I +L
Sbjct: 73 KMIGKHKNIINLLG 86
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 48.9 bits (116), Expect = 6e-07
Identities = 11/66 (16%), Positives = 31/66 (46%), Gaps = 1/66 (1%)
Query: 361 DEFSENNLIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNL 419
+ + ++G+G V + E AVK+ ++ G +F + +V+ ++ ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 420 IKILHG 425
++ + G
Sbjct: 63 LRKVSG 68
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 6e-07
Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 5/71 (7%)
Query: 199 NLEYLFLGYNRLQGS-IPDSFGDLISLKFLNLSNNNLSG----AIPASLEKLSYLENLNL 253
+++ L + L + + L + + L + L+ I ++L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 254 SFNKLEGEIPR 264
N+L
Sbjct: 63 RSNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 3e-06
Identities = 19/76 (25%), Positives = 27/76 (35%), Gaps = 9/76 (11%)
Query: 198 KNLEYLFLGYNRLQG----SIPDSFGDLISLKFLNLSNNNLSGAIPASL-----EKLSYL 248
L L+L + S+ + SL+ L+LSNN L A L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 249 ENLNLSFNKLEGEIPR 264
E L L E+
Sbjct: 429 EQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 4e-06
Identities = 16/93 (17%), Positives = 30/93 (32%), Gaps = 13/93 (13%)
Query: 172 NLKVLIGIDFSMNNFSGVIPTEI-GGLKNLEYLFLGYNRLQG----SIPDSFGDLISLKF 226
+++ L D S E+ L+ + + L L I + +L
Sbjct: 3 DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 227 LNLSNNNLSGAIPASL-----EKLSYLENLNLS 254
LNL +N L + ++ L+L
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 15/83 (18%), Positives = 28/83 (33%), Gaps = 12/83 (14%)
Query: 172 NLKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLI----- 222
L+VL + + S + + +L L L N L + + +
Sbjct: 370 VLRVL---WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 223 SLKFLNLSNNNLSGAIPASLEKL 245
L+ L L + S + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 12/91 (13%), Positives = 25/91 (27%), Gaps = 5/91 (5%)
Query: 151 DILNLNFSSNFLT-SPLPLEIGNLKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFL 205
DI +L+ L+ + + L+ + + I + + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 206 GYNRLQGSIPDSFGDLISLKFLNLSNNNLSG 236
N L + + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 17/92 (18%), Positives = 35/92 (38%), Gaps = 10/92 (10%)
Query: 56 NSTIVNLGGNKLNGS-IPITLSKLQKLQGLGLEDNKLEG----SIPDDICHLAELYRLDL 110
+ +++ +L+ + L LQ+ Q + L+D L I + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 111 DGNKLSGS-----LPACFSNLTSLRIVSLGSN 137
N+L L + ++ +SL +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 13/85 (15%), Positives = 30/85 (35%), Gaps = 9/85 (10%)
Query: 31 HSLEDFRMYNCNISG----GIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQK-----L 81
L + +C++S + + + ++L N L + + L + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 82 QGLGLEDNKLEGSIPDDICHLAELY 106
+ L L D + D + L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 12/66 (18%), Positives = 28/66 (42%), Gaps = 5/66 (7%)
Query: 81 LQGLGLEDNKLEGSIPDDIC-HLAELYRLDLDGNKLSG----SLPACFSNLTSLRIVSLG 135
+Q L ++ +L + ++ L + + LD L+ + + +L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 136 SNKLTS 141
SN+L
Sbjct: 64 SNELGD 69
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.0 bits (110), Expect = 1e-06
Identities = 36/200 (18%), Positives = 80/200 (40%), Gaps = 15/200 (7%)
Query: 52 SNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111
+ L LG + ++ + L ++ L + ++ SI D + +L L +++
Sbjct: 15 TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 70
Query: 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIG 171
N+L+ NLT L + + +N++ + F++ +
Sbjct: 71 NNQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128
Query: 172 NLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSN 231
NL L ++++ S + L ++ Q + +L +L+ L++S+
Sbjct: 129 NLNRLELSSNTISDISALSGLTS-------LQQLNFSSNQVTDLKPLANLTTLERLDISS 181
Query: 232 NNLSGAIPASLEKLSYLENL 251
N +S + L KL+ LE+L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (112), Expect = 2e-06
Identities = 9/59 (15%), Positives = 24/59 (40%), Gaps = 7/59 (11%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFESFDVECE-MMKNIRHRNLIKILH 424
++G G G V + + + A+K+ + E E + + ++++I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVD 72
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (111), Expect = 2e-06
Identities = 17/66 (25%), Positives = 29/66 (43%), Gaps = 9/66 (13%)
Query: 368 LIGKGGFGSVYKAR-LGDRMEVAVKVFNLQCGRAFES------FDVECEMMKNIR--HRN 418
L+G GGFGSVY + D + VA+K + +E ++K +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 419 LIKILH 424
+I++L
Sbjct: 71 VIRLLD 76
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 3e-05
Identities = 21/232 (9%), Positives = 49/232 (21%), Gaps = 10/232 (4%)
Query: 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGN 65
S + + + I P +L + + R + S + + + N
Sbjct: 9 SNRVFLCQESKVTEI-PS----DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 63
Query: 66 KLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLS-----GSLP 120
+ I + + + L +
Sbjct: 64 DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK 123
Query: 121 ACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180
L I + + + L + N + ++
Sbjct: 124 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNL 183
Query: 181 FSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNN 232
NN + G L + R+ +L L+ + N
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 7e-05
Identities = 9/44 (20%), Positives = 13/44 (29%)
Query: 214 IPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNK 257
D F L++S + LE L L + K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 5e-04
Identities = 10/49 (20%), Positives = 15/49 (30%), Gaps = 2/49 (4%)
Query: 95 IPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVP 143
D + LD+ ++ NL LR S L +P
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP 239
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 5e-05
Identities = 24/130 (18%), Positives = 44/130 (33%), Gaps = 3/130 (2%)
Query: 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182
++N R + L K+ + L ++FS N + L+ L + +
Sbjct: 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTLLVN 71
Query: 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPDSFGDLISLKFLNLSNNNLSGAIPAS 241
N + L +L L L N L D L SL +L + N ++
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131
Query: 242 LEKLSYLENL 251
L + + +
Sbjct: 132 LYVIYKVPQV 141
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 3e-04
Identities = 8/88 (9%), Positives = 25/88 (28%), Gaps = 2/88 (2%)
Query: 217 SFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESF 276
+ + + + L+L + I L + ++ S N++ ++
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLV 70
Query: 277 EGNELLCGSPNLQVPPCKTSIHHTSWKN 304
N + L + + +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNS 98
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 4e-04
Identities = 17/71 (23%), Positives = 24/71 (33%), Gaps = 11/71 (15%)
Query: 202 YLFLGYNRLQGSIPDSFGD------LISLKFLNLSNNNLSGAIPASL-----EKLSYLEN 250
L L L + D I L+ L L N + +L EK+ L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 251 LNLSFNKLEGE 261
L L+ N+ E
Sbjct: 307 LELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 5e-04
Identities = 13/109 (11%), Positives = 28/109 (25%), Gaps = 5/109 (4%)
Query: 198 KNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSG----AIPASLEKLSYLENLNL 253
K+L+ + + S+ + S+K + LS N + + ++ LE
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 254 SFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHTSW 302
S ++ L T+
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 115
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.003
Identities = 10/87 (11%), Positives = 22/87 (25%), Gaps = 11/87 (12%)
Query: 86 LEDNKLEGSIPDDI------CHLAELYRLDLDGNKLSGS-----LPACFSNLTSLRIVSL 134
L D L + L L L N++ + L + L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 135 GSNKLTSVPLTFWNLKDILNLNFSSNF 161
N+ + ++++ +
Sbjct: 310 NGNRFSEEDDVVDEIREVFSTRGRGEL 336
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.5 bits (80), Expect = 0.004
Identities = 23/107 (21%), Positives = 38/107 (35%), Gaps = 2/107 (1%)
Query: 178 GIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-DSFGDLISLKFLNLSNNNLSG 236
G+ + + + G +NL L++ + + L L+ L + + L
Sbjct: 12 GLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 237 AIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC 283
P + L LNLSFN LE + + GN L C
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 499 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.88 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.87 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.87 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.87 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.87 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.86 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.86 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.86 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.86 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.86 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.86 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.85 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.85 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.85 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.85 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.85 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.85 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.84 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.84 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.84 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.84 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.83 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.83 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.83 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.83 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.83 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.83 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.83 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.83 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.83 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.82 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.82 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.81 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.81 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.81 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.81 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.81 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.81 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.8 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.8 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.8 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.8 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.8 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.8 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.79 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.79 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.79 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.79 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.79 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.79 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.78 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.78 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.77 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.76 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.76 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.76 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.76 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.75 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.75 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.74 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.72 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.71 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.7 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.69 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.68 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.66 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.65 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.64 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.62 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.62 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.6 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.6 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.6 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.59 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.54 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.53 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.48 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.46 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.46 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.74 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.64 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.07 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.96 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.56 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.43 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 95.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 86.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 81.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 80.69 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=9.7e-33 Score=263.73 Aligned_cols=257 Identities=32% Similarity=0.582 Sum_probs=235.9
Q ss_pred cccEEEcccCCCcc--cCCccccCCCCCCEEeccC-CcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEE
Q 010856 32 SLEDFRMYNCNISG--GIPEEISNLTNSTIVNLGG-NKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRL 108 (499)
Q Consensus 32 ~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 108 (499)
+++.|+|++|++++ .+|..+.++++|++|+|++ |++++.+|..|.++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 59999999999987 4788999999999999987 88998899999999999999999999999889999999999999
Q ss_pred eeecCCCCCcCCccccCCccCCeeeccccCCCC-CCccccCCCCC-cEEEcCCCcCCCCCcccccCCCCccEEEccCCcc
Q 010856 109 DLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS-VPLTFWNLKDI-LNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNF 186 (499)
Q Consensus 109 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 186 (499)
++++|.+.+..|..+..++.|+.+++++|.++. +|..+..+.++ +.+++++|++++..+..+..+..+ .++++++..
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 999999999999999999999999999999985 88888888876 899999999998888888877655 799999999
Q ss_pred cccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCC
Q 010856 187 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGG 266 (499)
Q Consensus 187 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 266 (499)
.+..|..+..+++|+.+++++|.+.+.+ ..+..+++|+.|++++|++++.+|..+.++++|++|+|++|+|+|.+|...
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 9999999999999999999999998654 468889999999999999999999999999999999999999999999887
Q ss_pred CCCCccccccCCCcCCCCCCCCCCCCC
Q 010856 267 SFGNFSAESFEGNELLCGSPNLQVPPC 293 (499)
Q Consensus 267 ~~~~l~~~~l~~N~~~c~~~~~~~~~~ 293 (499)
.+..+..+++.||+.+||.| +|+|
T Consensus 289 ~L~~L~~l~l~~N~~l~g~p---lp~c 312 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSP---LPAC 312 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTT---SSCC
T ss_pred cCCCCCHHHhCCCccccCCC---CCCC
Confidence 88899999999999999975 3566
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=8.7e-31 Score=250.05 Aligned_cols=251 Identities=30% Similarity=0.446 Sum_probs=227.0
Q ss_pred CCCEEECcCCCCCcc--CChhccccccccccEEEccc-CCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCC
Q 010856 6 SLTLIYLSNNPLDGI--LPKTSVGNLSHSLEDFRMYN-CNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQ 82 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~--~~~~~~~~l~~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 82 (499)
+++.|+|++|.+++. .|. .+++++ +|++|+|++ |++++.+|..|+++++|++|+|++|++.+..+..+..+.+|+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~-~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPS-SLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CEEEEEEECCCCSSCEECCG-GGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred EEEEEECCCCCCCCCCCCCh-HHhcCc-cccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 589999999999874 566 889999 999999987 899999999999999999999999999999999999999999
Q ss_pred eEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccC-CeeeccccCCCC-CCccccCCCCCcEEEcCCC
Q 010856 83 GLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSL-RIVSLGSNKLTS-VPLTFWNLKDILNLNFSSN 160 (499)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n 160 (499)
.+++++|.+....|..+..++.|+.+++++|.+.+..|..+..+..+ +.+++++|+++. .|..+..+. ...++++.+
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~-~~~l~l~~~ 207 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 99999999999999999999999999999999999999988888876 889999999987 555565554 557999999
Q ss_pred cCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcc
Q 010856 161 FLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240 (499)
Q Consensus 161 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 240 (499)
...+..+..+..+++++.+++++|.+.+.++ .+..+++|+.|+|++|++++.+|..|..+++|++|+|++|++++.+|.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 9988899999999999999999999987654 688899999999999999999999999999999999999999988884
Q ss_pred cccCCCCCCEEEccCCcC-ccc
Q 010856 241 SLEKLSYLENLNLSFNKL-EGE 261 (499)
Q Consensus 241 ~~~~l~~L~~L~l~~N~l-~~~ 261 (499)
+..+++|+.+++++|+. .|.
T Consensus 287 -~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 287 -GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp -STTGGGSCGGGTCSSSEEEST
T ss_pred -cccCCCCCHHHhCCCccccCC
Confidence 57889999999999984 443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=2.9e-27 Score=224.50 Aligned_cols=267 Identities=23% Similarity=0.283 Sum_probs=226.8
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEe
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLG 85 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 85 (499)
.++++|.++++++.+++. +++++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|..|.++++|+.|+
T Consensus 11 ~~~~~~C~~~~L~~lP~~-----l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~ 85 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKD-----LPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85 (305)
T ss_dssp ETTEEECTTSCCCSCCCS-----CCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred cCCEEEecCCCCCccCCC-----CCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence 467889999999866432 345899999999999988778899999999999999999988899999999999999
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC---CCccccCCCCCcEEEcCCCcC
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS---VPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~~~~~~~l~~L~~L~l~~n~l 162 (499)
+++|+++.. |.. ....++.|++.+|.+....+..+.....+..++...|.... .+..+..+++|+.+++++|.+
T Consensus 86 l~~n~l~~l-~~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l 162 (305)
T d1xkua_ 86 LSKNQLKEL-PEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162 (305)
T ss_dssp CCSSCCSBC-CSS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred ccCCccCcC-ccc--hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCc
Confidence 999999854 433 34578999999999998877778888889999998887654 345678899999999999998
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
+.. +.. ..++|+.|++++|.++...+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+. +|..+
T Consensus 163 ~~l-~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l 238 (305)
T d1xkua_ 163 TTI-PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGL 238 (305)
T ss_dssp CSC-CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTT
T ss_pred ccc-Ccc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc-ccccc
Confidence 864 332 35789999999999998889999999999999999999999889999999999999999999995 57789
Q ss_pred cCCCCCCEEEccCCcCcccCCCC-------CCCCCccccccCCCcCCCC
Q 010856 243 EKLSYLENLNLSFNKLEGEIPRG-------GSFGNFSAESFEGNELLCG 284 (499)
Q Consensus 243 ~~l~~L~~L~l~~N~l~~~~~~~-------~~~~~l~~~~l~~N~~~c~ 284 (499)
..+++|+.|++++|+|+...... .....+..+++.||||.+.
T Consensus 239 ~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred ccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 99999999999999998643221 2345678899999998764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=3.9e-27 Score=223.62 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=218.0
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
+++++|+|++|+|+.+.+. .+.+++ +|++|++++|.+..+.|.+|.++++|++|++++|+++.+... ....++.|
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~-~f~~l~-~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~---~~~~l~~L 105 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDG-DFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK---MPKTLQEL 105 (305)
T ss_dssp TTCCEEECCSSCCCCBCTT-TTTTCT-TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS---CCTTCCEE
T ss_pred CCCCEEECcCCcCCCcChh-Hhhccc-cccccccccccccccchhhhhCCCccCEecccCCccCcCccc---hhhhhhhh
Confidence 6799999999999987665 788888 999999999999998899999999999999999999955432 34578999
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCC--CcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcC
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLS--GSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFL 162 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l 162 (499)
++.+|.+....+..+.....+..++...|... ...+..+..+++|+.+++++|.++.+|..+ +++|+.|++++|.+
T Consensus 106 ~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~ 183 (305)
T d1xkua_ 106 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKI 183 (305)
T ss_dssp ECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCC
T ss_pred hccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCccc--CCccCEEECCCCcC
Confidence 99999999877777888888999999888654 334567888999999999999999987654 58999999999999
Q ss_pred CCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccc
Q 010856 163 TSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASL 242 (499)
Q Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~ 242 (499)
+...+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|..|..+++|+.|++++|+|+......|
T Consensus 184 ~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f 262 (305)
T d1xkua_ 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 262 (305)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhc
Confidence 9888899999999999999999999999999999999999999999999 457789999999999999999997655444
Q ss_pred ------cCCCCCCEEEccCCcCcc
Q 010856 243 ------EKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 243 ------~~l~~L~~L~l~~N~l~~ 260 (499)
..+++|+.|++++|+++.
T Consensus 263 ~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 263 CPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cCcchhcccCCCCEEECCCCcCcc
Confidence 457889999999999973
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.3e-28 Score=226.64 Aligned_cols=207 Identities=28% Similarity=0.265 Sum_probs=111.4
Q ss_pred CCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee-cCCCCCcCCccccCCccCCeeecc
Q 010856 57 STIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD-GNKLSGSLPACFSNLTSLRIVSLG 135 (499)
Q Consensus 57 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~~~~l~~L~~L~L~ 135 (499)
+++|+|++|+|+.+.+.+|.++++|++|++++|++..+.+..+..+..++.+... .|.++...+..|.++++|+.|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 4444444444443333444444444444444444444444444444444444332 333333444444555555555555
Q ss_pred ccCCCCCC-ccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCC
Q 010856 136 SNKLTSVP-LTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI 214 (499)
Q Consensus 136 ~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 214 (499)
+|.+..++ ..+...++|+.+++++|.++++.+..|..+++|+.|++++|++++..+..|.++++|+++++++|+++++.
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 55544432 23334455555555555555544555555566666666666666555666666666666666666666666
Q ss_pred CccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCC
Q 010856 215 PDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIP 263 (499)
Q Consensus 215 ~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 263 (499)
|..|..+++|++|++++|++.+..+..|..+++|++|++++|++.+..+
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 6666666666666666666666666666666666666666666665443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.4e-28 Score=226.60 Aligned_cols=252 Identities=22% Similarity=0.254 Sum_probs=214.7
Q ss_pred CEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecc
Q 010856 8 TLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLE 87 (499)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 87 (499)
..++.++++++.+ |. .+|.++++|+|++|+|+.+.+.+|.++++|++|++++|++..+.+..+..+..++.++..
T Consensus 14 ~~v~c~~~~L~~i-P~----~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~ 88 (284)
T d1ozna_ 14 VTTSCPQQGLQAV-PV----GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88 (284)
T ss_dssp CEEECCSSCCSSC-CT----TCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred eEEEcCCCCCCcc-CC----CCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc
Confidence 4568888888854 43 245689999999999998888899999999999999999998888889999999998765
Q ss_pred -cccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCc-cccCCCCCcEEEcCCCcCCCC
Q 010856 88 -DNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL-TFWNLKDILNLNFSSNFLTSP 165 (499)
Q Consensus 88 -~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~ 165 (499)
.|.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|+++.++. .+..+++|+.|++++|+++.+
T Consensus 89 ~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l 168 (284)
T d1ozna_ 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (284)
T ss_dssp SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc
Confidence 667777778889999999999999999998888888999999999999999999864 577889999999999999998
Q ss_pred CcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCC
Q 010856 166 LPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKL 245 (499)
Q Consensus 166 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 245 (499)
.+..|.++++|+.+++++|++++..|..|.++++|++|++++|++.+..+..|..+++|+.|++++|++...-+ ...-.
T Consensus 169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~ 247 (284)
T d1ozna_ 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLW 247 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHH
T ss_pred chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHH
Confidence 88999999999999999999999999999999999999999999999888999999999999999999874322 11111
Q ss_pred CCCCEEEccCCcCcccCCCC
Q 010856 246 SYLENLNLSFNKLEGEIPRG 265 (499)
Q Consensus 246 ~~L~~L~l~~N~l~~~~~~~ 265 (499)
..++.+....+.+.+..|..
T Consensus 248 ~~l~~~~~~~~~~~C~~p~~ 267 (284)
T d1ozna_ 248 AWLQKFRGSSSEVPCSLPQR 267 (284)
T ss_dssp HHHHHCCSEECCCBEEESGG
T ss_pred HHHHhCcCCCCceEeCCchH
Confidence 23445555667777655543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=6e-26 Score=222.48 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=165.7
Q ss_pred CCCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCe
Q 010856 4 CKSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQG 83 (499)
Q Consensus 4 l~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 83 (499)
+.+|++|++++|+|++. . .+..++ +|++|++++|+|+++. .|+++++|++|++++|++++..+ +.++++|+.
T Consensus 43 l~~l~~L~l~~~~I~~l-~--gl~~L~-nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~ 114 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI-D--GVEYLN-NLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITP--LANLTNLTG 114 (384)
T ss_dssp HTTCCEEECCSSCCCCC-T--TGGGCT-TCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hCCCCEEECCCCCCCCc-c--ccccCC-CCCEEeCcCCcCCCCc--cccCCcccccccccccccccccc--ccccccccc
Confidence 46788888888888764 1 455666 8888888888888653 38888888888888888875433 778888888
Q ss_pred EecccccccccC---------------------------------------------------------------Ccccc
Q 010856 84 LGLEDNKLEGSI---------------------------------------------------------------PDDIC 100 (499)
Q Consensus 84 L~L~~n~l~~~~---------------------------------------------------------------~~~~~ 100 (499)
|++++|.+++.. ...+.
T Consensus 115 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (384)
T d2omza2 115 LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194 (384)
T ss_dssp EECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccc
Confidence 888776654210 11234
Q ss_pred CcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEE
Q 010856 101 HLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGID 180 (499)
Q Consensus 101 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 180 (499)
.+++++.+++++|.+++..+ +..+++|+.|++++|++++++ .+..+++|+.|++++|.+++.. .+..+++|+.|+
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~ 269 (384)
T d2omza2 195 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELK 269 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred cccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCcc-hhhcccccchhccccCccCCCC--cccccccCCEee
Confidence 45667777777777775543 344567777777777777655 4566677777777777776543 356667777777
Q ss_pred ccCCcccccCc--------------------ccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcc
Q 010856 181 FSMNNFSGVIP--------------------TEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPA 240 (499)
Q Consensus 181 l~~n~l~~~~~--------------------~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 240 (499)
+++|++++..+ ..+..+++++.|++++|++++.. .+..+++|+.|++++|++++. +
T Consensus 270 l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~- 345 (384)
T d2omza2 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S- 345 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-
T ss_pred ccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-
Confidence 77776654321 22444556666666666665432 255666666666666666532 2
Q ss_pred cccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCC
Q 010856 241 SLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGN 279 (499)
Q Consensus 241 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N 279 (499)
.+..+++|++|++++|++++..| ...++.++.+++++|
T Consensus 346 ~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 346 SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 45566666666666666665433 344555666666555
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.4e-26 Score=213.40 Aligned_cols=201 Identities=25% Similarity=0.205 Sum_probs=124.2
Q ss_pred cCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCe
Q 010856 52 SNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRI 131 (499)
Q Consensus 52 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 131 (499)
.+...+.+++.+++.++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++... .++.+++|+.
T Consensus 7 ~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccc
Confidence 345566667788877774 444342 46777778777777666667777777777777777777432 3456677777
Q ss_pred eeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCC
Q 010856 132 VSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 211 (499)
Q Consensus 132 L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 211 (499)
|++++|+++..+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+++
T Consensus 82 L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp EECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 77777777766666666666666666666666655555555666666666666665555555555555555555555555
Q ss_pred CCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcC
Q 010856 212 GSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKL 258 (499)
Q Consensus 212 ~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 258 (499)
+..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 555555555555555555555555 3344444445555554444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.2e-25 Score=206.88 Aligned_cols=202 Identities=26% Similarity=0.250 Sum_probs=102.6
Q ss_pred CCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcC
Q 010856 79 QKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFS 158 (499)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~ 158 (499)
..+.+++.++++++. +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+|+.++. +..+++|++|+++
T Consensus 10 ~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLDLS 85 (266)
T ss_dssp TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEEECC
T ss_pred CCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-ccccccccccccc
Confidence 334444555555552 333331 345555555555554444455555555555555555555442 3445555555555
Q ss_pred CCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccC
Q 010856 159 SNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAI 238 (499)
Q Consensus 159 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 238 (499)
+|+++. .+..+..+++|+.|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.+++++|++++..
T Consensus 86 ~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 86 HNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred cccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence 555543 2334455555555555555555544455555555555555555555444455555555555555555555555
Q ss_pred cccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcCCCCC
Q 010856 239 PASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS 285 (499)
Q Consensus 239 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~~c~~ 285 (499)
+..|..+++|++|+|++|+|+...+.....+.++.+++.||||.|+|
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCc
Confidence 55555555555555555555532222233444555555555555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=1.4e-24 Score=212.64 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=191.0
Q ss_pred ECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEeccccc
Q 010856 11 YLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNK 90 (499)
Q Consensus 11 ~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 90 (499)
.+..+.+++.... ..+. +|++|++++|+|+.+ +.+..+++|++|+|++|+|++..+ +.++++|++|++++|+
T Consensus 28 ~l~~~~~~~~~~~---~~l~-~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~ 99 (384)
T d2omza2 28 VLGKTNVTDTVSQ---TDLD-QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99 (384)
T ss_dssp HTTCSSTTSEECH---HHHT-TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HhCCCCCCCccCH---HHhC-CCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccc
Confidence 4556666665443 3445 899999999999865 468899999999999999996543 8999999999999999
Q ss_pred ccccCCccccCcccccEEeeecCCCCCcC---------------------------------------------------
Q 010856 91 LEGSIPDDICHLAELYRLDLDGNKLSGSL--------------------------------------------------- 119 (499)
Q Consensus 91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--------------------------------------------------- 119 (499)
+.+.. .+..+++|+.|++++|.+++..
T Consensus 100 i~~i~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (384)
T d2omza2 100 IADIT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177 (384)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTC
T ss_pred ccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccc
Confidence 98653 4889999999999988765311
Q ss_pred ------------CccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCccc
Q 010856 120 ------------PACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFS 187 (499)
Q Consensus 120 ------------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (499)
...+..+++++.+++++|.++.++. ....++|++|++++|.+++. ..+..+++|+.|++++|.++
T Consensus 178 ~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~ 254 (384)
T d2omza2 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS 254 (384)
T ss_dssp CEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred ccccccccccccccccccccccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccC
Confidence 1234456789999999999998764 56678999999999999864 46788999999999999998
Q ss_pred ccCcccccCCcCCceeeCcCCcCCCCCC--------------------ccccCCCCCCEEeCCCCcCCccCcccccCCCC
Q 010856 188 GVIPTEIGGLKNLEYLFLGYNRLQGSIP--------------------DSFGDLISLKFLNLSNNNLSGAIPASLEKLSY 247 (499)
Q Consensus 188 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~--------------------~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 247 (499)
+.. .+..+++|++|++++|++++..+ ..+..+++++.|++++|++++.. .+..+++
T Consensus 255 ~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~ 330 (384)
T d2omza2 255 NLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTK 330 (384)
T ss_dssp CCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTT
T ss_pred CCC--cccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCc--ccccCCC
Confidence 654 47889999999999998875421 22444566666677777666543 2566677
Q ss_pred CCEEEccCCcCcccCCCCCCCCCccccccCCCcC
Q 010856 248 LENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281 (499)
Q Consensus 248 L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~ 281 (499)
|++|++++|++++ ++....+++++.+++++|..
T Consensus 331 L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l 363 (384)
T d2omza2 331 LQRLFFANNKVSD-VSSLANLTNINWLSAGHNQI 363 (384)
T ss_dssp CCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcC
Confidence 7777777777664 33344556667777766653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.3e-23 Score=196.29 Aligned_cols=136 Identities=18% Similarity=0.208 Sum_probs=111.7
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.+|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++...+ ..++++|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--EEEEEEE
Confidence 4699999999999999999995 579999999998766556788999999999999999999999998744 3456778
Q ss_pred ccCCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|+.|+.+..+... +...+.++.|++.||+|||+ |+||.||+++.++.++++|||+++.+
T Consensus 98 y~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheee
Confidence 7766554444322 22344556899999998876 89999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.87 E-value=3.1e-24 Score=200.60 Aligned_cols=140 Identities=18% Similarity=0.144 Sum_probs=110.8
Q ss_pred HHHHhhhcccccccccCCcceEEEEEeC-CCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 356 LFRATDEFSENNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 356 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
++...++|++.+.||+|+||+||+|+.+ +++.||||+++... ...++|.+|++++++++|||||+++|+|...+ ..
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~ 88 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PF 88 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SC
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC--ee
Confidence 3344568999999999999999999974 68999999997554 34678999999999999999999999987643 34
Q ss_pred eeeecccCCC-ccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSAS-ASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~~-~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++||+.++ +...+.. .+.....++.|+++||+|||+ |+||.|||++.++.+|++|||+++..
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 5567777554 4333322 222334456899999999876 89999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.9e-23 Score=193.21 Aligned_cols=137 Identities=15% Similarity=0.163 Sum_probs=108.1
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++...+ ..+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~--~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--eeEEE
Confidence 46799999999999999999996 579999999997654 233467899999999999999999999988743 44556
Q ss_pred ecccC-CCcccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSS-ASASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~-~~~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+||+. |++.+.+..... ..+.++.|+++||+|||+ |+||+||++++++.++++|||+++.+
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence 77775 455555543332 234456899999999977 89999999999999999999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=7.7e-24 Score=195.82 Aligned_cols=138 Identities=13% Similarity=0.129 Sum_probs=106.1
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
++|++.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|++++++++|||||++++++.+.+....+++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999996 579999999997654 2335678999999999999999999999876444445567
Q ss_pred ecccCCCcc-cccc--------ccccccccccccccccceee-----------ccCCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASAS-ASLV--------SSLTLSRPAKGGGFRGCVLW-----------HVGVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~-~~l~--------~~~~~~~~~~~~i~~gl~yL-----------H~~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+||+.|+.+ +.+. ..+.....++.|++.||+|| |+++||.||+++.++.++++|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 777765543 3332 12233455578999999998 558999999999999999999999865
Q ss_pred c
Q 010856 498 L 498 (499)
Q Consensus 498 ~ 498 (499)
+
T Consensus 164 ~ 164 (269)
T d2java1 164 L 164 (269)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=9.7e-24 Score=195.82 Aligned_cols=136 Identities=15% Similarity=0.211 Sum_probs=108.8
Q ss_pred HhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
..++|+..+.||+|+||+||+|++++++.||||+++... ...+.|.+|++++++++|||||+++|++... .. ++++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~-~iv~ 86 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE--PI-YIIT 86 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC-EEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC--Ce-EEEE
Confidence 346789999999999999999999888899999997644 3457899999999999999999999987542 22 4566
Q ss_pred cccCCCcc-ccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 439 HHSSASAS-ASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~~~-~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
||+.++.+ +.+.. .+.....++.||++||+|||+ ++||.||++++++.++++|||+++.+
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 66655443 33322 223345567999999999866 89999999999999999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=2.2e-23 Score=192.45 Aligned_cols=135 Identities=17% Similarity=0.119 Sum_probs=105.3
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+ ..++++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC--ceEEEEEe
Confidence 4688899999999999999999888899999997644 34578999999999999999999999997643 34456777
Q ss_pred cCCCc-ccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 441 SSASA-SASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 441 ~~~~~-~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+.++. .+.+... +.....++.|+|+||+|||+ ++||.|++++.++.+|++|||+++..
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence 75553 3333221 22234467999999999876 89999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=2.4e-23 Score=194.31 Aligned_cols=135 Identities=19% Similarity=0.279 Sum_probs=110.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+.|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++...+ ..++++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--eEEEEEe
Confidence 4588899999999999999996 579999999998776666788999999999999999999999987743 4455778
Q ss_pred ccCCCccccc-cc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASL-VS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l-~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+.|+.+..+ .. .+...+.++.|+++||+|||+ |+||.||+++.++.++++|||+++.
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhc
Confidence 8766544332 21 222344556899999999966 8999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=2.4e-23 Score=198.01 Aligned_cols=136 Identities=12% Similarity=0.095 Sum_probs=110.1
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|+..+.||+|+||+||+|+. .+|+.||+|+++... ....+++.+|++++++++|||||+++++|...+ ..+++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--EEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEE
Confidence 46899999999999999999996 579999999997654 344578999999999999999999999998743 44567
Q ss_pred ecccCCC-ccccccc----cccccccccccccccceeecc-------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSAS-ASASLVS----SLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~-~~~~l~~----~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+||+.|+ +...+.. .+...+.++.|+++||+|||+ |+||+|||+++++.++++|||+++.
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 7777654 4433432 223344556899999999984 8999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.86 E-value=3e-23 Score=195.06 Aligned_cols=136 Identities=18% Similarity=0.160 Sum_probs=100.2
Q ss_pred hhcccccccccCCcceEEEEEeC-CC---CEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DR---MEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
++|+..+.||+|+||+||+|+.+ ++ ..||||.+.... ....+.|.+|++++++++|||||+++|+|...+ ..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--PVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC--EEE
Confidence 34566789999999999999964 33 368999886544 334578999999999999999999999987643 445
Q ss_pred eeecccCCCcccc-ccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASASAS-LVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~~-l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++||+.++.+.. +.. .+.....++.|||+||+|||+ ++||.|||++.++.+|++|||+++.+
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 6778886664443 222 122234556899999999977 89999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=6.3e-23 Score=188.39 Aligned_cols=134 Identities=13% Similarity=0.104 Sum_probs=108.8
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
++|+..+.||+|+||+||+|+.++++.||||+++... ...++|.+|++++++++|||||+++|+|... ...++++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEEEc
Confidence 5788999999999999999999888899999998654 3457899999999999999999999998763 344557777
Q ss_pred cCCCc-cccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 441 SSASA-SASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 441 ~~~~~-~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+.++. ...+.. .+.....++.|+++||+|||+ +++|.|++++.++.+|++|||+++.
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhee
Confidence 76543 333221 122344567899999999987 7999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.86 E-value=4.9e-23 Score=194.14 Aligned_cols=135 Identities=21% Similarity=0.217 Sum_probs=108.6
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG---RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
..|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++...+ ..++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--EEEE
Confidence 4589999999999999999995 5799999999976542 23467899999999999999999999987643 4456
Q ss_pred eecccCCCcccccc-c----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSASASASLV-S----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~~~~~l~-~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++||+.|+....+. . .+.....++.||+.||+|||+ |+||.||++++++.++++|||++..
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence 77887666544322 1 223345557999999999876 8999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1e-22 Score=187.39 Aligned_cols=136 Identities=16% Similarity=0.201 Sum_probs=109.4
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|++.+.||+|+||+||+|+. .+|+.||+|++.+.. ....+.+.+|++++++++|||||++++++...+ ..+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--RVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC--EEE
Confidence 46799999999999999999996 479999999997543 344677999999999999999999999998743 345
Q ss_pred eeecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++||+.| ++.+.+.... .....++.|+++||+|||+ |+||.|++++.++.++++|||+++.
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeee
Confidence 57777765 4444443322 2344456899999999876 8999999999999999999999864
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=4.9e-21 Score=174.69 Aligned_cols=199 Identities=17% Similarity=0.145 Sum_probs=95.6
Q ss_pred CCCEEeccCCcCCccCCccccCCCCCCeEeccccccccc-CCccccCcccccEEeeec-CCCCCcCCccccCCccCCeee
Q 010856 56 NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGS-IPDDICHLAELYRLDLDG-NKLSGSLPACFSNLTSLRIVS 133 (499)
Q Consensus 56 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 133 (499)
++++|+|++|+|+.+.+..|.++++|++|++++|.+... .+..|.+++.++++.+.. |++....+..|.++++|+.|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 344444444444433333444444444444444443321 222344444444444332 334334444444444444444
Q ss_pred ccccCCCCCCc--cccCCCCCcEEEcCCCcCCCCCcccccCCC-CccEEEccCCcccccCcccccCCcCCceeeCcCCcC
Q 010856 134 LGSNKLTSVPL--TFWNLKDILNLNFSSNFLTSPLPLEIGNLK-VLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRL 210 (499)
Q Consensus 134 L~~n~l~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 210 (499)
+++|++...+. .+..+..+..+...++.+..+.+..|..++ .++.|++++|+++.+.+..+.....++.+++++|++
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l 189 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTC
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhcccccccccc
Confidence 44444443321 122233344444444444444444444443 556666666666654444443322233334566666
Q ss_pred CCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEcc
Q 010856 211 QGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 254 (499)
Q Consensus 211 ~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 254 (499)
+.+.+..|.++++|+.|++++|+|+...+..|.++++|+.+++.
T Consensus 190 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred ccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 65555566777777777777777775555556666555555443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.1e-22 Score=189.78 Aligned_cols=136 Identities=14% Similarity=0.138 Sum_probs=109.3
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++...+ ..++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS--EEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC--EEEE
Confidence 5799999999999999999996 579999999997543 344577999999999999999999999987643 3455
Q ss_pred eecccCCC-cccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHSSAS-ASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++||+.|+ +.+.+... +...+.++.|++.||+|||+ |+||+||++++++.++++|||++..+
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceec
Confidence 67777654 43433332 22344456899999999876 89999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=3.7e-23 Score=191.99 Aligned_cols=134 Identities=18% Similarity=0.236 Sum_probs=105.0
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.++|.+.+.||+|+||+||+|+++ ..||||+++... ....+.|.+|++++++++|||||++++++... ..+++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~---~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc---EEEEE
Confidence 467889999999999999999863 369999997543 34567899999999999999999999987542 23456
Q ss_pred ecccC-CCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 438 FHHSS-ASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~-~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+||+. |++.+.+... +.....++.|||+||+|||+ ++||.|||++.++.+|++|||+++..
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 77775 4444444322 22234456899999999877 89999999999999999999998653
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=1.4e-20 Score=169.76 Aligned_cols=204 Identities=22% Similarity=0.291 Sum_probs=139.5
Q ss_pred cEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecC
Q 010856 34 EDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGN 113 (499)
Q Consensus 34 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 113 (499)
..++++.+.+++.. .++.+.+|++|++.+|.|+.. ..+..+++|++|++++|.+++.. .+..+++|+++++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--cccccccccccccccc
Confidence 33455666666443 345566777777777777643 24667777777777777776443 3667777777777777
Q ss_pred CCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCccc
Q 010856 114 KLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTE 193 (499)
Q Consensus 114 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 193 (499)
.++.. ..+.++++|+.+++++|....++ .+...+.+..+.++++.+... ..+..+++|+.|++++|.+.+. ..
T Consensus 96 ~~~~i--~~l~~l~~L~~l~l~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~ 168 (227)
T d1h6ua2 96 PLKNV--SAIAGLQSIKTLDLTSTQITDVT-PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TP 168 (227)
T ss_dssp CCSCC--GGGTTCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG
T ss_pred ccccc--ccccccccccccccccccccccc-hhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hh
Confidence 77643 24666777777777777766544 345567777777777776543 3456677788888888877643 34
Q ss_pred ccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEcc
Q 010856 194 IGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLS 254 (499)
Q Consensus 194 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 254 (499)
+.++++|++|++++|++++. ..+..+++|++|++++|++++.. .+.++++|+.|+++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred hcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 77788888888888888754 34778888888888888888554 37788888888886
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.85 E-value=1.9e-22 Score=190.76 Aligned_cols=137 Identities=15% Similarity=0.145 Sum_probs=110.3
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++...+ ..+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ--QIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS--EEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC--eee
Confidence 46799999999999999999996 579999999997542 345678999999999999999999999988743 445
Q ss_pred eeecccCCCcccccc-cc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASASASLV-SS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~~l~-~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++||+.|+....+. .. ....+.++.|++.||+|||+ ++||.|||++.++.++++|||+++..
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 677887766443322 21 12234456899999999887 79999999999999999999998754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=1.1e-20 Score=170.41 Aligned_cols=202 Identities=19% Similarity=0.323 Sum_probs=145.0
Q ss_pred EECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccc
Q 010856 10 IYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDN 89 (499)
Q Consensus 10 L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 89 (499)
++++.+++++... ...+. +|++|++.+|+|+.+ ..+..+++|++|++++|.+++..+ +..+++|+.+++++|
T Consensus 24 ~~l~~~~~~d~~~---~~~l~-~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 24 IAAGKSNVTDTVT---QADLD-GITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHTTCSSTTSEEC---HHHHH-TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHhCCCCcCCcCC---HHHcC-CcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 4556666665533 23445 788888888888754 347788888888888888875433 777888888888888
Q ss_pred cccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCccc
Q 010856 90 KLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLE 169 (499)
Q Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 169 (499)
.++.. ..+.++++|+.++++++...+. ..+...+.++.+.++++.+.... .+..+++|++|++++|.+++. ..
T Consensus 96 ~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~~~~--~~ 168 (227)
T d1h6ua2 96 PLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSDL--TP 168 (227)
T ss_dssp CCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GG
T ss_pred ccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh-hhccccccccccccccccccc--hh
Confidence 77643 3577788888888888877643 33566677888888887776643 356677888888888877643 23
Q ss_pred ccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCC
Q 010856 170 IGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLS 230 (499)
Q Consensus 170 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 230 (499)
+.++++|+.|++++|++++. ..+.++++|++|++++|+++++. .+..+++|+.|+++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred hcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 67788888888888888754 33777888888888888887543 37788888888876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.4e-22 Score=189.10 Aligned_cols=136 Identities=18% Similarity=0.195 Sum_probs=103.0
Q ss_pred hhcccccccccCCcceEEEEEeCC-C----CEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGD-R----MEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
+.|+..++||+|+||+||+|.++. + ..||||+++.... ...++|.+|++++++++|||||+++|++...+ ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--PM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC--ce
Confidence 468888999999999999999642 2 4799999976542 33567999999999999999999999987643 34
Q ss_pred eeeecccCCCcccccc-c-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSASASASLV-S-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~-~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++|++.++...... . .+.....++.|+++||+|||+ ++||.|||++.++.+|++|||+++.+
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 5567777665433321 1 122234557899999999966 89999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.84 E-value=2.8e-22 Score=192.30 Aligned_cols=136 Identities=15% Similarity=0.134 Sum_probs=108.3
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+.|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++...+ ..++++|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--EMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--EEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEE
Confidence 5699999999999999999996 579999999998765455677899999999999999999999987633 4455777
Q ss_pred ccCCC-ccccccc-----cccccccccccccccceeecc------CCCcccEEEe--eCCCeEEEEEEEeecc
Q 010856 440 HSSAS-ASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFV--LEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~-~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~--~~~~~~~~~f~~~~~~ 498 (499)
|+.|+ +.+.+.. .+.....++.||+.||+|||+ |+||.||+++ .++.++++|||++..+
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 77654 4333322 223344556899999999876 8999999997 4678999999998754
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=1.1e-20 Score=172.25 Aligned_cols=219 Identities=13% Similarity=0.075 Sum_probs=173.2
Q ss_pred CCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCc-cCCccccCCCCCCeEe
Q 010856 7 LTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNG-SIPITLSKLQKLQGLG 85 (499)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~ 85 (499)
.+.++.++++++.+++. ++.++++|++++|.|+.+.+.+|.++++|++|++++|.+.. +.+..|.+++++++++
T Consensus 10 ~~~i~c~~~~l~~iP~~-----l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 10 NRVFLCQESKVTEIPSD-----LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp SSEEEEESCSCSSCCSC-----SCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred CCEEEEeCCCCCCcCCC-----CCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence 36788999998854332 34589999999999998888889999999999999999875 4466789999999999
Q ss_pred ccc-ccccccCCccccCcccccEEeeecCCCCCcCCc-cccCCccCCeeeccccCCCCCCc-cccCC-CCCcEEEcCCCc
Q 010856 86 LED-NKLEGSIPDDICHLAELYRLDLDGNKLSGSLPA-CFSNLTSLRIVSLGSNKLTSVPL-TFWNL-KDILNLNFSSNF 161 (499)
Q Consensus 86 L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~-~~~~l-~~L~~L~l~~n~ 161 (499)
+.. |.+....+..|.++++|++|++++|.+....+. .+..+..+..+...++++..++. .+..+ ..++.|++++|+
T Consensus 85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~ 164 (242)
T d1xwdc1 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 164 (242)
T ss_dssp EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred ccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccc
Confidence 864 678878888899999999999999999854332 33455666677778888888653 45544 478999999999
Q ss_pred CCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCC
Q 010856 162 LTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLS 230 (499)
Q Consensus 162 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 230 (499)
++.+.+..+.....++.+++++|+++.+.+..|.++++|++|++++|+++.+.+..|.++++|+.+++.
T Consensus 165 l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 165 IQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred ccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 997666655544344455678899997777789999999999999999997777777777777666553
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=2.5e-22 Score=186.92 Aligned_cols=135 Identities=19% Similarity=0.171 Sum_probs=107.8
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|++.+.||+|+||+||+|+.++++.||||+++... ...+.|.+|+.++++++|||||+++|++... ..++++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecC---CeEEEEE
Confidence 46799999999999999999998888889999997554 3457899999999999999999999988542 2345677
Q ss_pred ccCCCccc-ccc------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 440 HSSASASA-SLV------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~-~l~------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
|+.++... .+. ..+.....++.||++||+|||+ ++||.||++++++.++++|||+++..
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 77655333 222 1233455667999999999987 89999999999999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=2e-22 Score=189.69 Aligned_cols=135 Identities=20% Similarity=0.244 Sum_probs=108.5
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++... ...+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--cceeEE
Confidence 5799999999999999999996 679999999996543 23457899999999999999999999999773 355668
Q ss_pred ecccCCCcccccc------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLV------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+|++.++....+. ..+...+.++.|++.||+|||+ |+||+||+++.++.++++|||++..
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 151 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCccee
Confidence 8888777544332 1223345557899999999987 7999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=3.3e-22 Score=189.73 Aligned_cols=136 Identities=18% Similarity=0.130 Sum_probs=105.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCC----EEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRM----EVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.+|+..+.||+|+||+||+|+. .+|+ .||+|+++... ....++|.+|++++++++|||||+++|+|...+ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--VQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS--EE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--ee
Confidence 4699999999999999999996 3454 58888886543 345678999999999999999999999997633 44
Q ss_pred eeeecccCCCcccccccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSASASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++++.+|++...+... +.....++.|||+||+|||+ ++||.|++++.++.+|++|||+++.+
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 556677777765544322 22244557899999999877 89999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=4.4e-22 Score=185.43 Aligned_cols=135 Identities=15% Similarity=0.197 Sum_probs=105.2
Q ss_pred hhcccccc-cccCCcceEEEEEeC---CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNL-IGKGGFGSVYKARLG---DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~-lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
++|...+. ||+|+||+||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|++... ..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eEE
Confidence 45667674 999999999999853 35679999997654 33467899999999999999999999988652 234
Q ss_pred eeecccCCCcccc-ccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 436 CLFHHSSASASAS-LVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 436 ~l~~~~~~~~~~~-l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++||+.++.+.. +.. ++.....++.|+|+||+|||+ ++||.|++++.++.+|++|||+++.+
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 5778876654333 222 222344557999999999876 89999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.83 E-value=4.2e-22 Score=190.95 Aligned_cols=137 Identities=16% Similarity=0.184 Sum_probs=109.1
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++...+ ..++++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--EMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT--EEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEE
Confidence 45799999999999999999996 579999999997665555678999999999999999999999987633 445677
Q ss_pred cccCC-Cccccccc-----cccccccccccccccceeecc------CCCcccEEEee--CCCeEEEEEEEeecc
Q 010856 439 HHSSA-SASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL--EPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~-~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~--~~~~~~~~f~~~~~~ 498 (499)
||+.| ++.+.+.. .+.....++.||+.||+|||+ ++||.||++.. ++.++++|||+++.+
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 77755 44444422 222344556899999999876 89999999964 467999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.83 E-value=6.8e-22 Score=186.15 Aligned_cols=137 Identities=13% Similarity=0.117 Sum_probs=98.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
.+.|+..+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|++++++++|||||++++++...+ ..+++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG--HLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS--EEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEE
Confidence 35599999999999999999996 479999999997654 233456889999999999999999999987643 34567
Q ss_pred ecccC-CCccccccccc----cccccccccccccceeecc------CCCcccEEEee---CCCeEEEEEEEeecc
Q 010856 438 FHHSS-ASASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---EPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~-~~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---~~~~~~~~f~~~~~~ 498 (499)
+||+. |++.+.+.... .....++.|++.||+|||+ |+||.|+++.. ++.++++|||++...
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 77776 45545443322 2344456899999999976 89999999953 567999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=7.8e-22 Score=187.88 Aligned_cols=136 Identities=15% Similarity=0.143 Sum_probs=109.9
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
.++|+..+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++.+.+ ..+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc--ccc
Confidence 46899999999999999999996 579999999997643 344678999999999999999999999998744 445
Q ss_pred eeecccCCC-cccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSAS-ASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~~-~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++||+.|+ +...+..... ..+.++.|++.||+|||+ |+||.|||++.++.++++|||+++.
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccc
Confidence 567777554 4344333222 344456899999999976 8999999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=7.6e-22 Score=182.26 Aligned_cols=136 Identities=17% Similarity=0.180 Sum_probs=103.7
Q ss_pred cccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcc--ccceeeee
Q 010856 363 FSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVI--TFTVCLCL 437 (499)
Q Consensus 363 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~--~~~~~~~l 437 (499)
|...+.||+|+||+||+|+. .+++.||+|.+.... ....+.+.+|++++++++|||||++++++... .....+++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 35667899999999999996 478999999997654 23456799999999999999999999998652 12334567
Q ss_pred ecccCCCcc-cccccc----ccccccccccccccceeecc--------CCCcccEEEee-CCCeEEEEEEEeecc
Q 010856 438 FHHSSASAS-ASLVSS----LTLSRPAKGGGFRGCVLWHV--------GVDFAAFVFVL-EPGVEVICFVFEILL 498 (499)
Q Consensus 438 ~~~~~~~~~-~~l~~~----~~~~~~~~~~i~~gl~yLH~--------~~~p~~~l~~~-~~~~~~~~f~~~~~~ 498 (499)
+||+.|+.+ +.+... +...+.++.||++||+|||+ |+||.||++++ ++.++++|||+++..
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 787765543 333322 22334556899999998875 68999999975 578999999998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.83 E-value=8.9e-22 Score=188.76 Aligned_cols=136 Identities=15% Similarity=0.120 Sum_probs=108.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~ 436 (499)
++|+..+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++...+ ..++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc--cccc
Confidence 5799999999999999999996 579999999997543 344678999999999999999999999987743 3344
Q ss_pred eeccc-CCCcccccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 437 LFHHS-SASASASLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~-~~~~~~~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+++++ +|++...+... +...+.++.|++.||+|||+ |+||.|||++.++.++++|||+++.+
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 55555 44544444322 23344556899999999965 89999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.2e-21 Score=183.70 Aligned_cols=136 Identities=17% Similarity=0.213 Sum_probs=107.3
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC------CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC------GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
+.|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++...+ .
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--D 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--E
Confidence 4699999999999999999996 579999999997643 123578999999999999999999999987743 4
Q ss_pred eeeeecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCC----CeEEEEEEEeecc
Q 010856 434 CLCLFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP----GVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~----~~~~~~f~~~~~~ 498 (499)
.++++||+.| ++.+.+.... ...+.++.|++.||+|||+ ++||.|++++.++ .++++|||++...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 4557777765 4444443322 2344556899999999976 8999999998765 4999999998653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.83 E-value=3.2e-22 Score=188.49 Aligned_cols=142 Identities=20% Similarity=0.168 Sum_probs=109.0
Q ss_pred HHHHHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEE
Q 010856 355 ELFRATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVA 427 (499)
Q Consensus 355 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~ 427 (499)
+++...++|+..+.||+|+||+||+|+.+ +++.||||+++.... ...++|.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 44455678999999999999999999852 457899999976543 33567999999999999999999999987
Q ss_pred ccccceeeeeecccC-CCccccccc----------------------------cccccccccccccccceeecc------
Q 010856 428 VITFTVCLCLFHHSS-ASASASLVS----------------------------SLTLSRPAKGGGFRGCVLWHV------ 472 (499)
Q Consensus 428 ~~~~~~~~~l~~~~~-~~~~~~l~~----------------------------~~~~~~~~~~~i~~gl~yLH~------ 472 (499)
..+ ....+++++. |++.+.+.. .+.....++.|+++||+|||+
T Consensus 87 ~~~--~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 87 VGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp SSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred cCC--ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 633 3344566654 444333321 111233446899999999976
Q ss_pred CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 473 GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 473 ~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++||.||+++.++.+|++|||+++.+
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~ 190 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNI 190 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred EEcccceEECCCCcEEEccchhheec
Confidence 89999999999999999999998653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.83 E-value=5.3e-22 Score=185.80 Aligned_cols=134 Identities=17% Similarity=0.212 Sum_probs=110.1
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|+..+.||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.++++++|||||++++++...+ ..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ceeEEE
Confidence 4789999999999999999998899999999996643 233578999999999999999999999988743 445677
Q ss_pred cccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 439 HHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 439 ~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
+++.++....+.. .....+.++.|++.||+|||+ |+||.||+++.++.++++|||.+.
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccce
Confidence 7877776554432 223344557899999999877 899999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.4e-21 Score=181.48 Aligned_cols=129 Identities=13% Similarity=0.128 Sum_probs=99.2
Q ss_pred cccccCCcceEEEEEeC---CCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeeccc
Q 010856 367 NLIGKGGFGSVYKARLG---DRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHHS 441 (499)
Q Consensus 367 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~~ 441 (499)
+.||+|+||+||+|.++ +++.||||+++... ....++|.+|++++++++|||||+++|+|.... .++++||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~---~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES---WMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS---EEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC---EEEEEEcC
Confidence 57999999999999853 35789999996543 233567999999999999999999999986522 34567777
Q ss_pred CCC-ccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 442 SAS-ASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 442 ~~~-~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
.++ +.+.+.... .....++.||++||+|||+ ++||.|++++.++.++++|||+++.+
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhc
Confidence 654 433333222 2344556899999999865 89999999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.3e-21 Score=179.82 Aligned_cols=134 Identities=19% Similarity=0.107 Sum_probs=104.1
Q ss_pred hhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++|++.+.||+|+||.||+|+. .|+.||||+++.. ...+.|.+|++++++++|||||+++|+|...+. ..++++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC-cEEEEEe
Confidence 45788899999999999999998 5778999999654 345789999999999999999999999865332 2345666
Q ss_pred cc-CCCccccccc------cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HS-SASASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~-~~~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+ +|++.+.+.. .+.....++.||++||+|||+ +++|.|++++.++.++++|||+++.
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccccee
Confidence 66 4455444432 333455667999999999987 8999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.1e-21 Score=181.82 Aligned_cols=135 Identities=19% Similarity=0.178 Sum_probs=97.4
Q ss_pred hhcccccccccCCcceEEEEEe--CCC--CEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCccccceeEEccccce
Q 010856 361 DEFSENNLIGKGGFGSVYKARL--GDR--MEVAVKVFNLQC---GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~--~~~--~~vavK~~~~~~---~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~ 433 (499)
++|+..+.||+|+||+||+|++ .++ ..||||++++.. ....++|.+|++++++++|||||+++|++... ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--ch
Confidence 5799999999999999999985 233 368999987653 23357899999999999999999999999652 23
Q ss_pred eeeeeccc-CCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 434 CLCLFHHS-SASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 434 ~~~l~~~~-~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
. +++||+ .|++.+.+.. .+.....++.|+|+||+|||+ ++||.||+++.++.++++|||+++.+
T Consensus 86 ~-lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 K-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp E-EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred h-eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 3 455555 4554433322 223344556899999999877 89999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.7e-21 Score=183.50 Aligned_cols=130 Identities=16% Similarity=0.188 Sum_probs=101.0
Q ss_pred ccccccCCcceEEEEEe-CCCCEEEEEEeeccCC-----ccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 366 NNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG-----RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
.++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++...+ ..++++|
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVFD 80 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehhh
Confidence 47899999999999996 5799999999965431 12356899999999999999999999987644 3456778
Q ss_pred ccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 440 HSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 440 ~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
|+.|+....+.. .+...+.++.||+.||+|||+ |+||.||+++.++.++++|||+++.
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccc
Confidence 887765554332 222344456899999999977 8999999999999999999999864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=2.6e-19 Score=157.70 Aligned_cols=177 Identities=20% Similarity=0.305 Sum_probs=107.6
Q ss_pred EEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCC
Q 010856 36 FRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKL 115 (499)
Q Consensus 36 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 115 (499)
+.+..+.+++..+ ...++++++|++++|.++.. ..+..+++|++|++++|++++.. .+.++++|++|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCcc--cccCCccccccccccccc
Confidence 3455555554332 23455666666666666532 23556666666666666666432 266666666666666666
Q ss_pred CCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCccccc
Q 010856 116 SGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIG 195 (499)
Q Consensus 116 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~ 195 (499)
.... .+.++++|+.|++++|.+..++ .+..+++|+.|++++|.+... ..+..+++|+.|++++|++++. ..+.
T Consensus 97 ~~~~--~l~~l~~L~~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l--~~l~ 169 (199)
T d2omxa2 97 ADIT--PLANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL--KPLA 169 (199)
T ss_dssp CCCG--GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGT
T ss_pred cccc--cccccccccccccccccccccc-ccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC--cccc
Confidence 5332 3566666667777666666543 355666777777777766542 2466667777777777777654 2366
Q ss_pred CCcCCceeeCcCCcCCCCCCccccCCCCCCEE
Q 010856 196 GLKNLEYLFLGYNRLQGSIPDSFGDLISLKFL 227 (499)
Q Consensus 196 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 227 (499)
++++|++|++++|+++++ ..+..+++|+.|
T Consensus 170 ~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 170 NLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp TCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred CCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 777777777777777643 346667777664
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=3.1e-20 Score=163.72 Aligned_cols=181 Identities=24% Similarity=0.391 Sum_probs=140.4
Q ss_pred CCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecc
Q 010856 56 NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLG 135 (499)
Q Consensus 56 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 135 (499)
+...+.++.+.+++..+ ...++++++|++++|.++.. +.+..+++|++|++++|++++..+ +.++++|+.|+++
T Consensus 19 ~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~ 92 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 92 (199)
T ss_dssp HHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccc
Confidence 34455677777765433 34678899999999998854 357888999999999999886543 8888999999999
Q ss_pred ccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCC
Q 010856 136 SNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 215 (499)
Q Consensus 136 ~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 215 (499)
+|.+..++ .+..++.|+.|++++|.+... ..+..+++|+.|++++|++... ..+..+++|++|++++|++++.
T Consensus 93 ~n~~~~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l-- 165 (199)
T d2omxa2 93 NNQIADIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL-- 165 (199)
T ss_dssp SSCCCCCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--
T ss_pred cccccccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC--
Confidence 99888877 477888999999988887753 3477888888999988888743 3577888888888888888754
Q ss_pred ccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEE
Q 010856 216 DSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENL 251 (499)
Q Consensus 216 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 251 (499)
..+.++++|+.|++++|++++. ..+..+++|+.|
T Consensus 166 ~~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 166 KPLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred ccccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 3478888888888888888753 247778888765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.81 E-value=3.3e-21 Score=178.63 Aligned_cols=136 Identities=16% Similarity=0.201 Sum_probs=109.0
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCc---------cHHHHHHHHHHHhcCC-CCCccccceeEEcc
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGR---------AFESFDVECEMMKNIR-HRNLIKILHGVAVI 429 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~il~~l~-H~niv~l~~~~~~~ 429 (499)
++|+..+.||+|+||+||+|+. .+|+.||||++++.... ..+.+.+|++++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999996 57999999999765411 1346889999999997 99999999998864
Q ss_pred ccceeeeeecccC-CCccccccc----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 430 TFTVCLCLFHHSS-ASASASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 430 ~~~~~~~l~~~~~-~~~~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+ ..++++||+. |++.+.+.. .+...+.++.||++||+|||+ +++|.|++++.++.++++|||++...
T Consensus 83 ~--~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 T--FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp S--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred c--ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 3 4456777775 455444433 233455556899999999877 89999999999999999999998753
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1.8e-19 Score=160.15 Aligned_cols=164 Identities=24% Similarity=0.318 Sum_probs=97.9
Q ss_pred CCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEc
Q 010856 78 LQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNF 157 (499)
Q Consensus 78 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l 157 (499)
+.+|++|++++|.++... .+..+++|++|++++|++++.. .+..+++|+.|++++|++++++ .+..+++|+.|++
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEEC
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc-ccccccccccccc
Confidence 345555555555554321 2455555566666666555432 2445566666666666666555 3555666666666
Q ss_pred CCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCcc
Q 010856 158 SSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGA 237 (499)
Q Consensus 158 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 237 (499)
++|.+... ..+..++.++.+++++|.+++. ..+..+++|+.+++++|++++. ..+..+++|+.|++++|+|++.
T Consensus 120 ~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i--~~l~~l~~L~~L~Ls~N~i~~l 193 (210)
T d1h6ta2 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISDL 193 (210)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBC
T ss_pred cccccccc--cccccccccccccccccccccc--cccccccccccccccccccccc--ccccCCCCCCEEECCCCCCCCC
Confidence 66665432 2455666666666666666532 3455667777777777777643 2366777777777777777643
Q ss_pred CcccccCCCCCCEEEcc
Q 010856 238 IPASLEKLSYLENLNLS 254 (499)
Q Consensus 238 ~~~~~~~l~~L~~L~l~ 254 (499)
+ .+..+++|+.|+|+
T Consensus 194 -~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 194 -R-ALAGLKNLDVLELF 208 (210)
T ss_dssp -G-GGTTCTTCSEEEEE
T ss_pred -h-hhcCCCCCCEEEcc
Confidence 2 46777777777775
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.81 E-value=6.2e-21 Score=182.15 Aligned_cols=135 Identities=16% Similarity=0.164 Sum_probs=107.8
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|+++. ||||+++++++...+....+.++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 57999999999753 3567899999999985 99999999998764444455577
Q ss_pred cccCCCccccccc--cccccccccccccccceeecc------CCCcccEEEeeCCC-eEEEEEEEeecc
Q 010856 439 HHSSASASASLVS--SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPG-VEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~~~~~l~~--~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~-~~~~~f~~~~~~ 498 (499)
+++.++.+..+.. .+...+.++.||+.||+|||+ |+||.|||++.+++ ++++|||+++.+
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceec
Confidence 7777665444322 233345567999999999955 99999999987665 899999998753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=2.9e-21 Score=185.50 Aligned_cols=138 Identities=17% Similarity=0.123 Sum_probs=106.7
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEcccc---cee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF---TVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~---~~~ 434 (499)
.++|...+.||+|+||+||+|+. .+|+.||||++++.. ....+++.+|+++|++++|||||++++++..... ...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35699999999999999999995 589999999997654 2345678999999999999999999999865322 234
Q ss_pred eeeecccCCCcccccc---ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASASLV---SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~~l~---~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++++.+|++.+.+. ..+...+.++.|++.||+|||+ |+||.|||+++++.++++|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4566776776655543 2233345557899999998876 8999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=4.3e-21 Score=181.94 Aligned_cols=135 Identities=13% Similarity=0.177 Sum_probs=106.6
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
++|.+.+.||+|+||+||+|+. .+|+.||||+++... .+...+.+|++++++++|||||++++++...+ ..++++|
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME--ELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--EEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--EEEEEEe
Confidence 5799999999999999999996 478999999997643 33456889999999999999999999987643 4556777
Q ss_pred ccCC-Ccccccccc-----ccccccccccccccceeecc------CCCcccEEEeeC--CCeEEEEEEEeecc
Q 010856 440 HSSA-SASASLVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE--PGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~-~~~~~l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~--~~~~~~~f~~~~~~ 498 (499)
|+.| ++.+.+... +.....++.||+.||+|||+ |+||+|++++.+ ..++++|||+++..
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 7765 554444322 22234456899999999977 899999999754 47999999998653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=4.7e-21 Score=180.80 Aligned_cols=132 Identities=20% Similarity=0.173 Sum_probs=102.1
Q ss_pred ccccccCCcceEEEEEeCC----CCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeecc
Q 010856 366 NNLIGKGGFGSVYKARLGD----RMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFHH 440 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~~ 440 (499)
.++||+|+||+||+|++.. ...||||+++... ....++|.+|++++++++|||||+++|++...+... ++++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~-~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE-EEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce-EEEEEE
Confidence 4689999999999999643 2368999997543 344578999999999999999999999987655443 456677
Q ss_pred cCCCcccc-cccc-----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 441 SSASASAS-LVSS-----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 441 ~~~~~~~~-l~~~-----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
+.++.... +... +.....++.|+++||+|+|+ ++||.|+|+++++.++++|||+++.+
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 76554443 2211 12234557899999999876 99999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.4e-21 Score=184.45 Aligned_cols=139 Identities=19% Similarity=0.203 Sum_probs=106.9
Q ss_pred HHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCccccceeEEccc
Q 010856 358 RATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT 430 (499)
Q Consensus 358 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~ 430 (499)
...++|...+.||+|+||+||+|++. +++.||||+++... ......|.+|++++++++|||||+++|++...+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 34578899999999999999999852 35789999997654 233456899999999999999999999987633
Q ss_pred cceeeeeecccCCC-ccccccc--------------cccccccccccccccceeecc------CCCcccEEEeeCCCeEE
Q 010856 431 FTVCLCLFHHSSAS-ASASLVS--------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEV 489 (499)
Q Consensus 431 ~~~~~~l~~~~~~~-~~~~l~~--------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~ 489 (499)
..+++++++.++ +...+.. .+.....++.|+|+||+|||+ ++||.|+|++.++.+|+
T Consensus 97 --~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 97 --PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred --ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 345566766554 3333321 112234456899999999866 89999999999999999
Q ss_pred EEEEEeecc
Q 010856 490 ICFVFEILL 498 (499)
Q Consensus 490 ~~f~~~~~~ 498 (499)
+|||+++.+
T Consensus 175 ~DFGla~~~ 183 (308)
T d1p4oa_ 175 GDFGMTRDI 183 (308)
T ss_dssp CCTTCCCGG
T ss_pred eecccceec
Confidence 999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=4.8e-21 Score=177.77 Aligned_cols=136 Identities=15% Similarity=0.121 Sum_probs=99.0
Q ss_pred hhhcccccccccCCcceEEEEEeCC----CCEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCccccceeEEcccccee
Q 010856 360 TDEFSENNLIGKGGFGSVYKARLGD----RMEVAVKVFNLQCG-RAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVC 434 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~ 434 (499)
.++|++.+.||+|+||+||+|++.. +..||||.++.... ...+.|.+|++++++++|||||+++|++.. .. .
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~-~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NP-V 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS-C
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--Ce-E
Confidence 4679999999999999999998632 35688998865442 335679999999999999999999998854 22 3
Q ss_pred eeeecccCCCcccc-ccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 435 LCLFHHSSASASAS-LVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~~~~~~-l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
++++|++.++.... +.. .+.....++.|+++||+|||+ ++||.||+++.++.+|++|||+++.+
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 45667775554332 221 122244456899999999987 89999999999999999999998753
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=4.5e-19 Score=157.52 Aligned_cols=182 Identities=20% Similarity=0.303 Sum_probs=134.4
Q ss_pred EEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCC
Q 010856 35 DFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNK 114 (499)
Q Consensus 35 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 114 (499)
..++..+.+++.++. ..+.+|++|++++|.++... .+..+++|++|++++|++++.. .+..+++|++|++++|+
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccc
Confidence 345566666654432 34567788888888887433 3677888888888888887543 36778888888888888
Q ss_pred CCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccc
Q 010856 115 LSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEI 194 (499)
Q Consensus 115 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 194 (499)
+++. + .+..+++|+.|++++|.+..++ .+..++.++.+++++|.+++. ..+..+++|+.+++++|++++.. .+
T Consensus 102 i~~l-~-~l~~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l 174 (210)
T d1h6ta2 102 VKDL-S-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PL 174 (210)
T ss_dssp CCCG-G-GGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred cccc-c-cccccccccccccccccccccc-ccccccccccccccccccccc--ccccccccccccccccccccccc--cc
Confidence 8753 2 4777888888888888887765 567778888888888888753 35667888888888888887543 37
Q ss_pred cCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCC
Q 010856 195 GGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSN 231 (499)
Q Consensus 195 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~ 231 (499)
.++++|++|++++|+++++ + .+..+++|++|+|++
T Consensus 175 ~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp TTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred cCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence 7888888999988888754 3 588888898888763
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.80 E-value=2.7e-20 Score=163.10 Aligned_cols=130 Identities=22% Similarity=0.277 Sum_probs=87.6
Q ss_pred CCEEECcCCCCCccCChhccccccccccEEEcccCCCcc-cCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEe
Q 010856 7 LTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISG-GIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLG 85 (499)
Q Consensus 7 L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 85 (499)
.++++.++++++.++.. +|.++++|+|++|+|+. ..+..|.++++|++|+|++|.+....+..|..+++|++|+
T Consensus 10 ~~~v~Cs~~~L~~iP~~-----lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~ 84 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRD-----IPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TTEEECTTSCCSSCCSC-----CCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCEEEEeCCCcCccCCC-----CCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceee
Confidence 45677777777754322 34467777777777764 3455567777777777777777766666777777777777
Q ss_pred cccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC
Q 010856 86 LEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS 141 (499)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 141 (499)
|++|+++.+.+..|.++++|++|+|++|+|+.+.+++|..+++|++|+|++|.+..
T Consensus 85 Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred eccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 77777776666667777777777777777776666666666666666666666554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=3.8e-21 Score=182.91 Aligned_cols=137 Identities=17% Similarity=0.185 Sum_probs=102.4
Q ss_pred HhhhcccccccccCCcceEEEEEeC-CC-----CEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-DR-----MEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVIT 430 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~ 430 (499)
..++|++.+.||+|+||+||+|+.. .+ ..||+|.+.... ......+.+|+++++++ +|||||++++++...+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3467999999999999999999852 22 369999986543 34457799999999998 8999999999997644
Q ss_pred cceeeeeecccC-CCcccccccc---------------------------ccccccccccccccceeecc------CCCc
Q 010856 431 FTVCLCLFHHSS-ASASASLVSS---------------------------LTLSRPAKGGGFRGCVLWHV------GVDF 476 (499)
Q Consensus 431 ~~~~~~l~~~~~-~~~~~~l~~~---------------------------~~~~~~~~~~i~~gl~yLH~------~~~p 476 (499)
..++++||+. |++.+.++.. +.....++.||++||+|||+ |+||
T Consensus 115 --~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 115 --PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp --SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred --eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 3445667665 4544443221 11233456899999998765 8999
Q ss_pred ccEEEeeCCCeEEEEEEEeec
Q 010856 477 AAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 477 ~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.|++++.++.+|++|||+++.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~ 213 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARD 213 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSC
T ss_pred hccccccCCeEEEeecccccc
Confidence 999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=6.8e-21 Score=180.31 Aligned_cols=135 Identities=14% Similarity=0.176 Sum_probs=107.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHHHHHHHh-cCCCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDVECEMMK-NIRHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~-~l~H~niv~l~~~~~~~~~~~~~ 435 (499)
++|.+.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.++. .++|||||++++++...+ ..+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~--~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC--cee
Confidence 5799999999999999999996 479999999997643 344567788888765 689999999999988744 445
Q ss_pred eeecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 436 CLFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
+++||+.| ++...+.... ...+.++.||+.||+|||+ ++||.|+++++++.++++|||++..
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence 67777755 4444443322 2344556899999999976 8999999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.2e-20 Score=177.28 Aligned_cols=135 Identities=16% Similarity=0.192 Sum_probs=108.6
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCL 437 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l 437 (499)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+.+++.++|||||++++++...+ ...++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--ceeEE
Confidence 4689999999999999999996 579999999997654 334678999999999999999999999998744 44556
Q ss_pred ecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 438 FHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 438 ~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++.|+....+.. .....+.++.|++.||+|||+ |+||.||+++.++.++++|||++..
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhc
Confidence 77776665443321 122344556899999999877 8999999999999999999999864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=7.3e-20 Score=160.35 Aligned_cols=176 Identities=21% Similarity=0.233 Sum_probs=126.4
Q ss_pred ccEEeeecCCCCCcCCccccCCccCCeeeccccCCCC-C-CccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEcc
Q 010856 105 LYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTS-V-PLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFS 182 (499)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 182 (499)
.++++.++++++. +|..+. +++++|+|++|+|+. + +..|.++++|+.|++++|.+....+..|..+++|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 3567888888884 444443 578888888888875 3 3456778888888888888888778888888888888888
Q ss_pred CCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccC
Q 010856 183 MNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEI 262 (499)
Q Consensus 183 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 262 (499)
+|+|+.+.+..|.++++|++|+|++|+|+.+.++.|..+++|++|+|++|.+....... .-...++.+.+..|.+++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCC
Confidence 88888877788888888888888888888777788888888888888888876432211 11123455566777777665
Q ss_pred CCCCCCCCccccccCCCcCCCCCC
Q 010856 263 PRGGSFGNFSAESFEGNELLCGSP 286 (499)
Q Consensus 263 ~~~~~~~~l~~~~l~~N~~~c~~~ 286 (499)
|.. +..+...++..|.+.|.++
T Consensus 166 p~~--l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 166 PSK--VRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp STT--TTTSBGGGSCTTTCCCCCC
T ss_pred Chh--hcCCEeeecCHhhCcCCCC
Confidence 543 4455666777787777553
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.1e-20 Score=178.59 Aligned_cols=136 Identities=18% Similarity=0.172 Sum_probs=102.6
Q ss_pred hhcccccccccCCcceEEEEEeC-CCC--EEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccccceee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLG-DRM--EVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVITFTVCL 435 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~~~~~~ 435 (499)
++|++.+.||+|+||+||+|+++ +|. .||||+++... ....+.|.+|+++++++ +|||||+++|+|...+ ..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--EEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--eeE
Confidence 57888999999999999999964 454 47788876543 34567899999999998 7999999999998633 445
Q ss_pred eeecccCC-Cccccccc--------------------cccccccccccccccceeecc------CCCcccEEEeeCCCeE
Q 010856 436 CLFHHSSA-SASASLVS--------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVE 488 (499)
Q Consensus 436 ~l~~~~~~-~~~~~l~~--------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~ 488 (499)
++++|+.| ++.+.++. .+.....++.|||+||+|+|+ ++||.||++++++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence 56776654 44443322 112234456899999998876 8999999999999999
Q ss_pred EEEEEEeecc
Q 010856 489 VICFVFEILL 498 (499)
Q Consensus 489 ~~~f~~~~~~ 498 (499)
++|||+++..
T Consensus 168 l~DfG~a~~~ 177 (309)
T d1fvra_ 168 IADFGLSRGQ 177 (309)
T ss_dssp ECCTTCEESS
T ss_pred Eccccccccc
Confidence 9999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.79 E-value=1.4e-20 Score=181.25 Aligned_cols=137 Identities=14% Similarity=0.075 Sum_probs=104.4
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC---CccHHHHHH---HHHHHhcCCCCCccccceeEEccccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC---GRAFESFDV---ECEMMKNIRHRNLIKILHGVAVITFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---E~~il~~l~H~niv~l~~~~~~~~~~ 432 (499)
.++|.+.+.||+|+||+||+|+. .+|+.||||++.+.. ......+.+ |+++++.++|||||++++++...+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~-- 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-- 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--
Confidence 46799999999999999999996 479999999997543 122333444 467788899999999999987743
Q ss_pred eeeeeecccCC-Cccccccccc----cccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 433 VCLCLFHHSSA-SASASLVSSL----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 433 ~~~~l~~~~~~-~~~~~l~~~~----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
..++++||+.| ++...+.... ...+.++.||+.||+|||+ |+||+|||++.++.++++|||+++.+
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 34556777764 4444443322 2344456899999998877 89999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.79 E-value=1.3e-20 Score=175.26 Aligned_cols=137 Identities=17% Similarity=0.172 Sum_probs=107.9
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCCCccccceeEEcccc--cee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGR---AFESFDVECEMMKNIRHRNLIKILHGVAVITF--TVC 434 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~--~~~ 434 (499)
++|.+.+.||+|+||+||+|+. .+|+.||||++++.... ..+.+.+|++++++++|||||++++++...+. ...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5699999999999999999995 57999999999765422 34578999999999999999999998876432 234
Q ss_pred eeeecccCCCccc-ccccc----ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 435 LCLFHHSSASASA-SLVSS----LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 435 ~~l~~~~~~~~~~-~l~~~----~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++++||+.|+.+. .+... +.....++.|++.||+|||+ |+||+||+++.++..+++|||+...
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence 5677887665433 33222 22344556899999998877 8999999999999999999997653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=8e-21 Score=178.83 Aligned_cols=144 Identities=16% Similarity=0.117 Sum_probs=99.5
Q ss_pred HHHHHHHhhhcccccccccCCcceEEEEEeC------CCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccce
Q 010856 353 YLELFRATDEFSENNLIGKGGFGSVYKARLG------DRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILH 424 (499)
Q Consensus 353 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~ 424 (499)
...++...++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++.++ +|+|||.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3444444578999999999999999999842 35689999997544 23456788888888776 7899999998
Q ss_pred eEEccccceeeeeecccC-CCcccccccc--------------------ccccccccccccccceeecc------CCCcc
Q 010856 425 GVAVITFTVCLCLFHHSS-ASASASLVSS--------------------LTLSRPAKGGGFRGCVLWHV------GVDFA 477 (499)
Q Consensus 425 ~~~~~~~~~~~~l~~~~~-~~~~~~l~~~--------------------~~~~~~~~~~i~~gl~yLH~------~~~p~ 477 (499)
++...+.. .++++||+. |++.+.+... +.....++.||++||+|||+ |+||.
T Consensus 85 ~~~~~~~~-~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 85 ACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EECSTTSC-CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeccCCCe-EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 87664433 345666665 4444333221 12233446899999999865 99999
Q ss_pred cEEEeeCCCeEEEEEEEeec
Q 010856 478 AFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 478 ~~l~~~~~~~~~~~f~~~~~ 497 (499)
||++++++.+|++|||+++.
T Consensus 164 NILl~~~~~~Kl~DFGla~~ 183 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARD 183 (299)
T ss_dssp GEEECGGGCEEECC------
T ss_pred ceeECCCCcEEEccCcchhh
Confidence 99999999999999999864
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.79 E-value=1.9e-17 Score=158.97 Aligned_cols=247 Identities=26% Similarity=0.272 Sum_probs=152.3
Q ss_pred CCCCEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeE
Q 010856 5 KSLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGL 84 (499)
Q Consensus 5 ~~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 84 (499)
.++++|||++|+++.. |+ .+++|++|++++|+|+ .+|+. +.+|+.|++++|+++.+ +.. .+.|++|
T Consensus 38 ~~l~~LdLs~~~L~~l-p~-----~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~~l---p~~L~~L 103 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSL-PE-----LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYL 103 (353)
T ss_dssp HTCSEEECTTSCCSCC-CS-----CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEE
T ss_pred cCCCEEEeCCCCCCCC-CC-----CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-hhh---ccccccc
Confidence 3689999999999854 43 2348999999999999 45654 45889999999998843 321 2469999
Q ss_pred ecccccccccCCccccCcccccEEeeecCCCCCcCC------------------ccccCCccCCeeeccccCCCCCCc--
Q 010856 85 GLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLP------------------ACFSNLTSLRIVSLGSNKLTSVPL-- 144 (499)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~------------------~~~~~l~~L~~L~L~~n~l~~~~~-- 144 (499)
++++|.+... | .+..+++|+.|++++|.+..... ..+..++.++.+.+++|.+..++.
T Consensus 104 ~L~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~ 181 (353)
T d1jl5a_ 104 GVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLP 181 (353)
T ss_dssp ECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCC
T ss_pred cccccccccc-c-chhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccc
Confidence 9999999844 4 36788999999999998764322 223445566666666665544321
Q ss_pred -----------------cccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcC
Q 010856 145 -----------------TFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGY 207 (499)
Q Consensus 145 -----------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~ 207 (499)
.+..++.|+.+++++|..... + ....++..+.+.++.+.... . ..+.+...++..
T Consensus 182 ~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~-~---~~~~~l~~~~~~~~~~~~~~-~---~~~~l~~~~~~~ 253 (353)
T d1jl5a_ 182 LSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTL-P---DLPPSLEALNVRDNYLTDLP-E---LPQSLTFLDVSE 253 (353)
T ss_dssp TTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC-C---SCCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccc-c---cccccccccccccccccccc-c---cccccccccccc
Confidence 123345556666665554421 1 12233444444444443211 1 112222233222
Q ss_pred CcCCC----------------CCCccccCCCCCCEEeCCCCcCCccCcccccCCCCCCEEEccCCcCcccCCCCCCCCCc
Q 010856 208 NRLQG----------------SIPDSFGDLISLKFLNLSNNNLSGAIPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNF 271 (499)
Q Consensus 208 n~l~~----------------~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l 271 (499)
+.+.+ ........+++|++|++++|+|+. +|. .+++|+.|++++|+|+. +|.. .+++
T Consensus 254 ~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~~-l~~~--~~~L 326 (353)
T d1jl5a_ 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLAE-VPEL--PQNL 326 (353)
T ss_dssp SCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCC--CTTC
T ss_pred ccccccccccchhcccccccCccccccccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCCc-cccc--cCCC
Confidence 22111 111122335788889998888884 343 35788888888888874 4543 4578
Q ss_pred cccccCCCcCC
Q 010856 272 SAESFEGNELL 282 (499)
Q Consensus 272 ~~~~l~~N~~~ 282 (499)
+.+++++|+..
T Consensus 327 ~~L~L~~N~L~ 337 (353)
T d1jl5a_ 327 KQLHVEYNPLR 337 (353)
T ss_dssp CEEECCSSCCS
T ss_pred CEEECcCCcCC
Confidence 88888888843
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.8e-20 Score=176.25 Aligned_cols=133 Identities=17% Similarity=0.106 Sum_probs=100.1
Q ss_pred hhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHH--HHHhcCCCCCccccceeEEcccc--ceeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVEC--EMMKNIRHRNLIKILHGVAVITF--TVCLC 436 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~--~il~~l~H~niv~l~~~~~~~~~--~~~~~ 436 (499)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .+.+.+|. ..+..++|||||++++++...+. ...++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5688899999999999999997 68899999996532 33444444 45567899999999999876432 34556
Q ss_pred eecccCCC-ccccccc---cccccccccccccccceee--------------ccCCCcccEEEeeCCCeEEEEEEEeec
Q 010856 437 LFHHSSAS-ASASLVS---SLTLSRPAKGGGFRGCVLW--------------HVGVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 437 l~~~~~~~-~~~~l~~---~~~~~~~~~~~i~~gl~yL--------------H~~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
++||+.++ +...+.. .+.....++.|+|.||+|+ |+|+||.|||+++++.+|++|||++..
T Consensus 79 v~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 78887554 4444432 2223345568889988888 558999999999999999999998764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.7e-20 Score=180.46 Aligned_cols=133 Identities=16% Similarity=0.164 Sum_probs=104.0
Q ss_pred hcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEcc----ccceeee
Q 010856 362 EFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVI----TFTVCLC 436 (499)
Q Consensus 362 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~----~~~~~~~ 436 (499)
+|+..++||+|+||+||+|+. .+|+.||||++..... ...+|++++++++|||||++++++... +....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588889999999999999996 5799999999976542 234799999999999999999988542 2233456
Q ss_pred eecccCCCcccccc--------ccccccccccccccccceeecc------CCCcccEEEeeCC-CeEEEEEEEeecc
Q 010856 437 LFHHSSASASASLV--------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEP-GVEVICFVFEILL 498 (499)
Q Consensus 437 l~~~~~~~~~~~l~--------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~-~~~~~~f~~~~~~ 498 (499)
++||+++++...+. ..+...+.++.|++.||+|||+ |+||+|||++.++ .++++|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 78888877544332 1222345567899999999987 8999999998765 7899999998643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.5e-20 Score=180.78 Aligned_cols=138 Identities=14% Similarity=0.106 Sum_probs=103.5
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEcccc----c
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVITF----T 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~----~ 432 (499)
.+.|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+. .
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 45799999999999999999996 579999999997543 2335678999999999999999999999876432 2
Q ss_pred eeeeeecccCCCcccccc---ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLV---SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~---~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++|+++..+..... ..+...+.++.|++.||+|||+ |+||.||+++.++.++++|||.++.
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 455678888554333221 2233345557899999999976 8999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.8e-20 Score=177.15 Aligned_cols=138 Identities=16% Similarity=0.154 Sum_probs=107.0
Q ss_pred HhhhcccccccccCCcceEEEEEe------CCCCEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCccccceeEEccc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL------GDRMEVAVKVFNLQC-GRAFESFDVECEMMKNI-RHRNLIKILHGVAVIT 430 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~H~niv~l~~~~~~~~ 430 (499)
..++|++.+.||+|+||.||+|++ .+++.||||+++... .....+|.+|+.+++++ +|||||+++|+|...+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 446899999999999999999984 246789999997654 33456799999999998 7999999999997643
Q ss_pred cceeeeeecccCCCcc-ccccc----------------------cccccccccccccccceeecc------CCCcccEEE
Q 010856 431 FTVCLCLFHHSSASAS-ASLVS----------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVF 481 (499)
Q Consensus 431 ~~~~~~l~~~~~~~~~-~~l~~----------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~ 481 (499)
..++++||+.++.. ..++. .+.....++.||++||+|||+ |+||+||++
T Consensus 101 --~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 101 --PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp --SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 34556777755433 22221 112333456899999999876 899999999
Q ss_pred eeCCCeEEEEEEEeecc
Q 010856 482 VLEPGVEVICFVFEILL 498 (499)
Q Consensus 482 ~~~~~~~~~~f~~~~~~ 498 (499)
+.++.++++|||.++..
T Consensus 179 ~~~~~~ki~DfG~~~~~ 195 (311)
T d1t46a_ 179 THGRITKICDFGLARDI 195 (311)
T ss_dssp ETTTEEEECCCGGGSCT
T ss_pred cccCcccccccchheec
Confidence 99999999999998753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=5.1e-20 Score=177.29 Aligned_cols=138 Identities=17% Similarity=0.168 Sum_probs=105.8
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEcc----ccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVI----TFT 432 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~----~~~ 432 (499)
.++|+..+.||+|+||+||+|+. .+|+.||||++++... ...+++.+|++++++++|||||++++++... +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999995 5799999999976542 3356789999999999999999999988542 223
Q ss_pred eeeeeecccCCCccccccc---cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 433 VCLCLFHHSSASASASLVS---SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 433 ~~~~l~~~~~~~~~~~l~~---~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..++++++.+|++.+.+.. .+...+.++.|++.||+|||+ |+||.||+++.++.++++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 3555666666665444322 223344556899999999987 8999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=8.7e-20 Score=173.31 Aligned_cols=138 Identities=16% Similarity=0.191 Sum_probs=105.9
Q ss_pred hhhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCccccceeEEccc------
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQC--GRAFESFDVECEMMKNIRHRNLIKILHGVAVIT------ 430 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~------ 430 (499)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|++++++++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57899999999999999999996 579999999986543 334577899999999999999999999875521
Q ss_pred cceeeeeecccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 FTVCLCLFHHSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 ~~~~~~l~~~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.....++++++.++....... .....+.++.|+++||+|||+ ++||.||+++.++.++++|||++..
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 123455777776665443221 222344556899999999877 8999999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=8.7e-20 Score=175.82 Aligned_cols=137 Identities=16% Similarity=0.106 Sum_probs=107.5
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCccccceeEEccc----cce
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG--RAFESFDVECEMMKNIRHRNLIKILHGVAVIT----FTV 433 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~----~~~ 433 (499)
.+|...++||+|+||+||+|+. .+|+.||||++..... ...+++.+|+.++++++|||||++++++...+ ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5699999999999999999996 4799999999976542 33457899999999999999999999986532 245
Q ss_pred eeeeecccCCCcccccccc--ccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 434 CLCLFHHSSASASASLVSS--LTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 434 ~~~l~~~~~~~~~~~l~~~--~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
.++++||+.+++...+... ....+.++.|++.||+|||+ ++||.|++++.++.++++|||+.+.
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence 5678888888876654432 22344556899999999876 8999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2e-20 Score=173.33 Aligned_cols=136 Identities=18% Similarity=0.233 Sum_probs=102.4
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCC------ccHHHHHHHHHHHhcCC--CCCccccceeEEcccc
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCG------RAFESFDVECEMMKNIR--HRNLIKILHGVAVITF 431 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~--H~niv~l~~~~~~~~~ 431 (499)
++|++.+.||+|+||+||+|+. .+|+.||||++++... ....++.+|+.++++++ |||||++++++...+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~- 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD- 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence 5699999999999999999996 5799999999976431 12244779999999886 999999999987744
Q ss_pred ceeeeeecccCC-Cc-cccccc----cccccccccccccccceeecc------CCCcccEEEeeC-CCeEEEEEEEeecc
Q 010856 432 TVCLCLFHHSSA-SA-SASLVS----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE-PGVEVICFVFEILL 498 (499)
Q Consensus 432 ~~~~~l~~~~~~-~~-~~~l~~----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~-~~~~~~~f~~~~~~ 498 (499)
..+.+++++.+ +. ...+.. .+...+.++.|+++||+|||+ |+||+||+++.+ +.++++|||+++..
T Consensus 83 -~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 -SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp -EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred -eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 33445555543 32 222222 223344556899999999877 899999999854 68999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=5.8e-20 Score=172.60 Aligned_cols=138 Identities=20% Similarity=0.184 Sum_probs=100.5
Q ss_pred HhhhcccccccccCCcceEEEEEeC-C-------CCEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCccccceeEEc
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARLG-D-------RMEVAVKVFNLQCG-RAFESFDVECEMMKNI-RHRNLIKILHGVAV 428 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~~-~-------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~H~niv~l~~~~~~ 428 (499)
..++|.+.+.||+|+||.||+|+.. . +..||||+++.... ....++.+|...+.++ +|||||+++++|..
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3467999999999999999999842 1 34799999976543 3457789999998887 89999999999976
Q ss_pred cccceeeeeecccCCC-ccccccc--------------------cccccccccccccccceeecc------CCCcccEEE
Q 010856 429 ITFTVCLCLFHHSSAS-ASASLVS--------------------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVF 481 (499)
Q Consensus 429 ~~~~~~~~l~~~~~~~-~~~~l~~--------------------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~ 481 (499)
.+ ..+.++||+.++ +.+.+.. .+.....++.|++.||+|||+ |+||.|||+
T Consensus 91 ~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 DG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp SS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CC--eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 33 345567777554 4333321 122234446899999999977 899999999
Q ss_pred eeCCCeEEEEEEEeecc
Q 010856 482 VLEPGVEVICFVFEILL 498 (499)
Q Consensus 482 ~~~~~~~~~~f~~~~~~ 498 (499)
+.++.++++|||+++..
T Consensus 169 ~~~~~~kl~dfg~~~~~ 185 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDI 185 (299)
T ss_dssp CTTCCEEECSTTCCCCG
T ss_pred cCCCCeEeccchhhccc
Confidence 99999999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.3e-19 Score=171.17 Aligned_cols=139 Identities=19% Similarity=0.212 Sum_probs=104.9
Q ss_pred HhhhcccccccccCCcceEEEEEe-CC-CCEEEEEEeeccC--CccHHHHHHHHHHHhcC---CCCCccccceeEEcc--
Q 010856 359 ATDEFSENNLIGKGGFGSVYKARL-GD-RMEVAVKVFNLQC--GRAFESFDVECEMMKNI---RHRNLIKILHGVAVI-- 429 (499)
Q Consensus 359 ~~~~~~~~~~lg~G~~g~v~~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~H~niv~l~~~~~~~-- 429 (499)
+.++|+..+.||+|+||+||+|+. ++ ++.||||+++... ......+.+|+++++.+ +|||||+++++|...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 346899999999999999999996 44 6789999996543 22344577888877655 899999999998642
Q ss_pred -ccceeeeeecccCCCcccccc------ccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEee
Q 010856 430 -TFTVCLCLFHHSSASASASLV------SSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEI 496 (499)
Q Consensus 430 -~~~~~~~l~~~~~~~~~~~l~------~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~ 496 (499)
.....++++|++.++...... ..+...+.++.|++.||+|||+ |+||+|||++.++.++++|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 223455677888776543221 1222344567899999999877 899999999999999999999976
Q ss_pred c
Q 010856 497 L 497 (499)
Q Consensus 497 ~ 497 (499)
.
T Consensus 165 ~ 165 (305)
T d1blxa_ 165 I 165 (305)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.9e-19 Score=171.39 Aligned_cols=134 Identities=11% Similarity=0.086 Sum_probs=101.7
Q ss_pred hhhcccc-cccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhc-CCCCCccccceeEEcc--cccee
Q 010856 360 TDEFSEN-NLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKN-IRHRNLIKILHGVAVI--TFTVC 434 (499)
Q Consensus 360 ~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~H~niv~l~~~~~~~--~~~~~ 434 (499)
.++|.+. ++||+|+||+||+|+. .+++.||||+++. .+.+.+|++++.+ .+|||||+++++|... .....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4678876 4699999999999996 5799999999964 3567899998765 5899999999988642 22345
Q ss_pred eeeecccCC-Cccccccc------cccccccccccccccceeecc------CCCcccEEEeeC---CCeEEEEEEEeecc
Q 010856 435 LCLFHHSSA-SASASLVS------SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLE---PGVEVICFVFEILL 498 (499)
Q Consensus 435 ~~l~~~~~~-~~~~~l~~------~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~---~~~~~~~f~~~~~~ 498 (499)
++++||+.| ++.+.+.. .+...+.++.|++.||+|||+ |+||+||+++++ +.++++|||+++..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 567777754 55554432 222345556899999999876 899999999863 45999999998753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=2.5e-19 Score=169.65 Aligned_cols=136 Identities=15% Similarity=0.146 Sum_probs=104.5
Q ss_pred hhhcccccccccCCcceEEEEEe----CCCCEEEEEEeeccC----CccHHHHHHHHHHHhcCCC-CCccccceeEEccc
Q 010856 360 TDEFSENNLIGKGGFGSVYKARL----GDRMEVAVKVFNLQC----GRAFESFDVECEMMKNIRH-RNLIKILHGVAVIT 430 (499)
Q Consensus 360 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~H-~niv~l~~~~~~~~ 430 (499)
.++|+..+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|++++++++| |||+++++++...+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 36799999999999999999984 258899999986542 2335678899999999977 89999998887643
Q ss_pred cceeeeeecccCC-Ccccccccccc----ccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeec
Q 010856 431 FTVCLCLFHHSSA-SASASLVSSLT----LSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEIL 497 (499)
Q Consensus 431 ~~~~~~l~~~~~~-~~~~~l~~~~~----~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~ 497 (499)
..+.++|++.| ++...+..... ....++.|++.|++|+|+ ++||.|++++.++.++++|||+++.
T Consensus 103 --~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 --KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 33445666654 44444332222 233345899999999877 8999999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.71 E-value=9.9e-19 Score=164.37 Aligned_cols=135 Identities=17% Similarity=0.142 Sum_probs=103.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCccccceeEEccccceeeeeec
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRNLIKILHGVAVITFTVCLCLFH 439 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~niv~l~~~~~~~~~~~~~~l~~ 439 (499)
+.|++.+.||+|+||+||+|+. .+|+.||||++..... .+++.+|+++++.++|+|+|..++++...+ ...++++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~-~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET-TEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC-CEEEEEEE
Confidence 3599999999999999999996 5799999999876432 245889999999999888887776665433 34556788
Q ss_pred ccCCCccccccc-----cccccccccccccccceeecc------CCCcccEEEee---CCCeEEEEEEEeecc
Q 010856 440 HSSASASASLVS-----SLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL---EPGVEVICFVFEILL 498 (499)
Q Consensus 440 ~~~~~~~~~l~~-----~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~---~~~~~~~~f~~~~~~ 498 (499)
++++++...+.. .......++.|++.||+|||+ |+||.||++.. +..++++|||+++.+
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 888776554332 223344556899999998866 89999999864 346999999998754
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.70 E-value=2.6e-15 Score=143.85 Aligned_cols=225 Identities=27% Similarity=0.285 Sum_probs=138.0
Q ss_pred cccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeee
Q 010856 32 SLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLD 111 (499)
Q Consensus 32 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 111 (499)
++++|+|++|.++. +|+. +++|++|++++|+|+ .+|.. +.+|+.|++++|+++.. ++ + .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-SD-L--PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-CS-C--CTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-hh-h--cccccccccc
Confidence 79999999999985 5643 578999999999999 45654 46899999999998843 32 1 2469999999
Q ss_pred cCCCCCcCCccccCCccCCeeeccccCCCCCCcc-------------------ccCCCCCcEEEcCCCcCCCCCc-----
Q 010856 112 GNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT-------------------FWNLKDILNLNFSSNFLTSPLP----- 167 (499)
Q Consensus 112 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-------------------~~~l~~L~~L~l~~n~l~~~~~----- 167 (499)
+|.+... |. +..+++|+.|++++|.+...+.. +..++.++.+++.+|.......
T Consensus 107 ~n~l~~l-p~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 107 NNQLEKL-PE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp SSCCSSC-CC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred ccccccc-cc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccc
Confidence 9999954 43 67899999999999988765432 2234445555555554432110
Q ss_pred -------------ccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEeCCCCcC
Q 010856 168 -------------LEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLNLSNNNL 234 (499)
Q Consensus 168 -------------~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l 234 (499)
..+..++.|+.+++++|..... + ....++..+.+.++.+... + ...+.+...++..+.+
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~-~---~~~~~l~~~~~~~~~~~~~-~---~~~~~l~~~~~~~~~~ 256 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKTL-P---DLPPSLEALNVRDNYLTDL-P---ELPQSLTFLDVSENIF 256 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC-C---SCCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCC
T ss_pred ccccccccccccccccccccccccccccccccccc-c---ccccccccccccccccccc-c---cccccccccccccccc
Confidence 1112233344444444433211 1 1122333444444433311 1 1122344444443332
Q ss_pred Ccc----------------CcccccCCCCCCEEEccCCcCcccCCCCCCCCCccccccCCCcC
Q 010856 235 SGA----------------IPASLEKLSYLENLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 281 (499)
Q Consensus 235 ~~~----------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~l~~~~l~~N~~ 281 (499)
.+. .......+++|++|++++|+++. +|. .+++++.+++.+|..
T Consensus 257 ~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~-lp~--~~~~L~~L~L~~N~L 316 (353)
T d1jl5a_ 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA--LPPRLERLIASFNHL 316 (353)
T ss_dssp SEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCC
T ss_pred cccccccchhcccccccCccccccccCCCCCEEECCCCccCc-ccc--ccCCCCEEECCCCcC
Confidence 211 01112335799999999999984 554 368899999998864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.69 E-value=2.3e-18 Score=161.07 Aligned_cols=134 Identities=13% Similarity=0.037 Sum_probs=103.0
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCC-CCccccceeEEccccceeeeee
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRH-RNLIKILHGVAVITFTVCLCLF 438 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H-~niv~l~~~~~~~~~~~~~~l~ 438 (499)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ..+.+.+|+++++.++| +|++.+++++.. ....++++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEE
Confidence 4699999999999999999996 479999999986543 23457789999999865 899999888765 33456678
Q ss_pred cccCCCccccccccc-----cccccccccccccceeecc------CCCcccEEEee-----CCCeEEEEEEEeecc
Q 010856 439 HHSSASASASLVSSL-----TLSRPAKGGGFRGCVLWHV------GVDFAAFVFVL-----EPGVEVICFVFEILL 498 (499)
Q Consensus 439 ~~~~~~~~~~l~~~~-----~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~-----~~~~~~~~f~~~~~~ 498 (499)
|++++++...+.... .....++.|++.||+|||+ |+||.||++.. ++.++++|||+++.+
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 888877655543222 2233446888899988776 89999999964 467999999998753
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=5.8e-19 Score=176.04 Aligned_cols=110 Identities=20% Similarity=0.231 Sum_probs=69.5
Q ss_pred CCCEEECcCCCCCccCChhccccccccccEEEcccCCCcc----cCCccccCCCCCCEEeccCCcCCccC----Ccccc-
Q 010856 6 SLTLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISG----GIPEEISNLTNSTIVNLGGNKLNGSI----PITLS- 76 (499)
Q Consensus 6 ~L~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~- 76 (499)
+|++||+++|++++..-...+..++ ++++|+|++|+++. .++.++..+++|++|+|++|.|+... ...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~-~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQ-QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHT-TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCC-CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 5777888888887543222344455 77888888887763 23445667777888888887775321 12222
Q ss_pred CCCCCCeEeccccccccc----CCccccCcccccEEeeecCCCC
Q 010856 77 KLQKLQGLGLEDNKLEGS----IPDDICHLAELYRLDLDGNKLS 116 (499)
Q Consensus 77 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~ 116 (499)
...+|++|+|++|+++.. ++..+..+++|++|++++|.++
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 234678888888777643 2345666777888888777653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=1.2e-17 Score=155.35 Aligned_cols=221 Identities=22% Similarity=0.204 Sum_probs=122.8
Q ss_pred CEEECcCCCCCccCChhccccccccccEEEcccCCCcccCCccccCCCCCCEEeccCCcCCcc-CCccccCCCCCCeEec
Q 010856 8 TLIYLSNNPLDGILPKTSVGNLSHSLEDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGS-IPITLSKLQKLQGLGL 86 (499)
Q Consensus 8 ~~L~L~~n~l~~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L 86 (499)
++|||+++.+...... .+ +...+..+.+..+.+..... ......+|++||++++.++.. ....+.++++|++|+|
T Consensus 3 ~~lDLs~~~l~~~~l~-~l--~~~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLHPDVTG-RL--LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCCHHHHH-HH--HHTTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCCchHHH-HH--HhccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 4788888877532211 11 11235566666655543222 233456788888888877643 2344677788888888
Q ss_pred ccccccccCCccccCcccccEEeeecC-CCCCcC-CccccCCccCCeeecccc-CCCC--CCcccc-CCCCCcEEEcCCC
Q 010856 87 EDNKLEGSIPDDICHLAELYRLDLDGN-KLSGSL-PACFSNLTSLRIVSLGSN-KLTS--VPLTFW-NLKDILNLNFSSN 160 (499)
Q Consensus 87 ~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~-~~~~~~l~~L~~L~L~~n-~l~~--~~~~~~-~l~~L~~L~l~~n 160 (499)
++|.+++..+..+..+++|++|+++++ .++... ...+.++++|++|++++| .+++ +...+. ..++|+.|+++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~ 158 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccc
Confidence 888777666666777778888888774 444211 112345677777777775 3432 222222 2356777776654
Q ss_pred --cCCCC-CcccccCCCCccEEEccCC-cccccCcccccCCcCCceeeCcCC-cCCCCCCccccCCCCCCEEeCCCC
Q 010856 161 --FLTSP-LPLEIGNLKVLIGIDFSMN-NFSGVIPTEIGGLKNLEYLFLGYN-RLQGSIPDSFGDLISLKFLNLSNN 232 (499)
Q Consensus 161 --~l~~~-~~~~~~~l~~L~~L~l~~n-~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~l~~N 232 (499)
.+++. ......++++|+.|++++| .+++.....+..+++|++|++++| .+++.....+..+++|+.|+++++
T Consensus 159 ~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 23221 1112234556666666654 344444455555566666666653 354444444555566666666555
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.1e-16 Score=135.20 Aligned_cols=127 Identities=20% Similarity=0.138 Sum_probs=70.7
Q ss_pred cCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCcee
Q 010856 124 SNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYL 203 (499)
Q Consensus 124 ~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 203 (499)
.+..+|++|+|++|+|+.++..+..+++|+.|++++|.|+.+ ..+..+++|++|++++|+++...+..+..+++|++|
T Consensus 15 ~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp ECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence 344455555555555555554444455555555555555543 234555666666666666655544445556666666
Q ss_pred eCcCCcCCCCCC-ccccCCCCCCEEeCCCCcCCccC---cccccCCCCCCEEE
Q 010856 204 FLGYNRLQGSIP-DSFGDLISLKFLNLSNNNLSGAI---PASLEKLSYLENLN 252 (499)
Q Consensus 204 ~L~~n~l~~~~~-~~l~~l~~L~~L~l~~N~l~~~~---~~~~~~l~~L~~L~ 252 (499)
++++|+++.... ..+..+++|+.|++++|+++... +..+..+|+|+.||
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 666666654321 34566666666666666665332 12455666666665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.64 E-value=1.5e-17 Score=159.53 Aligned_cols=234 Identities=21% Similarity=0.201 Sum_probs=159.6
Q ss_pred cccccccccEEEcccCCCccc----CCccccCCCCCCEEeccCCcCCccC----------CccccCCCCCCeEecccccc
Q 010856 26 VGNLSHSLEDFRMYNCNISGG----IPEEISNLTNSTIVNLGGNKLNGSI----------PITLSKLQKLQGLGLEDNKL 91 (499)
Q Consensus 26 ~~~l~~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----------~~~~~~l~~L~~L~L~~n~l 91 (499)
+.... +|++|+|++|.+... +...+...++|+.|+++++...... ...+..+++|++|+|++|.+
T Consensus 27 L~~~~-~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i 105 (344)
T d2ca6a1 27 LLEDD-SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 105 (344)
T ss_dssp HHHCS-CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HhhCC-CCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccc
Confidence 44444 788888888887643 2334667788888888877654221 12245678899999998888
Q ss_pred cccC----CccccCcccccEEeeecCCCCCcCCc-------------cccCCccCCeeeccccCCCC-----CCccccCC
Q 010856 92 EGSI----PDDICHLAELYRLDLDGNKLSGSLPA-------------CFSNLTSLRIVSLGSNKLTS-----VPLTFWNL 149 (499)
Q Consensus 92 ~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~L~L~~n~l~~-----~~~~~~~l 149 (499)
+... ...+...++|+.|++++|.+...... .....+.|+.+.+++|+++. +...+...
T Consensus 106 ~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~ 185 (344)
T d2ca6a1 106 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185 (344)
T ss_dssp CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred ccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh
Confidence 6542 23345678889999988887521111 11345678889999888874 23345567
Q ss_pred CCCcEEEcCCCcCCCC-----CcccccCCCCccEEEccCCccccc----CcccccCCcCCceeeCcCCcCCCCCCcc---
Q 010856 150 KDILNLNFSSNFLTSP-----LPLEIGNLKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFLGYNRLQGSIPDS--- 217 (499)
Q Consensus 150 ~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~~~~~--- 217 (499)
+.|++|++++|.++.. ....+..+++|+.|++++|.++.. ....+..+++|++|++++|.|++.....
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 8899999999988642 233466778899999999987643 2345677888999999999887542222
Q ss_pred -cc--CCCCCCEEeCCCCcCCccC----ccccc-CCCCCCEEEccCCcCcc
Q 010856 218 -FG--DLISLKFLNLSNNNLSGAI----PASLE-KLSYLENLNLSFNKLEG 260 (499)
Q Consensus 218 -l~--~l~~L~~L~l~~N~l~~~~----~~~~~-~l~~L~~L~l~~N~l~~ 260 (499)
+. ..+.|+.|++++|+|+... ...+. ++++|+.|++++|++..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 22 2467899999999887432 23332 56789999999998863
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2e-16 Score=133.47 Aligned_cols=110 Identities=17% Similarity=0.160 Sum_probs=58.2
Q ss_pred ccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCcc-ccCCCCCc
Q 010856 75 LSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLT-FWNLKDIL 153 (499)
Q Consensus 75 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~l~~L~ 153 (499)
|.++.+|++|+|++|+|+.+ +..+..+++|+.|+|++|+++.. +.|..+++|+.|++++|+++.++.. +..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 44555666666666666633 44445566666666666666643 2355566666666666666655443 23455555
Q ss_pred EEEcCCCcCCCCCc-ccccCCCCccEEEccCCccc
Q 010856 154 NLNFSSNFLTSPLP-LEIGNLKVLIGIDFSMNNFS 187 (499)
Q Consensus 154 ~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~ 187 (499)
+|++++|++++... ..+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCccc
Confidence 55555555543211 23334444444444444443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.62 E-value=9.8e-17 Score=139.95 Aligned_cols=126 Identities=13% Similarity=0.082 Sum_probs=93.1
Q ss_pred ccccccccCCcceEEEEEeCCCCEEEEEEeeccCC------------------ccHHHHHHHHHHHhcCCCCCcccccee
Q 010856 364 SENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCG------------------RAFESFDVECEMMKNIRHRNLIKILHG 425 (499)
Q Consensus 364 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~l~H~niv~l~~~ 425 (499)
.+.+.||+|+||+||+|+..+|+.||||+++.... .......+|.+.+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999988899999998753210 002335678899999999999987654
Q ss_pred EEccccceeeeeecccCCCccccccccccccccccccccccceeecc------CCCcccEEEeeCCCeEEEEEEEeecc
Q 010856 426 VAVITFTVCLCLFHHSSASASASLVSSLTLSRPAKGGGFRGCVLWHV------GVDFAAFVFVLEPGVEVICFVFEILL 498 (499)
Q Consensus 426 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~~~~i~~gl~yLH~------~~~p~~~l~~~~~~~~~~~f~~~~~~ 498 (499)
. ...++++++.+.....+ .......++.|+++|++|||+ |+||.||+++ ++++++||||.++..
T Consensus 83 ~------~~~lvme~~~~~~~~~l--~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~-~~~~~liDFG~a~~~ 152 (191)
T d1zara2 83 E------GNAVLMELIDAKELYRV--RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152 (191)
T ss_dssp E------TTEEEEECCCCEEGGGC--CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEET
T ss_pred c------CCEEEEEeeccccccch--hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee-CCCEEEEECCCcccC
Confidence 2 12457788877654433 223344566888888888766 8999999996 578999999988754
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.60 E-value=1.9e-17 Score=158.87 Aligned_cols=233 Identities=18% Similarity=0.166 Sum_probs=170.0
Q ss_pred CCCCCCEEECcCCCCCccCCh---hccccccccccEEEcccCCCccc----------CCccccCCCCCCEEeccCCcCCc
Q 010856 3 NCKSLTLIYLSNNPLDGILPK---TSVGNLSHSLEDFRMYNCNISGG----------IPEEISNLTNSTIVNLGGNKLNG 69 (499)
Q Consensus 3 ~l~~L~~L~L~~n~l~~~~~~---~~~~~l~~~L~~L~l~~n~i~~~----------~~~~~~~l~~L~~L~L~~n~l~~ 69 (499)
+++.|++|+|++|.+...... ..+...+ +|+.|+++++..... +..++..+++|++|+|++|.++.
T Consensus 29 ~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~-~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 107 (344)
T d2ca6a1 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 107 (344)
T ss_dssp HCSCCCEEECTTSEECHHHHHHHHHTTTTCT-TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred hCCCCCEEECcCCcCCHHHHHHHHHHHHhCC-CCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccc
Confidence 467899999999998654222 1344455 899999998765421 22345678999999999999875
Q ss_pred cCC----ccccCCCCCCeEecccccccccCCcc-------------ccCcccccEEeeecCCCCCcC----CccccCCcc
Q 010856 70 SIP----ITLSKLQKLQGLGLEDNKLEGSIPDD-------------ICHLAELYRLDLDGNKLSGSL----PACFSNLTS 128 (499)
Q Consensus 70 ~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~-------------~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~ 128 (499)
... ..+...++|++|++++|.+....... ....+.|+.+++++|.++... ...+...+.
T Consensus 108 ~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~ 187 (344)
T d2ca6a1 108 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187 (344)
T ss_dssp TTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT
T ss_pred ccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhh
Confidence 432 23456789999999999875321111 134678999999999987432 233456789
Q ss_pred CCeeeccccCCCC------CCccccCCCCCcEEEcCCCcCCCC----CcccccCCCCccEEEccCCcccccCcccc----
Q 010856 129 LRIVSLGSNKLTS------VPLTFWNLKDILNLNFSSNFLTSP----LPLEIGNLKVLIGIDFSMNNFSGVIPTEI---- 194 (499)
Q Consensus 129 L~~L~L~~n~l~~------~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~l---- 194 (499)
|+.|++++|+++. +...+..+++|+.|++++|.++.. +...+..+++|++|++++|.|++.....+
T Consensus 188 L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l 267 (344)
T d2ca6a1 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 267 (344)
T ss_dssp CCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHH
T ss_pred hcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHh
Confidence 9999999999875 234567789999999999998642 23456788999999999999986533333
Q ss_pred c--CCcCCceeeCcCCcCCCCC----Cccc-cCCCCCCEEeCCCCcCCc
Q 010856 195 G--GLKNLEYLFLGYNRLQGSI----PDSF-GDLISLKFLNLSNNNLSG 236 (499)
Q Consensus 195 ~--~l~~L~~L~L~~n~l~~~~----~~~l-~~l~~L~~L~l~~N~l~~ 236 (499)
. ..+.|++|++++|+|+... ...+ .++++|+.|++++|++..
T Consensus 268 ~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 2 2467999999999987532 2233 257899999999999974
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.60 E-value=3e-15 Score=120.01 Aligned_cols=100 Identities=30% Similarity=0.349 Sum_probs=40.6
Q ss_pred eeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCC
Q 010856 132 VSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 211 (499)
Q Consensus 132 L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 211 (499)
|++++|+++.++ .+..+++|++|++++|++++ +|..+..+++|+.|++++|.|++. ..+..+++|++|++++|+++
T Consensus 3 L~Ls~n~l~~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N~i~ 78 (124)
T d1dcea3 3 LHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQ 78 (124)
T ss_dssp EECTTSCCSSCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSSCCC
T ss_pred EEcCCCCCCCCc-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc--CccccccccCeEECCCCccC
Confidence 344444444333 13333444444444444432 222333344444444444444322 12444444444444444444
Q ss_pred CCC-CccccCCCCCCEEeCCCCcCC
Q 010856 212 GSI-PDSFGDLISLKFLNLSNNNLS 235 (499)
Q Consensus 212 ~~~-~~~l~~l~~L~~L~l~~N~l~ 235 (499)
+.. ...+..+++|+.|++++|+++
T Consensus 79 ~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 79 QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCchhhcCCCCCCEEECCCCcCC
Confidence 322 133444445555555555443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.60 E-value=2.3e-15 Score=120.65 Aligned_cols=87 Identities=22% Similarity=0.195 Sum_probs=41.2
Q ss_pred ccCCccCCeeeccccCCCCCCccccCCCCCcEEEcCCCcCCCCCcccccCCCCccEEEccCCcccccC-cccccCCcCCc
Q 010856 123 FSNLTSLRIVSLGSNKLTSVPLTFWNLKDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMNNFSGVI-PTEIGGLKNLE 201 (499)
Q Consensus 123 ~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~l~~l~~L~ 201 (499)
+..+++|++|++++|+++++|..+..+++|+.|++++|.+++. + .+..+++|+.|++++|+++... ...+..+++|+
T Consensus 16 l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~ 93 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 93 (124)
T ss_dssp GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC
T ss_pred cccCCCCCEEECCCCccCcchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCCC
Confidence 3444444444444444444444444444444444444444432 1 2444455555555555554332 13345555555
Q ss_pred eeeCcCCcCC
Q 010856 202 YLFLGYNRLQ 211 (499)
Q Consensus 202 ~L~L~~n~l~ 211 (499)
.|++++|+++
T Consensus 94 ~L~l~~N~i~ 103 (124)
T d1dcea3 94 LLNLQGNSLC 103 (124)
T ss_dssp EEECTTSGGG
T ss_pred EEECCCCcCC
Confidence 5555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=2.3e-16 Score=146.57 Aligned_cols=221 Identities=15% Similarity=0.159 Sum_probs=160.8
Q ss_pred cEEEcccCCCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEeccccccccc-CCccccCcccccEEeeec
Q 010856 34 EDFRMYNCNISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGS-IPDDICHLAELYRLDLDG 112 (499)
Q Consensus 34 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~ 112 (499)
++||++++.+.......+.. ..+..+.++...+.... .......+|++||+++|.++.. ....+..+++|++|++++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 46889888775322222211 23456666666655322 2234557899999999988644 344578899999999999
Q ss_pred CCCCCcCCccccCCccCCeeecccc-CCCC--CCccccCCCCCcEEEcCCC-cCCCC-Cccccc-CCCCccEEEccCCc-
Q 010856 113 NKLSGSLPACFSNLTSLRIVSLGSN-KLTS--VPLTFWNLKDILNLNFSSN-FLTSP-LPLEIG-NLKVLIGIDFSMNN- 185 (499)
Q Consensus 113 n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~--~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~-~l~~L~~L~l~~n~- 185 (499)
|.+++.....+..+++|+.|++++| .+++ +......+++|++|+++++ .+++. ....+. ..+.|+.|+++++.
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 9998777778888999999999996 5664 3334567899999999996 44431 112222 34789999999763
Q ss_pred -cccc-CcccccCCcCCceeeCcCC-cCCCCCCccccCCCCCCEEeCCCC-cCCccCcccccCCCCCCEEEccCC
Q 010856 186 -FSGV-IPTEIGGLKNLEYLFLGYN-RLQGSIPDSFGDLISLKFLNLSNN-NLSGAIPASLEKLSYLENLNLSFN 256 (499)
Q Consensus 186 -l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N 256 (499)
++.. ....+..+++|++|++++| .+++.....+..+++|++|++++| .+++.....+..+++|+.|+++++
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 4432 2223357899999999986 477777788899999999999995 688777778889999999999987
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=1.3e-16 Score=158.70 Aligned_cols=159 Identities=16% Similarity=0.025 Sum_probs=112.6
Q ss_pred cCCccCCeeeccccCCCCC-----CccccCCCCCcEEEcCCCcCCCCCccc-----ccCCCCccEEEccCCcccccCccc
Q 010856 124 SNLTSLRIVSLGSNKLTSV-----PLTFWNLKDILNLNFSSNFLTSPLPLE-----IGNLKVLIGIDFSMNNFSGVIPTE 193 (499)
Q Consensus 124 ~~l~~L~~L~L~~n~l~~~-----~~~~~~l~~L~~L~l~~n~l~~~~~~~-----~~~l~~L~~L~l~~n~l~~~~~~~ 193 (499)
.....++.+++++|.+... ...+...+.++.+++++|.+++..... ......|+.+++++|.++......
T Consensus 252 ~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~ 331 (460)
T d1z7xw1 252 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH 331 (460)
T ss_dssp STTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhh
Confidence 3456899999999998752 234566889999999999986422211 123468999999999987654333
Q ss_pred c----cCCcCCceeeCcCCcCCCCC----Cccc-cCCCCCCEEeCCCCcCCcc----CcccccCCCCCCEEEccCCcCcc
Q 010856 194 I----GGLKNLEYLFLGYNRLQGSI----PDSF-GDLISLKFLNLSNNNLSGA----IPASLEKLSYLENLNLSFNKLEG 260 (499)
Q Consensus 194 l----~~l~~L~~L~L~~n~l~~~~----~~~l-~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~ 260 (499)
+ ...++|++|+|++|++++.. +..+ ...+.|+.|+|++|+|+.. ++..+..+++|++|+|++|+++.
T Consensus 332 l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 332 FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred cccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 3 45678999999999987532 2233 2467899999999999853 34556778999999999999974
Q ss_pred cCCCC------CCCCCccccccCCCcCC
Q 010856 261 EIPRG------GSFGNFSAESFEGNELL 282 (499)
Q Consensus 261 ~~~~~------~~~~~l~~~~l~~N~~~ 282 (499)
..... .....++.+.+.+|.+.
T Consensus 412 ~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 412 AGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 21110 11235778888887754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.53 E-value=8.3e-16 Score=148.29 Aligned_cols=137 Identities=12% Similarity=0.118 Sum_probs=95.2
Q ss_pred hhcccccccccCCcceEEEEEe-CCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-----------CCCccccceeEEc
Q 010856 361 DEFSENNLIGKGGFGSVYKARL-GDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-----------HRNLIKILHGVAV 428 (499)
Q Consensus 361 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------H~niv~l~~~~~~ 428 (499)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3499999999999999999996 579999999997543 23467889999988775 5788999888754
Q ss_pred ccc-ceeeeeecccCCCc-cccc------cccccccccccccccccceeecc-------CCCcccEEEeeCCC------e
Q 010856 429 ITF-TVCLCLFHHSSASA-SASL------VSSLTLSRPAKGGGFRGCVLWHV-------GVDFAAFVFVLEPG------V 487 (499)
Q Consensus 429 ~~~-~~~~~l~~~~~~~~-~~~l------~~~~~~~~~~~~~i~~gl~yLH~-------~~~p~~~l~~~~~~------~ 487 (499)
... ....++..+..++. .... .......+.++.|+++||+|||+ |+||+||+++.++. +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 222 22222222222221 1111 11222344556899999988875 78999999986654 9
Q ss_pred EEEEEEEeecc
Q 010856 488 EVICFVFEILL 498 (499)
Q Consensus 488 ~~~~f~~~~~~ 498 (499)
+++|||.+...
T Consensus 172 kl~dfg~s~~~ 182 (362)
T d1q8ya_ 172 KIADLGNACWY 182 (362)
T ss_dssp EECCCTTCEET
T ss_pred eEeeccccccc
Confidence 99999988653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=8.9e-14 Score=116.17 Aligned_cols=108 Identities=22% Similarity=0.162 Sum_probs=64.8
Q ss_pred CCCcEEEcCCCcCCCCCcccccCCCCccEEEccCC-cccccCcccccCCcCCceeeCcCCcCCCCCCccccCCCCCCEEe
Q 010856 150 KDILNLNFSSNFLTSPLPLEIGNLKVLIGIDFSMN-NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPDSFGDLISLKFLN 228 (499)
Q Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 228 (499)
...+.++.+++.+.. .|..+..+++|+.|++++| .++.+.+..|.++++|+.|+|++|+|+.+.+..|..+++|+.|+
T Consensus 8 ~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 344556666666653 3445566666666666544 36655556666666666666666666666566666666666666
Q ss_pred CCCCcCCccCcccccCCCCCCEEEccCCcCc
Q 010856 229 LSNNNLSGAIPASLEKLSYLENLNLSFNKLE 259 (499)
Q Consensus 229 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 259 (499)
|++|+|+...+..|..+ +|+.|+|++|++.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCccc
Confidence 66666665444444433 4666666666654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.46 E-value=2.9e-16 Score=137.29 Aligned_cols=86 Identities=23% Similarity=0.267 Sum_probs=35.9
Q ss_pred cccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeeccccCCCCCCccccCCCCCc
Q 010856 74 TLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPLTFWNLKDIL 153 (499)
Q Consensus 74 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~ 153 (499)
.+..+++|++|+|++|+|+.+ +.+..+++|++|++++|+++. ++..+..+++|+.|++++|+++.++ .+..+++|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l~-~~~~l~~L~ 118 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASLS-GIEKLVNLR 118 (198)
T ss_dssp HHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCHH-HHHHHHHSS
T ss_pred HHhcccccceeECcccCCCCc--ccccCCccccChhhccccccc-ccccccccccccccccccccccccc-ccccccccc
Confidence 344444455555555544422 124444444444444444442 2222222334444444444444432 233334444
Q ss_pred EEEcCCCcCC
Q 010856 154 NLNFSSNFLT 163 (499)
Q Consensus 154 ~L~l~~n~l~ 163 (499)
.|++++|+++
T Consensus 119 ~L~L~~N~i~ 128 (198)
T d1m9la_ 119 VLYMSNNKIT 128 (198)
T ss_dssp EEEESEEECC
T ss_pred ccccccchhc
Confidence 4444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.46 E-value=5.3e-16 Score=135.60 Aligned_cols=126 Identities=21% Similarity=0.246 Sum_probs=86.7
Q ss_pred cccEEEcccC--CCcccCCccccCCCCCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEe
Q 010856 32 SLEDFRMYNC--NISGGIPEEISNLTNSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLD 109 (499)
Q Consensus 32 ~L~~L~l~~n--~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 109 (499)
.++.+++.+. .+. ..+.++..+++|++|+|++|+|+.+ + .+.++++|+.|+|++|.++. ++..+..+++|+.|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEE
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-ccccccccccccccc
Confidence 4555666543 233 3456677788888888888888744 3 47778888888888888773 344445566788888
Q ss_pred eecCCCCCcCCccccCCccCCeeeccccCCCCCCc--cccCCCCCcEEEcCCCcCC
Q 010856 110 LDGNKLSGSLPACFSNLTSLRIVSLGSNKLTSVPL--TFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 110 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~~l~~L~~L~l~~n~l~ 163 (499)
+++|+++.. ..+..+++|+.|++++|++++++. .+..+++|+.|++++|.+.
T Consensus 100 l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 100 ISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp CSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 888888753 346677888888888888877653 4666677777777766654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=1.3e-13 Score=115.12 Aligned_cols=106 Identities=22% Similarity=0.145 Sum_probs=59.9
Q ss_pred CCEEeccCCcCCccCCccccCCCCCCeEecccc-cccccCCccccCcccccEEeeecCCCCCcCCccccCCccCCeeecc
Q 010856 57 STIVNLGGNKLNGSIPITLSKLQKLQGLGLEDN-KLEGSIPDDICHLAELYRLDLDGNKLSGSLPACFSNLTSLRIVSLG 135 (499)
Q Consensus 57 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 135 (499)
.+.++.+++.+. ..|..+..+++|++|++++| .++.+.+..|.++++|+.|++++|+|+.+.+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555555554 23444555556666666544 3555555556666666666666666665555666666666666666
Q ss_pred ccCCCCCCccccCCCCCcEEEcCCCcCC
Q 010856 136 SNKLTSVPLTFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 136 ~n~l~~~~~~~~~l~~L~~L~l~~n~l~ 163 (499)
+|+++.+|.......+|+.|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCcccChhhhccccccccccCCCccc
Confidence 6666665554444445566666666553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.74 E-value=3.8e-10 Score=94.35 Aligned_cols=64 Identities=25% Similarity=0.178 Sum_probs=24.9
Q ss_pred CCCCCcEEEcCCCcCCCCC--cccccCCCCccEEEccCCcccccCcccccCCcCCceeeCcCCcCC
Q 010856 148 NLKDILNLNFSSNFLTSPL--PLEIGNLKVLIGIDFSMNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 211 (499)
Q Consensus 148 ~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 211 (499)
.+++|++|+|++|+|+.+. +..+..+++|+.|++++|.|+...+-.+....+|+.|++++|++.
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 3444444444444444321 122233344444444444443322212222233444444444443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=6.3e-10 Score=92.95 Aligned_cols=103 Identities=18% Similarity=0.142 Sum_probs=49.5
Q ss_pred CCCEEeccCCcCCccCCccccCCCCCCeEecccccccccCCccccCcccccEEeeecCCCCCcC--CccccCCccCCeee
Q 010856 56 NSTIVNLGGNKLNGSIPITLSKLQKLQGLGLEDNKLEGSIPDDICHLAELYRLDLDGNKLSGSL--PACFSNLTSLRIVS 133 (499)
Q Consensus 56 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~ 133 (499)
..+.|+++++... ..+..+..+..++..++... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666554422 12333344444444444332 22333445666666666666666432 22344556666666
Q ss_pred ccccCCCCCCc-cccCCCCCcEEEcCCCcCC
Q 010856 134 LGSNKLTSVPL-TFWNLKDILNLNFSSNFLT 163 (499)
Q Consensus 134 L~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~ 163 (499)
+++|+|++++. .......|+.|++++|.+.
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcC
Confidence 66666665443 1222334455555555444
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.07 E-value=8e-07 Score=73.91 Aligned_cols=88 Identities=18% Similarity=0.054 Sum_probs=48.9
Q ss_pred ccCCCCccEEEccCCcccccC----cccccCCcCCceeeCcCCcCCCC----CCccccCCCCCCEEeCCCCcCCcc----
Q 010856 170 IGNLKVLIGIDFSMNNFSGVI----PTEIGGLKNLEYLFLGYNRLQGS----IPDSFGDLISLKFLNLSNNNLSGA---- 237 (499)
Q Consensus 170 ~~~l~~L~~L~l~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~---- 237 (499)
+...+.|+.|++++|.+.... ...+...+.|++|+|++|.+++. +...+...++|++|++++|.+...
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~ 119 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 119 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence 334455555555555554221 22334456677777777766642 123355566777777777755422
Q ss_pred ---CcccccCCCCCCEEEccCCc
Q 010856 238 ---IPASLEKLSYLENLNLSFNK 257 (499)
Q Consensus 238 ---~~~~~~~l~~L~~L~l~~N~ 257 (499)
+...+...++|+.|+++++.
T Consensus 120 ~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 120 EMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHHhCCCccEeeCcCCC
Confidence 23444556777777776654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.96 E-value=1.2e-06 Score=72.88 Aligned_cols=62 Identities=10% Similarity=-0.067 Sum_probs=33.2
Q ss_pred CCCCccEEEccCCccccc----CcccccCCcCCceeeCcCCcCCCC-------CCccccCCCCCCEEeCCCCc
Q 010856 172 NLKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFLGYNRLQGS-------IPDSFGDLISLKFLNLSNNN 233 (499)
Q Consensus 172 ~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~~-------~~~~l~~l~~L~~L~l~~N~ 233 (499)
..+.|+.|++++|.++.. +...+...++|++|++++|.+... +...+...++|+.|+++.+.
T Consensus 70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 344555555555555432 122344556677777766654432 12334455777777776654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.56 E-value=7.9e-06 Score=67.63 Aligned_cols=88 Identities=17% Similarity=0.154 Sum_probs=47.4
Q ss_pred cCCCCccEEEccCCcccccC----cccccCCcCCceeeCcCCcCCCC----CCccccCCCCCCEEeC--CCCcCCc----
Q 010856 171 GNLKVLIGIDFSMNNFSGVI----PTEIGGLKNLEYLFLGYNRLQGS----IPDSFGDLISLKFLNL--SNNNLSG---- 236 (499)
Q Consensus 171 ~~l~~L~~L~l~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~l--~~N~l~~---- 236 (499)
...++|++|++++|.++... ...+...++++.+++++|.+... +...+...++|+.++| ++|++..
T Consensus 43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~ 122 (166)
T d1io0a_ 43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 122 (166)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence 34455555555555554321 12234456667777776666532 1234555667776544 4555643
Q ss_pred cCcccccCCCCCCEEEccCCcC
Q 010856 237 AIPASLEKLSYLENLNLSFNKL 258 (499)
Q Consensus 237 ~~~~~~~~l~~L~~L~l~~N~l 258 (499)
.+...+...++|+.|+++.+..
T Consensus 123 ~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 123 EIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCCCcCEEeCcCCCC
Confidence 2334455677777777766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.43 E-value=1.2e-05 Score=66.39 Aligned_cols=87 Identities=13% Similarity=0.089 Sum_probs=42.7
Q ss_pred CCCCCcEEEcCCCcCCCC----CcccccCCCCccEEEccCCccccc----CcccccCCcCCceeeC--cCCcCCCC----
Q 010856 148 NLKDILNLNFSSNFLTSP----LPLEIGNLKVLIGIDFSMNNFSGV----IPTEIGGLKNLEYLFL--GYNRLQGS---- 213 (499)
Q Consensus 148 ~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L--~~n~l~~~---- 213 (499)
..+.|++|++++|.++.. +...+...+.++.+++++|.+... +...+...++|+.++| ++|.+...
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 344444455544444321 111233345555555555555422 1234455666665444 45555431
Q ss_pred CCccccCCCCCCEEeCCCCcC
Q 010856 214 IPDSFGDLISLKFLNLSNNNL 234 (499)
Q Consensus 214 ~~~~l~~l~~L~~L~l~~N~l 234 (499)
+...+...++|+.|+++.+..
T Consensus 124 La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCCCcCEEeCcCCCC
Confidence 233445667778887776643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=95.73 E-value=0.0039 Score=54.72 Aligned_cols=88 Identities=15% Similarity=0.029 Sum_probs=51.0
Q ss_pred HHHHHHhhhcccccccccCCcceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCccccceeEEccccc
Q 010856 354 LELFRATDEFSENNLIGKGGFGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR-HRNLIKILHGVAVITFT 432 (499)
Q Consensus 354 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H~niv~l~~~~~~~~~~ 432 (499)
.++....+.|...+..+-++-+.||+... +++.+.+|+...........+.+|...+..+. +--+.+++++.... .
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-~- 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-G- 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-T-
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC-C-
Confidence 34555556677666544455578998865 55677888886554444455778888876553 32245555544332 2
Q ss_pred eeeeeecccCCC
Q 010856 433 VCLCLFHHSSAS 444 (499)
Q Consensus 433 ~~~~l~~~~~~~ 444 (499)
..+++++++.|.
T Consensus 84 ~~~lv~~~l~G~ 95 (263)
T d1j7la_ 84 WSNLLMSEADGV 95 (263)
T ss_dssp EEEEEEECCSSE
T ss_pred ceEEEEEecccc
Confidence 223355555543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=86.78 E-value=0.54 Score=39.88 Aligned_cols=71 Identities=13% Similarity=-0.006 Sum_probs=42.6
Q ss_pred cccCCc-ceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC--ccccceeEEccccceeeeeecccCCC
Q 010856 369 IGKGGF-GSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIRHRN--LIKILHGVAVITFTVCLCLFHHSSAS 444 (499)
Q Consensus 369 lg~G~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H~n--iv~l~~~~~~~~~~~~~~l~~~~~~~ 444 (499)
+..|.. +.||+....++..+.+|.-..... ..+.+|.+.++.+.... +.+++++.... . ..+++++++.|.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-~-~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEA-G-RDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-S-CEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccc-c-ceEEEEEeeecc
Confidence 344443 678999887787788887654432 34677888777653322 44555554432 2 234566777654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=81.75 E-value=0.51 Score=42.06 Aligned_cols=41 Identities=17% Similarity=0.165 Sum_probs=31.6
Q ss_pred cceEEEEEeCCCCEEEEEEeeccCCccHHHHHHHHHHHhcCC
Q 010856 374 FGSVYKARLGDRMEVAVKVFNLQCGRAFESFDVECEMMKNIR 415 (499)
Q Consensus 374 ~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~ 415 (499)
--.||+++.++|+.|++|+..... ...+++..|.+.+..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLV 75 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHH
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHH
Confidence 358999998899999999987653 23466888888877664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=80.69 E-value=0.96 Score=41.38 Aligned_cols=60 Identities=12% Similarity=0.139 Sum_probs=36.3
Q ss_pred ccccccCCcceEEEEEeC-CCCEEEEEEeeccC-------CccHHHHHHHHHHHhcC-CC--CCcccccee
Q 010856 366 NNLIGKGGFGSVYKARLG-DRMEVAVKVFNLQC-------GRAFESFDVECEMMKNI-RH--RNLIKILHG 425 (499)
Q Consensus 366 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l-~H--~niv~l~~~ 425 (499)
.+.+|.|....||+.... +++.|.+|.-.... ....++...|.+.++.+ .+ ..+.+++++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 346899999999999864 46788898754311 11234556788777654 22 345555543
|